Citrus Sinensis ID: 007266
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 610 | 2.2.26 [Sep-21-2011] | |||||||
| Q2QMH1 | 591 | Serine/threonine-protein | yes | no | 0.957 | 0.988 | 0.650 | 0.0 | |
| A2ZMH2 | 591 | Serine/threonine-protein | N/A | no | 0.959 | 0.989 | 0.648 | 0.0 | |
| Q10GB1 | 599 | Serine/threonine-protein | no | no | 0.967 | 0.984 | 0.621 | 0.0 | |
| Q9CAU7 | 606 | Serine/threonine-protein | yes | no | 0.959 | 0.965 | 0.599 | 0.0 | |
| Q8RXT4 | 555 | Serine/threonine-protein | no | no | 0.885 | 0.972 | 0.582 | 0.0 | |
| Q6ZEZ5 | 585 | Serine/threonine-protein | no | no | 0.955 | 0.996 | 0.606 | 0.0 | |
| Q9SLI2 | 612 | Serine/threonine-protein | no | no | 0.934 | 0.931 | 0.609 | 0.0 | |
| Q8RX66 | 568 | Serine/threonine-protein | no | no | 0.893 | 0.959 | 0.584 | 1e-180 | |
| Q0WPH8 | 956 | Serine/threonine-protein | no | no | 0.429 | 0.274 | 0.732 | 1e-125 | |
| Q94CU5 | 943 | Serine/threonine-protein | no | no | 0.429 | 0.277 | 0.721 | 1e-121 |
| >sp|Q2QMH1|NEK2_ORYSJ Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. japonica GN=NEK2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/615 (65%), Positives = 457/615 (74%), Gaps = 31/615 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M+QYEVLEQIGKG+FGSALLVRHK E+KKYVLKKIRLARQTDR RRSAHQEM+LI+ VRN
Sbjct: 1 MDQYEVLEQIGKGAFGSALLVRHKLEKKKYVLKKIRLARQTDRTRRSAHQEMQLIATVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCI+IGYCEGGDMAEAIK+ANG +F EEKLCKWLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGTYFSEEKLCKWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIF+ RDQ IRLGDFGLAK+L SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFIARDQSIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
G+KSDIWSLGCC+YEM+A + AFKAFDMQALINKI KSIV+PLPT YSGAFRGL+KSMLR
Sbjct: 181 GTKSDIWSLGCCIYEMTALRPAFKAFDMQALINKITKSIVSPLPTKYSGAFRGLIKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSN-FKKTRFMEPEAISI 299
K+PE RPSAA+LL HP LQPYVL + LK + P RN P+ S ++ KK F S
Sbjct: 241 KSPEHRPSAAQLLKHPQLQPYVLQVQLK-SSPTRNILPIHQSLTDKVKKMTFPSDVVDSA 299
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNY-MNQKFKELSIGVVHEELGV 358
+R S N+R + S E++S+SST R+ Y Q K LS+ E G
Sbjct: 300 RRRMARRNSLGNERTVTFSKPSPERNSVSST---RSIKEYTTTQSVKGLSVD--SSEAGD 354
Query: 359 DMSTTPNVCNAG---KTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSR 415
++++ + +TP+ PAK + T R Q P K ++ + R LP P K +R
Sbjct: 355 EVTSKAIITKTSSILRTPKSLPAK-TYTARNQLEPPKTSYNRTYRSELPSKTTP-NKIAR 412
Query: 416 PARRASLPLTTTRASESHYQPITCIMKSPDVSVNAPRIDKIAEFPLASSEDPLLPI-PKT 474
PARRASLPL+T I + SPDVSVNAPRID+IAEFPLASSEDPLLPI K
Sbjct: 413 PARRASLPLSTYETPTKRSISILEQLDSPDVSVNAPRIDRIAEFPLASSEDPLLPIHNKL 472
Query: 475 SSTSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPAT 534
S C S+P I+ SITKDKCTIQV+ T G NGS+ S N AT
Sbjct: 473 SPGHGSC--STPPFINRSITKDKCTIQVL------------RTDG--DNGSDSSGRN-AT 515
Query: 535 GVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSP 594
SS S +S+ +RFDTSSFQQRAEALEGLLEFSA+LLQQER+EELG+LLKPFGPEK SP
Sbjct: 516 AASSRGSNDSRQQRFDTSSFQQRAEALEGLLEFSAQLLQQERYEELGILLKPFGPEKASP 575
Query: 595 RETAIWLAKSFKETA 609
RETAIWL KSFKETA
Sbjct: 576 RETAIWLTKSFKETA 590
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2ZMH2|NEK2_ORYSI Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. indica GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 749 bits (1934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/614 (64%), Positives = 456/614 (74%), Gaps = 29/614 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M+QYEVLEQIGKG+FGSALLVRHK E+KKYVLKKIRLARQTDR RRSAHQEM+LI+ VRN
Sbjct: 1 MDQYEVLEQIGKGAFGSALLVRHKLEKKKYVLKKIRLARQTDRTRRSAHQEMQLIATVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCI+IGYCEGGDMAEAIK+ANG +F EEKLCKWLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGTYFSEEKLCKWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIF+ RDQ IRLGDFGLAK+L SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFIARDQSIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
G+KSDIWSLGCC+YEM+A + AFKAFDMQALINKI KSIV+PLPT YSGAFRGL+KSMLR
Sbjct: 181 GTKSDIWSLGCCIYEMTALRPAFKAFDMQALINKITKSIVSPLPTKYSGAFRGLIKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSN-FKKTRFMEPEAISI 299
K+PE RPSAA+LL HP LQPYVL + LK + P RN P+ S ++ KK F S
Sbjct: 241 KSPEHRPSAAQLLKHPQLQPYVLQVQLK-SSPTRNILPIHQSLTDKVKKMTFPSDVVDSA 299
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
+R S N+R + S E++S+SST R+ Y + E + V E G +
Sbjct: 300 RRRMARRNSLGNERTVTFSKPSPERNSVSST---RSIKEYTTTQSVE-GLSVDSSEAGDE 355
Query: 360 MSTTPNVCNAG---KTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRP 416
+++ + +TP+ PAK + T R Q P K ++ + R LP P K +RP
Sbjct: 356 VTSKAIITKTSSILRTPKSLPAK-TYTARNQLEPPKTSYNRTYRSELPSKTTP-NKIARP 413
Query: 417 ARRASLPLTTTRASESHYQPITCIMKSPDVSVNAPRIDKIAEFPLASSEDPLLPI-PKTS 475
ARRASLPL+T I + SPDVSVNAPRID+IAEFPLASSEDPLLPI K S
Sbjct: 414 ARRASLPLSTYETPTKRSISILEQLDSPDVSVNAPRIDRIAEFPLASSEDPLLPIHNKLS 473
Query: 476 STSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATG 535
C S+P I+ SITKDKCTIQV+ T G NGS+ S N AT
Sbjct: 474 PGHGSC--STPPFINRSITKDKCTIQVL------------RTDG--DNGSDSSGRN-ATA 516
Query: 536 VSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPR 595
SS S +S+ +RFDTSSFQQRAEALEGLLEFSA+LLQQER+EELG+LLKPFGPEK SPR
Sbjct: 517 ASSRGSNDSRQQRFDTSSFQQRAEALEGLLEFSAQLLQQERYEELGILLKPFGPEKASPR 576
Query: 596 ETAIWLAKSFKETA 609
ETAIWL KSFKETA
Sbjct: 577 ETAIWLTKSFKETA 590
|
May be involved in plant development processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10GB1|NEK1_ORYSJ Serine/threonine-protein kinase Nek1 OS=Oryza sativa subsp. japonica GN=NEK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 704 bits (1816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/619 (62%), Positives = 450/619 (72%), Gaps = 29/619 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYEVLEQIGKG+FGSALLVRHK E+KKYVLKKIRLARQTDR RRSAHQEM+LI+ VRN
Sbjct: 1 MEQYEVLEQIGKGAFGSALLVRHKVEKKKYVLKKIRLARQTDRTRRSAHQEMQLIATVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK+A G HF EEKLCKWLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKRATGDHFSEEKLCKWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIFLTRDQ IRLGDFGLAK+L SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTRDQSIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
G+KSDIWSLGCC+YEM+A + AFKAFDMQALI+KI KSIV+PLPT YSGAFRGL+KSMLR
Sbjct: 181 GTKSDIWSLGCCIYEMTALRPAFKAFDMQALISKITKSIVSPLPTRYSGAFRGLIKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIH 300
K+PE RPSAAELL HPHLQPYVL +HLK + P RN P S K + M S+
Sbjct: 241 KSPEHRPSAAELLKHPHLQPYVLQVHLK-SSPARNIIPSH--QSPIDKVKKMTFPTESMC 297
Query: 301 SNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGV-VHEELGVD 359
++ +R S N+R + S E+ SS + + + K+LSI V + EE+
Sbjct: 298 RSKGRRNSLGNERIVTFSKPSPERKFTSSIQSIKDYST--TRSVKDLSIDVSLVEEVSSK 355
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARR 419
+ T + KTP+ TP+K TP Q P K ++ R L +S P + +R RR
Sbjct: 356 TTFTTRTSSIVKTPKRTPSKTITTP--QLEPPKVSYNRVNRSEL-LSRTPVNRSARVIRR 412
Query: 420 ASLPLTTTRASESHYQPITCI-----MKSPDVSVNAPRIDKIAEFPLASSEDPLLPIPKT 474
ASLPL +SE+ + ++ I ++SPDVSVN+PRID+IAEFPLASSEDP P K
Sbjct: 413 ASLPLPLP-SSETPKRGVSSISILEQLESPDVSVNSPRIDRIAEFPLASSEDP--PFLKL 469
Query: 475 SSTSACCSSSSPDSIDCSITKDKCTIQ---VMDRTASRPNFVVHTTHGTIQNGSEFSEPN 531
+ + ID SITKDKC ++ ++D V G + S +
Sbjct: 470 HGRRSPTPTPQHCVIDQSITKDKCMVEAFHIID---------VDDDDGRSDSSSGRNNAA 520
Query: 532 PATGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEK 591
A + SS ++ RRFDTSS+QQRAEALEGLLEFSA+LLQQER++ELGVLLKPFGPEK
Sbjct: 521 AAASSRAGSSESTRQRRFDTSSYQQRAEALEGLLEFSAQLLQQERYDELGVLLKPFGPEK 580
Query: 592 VSPRETAIWLAKSFKETAV 610
VSPRETAIWL KSFKET +
Sbjct: 581 VSPRETAIWLTKSFKETGL 599
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAU7|NEK2_ARATH Serine/threonine-protein kinase Nek2 OS=Arabidopsis thaliana GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 690 bits (1781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/622 (59%), Positives = 437/622 (70%), Gaps = 37/622 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME YEVLEQIGKGSFGSALLVRHKHE+K YVLKKIRLARQT R RRSAHQEMELIS++ N
Sbjct: 1 MENYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIHN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCIIIGYC+GGDMAEAIKK NGVHF EEKLCKWLVQ+L+AL YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCKGGDMAEAIKKTNGVHFTEEKLCKWLVQILLALEYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIFLT+DQDIRLGDFGLAK+L SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKVLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K AFKAFDMQ LIN+IN+SIV PLP YS AFRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMTAMKPAFKAFDMQGLINRINRSIVPPLPAQYSAAFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDS-NFKKTRFMEPEAISI 299
KNPE RPSAAELL P LQPY+ IHLK+N P N P +W +S + ++ F E
Sbjct: 241 KNPELRPSAAELLRQPLLQPYIQKIHLKVNDPGSNVLPAQWPESESARRNSFPE------ 294
Query: 300 HSNREKRQSFSNDRALNPS-VSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGV 358
++R+ + PS +DS+SS + Y+N +E + + + G
Sbjct: 295 ----QRRRPAGKSHSFGPSRFRGNLEDSVSSI--KKTVPAYLN---RERQVDLSTDASG- 344
Query: 359 DMSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHN-PGGKPSRPA 417
D + A K+ R P + SA+P R P + +G LP+S KP+
Sbjct: 345 DGTVVRRTSEASKSSRYVPVRASASPVRPRQP--RSDLG----QLPVSSQLKNRKPAALI 398
Query: 418 RRASLPLTTTRASE---SHYQPITCIM---KSPDVSVNAPRIDKIAEFPLAS-SEDPLLP 470
RRAS+P + A E S Y T + SPDVS+NAPRIDKI EFPLAS E+P +P
Sbjct: 399 RRASMPSSRKPAKEIKDSLYISKTSFLHQINSPDVSMNAPRIDKI-EFPLASYEEEPFVP 457
Query: 471 I----PKTSSTSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSE 526
+ K +S+ S +DCSITKDK T++ V+ +++ SE
Sbjct: 458 VVRGKKKKASSRGSYSPPPEPPLDCSITKDKFTLEPGQNREGAIMKAVYEEDAYLEDRSE 517
Query: 527 FSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKP 586
S+ N G SS +S + +RFD SS+QQRAEALEGLLEFSARLLQ ER++EL VLL+P
Sbjct: 518 SSDQNATAGASSRASSGVRRQRFDPSSYQQRAEALEGLLEFSARLLQDERYDELNVLLRP 577
Query: 587 FGPEKVSPRETAIWLAKSFKET 608
FGP KVSPRETAIWL+KSFKET
Sbjct: 578 FGPGKVSPRETAIWLSKSFKET 599
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXT4|NEK4_ARATH Serine/threonine-protein kinase Nek4 OS=Arabidopsis thaliana GN=NEK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 687 bits (1773), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/625 (58%), Positives = 432/625 (69%), Gaps = 85/625 (13%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME+YEVLEQIGKGSFGSALLVRHK ERKKYVLKKIRLARQ+DRARRSAHQEMELIS VRN
Sbjct: 1 MERYEVLEQIGKGSFGSALLVRHKQERKKYVLKKIRLARQSDRARRSAHQEMELISTVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PF+VEYKDSWVEKGCYVCI+IGYC+GGDM + IK+A GVHFPEEKLC+WLVQLLMAL+YL
Sbjct: 61 PFVVEYKDSWVEKGCYVCIVIGYCQGGDMTDTIKRACGVHFPEEKLCQWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H+NHILHRDVKCSNIFLT++QDIRLGDFGLAK+L SDDL SSVVGTPSYMCPELLADIPY
Sbjct: 121 HSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K FKA D+Q LI KI+K I+ P+P +YSG+FRGL+KSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMAAHKPPFKASDVQTLITKIHKLIMDPIPAMYSGSFRGLIKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWS--DSNFKKTRFMEPEAIS 298
KNPE RPSA ELL HPHLQPY+ +++KL PRR+TFPL++S D+ K+ R
Sbjct: 241 KNPELRPSANELLNHPHLQPYISMVYMKLESPRRSTFPLQFSERDATLKERR-------- 292
Query: 299 IHSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGV 358
R SFSNDR LNPSVS+TE S+SS+ + + +K E+++GVV EE+
Sbjct: 293 -------RSSFSNDRRLNPSVSDTEAGSVSSSGKASPTPMFNGRKVSEVTVGVVREEIVP 345
Query: 359 D-MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPA 417
A +TPR+ A+ +R K + + +S+ P+
Sbjct: 346 QRQEEAKKQSGAARTPRVAGTSAKASTQRTVF---------KHELMKVSN-----PTERR 391
Query: 418 RRASLPLTTTRASESHYQPIT--CIMKSPDVSVNAPRIDKIAEFP----------LASSE 465
RR SLPL ++ IT C + SPDVSVN PR DKIAEFP AS
Sbjct: 392 RRVSLPLVVENPY-TYESDITALCSLNSPDVSVNTPRFDKIAEFPEDIFQNQNRETASRR 450
Query: 466 DPLLPIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGS 525
+ + + S +S C D+ + SITKDKCT+Q R+ S
Sbjct: 451 E----VARHSFSSPPCPPHGEDNSNGSITKDKCTVQ--KRSVS----------------- 487
Query: 526 EFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLK 585
E + RRFDTSS+QQRAEALEGLLEFSA+LLQQER++ELGVLLK
Sbjct: 488 -----------------EVKQRRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLLK 530
Query: 586 PFGPEKVSPRETAIWLAKSFKETAV 610
PFG E+VS RETAIWL KSFKE +V
Sbjct: 531 PFGAERVSSRETAIWLTKSFKEASV 555
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZEZ5|NEK3_ORYSJ Serine/threonine-protein kinase Nek3 OS=Oryza sativa subsp. japonica GN=NEK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 684 bits (1766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/612 (60%), Positives = 439/612 (71%), Gaps = 29/612 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYEVLEQIGKGSFGSALLVRHK E+K+YVLKKIRLARQTDR RRSAHQEMELI++VRN
Sbjct: 1 MEQYEVLEQIGKGSFGSALLVRHKVEKKRYVLKKIRLARQTDRCRRSAHQEMELIAKVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P+IVEYKDSWVEKGCYVCI+IGYCEGGDM+EAIKKAN +F EE+LC WLVQLLMAL+YL
Sbjct: 61 PYIVEYKDSWVEKGCYVCIVIGYCEGGDMSEAIKKANSNYFSEERLCMWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H NHILHRDVKCSNIFLT+DQ+IRLGDFGLAK+L SDDL SSVVGTPSYMCPELLADIPY
Sbjct: 121 HVNHILHRDVKCSNIFLTKDQNIRLGDFGLAKVLTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K AFKAFDMQ LINKI+KS++APLPT+YSGAFRGL+KSMLR
Sbjct: 181 GSKSDIWSLGCCLYEMTALKPAFKAFDMQTLINKISKSVLAPLPTIYSGAFRGLIKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIH 300
K+P+ RPSAAELL HPHLQP+VL + LK + P RN FP D+N E + +
Sbjct: 241 KSPDHRPSAAELLKHPHLQPFVLELQLK-SSPARNLFP----DTNKASCSDDENNWKAKY 295
Query: 301 SNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVDM 360
S K SF DR + SST + + + Q EL +G + E++ VD
Sbjct: 296 S---KSHSFKVDRIVKVDKVAANNGHPSSTGTAKDYQELLKQPMDEL-LGQLTEKV-VDE 350
Query: 361 STTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARRA 420
N K+P TP + S+TPR + PSK H ++ P S + S+P RRA
Sbjct: 351 VIHGNHSRVTKSPAPTPRRASSTPRIRLEPSKTFH--ARAAETPPSKCSLERASQPTRRA 408
Query: 421 SLPLTTTRASESHY-QPITCIMKSPDVSVNAPRIDKIAEFPLASSEDPLL-PIPKTSSTS 478
S P+ + E I +KSPDVSVN+PRID+IAEFP+ S +D L P K
Sbjct: 409 STPVNMLQTPEKRQGADILTRLKSPDVSVNSPRIDRIAEFPIPSFDDEQLHPTTK----- 463
Query: 479 ACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSS 538
P D SITKDKCT QV+ R+ S N ++ +I ++ NP + +
Sbjct: 464 --LKLYPPSITDQSITKDKCTFQVL-RSDSSKNHTGDSSDPSILG----TDSNP---LIT 513
Query: 539 HSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETA 598
SS + RRFDT+S++QRAEALEGLLEFSA+LLQQERFEELG+LLKPFGP K SPRETA
Sbjct: 514 SSSDWMKQRRFDTTSYRQRAEALEGLLEFSAQLLQQERFEELGILLKPFGPGKASPRETA 573
Query: 599 IWLAKSFKETAV 610
IWL+KSFK T +
Sbjct: 574 IWLSKSFKGTGL 585
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SLI2|NEK1_ARATH Serine/threonine-protein kinase Nek1 OS=Arabidopsis thaliana GN=NEK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 681 bits (1758), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/627 (60%), Positives = 437/627 (69%), Gaps = 57/627 (9%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYE LEQIGKGSFGSALLVRHKHE+KKYVLKKIRLARQT R RRSAHQEMELIS++R+
Sbjct: 1 MEQYEFLEQIGKGSFGSALLVRHKHEKKKYVLKKIRLARQTQRTRRSAHQEMELISKMRH 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEK CYVCI+IGYCEGGDMA+AIKK+NGVHF EEKLCKWLVQLLM L YL
Sbjct: 61 PFIVEYKDSWVEKACYVCIVIGYCEGGDMAQAIKKSNGVHFQEEKLCKWLVQLLMGLEYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H+NHILHRDVKCSNIFLT++QDIRLGDFGLAK+L SDDL SSVVGTPSYMCPELLADIPY
Sbjct: 121 HSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+ K AFKAFDMQALINKINK+IV+PLP YSG FRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMAYLKPAFKAFDMQALINKINKTIVSPLPAKYSGPFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSN--FKKTRFMEPEAIS 298
KNPE RPSA++LL HPHLQPYVL + L+LN RR T P E S KK F EP
Sbjct: 241 KNPEVRPSASDLLRHPHLQPYVLDVKLRLNNLRRKTLPPELPSSKRIMKKAHFSEPAVTC 300
Query: 299 IHSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGV 358
+ +S NDRALNP E E+D+ SS ++++ +LSI + +
Sbjct: 301 PAFGERQHRSLWNDRALNP---EAEEDTASSI-------KCISRRISDLSIESSSKGTLI 350
Query: 359 DMSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSL-PISHNPGGKPSR-- 415
+ + C K P AK S T RR G + D L P+S GG S+
Sbjct: 351 CKQVSSSACKVSKYPL---AKSSVTSRRI------METGRRSDHLHPVSG--GGTTSKII 399
Query: 416 -PARRASLPLT--TTRASESHYQPITCIM---KSPDVSVNAPRIDKIAEFPLASSEDPLL 469
ARR SLPLT T + Y PI I+ KSP+ S+N P++DKIA FPLA E +
Sbjct: 400 PSARRTSLPLTKRATNQEVAAYNPIVGILQNVKSPEYSINEPQVDKIAIFPLAPYEQDIF 459
Query: 470 PIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQ------- 522
P TS+ SS S SITKDKCT+Q HTT IQ
Sbjct: 460 FTPMQRKTSSKSSSVSDR----SITKDKCTVQ------------THTTWQGIQLNMVDNI 503
Query: 523 -NGSEFSEPNPATGVSSHSSLESQHR-RFDTSSFQQRAEALEGLLEFSARLLQQERFEEL 580
+GS S+ N G SSH++ S R RFD SS++QRA+ALEGLLEFSARLLQ+ R++EL
Sbjct: 504 SDGSSSSDQNATAGASSHTTSSSSRRCRFDPSSYRQRADALEGLLEFSARLLQEGRYDEL 563
Query: 581 GVLLKPFGPEKVSPRETAIWLAKSFKE 607
VLLKPFGP KVSPRETAIW+AKS KE
Sbjct: 564 NVLLKPFGPGKVSPRETAIWIAKSLKE 590
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RX66|NEK3_ARATH Serine/threonine-protein kinase Nek3 OS=Arabidopsis thaliana GN=NEK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 630 bits (1626), Expect = e-180, Method: Compositional matrix adjust.
Identities = 365/625 (58%), Positives = 426/625 (68%), Gaps = 80/625 (12%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME YEVLEQIGKGSFGSALLVRHKHE+K YVLKKIRLARQT R RRSAHQEMELIS++RN
Sbjct: 1 MEHYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCI+IGYC+GGDMAEAIKKANGV F EEKLCKWLVQLLMAL YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCKGGDMAEAIKKANGVEFSEEKLCKWLVQLLMALEYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HA+HILHRDVKCSNIFLT+DQDIRLGDFGLAK+L SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HASHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K AFKAFDMQ LIN+IN+SIVAPLP YS AFR LVKSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMTALKPAFKAFDMQGLINRINRSIVAPLPAQYSTAFRSLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIH 300
KNPE RPSA++LL P LQPYV + LKL+ +T P E E S +
Sbjct: 241 KNPELRPSASDLLRQPLLQPYVQKVLLKLSFREHDTLP-------------SESERRSSY 287
Query: 301 SNREKRQSFSNDRALNPSVSETEQ-DSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
+ KR S + PS +Q DS+SS + Y+ H VD
Sbjct: 288 PQQRKRTS-GKSVSFGPSRFGVDQEDSVSSV---KPVHTYL------------HRHRPVD 331
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHN---PGG--KPS 414
+S A T R+ + P+ ++ + + +P+ N GG KP+
Sbjct: 332 LS-------ANDTSRVVVRR----------PAVSSVVSNSSKYVPVRSNQPKSGGLLKPA 374
Query: 415 RPARRASLPLTTTRA---SESHYQPITCI---MKSPDVSVNAPRIDKIAEFPLASSED-P 467
RRASLP++ A +S Y P I + SPDVSVN+PRID+I +FPLAS E+ P
Sbjct: 375 VVTRRASLPISQKPAKGTKDSLYHPNIGILHQLNSPDVSVNSPRIDRI-KFPLASYEEMP 433
Query: 468 LLPIPKTSSTSACCSSSSPDS--IDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGS 525
+P+ + S+ S S P +DCSITKDK T++ T S
Sbjct: 434 FIPVVRKKKGSSRGSYSPPPEPPLDCSITKDKFTLEPERETK-----------------S 476
Query: 526 EFSEPN-PATGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLL 584
+ S+ N A S SS S+ +RFD SS++QRAEALEGLLEFSARLL ER++EL VLL
Sbjct: 477 DLSDQNATAGASSRASSGASRRQRFDPSSYRQRAEALEGLLEFSARLLIDERYDELNVLL 536
Query: 585 KPFGPEKVSPRETAIWLAKSFKETA 609
KPFGP KVSPRETAIWL+KSFKE++
Sbjct: 537 KPFGPGKVSPRETAIWLSKSFKESS 561
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WPH8|NEK5_ARATH Serine/threonine-protein kinase Nek5 OS=Arabidopsis thaliana GN=NEK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1159), Expect = e-125, Method: Compositional matrix adjust.
Identities = 192/262 (73%), Positives = 236/262 (90%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M+QYE++EQIG+G+FG+A+LV HK ERKKYVLKKIRLARQT+R RRSAHQEM LI+RV++
Sbjct: 5 MDQYELMEQIGRGAFGAAILVHHKAERKKYVLKKIRLARQTERCRRSAHQEMSLIARVQH 64
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P+IVE+K++WVEKGCYVCI+ GYCEGGDMAE +KK+NGV+FPEEKLCKW QLL+A+ YL
Sbjct: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGVYFPEEKLCKWFTQLLLAVEYL 124
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H+N++LHRD+KCSNIFLT+DQD+RLGDFGLAK L +DDL SSVVGTP+YMCPELLADIPY
Sbjct: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLTSSVVGTPNYMCPELLADIPY 184
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
G KSDIWSLGCC+YEM+A + AFKAFDM LI+K+N+S + PLP YS + + L+K MLR
Sbjct: 185 GFKSDIWSLGCCIYEMAAYRPAFKAFDMAGLISKVNRSSIGPLPPCYSPSLKALIKGMLR 244
Query: 241 KNPEFRPSAAELLCHPHLQPYV 262
KNPE+RP+A+E+L HP+LQPYV
Sbjct: 245 KNPEYRPNASEILKHPYLQPYV 266
|
Involved in epidermal-cell morphogenesis in hypocotyls and roots. May act on the microtubule function. May have a secondary role in trichome branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94CU5|NEK5_ORYSJ Serine/threonine-protein kinase Nek5 OS=Oryza sativa subsp. japonica GN=NEK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1120), Expect = e-121, Method: Compositional matrix adjust.
Identities = 189/262 (72%), Positives = 232/262 (88%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M+QYEV+EQIG+G+FG+A+LV HK E+KKYVLKKIRLARQT+R R+SAHQEM LI+R+++
Sbjct: 5 MDQYEVMEQIGRGAFGAAILVNHKTEKKKYVLKKIRLARQTERCRKSAHQEMALIARLQH 64
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P+IVE+K++WVEKGCYVCI+ GYCEGGDMAE +KKANG +FPEEKL KW QL +A++YL
Sbjct: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKANGTYFPEEKLLKWFAQLALAVDYL 124
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H+N +LHRD+KCSNIFLT+DQDIRLGDFGLAK L +DDL SSVVGTP+YMCPELLADIPY
Sbjct: 125 HSNFVLHRDLKCSNIFLTKDQDIRLGDFGLAKTLKADDLTSSVVGTPNYMCPELLADIPY 184
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
G KSDIWSLGCC+YEM+A + AFKAFDM LI+KIN+S + PLP YS + + L+KSMLR
Sbjct: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPPCYSPSMKSLIKSMLR 244
Query: 241 KNPEFRPSAAELLCHPHLQPYV 262
K+PE RP+A+E+L P+LQPYV
Sbjct: 245 KSPEHRPTASEILKSPYLQPYV 266
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 610 | ||||||
| 359479671 | 614 | PREDICTED: serine/threonine-protein kina | 0.998 | 0.991 | 0.764 | 0.0 | |
| 255567504 | 612 | ATP binding protein, putative [Ricinus c | 0.995 | 0.991 | 0.769 | 0.0 | |
| 296085239 | 585 | unnamed protein product [Vitis vinifera] | 0.950 | 0.991 | 0.743 | 0.0 | |
| 224066438 | 606 | predicted protein [Populus trichocarpa] | 0.973 | 0.980 | 0.739 | 0.0 | |
| 449491563 | 608 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.985 | 0.988 | 0.729 | 0.0 | |
| 449458518 | 608 | PREDICTED: serine/threonine-protein kina | 0.985 | 0.988 | 0.727 | 0.0 | |
| 356500172 | 609 | PREDICTED: serine/threonine-protein kina | 0.988 | 0.990 | 0.721 | 0.0 | |
| 356536779 | 610 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.990 | 0.724 | 0.0 | |
| 224130678 | 620 | predicted protein [Populus trichocarpa] | 0.985 | 0.969 | 0.696 | 0.0 | |
| 18766642 | 621 | NIMA-related protein kinase [Populus tre | 0.985 | 0.967 | 0.696 | 0.0 |
| >gi|359479671|ref|XP_003632328.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 955 bits (2469), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/615 (76%), Positives = 526/615 (85%), Gaps = 6/615 (0%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M+QYE+LEQIGKGSFGSALLVRHKHE+KKYVLKKIRLARQTDR RRSAH EMELIS+VRN
Sbjct: 1 MDQYEILEQIGKGSFGSALLVRHKHEKKKYVLKKIRLARQTDRTRRSAHLEMELISKVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCI+IGYCEGGDMAEAIK+ANGVHFPEEKLCKWLVQLL AL YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGVHFPEEKLCKWLVQLLTALEYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIFLT+DQDIRLGDFGLAKML SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKMLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A + AFKAFDMQALINKINKSIVAPLPT+YSGAFRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMTAHRPAFKAFDMQALINKINKSIVAPLPTMYSGAFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RPSAAELL H HLQPY+L IHLK N PRRNTFP +WSDSN+ KKTRF+EPEA+ +
Sbjct: 241 KNPELRPSAAELLTHSHLQPYILKIHLKSNSPRRNTFPFQWSDSNYIKKTRFLEPEAVPM 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
S+REKR+SFSNDR LNPS+S TEQDS S+ + + F +++N+KF ELS+G HE++G+D
Sbjct: 301 FSDREKRRSFSNDRTLNPSISGTEQDSPCSSQKMQEFSSHLNRKFAELSVGSTHEDIGID 360
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARR 419
S +A KTPR TP+K S+TPRRQ SK + IGS DS P+SH P K S RR
Sbjct: 361 KSVVTKFSSATKTPRSTPSKTSSTPRRQTATSKISRIGSNHDSFPVSHTPVSKSSWSTRR 420
Query: 420 ASLPLTTTRAS-ESHYQPITCIMK---SPDVSVNAPRIDKIAEFPLASSEDPLLPIPKTS 475
ASLP T A+ E+ Y+P +++ SPD+SVNAPRID+IAEFPLAS ++PL PI KTS
Sbjct: 421 ASLPFPTRAATLETPYRPNVRLLRSVESPDISVNAPRIDRIAEFPLASCDEPLFPIRKTS 480
Query: 476 STSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATG 535
STSA CSS+SPDS DCSITKDKCT+Q++D+ R NF HG +NGSE SE NP TG
Sbjct: 481 STSAQCSSNSPDSGDCSITKDKCTVQILDKAFVRQNF-TDADHGVPRNGSECSEHNPTTG 539
Query: 536 VSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPR 595
VSS SS +S+ RRFDTSS+QQRAEALEGLLEFSARLLQQERF+ELGVLLKPFGPEKVSPR
Sbjct: 540 VSSRSSSDSRQRRFDTSSYQQRAEALEGLLEFSARLLQQERFDELGVLLKPFGPEKVSPR 599
Query: 596 ETAIWLAKSFKETAV 610
ETAIWL KSFKETA
Sbjct: 600 ETAIWLTKSFKETAA 614
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567504|ref|XP_002524731.1| ATP binding protein, putative [Ricinus communis] gi|223535915|gb|EEF37574.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 919 bits (2374), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/615 (76%), Positives = 525/615 (85%), Gaps = 8/615 (1%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYE+LEQIGKGSFGSALLVRH+HE+KKYV+KKIRLARQTDRARRSAHQEMELIS+VRN
Sbjct: 1 MEQYEILEQIGKGSFGSALLVRHRHEKKKYVMKKIRLARQTDRARRSAHQEMELISKVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCIIIGYCEGGDM EAIKKAN VHFPEEKLCKWLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMQEAIKKANSVHFPEEKLCKWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H NHILHRDVKCSNIFLT+DQDIRLGDFGLAKML SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HGNHILHRDVKCSNIFLTKDQDIRLGDFGLAKMLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K AFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMAAHKPAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RPSA+ELL HPHLQP++L IHLKLN PRRNT P+ WSDS+F KKT+F EPEA+
Sbjct: 241 KNPELRPSASELLSHPHLQPHLLKIHLKLNSPRRNTLPVRWSDSDFIKKTKFREPEAVPH 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
++REKR+SFSNDR LNPS+SETEQDSL S+ R F +Y+N++F+ELS GV EE+ +
Sbjct: 301 FTDREKRRSFSNDRTLNPSISETEQDSLDSSHRVEQFPSYLNRRFRELSFGVALEEIDIQ 360
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARR 419
+ T + A KTPR+ P K SATPRRQ TPSK H SKRDSLP+S P GK S+ RR
Sbjct: 361 NAVTTKISMAAKTPRMMPVKASATPRRQ-TPSKIPHTCSKRDSLPVSCTPAGK-SQSTRR 418
Query: 420 ASLPLTTTRAS-ESHYQPITCIM---KSPDVSVNAPRIDKIAEFPLASSEDPLLPIPKTS 475
ASLP T + + Y+ ++ +SP+VSVNAPRIDKIAEFPLASSEDP +PI TS
Sbjct: 419 ASLPFPTRAGNFPTPYRSNVGLLPSIESPNVSVNAPRIDKIAEFPLASSEDPFIPIRGTS 478
Query: 476 STSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATG 535
STSA CSSSSP S DCSITKDKCTIQV+DR ++P + ++ ++GSE SE NP
Sbjct: 479 STSAQCSSSSPGSADCSITKDKCTIQVLDRAIAKPA-LPDISNEITRSGSECSEHNPTVA 537
Query: 536 VSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPR 595
+SS SS ES+ RRFDTSS+QQRAEALEGLLEFSARLLQQERF ELGVLLKPFGPEKVSPR
Sbjct: 538 ISSRSSSESRLRRFDTSSYQQRAEALEGLLEFSARLLQQERFAELGVLLKPFGPEKVSPR 597
Query: 596 ETAIWLAKSFKETAV 610
ETAIWLAKSFKETAV
Sbjct: 598 ETAIWLAKSFKETAV 612
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085239|emb|CBI28734.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2366), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/615 (74%), Positives = 508/615 (82%), Gaps = 35/615 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M+QYE+LEQIGKGSFGSALLVRHKHE+KKYVLKKIRLARQTDR RRSAH EMELIS+VRN
Sbjct: 1 MDQYEILEQIGKGSFGSALLVRHKHEKKKYVLKKIRLARQTDRTRRSAHLEMELISKVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCI+IGYCEGGDMAEAIK+ANGVHFPEEKLCKWLVQLL AL YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGVHFPEEKLCKWLVQLLTALEYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIFLT+DQDIRLGDFGLAKML SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKMLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A + AFKAFDMQALINKINKSIVAPLPT+YSGAFRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMTAHRPAFKAFDMQALINKINKSIVAPLPTMYSGAFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RPSAAELL H HLQPY+L IHLK N PRRNTFP +WSDSN+ KKTRF+EPEA+ +
Sbjct: 241 KNPELRPSAAELLTHSHLQPYILKIHLKSNSPRRNTFPFQWSDSNYIKKTRFLEPEAVPM 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
S+REKR+SFSNDR LNPS+S TEQDS S+ + + F +++N+KF ELS+G HE++G+D
Sbjct: 301 FSDREKRRSFSNDRTLNPSISGTEQDSPCSSQKMQEFSSHLNRKFAELSVGSTHEDIGID 360
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARR 419
S +A KTPR TP+K S+TPRRQ SK + IGS DS P+SH P K S RR
Sbjct: 361 KSVVTKFSSATKTPRSTPSKTSSTPRRQTATSKISRIGSNHDSFPVSHTPVSKSSWSTRR 420
Query: 420 ASLPLTTTRAS-ESHYQPITCIMKS---PDVSVNAPRIDKIAEFPLASSEDPLLPIPKTS 475
ASLP T A+ E+ Y+P +++S PD+SVNAPRID+IAEFPLAS ++PL PI KTS
Sbjct: 421 ASLPFPTRAATLETPYRPNVRLLRSVESPDISVNAPRIDRIAEFPLASCDEPLFPIRKTS 480
Query: 476 STSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATG 535
STSA CSS+SPDS DCSITKDKCT NP TG
Sbjct: 481 STSAQCSSNSPDSGDCSITKDKCT------------------------------HNPTTG 510
Query: 536 VSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPR 595
VSS SS +S+ RRFDTSS+QQRAEALEGLLEFSARLLQQERF+ELGVLLKPFGPEKVSPR
Sbjct: 511 VSSRSSSDSRQRRFDTSSYQQRAEALEGLLEFSARLLQQERFDELGVLLKPFGPEKVSPR 570
Query: 596 ETAIWLAKSFKETAV 610
ETAIWL KSFKETA
Sbjct: 571 ETAIWLTKSFKETAA 585
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066438|ref|XP_002302101.1| predicted protein [Populus trichocarpa] gi|222843827|gb|EEE81374.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 893 bits (2307), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/622 (73%), Positives = 510/622 (81%), Gaps = 28/622 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYE+LEQIGKGSFGSALLVRHKHE+KKYVLKKIRLARQTDR RRSA+QEMELIS+ N
Sbjct: 1 MEQYEILEQIGKGSFGSALLVRHKHEKKKYVLKKIRLARQTDRTRRSAYQEMELISKASN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA+GVHFPEEKLCKWLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKASGVHFPEEKLCKWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIFLT+DQDIRLGDFGLAKML SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKMLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K+AFKAFD+Q LINKINKSIVAPLPTVYSG RGL+KSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMAAHKSAFKAFDIQTLINKINKSIVAPLPTVYSGPLRGLIKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RPSAAELL HPHLQPY+L IHLKLN PRRNTFP+EWSDS F KK F++P+A+
Sbjct: 241 KNPELRPSAAELLGHPHLQPYLLKIHLKLNSPRRNTFPVEWSDSTFVKKASFLDPQAVPS 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGN--YMNQKFKELSIGVVHEELG 357
+ REKR+SF+NDRALNPS+S TEQDS S+ R + Y+NQ+F ELS+GVVHEE G
Sbjct: 301 FTTREKRRSFNNDRALNPSISGTEQDSPHSSQRDQESPAPIYLNQRFTELSVGVVHEEFG 360
Query: 358 VDMSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPA 417
+T +TPRL P+K+SATPRRQ+TPSK ++I SK +S K S A
Sbjct: 361 ---NTAAKFSTYARTPRLMPSKISATPRRQSTPSKISYITSKLSCTTVS-----KSSHTA 412
Query: 418 RRASLPLTT--------TRASESHYQPITCIMKSPDVSVNAPRIDKIAEFPLASSEDPLL 469
RRASLP T T+ SH + M SP+VSVNAPRIDKIAEFPLASSEDPL+
Sbjct: 413 RRASLPFPTRAAAAAAGTQYKASH--GLLHSMDSPNVSVNAPRIDKIAEFPLASSEDPLI 470
Query: 470 PIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSE 529
PI TS+++ SSSP S+DCSITKDKCT+QV++R S+ T + GSE SE
Sbjct: 471 PIHGTSTSAQF--SSSPYSVDCSITKDKCTVQVLERAVSKHR----VTDACQRIGSECSE 524
Query: 530 PNPATGV-SSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFG 588
NP +GV S SS Q RRFDTSS+QQRAEALEGLLEFSARLLQQERF ELGVLLKPFG
Sbjct: 525 HNPTSGVSSRSSSDSRQQRRFDTSSYQQRAEALEGLLEFSARLLQQERFAELGVLLKPFG 584
Query: 589 PEKVSPRETAIWLAKSFKETAV 610
PEKVSPRETAIWLAKSFKETAV
Sbjct: 585 PEKVSPRETAIWLAKSFKETAV 606
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449491563|ref|XP_004158937.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase Nek2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2304), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/617 (72%), Positives = 510/617 (82%), Gaps = 16/617 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYEVLEQIGKGSFGSALLVRHK E+++YVLKKIRLARQTDR RRSAHQEMELIS+ RN
Sbjct: 1 MEQYEVLEQIGKGSFGSALLVRHKLEKRRYVLKKIRLARQTDRTRRSAHQEMELISKARN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGC+VCI+IGYCEGGDMAEAIK+ANGV FPEEKLC+WLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCFVCIVIGYCEGGDMAEAIKRANGVXFPEEKLCRWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H NHILHRDVKCSNIFLT+DQDIRLGDFGLAKML SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HCNHILHRDVKCSNIFLTKDQDIRLGDFGLAKMLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K AFKAFDMQ+LINKINKSIVAPLPT+YSGAFRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMAAHKPAFKAFDMQSLINKINKSIVAPLPTMYSGAFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RPSAAELL HPHLQPY+L +HLKLN PRRNTFPL+ SD+N+ KKTRF EP + S+
Sbjct: 241 KNPELRPSAAELLNHPHLQPYILKVHLKLNSPRRNTFPLQRSDTNYIKKTRFEEPGSDSL 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
+ REKR SFSNDRA+NPSVS TE +S S+ R +Y+N+KF+ELSI +E VD
Sbjct: 301 RAFREKRLSFSNDRAVNPSVSVTEAESQCSSRRSLQLPSYLNKKFEELSIA--GKESNVD 358
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGK-PSRPAR 418
+S T + KTPRLT AKVSATP++Q I SK +P SH+P + S R
Sbjct: 359 LSRTSKLQTISKTPRLTNAKVSATPKKQT-------ISSKFSPIPASHSPASRGSSHTNR 411
Query: 419 RASLPLTTTRAS-ESHYQPITCI---MKSPDVSVNAPRIDKIAEFPLASSEDPLLPIPKT 474
RASLPL+T A + Y+ T + M SPD+SVNAPRIDKIAEFPL SSEDPLL I T
Sbjct: 412 RASLPLSTKTAGFGTPYRSNTGLLHGMNSPDISVNAPRIDKIAEFPLVSSEDPLLHIRGT 471
Query: 475 SSTSACCSSSS-PDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPA 533
SSTSA CS++S DS +CSITKDKCT+QV+D+T + + V+ ++ + S++ + NPA
Sbjct: 472 SSTSAQCSNNSQDDSTNCSITKDKCTVQVVDKTTIKKSDVLSSSFRVPGSESDYFDRNPA 531
Query: 534 TGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVS 593
SS S ES+ RRFDTSS+QQRAEALEGLLEFSA+LLQQERFEELGVLLKPFGPEKVS
Sbjct: 532 IASSSRLSFESRQRRFDTSSYQQRAEALEGLLEFSAKLLQQERFEELGVLLKPFGPEKVS 591
Query: 594 PRETAIWLAKSFKETAV 610
PRETAIWLAKSFKE V
Sbjct: 592 PRETAIWLAKSFKEATV 608
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458518|ref|XP_004146994.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 891 bits (2303), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/617 (72%), Positives = 510/617 (82%), Gaps = 16/617 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYE+LEQIGKGSFGSALLVRHK E+++YVLKKIRLARQTDR RRSAHQEMELIS+ RN
Sbjct: 1 MEQYEILEQIGKGSFGSALLVRHKLEKRRYVLKKIRLARQTDRTRRSAHQEMELISKARN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGC+VCI+IGYCEGGDMAEAIK+ANGV FPEEKLC+WLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCFVCIVIGYCEGGDMAEAIKRANGVFFPEEKLCRWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H NHILHRDVKCSNIFLT+DQDIRLGDFGLAKML SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HCNHILHRDVKCSNIFLTKDQDIRLGDFGLAKMLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K AFKAFDMQ+LINKINKSIVAPLPT+YSGAFRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMAAHKPAFKAFDMQSLINKINKSIVAPLPTMYSGAFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RPSAAELL HPHLQPY+L +HLKLN PRRNTFPL+ SD+N+ KKTRF EP + S+
Sbjct: 241 KNPELRPSAAELLNHPHLQPYILKVHLKLNSPRRNTFPLQRSDTNYIKKTRFEEPGSDSL 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
+ REKR SFSNDRA+NPSVS TE +S S+ R +Y+N+KF+ELSI +E VD
Sbjct: 301 RAFREKRLSFSNDRAVNPSVSVTEAESQCSSRRSLQLPSYLNKKFEELSIA--GKESNVD 358
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGK-PSRPAR 418
+S T + KTPRLT AKVSATP++Q I SK +P SH+P + S R
Sbjct: 359 LSRTSKLQTISKTPRLTNAKVSATPKKQT-------ISSKFSPIPASHSPASRGSSHTNR 411
Query: 419 RASLPLTTTRAS-ESHYQPITCI---MKSPDVSVNAPRIDKIAEFPLASSEDPLLPIPKT 474
RASLPL+T A + Y+ T + M SPD+SVNAPRIDKIAEFPL SSEDPLL I T
Sbjct: 412 RASLPLSTKTAGFGTPYRSNTGLLHGMNSPDISVNAPRIDKIAEFPLVSSEDPLLHIRGT 471
Query: 475 SSTSACCSSSS-PDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPA 533
SSTSA CS++S DS +CSITKDKCT+QV+D+T + + V+ ++ + S++ + NPA
Sbjct: 472 SSTSAQCSNNSQDDSTNCSITKDKCTVQVVDKTTIKKSDVLSSSFRVPGSESDYFDRNPA 531
Query: 534 TGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVS 593
SS S ES+ RRFDTSS+QQRAEALEGLLEFSA+LLQQERFEELGVLLKPFGPEKVS
Sbjct: 532 IASSSRLSFESRQRRFDTSSYQQRAEALEGLLEFSAKLLQQERFEELGVLLKPFGPEKVS 591
Query: 594 PRETAIWLAKSFKETAV 610
PRETAIWLAKSFKE V
Sbjct: 592 PRETAIWLAKSFKEATV 608
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500172|ref|XP_003518907.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2272), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/614 (72%), Positives = 495/614 (80%), Gaps = 11/614 (1%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYE+LEQIG+GSF SALLVRHKHE KKYVLKKIRLARQTDR RRSAHQEMELIS+VRN
Sbjct: 1 MEQYEILEQIGRGSFASALLVRHKHENKKYVLKKIRLARQTDRTRRSAHQEMELISKVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGC+VCI+IGYCEGGDM EAIKKANGVHFPEE+LCK LVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCFVCIVIGYCEGGDMTEAIKKANGVHFPEERLCKLLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIFLT+DQDIRLGDFGLAKML DDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKMLTCDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCCVYEM+A K AFKA DMQALINKINKS+VAPLPTVYSG+FRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCVYEMAAHKPAFKALDMQALINKINKSLVAPLPTVYSGSFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RPSAAELL HPHLQPY+L IHLKLN PRR+T+P WSDSN+ ++T+F+EP ++S
Sbjct: 241 KNPELRPSAAELLNHPHLQPYILKIHLKLNNPRRSTYPFPWSDSNYVRRTQFVEPGSVST 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
S+R KR SFSNDRALNPS+S TE S+ ST R F +K ELS+G VH+E +
Sbjct: 301 LSDRGKRFSFSNDRALNPSISGTELGSVCSTQRALGFSTCSKEKHYELSVGRVHKECNSN 360
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARR 419
S + PRL AK ATPR Q PSK +H GSKR+ LP PG K + P RR
Sbjct: 361 KSRDTKSSTVDRMPRLRTAKEYATPRWQTIPSKISHTGSKRELLP--STPGCKFTLPTRR 418
Query: 420 ASLPL-TTTRASESHYQPITCIMK---SPDVSVNAPRIDKIAEFPLASSEDPLLPIPKTS 475
ASLPL T T + Y+ +++ SPD+SVNAPRIDKIAEFPLAS ED L P+ TS
Sbjct: 419 ASLPLPTRTTGMITSYRANVGLLRGVDSPDISVNAPRIDKIAEFPLASCEDSLFPVCGTS 478
Query: 476 STSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATG 535
STSA CSS SP S DC IT+DKCTIQV+D+ + + + +G+E SE
Sbjct: 479 STSAQCSSGSPKSADCLITQDKCTIQVVDKASVPSSGSDACPAAPVSHGNECSE----HA 534
Query: 536 VSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPR 595
+SSHSS ES+ RFDTSS+QQRA+ALEGLLEFSARLLQQ+RFEELGVLLKPFGPEKVSPR
Sbjct: 535 ISSHSSAESRKHRFDTSSYQQRAKALEGLLEFSARLLQQQRFEELGVLLKPFGPEKVSPR 594
Query: 596 ETAIWLAKSFKETA 609
ETAIWLAKSFKET
Sbjct: 595 ETAIWLAKSFKETV 608
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356536779|ref|XP_003536912.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2265), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/614 (72%), Positives = 501/614 (81%), Gaps = 10/614 (1%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYE+LEQIG+GSF SALLVRH+HE K+YVLKKIRLARQTDR RRSAHQEMELIS+VRN
Sbjct: 1 MEQYEILEQIGRGSFASALLVRHRHENKRYVLKKIRLARQTDRTRRSAHQEMELISKVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGC+VCI+IGYCEGGDMAEAIKKANGV+FPEE+LCKWLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCFVCIVIGYCEGGDMAEAIKKANGVYFPEERLCKWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIFLT+DQDIRLGDFGLAKML DDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKMLTCDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCCVYEM+A K AFKA DMQALINKINKS+VAPLPTVYSG+FRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCVYEMAAHKPAFKALDMQALINKINKSLVAPLPTVYSGSFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RPSAAELL HPHLQPY+L IHLKLN PRR+T+P +WSDSN+ ++T+F+EP ++S
Sbjct: 241 KNPELRPSAAELLNHPHLQPYILKIHLKLNNPRRSTYPFQWSDSNYVRRTQFLEPGSVST 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
S+R+KR SFSNDRALNPS+S TE S+ ST R F +K ELS+G+V EE +
Sbjct: 301 LSDRDKRLSFSNDRALNPSISGTELGSVCSTQRALGFSTCSKEKHYELSVGLVREECNFN 360
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARR 419
S + PRL AK ATPRRQ PSK ++ GSKR+ LP S GGK + P RR
Sbjct: 361 KSRDTKSSTVDRLPRLRSAKEYATPRRQTIPSKISYTGSKRELLP-STPAGGKFTPPTRR 419
Query: 420 ASLPL-TTTRASESHYQPITCIMK---SPDVSVNAPRIDKIAEFPLASSEDPLLPIPKTS 475
ASLPL T T + + Y+ +++ SPD+SVNAPRIDK+AEFPLAS ED L P+ TS
Sbjct: 420 ASLPLPTRTMCTTTPYRANVGLLRGVDSPDISVNAPRIDKMAEFPLASCEDSLFPVRGTS 479
Query: 476 STSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATG 535
STSA CSS SP S DC ITKDKCTIQV+D+ + + + +G+E SE
Sbjct: 480 STSAQCSSGSPKSADCLITKDKCTIQVVDKASVPSSGSDACPAAPVSHGNECSE----HA 535
Query: 536 VSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPR 595
VSSHSS ES RFDTSS+QQRAEALEGLLEFSARLLQQ+RFEELGVLLKPFGPEKVSPR
Sbjct: 536 VSSHSSAESSRHRFDTSSYQQRAEALEGLLEFSARLLQQQRFEELGVLLKPFGPEKVSPR 595
Query: 596 ETAIWLAKSFKETA 609
ETAIWLAKSFKET
Sbjct: 596 ETAIWLAKSFKETV 609
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130678|ref|XP_002328349.1| predicted protein [Populus trichocarpa] gi|222838064|gb|EEE76429.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2188), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/619 (69%), Positives = 485/619 (78%), Gaps = 18/619 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYEVLEQIGKGSFGSALLV+HKHE+KKYVLKKIRLARQTDR+RRSAHQE ELISR+RN
Sbjct: 1 MEQYEVLEQIGKGSFGSALLVKHKHEKKKYVLKKIRLARQTDRSRRSAHQEKELISRIRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H NHILHRDVKCSNIFLT+ +DIRLGDFGLAK+L SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HMNHILHRDVKCSNIFLTKGKDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM++ K AFKAFDMQALINKINKSIVAPLPT YSGAFRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RP AAELL HPHLQPYVL IHLK+N PR+NT P +W + ++ KKT+F+ PE +
Sbjct: 241 KNPELRPGAAELLRHPHLQPYVLKIHLKMNSPRQNTLPFQWPEPHYMKKTKFLVPEDNPL 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
++REKR S SNDRALNPS+S EQDS+ ST +Y+N+ + SI HE +
Sbjct: 301 KAHREKRYSLSNDRALNPSISAAEQDSVCSTEGIHDTPSYLNRSLSDSSIESSHEGTVIC 360
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARR 419
S N KT + P K S T RR+ P K KR+SLP++ P K + RR
Sbjct: 361 RSIASKPSNIAKTTKPAPTKASVTTRRRTEPVK------KRESLPVTRTPTKKSNPTTRR 414
Query: 420 ASLPLTTTRASESHYQ----PITCIMKSPDVSVNAPRIDKIAEFPLASSEDPLLPIPKTS 475
SLPL + A ++ + I +KSPDVSVNAPRID+IAEFPLAS E+P LP +TS
Sbjct: 415 TSLPLPSRTAIQNSARGTNNSILLQIKSPDVSVNAPRIDRIAEFPLASYEEPFLPFRRTS 474
Query: 476 STSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFV---VHTTHGTIQ----NGSEFS 528
STSA SS+S D SITKDKCT+Q+ DRT+++PNF HG Q NGS S
Sbjct: 475 STSAQGSSNSLHHGDRSITKDKCTVQISDRTSAKPNFTEAWQGIEHGMFQVDEENGSNSS 534
Query: 529 EPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFG 588
N G SSH+S + + RRFDTSSFQQRAEALEGLLEFSARLLQ R++ELGVLLKPFG
Sbjct: 535 NQNATAGASSHTSSDMRRRRFDTSSFQQRAEALEGLLEFSARLLQDARYDELGVLLKPFG 594
Query: 589 PEKVSPRETAIWLAKSFKE 607
P KVSPRETAIWL KSFKE
Sbjct: 595 PGKVSPRETAIWLTKSFKE 613
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18766642|gb|AAL79042.1|AF469649_1 NIMA-related protein kinase [Populus tremula x Populus alba] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/619 (69%), Positives = 483/619 (78%), Gaps = 18/619 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYEVLEQIGKGSFGSALLV+HKHE+KKYVLKKIRLARQTDR+RRSAHQE ELISR+RN
Sbjct: 1 MEQYEVLEQIGKGSFGSALLVKHKHEKKKYVLKKIRLARQTDRSRRSAHQEKELISRIRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL+YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H NHILHRDVKCSNIFLT+ QDIRLGDFGLAK+L SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HMNHILHRDVKCSNIFLTKGQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM++ K AFKAFDMQALINKINKSIVAPLPT YSGAFRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF-KKTRFMEPEAISI 299
KNPE RPSAAELL HPHLQPYVL IH+K+N PR+NT P +W + ++ KKT+F+ PE +
Sbjct: 241 KNPELRPSAAELLRHPHLQPYVLKIHIKMNSPRQNTLPFQWPEPHYMKKTKFLVPEDNPL 300
Query: 300 HSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
++REKR S SNDRALNPS+S EQDS+ ST +Y+NQ + SI HE +
Sbjct: 301 KAHREKRYSLSNDRALNPSISAAEQDSVCSTEGIHDTPSYLNQSLSDSSIESSHEGTVIC 360
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARR 419
S N KT + P K S T RR+ P K KR+SLP++ P K + RR
Sbjct: 361 RSIASKPSNFAKTTKPAPTKASVTTRRRTEPVK------KRESLPVTRTPTKKSNPTTRR 414
Query: 420 ASLPLTTTRASESHYQ----PITCIMKSPDVSVNAPRIDKIAEFPLASSEDPLLPIPKTS 475
SLPL + A ++ I +KSPDVSVNAPRID+IAEFPLAS + P LP +TS
Sbjct: 415 TSLPLPSRTAIQNSAHGTNNSILLQIKSPDVSVNAPRIDRIAEFPLASYDKPYLPFRRTS 474
Query: 476 STSACCSSSSPDSIDCSITKDKCTIQVMDRTASRPNFV---VHTTHGTIQ----NGSEFS 528
STSA SS+S D SITKDKCT+Q+ DRT+++PNF HG Q NGS S
Sbjct: 475 STSAQGSSNSLHHGDRSITKDKCTVQISDRTSAKPNFTEAWQGIEHGMFQVDEENGSNSS 534
Query: 529 EPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFG 588
N G SS +S + + RRFDTSSFQQRAEALEGLLEFSARLLQ R++ELGVLLKPFG
Sbjct: 535 NQNATAGASSRTSSDIRRRRFDTSSFQQRAEALEGLLEFSARLLQDARYDELGVLLKPFG 594
Query: 589 PEKVSPRETAIWLAKSFKE 607
P KVSPRETAIWL KSFKE
Sbjct: 595 PGKVSPRETAIWLTKSFKE 613
|
Source: Populus tremula x Populus alba Species: Populus tremula x Populus alba Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 610 | ||||||
| TAIR|locus:2114885 | 606 | NEK2 "NIMA-related kinase 2" [ | 0.967 | 0.973 | 0.581 | 1.3e-171 | |
| TAIR|locus:2077274 | 555 | NEK4 "NIMA-related kinase 4" [ | 0.649 | 0.713 | 0.649 | 1.9e-166 | |
| TAIR|locus:2185314 | 568 | NEK3 "NIMA-related kinase 3" [ | 0.459 | 0.492 | 0.839 | 2.8e-163 | |
| TAIR|locus:2020148 | 612 | NEK1 "NIMA-related serine/thre | 0.783 | 0.781 | 0.603 | 7.9e-149 | |
| TAIR|locus:2081383 | 956 | NEK6 ""NIMA (never in mitosis, | 0.527 | 0.336 | 0.625 | 1.9e-136 | |
| UNIPROTKB|P51957 | 841 | NEK4 "Serine/threonine-protein | 0.419 | 0.304 | 0.455 | 2.5e-70 | |
| ZFIN|ZDB-GENE-040426-1392 | 849 | nek4 "NIMA (never in mitosis g | 0.491 | 0.353 | 0.408 | 1.2e-67 | |
| UNIPROTKB|E2QRX7 | 839 | NEK4 "Uncharacterized protein" | 0.463 | 0.337 | 0.421 | 2.3e-66 | |
| UNIPROTKB|F6V6J5 | 785 | NEK4 "Uncharacterized protein" | 0.463 | 0.360 | 0.421 | 2.3e-66 | |
| UNIPROTKB|E1BWZ5 | 838 | NEK4 "Uncharacterized protein" | 0.522 | 0.380 | 0.383 | 1.3e-65 |
| TAIR|locus:2114885 NEK2 "NIMA-related kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1668 (592.2 bits), Expect = 1.3e-171, P = 1.3e-171
Identities = 359/617 (58%), Positives = 417/617 (67%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME YEVLEQIGKGSFGSALLVRHKHE+K YVLKKIRLARQT R RRSAHQEMELIS++ N
Sbjct: 1 MENYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIHN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCIIIGYC+GGDMAEAIKK NGVHF EEKLCKWLVQ+L+AL YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCKGGDMAEAIKKTNGVHFTEEKLCKWLVQILLALEYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HANHILHRDVKCSNIFLT+DQDIRLGDFGLAK+L SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKVLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K AFKAFDMQ LIN+IN+SIV PLP YS AFRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMTAMKPAFKAFDMQGLINRINRSIVPPLPAQYSAAFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIH 300
KNPE RPSAAELL P LQPY+ IHLK+N P N P +W +S + R PE
Sbjct: 241 KNPELRPSAAELLRQPLLQPYIQKIHLKVNDPGSNVLPAQWPESESAR-RNSFPE----- 294
Query: 301 SNREKRQSFSNDRALNPSVSETE-QDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD 359
++R+ + PS +DS+SS + Y+N +E + + + G D
Sbjct: 295 ---QRRRPAGKSHSFGPSRFRGNLEDSVSSIKK--TVPAYLN---RERQVDLSTDASG-D 345
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARR 419
+ A K+ R P + SA+P R P + +G S + + R A
Sbjct: 346 GTVVRRTSEASKSSRYVPVRASASPVRPRQPRSD--LGQLPVSSQLKNRKPAALIRRASM 403
Query: 420 ASLPLTTTRASESHYQPITCIM---KSPDVSVNAPRIDKIAEFPLAS-SEDPLLPI---- 471
S +S Y T + SPDVS+NAPRIDKI EFPLAS E+P +P+
Sbjct: 404 PSSRKPAKEIKDSLYISKTSFLHQINSPDVSMNAPRIDKI-EFPLASYEEEPFVPVVRGK 462
Query: 472 PKXXXXXXXXXXXXXXXXXXXXXKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPN 531
K KDK T++ V+ +++ SE S+ N
Sbjct: 463 KKKASSRGSYSPPPEPPLDCSITKDKFTLEPGQNREGAIMKAVYEEDAYLEDRSESSDQN 522
Query: 532 PATGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEK 591
G SS +S + +RFD SS+QQRAEALEGLLEFSARLLQ ER++EL VLL+PFGP K
Sbjct: 523 ATAGASSRASSGVRRQRFDPSSYQQRAEALEGLLEFSARLLQDERYDELNVLLRPFGPGK 582
Query: 592 VSPRETAIWLAKSFKET 608
VSPRETAIWL+KSFKET
Sbjct: 583 VSPRETAIWLSKSFKET 599
|
|
| TAIR|locus:2077274 NEK4 "NIMA-related kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1356 (482.4 bits), Expect = 1.9e-166, Sum P(2) = 1.9e-166
Identities = 270/416 (64%), Positives = 321/416 (77%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME+YEVLEQIGKGSFGSALLVRHK ERKKYVLKKIRLARQ+DRARRSAHQEMELIS VRN
Sbjct: 1 MERYEVLEQIGKGSFGSALLVRHKQERKKYVLKKIRLARQSDRARRSAHQEMELISTVRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PF+VEYKDSWVEKGCYVCI+IGYC+GGDM + IK+A GVHFPEEKLC+WLVQLLMAL+YL
Sbjct: 61 PFVVEYKDSWVEKGCYVCIVIGYCQGGDMTDTIKRACGVHFPEEKLCQWLVQLLMALDYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H+NHILHRDVKCSNIFLT++QDIRLGDFGLAK+L SDDL SSVVGTPSYMCPELLADIPY
Sbjct: 121 HSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K FKA D+Q LI KI+K I+ P+P +YSG+FRGL+KSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMAAHKPPFKASDVQTLITKIHKLIMDPIPAMYSGSFRGLIKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIH 300
KNPE RPSA ELL HPHLQPY+ +++KL PRR+TFPL++S E +A ++
Sbjct: 241 KNPELRPSANELLNHPHLQPYISMVYMKLESPRRSTFPLQFS----------ERDA-TLK 289
Query: 301 SNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGVD- 359
R R SFSNDR LNPSVS+TE S+SS+ + + +K E+++GVV EE+
Sbjct: 290 ERR--RSSFSNDRRLNPSVSDTEAGSVSSSGKASPTPMFNGRKVSEVTVGVVREEIVPQR 347
Query: 360 MSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTHIGS-----KRDSLP-ISHNP 409
A +TPR+ A+ +R + + + +R SLP + NP
Sbjct: 348 QEEAKKQSGAARTPRVAGTSAKASTQRTVFKHELMKVSNPTERRRRVSLPLVVENP 403
|
|
| TAIR|locus:2185314 NEK3 "NIMA-related kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 2.8e-163, Sum P(2) = 2.8e-163
Identities = 235/280 (83%), Positives = 252/280 (90%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME YEVLEQIGKGSFGSALLVRHKHE+K YVLKKIRLARQT R RRSAHQEMELIS++RN
Sbjct: 1 MEHYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIRN 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEKGCYVCI+IGYC+GGDMAEAIKKANGV F EEKLCKWLVQLLMAL YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCKGGDMAEAIKKANGVEFSEEKLCKWLVQLLMALEYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
HA+HILHRDVKCSNIFLT+DQDIRLGDFGLAK+L SDDLASSVVGTPSYMCPELLADIPY
Sbjct: 121 HASHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+A K AFKAFDMQ LIN+IN+SIVAPLP YS AFR LVKSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMTALKPAFKAFDMQGLINRINRSIVAPLPAQYSTAFRSLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLE 280
KNPE RPSA++LL P LQPYV + LKL+ +T P E
Sbjct: 241 KNPELRPSASDLLRQPLLQPYVQKVLLKLSFREHDTLPSE 280
|
|
| TAIR|locus:2020148 NEK1 "NIMA-related serine/threonine kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1453 (516.5 bits), Expect = 7.9e-149, P = 7.9e-149
Identities = 308/510 (60%), Positives = 352/510 (69%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
MEQYE LEQIGKGSFGSALLVRHKHE+KKYVLKKIRLARQT R RRSAHQEMELIS++R+
Sbjct: 1 MEQYEFLEQIGKGSFGSALLVRHKHEKKKYVLKKIRLARQTQRTRRSAHQEMELISKMRH 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PFIVEYKDSWVEK CYVCI+IGYCEGGDMA+AIKK+NGVHF EEKLCKWLVQLLM L YL
Sbjct: 61 PFIVEYKDSWVEKACYVCIVIGYCEGGDMAQAIKKSNGVHFQEEKLCKWLVQLLMGLEYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H+NHILHRDVKCSNIFLT++QDIRLGDFGLAK+L SDDL SSVVGTPSYMCPELLADIPY
Sbjct: 121 HSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
GSKSDIWSLGCC+YEM+ K AFKAFDMQALINKINK+IV+PLP YSG FRGLVKSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMAYLKPAFKAFDMQALINKINKTIVSPLPAKYSGPFRGLVKSMLR 240
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSN--FKKTRFMEPEAIS 298
KNPE RPSA++LL HPHLQPYVL + L+LN RR T P E S KK F EP
Sbjct: 241 KNPEVRPSASDLLRHPHLQPYVLDVKLRLNNLRRKTLPPELPSSKRIMKKAHFSEPAVTC 300
Query: 299 IHSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKELSIGVVHEELGV 358
+ +S NDRALNP E E+D+ SS ++++ +LSI + +
Sbjct: 301 PAFGERQHRSLWNDRALNP---EAEEDTASSI-------KCISRRISDLSIESSSKGTLI 350
Query: 359 DMSTTPNVCNAGKTPRLTPAKVSATPRR-QATPSKNTHIGSKRDSLPISHNPGGKPSRP- 416
+ + C K P AK S T RR T ++ H+ P+S P
Sbjct: 351 CKQVSSSACKVSKYPL---AKSSVTSRRIMETGRRSDHLH------PVSGGGTTSKIIPS 401
Query: 417 ARRASLPLT--TTRASESHYQPITCIM---KSPDVSVNAPRIDKIAEFPLASSEDPLLPI 471
ARR SLPLT T + Y PI I+ KSP+ S+N P++DKIA FPLA E +
Sbjct: 402 ARRTSLPLTKRATNQEVAAYNPIVGILQNVKSPEYSINEPQVDKIAIFPLAPYEQDIFFT 461
Query: 472 PKXXXXXXXXXXXXXXXXXXXXXKDKCTIQ 501
P KDKCT+Q
Sbjct: 462 PMQRKTSSKSSSVSDRSIT----KDKCTVQ 487
|
|
| TAIR|locus:2081383 NEK6 ""NIMA (never in mitosis, gene A)-related 6"" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 1.9e-136, Sum P(3) = 1.9e-136
Identities = 207/331 (62%), Positives = 264/331 (79%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M+QYE++EQIG+G+FG+A+LV HK ERKKYVLKKIRLARQT+R RRSAHQEM LI+RV++
Sbjct: 5 MDQYELMEQIGRGAFGAAILVHHKAERKKYVLKKIRLARQTERCRRSAHQEMSLIARVQH 64
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P+IVE+K++WVEKGCYVCI+ GYCEGGDMAE +KK+NGV+FPEEKLCKW QLL+A+ YL
Sbjct: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGVYFPEEKLCKWFTQLLLAVEYL 124
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H+N++LHRD+KCSNIFLT+DQD+RLGDFGLAK L +DDL SSVVGTP+YMCPELLADIPY
Sbjct: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLTSSVVGTPNYMCPELLADIPY 184
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
G KSDIWSLGCC+YEM+A + AFKAFDM LI+K+N+S + PLP YS + + L+K MLR
Sbjct: 185 GFKSDIWSLGCCIYEMAAYRPAFKAFDMAGLISKVNRSSIGPLPPCYSPSLKALIKGMLR 244
Query: 241 KNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIH 300
KNPE+RP+A+E+L HP+LQPYV L+ + P + N ++ R E+ + +
Sbjct: 245 KNPEYRPNASEILKHPYLQPYVEQYRPTLSAA--SITPEK--PLNSREGRRSMAESQNSN 300
Query: 301 SNREKRQSFSNDRALN---PSVSE--TEQDS 326
S+ EK + +D+ + PS TE DS
Sbjct: 301 SSSEKDNFYVSDKNIRYVVPSNGNKVTETDS 331
|
|
| UNIPROTKB|P51957 NEK4 "Serine/threonine-protein kinase Nek4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 2.5e-70, Sum P(3) = 2.5e-70
Identities = 117/257 (45%), Positives = 175/257 (68%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y L +GKGS+G LV+H+ + K+YV+KK+ L + R RR+A QE +L+S++++P I
Sbjct: 6 YCYLRVVGKGSYGEVTLVKHRRDGKQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNI 65
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V YK+SW + I++G+CEGGD+ +K+ G PE ++ +W VQ+ MAL YLH
Sbjct: 66 VTYKESWEGGDGLLYIVMGFCEGGDLYRKLKEQKGQLLPENQVVEWFVQIAMALQYLHEK 125
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGS 182
HILHRD+K N+FLTR I++GD G+A++L + D+AS+++GTP YM PEL ++ PY
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHCDMASTLIGTPYYMSPELFSNKPYNY 185
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
KSD+W+LGCCVYEM+ K AF A DM +L+ +I + + P+P YS L+++ML K
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPRDYSPELAELIRTMLSKR 245
Query: 243 PEFRPSAAELLCHPHLQ 259
PE RPS +L P+++
Sbjct: 246 PEERPSVRSILRQPYIK 262
|
|
| ZFIN|ZDB-GENE-040426-1392 nek4 "NIMA (never in mitosis gene a)-related kinase 4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 648 (233.2 bits), Expect = 1.2e-67, Sum P(2) = 1.2e-67
Identities = 127/311 (40%), Positives = 199/311 (63%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M+ Y + +GKGS+G LVRHK +RK+YV+KK+ L + R RR+A QE +L+S++++
Sbjct: 1 MDGYLFVRVVGKGSYGEVNLVRHKSDRKQYVIKKLNLRTSSRRERRAAEQEAQLLSQLKH 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P IV Y++SW + C + I++G+CEGGD+ +K+ G PE ++ +W VQ+ MAL YL
Sbjct: 61 PNIVMYRESWEGEDCQLYIVMGFCEGGDLYHRLKQQKGELLPERQVVEWFVQIAMALQYL 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIP 179
H HILHRD+K NIFLT+ I++GD G+A++L + +D+AS+++GTP YM PEL ++ P
Sbjct: 121 HEKHILHRDLKTQNIFLTKTNIIKVGDLGIARVLENQNDMASTLIGTPYYMSPELFSNKP 180
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
Y KSD+W+LGCCVYEM+ K AF A DM +L+ +I + + +P+ Y L+K ML
Sbjct: 181 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIVEGKLPQMPSKYDPQLGELIKRML 240
Query: 240 RKNPEFRPSAAELLCHPHLQPYVLGIHL-----KLNGPRRNT----FPLEWSDSNFKKTR 290
K PE RP +L P+++ + + + L K R+N SD++ K +
Sbjct: 241 CKKPEDRPDVKHILRQPYIK-HQISMFLEATKEKTAKSRKNAANGKLNSAGSDASTKPNQ 299
Query: 291 FMEPEAISIHS 301
++P+ ++ S
Sbjct: 300 VVQPQCLNSES 310
|
|
| UNIPROTKB|E2QRX7 NEK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 645 (232.1 bits), Expect = 2.3e-66, Sum P(2) = 2.3e-66
Identities = 120/285 (42%), Positives = 189/285 (66%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y L +G+GS+G LVRH+ + ++YV+KK+ L + R RR+A QE +L+S++++P I
Sbjct: 6 YCYLRVVGRGSYGEVTLVRHRRDGRQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNI 65
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V YK+SW + I++G+CEGGD+ +K+ G PE ++ +W VQ+ MAL YLH
Sbjct: 66 VTYKESWEGGDGLLYIVMGFCEGGDLYRKLKERKGQLLPESQVVEWFVQIAMALQYLHEK 125
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGS 182
HILHRD+K N+FLTR I++GD G+A++L ++ D+A++++GTP YM PEL ++ PY
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENNGDMANTLIGTPYYMSPELFSNKPYNY 185
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
KSD+W+LGCCVYEM+ K AF A DM +L+ +I + + P+P YS L+++ML K
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELSELIRTMLSKR 245
Query: 243 PEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFK 287
PE RPS +L P+++ + + + L+ + + ++ SDS K
Sbjct: 246 PEERPSVRSILRQPYIK-HQISLFLEATKAKTSKSNIKSSDSKSK 289
|
|
| UNIPROTKB|F6V6J5 NEK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 645 (232.1 bits), Expect = 2.3e-66, Sum P(2) = 2.3e-66
Identities = 120/285 (42%), Positives = 189/285 (66%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y L +G+GS+G LVRH+ + ++YV+KK+ L + R RR+A QE +L+S++++P I
Sbjct: 6 YCYLRVVGRGSYGEVTLVRHRRDGRQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNI 65
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V YK+SW + I++G+CEGGD+ +K+ G PE ++ +W VQ+ MAL YLH
Sbjct: 66 VTYKESWEGGDGLLYIVMGFCEGGDLYRKLKERKGQLLPESQVVEWFVQIAMALQYLHEK 125
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGS 182
HILHRD+K N+FLTR I++GD G+A++L ++ D+A++++GTP YM PEL ++ PY
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENNGDMANTLIGTPYYMSPELFSNKPYNY 185
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
KSD+W+LGCCVYEM+ K AF A DM +L+ +I + + P+P YS L+++ML K
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELSELIRTMLSKR 245
Query: 243 PEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFK 287
PE RPS +L P+++ + + + L+ + + ++ SDS K
Sbjct: 246 PEERPSVRSILRQPYIK-HQISLFLEATKAKTSKSNIKSSDSKSK 289
|
|
| UNIPROTKB|E1BWZ5 NEK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 639 (230.0 bits), Expect = 1.3e-65, Sum P(2) = 1.3e-65
Identities = 123/321 (38%), Positives = 199/321 (61%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y L +GKGS+G LVRH+ + K+YV+KK+ L + R R++A QE +L+S++++P I
Sbjct: 6 YCFLRAVGKGSYGEVSLVRHRQDSKQYVIKKLNLKHASSRERKAAEQEAQLLSQLKHPNI 65
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V Y++SW + + I++G+CEGGD+ +K+ G PE ++ +W VQ+ MAL YLH
Sbjct: 66 VAYRESWQGEDGLLYIVMGFCEGGDLYHRLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 125
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGS 182
HILHRD+K N+FLTR I++GD G+A++L + D+AS+++GTP YM PEL ++ PY
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 185
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
KSD+W+LGCCVYEM+ K AF A DM +L+ +I + + P+P YS ++++ML K
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPQLVEIIQTMLSKR 245
Query: 243 PEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSN 302
PE RPS +L P+++ + + + L+ + + + S K + + P H+
Sbjct: 246 PEQRPSVKSILRQPYIK-HQISLFLEATKMKAAKSHKKMAGSKLKDSSSVVPVKNESHNK 304
Query: 303 REKRQSFSNDRALNPSVSETE 323
S+++ V+E +
Sbjct: 305 NVIPPDSSSEQGRKCRVNEED 325
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q2QMH1 | NEK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6504 | 0.9573 | 0.9881 | yes | no |
| A2ZMH2 | NEK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.6482 | 0.9590 | 0.9898 | N/A | no |
| Q9CAU7 | NEK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5996 | 0.9590 | 0.9653 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00023772001 | SubName- Full=Chromosome chr7 scaffold_31, whole genome shotgun sequence; (614 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 610 | |||
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-124 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-86 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-81 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-79 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-74 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-71 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-71 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-70 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-70 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-69 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-67 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-65 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-63 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-59 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-59 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-54 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-52 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-50 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-49 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-49 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-48 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-47 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-46 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-45 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-45 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-44 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-43 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-42 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-42 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-41 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-41 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-40 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-40 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-39 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-39 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-39 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-39 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-37 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-37 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-37 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-37 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-37 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-36 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-35 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-35 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-35 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-33 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-33 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-33 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-32 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-32 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-32 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-31 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-31 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-31 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-31 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-31 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-31 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-31 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-30 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-30 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-30 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-30 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-30 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-29 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-29 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-29 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-29 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-28 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-28 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-28 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-28 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-28 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-28 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-27 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-27 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-27 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-27 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-26 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-26 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-26 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-26 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-26 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-26 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-26 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-26 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-26 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-25 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-25 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-25 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-25 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-25 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-25 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-25 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-25 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-25 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-24 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-24 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-24 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-23 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-23 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-23 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-23 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-23 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-23 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-22 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-22 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-22 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-21 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-21 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-20 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-18 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-17 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-16 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 366 bits (943), Expect = e-124
Identities = 122/259 (47%), Positives = 177/259 (68%), Gaps = 4/259 (1%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+YE+++QIGKGSFG LVR K + K YVLK+I L+ +++ R A E++++ ++ +P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYL 120
I++Y +S+ EKG +CI++ Y +GGD+++ IKK G FPEE++ W VQL +AL YL
Sbjct: 61 IIKYYESFEEKG-KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIP 179
H+ ILHRD+K NIFLT + ++LGDFG++K+L S DLA +VVGTP Y+ PEL + P
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
Y KSDIWSLGC +YE+ K F+ ++ L KI K P+P+ YS R LV S+L
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239
Query: 240 RKNPEFRPSAAELLCHPHL 258
+K+PE RPS A++L P +
Sbjct: 240 QKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 268 bits (686), Expect = 6e-86
Identities = 115/256 (44%), Positives = 174/256 (67%), Gaps = 1/256 (0%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y + +GKGS+G LVRH+ + K+YV+KK+ L + R R++A QE +L+S++++P I
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V Y++SW + + I++G+CEGGD+ +K+ G PE ++ +W VQ+ MAL YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGS 182
HILHRD+K N+FLTR I++GD G+A++L + D+AS+++GTP YM PEL ++ PY
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
KSD+W+LGCCVYEM+ K AF A DM +L+ +I + + P+P YS L+ +ML K
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKR 241
Query: 243 PEFRPSAAELLCHPHL 258
PE RPS +L P++
Sbjct: 242 PEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 256 bits (657), Expect = 1e-81
Identities = 93/256 (36%), Positives = 142/256 (55%), Gaps = 7/256 (2%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
YE+LE++G+GSFG L R K K +K I+ + R +E++++ ++++P I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNI 59
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V D + ++ + +++ YCEGGD+ + +KK E++ +L Q+L AL YLH+
Sbjct: 60 VRLYDVFEDED-KLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSK 116
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 183
I+HRD+K NI L D ++L DFGLA+ L + ++ VGTP YM PE+L YG
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 184 SDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLP--TVYSGAFRGLVKSMLR 240
DIWSLG +YE+ K F D + L KI K P S + L++ +L
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 241 KNPEFRPSAAELLCHP 256
K+PE R +A E L HP
Sbjct: 237 KDPEKRLTAEEALQHP 252
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 251 bits (642), Expect = 2e-79
Identities = 107/252 (42%), Positives = 173/252 (68%), Gaps = 2/252 (0%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+Y +++IG+GSFG A+LV+ K + K+YV+K+I +++ + + R + +E+ ++S +++P
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
IV+Y++S+ E G + I++ YCEGGD+ + I GV FPE+++ W VQ+ +AL ++H
Sbjct: 61 IVQYQESFEENGN-LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYG 181
ILHRD+K NIFLT+D I+LGDFG+A++L S +LA + +GTP Y+ PE+ + PY
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241
+KSDIW+LGC +YEM K AF+A +M+ L+ KI + P+ + YS R LV + ++
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239
Query: 242 NPEFRPSAAELL 253
NP RPS +L
Sbjct: 240 NPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 1e-74
Identities = 107/263 (40%), Positives = 152/263 (57%), Gaps = 9/263 (3%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
YEVLE IGKGSFG+ VR K + K V K+I T++ ++ E+ ++ +++P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 63 IVEYKDSWVEKGCYVC-IIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNY 119
IV Y D +++ I++ YCEGGD+A+ I+K + EE + + L QLL+AL
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 120 LH-----ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE 173
H N +LHRD+K +NIFL + +++LGDFGLAK+L A + VGTP YM PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233
L + Y KSDIWSLGC +YE+ A F A + L +KI + +P YS
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE 240
Query: 234 LVKSMLRKNPEFRPSAAELLCHP 256
++KSML +P+ RPS ELL P
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 2e-71
Identities = 106/252 (42%), Positives = 165/252 (65%), Gaps = 3/252 (1%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
QY VL +G+GSFG ALLV+H + +KY +K+IRL + + S +E L++++++P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPN 59
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
IV +K+S+ G ++ I++ YC+GGD+ + IK G FPE+ + +W VQ+ + + ++H
Sbjct: 60 IVAFKESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYG 181
+LHRD+K NIFLT++ ++LGDFG A++L S A + VGTP Y+ PE+ ++PY
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241
+KSDIWSLGC +YE+ K F+A + LI K+ + PLP+ YS R L+K M ++
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238
Query: 242 NPEFRPSAAELL 253
NP RPSA +L
Sbjct: 239 NPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 7e-71
Identities = 100/256 (39%), Positives = 156/256 (60%), Gaps = 2/256 (0%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y + +GKG+FG A L R + V K++ L R +++ RR A E+ ++S +++P I
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
+ Y + +++ + I + Y GG + + I + G F EE + +L Q++ A++Y+H
Sbjct: 62 IAYYNHFMDDNTLL-IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGS 182
ILHRD+K NIFLT+ I+LGDFG++K+L S+ +A +VVGTP YM PEL + Y
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
KSDIW+LGC +YE+ K F A + L+ KI + P+ +VYS LV S+L+++
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240
Query: 243 PEFRPSAAELLCHPHL 258
PE RP+A E+L P L
Sbjct: 241 PEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 1e-70
Identities = 91/261 (34%), Positives = 146/261 (55%), Gaps = 11/261 (4%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
YE+L ++G GSFG+ +HK K +K ++ + + ++A +E+ ++ R+ +P I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V D++ +K ++ +++ YCEGGD+ + + + E++ K +Q+L L YLH+N
Sbjct: 61 VRLIDAFEDKD-HLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN 117
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLAD-IPYG 181
I+HRD+K NI L + +++ DFGLAK L+ S ++ VGTP YM PE+L YG
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 182 SKSDIWSLGCCVYEMSAQKAAF---KAFDMQALINKINKSIV-APLPTVYSG--AFRGLV 235
K D+WSLG +YE+ K F D LI +I + P SG + L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 236 KSMLRKNPEFRPSAAELLCHP 256
K L K+P RP+A E+L HP
Sbjct: 238 KKCLNKDPSKRPTAEEILQHP 258
|
Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 227 bits (579), Expect = 4e-70
Identities = 93/256 (36%), Positives = 157/256 (61%), Gaps = 2/256 (0%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
+E+L +IGKGSFG V K +++ Y +K+I L++ R R A E +++++ + +I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
+ Y +S+++KG + I++ Y E GD+ + +K G PE+++ ++ +Q+L+ L +LH+
Sbjct: 62 IRYYESFLDKG-KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIPYGS 182
ILHRD+K N+FL ++++GD G+AK+L + + A+++VGTP Y+ PEL D PY
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
KSD+W+LG +YE K F A + ALI KI + + P+ +YS L+ L K+
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 243 PEFRPSAAELLCHPHL 258
RP +LL +P L
Sbjct: 241 YRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 4e-69
Identities = 92/258 (35%), Positives = 157/258 (60%), Gaps = 4/258 (1%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
++VL+++GKGS+GS V+ + + Y LK++ L + + R A E+ +++ V +P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYL 120
I+ YK+++++ G +CI++ Y GD+++AI K PE+++ + +QLL L L
Sbjct: 61 IISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H ILHRD+K +NI L + +++GD G++K+L + +A + +GTP YM PE+ PY
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPY 178
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
KSDIWSLGC +YEM+ F+A MQ L K+ + P+P +YS + ++SML+
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238
Query: 241 KNPEFRPSAAELLCHPHL 258
P+ RP+ ++L P +
Sbjct: 239 VKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 6e-67
Identities = 90/255 (35%), Positives = 146/255 (57%), Gaps = 6/255 (2%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
+E+LE+IGKG FG RHK K+ +K I+L ++ + E++++ + ++P I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL--ESKEKKEKIINEIQILKKCKHPNI 59
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V+Y S+++K + I++ +C GG + + +K N E ++ +LL L YLH+N
Sbjct: 60 VKYYGSYLKKD-ELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN 117
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 183
I+HRD+K +NI LT D +++L DFGL+ L +++VGTP +M PE++ PY K
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 184 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRK 241
+DIWSLG E++ K + + KI + L P +S F+ +K L+K
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237
Query: 242 NPEFRPSAAELLCHP 256
NPE RP+A +LL HP
Sbjct: 238 NPEKRPTAEQLLKHP 252
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 5e-65
Identities = 95/255 (37%), Positives = 158/255 (61%), Gaps = 2/255 (0%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+YE + +G+G+FG L R K ++K ++K+I + + T R +A E +++ + +P
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
I+EY ++++E + I++ Y GG +AE I+K E+ + + VQ+L+AL+++H
Sbjct: 61 IIEYYENFLEDKA-LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 123 NHILHRDVKCSNIFLTRDQDI-RLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 181
ILHRD+K NI L + + + ++GDFG++K+L S A +VVGTP Y+ PEL PY
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241
KSDIW+LGC +YE+++ K AF+A ++ AL+ KI AP+ YS R L+ SML
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239
Query: 242 NPEFRPSAAELLCHP 256
+P RP ++++ P
Sbjct: 240 DPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 7e-63
Identities = 106/263 (40%), Positives = 166/263 (63%), Gaps = 10/263 (3%)
Query: 3 QYEVLEQIGKGSFGSALLVRHK----HERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
+Y + +++GKGSFG+ LV+ K ER K VLK+I + A+QE +L+S++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLK-VLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLVQLLMA 116
+P IV++ S++E+ + CII YCEG D+ ++ K G E ++C+W +QLL+
Sbjct: 60 DHPAIVKFHASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELL 175
++Y+H ILHRD+K NIFL ++ +++GDFG++++L+ S DLA++ GTP YM PE L
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235
Y SKSDIWSLGC +YEM AF+ + +++ +I + LP YS ++
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237
Query: 236 KSMLRKNPEFRPSAAELLCHPHL 258
+SML K+P RPSAAE+L +P +
Sbjct: 238 QSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 3e-62
Identities = 84/250 (33%), Positives = 133/250 (53%), Gaps = 38/250 (15%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDS 69
+G+G FG+ L R K KK +K I+ + +E+E++ ++ +P IV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK-EDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 70 WVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRD 129
+ ++ +++ YCEGG + + +K+ N E+++ + L+Q+L L YLH+N I+HRD
Sbjct: 60 FEDENHL-YLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 130 VKCSNIFLTRDQD-IRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIP-YGSKSDI 186
+K NI L D ++L DFGL+K+L SD L ++VGTP+YM PE+L Y KSDI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 187 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 246
WSLG +YE+ + L++ ML+K+PE R
Sbjct: 178 WSLGVILYELP--------------------------------ELKDLIRKMLQKDPEKR 205
Query: 247 PSAAELLCHP 256
PSA E+L H
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 198 bits (507), Expect = 2e-59
Identities = 90/260 (34%), Positives = 141/260 (54%), Gaps = 8/260 (3%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
++ E +G+GSFGS L K + +K + L+ ++ + +E+ ++S +++P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 63 IVEYKDS-WVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV Y S E+ + I + Y GG ++ +KK G PE + K+ Q+L L YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FG-KLPEPVIRKYTRQILEGLAYLH 118
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA---SSVVGTPSYMCPELLADI 178
+N I+HRD+K +NI + D ++L DFG AK L + SV GTP +M PE++
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVAP-LPTVYSGAFRGLVK 236
YG +DIWSLGC V EM+ K + + A + KI S P +P S + ++
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 237 SMLRKNPEFRPSAAELLCHP 256
LR++P+ RP+A ELL HP
Sbjct: 239 KCLRRDPKKRPTADELLQHP 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 3e-59
Identities = 94/258 (36%), Positives = 163/258 (63%), Gaps = 3/258 (1%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+YE++++IG+GSFG L + K + + V+K+I L + + + ++ +E+ L++++++P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
IV + S+ E G + I++ YC+GGD+ + I + GV F E+++ W VQ+ + L ++H
Sbjct: 61 IVTFFASFQENG-RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 123 NHILHRDVKCSNIFLTRDQDI-RLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIPY 180
ILHRD+K NIFL+++ + +LGDFG+A+ L S +LA + VGTP Y+ PE+ + PY
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
+K+DIWSLGC +YE+ K F+ ++ L+ KI + AP+ +S R L+ + +
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239
Query: 241 KNPEFRPSAAELLCHPHL 258
+P RPS +L P L
Sbjct: 240 VSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 3e-54
Identities = 89/253 (35%), Positives = 135/253 (53%), Gaps = 11/253 (4%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEME--LISRVRNPFIVEYK 67
+GKGSFG LLVR K K Y +K ++ + R + H E ++SR+ +PFIV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
++ + + +++ Y GG++ + K F EE+ + ++++AL YLH+ I++
Sbjct: 60 YAFQTEE-KLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDI 186
RD+K NI L D I+L DFGLAK L S+ ++ GTP Y+ PE+L YG D
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 187 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 246
WSLG +YEM K F A D + + KI K + P S R L+ +L+K+P R
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR-FPEFLSPEARDLISGLLQKDPTKR 235
Query: 247 ---PSAAELLCHP 256
A E+ HP
Sbjct: 236 LGSGGAEEIKAHP 248
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 6e-52
Identities = 87/266 (32%), Positives = 140/266 (52%), Gaps = 10/266 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E ++ +G+GS G VRHK K Y LKKI + + R+ +E++ + +P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF-RKQLLRELKTLRSCESP 59
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
++V+ + K + I++ Y +GG +A+ +KK PE L Q+L L+YLH
Sbjct: 60 YVVKCYGA-FYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLH 116
Query: 122 AN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIP 179
HI+HRD+K SN+ + ++++ DFG++K+L + D ++ VGT +YM PE +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKA---FDMQALINKINKSIVAPLP-TVYSGAFRGLV 235
Y +DIWSLG + E + K F L+ I LP +S FR +
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236
Query: 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261
+ L+K+P+ RPSAAELL HP ++
Sbjct: 237 SACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 1e-50
Identities = 89/260 (34%), Positives = 146/260 (56%), Gaps = 8/260 (3%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVR 59
+ +++ ++IGKG F + + LKK+++ D +AR+ +E++L+ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLVQLLMAL 117
+P +++Y S++E + I++ + GD++ IK K PE + K+ VQL AL
Sbjct: 61 HPNVIKYLASFIENN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-SVVGTPSYMCPELLA 176
++H+ I+HRD+K +N+F+T ++LGD GL + S A+ S+VGTP YM PE +
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ--ALINKINKSIVAPLPT-VYSGAFRG 233
+ Y KSDIWSLGC +YEM+A ++ F M +L KI K PLP YS R
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239
Query: 234 LVKSMLRKNPEFRPSAAELL 253
LV + +PE RP + +L
Sbjct: 240 LVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 89/262 (33%), Positives = 137/262 (52%), Gaps = 18/262 (6%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
Y++ + IG+G+FG + +K+I L + + A +S QE++L+ +++P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
IV+Y S +E + II+ Y E G + + IKK FPE + ++ Q+L L YLH
Sbjct: 61 IVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHE 117
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-SVVGTPSYMCPELLADIPYG 181
++HRD+K +NI T+D ++L DFG+A L SVVGTP +M PE++
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIVA----PLPTVYSGAFRGL 234
+ SDIWSLGC V E+ + +D M AL IV PLP S +
Sbjct: 178 TASDIWSLGCTVIELLTGNPPY--YDLNPMAALFR-----IVQDDHPPLPEGISPELKDF 230
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
+ +K+P RP+A +LL HP
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHP 252
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 6e-49
Identities = 87/258 (33%), Positives = 140/258 (54%), Gaps = 15/258 (5%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRL--------ARQTDRARRSAHQEMEL 54
Y VLE +G G+FG VR K+ + + LK+I + R+ D++ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 55 I-SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLV 111
I ++R+P IV Y +++E + I++ EG + E K F EE++ V
Sbjct: 62 IKEQLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 112 QLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYM 170
Q+++AL YLH I+HRD+ +NI L D + + DFGLAK + +SVVGT Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 171 CPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-TVYSG 229
CPE++ + PYG K+D+W+ GC +Y+M + F + +M +L KI +++ PLP +YS
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 230 AFRGLVKSMLRKNPEFRP 247
++ S L + E RP
Sbjct: 241 DVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 7e-49
Identities = 85/254 (33%), Positives = 140/254 (55%), Gaps = 8/254 (3%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRAR---RSAHQEMELISRVRNPFIV 64
E +G GSFGS + + + +K++ LA + + QE+ L+S++++P IV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
+Y + E+ + I + GG +A+ +KK FPE + + Q+L+ L YLH +
Sbjct: 66 QYLGTEREEDN-LYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRN 122
Query: 125 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-PYGSK 183
+HRD+K +NI + + ++L DFG+AK ++ A S G+P +M PE++A YG
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182
Query: 184 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKN 242
+DIWSLGC V EM+ K + + A + KI +S P +P S + + L+++
Sbjct: 183 ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRD 242
Query: 243 PEFRPSAAELLCHP 256
P RP+AAELL HP
Sbjct: 243 PSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 4e-48
Identities = 89/262 (33%), Positives = 144/262 (54%), Gaps = 10/262 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E Y+ LE+IG+G+ G + K+ +KK+RL +Q + E+ ++ ++P
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN---KELIINEILIMKDCKHP 75
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV+Y DS++ + +++ Y +GG + + I + N V E ++ ++L L YLH
Sbjct: 76 NIVDYYDSYLVGD-ELWVVMEYMDGGSLTDIITQ-NFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPY 180
+ +++HRD+K NI L++D ++L DFG A L + +SVVGTP +M PE++ Y
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPL--PTVYSGAFRGLVKS 237
G K DIWSLG EM+ + + ++AL I + PL P +S F+ +
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIPPLKNPEKWSPEFKDFLNK 252
Query: 238 MLRKNPEFRPSAAELLCHPHLQ 259
L K+PE RPSA ELL HP L+
Sbjct: 253 CLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 88/261 (33%), Positives = 135/261 (51%), Gaps = 15/261 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E + +LE IGKGSFG K + +K I L D QE++ +S+ R+P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ-QEIQFLSQCRSP 59
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+I +Y S++ KG + II+ YC GG + +K E + L ++L+ L YLH
Sbjct: 60 YITKYYGSFL-KGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLH 115
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLADIPY 180
+HRD+K +NI L+ + D++L DFG++ L S ++ VGTP +M PE++ Y
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTV----YSGAFRGLV 235
K+DIWSLG E++ + M+ L I K+ P++ +S F+ V
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKN---NPPSLEGNKFSKPFKDFV 231
Query: 236 KSMLRKNPEFRPSAAELLCHP 256
L K+P+ RPSA ELL H
Sbjct: 232 SLCLNKDPKERPSAKELLKHK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 86/266 (32%), Positives = 136/266 (51%), Gaps = 18/266 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E YE++++IG G++G R + +K I+L D QE+ ++ R+P
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE--IIQQEISMLKECRHP 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV Y S++ + + I++ YC GG + + + G E ++ + L L YLH
Sbjct: 61 NIVAYFGSYL-RRDKLWIVMEYCGGGSLQDIYQVTRG-PLSELQIAYVCRETLKGLAYLH 118
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELLA--- 176
+HRD+K +NI LT D D++L DFG++ ++ +A S +GTP +M PE+ A
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSA-QLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 177 DIPYGSKSDIWSLGCCVYEMS-AQKAAFKAFDMQALINKINKSIVAPLPTV-----YSGA 230
Y K DIW+LG E++ Q F M+AL I+KS P P + +S
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFPP-PKLKDKEKWSPV 235
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHP 256
F +K L K+P+ RP+A +LL HP
Sbjct: 236 FHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 2e-45
Identities = 81/289 (28%), Positives = 143/289 (49%), Gaps = 45/289 (15%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLK---KIRLARQTDRARRSAHQEMELISRV 58
+ ++ + IG+GSF + +L + K K+Y +K K +L ++ + + E E+++R+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE--KKVKYVKIEKEVLTRL 58
Query: 59 -RNPFIVE----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV-Q 112
+P I++ ++D E +V + Y G++ + I+K + +EK ++ +
Sbjct: 59 NGHPGIIKLYYTFQDE--ENLYFV---LEYAPNGELLQYIRKYGSL---DEKCTRFYAAE 110
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL------------- 159
+L+AL YLH+ I+HRD+K NI L +D I++ DFG AK+L +
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 160 --------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 211
+S VGT Y+ PELL + P G SD+W+LGC +Y+M K F+ +
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 212 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP----SAAELLCHP 256
KI K + P + + L++ +L +P+ R EL HP
Sbjct: 231 FQKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 88/267 (32%), Positives = 141/267 (52%), Gaps = 27/267 (10%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E +++LE++G+GS+GS HK + +K + + + +E+ ++ + +P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSP 58
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGG---DMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+IV+Y S+ + + I++ YC G D+ + K EE++ L Q L L
Sbjct: 59 YIVKYYGSYFKNT-DLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKGLE 113
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD 177
YLH+N +HRD+K NI L + +L DFG++ L ++V+GTP +M PE++ +
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIVAPLPTV-----YSG 229
I Y +K+DIWSLG EM+ K + D M+A+ NK P PT+ +S
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPY--SDIHPMRAIFMIPNK----PPPTLSDPEKWSP 227
Query: 230 AFRGLVKSMLRKNPEFRPSAAELLCHP 256
F VK L K+PE RPSA +LL HP
Sbjct: 228 EFNDFVKKCLVKDPEERPSAIQLLQHP 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-44
Identities = 89/272 (32%), Positives = 140/272 (51%), Gaps = 25/272 (9%)
Query: 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV 64
E L ++G G+ G V H+ K +K IRL + ++ +E++++ + +P+IV
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIV 62
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
+ ++ G + I + Y +GG + + +K+ G PE L K V +L L YLH H
Sbjct: 63 GFYGAFYNNG-DISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEKH 120
Query: 125 -ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 183
I+HRDVK SNI + I+L DFG++ L+ + LA + VGT SYM PE + Y K
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 184 SDIWSLGCCVYEMSAQKAAFKA--------FD-MQALINKINKSIVAPLPT----VYSGA 230
SDIWSLG + E++ + + F+ +Q ++N+ P P +S
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-------PPPRLPSGKFSPD 232
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262
F+ V L K+P RPS ELL HP ++ Y
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 87/254 (34%), Positives = 147/254 (57%), Gaps = 8/254 (3%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVR 59
+ +++ ++IG+G F +RK LKK+++ D +AR+ +E++L+ ++
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLVQLLMAL 117
+P +++Y DS++E + I++ + GD+++ IK K PE + K+ VQL A+
Sbjct: 61 HPNVIKYLDSFIEDN-ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-SVVGTPSYMCPELLA 176
++H+ ++HRD+K +N+F+T ++LGD GL + S A+ S+VGTP YM PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ--ALINKINKSIVAPLPTV-YSGAFRG 233
+ Y KSDIWSLGC +YEM+A ++ F M +L KI + PLPT YS R
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239
Query: 234 LVKSMLRKNPEFRP 247
LV + +P+ RP
Sbjct: 240 LVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 74/255 (29%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKK---IRLARQTDRARRSAHQEMELI 55
+ +E ++ +G GSFG +LVRHK K Y +L K ++L +Q + E ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL-KQVEHV----LNEKRIL 55
Query: 56 SRVRNPFIVE----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
+R+PF+V ++D + +++ Y GG++ ++K+ FPE +
Sbjct: 56 QSIRHPFLVNLYGSFQDDS-----NLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAA 108
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMC 171
Q+++AL YLH+ I++RD+K N+ L D I++ DFG AK + ++ GTP Y+
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLA 166
Query: 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231
PE++ YG D W+LG +YEM A F + + KI + V P+ +S
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR-FPSFFSPDA 225
Query: 232 RGLVKSMLRKNPEFR 246
+ L++++L+ + R
Sbjct: 226 KDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 5e-42
Identities = 71/256 (27%), Positives = 123/256 (48%), Gaps = 24/256 (9%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRAR-RSAHQEMELISRVRNP 61
+E+L IGKG+FG +V+ + +K + +K + + ++ R+ E ++ + +P
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 62 FIV----EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
F+V ++D E+ Y +++ GGD+ + + V F EE++ W+ ++++AL
Sbjct: 61 FLVNLWYSFQD---EENMY--LVVDLLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLAL 113
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
YLH+ I+HRD+K NI L + + DF +A + D L +S GTP YM PE+L
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-------PLPTVYSGA 230
Y D WSLG YE K ++ I I A P +S
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHS-----RTIRDQIRAKQETADVLYPATWSTE 228
Query: 231 FRGLVKSMLRKNPEFR 246
+ +L ++P+ R
Sbjct: 229 AIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 6e-42
Identities = 82/260 (31%), Positives = 134/260 (51%), Gaps = 18/260 (6%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDS 69
IG G+FG + + +K+IR+ + + EM+++ +++P +V+Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 70 WVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRD 129
V + V I + YC GG + E ++ +G E + + +QLL L YLH++ I+HRD
Sbjct: 68 EVHRE-KVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 130 VKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-----SSVVGTPSYMCPELLADIP---YG 181
+K +NIFL + I+LGDFG A L ++ S+ GTP+YM PE++ +G
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
+DIWSLGC V EM+ K + D + ++ + P+P S K L
Sbjct: 185 RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD--SLQLSPEGKDFLD 242
Query: 241 K----NPEFRPSAAELLCHP 256
+ +P+ RP+A+ELL HP
Sbjct: 243 RCLESDPKKRPTASELLQHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 8e-41
Identities = 84/267 (31%), Positives = 145/267 (54%), Gaps = 14/267 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ-EMELISRVRN 60
+ +E++ ++G G+FG +HK K I++ E++++S ++
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKH 61
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P IV +++ + + I+I +C+GG + ++I E ++ Q+L ALN+L
Sbjct: 62 PNIVGLYEAYFYEN-KLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSYMCPELLA--- 176
H++ ++HRD+K NI LT D D++L DFG+ AK + + +GTP +M PE++A
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 177 --DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFR 232
D PY K+DIWSLG + E++ + + ++ KI KS L P+ +S +F
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239
Query: 233 GLVKSMLRKNPEFRPSAAELLCHPHLQ 259
+KS L K+P+ RP+AAELL HP +
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 9e-41
Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 24/272 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRN 60
+ YE++E IG G+ +K +K+I L + QT +E++ +S+ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV--DELRKEVQAMSQCNH 58
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALN 118
P +V+Y S+V + +++ Y GG + + +K + G E + L ++L L
Sbjct: 59 PNVVKYYTSFVVGDE-LWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLE 116
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS-----VVGTPSYMCPE 173
YLH+N +HRD+K NI L D +++ DFG++ L + VGTP +M PE
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 174 LLA-DIPYGSKSDIWSLGCCVYEMSAQKAAF-KAFDMQALINKINKSIVAP--LPT---- 225
++ Y K+DIWS G E++ A + K M+ L+ + P L T
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADY 233
Query: 226 -VYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
YS +FR ++ L+K+P RP+A ELL H
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 83/284 (29%), Positives = 124/284 (43%), Gaps = 35/284 (12%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
YE LE++G+G++G R K + LKKIRL + + +A +E+ L+ +++P I
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V+ D + + ++ YC+ D+ + + K + + QLL L Y H++
Sbjct: 61 VKLLDVIHTERK-LYLVFEYCDM-DLKKYLDK-RPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPE-LLADIPYG 181
ILHRD+K NI + RD ++L DFGLA+ + V T Y PE LL Y
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYS 177
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------------------NKSIVAP 222
+ DIWS+GC EM K F + KI + P
Sbjct: 178 TAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237
Query: 223 ----------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
LP + L+ ML+ NP R SA E L HP
Sbjct: 238 KFPPKDLEKVLPRLDPEGID-LLSKMLQYNPAKRISAKEALKHP 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 5e-40
Identities = 84/254 (33%), Positives = 143/254 (56%), Gaps = 8/254 (3%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVR 59
+ + + ++IG+G F + LKK+++ D +AR +E++L+ ++
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLVQLLMAL 117
+P +++Y S++E + I++ + GD++ IK K PE+ + K+ VQL AL
Sbjct: 61 HPNVIKYYASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-SVVGTPSYMCPELLA 176
++H+ ++HRD+K +N+F+T ++LGD GL + S A+ S+VGTP YM PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAF--KAFDMQALINKINKSIVAPLPT-VYSGAFRG 233
+ Y KSDIWSLGC +YEM+A ++ F ++ +L KI + PLP+ YS R
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 234 LVKSMLRKNPEFRP 247
LV + +PE RP
Sbjct: 240 LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 25/265 (9%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLA-----RQTDRARRSAHQEMELISRVRNPFIV 64
I KG++G L + K Y +K I+ A Q D+ E +++S+ ++P++V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL----TERDILSQAQSPYVV 56
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
+ S+ K + +++ Y GGD+A ++ E+ ++ ++++AL YLH+N
Sbjct: 57 KLYYSFQGKK-NLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG 113
Query: 125 ILHRDVKCSNIFLTRDQDIRLGDFGLAK---------MLISDDLASSVVGTPSYMCPELL 175
I+HRD+K NI + + ++L DFGL+K + + +VGTP Y+ PE++
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGL 234
+ D WSLGC +YE F + + I N I P S L
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 235 VKSMLRKNPEFRP---SAAELLCHP 256
+ +L +PE R S E+ HP
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHP 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 80/255 (31%), Positives = 131/255 (51%), Gaps = 11/255 (4%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARR---SAHQEMELISRVRNPFIVEY 66
+G+G+FG L ++ +K++ + ++ + E++L+ +++ IV+Y
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 126
+ + I + Y GG + + +K A G E K+ Q+L + YLH+N I+
Sbjct: 70 YGCLRDDE-TLSIFMEYMPGGSVKDQLK-AYGA-LTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 127 HRDVKCSNIFLTRDQDIRLGDFGLAKML----ISDDLASSVVGTPSYMCPELLADIPYGS 182
HRD+K +NI +++LGDFG +K L S SV GTP +M PE+++ YG
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRK 241
K+D+WS+GC V EM +K + F+ A I KI P LP+ S R ++ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE 246
Query: 242 NPEFRPSAAELLCHP 256
N + RPSA ELL H
Sbjct: 247 NAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 77/286 (26%), Positives = 134/286 (46%), Gaps = 34/286 (11%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y+ L +IG+G++G R K + +KKI+L +++ ++A +E++L+ + +P I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
++ D + KG + ++ + + D+ + IK PE + +L QLL L + H++
Sbjct: 61 IKLLDVFRHKG-DLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPE-LLADIPYG 181
ILHRD+K N+ + + ++L DFGLA+ S + V T Y PE LL D Y
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----LPTVYSGAF------ 231
+ DIWS+GC E+ +++ F + KI +++ P P S A
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 232 -------------------RGLVKSMLRKNPEFRPSAAELLCHPHL 258
L+ ML +P R +A + L HP+
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 77/264 (29%), Positives = 138/264 (52%), Gaps = 17/264 (6%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ----TDRARRSAHQEMELISRVRNPFI 63
E +GKG++G+ ++ + +K++ L ++ +E++L+ +++ I
Sbjct: 6 EVLGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V+Y + ++ + I + + GG ++ + + PE CK+ Q+L + YLH N
Sbjct: 65 VQYLGTCLDD-NTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNN 121
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKML-------ISDDLASSVVGTPSYMCPELLA 176
++HRD+K +N+ L + I+L DFG A+ L ++ S+ GTP +M PE++
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI--NKSIVAPLPTVYSGAFRGL 234
+ YG KSDIWS+GC V+EM+ K + D A + I ++ ++ LP +S A
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDF 241
Query: 235 VKSMLRKNPEFRPSAAELLCHPHL 258
V S L ++ RPSA +LL H L
Sbjct: 242 VTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 72/246 (29%), Positives = 119/246 (48%), Gaps = 17/246 (6%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAH--QEMELISRVRNPFIVE-- 65
+G G FG LV+ K + + + LK ++ + + H E E++ +PFIV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET-GQQEHIFSEKEILEECNHPFIVKLY 59
Query: 66 --YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
+KD Y+ +++ YC GG++ ++ F E ++ +++A YLH
Sbjct: 60 RTFKDKK-----YIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNR 112
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 183
I++RD+K N+ L + ++L DFG AK L S + GTP Y+ PE++ + Y
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 184 SDIWSLGCCVYEMSAQKAAFKAFDMQALI--NKINKSI-VAPLPTVYSGAFRGLVKSMLR 240
D WSLG +YE+ + F D + N I K P A + L+K +LR
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232
Query: 241 KNPEFR 246
+NPE R
Sbjct: 233 RNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 71/288 (24%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+Y++L +IG+G+ G + + + LKK+ L R A +E++ + ++P+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
+V+ D + +V +++ Y D++E ++ PE ++ ++ LL + Y+HA
Sbjct: 61 VVKLLDVFPHGSGFV-LVMEYM-PSDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHA 117
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIP- 179
N I+HRD+K +N+ ++ D +++ DFGLA++ ++ L S V T Y PELL
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG---------- 229
Y D+W++GC E+ F + + + +++ P + G
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237
Query: 230 AFR-------------------GLVKSMLRKNPEFRPSAAELLCHPHL 258
F L+K +L +P R SAAE L HP+
Sbjct: 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-37
Identities = 90/265 (33%), Positives = 147/265 (55%), Gaps = 16/265 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E +E++ ++G G+FG ++K K I +++ E+E+++ +P
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHP 69
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDM-AEAIKKANGVHFPEEK-LCKWLVQLLMALNY 119
+IV+ ++ G + I+I +C GG + A ++ G+ P+ + +C+ Q+L AL Y
Sbjct: 70 YIVKLLGAFYWDG-KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR---QMLEALQY 125
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSYMCPEL---- 174
LH+ I+HRD+K N+ LT D DI+L DFG+ AK + + S +GTP +M PE+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 175 -LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAF 231
+ D PY K+DIWSLG + EM+ + + ++ KI KS L P+ +S F
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHP 256
R +K+ L K+PE RPSAA+LL HP
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHP 270
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 17/263 (6%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT----DRARRSAHQEMELISRVRNPFI 63
+Q+G G+F S R +K++ R T + + +E+ L++R+ +P I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
+ + E + + + + GG ++ + K F E + + QLL L+YLH N
Sbjct: 66 IRMLGATCEDSHF-NLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHEN 122
Query: 124 HILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLISD-----DLASSVVGTPSYMCPELLAD 177
I+HRDVK +N+ + + Q +R+ DFG A L + + ++GT ++M PE+L
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---ALINKINKSIVAP-LPTVYSGAFRG 233
YG D+WS+GC + EM+ K + A ALI KI + AP +P S R
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRD 242
Query: 234 LVKSMLRKNPEFRPSAAELLCHP 256
+ L PE RP + ELL HP
Sbjct: 243 VTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 142 bits (357), Expect = 4e-37
Identities = 98/360 (27%), Positives = 163/360 (45%), Gaps = 31/360 (8%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVR-NP 61
Y +L ++G+GSFG L R + K LK + ++ +E+++++ + P
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK-ANGVHFPEEKLCKWLVQLLMALNYL 120
IV+ D + ++G + +++ Y +GG + + +KK E + L Q+L AL YL
Sbjct: 59 NIVKLYDFFQDEG-SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 121 HANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDD-------LASSVVGTPSYMCP 172
H+ I+HRD+K NI L RD + ++L DFGLAK+L L S+ VGTP YM P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 173 ELLADI---PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---------- 219
E+L + S SDIWSLG +YE+ F+ + ++ K I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 220 --VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP-HLQPYVLGIHLKLNGPRRNT 276
P + S A L+K +L K+P+ R S++ L H + L ++
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 277 FPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAF 336
PL S + +++I + K + + L P+ + + SS L A
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTAS 357
|
Length = 384 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 84/294 (28%), Positives = 142/294 (48%), Gaps = 47/294 (15%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARR--SAH--QEMELISR 57
+ +EV++ IG+G+FG LVR K + Y +K +R ++D +R AH E ++++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR---KSDMIKRNQIAHVRAERDILAD 57
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV-QLLMA 116
+P+IV+ S+ ++ ++ +++ Y GGD+ + + + E+ ++ + +L++A
Sbjct: 58 ADSPWIVKLYYSFQDEE-HLYLVMEYMPGGDLMNLLIRKDVF---PEETARFYIAELVLA 113
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD------------------ 158
L+ +H +HRD+K NI + D I+L DFGL K +
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 159 ------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 206
A+S VGTP Y+ PE+L PYG + D WSLG +YEM F +
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 207 DMQALINKI---NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-PSAAELLCHP 256
+Q NKI +S+ P S L+ +L +PE R S E+ HP
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 84/290 (28%), Positives = 133/290 (45%), Gaps = 42/290 (14%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
YE + QIG+G++G R+K + LKKIR+ + + +A +E++L+ ++R+P I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 64 VEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
V K+ KG Y ++ Y + D+ + V F E ++ ++ QLL L YL
Sbjct: 61 VRLKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYL 116
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELL-A 176
H+N ILHRD+K SNI + D ++L DFGLA+ D + V+ T Y PELL
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI--------------------- 215
YG + D+WS+GC + E+ K F+ + KI
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235
Query: 216 -----NKSIVAPLPTVYSG----AFRGLVKSMLRKNPEFRPSAAELLCHP 256
K L + + L+ +L +P+ R SA + L H
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 84/270 (31%), Positives = 137/270 (50%), Gaps = 29/270 (10%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA-RQTDRARRSAHQEMELISRVRNPF 62
+ L +IG GSFG+ R + +KK+ + +Q++ + +E+ + ++R+P
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 63 IVEYKDSWVEKGCYV-----CIIIGYCEG--GDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+EYK GCY+ +++ YC G D+ E KK E ++ L
Sbjct: 77 TIEYK------GCYLREHTAWLVMEYCLGSASDILEVHKKP----LQEVEIAAICHGALQ 126
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
L YLH++ +HRD+K NI LT ++L DFG A ++ A+S VGTP +M PE++
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPANSFVGTPYWMAPEVI 183
Query: 176 ADI---PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPLPTV-YSG 229
+ Y K D+WSLG E++ +K F+M A+ + I ++ L + +S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNDSPTLSSNDWSD 241
Query: 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
FR V S L+K P+ RPS+ ELL H +
Sbjct: 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 84/261 (32%), Positives = 133/261 (50%), Gaps = 6/261 (2%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E + LE+IGKGSFG ++ +K I L D QE+ ++S+ +P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSP 62
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+I Y S++ KG + II+ Y GG + +K E + L ++L L+YLH
Sbjct: 63 YITRYYGSYL-KGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLH 118
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLADIPY 180
+ +HRD+K +N+ L+ D++L DFG+A L + ++ VGTP +M PE++ Y
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
K+DIWSLG E++ + ++ I K+ L YS F+ V++ L
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238
Query: 241 KNPEFRPSAAELLCHPHLQPY 261
K+P FRP+A ELL H + Y
Sbjct: 239 KDPRFRPTAKELLKHKFITRY 259
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 89/264 (33%), Positives = 140/264 (53%), Gaps = 25/264 (9%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN-- 60
Y+ LE IG+G++G+ +H + LK I L D E+ L+S++R
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR-EVALLSQLRQSQ 60
Query: 61 -PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV-QLLMALN 118
P I +Y S++ KG + II+ Y EGG + + KA + EK ++ ++L+AL
Sbjct: 61 PPNITKYYGSYL-KGPRLWIIMEYAEGGSV-RTLMKAGPI---AEKYISVIIREVLVALK 115
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLAD 177
Y+H ++HRD+K +NI +T +++L DFG+A +L + S+ VGTP +M PE++ +
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 178 -IPYGSKSDIWSLGCCVYEMS------AQKAAFKAFDMQALINKINKSIVAPLP-TVYSG 229
Y +K+DIWSLG +YEM+ + AF+A + I KS L YS
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML------IPKSKPPRLEDNGYSK 229
Query: 230 AFRGLVKSMLRKNPEFRPSAAELL 253
R V + L + P+ R SA ELL
Sbjct: 230 LLREFVAACLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 5e-35
Identities = 81/255 (31%), Positives = 134/255 (52%), Gaps = 6/255 (2%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E + LE+IGKGSFG ++ +K I L D QE+ ++S+ +P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSP 62
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
++ +Y S++ KG + II+ Y GG + ++ F E ++ L ++L L+YLH
Sbjct: 63 YVTKYYGSYL-KGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLH 118
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLADIPY 180
+ +HRD+K +N+ L+ D++L DFG+A L + ++ VGTP +M PE++ Y
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
SK+DIWSLG E++ + ++ I K+ L +S F+ + + L
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238
Query: 241 KNPEFRPSAAELLCH 255
K+P FRP+A ELL H
Sbjct: 239 KDPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 29/276 (10%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLK--KIRLARQTDRARRSAHQEMELISRVRN- 60
+E++E IG+G++G RHK + +K I + + +E ++ + N
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-----IKEEYNILRKYSNH 62
Query: 61 PFIVEYKDSWVEKGCYVC-----IIIGYCEGG---DMAEAIKKANGVHFPEEKLCKWLVQ 112
P I + ++++K +++ C GG D+ + ++K EE + L +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRE 121
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMC 171
L L YLH N ++HRD+K NI LT++ +++L DFG++ L S ++ +GTP +M
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 172 PELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKI--NKSIVAP 222
PE++A D Y ++SD+WSLG E++ K DM + + KI N
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--CDMHPMRALFKIPRNPPPTLK 239
Query: 223 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258
P +S F + L KN E RP ELL HP +
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 80/256 (31%), Positives = 138/256 (53%), Gaps = 15/256 (5%)
Query: 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKD 68
+IG+GS G + K ++ +KK+ L +Q + R E+ ++ ++P IVE
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 69 SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHR 128
S++ G + +++ + EGG + + + EE++ + +L AL++LHA ++HR
Sbjct: 84 SYL-VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 129 DVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELLADIPYGSKSDI 186
D+K +I LT D ++L DFG +S ++ S+VGTP +M PE+++ +PYG++ DI
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQ-VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198
Query: 187 WSLGCCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPL--PTVYSGAFRGLVKSMLRKN 242
WSLG V EM + + F+ L + +I ++ L S R + ML ++
Sbjct: 199 WSLGIMVIEMVDGEPPY--FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRD 256
Query: 243 PEFRPSAAELLCHPHL 258
P R +AAELL HP L
Sbjct: 257 PAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 79/290 (27%), Positives = 136/290 (46%), Gaps = 38/290 (13%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN--- 60
YE L +IG+G++G+ R + + LKK+R+ + S +E+ L+ ++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 61 PFIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV-QLLM 115
P IV D ++ + ++ + + D+A + K P E + K L+ QLL
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETI-KDLMRQLLR 118
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
+++LH++ I+HRD+K NI +T D +++ DFGLA++ + +SVV T Y PE+L
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSI-----------VAPL 223
Y + D+WS+GC E+ ++ F+ + L +KI I V+
Sbjct: 179 LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL-DKIFDVIGLPSEEEWPRNVSLP 237
Query: 224 PTVYSGAFRG---------------LVKSMLRKNPEFRPSAAELLCHPHL 258
+ + L+K ML NP R SA E L HP+
Sbjct: 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 80/255 (31%), Positives = 130/255 (50%), Gaps = 6/255 (2%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E + LE+IGKGSFG +K +K I L D QE+ ++S+ +P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSP 62
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
++ +Y S++ K + II+ Y GG + ++ E ++ L ++L L+YLH
Sbjct: 63 YVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 118
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV-VGTPSYMCPELLADIPY 180
+ +HRD+K +N+ L+ +++L DFG+A L + + VGTP +M PE++ Y
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
SK+DIWSLG E++ + ++ I K+ L YS + V++ L
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238
Query: 241 KNPEFRPSAAELLCH 255
K P FRP+A ELL H
Sbjct: 239 KEPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 84/269 (31%), Positives = 135/269 (50%), Gaps = 16/269 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+ L ++G+G+ GS R K+ + LK I ++ +E+E+ ++P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSP 59
Query: 62 FIVEYKDSWV-EKGCYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALN 118
+IV+Y +++ E + I + YCEGG + KK G E+ L K +L L+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
YLH+ I+HRD+K SNI LTR ++L DFG++ L++ LA + GT YM PE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQGK 178
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPLP---------TVY 227
PY SD+WSLG + E++ + F L I ++ + P P +
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238
Query: 228 SGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
S F+ +K L K+P RP+ ++L HP
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 76/273 (27%), Positives = 141/273 (51%), Gaps = 18/273 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRAR-RSAHQEMELISRVRN 60
++ EVL+++GKG++GS V H+ +K+IRL + D ++ E++++ + +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 61 PFIVEYKDSWVEKGC-YVCIIIGYCEGGDMAEAIKKANGVH-FPEEKLCKWLVQLLMALN 118
P+IV++ ++ +G Y+C+ Y + G + + PE+ L + ++ L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCM--EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 119 YLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL-- 175
+L H I+HRDVK +N+ + + ++L DFG++ L++ LA + +G SYM PE +
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKS 175
Query: 176 ----ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYS 228
+ Y +SD+WSLG + EM+ + + + +++ + LP+ YS
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235
Query: 229 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
+ V L K P RP+ A+LL HP L Y
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 76/291 (26%), Positives = 131/291 (45%), Gaps = 37/291 (12%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+YEVL +G+G++G L R+K + +KK + + + +++A +E++++ ++R+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV K+++ KG ++ Y E + G+ + W QLL A+ Y H
Sbjct: 61 NIVNLKEAFRRKGRLY-LVFEYVERTLLELLEASPGGLPPDAVRSYIW--QLLQAIAYCH 117
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI--SDDLASSVVGTPSYMCPELL-ADI 178
+++I+HRD+K NI ++ ++L DFG A+ L + V T Y PELL D
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAF-------------KAF-----DMQALINK------ 214
YG D+W++GC + E+ + F K Q L +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 215 ---INKSIVAPLPTVYSGAFRG----LVKSMLRKNPEFRPSAAELLCHPHL 258
S L Y G +K+ LR +P+ R + ELL HP+
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 46/290 (15%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMEL-----ISRV 58
Y+V++Q+G G+FGS L R+K + +KK++ + S + M L + ++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK------KKFYSWEECMNLREVKSLRKL 54
Query: 59 -RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+P IV+ K+ + E + + Y EG ++ + +K G F E + + Q+L L
Sbjct: 55 NEHPNIVKLKEVFRENDE-LYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE-LLA 176
++H + HRD+K N+ ++ + +++ DFGLA+ + S + V T Y PE LL
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFK---AFDM-------------------QALINK 214
Y S DIW+LGC + E+ + F D L +K
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232
Query: 215 IN--------KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ S+ +P A L+K MLR +P+ RP+A++ L HP
Sbjct: 233 LGFRFPQFAPTSLHQLIPNASPEAID-LIKDMLRWDPKKRPTASQALQHP 281
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 83/259 (32%), Positives = 137/259 (52%), Gaps = 21/259 (8%)
Query: 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE-YK 67
+IG+GS G + R KH ++ +K + L +Q + R E+ ++ ++ +VE YK
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
V + +V ++ + +GG + + + + EE++ +L AL YLH+ ++H
Sbjct: 86 SYLVGEELWV--LMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIH 140
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS--SVVGTPSYMCPELLADIPYGSKSD 185
RD+K +I LT D ++L DFG IS D+ S+VGTP +M PE+++ PYG++ D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQ-ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 186 IWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTV-----YSGAFRGLVKSML 239
IWSLG V EM + F +QA+ ++ S P P + S R ++ ML
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDS---PPPKLKNAHKISPVLRDFLERML 255
Query: 240 RKNPEFRPSAAELLCHPHL 258
+ P+ R +A ELL HP L
Sbjct: 256 TREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 74/252 (29%), Positives = 123/252 (48%), Gaps = 16/252 (6%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRVRN-PFIVEY 66
+GKGSFG LL K + Y +K ++ + Q D E +++ PF+ +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVE-CTMTEKRVLALAGKHPFLTQL 61
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 126
+ K + ++ Y GGD+ I+++ F E + + ++++ L +LH I+
Sbjct: 62 HSCFQTKD-RLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 127 HRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADIPYGSKSD 185
+RD+K N+ L + I++ DFG+ K ++ S+ GTP Y+ PE+L+ PYG D
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178
Query: 186 IWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244
W+LG +YEM A ++ F+ D L I + P S + ++KS L KNPE
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPE 236
Query: 245 FRPSAAELLCHP 256
R L C P
Sbjct: 237 KR-----LGCLP 243
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-31
Identities = 86/276 (31%), Positives = 143/276 (51%), Gaps = 22/276 (7%)
Query: 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKD 68
+IG+GS G + KH K+ +KK+ L +Q + R E+ ++ + +V+ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 69 SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHR 128
S++ G + +++ + EGG + + + EE++ + +L AL+YLH ++HR
Sbjct: 87 SYL-VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 129 DVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS--SVVGTPSYMCPELLADIPYGSKSDI 186
D+K +I LT D I+L DFG +S ++ S+VGTP +M PE+++ +PYG++ DI
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQ-VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 187 WSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVY--SGAFRGLVKSMLRKNP 243
WSLG V EM + F +QA+ +I ++ + + S RG + ML + P
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAM-RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP 260
Query: 244 EFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPL 279
R +A ELL HP LKL GP PL
Sbjct: 261 SQRATAQELLQHP---------FLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 3e-31
Identities = 79/259 (30%), Positives = 134/259 (51%), Gaps = 12/259 (4%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRL---ARQTDRARRSAHQEMELISRVRNPFIVEY 66
+G+G+FG L ++ K+++ + +T + + E++L+ +++ IV+Y
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 67 KDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
++ + I + Y GG + + +K + E K+ Q+L ++YLH+N I
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGAL--TESVTRKYTRQILEGMSYLHSNMI 127
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAKML----ISDDLASSVVGTPSYMCPELLADIPYG 181
+HRD+K +NI +++LGDFG +K L +S SV GTP +M PE+++ YG
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLR 240
K+D+WSLGC V EM +K + ++ A I KI + LP+ S R + +
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFV 247
Query: 241 KNPEFRPSAAELLCHPHLQ 259
+ RPSA ELL HP Q
Sbjct: 248 EARH-RPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 72/255 (28%), Positives = 120/255 (47%), Gaps = 26/255 (10%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIR----LARQTDRARRSAHQEMELISRVRNPFIVE 65
+G+G FG LL +K + Y +K ++ +AR + + E + R+PF+V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 66 YKDSWVEKGCY-----VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
C+ VC ++ Y GGD+ I F E + + +++ L YL
Sbjct: 67 LF------ACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYL 117
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIP 179
H N I++RD+K N+ L + +++ DFGL K + D S+ GTP ++ PE+L +
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS 177
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGLVK 236
Y D W LG +YEM ++ F D + + + SIV P S +++
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD----SIVNDEVRYPRFLSREAISIMR 233
Query: 237 SMLRKNPEFRPSAAE 251
+LR+NPE R + E
Sbjct: 234 RLLRRNPERRLGSGE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 85/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ---EMELISRV 58
E +E ++ I G++G+ LVRHK R+++ +KKI +Q R Q E ++++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFA 58
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
NPF+V S+ E ++C+++ Y EGGD A +K + P + + + ++AL
Sbjct: 59 ENPFVVSMFCSF-ETKRHLCMVMEYVEGGDCATLLKNIGAL--PVDMARMYFAETVLALE 115
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM------------LISDD----LASS 162
YLH I+HRD+K N+ +T I+L DFGL+K+ I D L
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK-INKSIVA 221
V GTP Y+ PE++ YG D W++G +YE F + L + I+ I
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235
Query: 222 P-----LPTVYSGAFRGLVKSMLRKNPEFR---PSAAELLCHPHLQ 259
P LP + L+ +LR+NP R A E+ H
Sbjct: 236 PEGDEALPA----DAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 75/291 (25%), Positives = 135/291 (46%), Gaps = 45/291 (15%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRL---ARQTDRARRSAHQEMELISRVR 59
+YE +++G+G++ R K + +KKI+L D +A +E++L+ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+P I+ D + K + ++ + E D+ + IK + V P + +++ L L Y
Sbjct: 61 HPNIIGLLDVFGHKSN-INLVFEFMET-DLEKVIKDKSIVLTPADIKS-YMLMTLRGLEY 117
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLAD 177
LH+N ILHRD+K +N+ + D ++L DFGLA+ S + + VV T Y PELL
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL-- 174
Query: 178 IPYGSKS-----DIWSLGCCVYEMSAQKA-------------AFKAF---------DMQA 210
+G++ D+WS+GC E+ + F+A + +
Sbjct: 175 --FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 211 LINKINKSIVAPLP--TVYSGAFR---GLVKSMLRKNPEFRPSAAELLCHP 256
L + + P P ++ A L++ +L NP R +A + L HP
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-31
Identities = 75/277 (27%), Positives = 148/277 (53%), Gaps = 14/277 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++Y + +G G+ G+ L + + + + +K + + ++ + A E+ +
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFF 91
Query: 62 FIVEYKDSWVEKG-------CYVCIIIGYCEGGDMAEAIK---KANGVHFPEEKLCKWLV 111
IV+ + + +K + +++ Y GD+ + IK K N F E + +
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRT-FREHEAGLLFI 150
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML---ISDDLASSVVGTPS 168
Q+L+A++++H+ H++HRD+K +NI L + ++LGDFG +KM +SDD+ + GTP
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYS 228
Y+ PE+ PY K+D++SLG +YE+ K F +M+ +++K PLP S
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS 270
Query: 229 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 265
+ +V ++L +P+ RPS+++LL P + ++ G+
Sbjct: 271 PEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGL 307
|
Length = 496 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 84/307 (27%), Positives = 141/307 (45%), Gaps = 59/307 (19%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+++++++ QIG+G++G R K + LKK+RL + + +A +E++++ ++ +
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 61 PFIVEYKDSWV----------EKGCYVCI-------IIGYCEGGDMAEAIKKANGVHFPE 103
IV K+ +KG + + ++G E G VHF E
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG----------LVHFSE 115
Query: 104 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LAS 161
+ + ++ QLL LNY H + LHRD+KCSNI L I+L DFGLA++ S++ +
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 162 SVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV 220
+ V T Y PE LL + YG D+WS GC + E+ +K F+A A + I++
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235
Query: 221 APLPTVYSGAFR-----------------------------GLVKSMLRKNPEFRPSAAE 251
+P P V+ + L+ ML +P R +A E
Sbjct: 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295
Query: 252 LLCHPHL 258
L P L
Sbjct: 296 ALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-31
Identities = 84/264 (31%), Positives = 135/264 (51%), Gaps = 19/264 (7%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRL----ARQTDRARR---SAHQEMELISRVRNPF 62
IG GSFGS L + + +K++ L A DR R + +E+ L+ +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
IV+Y S ++ ++ I + Y GG +A + F E + ++ Q+L LNYLH
Sbjct: 68 IVQYLGSSLDAD-HLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHN 124
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-------SVVGTPSYMCPELL 175
I+HRD+K +NI + I++ DFG++K L ++ L++ S+ G+ +M PE++
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTVYSGAFRGL 234
Y K+DIWSLGC V EM K F +QA I KI ++ +P+ S
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IFKIGENASPEIPSNISSEAIDF 243
Query: 235 VKSMLRKNPEFRPSAAELLCHPHL 258
++ + RP+AAELL HP L
Sbjct: 244 LEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 84/258 (32%), Positives = 126/258 (48%), Gaps = 15/258 (5%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ--EMELISRV---RNPFIV 64
IGKG+FG VR K R+ Y +K + ++ + AH E ++ R +PFIV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS-KKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
K S+ + + ++ Y GG++ ++K F E++ ++ +L++AL +LH
Sbjct: 60 GLKFSF-QTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD 116
Query: 125 ILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPE-LLADIPYGS 182
I++RD+K NI L I L DFGL+K L + ++ GT Y+ PE LL + Y
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
D WSLG V+EM + F A D Q + I V V S R VK +L +N
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRN 236
Query: 243 PEFR----PSAAELLCHP 256
P+ R A EL HP
Sbjct: 237 PQHRLGAHRDAVELKEHP 254
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 85/300 (28%), Positives = 136/300 (45%), Gaps = 51/300 (17%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHE----RKKYVLKKIRLARQTDRARRSAHQEMELISR 57
+ +E L ++G G+ G V H+ +K + +I+ A R +E++++
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-----IRNQIIRELKVLHE 55
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+P+IV + ++ G + I + + +GG + + +KKA + PE L K + +L L
Sbjct: 56 CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRI--PENILGKISIAVLRGL 112
Query: 118 NYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 176
YL H I+HRDVK SNI + +I+L DFG++ LI D +A+S VGT SYM PE L
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 171
Query: 177 DIPYGSKSDIWSLGCCVYEM-----------SAQKAAFKAFDMQALINKINKSIVAPLPT 225
Y +SDIWSLG + EM + + A + K + V+ P
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 226 --------------------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
+S F+ V L+KNP+ R EL HP ++
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 82/261 (31%), Positives = 133/261 (50%), Gaps = 25/261 (9%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLA-RQTDRARRSAHQEMELISRVRNPFIVE 65
L +IG GSFG+ + H + +KK+ + +QT+ + +E++ + ++++P +E
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 66 YKDSWVEKGCYV-----CIIIGYCEGG--DMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
YK GCY+ +++ YC G D+ E KK E ++ L L
Sbjct: 86 YK------GCYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLA 135
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
YLH+++++HRD+K NI LT ++L DFG A A+S VGTP +M PE++ +
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAM 192
Query: 179 ---PYGSKSDIWSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
Y K D+WSLG E++ +K F M AL + ++ +FRG
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252
Query: 235 VKSMLRKNPEFRPSAAELLCH 255
V L+K P+ RP++AELL H
Sbjct: 253 VDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 79/256 (30%), Positives = 130/256 (50%), Gaps = 15/256 (5%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQ--EMELISRVRNPFIVEY 66
+GKG+FG +LVR K K Y +K ++ ++ A+ AH E ++ R+PF+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILK--KEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 126
K S+ +C ++ Y GG++ + + V F E++ + +++ AL YLH+ ++
Sbjct: 61 KYSFQTHD-RLCFVMEYANGGELFFHLSR-ERV-FSEDRARFYGAEIVSALGYLHSCDVV 117
Query: 127 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSD 185
+RD+K N+ L +D I++ DFGL K ISD + GTP Y+ PE+L D YG D
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 186 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 245
W LG +YEM + F D + L I + P S + L+ +L+K+P+
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FPRTLSPEAKSLLAGLLKKDPKQ 236
Query: 246 R-----PSAAELLCHP 256
R A E++ H
Sbjct: 237 RLGGGPEDAKEIMEHR 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 78/270 (28%), Positives = 119/270 (44%), Gaps = 27/270 (10%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQEMELISRVRNP 61
Y VL GKG FG + + K Y KK+ R R + A E +++ +V +
Sbjct: 4 HYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 62 FIV------EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
F+V E KD+ +C+++ GGD+ I F EE+ + ++
Sbjct: 61 FVVSLAYAYETKDA-------LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
L LH I++RD+K NI L IR+ D GLA + + VGT YM PE++
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV 173
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF---- 231
+ Y D W LGC +YEM K+ F+ + ++ + V YS F
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-VKEDQEEYSEKFSEAA 232
Query: 232 RGLVKSMLRKNPEFR-----PSAAELLCHP 256
R + + +L K+P FR A E+ HP
Sbjct: 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRN 60
+ E ++ +G G+FG LVR + Y LK + + + + H E ++ V +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 61 PFIVE-YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN------GVHFPEEKLCKWLVQL 113
PFI+ + ++ Y +++ Y GG++ ++ + G+ + E +C
Sbjct: 61 PFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC------ 112
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
AL YLH+ I++RD+K NI L ++ I+L DFG AK L D ++ GTP Y+ PE
Sbjct: 113 --ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPE 168
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAF 203
++ + D W+LG +YEM F
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 25/265 (9%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLA-RQTDRARRSAHQEMELISRVRNPFIVE 65
L +IG GSFG+ R + +KK+ + +Q++ + +E+ + ++R+P ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 66 YKDSWVEKGCYV-----CIIIGYCEGG--DMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
Y+ GCY+ +++ YC G D+ E KK E ++ L L
Sbjct: 80 YR------GCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
YLH+++++HRDVK NI L+ ++LGDFG A ++ A+ VGTP +M PE++ +
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAM 186
Query: 179 ---PYGSKSDIWSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
Y K D+WSLG E++ +K F M AL + A +S FR
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
Query: 235 VKSMLRKNPEFRPSAAELLCHPHLQ 259
V S L+K P+ RP++ LL H +
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 86/263 (32%), Positives = 135/263 (51%), Gaps = 19/263 (7%)
Query: 7 LEQIGKGSFGSALLVRHKHERKK------YVLKKIRLAR-QTDRARRSAHQEMELISRVR 59
L+ +GKG +G VR VLKK + R Q D A A E ++ V+
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA--ERNILEAVK 58
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+PFIV+ ++ + G + +I+ Y GG++ +++ G+ F E+ C +L ++ +AL +
Sbjct: 59 HPFIVDLIYAF-QTGGKLYLILEYLSGGELFMHLER-EGI-FMEDTACFYLSEISLALEH 115
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI 178
LH I++RD+K NI L ++L DFGL K I + + + GT YM PE+L
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS 175
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+G D WSLG +Y+M F A + + I+KI K + LP + R L+K +
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN-LPPYLTPEARDLLKKL 234
Query: 239 LRKNPEFR----PS-AAELLCHP 256
L++NP R P AAE+ HP
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHP 257
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 84/265 (31%), Positives = 141/265 (53%), Gaps = 16/265 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E +E++ ++G G+FG ++K E K+ + +++ E+++++ +P
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNK-ETGVLAAAKV-IDTKSEEELEDYMVEIDILASCDHP 62
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDM-AEAIKKANGVHFPEEKL-CKWLVQLLMALNY 119
IV+ D++ + + I+I +C GG + A ++ + P+ ++ CK Q L ALNY
Sbjct: 63 NIVKLLDAFYYEN-NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCK---QTLEALNY 118
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSYMCPELL--- 175
LH N I+HRD+K NI T D DI+L DFG+ AK + S +GTP +M PE++
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 176 --ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAF 231
D PY K+D+WSLG + EM+ + + ++ KI KS L P+ +S F
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHP 256
+ +K L KN + R + +LL HP
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHP 263
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 78/259 (30%), Positives = 136/259 (52%), Gaps = 18/259 (6%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRL---ARQTDRARRSAHQEMELISRVRNPFIVEY 66
+G+G+FG L ++ +K++ +++T + + E++L+ +R+ IV+Y
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 67 ----KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
+D +K + I + Y GG + + +K + E ++ Q+L ++YLH+
Sbjct: 70 YGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGAL--TENVTRRYTRQILQGVSYLHS 124
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKML----ISDDLASSVVGTPSYMCPELLADI 178
N I+HRD+K +NI +++LGDFG +K + +S SV GTP +M PE+++
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLVKS 237
YG K+D+WS+ C V EM +K + ++ A I KI P LP S A R +K
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQ 244
Query: 238 MLRKNPEFRPSAAELLCHP 256
+ + + RP+A LL HP
Sbjct: 245 IFVEE-KRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 74/256 (28%), Positives = 121/256 (47%), Gaps = 10/256 (3%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKD 68
+GKG FG + K K Y KK+ R R + A E +++ +V + FIV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 69 SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHR 128
++ E +C+++ GGD+ I FPE + + Q++ L +LH I++R
Sbjct: 61 AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 129 DVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 188
D+K N+ L ++R+ D GLA L GTP YM PE+L Y D ++
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFA 179
Query: 189 LGCCVYEMSAQKAAFKAFDMQAL---INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 245
LGC +YEM A ++ F+ + + + + P +S + L +++L+K+PE
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239
Query: 246 R-----PSAAELLCHP 256
R SA E+ HP
Sbjct: 240 RLGCRGGSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 82/261 (31%), Positives = 131/261 (50%), Gaps = 25/261 (9%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLA-RQTDRARRSAHQEMELISRVRNPFIVE 65
L +IG GSFG+ R + +KK+ + +Q++ + +E++ + R+++P +E
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 66 YKDSWVEKGCYV-----CIIIGYCEGG--DMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
YK GCY+ +++ YC G D+ E KK E ++ L L
Sbjct: 90 YK------GCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLA 139
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
YLH+++++HRD+K NI LT ++L DFG A + A+S VGTP +M PE++ +
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAM 196
Query: 179 ---PYGSKSDIWSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
Y K D+WSLG E++ +K F M AL + +S FR
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256
Query: 235 VKSMLRKNPEFRPSAAELLCH 255
V S L+K P+ RP++ ELL H
Sbjct: 257 VDSCLQKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 76/267 (28%), Positives = 124/267 (46%), Gaps = 15/267 (5%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQEMELISRVRNP 61
QY VL GKG FG + + K Y K++ R R S A E +++ +V +
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
F+V ++ K +C+++ GGD+ I F EE+ + ++L L LH
Sbjct: 61 FVVNLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 181
+ ++RD+K NI L IR+ D GLA + + VGT YM PE+L + Y
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF----RGLVKS 237
D W LGC +YEM ++ F+ + ++++ ++ VYS F + + K
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-EEVYSAKFSEEAKSICKM 238
Query: 238 MLRKNPEFR-----PSAAELLCHPHLQ 259
+L K+P+ R A E+ HP +
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 78/254 (30%), Positives = 125/254 (49%), Gaps = 13/254 (5%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQEMELISRVRNPFIVEYKD 68
IGKGSFG + VR + ++ Y LK IR A R+ + E ++++V PFIV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 69 SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHR 128
S+ + +++ + GG++ +++ F + + +LL AL LH ++++R
Sbjct: 61 SFQSPE-KLYLVLAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 129 DVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 187
D+K NI L I L DFGL K+ + D D ++ GTP Y+ PELL Y D W
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 188 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEF 245
+LG +YEM F ++ + KI + PL P + + L+ +L ++P
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKI---LQEPLRFPDGFDRDAKDLLIGLLSRDPTR 234
Query: 246 R---PSAAELLCHP 256
R A E+ HP
Sbjct: 235 RLGYNGAQEIKNHP 248
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 67/264 (25%), Positives = 123/264 (46%), Gaps = 26/264 (9%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-------RARRSAHQEMELISRVR 59
L+ I KG+FGS L + + + +K ++ + +A R+ ++ +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-----MMIQGE 55
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+P++ + S+ K Y+ +++ Y GGD A IK G+ PE+ +++ ++++ +
Sbjct: 56 SPYVAKLYYSFQSKD-YLYLVMEYLNGGDCASLIKTLGGL--PEDWAKQYIAEVVLGVED 112
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADI 178
LH I+HRD+K N+ + + ++L DFGL++ L + VGTP Y+ PE + +
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF----VGTPDYLAPETILGV 168
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGLV 235
SD WSLGC ++E F A A+ + I + + S L+
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI 228
Query: 236 KSMLRKNPEFRPSA---AELLCHP 256
+L +P R A E+ HP
Sbjct: 229 NRLLCMDPAKRLGANGYQEIKSHP 252
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 9e-29
Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 8/198 (4%)
Query: 5 EVLEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+ +++G+G+FG L + V K ++ R +E ++ ++ +P
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV +G + I+ Y GGD+ + ++K +G + L + +Q+ + YL
Sbjct: 62 NIVRLL-GVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS---YMCPELLADI 178
+ + +HRD+ N +T + +++ DFGL++ + DD G +M PE L D
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 179 PYGSKSDIWSLGCCVYEM 196
+ SKSD+WS G ++E+
Sbjct: 180 KFTSKSDVWSFGVLLWEI 197
|
Length = 258 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 76/241 (31%), Positives = 124/241 (51%), Gaps = 10/241 (4%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQ--EMELISRVRNPFIVEY 66
+GKG+FG +LVR K K Y +K ++ ++ A+ AH E ++ R+PF+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILK--KEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 126
K S+ K +C ++ Y GG++ + + F E++ + +++ AL+YLH+ I+
Sbjct: 61 KYSFQTKD-RLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 127 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLADIPYGSKSD 185
+RD+K N+ L +D I++ DFGL K I+D + GTP Y+ PE+L D YG D
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 186 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 245
W LG +YEM + F D + L I + P S + L+ +L K+P
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK-FPRTLSADAKSLLSGLLIKDPNK 236
Query: 246 R 246
R
Sbjct: 237 R 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 62/307 (20%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ--TDRARRSAHQEMELISRVRNP 61
YE+L+ IG G++G K +K +KKI D A+R +E++L+ +R+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID-AKR-ILREIKLLRHLRHE 59
Query: 62 FIV------------EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 109
I+ ++ D V I+ E D+ + IK + ++ + +
Sbjct: 60 NIIGLLDILRPPSPEDFND--------VYIVTELMET-DLHKVIK--SPQPLTDDHIQYF 108
Query: 110 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV----VG 165
L Q+L L YLH+ +++HRD+K SNI + + D+++ DFGLA+ + D+ V
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 166 TPSYMCPELLADIPYGSKS-DIWSLGCCVYEMSAQKAAFK-------------------A 205
T Y PELL +K+ DIWS+GC E+ +K F
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 206 FDMQALIN-KINKSIVA-------PLPTVYSGA---FRGLVKSMLRKNPEFRPSAAELLC 254
D++ + + K + + PL ++ GA L++ ML +P+ R +A E L
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
Query: 255 HPHLQPY 261
HP+L
Sbjct: 289 HPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 41/291 (14%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKI--RLARQTDRARRSAHQEMELISRVRNP 61
++ ++ +GKG G LVR K K + LK + + + ++ +R E E+++ + +P
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR-VLTEQEILATLDHP 61
Query: 62 FIVE-YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
F+ Y E Y+C+++ YC GG++ +++ G EE + ++L+AL YL
Sbjct: 62 FLPTLYASFQTET--YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML----------------------ISDD 158
H I++RD+K NI L I L DF L+K I +
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 159 LAS--------SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA 210
S S VGT Y+ PE+++ +GS D W+LG +YEM FK +
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239
Query: 211 -LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE----FRPSAAELLCHP 256
N + K + P S + R L++ +L K+P + AAE+ HP
Sbjct: 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 81/261 (31%), Positives = 133/261 (50%), Gaps = 24/261 (9%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRL---ARQTDRARRSAHQEMELISRVRNPFIVEY 66
+G+G+FG L ++ +K+++ + +T + + E++L+ + + IV+Y
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 67 KDSWVEKGCY-------VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
GC + I + + GG + + +K + E K+ Q+L ++Y
Sbjct: 70 Y------GCLRDPMERTLSIFMEHMPGGSIKDQLKSYGAL--TENVTRKYTRQILEGVSY 121
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML----ISDDLASSVVGTPSYMCPELL 175
LH+N I+HRD+K +NI +++LGDFG +K L +S SV GTP +M PE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGL 234
+ YG K+DIWS+GC V EM +K + F+ A I KI P LP S R
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241
Query: 235 VKSMLRKNPEFRPSAAELLCH 255
+K + + + RPSA ELL H
Sbjct: 242 LKRIFVE-AKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 56/253 (22%), Positives = 115/253 (45%), Gaps = 7/253 (2%)
Query: 7 LEQIGKGSFG---SALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
+++G+G+FG L ++ V K +++ +E ++ ++ +P I
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V+ + + I++ Y GGD+ + ++K L + +Q+ + YL +
Sbjct: 64 VKLL-GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT-P-SYMCPELLADIPYG 181
+ +HRD+ N + + +++ DFGL++ L DD G P +M PE L + +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 182 SKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
SKSD+WS G ++E+ + + + ++ + K P P L+
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWA 242
Query: 241 KNPEFRPSAAELL 253
++PE RP+ +EL+
Sbjct: 243 EDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 89/285 (31%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ +YEV+++IG G FG LV+HK ++ + K I +R + E+ ++ +++
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 61 PFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGV--HFPEEKLCKWLVQLLMAL 117
IV Y D ++ K + I++ +C+ GD++ I+K + E + QLL AL
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 118 NYLH-------ANHILHRDVKCSNIFLTRDQDIR-------------------LGDFGLA 151
Y H +LHRD+K NIFL+ IR +GDFGL+
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLS--TGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 152 KMLISDDLASSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCVYEMSAQKAAF-KAFDM 208
K + + +A S VGTP Y PELL Y KSD+W+LGC +YE+ + K F KA +
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 209 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
LI+++ + P+ S L+K++L + + RPSA + L
Sbjct: 250 SQLISELKRGPDLPIKG-KSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 79/267 (29%), Positives = 140/267 (52%), Gaps = 17/267 (6%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
++EVL +G+G++G L RHK ++ +KK + + + + + + +E++++ ++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK-ANGVHFPEEKLCKWLVQLLMALNYLH 121
IVE K+++ +G + ++ Y E +M E +++ NGV P EK+ ++ QL+ A+++ H
Sbjct: 62 IVELKEAFRRRG-KLYLVFEYVEK-NMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCH 117
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI--SDDLASSVVGTPSYMCPELLADIP 179
N I+HRD+K N+ ++ + ++L DFG A+ L S+ + V T Y PELL P
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
YG D+WS+GC + E+S + F + I K ++ PLP F
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK-VLGPLPAEQMKLF-------- 228
Query: 240 RKNPEFRPSAAELLCHPH-LQPYVLGI 265
NP F + HP L+ LGI
Sbjct: 229 YSNPRFHGLRFPAVNHPQSLERRYLGI 255
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-28
Identities = 96/361 (26%), Positives = 160/361 (44%), Gaps = 34/361 (9%)
Query: 21 VRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80
R ++K V K + L +R A E+ ++ + IV++ D + + +I
Sbjct: 87 TRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-KLLLI 143
Query: 81 IGYCEGGDMAEAIKKANGVHFP--EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 138
+ Y GGD+ + IK+ H P E ++ Q+++AL+ +H+ ++HRD+K +NIFL
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM 203
Query: 139 RDQDIRLGDFGLAKML---ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYE 195
I+LGDFG +K +S D+ASS GTP Y+ PEL Y K+D+WSLG +YE
Sbjct: 204 PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE 263
Query: 196 MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255
+ FK + ++ ++ P P S + L+ +L KNP RP+ +LL H
Sbjct: 264 LLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL-H 322
Query: 256 PHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRAL 315
YV +N + E IS H E +
Sbjct: 323 TEFLKYV---------------------ANLFQDIVRHSETISPHDREEILRQLQESGER 361
Query: 316 NPSVSETEQDSLSS--TLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTP 373
P S ++S T G + + ++K+ + + +L + +S P N G P
Sbjct: 362 APPPSSIRYGVVTSDVTHGGYLYKYSSDMRWKKRYFYIGNGQLRISLSENPE--NDGVAP 419
Query: 374 R 374
+
Sbjct: 420 K 420
|
Length = 478 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 75/287 (26%), Positives = 129/287 (44%), Gaps = 41/287 (14%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPF 62
Y++L +IG+G+F L + + K Y +K ++ + + +E++ + R+ +P
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 63 IVEYKDSWVEK--GCYVCIIIGYCEGGDMA--EAIKKANGVHFPEEKLCKWLVQLLMALN 118
I+ + ++ G + E DM E IK PE+++ ++ QLL +L+
Sbjct: 60 ILRLIEVLFDRKTGRLALV----FELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLD 114
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE-LLAD 177
++H N I HRD+K NI L +D ++L DFG + + S + + T Y PE LL D
Sbjct: 115 HMHRNGIFHRDIKPENI-LIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV----------- 226
YG K DIW++GC +E+ + F + I KI+ + P V
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233
Query: 227 -----------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
S L+K +L +P+ R +A + L HP
Sbjct: 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-28
Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 15/255 (5%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQ--EMELISRVRNPFIVEY 66
+GKG+FG +LVR K + Y +K +R ++ A+ AH E ++ R+PF+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 126
K ++ + +C ++ Y GG++ + + F EE+ + +++ AL YLH+ ++
Sbjct: 61 KYAF-QTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 127 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLADIPYGSKSD 185
+RD+K N+ L +D I++ DFGL K ISD + GTP Y+ PE+L D YG D
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 186 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 245
W LG +YEM + F D + L I + P S + L+ +L+K+P+
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-FPRTLSPEAKSLLAGLLKKDPKQ 236
Query: 246 R----PS-AAELLCH 255
R PS A E++ H
Sbjct: 237 RLGGGPSDAKEVMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 37/281 (13%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN- 60
E L +IG G+ G +R K +K++R + +R +++++ + +
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRIL-MDLDVVLKSHDC 73
Query: 61 PFIVEYKDSWVEKGCYVCII-----------IGYCEGGDMAEAIKKANGVHFPEEKLCKW 109
P+IV+ CY I + C + + K PE+ L K
Sbjct: 74 PYIVK---------CYGYFITDSDVFICMELMSTC-----LDKLLKRIQGPIPEDILGKM 119
Query: 110 LVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS 168
V ++ AL+YL H ++HRDVK SNI L +++L DFG++ L+ + G +
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 169 YMCPELLADIP-----YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKI--NKSIV 220
YM PE + D P Y ++D+WSLG + E++ + +K + ++ KI +
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238
Query: 221 APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
P +S F V L K+ RP ELL HP ++ Y
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 77/241 (31%), Positives = 121/241 (50%), Gaps = 17/241 (7%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEME----LISRVRNPFIVE 65
IGKGSFG LL +HK + K Y +K L ++ ++ M L+ V++PF+V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 66 YKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
S+ +K +V + Y GG++ +++ FPE + + ++ AL YLH+
Sbjct: 61 LHYSFQTADKLYFV---LDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL 115
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGS 182
+I++RD+K NI L + L DFGL K I S+ GTP Y+ PE+L PY
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRK 241
D W LG +YEM F + D + + I NK + L S + R L++ +L+K
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSARHLLEGLLQK 233
Query: 242 N 242
+
Sbjct: 234 D 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 76/249 (30%), Positives = 130/249 (52%), Gaps = 8/249 (3%)
Query: 7 LEQIGKGSFGSALLVRHKHERKK---YVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
L+ +G+GSFG LVR Y +K ++ A R R E ++++ V +PFI
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V+ ++ +G + +I+ + GGD+ + K V F EE + +L +L +AL++LH+
Sbjct: 61 VKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL 117
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGS 182
I++RD+K NI L + I+L DFGL+K I + A S GT YM PE++ +
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
+D WS G ++EM F+ D + + I K+ + +P S + L++++ ++N
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-MPQFLSPEAQSLLRALFKRN 236
Query: 243 PEFRPSAAE 251
P R A
Sbjct: 237 PANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 78/254 (30%), Positives = 136/254 (53%), Gaps = 11/254 (4%)
Query: 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKD 68
+IG+GS G + K K +KK+ L +Q + R E+ ++ ++ +VE +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 69 SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHR 128
S++ G + +++ + EGG + + + EE++ + +L AL+ LHA ++HR
Sbjct: 85 SYL-VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 129 DVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 187
D+K +I LT D ++L DFG + + S+VGTP +M PEL++ +PYG + DIW
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 188 SLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVY--SGAFRGLVKSMLRKNPE 244
SLG V EM + F ++A+ I ++ L ++ S + +G + +L ++P
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259
Query: 245 FRPSAAELLCHPHL 258
R +AAELL HP L
Sbjct: 260 QRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 79/268 (29%), Positives = 132/268 (49%), Gaps = 15/268 (5%)
Query: 3 QYEVLEQ-----IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR 57
+YE E +GKG++G R + + +K+I + R + H+E+ L S
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSY 61
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMA 116
+++ IV+Y S E G + I + GG ++ ++ G + E+ + + Q+L
Sbjct: 62 LKHRNIVQYLGSDSENG-FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 117 LNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPEL 174
L YLH N I+HRD+K N+ + T +++ DFG +K L + + GT YM PE+
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEV 180
Query: 175 LADIP--YGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVAP-LPTVYSGA 230
+ P YG+ +DIWSLGC + EM+ K F + QA + K+ + P +P S
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHPHL 258
+ + +P+ R SA +LL P L
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 79/276 (28%), Positives = 137/276 (49%), Gaps = 32/276 (11%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVE 65
L +IG+G+FG+ + HK +K+IR ++ ++ +++++ R + P+IV+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST-VDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 66 -YKDSWVEKGCYVCIIIGYCEGGDMAEAIKK-------ANGVHFPEEKLCKWLVQLLMAL 117
Y + E C++C+ + M ++ K PEE L K V + AL
Sbjct: 68 FYGALFREGDCWICMEL-------MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 118 NYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV-VGTPSYMCPELL 175
NYL I+HRDVK SNI L R+ +I+L DFG++ L+ D +A + G YM PE +
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERI 179
Query: 176 A---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-------T 225
Y +SD+WSLG +YE++ K + ++ ++ +++ + + P
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSEER 237
Query: 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
+S +F + L K+ RP ELL HP ++ Y
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 56/254 (22%), Positives = 116/254 (45%), Gaps = 10/254 (3%)
Query: 7 LEQIGKGSFG---SALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
+++G+G+FG L ++K V K +++ +E ++ ++ +P +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V+ + + I++ Y EGGD+ ++K N L + +Q+ + YL +
Sbjct: 64 VKLL-GVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS---YMCPELLADIPY 180
+ +HRD+ N + + +++ DFGL++ L DD G +M PE L + +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-RKRGGKLPIRWMAPESLKEGKF 180
Query: 181 GSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
SKSD+WS G ++E+ + + + + ++ + P P L+
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCW 240
Query: 240 RKNPEFRPSAAELL 253
++PE RP+ +EL+
Sbjct: 241 AEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 75/272 (27%), Positives = 137/272 (50%), Gaps = 19/272 (6%)
Query: 4 YEVLEQIGKGSFGSALLVRH---KHERKKYVLKKIRLARQTDRARRSAHQ--EMELISRV 58
+E+L +G G++G LVR K Y +K ++ A +A+ + H E +++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 59 R-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
R PF+V ++ + + +I+ Y GG++ + + HF E ++ ++ ++++AL
Sbjct: 62 RRCPFLVTLHYAF-QTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLAL 118
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--DLASSVVGTPSYMCPELL 175
++LH I++RD+K NI L + + L DFGL+K +++ + A S GT YM PE++
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 176 --ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGA 230
+ D WSLG +E+ + F Q ++I++ I+ P P S
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238
Query: 231 FRGLVKSMLRKNPEFR---PSAAELLCHPHLQ 259
R ++ +L K+P+ R A E+ HP Q
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 81/272 (29%), Positives = 132/272 (48%), Gaps = 20/272 (7%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVL-KKIRLARQTDRARRSAHQEMELISRVRN 60
E E + +G G+ GS V KH V+ KK+ R+ +E++++ R+
Sbjct: 5 EDLETISDLGAGNGGSVSKV--KHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P+IV + +++ + +C+ + + + G + KK + P E L K V ++ L YL
Sbjct: 63 PYIVSFYGAFLNEN-NICMCMEFMDCGSLDRIYKKGGPI--PVEILGKIAVAVVEGLTYL 119
Query: 121 H-ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
+ + I+HRD+K SNI + I+L DFG++ LI + +A + VGT +YM PE +
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI-NSIADTFVGTSTYMSPERIQGGK 178
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAF-------KAFDMQALINKINKSIV-APLPTVYSGAF 231
Y KSD+WSLG + E++ K F D I + + IV P P + S F
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238
Query: 232 ----RGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
R V + L K+P RP+ +L P
Sbjct: 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 80/266 (30%), Positives = 132/266 (49%), Gaps = 19/266 (7%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ + E + +IG G+ G+ V H+ + Y LK I D RR +E+E++ V +
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNH 131
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK-LCKWLVQLLMALNY 119
P +V+ D + + + +++ + +GG + G H +E+ L Q+L + Y
Sbjct: 132 PNVVKCHDMF-DHNGEIQVLLEFMDGGSL-------EGTHIADEQFLADVARQILSGIAY 183
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPEL---- 174
LH HI+HRD+K SN+ + +++++ DFG++++L D +S VGT +YM PE
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTD 243
Query: 175 LADIPY-GSKSDIWSLGCCVYEMSAQKAAF---KAFDMQALINKINKSIVAPLPTVYSGA 230
L Y G DIWSLG + E + F + D +L+ I S P S
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHP 256
FR + L++ P R SA +LL HP
Sbjct: 304 FRHFISCCLQREPAKRWSAMQLLQHP 329
|
Length = 353 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 77/261 (29%), Positives = 131/261 (50%), Gaps = 9/261 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++Y E+IG+G+ G+ ++ +K++ L +Q + E+ ++ +NP
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKNP 76
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV Y DS++ G + +++ Y GG + + + + +C+ + L AL++LH
Sbjct: 77 NIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---ECLQALDFLH 132
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSYMCPELLADIPY 180
+N ++HRD+K NI L D ++L DFG A++ S++VGTP +M PE++ Y
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 181 GSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL-INKINKSIVAPLPTVYSGAFRGLVKSM 238
G K DIWSLG EM + ++AL + N + P S FR +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 239 LRKNPEFRPSAAELLCHPHLQ 259
L + + R SA ELL HP L+
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 78/261 (29%), Positives = 131/261 (50%), Gaps = 9/261 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++Y E+IG+G+ G+ ++ +K+I L +Q + E+ ++ ++NP
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK--ELIINEILVMKELKNP 76
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV + DS++ G + +++ Y GG + + + + E ++ + L AL +LH
Sbjct: 77 NIVNFLDSFL-VGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQALEFLH 132
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSYMCPELLADIPY 180
AN ++HRD+K N+ L D ++L DFG A++ S++VGTP +M PE++ Y
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 181 GSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL-INKINKSIVAPLPTVYSGAFRGLVKSM 238
G K DIWSLG EM + ++AL + N + P S FR +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 239 LRKNPEFRPSAAELLCHPHLQ 259
L + E R SA ELL HP L+
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 9/261 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++Y E+IG+G+ G+ ++ +K++ L +Q + E+ ++ ++P
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKHP 76
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV Y DS++ G + +++ Y GG + + + + +C+ + L AL +LH
Sbjct: 77 NIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---ECLQALEFLH 132
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSYMCPELLADIPY 180
+N ++HRD+K NI L D ++L DFG A++ S++VGTP +M PE++ Y
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 181 GSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL-INKINKSIVAPLPTVYSGAFRGLVKSM 238
G K DIWSLG EM + ++AL + N + P S FR +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252
Query: 239 LRKNPEFRPSAAELLCHPHLQ 259
L + E R SA ELL HP L+
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 76/268 (28%), Positives = 127/268 (47%), Gaps = 23/268 (8%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRL----ARQTDRARRSA----HQEMELISRVR 59
E IGKG++G L + + +K++ L A + D ++ E+E + +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV-QLLMALN 118
+ IV+Y + Y+ I + Y GG + ++ EE+L ++ Q+L L
Sbjct: 67 HLNIVQYL-GFETTEEYLSIFLEYVPGGSIGSCLRTYGRF---EEQLVRFFTEQVLEGLA 122
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM---LISDDLASSVVGTPSYMCPELL 175
YLH+ ILHRD+K N+ + D ++ DFG++K + +D S+ G+ +M PE++
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 176 AD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-----LPTVYS 228
Y +K DIWSLGC V EM A + + + A + K+ AP + S
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 229 GAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ + NP+ RP+A ELL HP
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHP 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 71/265 (26%), Positives = 127/265 (47%), Gaps = 15/265 (5%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQEMELISRVRNPF 62
++V +G+G FG +VR K Y +K ++ + + S +E +++S +P+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
I + + ++ +K + +++ Y GGD+ + + F E+ +L +L++A++ +H
Sbjct: 63 IPQLQYAFQDKD-NLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQ 120
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADI-- 178
+HRD+K N+ + R I+L DFG A L ++ + VGTP Y+ PE+L +
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 179 ----PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI---NKSIVAPLPTVYSGAF 231
YG + D WSLG YEM ++ F N I + + P S F
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHP 256
L++S+L + R L CHP
Sbjct: 241 LDLIQSLL-CGQKERLGYEGLCCHP 264
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 77/251 (30%), Positives = 120/251 (47%), Gaps = 29/251 (11%)
Query: 10 IGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVE 65
+GKGSFG +L R K + Y VLKK + + D E ++S RN PF+ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDV--ECTMTEKRILSLARNHPFLTQ 60
Query: 66 YKDSWVEKGCYVCI--------IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
Y C ++ + GGD+ I+K+ F E + + ++ AL
Sbjct: 61 L---------YCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSAL 109
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLA 176
+LH I++RD+K N+ L + +L DFG+ K I + S+ GTP Y+ PE+L
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLV 235
++ YG D W++G +YEM A F+A + L I N +V PT S ++
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLSQDAVDIL 227
Query: 236 KSMLRKNPEFR 246
K+ + KNP R
Sbjct: 228 KAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 62/197 (31%), Positives = 106/197 (53%), Gaps = 5/197 (2%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+YE L +IG+GS+G R++ + +KK + ++ A +E+ ++ ++++P
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V + + K + ++ YC+ + E K GV PE + K + Q L A+N+ H
Sbjct: 61 NLVNLIEVFRRKR-KLHLVFEYCDHTVLNELEKNPRGV--PEHLIKKIIWQTLQAVNFCH 117
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELL-ADIP 179
++ +HRDVK NI +T+ I+L DFG A++L D + V T Y PELL D
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 180 YGSKSDIWSLGCCVYEM 196
YG D+W++GC E+
Sbjct: 178 YGPPVDVWAIGCVFAEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 78/264 (29%), Positives = 121/264 (45%), Gaps = 15/264 (5%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQEMELISRVRNP 61
QY VL GKG FG + + K Y KK+ R R S A E +++ +V +
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
F+V ++ K +C+++ GGD+ I F E + + ++ L LH
Sbjct: 61 FVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 181
I++RD+K NI L IR+ D GLA + VGT YM PE++ + Y
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF----RGLVKS 237
D W+LGC +YEM A ++ F+ + ++ + +V + YS F R L K
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-LVKEVQEEYSEKFSPDARSLCKM 238
Query: 238 MLRKNPEFR-----PSAAELLCHP 256
+L K+P+ R A E+ HP
Sbjct: 239 LLCKDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 26/275 (9%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
+E++E IGKG++G V +K + +K + D + + ++ + +P +
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN--HPNV 81
Query: 64 VEYKDSWVEKGCYV----CIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMAL 117
V++ + + V +++ C GG + E +K G E + L L+ L
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLA 176
+LH N I+HRDVK +NI LT + ++L DFG++ L S L ++ VGTP +M PE++A
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 177 -----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPLPTV--- 226
D Y ++ D+WSLG E+ FDM + + KI ++ P PT+
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPL--FDMHPVKTLFKIPRN---PPPTLLHP 256
Query: 227 --YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
+ +F + L K+ E RPS LL HP ++
Sbjct: 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 80/263 (30%), Positives = 131/263 (49%), Gaps = 15/263 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
YE+++++G G++G R+ H + +K I+L D + QE+ ++ ++
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHC 66
Query: 62 FIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
IV Y S++ + ++C+ YC GG + + I G E ++ + L L YL
Sbjct: 67 NIVAYFGSYLSREKLWICM--EYCGGGSLQD-IYHVTG-PLSELQIAYVCRETLQGLAYL 122
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSYMCPELLA--- 176
H+ +HRD+K +NI LT + D++L DFG+ AK+ + S +GTP +M PE+ A
Sbjct: 123 HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 177 DIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFR 232
+ Y DIW++G E++ Q F M+AL + P T +S F
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242
Query: 233 GLVKSMLRKNPEFRPSAAELLCH 255
VK L KNP+ RP+A LL H
Sbjct: 243 NFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+YE L +IG+G+FG RHK ++ LKK+ + + + +A +E++++ +++
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 63 IVE-----YKDSWVEKGCYVCI--IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+V + + +CE D+A + N V F ++ K + LL
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLN 130
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-----SDDLASSVVGTPSYM 170
L Y+H N ILHRD+K +NI +T+D ++L DFGLA+ + ++ V T Y
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 171 CPE-LLADIPYGSKSDIWSLGCCVYEM 196
PE LL + YG D+W GC + EM
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 79/269 (29%), Positives = 136/269 (50%), Gaps = 18/269 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +E++E IGKG++G V +K K +K + D + + ++ +S +P
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD--HP 75
Query: 62 FIVEYKDSWVEK----GCYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLM 115
+V++ + +K G + +++ C GG + + +K G E + L + LM
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPEL 174
L +LH N +HRDVK +NI LT + ++L DFG++ L S L ++ VGTP +M PE+
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 175 LA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPL--PTV 226
+A D Y ++ D+WSLG E+ M+AL KI ++ L P +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPPPTLHQPEL 254
Query: 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCH 255
+S F ++ L K+ E RP+ ++LL H
Sbjct: 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 15/260 (5%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKD 68
+GKG FG + + K Y KK+ R R A E ++++V + FIV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 69 SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH--FPEEKLCKWLVQLLMALNYLHANHIL 126
++ K +C+++ GGD+ I + + FPE + C + Q++ L +LH I+
Sbjct: 61 AFQTK-TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 127 HRDVKCSNIFLTRDQDIRLGDFGLA-KMLISDDLASSVVGTPSYMCPELLADIPYGSKSD 185
+RD+K N+ L D ++R+ D GLA ++ GTP +M PELL Y D
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVD 179
Query: 186 IWSLGCCVYEMSAQKAAFKA----FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241
++LG +YEM A + F+A + + L +I V P +S A + +++L K
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT-YPDKFSPASKSFCEALLAK 238
Query: 242 NPEFR-----PSAAELLCHP 256
+PE R + L HP
Sbjct: 239 DPEKRLGFRDGNCDGLRTHP 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 60/265 (22%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 8 EQIGKGSFGSALL--VRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVRNPFIV 64
+++G+G+FG ++ K + V +K ++ ++ R+ +E ++ ++ +P +V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA-SEEERKDFLKEARVMKKLGHPNVV 59
Query: 65 EY-----KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK-------LCKWLVQ 112
++ + +++ Y EGGD+ + ++K+ V EK L + +Q
Sbjct: 60 RLLGVCTEEEPL------YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS---Y 169
+ + YL + +HRD+ N + D +++ DFGL++ + DD G +
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYS 228
M PE L D + SKSD+WS G ++E + + + ++ + K P P
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233
Query: 229 GAFRGLVKSMLRKNPEFRPSAAELL 253
L+ S + +PE RP+ +EL+
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 74/302 (24%), Positives = 147/302 (48%), Gaps = 23/302 (7%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHER------KKYVLKKIRLARQTDRARRSAHQEMELI 55
E + + +G GSFG +L +K+E K++ KI +Q D E +++
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV----FSERKIL 85
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+ + +PF V S+ ++ Y+ +++ + GG+ +++ FP + C + Q+++
Sbjct: 86 NYINHPFCVNLYGSFKDES-YLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVL 142
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
YL + +I++RD+K N+ L +D I++ DFG AK + D ++ GTP Y+ PE+L
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYTLCGTPEYIAPEIL 200
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235
++ +G +D W+LG +YE+ F A + + KI + I+ P + L+
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY-FPKFLDNNCKHLM 259
Query: 236 KSML-----RKNPEFRPSAAELLCHPHLQ--PYVLGIHLKLNGPRRNTFPLEWSDSNFKK 288
K +L ++ + A + HP +V +H + P + + + SNF++
Sbjct: 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFER 319
Query: 289 TR 290
+
Sbjct: 320 VQ 321
|
Length = 340 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 67/223 (30%), Positives = 120/223 (53%), Gaps = 15/223 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLK---KIRLARQTDRARRSAHQEMELISRV 58
E YEV++ IG+G+FG LVRHK RK Y +K K + +++D A +E ++++
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA--FFWEERDIMAFA 100
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+P++V+ ++ + Y+ +++ Y GGD+ + + PE+ + ++++AL+
Sbjct: 101 NSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALD 156
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELL- 175
+H+ +HRDVK N+ L + ++L DFG + + + + VGTP Y+ PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 176 ---ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 215
D YG + D WS+G +YEM F A + +KI
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 76/261 (29%), Positives = 129/261 (49%), Gaps = 9/261 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++Y E+IG+G+ G+ ++ ++++ L +Q + E+ ++ +NP
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV Y DS++ G + +++ Y GG + + + + E ++ + L AL +LH
Sbjct: 78 NIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSYMCPELLADIPY 180
+N ++HRD+K NI L D ++L DFG A++ S++VGTP +M PE++ Y
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 181 GSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL-INKINKSIVAPLPTVYSGAFRGLVKSM 238
G K DIWSLG EM + ++AL + N + P S FR +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 239 LRKNPEFRPSAAELLCHPHLQ 259
L + E R SA ELL H L+
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/240 (28%), Positives = 119/240 (49%), Gaps = 7/240 (2%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRVRNPFIVEYK 67
+GKGSFG +L K + Y +K ++ + Q D + ++ L ++PF+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
+ K + ++ Y GGD+ I+++ F E + + ++ +AL +LH + +++
Sbjct: 63 CCFQTKD-RLFFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDI 186
RD+K NI L + +L DFG+ K I + ++ GTP Y+ PE+L ++ YG D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 187 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 246
W+LG +YEM A + F+A + L I V P S ++K+ + KNP R
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-YPVWLSKEAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 15/264 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E +E++++IG G++G R+ + + +K I+L D A QE+ ++ ++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA--VVQQEIIMMKDCKHS 66
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV Y S++ + + I + +C GG + + I G E ++ + L L YLH
Sbjct: 67 NIVAYFGSYLRRD-KLWICMEFCGGGSLQD-IYHVTG-PLSESQIAYVSRETLQGLYYLH 123
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELLA--- 176
+ +HRD+K +NI LT + ++L DFG++ I+ +A S +GTP +M PE+ A
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQ-ITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 177 DIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFR 232
Y DIW++G E++ Q F M+AL + P +S +F
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242
Query: 233 GLVKSMLRKNPEFRPSAAELLCHP 256
VK L KNP+ RP+A +LL HP
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQHP 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 42/300 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+Y+ +E IG G++G KK +KKI A + +E++++ ++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 62 FIVEYKD---SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
I+ +D V +++ E D+ I + EE + +L QLL L
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQPLTEEHIRYFLYQLLRGLK 121
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-----ASSVVGTPSYMCPE 173
Y+H+ +++HRD+K SN+ + D ++R+GDFG+A+ L S + V T Y PE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 174 LLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------------QALINKINK 217
LL +P Y + D+WS+GC EM ++ F + + ++N+I
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 218 SIV------------APLPTVYSGA---FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262
V P ++ A L+ ML+ +PE R + + L HP L Y
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 71/251 (28%), Positives = 129/251 (51%), Gaps = 15/251 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAH--QEMELISRV 58
+ +E+ E +G GSFG + +HK + Y +K ++ R+ + ++ H QE ++ +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK-KREILKMKQVQHVAQEKSILMEL 75
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+PFIV S+ ++ V ++ + GG++ ++KA FP + + +L++A
Sbjct: 76 SHPFIVNMMCSFQDEN-RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFE 132
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
YLH+ I++RD+K N+ L +++ DFG AK + D ++ GTP Y+ PE++
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV--PDRTFTLCGTPEYLAPEVIQSK 190
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLV 235
+G D W++G +YE A F FD +I + I+A P + G R LV
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPF--FDDTPF--RIYEKILAGRLKFPNWFDGRARDLV 246
Query: 236 KSMLRKNPEFR 246
K +L+ + R
Sbjct: 247 KGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 72/242 (29%), Positives = 126/242 (52%), Gaps = 11/242 (4%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQ--EMELISRVRNPFIVEY 66
+GKG+FG +LV+ K + Y +K ++ ++ A+ AH E ++ R+PF+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HI 125
K S+ + +C ++ Y GG++ + + F E++ + +++ AL+YLH+ ++
Sbjct: 61 KYSF-QTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLADIPYGSKS 184
++RD+K N+ L +D I++ DFGL K I D + GTP Y+ PE+L D YG
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 177
Query: 185 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244
D W LG +YEM + F D + L I + P S + L+ +L+K+P+
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FPRTLSPEAKSLLSGLLKKDPK 236
Query: 245 FR 246
R
Sbjct: 237 QR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 78/268 (29%), Positives = 122/268 (45%), Gaps = 39/268 (14%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ-EMELISRVRN-PFIVEYK 67
IG+GS+ LLV K R+ Y +K I+ D Q E + N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV--- 59
Query: 68 DSWVEKGCYVC--------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
G + C +I + GGD+ +++ PEE + ++ +ALN+
Sbjct: 60 ------GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNF 111
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI 178
LH I++RD+K N+ L + I+L D+G+ K I D S+ GTP+Y+ PE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK----------INKSIVAPLPTVYS 228
YG D W+LG ++EM A ++ F M ++ + K I +P S
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLS 229
Query: 229 GAFRGLVKSMLRKNPEFRPSAAELLCHP 256
++K L K+P+ R L CHP
Sbjct: 230 VKASSVLKGFLNKDPKER-----LGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 69/228 (30%), Positives = 114/228 (50%), Gaps = 22/228 (9%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +E+++ IG+G+FG +V+ KH + Y +K + RA + +E RN
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE------RN- 53
Query: 62 FIVEYKDSWV-------EKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+V W+ + Y+ +++ Y GGD+ + K PE+ ++ +++
Sbjct: 54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMV 112
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG-LAKMLISDDLASSV-VGTPSYMCP 172
+A++ +H H +HRD+K N+ L + IRL DFG KM + SSV VGTP Y+ P
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 173 ELLADI-----PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 215
E+L + YG + D WSLG C+YEM + F A + KI
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLK----KIRLARQTDR---ARRSAHQEMELISRVRNPF 62
IGKGSFG LL + K + K Y +K KI L R+ + A R+ L+ V++PF
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-----LLKNVKHPF 57
Query: 63 IV--EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+V Y EK +V + + GG++ +++ FPE + + ++ AL YL
Sbjct: 58 LVGLHYSFQTTEKLYFV---LDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYL 112
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIP 179
H+ +I++RD+K NI L + L DFGL K I+ D ++ GTP Y+ PE++ P
Sbjct: 113 HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
Y + D W LG +YEM F D+ + + I + P A+ +++ +L
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW-SILEELL 231
Query: 240 RKNPEFRPSAAE 251
K+ + R A E
Sbjct: 232 EKDRQRRLGAKE 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 9/241 (3%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLK--KIRLARQTDRARRSAHQEMELISRVRNPFIVEYK 67
+GKGSFG +L K + + +K K + + D + + L +PF+
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
++ K ++ ++ Y GGD+ I+ + F E + + +++ L +LH I++
Sbjct: 63 CTFQTKE-HLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADIPYGSKSDI 186
RD+K N+ L +D I++ DFG+ K + + AS+ GTP Y+ PE+L Y D
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 187 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKNPEF 245
WS G +YEM ++ F D L + I P P S + + + ++P
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--PHFPRWISKEAKDCLSKLFERDPTK 237
Query: 246 R 246
R
Sbjct: 238 R 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 23/271 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ + E +G G+ G+ H R+ +K I L T ++ E+E++ + +P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPL-DITVELQKQIMSELEILYKCDSP 59
Query: 62 FIVE-YKDSWVEKGCYVCIIIGYCEGG--DMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+I+ Y +VE +C + +GG D+ I PE L + V ++ L
Sbjct: 60 YIIGFYGAFFVENRISICT--EFMDGGSLDVYRKI--------PEHVLGRIAVAVVKGLT 109
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
YL + ILHRDVK SN+ + ++L DFG++ L+ + +A + VGT +YM PE ++
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGE 168
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAF-KAFDMQALINKIN--KSIVAPLPTV-----YSGA 230
YG SD+WSLG E++ + + + Q + + + IV P V +S
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
F + +RK P+ RP+ L+ HP + Y
Sbjct: 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQY 259
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 79/292 (27%), Positives = 129/292 (44%), Gaps = 30/292 (10%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRA-RRSAHQEMELISRVRNPFIVEYKD 68
+GKG FG V+ K+ K Y KK+ R ++ + A E E++ +V +PFIV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 69 SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHR 128
++ E ++C+++ GGD+ I E++ + Q+ + +LH+ I++R
Sbjct: 61 AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 129 DVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 188
D+K N+ L + RL D GLA L + GT YM PE+L + PY D ++
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFA 179
Query: 189 LGCCVYEMSAQKAAFKAF----DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244
+GC +YEM A + FK + L + + V ++ + + + L K PE
Sbjct: 180 MGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239
Query: 245 FRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEA 296
R LG K + PR++ F FK F EA
Sbjct: 240 DR----------------LGSREKNDDPRKHEF--------FKTINFPRLEA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 60/209 (28%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +E+L+ IG+G+FG +V+ K+ + Y +K + RA + +E
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFRE-------ERD 53
Query: 62 FIVEYKDSWV-------EKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+V W+ + + +++ Y GGD+ + K PE+ +L +++
Sbjct: 54 VLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMV 112
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG-LAKMLISDDLASSV-VGTPSYMCP 172
+A++ +H +HRD+K N+ L ++ IRL DFG ++L + S+V VGTP Y+ P
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 173 ELLADIP-----YGSKSDIWSLGCCVYEM 196
E+L + YG + D WSLG C+YEM
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 69/211 (32%), Positives = 113/211 (53%), Gaps = 6/211 (2%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +E + ++G G+ G V+HK K I L + R +E++++ +P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECNSP 63
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+IV + ++ G + I + + +GG + + +K+A + PEE L K + +L L YL
Sbjct: 64 YIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKRI--PEEILGKVSIAVLRGLAYLR 120
Query: 122 ANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H I+HRDVK SNI + +I+L DFG++ LI D +A+S VGT SYM PE L Y
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHY 179
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 211
+SDIWS+G + E++ + D + L
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 85/290 (29%), Positives = 138/290 (47%), Gaps = 36/290 (12%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
++E L +IG+G++G R + LKK+R+ + D S+ +E+ L+ +R+P
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 63 IVEYKDSWVEKGC-YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IVE K+ V K + +++ YCE D+A + F E ++ ++QLL L YLH
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM--LISDDLASSVVGTPSYMCPELL-ADI 178
N I+HRD+K SN+ LT +++ DFGLA+ L + + VV T Y PELL
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCT 184
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------NKSI---VAPLPTV-- 226
Y + D+W++GC + E+ A K ++ I N+SI + LP V
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244
Query: 227 -----------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
S A L+ +L +P+ R +A E L + +
Sbjct: 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 64/223 (28%), Positives = 120/223 (53%), Gaps = 15/223 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLK---KIRLARQTDRARRSAHQEMELISRV 58
E Y+V++ IG+G+FG LVRHK +K Y +K K + +++D A +E ++++
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSA--FFWEERDIMAFA 100
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+P++V+ ++ + Y+ +++ Y GGD+ + + PE+ + ++++AL+
Sbjct: 101 NSPWVVQLFCAFQDDK-YLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALD 156
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELL- 175
+H+ ++HRDVK N+ L + ++L DFG + + + VGTP Y+ PE+L
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 176 ---ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 215
D YG + D WS+G ++EM F A + +KI
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 77/287 (26%), Positives = 135/287 (47%), Gaps = 35/287 (12%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+YE L +G+GS+G + +HK + +KK + ++ A +E+ ++ ++R+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V + + K ++ + + + + K NG+ E ++ K+L Q+L + + H
Sbjct: 61 NLVNLIEVFRRKKRLY-LVFEFVDHTVLDDLEKYPNGLD--ESRVRKYLFQILRGIEFCH 117
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELL-ADIP 179
+++I+HRD+K NI +++ ++L DFG A+ L + ++ + V T Y PELL D
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAF-------------KAF-----DMQALINKINKSIVA 221
YG DIW++GC V EM + F K Q + K
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 222 PLPTV------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
LP V SG L K LR +P+ RPS+++LL H
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 22/228 (9%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E +E+L+ IG+G+FG +V+ K+ K + +K + RA + +E
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE-------ERD 53
Query: 62 FIVEYKDSWVEKGCY-------VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+V + W+ Y + +++ Y GGD+ + K PE+ +L +++
Sbjct: 54 VLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMV 112
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS--VVGTPSYMCP 172
+A++ +H H +HRD+K NI + + IRL DFG L+ D S VGTP Y+ P
Sbjct: 113 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
Query: 173 ELLADIP-----YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 215
E+L + YG + D WSLG C+YEM + F A + KI
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLK--KIRLARQTDRARRSAHQEMELISRVRN 60
+++L Q+G+G +G L + K + LK K L + + R E ++++ ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTKS 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
++V+ ++ + Y+ + + Y GGD + GV E+ ++ ++ A++ L
Sbjct: 61 EWLVKLLYAFQDDE-YLYLAMEYVPGGDF-RTLLNNLGV-LSEDHARFYMAEMFEAVDAL 117
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H +HRD+K N + I+L DFGL+K +++ A+SVVG+P YM PE+L Y
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGY 175
Query: 181 GSKSDIWSLGCCVYEM 196
D WSLGC +YE
Sbjct: 176 DFTVDYWSLGCMLYEF 191
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 76/275 (27%), Positives = 138/275 (50%), Gaps = 30/275 (10%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV---RN 60
+E++E +G G++G RH K L I++ T QE+ ++ + RN
Sbjct: 8 FELVELVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 61 PFIVEYKDSWVEKGC-----YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
I Y ++++K + +++ +C G + + IK G EE + ++L
Sbjct: 65 --IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPEL 174
L++LH + ++HRD+K N+ LT + +++L DFG++ L + ++ +GTP +M PE+
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182
Query: 175 LA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPLPTV- 226
+A D Y KSD+WSLG EM+ + A DM + + I ++ P P +
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMA--EGAPPLCDMHPMRALFLIPRN---PAPRLK 237
Query: 227 ---YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258
+S F+ ++S L KN RP+ +L+ HP +
Sbjct: 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 76/275 (27%), Positives = 136/275 (49%), Gaps = 30/275 (10%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELI---SRVRN 60
+E++E +G G++G RH K L I++ T+ E+ ++ S RN
Sbjct: 18 FELVEVVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRN 74
Query: 61 PFIVEYKDSWVEKGC-----YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
I Y ++++K + +++ +C G + + +K G E+ + ++L
Sbjct: 75 --IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPEL 174
L +LHA+ ++HRD+K N+ LT + +++L DFG++ L + ++ +GTP +M PE+
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192
Query: 175 LA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPLPTV- 226
+A D Y +SDIWSLG EM+ + A DM + + I ++ P P +
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMA--EGAPPLCDMHPMRALFLIPRN---PPPKLK 247
Query: 227 ---YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258
+S F ++ L KN RPS +LL HP +
Sbjct: 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++YE L +I +G++G R K + LKK+++ ++ + ++ +E+ ++ ++++P
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 62 FIVEYKDSWVEKGC-YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
IV K+ V + +++ Y E D+ ++ E C ++QLL + +L
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKC-LMLQLLSGVAHL 122
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS--DDLASSVVGTPSYMCPELLADI 178
H N ILHRD+K SN+ L +++ DFGLA+ S VV T Y PELL
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGA 181
Query: 179 P-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------LPTVY 227
Y + D+WS+GC E+ +K F +NKI K + P LP
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 228 SGAFRG---------------------LVKSMLRKNPEFRPSAAELLCHP 256
F L+ +L +P R SA + L HP
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 67/197 (34%), Positives = 108/197 (54%), Gaps = 6/197 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +E + ++G G+ G V HK K I L + R +E++++ +P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECNSP 63
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+IV + ++ G + I + + +GG + + +KKA + PE+ L K + ++ L YL
Sbjct: 64 YIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLR 120
Query: 122 ANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H I+HRDVK SNI + +I+L DFG++ LI D +A+S VGT SYM PE L Y
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHY 179
Query: 181 GSKSDIWSLGCCVYEMS 197
+SDIWS+G + EM+
Sbjct: 180 SVQSDIWSMGLSLVEMA 196
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 31/225 (13%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHER--KKYVLKKIR-LARQTDRARRSAHQEMELISRVR 59
+YE+ IG+G++G + K+ + K+Y +KK + Q +SA +E+ L+ ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 60 NPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIK---KANGVHFPEEKLCKWLVQLLM 115
+ +V + ++E V ++ Y E D+ + IK +A V P + L Q+L
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQD----IRLGDFGLA-------KMLISDDLASSVV 164
++YLH+N +LHRD+K +NI + + +++GD GLA K L D VV
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---PVV 176
Query: 165 GTPSYMCPELLADIPYGSKS-----DIWSLGCCVYEMSAQKAAFK 204
T Y PELL G++ DIW++GC E+ + FK
Sbjct: 177 VTIWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 87/310 (28%), Positives = 143/310 (46%), Gaps = 63/310 (20%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA--RQTDRARRSAHQEMELISRV 58
+ +YE+L+++GKG++G + ++ LKKI A TD A+R+ +E+ + +
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-AQRT-FREIMFLQEL 63
Query: 59 RN-PFIVEYKDSWV-----EKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWL 110
+ P IV+ + V +K Y+ + Y E D+ I+ VH K
Sbjct: 64 GDHPNIVKLLN--VIKAENDKDIYL--VFEYMET-DLHAVIRANILEDVH-------KRY 111
Query: 111 V--QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML--ISDDLASSV--- 163
+ QLL AL Y+H+ +++HRD+K SNI L D ++L DFGLA+ L + ++ + V
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 164 -VGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAF------------------ 203
V T Y PE LL Y D+WS+GC + EM K F
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 204 -KAFDMQAL--------INKINKSIVAPLPTVYSGAFR---GLVKSMLRKNPEFRPSAAE 251
A D++++ ++ + PL + A L+K +L NP R +A E
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291
Query: 252 LLCHPHLQPY 261
L HP++ +
Sbjct: 292 ALEHPYVAQF 301
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 86/291 (29%), Positives = 127/291 (43%), Gaps = 38/291 (13%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR--- 59
QYE + +IG G++G+ R H LK +R+ D S +E+ L+ R+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 60 NPFIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+P IV D S ++ V ++ + + D+ + K P E + + Q L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
L++LHAN I+HRD+K NI +T ++L DFGLA++ + VV T Y PE+L
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAF----------KAFDMQAL-----------INK 214
Y + D+WS+GC EM +K F K FD+ L + +
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239
Query: 215 INKSIVAPLPTV-------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258
S P P SGA L+ ML NP R SA L HP
Sbjct: 240 GAFSPRGPRPVQSVVPEIEESGA--QLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 73/237 (30%), Positives = 121/237 (51%), Gaps = 9/237 (3%)
Query: 10 IGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEY 66
IGKGSFG LL RHK E K Y VL+K + ++ + + + + L+ V++PF+V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGL 61
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 126
S+ + + ++ Y GG++ +++ P + + ++ AL YLH+ +I+
Sbjct: 62 HFSF-QTADKLYFVLDYINGGELFYHLQRERCFLEPRARF--YAAEIASALGYLHSLNIV 118
Query: 127 HRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSD 185
+RD+K NI L I L DFGL K I + S+ GTP Y+ PE+L PY D
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVD 178
Query: 186 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
W LG +YEM F + + + + I + P + + A R L++ +L+K+
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA-RHLLEGLLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 66/236 (27%), Positives = 111/236 (47%), Gaps = 45/236 (19%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAH--QEMELISRVR 59
+ +E ++ IG+G+FG LV+ K Y +KK+R + ++ + AH E ++++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK-EQVAHVRAERDILAEAD 59
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
NP++V+ S+ ++ Y+ +I+ Y GGDM + K + F EE+ ++ + ++A++
Sbjct: 60 NPWVVKLYYSFQDEN-YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDS 116
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGL------------------AKMLISDD--- 158
+H +HRD+K N+ L I+L DFGL A D
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 159 ------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
LA S VGTP Y+ PE+ Y + D WSLG +YEM
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 33/291 (11%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+Y L+Q+G G++GS K +K +KK+ Q++ + A++E+ L+ +++
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
++ D + Y M ++K G E+K+ + Q+L L Y+H
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPY 180
+ I+HRD+K N+ + D ++++ DFGLA+ +D + V T Y PE++ + + Y
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPEVILNWMHY 192
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFD-------------------MQALINKINKSIVA 221
DIWS+GC + EM K FK D +Q L +K KS +
Sbjct: 193 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252
Query: 222 PLPTVYSGAFR-----------GLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
LP F L++ ML + + R +A E L HP+ +
Sbjct: 253 SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 6/197 (3%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVR-NPFIVEYK 67
IG+GS+ LLVR K + Y +K ++ D E + + NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
S + + ++I Y GGD+ +++ PEE + ++ +ALN+LH I++
Sbjct: 63 -SCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDI 186
RD+K N+ L D I+L D+G+ K + D S+ GTP+Y+ PE+L YG D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 187 WSLGCCVYEMSAQKAAF 203
W+LG ++EM A ++ F
Sbjct: 180 WALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 84/312 (26%), Positives = 157/312 (50%), Gaps = 25/312 (8%)
Query: 4 YEVLEQIGKGSFGSALLVRH--KHERKK-YVLKKIRLARQTDRARRSAHQEME--LISRV 58
+E+L+ +G G++G LVR H+ K Y +K ++ A +A+ H E ++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 59 R-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
R +PF+V ++ + + +I+ Y GG+M + + + +F E+++ + ++++AL
Sbjct: 62 RQSPFLVTLHYAF-QTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILAL 118
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--DLASSVVGTPSYMCPELL 175
+LH I++RD+K NI L + + L DFGL+K +S+ + S GT YM PE++
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 176 -ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAF 231
+G D WSLG ++E+ + F + +++++ I+ P P+
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 232 RGLVKSMLRKNPEFR-----PSAAELLCHPHLQ--PYVLGIHLKLNGPRRNTFPLEWSDS 284
+ L+ +LRK+P+ R A+E+ HP + + K+N P R + E
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVG 298
Query: 285 NFKK--TRFMEP 294
NF + T +EP
Sbjct: 299 NFAEEFTN-LEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 75/274 (27%), Positives = 142/274 (51%), Gaps = 21/274 (7%)
Query: 4 YEVLEQIGKGSFGSALLVRH--KHERKK-YVLKKIRLARQTDRARRSAHQ--EMELISRV 58
+E+L+ +G G++G LVR H+ K Y +K ++ A +A+ + H E +++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 59 R-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
R +PF+V ++ + + +I+ Y GG++ + + F E+++ + ++++AL
Sbjct: 62 RQSPFLVTLHYAF-QTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLAL 118
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELL 175
+LH I++RD+K NI L + + L DFGL+K D++ A S GT YM P+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 176 A--DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGA 230
D + D WS+G +YE+ + F + +I++ I+ P P S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
Query: 231 FRGLVKSMLRKNPEFR----PSAA-ELLCHPHLQ 259
+ +++ +L K+P+ R PS A E+ HP Q
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 75/274 (27%), Positives = 140/274 (51%), Gaps = 29/274 (10%)
Query: 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN-PFI 63
EV+E++G+G++G +RH +K+IR A + ++ ++++ R + P+
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIR-ATVNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 64 VEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKK------ANGVHFPEEKLCKWLVQLLMA 116
V + + +G ++C+ + M ++ K G+ PE+ L K V ++ A
Sbjct: 63 VTFYGALFREGDVWICMEV-------MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 117 LNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV-VGTPSYMCPEL 174
L YLH+ ++HRDVK SN+ + R+ ++L DFG++ L+ D +A ++ G YM PE
Sbjct: 116 LEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPER 174
Query: 175 ----LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV---- 226
L Y KSD+WSLG + E++ + + ++ + ++ + + P P +
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW--KTPFQQLKQVVEEPSPQLPAEK 232
Query: 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260
+S F+ V L+KN + RP+ ELL HP +
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 74/264 (28%), Positives = 116/264 (43%), Gaps = 15/264 (5%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQEMELISRVRNP 61
Y VL GKG FG + + K Y KK+ R R + A E ++ +V +
Sbjct: 4 HYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
F+V ++ K +C+++ GGD+ I F E++ + +L L L
Sbjct: 61 FVVSLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 181
I++RD+K NI L IR+ D GLA + + VGT YM PE++ + Y
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR- 240
D W LGC +YEM ++ F+ + ++++ + YS F KS+ R
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE-YSEKFSEDAKSICRM 238
Query: 241 ---KNPEFR-----PSAAELLCHP 256
KNP+ R AA + HP
Sbjct: 239 LLTKNPKERLGCRGNGAAGVKQHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 77/296 (26%), Positives = 135/296 (45%), Gaps = 42/296 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++Y+ L +G G++G +K +KK+ Q+ + ++E+ L+ + +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 62 FIVEYKD-----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
++ D S +E V ++ G D+ +K ++ + + Q+L
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK---LSDDHIQFLVYQILRG 130
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE-LL 175
L Y+H+ I+HRD+K SNI + D ++++ DFGLA+ DD + V T Y PE +L
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIML 188
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--------MQ-------ALINKIN---- 216
+ Y DIWS+GC + E+ K F D M L+ KI+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 217 KSIVAPLPTV----YSGAFRG-------LVKSMLRKNPEFRPSAAELLCHPHLQPY 261
++ + LP + + F G L++ ML +P+ R +AAE L HP+L Y
Sbjct: 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 74/253 (29%), Positives = 121/253 (47%), Gaps = 24/253 (9%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ-EMELISRVRN-PFIVEYK 67
IG+GS+ LLVR K + Y +K ++ D Q E + + N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
S + + +I Y GGD+ +++ PEE + ++ +ALNYLH I++
Sbjct: 63 -SCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADIPYGSKSDI 186
RD+K N+ L + I+L D+G+ K L D S+ GTP+Y+ PE+L YG D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 187 WSLGCCVYEMSAQKAAF-------------KAFDMQALINKINKSIVAPLPTVYSGAFRG 233
W+LG ++EM A ++ F + + Q ++ K + +P S
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----IPRSLSVKAAS 234
Query: 234 LVKSMLRKNPEFR 246
++KS L K+P+ R
Sbjct: 235 VLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 69/246 (28%), Positives = 120/246 (48%), Gaps = 7/246 (2%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRVRNP 61
+ L +GKGSFG +L K + Y +K ++ + Q D + ++ L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
F+ + S + + ++ Y GGD+ I++ F E + ++ + L +LH
Sbjct: 62 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH 118
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-SVVGTPSYMCPELLADIPY 180
+ I++RD+K N+ L + I++ DFG+ K + D + + + GTP Y+ PE++A PY
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
G D W+ G +YEM A +A F+ D L I + VA P S + K ++
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-YPKSMSKEAVAICKGLMT 237
Query: 241 KNPEFR 246
K+P R
Sbjct: 238 KHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 11/248 (4%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLK--KIRLARQTDRARRSAHQEMELISRVRNP 61
+ L +GKGSFG +L K + Y +K K + Q D + ++ L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 62 FIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
F+ + + +++ +V + Y GGD+ I++ F E + ++ + L +
Sbjct: 62 FLTQLHSCFQTMDRLYFV---MEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFF 116
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADI 178
LH+ I++RD+K N+ L + I++ DFG+ K + + GTP Y+ PE++A
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
PYG D W+ G +YEM A + F D L I + V+ P S + K +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICKGL 235
Query: 239 LRKNPEFR 246
L K+P R
Sbjct: 236 LTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 74/290 (25%), Positives = 128/290 (44%), Gaps = 35/290 (12%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVR- 59
+QYE + +IG+G++G R ++V LK++R+ + S +E+ ++ +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 60 --NPFIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+P +V D S ++ + ++ + + D+ + K P E + + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
L L++LH++ ++HRD+K NI +T I+L DFGLA++ +SVV T Y PE
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAF----------KAFDMQALINK--------I 215
+L Y + D+WS+GC EM +K F K D+ L + +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 216 NKSIVAPLPTVYSGAF--------RGLVKSMLRKNPEFRPSAAELLCHPH 257
+ F + L+ L NP R SA L HP+
Sbjct: 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 75/303 (24%), Positives = 133/303 (43%), Gaps = 53/303 (17%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
YE+L ++G+G+FG R + LKKI + + D +A +E++++ ++++P +
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 64 VEYKDSWVE--------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
V D VE +G V ++ Y + D++ ++ + V E ++ +++QLL
Sbjct: 70 VPLIDMAVERPDKSKRKRGS-VYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLE 126
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML------------ISDDLASSV 163
+NYLH NHILHRD+K +NI + +++ DFGLA+ +++
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 164 VGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAF----------KAFDM---- 208
V T Y PELL + Y + DIW +GC EM ++ F +
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246
Query: 209 --------QALINKINKSIVAPLPTVYSGAFR-------GLVKSMLRKNPEFRPSAAELL 253
++L P F L+ +L +P R +A++ L
Sbjct: 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306
Query: 254 CHP 256
HP
Sbjct: 307 EHP 309
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 76/287 (26%), Positives = 138/287 (48%), Gaps = 36/287 (12%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+YE LE+IG+G++G+ +++ + LK++RL + SA +E+ L+ +++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK-WLVQLLMALNYLH 121
IV D + + ++ YC+ D+ + NG + ++ K ++ QLL L + H
Sbjct: 61 IVRLYDV-LHSDKKLTLVFEYCDQ-DLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCH 116
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLADIP 179
++++LHRD+K N+ + ++ +++L DFGLA+ I S+ V T Y P+ L
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 180 YGSKSDIWSLGCCVYEMS-AQKAAFKAFDMQALINKINKSIVAP----------LP---- 224
Y + D+WS GC E++ A + F D+ + +I + + P LP
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236
Query: 225 ------------TVYSGAFRG--LVKSMLRKNPEFRPSAAELLCHPH 257
V G L++++L NP R SA E L HP+
Sbjct: 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y+ +E+IG+G++G R K + LKKIRL + + +A +E+ L+ + +P I
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
V D V + ++ + + D+ + + + + +L QLL + Y H++
Sbjct: 61 VRLLDV-VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV--------VGTPSYMCPE-L 174
+LHRD+K N+ + R+ ++L DFGLA+ A V V T Y PE L
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLAR-------AFGVPVRTYTHEVVTLWYRAPEIL 171
Query: 175 LADIPYGSKSDIWSLGCCVYEMSAQKAAF----------KAFDMQALINKINKSIVAPLP 224
L Y + DIWS+GC EM ++ F + F ++ V LP
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231
Query: 225 TVYSGAF-------------------RGLVKSMLRKNPEFRPSAAELLCHPHL 258
Y F L+ ML +P R SA L HP+
Sbjct: 232 D-YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 80/286 (27%), Positives = 130/286 (45%), Gaps = 36/286 (12%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
++ +E+IG+G++G R+K + LKKIRL +T+ +A +E+ L+ + +P I
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 64 VEYKDS-WVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
V+ D E Y ++ + D+ + + + P + +L QLL L + H+
Sbjct: 62 VKLLDVIHTENKLY--LVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIPYG 181
+ +LHRD+K N+ + + I+L DFGLA+ + + V T Y PE+L Y
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 182 SKS-DIWSLGCCVYEMSAQKAAF----------KAFDMQALINKINKSIVAPLPTVYSGA 230
S + DIWSLGC EM ++A F + F +++ V LP Y +
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD-YKPS 237
Query: 231 F-------------------RGLVKSMLRKNPEFRPSAAELLCHPH 257
F R L+ ML +P R SA L HP
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-22
Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 42/296 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+Y+ L +G G++GS R+K +KK+ Q+ R ++E+ L+ +++
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 62 FIVEYKDSW-----VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
++ D + +E V ++ G D+ +K +E + + QLL
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQK---LSDEHVQFLIYQLLRG 130
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 176
L Y+H+ I+HRD+K SN+ + D ++R+ DFGLA+ +DD + V T Y PE++
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYVATRWYRAPEIML 188
Query: 177 D-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV--------- 226
+ + Y DIWS+GC + E+ KA F D + +I + + P P V
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248
Query: 227 --------------YSGAFRG-------LVKSMLRKNPEFRPSAAELLCHPHLQPY 261
FRG L++ ML + + R SA+E L HP+ Y
Sbjct: 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 72/246 (29%), Positives = 121/246 (49%), Gaps = 13/246 (5%)
Query: 10 IGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISRVRNPFIV-- 64
IGKGSFG LL + K + Y VL+K + ++ ++ A + + L+ +++PF+V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
Y EK +V + Y GG++ +++ P + + ++ A+ YLH+ +
Sbjct: 62 HYSFQTAEKLYFV---LDYVNGGELFFHLQRERCFLEPRARF--YAAEVASAIGYLHSLN 116
Query: 125 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSK 183
I++RD+K NI L + L DFGL K + ++ S+ GTP Y+ PE+L PY
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 184 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 243
D W LG +YEM F + D+ + + I + LP + A L+ +L K+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ-LPGGKTVAACDLLVGLLHKDQ 235
Query: 244 EFRPSA 249
R A
Sbjct: 236 RRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 67/242 (27%), Positives = 119/242 (49%), Gaps = 11/242 (4%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRVRNPFIVEYK 67
+GKGSFG +L K + Y +K ++ + Q D + ++ L + + PF+ +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 68 DSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
+ V++ +V + Y GGD+ I++ F E + + ++ + L +LH I
Sbjct: 68 SCFQTVDRLYFV---MEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-SVVGTPSYMCPELLADIPYGSKS 184
++RD+K N+ L + I++ DFG+ K + D + + + GTP Y+ PE++A PYG
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 185 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244
D W+ G +YEM A + F D L I + V+ P S + K ++ K+P
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICKGLMTKHPS 241
Query: 245 FR 246
R
Sbjct: 242 KR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 83/301 (27%), Positives = 129/301 (42%), Gaps = 51/301 (16%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRVRN 60
+Y++ E IGKGS+G H +K +KKI +D R +E++L+ +R+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 58
Query: 61 PFIVEYKDSWVE------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
P IVE K + K YV + D+ + IK AN PE +L QLL
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFEL---MESDLHQVIK-ANDDLTPEHHQF-FLYQLL 113
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYM 170
AL Y+H ++ HRD+K NI D +++ DFGLA++ +D + V T Y
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 171 CPELLADI--PYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------MQALINKINKSIVA 221
PEL Y DIWS+GC E+ K F + + L+ + ++
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 222 ----------------PLPTVYSGAFRG-------LVKSMLRKNPEFRPSAAELLCHPHL 258
P +S F L++ +L +P+ RP+A E L P+
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293
Query: 259 Q 259
+
Sbjct: 294 K 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 7/207 (3%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M+QYE +E+IG+G++G R + + LKKIRL ++ + +A +E+ L+ +++
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 PFIVEYKDS-WVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
IV +D EK Y ++ Y + D+ + + + + +L Q+L + Y
Sbjct: 61 GNIVRLQDVVHSEKRLY--LVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 120 LHANHILHRDVKCSNIFLTRDQD-IRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLA 176
H++ +LHRD+K N+ + R + ++L DFGLA+ I + V T Y PE LL
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAF 203
Y + DIWS+GC EM QK F
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 61/208 (29%), Positives = 116/208 (55%), Gaps = 23/208 (11%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLK---KIRLARQTDRARRSAHQEMELISRV 58
E ++V++ IG+G+FG LVRHK ++ Y +K K + +++D A +E ++++
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSA--FFWEERDIMAHA 100
Query: 59 RNPFIVE----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+ +IV+ ++D +K Y+ +++ Y GGD+ + + PE+ + +++
Sbjct: 101 NSEWIVQLHYAFQD---DK--YLYMVMEYMPGGDLVNLMSNYD---IPEKWARFYTAEVV 152
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCP 172
+AL+ +H+ +HRDVK N+ L + ++L DFG + ++ + + VGTP Y+ P
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212
Query: 173 ELL----ADIPYGSKSDIWSLGCCVYEM 196
E+L D YG + D WS+G +YEM
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 8e-21
Identities = 69/249 (27%), Positives = 111/249 (44%), Gaps = 52/249 (20%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAH--QEMELISRVRNP 61
+ ++ IG G+FG LVR Y +K +R A R ++AH E ++++ N
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-NQAAHVKAERDILAEADNE 61
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGD-MAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
++V+ S+ +K + ++ Y GGD M+ I+ G+ F E+ ++ +L A+ +
Sbjct: 62 WVVKLYYSFQDKDN-LYFVMDYIPGGDMMSLLIRL--GI-FEEDLARFYIAELTCAIESV 117
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLA---------------------KMLISDD- 158
H +HRD+K NI + RD I+L DFGL M S++
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177
Query: 159 ----------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
LA S+VGTP+Y+ PE+L Y D WS+G +YEM
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237
Query: 197 SAQKAAFKA 205
+ F A
Sbjct: 238 LVGQPPFLA 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 6/209 (2%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRVRNPFIVEYK 67
+GKGSFG LL K + + + +K ++ + D + ++ L NPF+
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
++ K ++ ++ + GGD+ I+ F + + +++ L +LH+ I++
Sbjct: 63 CTFQTKE-HLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADIPYGSKSDI 186
RD+K N+ L RD I++ DFG+ K + D+ AS+ GTP Y+ PE+L + Y D
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 187 WSLGCCVYEMSAQKAAFKAFDMQALINKI 215
WS G +YEM ++ F D L I
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-20
Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 50/267 (18%)
Query: 2 EQYEVLEQIG--KGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR 59
+ E+++++ G FG +++HK +K +V K I+ A+ + HQ M+
Sbjct: 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIK-AKNFNAIEPMVHQLMK-----D 67
Query: 60 NP-FI-----VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV-Q 112
NP FI V V +I+ Y + GD+ + +KK + E K ++ Q
Sbjct: 68 NPNFIKLYYSVTTLKGHV-------LIMDYIKDGDLFDLLKKEGKL---SEAEVKKIIRQ 117
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQD-IRLGDFGLAKMLISDDLASSVVGTPS--- 168
L+ ALN LH ++I+H D+K N+ R +D I L D+GL K ++GTPS
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK----------IIGTPSCYD 167
Query: 169 ----YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA-----FDMQALINKINKSI 219
Y PE + Y D W++G YE+ K FK D+++L+ + K +
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
Query: 220 VAPLPTVYSGAFRGLVKSMLRKNPEFR 246
P S V+SML+ N +R
Sbjct: 228 --PFIKNVSKNANDFVQSMLKYNINYR 252
|
Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 81/331 (24%), Positives = 135/331 (40%), Gaps = 36/331 (10%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRVRNPFIVE 65
+ +GKGSFG L K + + +K ++ + D + ++ L +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
++ K + ++ Y GGD+ I+ + P + +++ L +LH+ I
Sbjct: 61 LYCTFQTKE-NLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGI 117
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAK-MLISDDLASSVVGTPSYMCPELLADIPYGSKS 184
++RD+K NI L D I++ DFG+ K ++ D + GTP Y+ PE+L Y +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177
Query: 185 DIWSLGCCVYEMSAQKAAFKAFDMQALINKIN--------------KSIVAPLPTVYSGA 230
D WS G +YEM ++ F D + L I K I+ L V
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL-FVREPE 236
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTR 290
R VK +R++P FR L ++P P + SNF K
Sbjct: 237 RRLGVKGDIRQHPFFREIDWSALEEREIEP-----------PFKPKVKSANDCSNFDKEF 285
Query: 291 FMEPEAISIHS----NREKRQSFSNDRALNP 317
E +S+ N + F N +NP
Sbjct: 286 LNEKPRLSVTDRMLINSMDQNMFENFSFINP 316
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 73/299 (24%), Positives = 122/299 (40%), Gaps = 50/299 (16%)
Query: 5 EVLEQIGKGSFGSA--LLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
E+L IGK L +HK +KKI L + + QE+ ++++P
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
I+ Y S++ + ++ G + +K PE + L +L AL+Y+H+
Sbjct: 61 ILPYVTSFIVDS-ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS--------DDLASSVVGTPSYMCPEL 174
+HR VK S+I L+ D + L + +I D S V ++ PE+
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 175 L-ADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA---LINKI-------------- 215
L ++ Y KSDI+S+G E++ FK DM A L+ K+
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFK--DMPATQMLLEKVRGTVPCLLDKSTYP 237
Query: 216 --------------NKSIVAPLPTVY----SGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ + + Y S F V+ L+++PE RPSA++LL H
Sbjct: 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 77/294 (26%), Positives = 134/294 (45%), Gaps = 42/294 (14%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+E Y+ L+++G+GS+ + R K + LK+IRL + A +A +E L+ +++
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIREASLLKDLKH 62
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK-ANGVHFPEEKLCKWLVQLLMALNY 119
IV D + + ++ Y + D+ + + G+ +L +L QLL L Y
Sbjct: 63 ANIVTLHDI-IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL--FLFQLLRGLAY 118
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLA--KMLISDDLASSVVGTPSYMCPE-LLA 176
H +LHRD+K N+ ++ +++L DFGLA K + S ++ VV T Y P+ LL
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLG 177
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSI----------VAPLPT 225
Y + D+W +GC YEM+ + F D++ ++KI + + V+ P
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237
Query: 226 VYSGAFR---------------------GLVKSMLRKNPEFRPSAAELLCHPHL 258
+F L L+ P+ R SAAE + HP+
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 74/296 (25%), Positives = 141/296 (47%), Gaps = 42/296 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++Y L+Q+G G++G+ + K +KK+ Q++ + A++E+ L+ +++
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 62 FIVEYKDSW-----VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
++ D + +++ +++ + G D+ + +K E+++ + Q+L
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSEDRIQFLVYQMLKG 130
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 176
L Y+HA I+HRD+K N+ + D ++++ DFGLA+ +D + V T Y PE++
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVIL 188
Query: 177 D-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------------------MQALINKIN 216
+ + Y DIWS+GC + EM K FK D +Q L ++
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248
Query: 217 KSIVAPLPTVYSGAFRGLVKS-----------MLRKNPEFRPSAAELLCHPHLQPY 261
K+ V LP FR L+ + ML + E R +AAE L HP+ + +
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 72/286 (25%), Positives = 131/286 (45%), Gaps = 36/286 (12%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
++ LE++G+G++ + R++ + LK+I L + + +A +E+ L+ +++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHEN 59
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFP-EEKLCKWLV-QLLMALNYL 120
IV D + + ++ Y + D+ + + +GV + K QLL + +
Sbjct: 60 IVRLHDV-IHTENKLMLVFEYMDK-DLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLADI 178
H N +LHRD+K N+ + + +++L DFGLA+ I + S+ V T Y P+ LL
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----LPTV-----YSG 229
Y + DIWS+GC + EM + F + + + KI + + P P + Y
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 230 AFR-------------------GLVKSMLRKNPEFRPSAAELLCHP 256
F L+ +L+ NPE R SA + L HP
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 86/296 (29%), Positives = 132/296 (44%), Gaps = 47/296 (15%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+Y L+ +G G+FG R + + +KKI T + ++E++L+ +R+
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 62 FIVEYKD---SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK--LCKWLVQLLMA 116
I+ D S +E +V ++G D+ + P EK + +L Q+L
Sbjct: 70 NIISLSDIFISPLEDIYFVTELLG----TDLHRLLTSR-----PLEKQFIQYFLYQILRG 120
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE-LL 175
L Y+H+ ++HRD+K SNI + + D+++ DFGLA+ I D + V T Y PE +L
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIML 178
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------------QALINKINKS-- 218
Y + DIWS GC EM K F D +IN I
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238
Query: 219 --IVAPLP----TVYSGAF-------RGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
V LP +S F L++ ML +P+ R SAAE L HP+L PY
Sbjct: 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 33/286 (11%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y +E+IG+G++G R+K + +KKIRL + + +A +E+ L+ +++P I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 64 VEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
V +D +++ Y+ + +++ K G + E + +L Q+L + + H+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS 119
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLADIPY 180
+LHRD+K N+ + I+L DFGLA+ I + + V T Y PE LL Y
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKA-------FDMQALINKINKSI---VAPLPTVYS-- 228
+ DIWS+G EM+ +K F F + ++ + + V LP +
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239
Query: 229 -----GAFRGLVKS-----------MLRKNPEFRPSAAELLCHPHL 258
G+ R VK+ ML +P R SA + L HP+
Sbjct: 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-18
Identities = 75/297 (25%), Positives = 116/297 (39%), Gaps = 56/297 (18%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y V++ + GS G + + VLK + + E L+ V +P +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--------GQKGTTLIEAMLLQNVNHPSV 119
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
+ KD+ V C+++ + D+ + K + ++ L Q+L L YLHA
Sbjct: 120 IRMKDTLVSGAI-TCMVLPHYSS-DLYTYLTKRSRPLPIDQALII-EKQILEGLRYLHAQ 176
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 183
I+HRDVK NIF+ + +GD G A+ + + GT PE+LA Y SK
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK 236
Query: 184 SDIWSLGCCVYEM------------SAQKAAFKAFDMQALINKINKSIVAP-----LPTV 226
+DIWS G ++EM S + K+ L+ I+ V P P
Sbjct: 237 ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH-LLKIISTLKVHPEEFPRDPGS 295
Query: 227 --------YSGAFRG-------------------LVKSMLRKNPEFRPSAAELLCHP 256
Y+ R LV ML + RPSA E+L +P
Sbjct: 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYP 352
|
Length = 357 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIR-LARQT--DRARRSAHQEMELISRV 58
+Y+ L IG+G++G HK K +KKI QT R R E++++ R
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRF 60
Query: 59 RNPFIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
++ I+ D E V I+ E D+ + IK + + + +L Q+L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH---LSNDHIQYFLYQIL 116
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV----VGTPSYM 170
L Y+H+ ++LHRD+K SN+ L + D+++ DFGLA++ + + V T Y
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 171 CPELLADIPYGSKS-DIWSLGCCVYEMSAQKAAF-------------------------- 203
PE++ + +K+ DIWS+GC + EM + + F
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 204 ----KAFD-MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258
+A + +++L K P A L+ ML NP R + E L HP+L
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKAL-DLLDKMLTFNPHKRITVEEALAHPYL 295
Query: 259 QPY 261
+ Y
Sbjct: 296 EQY 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 6e-18
Identities = 43/94 (45%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA-KMLISDDLASSV--VGTPSY 169
LL AL YLH I+HRDVK NIFL ++ LGDFG A K+ D GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 203
PELLA PY +K+DIWS G ++EMS +
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 83/310 (26%), Positives = 133/310 (42%), Gaps = 60/310 (19%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNP 61
+Y L +G GS G K+ +KKI L TD ++ + A +E+++I R+ +
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL---TDPQSVKHALREIKIIRRLDHD 62
Query: 62 FIVEYKDSWVEKGC-------------YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 108
IV+ + G V I+ Y E D+A +++ EE
Sbjct: 63 NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LSEEHARL 118
Query: 109 WLVQLLMALNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLISD-----DLASS 162
++ QLL L Y+H+ ++LHRD+K +N+F+ T D +++GDFGLA+++ L+
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 163 VVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-- 219
+V T Y P LL+ Y D+W+ GC EM K F + I +S+
Sbjct: 179 LV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 220 -----------VAP-----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAE 251
V P LP V A ++ +L NP R +A E
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL-DFLEQILTFNPMDRLTAEE 296
Query: 252 LLCHPHLQPY 261
L HP++ Y
Sbjct: 297 ALMHPYMSCY 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 65/232 (28%), Positives = 116/232 (50%), Gaps = 8/232 (3%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+E Y L+++G+G++ + R K LK+IRL + + A +A +E+ L+ +++
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKH 63
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK-ANGVHFPEEKLCKWLVQLLMALNY 119
IV D + + ++ Y + D+ + + N ++ KL +L QLL LNY
Sbjct: 64 ANIVTLHDI-IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL--FLFQLLRGLNY 119
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPE-LLAD 177
H +LHRD+K N+ + +++L DFGLA+ I S+ V T Y P+ LL
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG 229
Y ++ D+W +GC YEMS + F ++ ++ I + + P + G
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 16/261 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ YE LE++G+GS+ + + K K LK IRL ++ + +A +E L+ +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL-QEEEGTPFTAIREASLLKGLKHA 63
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV D + + ++ Y K G+H KL +L QLL L+Y+H
Sbjct: 64 NIVLLHDI-IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL--FLFQLLRGLSYIH 120
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPE-LLADIP 179
+ILHRD+K N+ ++ +++L DFGLA+ + S+ V T Y P+ LL
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
Y + D+W +GC EM AAF D+Q + +I + P + G V S+
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG-----VHSL 235
Query: 239 LRKNPEFRPSAAELLCHPHLQ 259
P F+P L +L+
Sbjct: 236 ----PHFKPERFTLYSPKNLR 252
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 67/260 (25%), Positives = 116/260 (44%), Gaps = 6/260 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+++Y+ L+ IG G+ G + +KK+ Q + A++E+ L+ V +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
I+ + + + Y M + + + E++ L Q+L + +L
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
H+ I+HRD+K SNI + D +++ DFGLA+ + + + V T Y PE++ + Y
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240
DIWS+GC + EM K F D NK+ + + P P F ++ +R
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE-----FMKKLQPTVR 250
Query: 241 KNPEFRPSAAELLCHPHLQP 260
E RP A L P L P
Sbjct: 251 NYVENRPKYAG-LTFPKLFP 269
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 70/310 (22%), Positives = 133/310 (42%), Gaps = 61/310 (19%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAH------------QEMELISR 57
+G+G++G K +KK+++ ++ + +E+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+++ I+ D +VE ++ +++ D+ + + + E ++ L+Q+L L
Sbjct: 77 IKHENIMGLVDVYVEGD-FINLVMDIMAS-DLKKVVD--RKIRLTESQVKCILLQILNGL 132
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK----MLISDDLA-----------SS 162
N LH + +HRD+ +NIF+ ++ DFGLA+ SD L+ +S
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 163 VVGTPSYMCPELL--ADIPYGSKSDIWSLGCCVYEMSAQKAAF----------KAFDMQA 210
V T Y PELL A+ Y D+WS+GC E+ K F + F++
Sbjct: 193 KVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 211 LINKIN--KSIVAPLPTVYSGAFR---------------GLVKSMLRKNPEFRPSAAELL 253
N+ N ++ PL T ++ L++S+L+ NP R SA E L
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 254 CHPHLQPYVL 263
H + + L
Sbjct: 312 KHEYFKSDPL 321
|
Length = 335 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 7 LEQIGKGSFGSALLVRHKHERKK---YVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
++Q+G+G FG L R+ V K ++ R +E+E++ + + I
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 64 VEYKDSWVEK--GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
V+YK EK G + +I+ Y G + + +++ + ++L + Q+ ++YL
Sbjct: 69 VKYK-GVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLG 126
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS-----YMCPELLA 176
+ +HRD+ NI + + +++ DFGLAK+L D V P + PE L
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK-DYYYVKEPGESPIFWYAPECLR 185
Query: 177 DIPYGSKSDIWSLGCCVYEM 196
+ S SD+WS G +YE+
Sbjct: 186 TSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 66/238 (27%), Positives = 102/238 (42%), Gaps = 52/238 (21%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +E L+ IG+G+FG LV+ K Y +K +R A ++ + AH R
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAH------IRAERD 53
Query: 62 FIVEYKDSWVEKGCY-------VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+VE +WV K Y + +I+ + GGDM + K + + EE ++ + +
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL--SEEATQFYIAETV 111
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI----------------SD- 157
+A++ +H +HRD+K N+ L ++L DFGL L SD
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 158 -------------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
LA S VGTP Y+ PE+ Y D WSLG +YEM
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 4/117 (3%)
Query: 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 143
G + + ++K HF LC + VQ+ + YL + +HRD+ NI L D +
Sbjct: 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKV 136
Query: 144 RLGDFGLAKML-ISDDLASSV--VGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
++GDFGL + L ++D + P ++ PE L + SD+W G ++EM
Sbjct: 137 KIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 67/256 (26%), Positives = 124/256 (48%), Gaps = 22/256 (8%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELISRVRNPFIV 64
IG+G FG R K Y +K +I++ +Q + + + L+S PFIV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60
Query: 65 --EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
Y +K +C I+ GGD+ + + +GV F E+++ + ++++ L ++H
Sbjct: 61 CMTYAFHTPDK---LCFILDLMNGGDLHYHLSQ-HGV-FSEKEMRFYATEIILGLEHMHN 115
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYG 181
+++RD+K +NI L +R+ D GLA S + VGT YM PE+L Y
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYD 174
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPLPTVYSGAFRGLVKSML 239
S +D +SLGC ++++ + F+ + I+++ ++ LP +S + L++ +L
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234
Query: 240 RKNPEFRPSAAELLCH 255
+ R + L C
Sbjct: 235 Q-----RDVSKRLGCL 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-17
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 52/238 (21%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E +E L+ IG+G+FG LV+ K Y +K +R A ++ + H R
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGH------IRAERD 53
Query: 62 FIVEYKDSWVEKGCY-------VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+VE WV K Y + +I+ + GGDM + K + + EE+ ++ + +
Sbjct: 54 ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL--TEEETQFYIAETV 111
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK----------------MLISD- 157
+A++ +H +HRD+K N+ L ++L DFGL L SD
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 158 -------------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
LA S VGTP Y+ PE+ Y D WSLG +YEM
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 53/186 (28%), Positives = 81/186 (43%), Gaps = 36/186 (19%)
Query: 109 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVG 165
+L Q+L L YLH+ ILHRD+K N+ + + +++ DFGLA++ D+ + VV
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV- 166
Query: 166 TPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP 224
T Y PE+L Y S DIWS+GC E+ ++ F+A ++ I + P
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226
Query: 225 TVYSGAFRGLVKSMLRK-------------------------------NPEFRPSAAELL 253
A G +LR +P+ R SAA+ L
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 254 CHPHLQ 259
HP+L
Sbjct: 287 AHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 33/187 (17%)
Query: 107 CKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVV 164
C++ + QLL L Y+H+ ++LHRD+K SN+ L + D+++ DFGLA+ D + V
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV 169
Query: 165 GTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKIN--- 216
T Y PELL + Y + D+WS+GC E+ +K F D ++ + +
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229
Query: 217 ------------KSIVAPLPTVYSGAFR-----------GLVKSMLRKNPEFRPSAAELL 253
+ + LP +F L++ ML +P R + E L
Sbjct: 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289
Query: 254 CHPHLQP 260
HP+L
Sbjct: 290 AHPYLAS 296
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 66/295 (22%), Positives = 132/295 (44%), Gaps = 40/295 (13%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+Y+ L +G G++GS + +KK+ Q+ + ++E+ L+ +++
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 62 FIVEYKDSWVEKGCYV----CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
++ D + ++ + G D+ +K ++ + + Q+L L
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 133
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
Y+H+ I+HRD+K SN+ + D ++++ DFGLA+ +DD + V T Y PE++ +
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 191
Query: 178 -IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------------QALINKIN----K 217
+ Y DIWS+GC + E+ + F D L+ KI+ +
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251
Query: 218 SIVAPLPTV----YSGAFRG-------LVKSMLRKNPEFRPSAAELLCHPHLQPY 261
+ + L + ++ F G L++ ML + + R +AA+ L H + Y
Sbjct: 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 65/247 (26%), Positives = 122/247 (49%), Gaps = 17/247 (6%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELISRVRNPFIV 64
IG+G FG R K Y +K +I++ +Q + + + L+S PFIV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60
Query: 65 --EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
Y +K + I+ GGD+ + + +GV F E ++ + ++++ L ++H
Sbjct: 61 CMSYAFHTPDK---LSFILDLMNGGDLHYHLSQ-HGV-FSEAEMRFYAAEIILGLEHMHN 115
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYG 181
+++RD+K +NI L +R+ D GLA S + VGT YM PE+L + Y
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYD 174
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQA--LINKINKSIVAPLPTVYSGAFRGLVKSML 239
S +D +SLGC ++++ + F+ + I+++ ++ LP +S R L++ +L
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234
Query: 240 RKNPEFR 246
+++ R
Sbjct: 235 QRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 43/296 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RN 60
+ YE LE+IG+G++G R K+ K LKK RL + +A +E+ L+ + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 61 PFIV-----EYKDSWVEKGCYVCIIIGYCEGGDMAEAI---KKANGVHFPEEKLCKWLVQ 112
+IV E+ + K + ++ Y + D+ + + + G P + + ++ Q
Sbjct: 61 IYIVRLLDVEHVEEKNGKPS-LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQD-IRLGDFGLAKML-ISDDLASSVVGTPSYM 170
LL + + H + ++HRD+K N+ + + + +++ D GL + I + + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR 178
Query: 171 CPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA-FDMQALINKINKSIVAPLPTVYS 228
PE LL Y + DIWS+GC EMS ++ F ++Q L+ I K + P V+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTPTEQVWP 237
Query: 229 G--AFRG-------------------------LVKSMLRKNPEFRPSAAELLCHPH 257
G R L++ MLR +P R SA L HP+
Sbjct: 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 65/314 (20%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS--AH--QEMELISRVR 59
+ ++ +G G+FG L R + Y +K +R + D R+ AH E ++++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR---KKDVLLRNQVAHVKAERDILAEAD 59
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
N ++V S+ +K + ++ Y GGDM + + G+ FPE+ ++ +L A+
Sbjct: 60 NEWVVRLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRM-GI-FPEDLARFYIAELTCAVES 116
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGL---------AKMLISDD------------ 158
+H +HRD+K NI + RD I+L DFGL +K S D
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 159 ---------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGC 191
LA S+VGTP+Y+ PE+L Y D WS+G
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 192 CVYEMSAQKAAFKA---FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-- 246
+YEM + F A + Q + S+ P S L+ + R PE R
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLG 295
Query: 247 -PSAAELLCHPHLQ 259
A E+ HP +
Sbjct: 296 KNGADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 43/269 (15%)
Query: 1 MEQYEVLEQIGKGSFG------SALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMEL 54
+++Y+ L+ IG G+ G A+L R+ +KK+ Q + A++E+ L
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 55 ISRVRNPFIV-------------EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHF 101
+ V + I+ E++D + I+ ++ + I+ +
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVY---------IVMELMDANLCQVIQ----MEL 123
Query: 102 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + + +
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 183
Query: 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA 221
V T Y PE++ + Y DIWS+GC + EM F D NK+ + +
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 222 PLPTVYSGAFRGLVKSMLRKNPEFRPSAA 250
P P F ++ +R E RP A
Sbjct: 244 PCP-----EFMKKLQPTVRTYVENRPKYA 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 17/249 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+E Y L+++G+G++ + R K LK+IRL + + A +A +E+ L+ +++
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKH 62
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK-ANGVHFPEEKLCKWLVQLLMALNY 119
IV D + C + ++ Y + D+ + + N + K+ ++ QLL L+Y
Sbjct: 63 ANIVTLHDIIHTERC-LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI--FMFQLLRGLSY 118
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPE-LLAD 177
H ILHRD+K N+ + +++L DFGLA+ + S+ V T Y P+ LL
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237
Y + D+W +GC +YEM+ + F ++ ++ I + + P + G
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG-------- 230
Query: 238 MLRKNPEFR 246
+ N EFR
Sbjct: 231 -ITSNEEFR 238
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 42/197 (21%)
Query: 104 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 163
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + + +
Sbjct: 118 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 177
Query: 164 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL 223
V T Y PE++ + Y DIWS+GC + EM F D NKI + + P
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
Query: 224 --------PTV---------YSG-AF------------------------RGLVKSMLRK 241
PTV Y+G +F R L+ ML
Sbjct: 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297
Query: 242 NPEFRPSAAELLCHPHL 258
+PE R S + L HP++
Sbjct: 298 DPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 60/258 (23%), Positives = 108/258 (41%), Gaps = 20/258 (7%)
Query: 8 EQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV 64
IG+G FG + + ++E+ +K + + QE ++ + +P IV
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFL-QEAYIMRQFDHPHIV 70
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
+ E + I++ G++ ++ N L + QL AL YL +
Sbjct: 71 KLIGVITENPVW--IVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 125 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTP-SYMCPELLADIPYGS 182
+HRD+ N+ ++ ++LGDFGL++ L + +S P +M PE + + S
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 183 KSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLP-----TVYSGAFRGLVK 236
SD+W G C++E + F+ +I +I P+P T+YS L+
Sbjct: 188 ASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-----LMT 242
Query: 237 SMLRKNPEFRPSAAELLC 254
+P RP EL
Sbjct: 243 KCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 39/87 (44%), Positives = 52/87 (59%), Gaps = 2/87 (2%)
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA--KMLISDDLASSVVGTPSYM 170
+L A+ YLH N I+HRD+K NIF+ D+ LGDFG A + I+ + GT +
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250
Query: 171 CPELLADIPYGSKSDIWSLGCCVYEMS 197
PELLA PYG DIWS G ++EM+
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMA 277
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 41/196 (20%)
Query: 104 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 163
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ ++ + +
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY 182
Query: 164 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP- 222
V T Y PE++ + Y DIWS+GC + E+ F+ D NK+ + + P
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242
Query: 223 -------LPTV---------YSG-AF-----------------------RGLVKSMLRKN 242
PTV Y G +F R L+ ML +
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302
Query: 243 PEFRPSAAELLCHPHL 258
P+ R S E L HP++
Sbjct: 303 PDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 60/231 (25%), Positives = 113/231 (48%), Gaps = 6/231 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME Y LE++G+G++ + R K LK+IRL + + A +A +E+ L+ +++
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKH 63
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
IV D V + ++ Y + D+ + + + + +L Q+L L Y
Sbjct: 64 ANIVTLHDI-VHTDKSLTLVFEYLDK-DLKQYMDDCGNI-MSMHNVKIFLYQILRGLAYC 120
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPE-LLADI 178
H +LHRD+K N+ + +++L DFGLA+ + S+ V T Y P+ LL
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG 229
Y ++ D+W +GC +EM++ + F ++ ++ I + + P + G
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 60/257 (23%), Positives = 119/257 (46%), Gaps = 17/257 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M++ ++L+ IGKG FG +L + K +K I+ D ++ E +++++R+
Sbjct: 5 MKELKLLQTIGKGEFGDVML--GDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRH 58
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+V+ VE+ + I+ Y G + + ++ + L K+ + + A+ YL
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP----SYMCPELLA 176
AN+ +HRD+ N+ ++ D ++ DFGL K ASS T + PE L
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE------ASSTQDTGKLPVKWTAPEALR 172
Query: 177 DIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235
+ + +KSD+WS G ++E+ S + + ++ ++ ++ K P ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232
Query: 236 KSMLRKNPEFRPSAAEL 252
K + RPS +L
Sbjct: 233 KQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 58/246 (23%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS--AH--QEMELISR 57
E + ++ IGKG+FG LV+ K K Y +K + +++ ++ AH E ++++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL---KSEMFKKDQLAHVKAERDVLAE 57
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+P++V S+ + Y+ +I+ + GGD+ + K + F E+ ++ + ++A+
Sbjct: 58 SDSPWVVSLYYSF-QDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAI 114
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA-------------KMLISDD------ 158
+H +HRD+K NI + R I+L DFGL+ K+L
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 159 -----------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSL 189
+A S VGTP Y+ PE+ YG + D WSL
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 190 GCCVYE 195
G ++E
Sbjct: 235 GAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 61/250 (24%), Positives = 123/250 (49%), Gaps = 11/250 (4%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYK 67
++IG G FG L +RK I+ R+ + +E +++ ++ +P +V+
Sbjct: 10 QEIGSGQFGLVWLGYWLEKRKV----AIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
E+ +C++ + E G +++ ++ G F +E L + + + YL +++++H
Sbjct: 66 GVCTERSP-ICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGSKS 184
RD+ N + +Q +++ DFG+ + ++ D SS GT + PE+ + Y SKS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 185 DIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 243
D+WS G ++E+ S K ++ ++ IN P + S + L++ ++ P
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERP 242
Query: 244 EFRPSAAELL 253
E RPS + LL
Sbjct: 243 EDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 11/255 (4%)
Query: 8 EQIGKGSFGSALLVRHKHERKK--YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65
E IG G FG R K K+ +V K + T++ RR E ++ + +P I+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
+ V K V II + E G + +++ +G F +L L + + YL +
Sbjct: 70 L-EGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNY 127
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAKML---ISDDLASSVVGTP---SYMCPELLADIP 179
+HRD+ NI + + ++ DFGL++ L SD +S +G + PE +A
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 180 YGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+ S SD+WS G ++E MS + + Q +IN I + P P A L+
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDC 247
Query: 239 LRKNPEFRPSAAELL 253
+K+ RP +++
Sbjct: 248 WQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 71/297 (23%), Positives = 133/297 (44%), Gaps = 45/297 (15%)
Query: 4 YEVLEQIGKGSFGSALLVRHK--HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN- 60
YE+++++G+G++G R+ E + +KKI + A +E++L+ R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 61 PFIVEYKD-SWVEKGCYVCIIIGYCE--GGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
I D V G + + + Y E D+ + I+ +G + ++ Q+L L
Sbjct: 62 KNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIR--SGQPLTDAHFQSFIYQILCGL 118
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-----ISDDLASSVVGTPSYMCP 172
Y+H+ ++LHRD+K N+ + D ++++ DFGLA+ + + V T Y P
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 173 E-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------NKSIVA--- 221
E +L+ Y D+WS+GC + E+ +K FK D +N+I ++ ++
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 222 -----------------PLPTVYSGAFR---GLVKSMLRKNPEFRPSAAELLCHPHL 258
P +++ A L++ +L +P R S E L HP+L
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 50/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 9 QIGKGSFGSALLVRHKH---ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65
++G+G+FG L + E+ K ++ L +D AR+ H+E EL++ +++ IV+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDM--------AEAIKKANG---VHFPEEKLCKWLVQLL 114
+ VE G + ++ Y + GD+ +A+ A G + ++ Q+
Sbjct: 72 FYGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 171
+ YL + H +HRD+ N + + +++GDFG+++ + S D + + +M
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190
Query: 172 PELLADIPYGSKSDIWSLGCCVYEM 196
PE + + ++SD+WSLG ++E+
Sbjct: 191 PESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-14
Identities = 51/174 (29%), Positives = 99/174 (56%), Gaps = 5/174 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ-EMELISRVR 59
+E++ +++ I +G+FG L R K+ K Y +K ++ A ++ Q E + ++ +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+PFIV S ++ V +++ Y GGD+ + +F EE K++ ++ +AL+Y
Sbjct: 63 SPFIVHLYYS-LQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDY 119
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCP 172
LH + I+HRD+K N+ ++ + I+L DFGL+K+ ++ +L ++ TPS P
Sbjct: 120 LHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 10/255 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKY--VLKKIRLARQTDRARRSAHQEMELISRVR 59
E++ + ++G G FG K+ + +LK L +Q D + E++ + R+R
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQK-----EVQALKRLR 60
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+ ++ + G V II E G + ++ G P L Q+ + Y
Sbjct: 61 HKHLISLF-AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP-SYMCPELLADI 178
L + +HRD+ NI + D ++ DFGLA+++ D SS P + PE +
Sbjct: 120 LEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG 179
Query: 179 PYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237
+ +KSD+WS G +YEM + + + + + ++I P P ++
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239
Query: 238 MLRKNPEFRPSAAEL 252
PE RPS L
Sbjct: 240 CWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 59/251 (23%), Positives = 116/251 (46%), Gaps = 11/251 (4%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEY 66
L+++G G FG +V R K + I++ R+ + +E +++ ++ +P +V+
Sbjct: 9 LKELGSGQFG---VVHLGKWRGKIDVA-IKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 126
++ + I+ Y G + +++ G E L + A+ YL +N +
Sbjct: 65 YGVCTKQRP-IFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 127 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGSK 183
HRD+ N + D +++ DFGLA+ ++ D SS GT + PE+ + SK
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSK 181
Query: 184 SDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
SD+WS G ++E+ S K ++ F ++ ++ P + ++ S +
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEK 241
Query: 243 PEFRPSAAELL 253
PE RP+ +LL
Sbjct: 242 PEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 61/274 (22%), Positives = 109/274 (39%), Gaps = 27/274 (9%)
Query: 1 MEQYEVLEQIGKGSFGS-----ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELI 55
E+ ++ ++G+GSFG A V K E + V K + R R E ++
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVV-KGEPETRVAIKTVNENASMRERIEFLNEASVM 63
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK-------ANGVHFPE-EKLC 107
+V V G +++ GD+ ++ G+ P +K
Sbjct: 64 KEFNCHHVVRLL-GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 108 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVV 164
+ ++ + YL A +HRD+ N + D +++GDFG+ + + D +
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK-----INKSI 219
+M PE L D + +KSD+WS G ++EM A Q L N+ +
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM----ATLAEQPYQGLSNEEVLKFVIDGG 238
Query: 220 VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
LP L++ + NP+ RP+ E++
Sbjct: 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 62/207 (29%), Positives = 88/207 (42%), Gaps = 39/207 (18%)
Query: 88 DMAE-AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 146
D+A+ I+ G+H +L ++ QLL L Y+H HILHRD+K N+ ++ +++L
Sbjct: 88 DLAQYMIQHPGGLHPYNVRL--FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLA 145
Query: 147 DFGLA--KMLISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAF 203
DFGLA K + S +S VV T Y P+ LL Y S DIW GC EM + AF
Sbjct: 146 DFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
Query: 204 KAF-DMQALINKINKSIVAPLPTVYSG-------------------------------AF 231
D+ + KI + P + G
Sbjct: 205 PGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKA 264
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHPHL 258
L ML P+ R SA + L HP+
Sbjct: 265 EDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 56/238 (23%), Positives = 105/238 (44%), Gaps = 15/238 (6%)
Query: 29 KYVLKKIRLARQTDRARRSAHQ-EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 87
+ +K +R + +R+ + E L +R+ +P IV DS + + Y G
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 88 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR--- 144
+ E + A+G P + + ++Q+L AL H I+HRD+K NI +++
Sbjct: 65 TLREVLA-ADGA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 145 LGDFGLAKML--------ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+ DFG+ +L + + V+GTP+Y PE L P SD+++ G E
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLEC 182
Query: 197 SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG-LVKSMLRKNPEFRPSAAELL 253
+ + + ++ + + LP +G G +++ L K+P R ++A L
Sbjct: 183 LTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 64/282 (22%), Positives = 116/282 (41%), Gaps = 36/282 (12%)
Query: 7 LEQIGKGSFGSALLVRH---KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
+ +G+G FG L + + V K + +E+ ++ + + I
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 64 VEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
V+YK E+G + +I+ Y G + + + K +L + Q+ + YLH+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHS 125
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKML--------ISDDLASSVVGTPSYMCPEL 174
H +HRD+ N+ L D+ +++GDFGLAK + + +D S V + E
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVEC 181
Query: 175 LADIPYGSKSDIWSLGCCVYEM-----SAQKAAFKAFDM----QALINKI------NKSI 219
L + + SD+WS G +YE+ S Q K +M Q + + + +
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 220 VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
P P L+K+ +FRP+ L+ P L+
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI--PILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKY-VLKKIRLARQTDRARRSAH--QEMELISRVRNPFI 63
+ +G+G FG L R+ E ++ + A +E+E++ + + I
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 64 VEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
V+YK E G + +I+ + G + E + + N ++ K+ VQ+ ++YL +
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKML--------ISDDLASSVVGTPSYMCPEL 174
+HRD+ N+ + + +++GDFGL K + + DDL S V + PE
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYAPEC 183
Query: 175 LADIPYGSKSDIWSLGCCVYEM 196
L + SD+WS G +YE+
Sbjct: 184 LIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 66/251 (26%), Positives = 110/251 (43%), Gaps = 9/251 (3%)
Query: 10 IGKGSFGSALLVRHKHERKK--YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYK 67
IG G FG R K K+ V K A T++ RR E ++ + +P I+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL- 70
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
+ V K V I+ Y E G + ++K +G F +L L + + YL +H
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVH 129
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTP---SYMCPELLADIPYGSK 183
RD+ NI + + ++ DFGL+++L D + A + G + PE +A + S
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 184 SDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
SD+WS G ++E MS + + Q +I I + P P A L+ +K+
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKD 249
Query: 243 PEFRPSAAELL 253
RP +++
Sbjct: 250 RNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 56/252 (22%), Positives = 125/252 (49%), Gaps = 13/252 (5%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE- 65
L+++G G FG +V++ R +Y + I++ ++ + +E +++ ++ + +V+
Sbjct: 9 LKELGTGQFG---VVKYGKWRGQYDVA-IKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
Y ++ Y I+ Y G + +++ +G F +L + + + YL +
Sbjct: 65 YGVCTKQRPIY--IVTEYMSNGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGS 182
+HRD+ N + +++ DFGL++ ++ D+ SS VG+ + PE+L + S
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFSS 180
Query: 183 KSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241
KSD+W+ G ++E+ S K ++ F+ + K+++ + P + S ++ S +
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHE 240
Query: 242 NPEFRPSAAELL 253
E RP+ +LL
Sbjct: 241 KAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 9 QIGKGSFGSALLVRHK--HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEY 66
++G+G++G + K + K+Y LK+I + SA +E+ L+ +++P ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIAL 63
Query: 67 KDSWVEKGCY-VCIIIGYCEGGDMAEAIK-----KANG--VHFPEEKLCKWLVQLLMALN 118
+ ++ V ++ Y E D+ IK KAN + P + L Q+L ++
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 119 YLHANHILHRDVKCSNIFLTRDQD----IRLGDFGLAKMLISD-----DLASSVVGTPSY 169
YLHAN +LHRD+K +NI + + +++ D G A++ S DL VV T Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181
Query: 170 MCPELLADIPYGSKS-DIWSLGCCVYEMSAQKAAF 203
PELL + +K+ DIW++GC E+ + F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 7 LEQIGKGSFGSALLVRHK--HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV 64
++Q+GKG+FGS L R+ + V+ +L T R +E+E++ +++ IV
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 65 EYKDSWVEKGCY------VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+YK CY + +++ Y G + + ++K + KL + Q+ +
Sbjct: 69 KYKGV-----CYSAGRRNLRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGME 122
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS-----YMCPE 173
YL + +HRD+ NI + + +++GDFGL K+L D V P + PE
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWYAPE 181
Query: 174 LLADIPYGSKSDIWSLGCCVYEM 196
L + + SD+WS G +YE+
Sbjct: 182 SLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG---LAKMLISDDLASSVVGTPS 168
QLL A++Y+H I+HRD+K N+ + +DI LGDFG A+ S + GT
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 202
PE+LA PY DIWS G ++E + A+
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS 361
|
Length = 461 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 9 QIGKGSFGSALLVRHK--HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEY 66
++G+G++G + K + + Y LK+I + SA +E+ L+ +++P ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISL 63
Query: 67 KDSWVEKGCY-VCIIIGYCEGGDMAEAIK-----KANG--VHFPEEKLCKWLVQLLMALN 118
+ ++ V ++ Y E D+ IK KAN V P + L Q+L ++
Sbjct: 64 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 119 YLHANHILHRDVKCSNIFLTRDQD----IRLGDFGLAKMLISD-----DLASSVVGTPSY 169
YLHAN +LHRD+K +NI + + +++ D G A++ S DL VV T Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL-DPVVVTFWY 181
Query: 170 MCPELLADIPYGSKS-DIWSLGCCVYEMSAQKAAF 203
PELL + +K+ DIW++GC E+ + F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 54/249 (21%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAH--QEMELISRVRNPFIV 64
++ +G G+FG L Y +K +R +R + AH E ++++ N ++V
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVV 64
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
+ S+ +K + ++ Y GGDM + + V FPE ++ +L +A+ +H
Sbjct: 65 KLYYSFQDKDN-LYFVMDYIPGGDMMSLLIRM-EV-FPEVLARFYIAELTLAIESVHKMG 121
Query: 125 ILHRDVKCSNIFLTRDQDIRLGDFGLAKML------------------------ISDD-- 158
+HRD+K NI + D I+L DFGL + DD
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 159 ----------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
LA S+VGTP+Y+ PE+L Y D WS+G ++EM
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 197 SAQKAAFKA 205
+ F A
Sbjct: 242 LVGQPPFLA 250
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRA-RRSAHQEMELISRVRNPFIVEYK 67
++G G+FG +K +K+ + L + +++ R +E E++ ++ NP+IV
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVR-- 59
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-----------VHFPEEKLCKWLVQLLMA 116
+IG CE + ++ A+G + + + Q+ M
Sbjct: 60 ------------MIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG 107
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP-SYMCP 172
+ YL + +HRD+ N+ L ++ DFGL+K L +DD A S P + P
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 173 ELLADIPYGSKSDIWSLGCCVYE 195
E + + S+SD+WS G ++E
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 106 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 165
L W VQ+ +NYL ++HRD+ N+ + Q +++ DFGLAK+L +D+ G
Sbjct: 111 LLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 166 --TP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
P +M E + Y +SD+WS G V+E+
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 62/280 (22%), Positives = 114/280 (40%), Gaps = 25/280 (8%)
Query: 1 MEQYEVLEQIGKGSFGSA----LLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELIS 56
+ LE++G+G+FG L ++ V K + ++ QE EL+S
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 57 RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE-AIKKA--NGVHFPEEK-------- 105
+++P IV K C++ Y GD+ E ++ + + V
Sbjct: 64 DLQHPNIVCLLGV-CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 106 ---LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---L 159
+Q+ + YL ++H +HRD+ N + +++ DFGL++ + S D +
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKS 218
S + +M PE + + ++SDIWS G ++E+ S + F Q +I I
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242
Query: 219 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258
+ P P L+ + P RP ++ H L
Sbjct: 243 QLLPCPEDCPARVYALMIECWNEIPARRPRFKDI--HTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 9 QIGKGSFGSALLVRHKHER-KKYVLKKIRLARQTDRA-RRSAHQEMELISRVRNPFIVEY 66
++G G+FG+ +K ++ +K V KI D A + +E ++ ++ NP+IV
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR- 60
Query: 67 KDSWVEKGCYVCIIIGYCEGG------DMAE--AIKK--ANGVHFPEEKLCKWLVQLLMA 116
+IG CE ++AE + K H E+ + + + Q+ M
Sbjct: 61 -------------MIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG 107
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP----SYMCP 172
+ YL + +HRD+ N+ L ++ DFGL+K L +D+ + P
Sbjct: 108 MKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 173 ELLADIPYGSKSDIWSLGCCVYE 195
E + + SKSD+WS G ++E
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 58/246 (23%), Positives = 105/246 (42%), Gaps = 9/246 (3%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYK 67
E+IG+G+FG R + + +K R D + QE ++ + +P IV
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 59
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
+K + I++ +GGD ++ G ++L + + + YL + H +H
Sbjct: 60 GVCTQKQP-IYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS----YMCPELLADIPYGSK 183
RD+ N +T +++ DFG+++ D + +S G + PE L Y S+
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREE-EDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 184 SDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
SD+WS G ++E S + Q I + + P P + A L++ +
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYD 236
Query: 243 PEFRPS 248
P RPS
Sbjct: 237 PGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 41 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 100
TD+ ++ +E L+S +P IV+ + II+ EGGD+ ++ A
Sbjct: 39 TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARVER 97
Query: 101 FPEEKLCKWLVQLL-MALN------YLHANHILHRDVKCSNIFLT-----RDQDIRLGDF 148
F L L +LL + L+ YL H +HRD+ N ++ D+ +++GDF
Sbjct: 98 FGPPLLT--LKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155
Query: 149 GLAKMLISDDLASSVVGTP----SYMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAF 203
GLA+ + D G +M PE L D + ++SD+WS G ++E ++ + +
Sbjct: 156 GLARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
Query: 204 KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 248
A + Q ++ + P L+ + ++P RP+
Sbjct: 215 PALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 49/198 (24%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 8 EQIGKGSFGSAL--LVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65
+++G G+FGS + + K ++ V K ++ +E +++++ +P IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV- 59
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
+ V KG + +++ G + + +KK P L + Q+ M + YL + H
Sbjct: 60 -RLIGVCKGEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP-SYMCPELLADIPYG 181
+HRD+ N+ L ++ DFG+++ L + A++ P + PE I YG
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC---INYG 173
Query: 182 ---SKSDIWSLGCCVYEM 196
SKSD+WS G ++E
Sbjct: 174 KFSSKSDVWSYGVTLWEA 191
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 49/213 (23%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 7 LEQIGKGSFGSALLVRHKH----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
++G+G+FG L H K+ V K ++ AR+ +E EL++ ++
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHF-------------PEEKLCKW 109
IV++ E + ++ Y E GD+ + ++ ++G +L +
Sbjct: 70 IVKFYGVCTEGDPPI-MVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 110 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGT 166
VQ+ + YL + H +HRD+ N + D +++GDFG+++ + + D + +
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 167 PSYMCPELLADIPYG---SKSDIWSLGCCVYEM 196
+M PE I Y ++SD+WS G ++E+
Sbjct: 188 IRWMPPE---SIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 40/230 (17%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRV 58
M++Y+++ IGKG G L ++ LKKIR L+ + ++ +E ++ + +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADL 59
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL-------- 110
+P IV S G V + Y EG + +K + +E L K L
Sbjct: 60 IHPGIVPVY-SICSDGDPVYYTMPYIEGYTLKSLLKSV----WQKESLSKELAEKTSVGA 114
Query: 111 -----VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM--LISDDLASS- 162
++ + Y+H+ +LHRD+K NI L ++ + D+G A L +DL
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 163 ----------------VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+VGTP YM PE L +P +DI++LG +Y+M
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 46/203 (22%), Positives = 96/203 (47%), Gaps = 7/203 (3%)
Query: 50 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 109
QE +++ ++R+ +V+ E+ Y I+ Y G + + +K G + +L
Sbjct: 50 QEAQVMKKLRHEKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 107
Query: 110 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP-- 167
Q+ + Y+ + +HRD++ +NI + + ++ DFGLA+ LI D+ ++ G
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFP 166
Query: 168 -SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPT 225
+ PE + KSD+WS G + E++ + + + + +++++ + P P
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226
Query: 226 VYSGAFRGLVKSMLRKNPEFRPS 248
+ L+ RK PE RP+
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 57/251 (22%), Positives = 115/251 (45%), Gaps = 11/251 (4%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE- 65
++++G G FG V H + + + I+ + + +E +++ ++ +P +V+
Sbjct: 9 MKELGSGQFG----VVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
Y +K Y I+ + E G + +++ G ++ L + + YL N
Sbjct: 65 YGVCTQQKPLY--IVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT-PSYMC-PELLADIPYGSK 183
+HRD+ N ++ +++ DFG+ + ++ D+ SS P PE+ Y SK
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 184 SDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
SD+WS G ++E+ + K F+ ++ I++ P + S ++ S +
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEK 241
Query: 243 PEFRPSAAELL 253
PE RP+ AELL
Sbjct: 242 PEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 76 YVCIIIGYCEG------------GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
Y+ ++G C G G + + +++ P+ +L W VQ+ + YL +
Sbjct: 70 YIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQ-RLLNWCVQIAKGMYYLEEH 128
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTP-SYMCPELLADIPY 180
++HR++ NI L D +++ DFG+A +L DD S TP +M E + Y
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 181 GSKSDIWSLGCCVYEM 196
+SD+WS G V+EM
Sbjct: 189 THQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 82/322 (25%), Positives = 129/322 (40%), Gaps = 75/322 (23%)
Query: 5 EVLEQIGKG--SFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
E+ +IG+G + S L RH ++ L T+ ++ E+ L R+P
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 63 IVEYKDSWV--EKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE---EKLCK-WLVQLLMA 116
I+ W G ++ +I + G +K +FPE E L L L
Sbjct: 61 IMTS---WTVFTTGSWLWVISPFMAYGSANSLLKT----YFPEGMSEALIGNILFGALRG 113
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVV--------GTPS 168
LNYLH N +HR++K S+I ++ D + L L+ + + VV
Sbjct: 114 LNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP 173
Query: 169 YMCPELLADIPYG--SKSDIWSLGCCVYEMSAQKAAFKAFDM---QALINK--------- 214
++ PELL YG KSDI+S+G E++ + F+ DM Q L+ K
Sbjct: 174 WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ--DMLRTQMLLQKLKGPPYSPL 231
Query: 215 ----------------------INKSIVA--------------PLPTVYSGAFRGLVKSM 238
I +S+VA P +S AF+ LV+
Sbjct: 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291
Query: 239 LRKNPEFRPSAAELLCHPHLQP 260
L+++PE RPSA+ LL H +
Sbjct: 292 LQQDPEKRPSASSLLSHAFFKQ 313
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 53/253 (20%), Positives = 114/253 (45%), Gaps = 11/253 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+++ + E IG+G FG+ L + ++ +K +K I+ D ++ +E +++++ +
Sbjct: 5 LQKLTLGEIIGEGEFGAVL--QGEYTGQKVAVKNIK----CDVTAQAFLEETAVMTKLHH 58
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+V + G Y I++ G++ ++ +L ++ + + + YL
Sbjct: 59 KNLVRLLGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
+ ++HRD+ NI ++ D ++ DFGLA+ + + + PE L +
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPVKWTAPEALKHKKF 174
Query: 181 GSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
SKSD+WS G ++E+ S +A + ++ + + K P L+ S
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW 234
Query: 240 RKNPEFRPSAAEL 252
P+ RPS +L
Sbjct: 235 ETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 57/254 (22%), Positives = 114/254 (44%), Gaps = 17/254 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E ++++++G G FG + + K I+ +Q + + E L+ ++++P
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV----AIKSLKQGSMSPEAFLAEANLMKQLQHP 61
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V ++ Y II Y E G + + +K G+ KL Q+ + ++
Sbjct: 62 RLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADI 178
+ +HRD++ +NI ++ ++ DFGLA+ LI D+ ++ G + PE I
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEA---I 175
Query: 179 PYGS---KSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
YG+ KSD+WS G + E+ + + + +I + + P P L
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235
Query: 235 VKSMLRKNPEFRPS 248
++ ++ PE RP+
Sbjct: 236 MRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 40/178 (22%), Positives = 82/178 (46%), Gaps = 5/178 (2%)
Query: 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 138
II + G++ + +++ N L Q+ A+ YL + +HRD+ N +
Sbjct: 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138
Query: 139 RDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCVYE 195
+ +++ DFGL++++ + D ++ G + PE LA + KSD+W+ G ++E
Sbjct: 139 ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 197
Query: 196 MSAQK-AAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 252
++ + + D+ + + K P L+++ + NP RPS AE+
Sbjct: 198 IATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 63/281 (22%), Positives = 123/281 (43%), Gaps = 37/281 (13%)
Query: 8 EQIGKGSFGSALLVR----HKHERKKY---------VLKKIRLARQ--TDRARRSAHQEM 52
E++G+G FG L K K + VL +++ R+ AR +E+
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 53 ELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM---------AEAIKKANGVHFPE 103
+++SR+++P I+ + +C+I Y E GD+ EA +KA+ V
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDP-LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 104 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LA 160
L Q+ + YL + + +HRD+ N + ++ I++ DFG+++ L S D +
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA--QKAAFKAFDMQALINKI--- 215
V +M E + + + SD+W+ G ++E+ ++ + + +I
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEF 249
Query: 216 ----NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 252
+ + P P + + L+ S R+N + RPS E+
Sbjct: 250 FRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 34/87 (39%), Positives = 49/87 (56%), Gaps = 2/87 (2%)
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYM 170
QL AL Y+H+ I HRD+K N+ + ++L DFG AK L++ + S + + Y
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237
Query: 171 CPEL-LADIPYGSKSDIWSLGCCVYEM 196
PEL L Y + D+WSLGC + EM
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 106 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 165
L W VQ+ ++YL ++HRD+ N+ + Q +++ DFGLAK+L D+ G
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 166 --TP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
P +M E + Y KSD+WS G V+E+
Sbjct: 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 3/103 (2%)
Query: 97 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156
P + L K++V + + + YL + +HRD+ N L D + + DFGL+K + S
Sbjct: 106 LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
Query: 157 DDL--ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
D + P ++ E LAD Y SKSD+W+ G ++E+
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 37/87 (42%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV--VGTPSY 169
QLL A+ Y+H ++HRD+K NIFL D I LGDFG A + A VGT +
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYEM 196
PE+LA Y +DIWS G + +M
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 39/160 (24%), Positives = 74/160 (46%), Gaps = 4/160 (2%)
Query: 99 VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158
+ P + L K++ + + YL + +HRD+ N L + ++ + DFGL+K + + D
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
Query: 159 L--ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINK 214
+ P ++ E LAD Y +KSD+WS G ++E++ + + + + + +
Sbjct: 167 YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226
Query: 215 INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254
+ + P L+ S NP+ RPS L C
Sbjct: 227 LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 44/203 (21%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 50 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 109
QE +++ ++R+ +V E+ Y I+ + G + + +K+ +G + +L
Sbjct: 50 QEAQIMKKLRHDKLVPLYAVVSEEPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 110 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP-- 167
Q+ + Y+ + +HRD++ +NI + + ++ DFGLA+ LI D+ ++ G
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFP 166
Query: 168 -SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPT 225
+ PE + KSD+WS G + E+ + + + + ++ ++ + P P
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQ 226
Query: 226 VYSGAFRGLVKSMLRKNPEFRPS 248
+ L+K +K+P+ RP+
Sbjct: 227 GCPESLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 59/269 (21%), Positives = 117/269 (43%), Gaps = 26/269 (9%)
Query: 10 IGKGSFGSALLV------RHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPF 62
+G+G FG ++ + K R V K+ + T++ EME++ + ++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA---------NGVHFPEEKLC-KWLV- 111
I+ + + G + +I+ Y G++ E ++ N PEE+L K LV
Sbjct: 86 IINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 112 ---QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG--- 165
Q+ + YL + +HRD+ N+ +T D +++ DFGLA+ + D
Sbjct: 145 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 204
Query: 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLP 224
+M PE L D Y +SD+WS G ++E+ + + + ++ L + + P
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP 264
Query: 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
+ + +++ P RP+ +L+
Sbjct: 265 SNCTNELYMMMRDCWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 51/251 (20%), Positives = 111/251 (44%), Gaps = 11/251 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E ++++++G G FG + K ++ + + S +E +++ ++R+
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV----AVKTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+ E+ Y I+ Y G + + +K G L Q+ + Y+
Sbjct: 62 KLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADI 178
+ +HRD++ +NI + ++ DFGLA+ LI D+ ++ G + PE
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 179 PYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237
+ KSD+WS G + E+ + + + + + ++ ++ + P P + L+
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ 238
Query: 238 MLRKNPEFRPS 248
+K+PE RP+
Sbjct: 239 CWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 48/211 (22%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 9 QIGKGSFGSALLVRHKH---ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65
++G+G+FG L + E+ K ++ L ++ AR+ +E EL++ +++ IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL--------CKWL------- 110
+ E G + ++ Y GD+ ++ H P+ K+ L
Sbjct: 72 FYGVCTE-GRPLLMVFEYMRHGDLNRFLRS----HGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 111 --VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVG 165
Q+ + YL + H +HRD+ N + + +++GDFG+++ + S D + +
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M PE + + ++SDIWS G ++E+
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 2 EQYEVLEQIGKGSFGSALLVR-------------HKHERKKYVLKKIRLARQTDRARRSA 48
+Q + E++G+G FG L + V K+ A T AR
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 49 HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE---------AIKKANGV 99
+E++++SR++NP I+ V +C+I Y E GD+ + AN +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDP-LCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 100 -HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158
L VQ+ + YL + + +HRD+ N + I++ DFG+++ L S D
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 159 ---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+ V +M E + + + SD+W+ G ++EM
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 10 IGKGSFGSALLV------RHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPF 62
+G+G FG ++ + K + V K+ TD+ EME++ + ++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--KANGVHF-------PEEKL-CKWLV- 111
I+ + + G + +++ Y G++ E ++ + G+ + PEE+L K LV
Sbjct: 80 IINLLGACTQDGP-LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 112 ---QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG--- 165
Q+ + YL + +HRD+ N+ +T D +++ DFGLA+ + + D
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M PE L D Y +SD+WS G ++E+
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 2 EQYEVLEQIGKGSFGSALLVRH----KHERKKYVLKKIRLARQTDRARRSAHQEMELISR 57
++ + + +G+G+FG + V K+ T++ EME++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 58 V-RNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIK---------KANGVHFPEEKL 106
+ ++ I+ ++G YV ++ Y G++ + ++ + PEE L
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 107 -CKWLV----QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161
K LV Q+ + +L + +HRD+ N+ +T D +++ DFGLA+ + D
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 162 SVVG--TP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
P +M PE L D Y +SD+WS G ++E+
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 34/130 (26%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 73 KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKC 132
G + +I YC GD+ +++ E L + Q+ + +L + + +HRD+
Sbjct: 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 169
Query: 133 SNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS------YMCPELLADIPYGSKSDI 186
N+ LT + +++ DFGLA+ +++D S+ V + +M PE + + Y +SD+
Sbjct: 170 RNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDV 226
Query: 187 WSLGCCVYEM 196
WS G ++E+
Sbjct: 227 WSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 18/255 (7%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRA--RRSAHQEMELISRVRNPFIVE 65
E+IGKG+FG K + V + R T +R QE E++ + +P IV+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAV----KTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
V+K + I++ GG + ++K +KL + + + YL + +
Sbjct: 57 LIGVCVQKQP-IYIVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAK------MLISDDLASSVVGTPSYMCPELLADIP 179
+HRD+ N + + +++ DFG+++ +SD L + + PE L
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI---KWTAPEALNYGR 171
Query: 180 YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
Y S+SD+WS G ++E S + Q +I P P + L+
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQC 231
Query: 239 LRKNPEFRPSAAELL 253
+PE RPS +E+
Sbjct: 232 WAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 34/145 (23%), Positives = 68/145 (46%), Gaps = 4/145 (2%)
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTP-S 168
Q+ + YL ++HRD+ N+ + + +++ DFGL++ + +D + S P
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK 194
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVAPLPTVY 227
+M E L D Y ++SD+WS G ++E+ + + L N + P
Sbjct: 195 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENC 254
Query: 228 SGAFRGLVKSMLRKNPEFRPSAAEL 252
S L+ + ++ P+ RP+ A++
Sbjct: 255 SEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 19 LLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78
LLV ++ ++LK +R + + R R + +I P +V V + V
Sbjct: 10 LLVMDTRTQQTFILKGLRKSSEYSRERLT------IIPHCV-PNMVCLHKYIVSEDS-VF 61
Query: 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 138
+++ + EGG + I K ++ PEE + +W ++++AL+ LH I+ RD+ +NI L
Sbjct: 62 LVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 139 RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 198
I+L F + D V Y PE+ D WSLG ++E+
Sbjct: 120 DRGHIQLTYFSRWSE-VEDSCDGEAVEN-MYCAPEVGGISEETEACDWWSLGAILFELLT 177
Query: 199 QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 251
K ++ + IN +P S R L++ +L+ NP R A
Sbjct: 178 GKTL-----VECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 54/263 (20%), Positives = 118/263 (44%), Gaps = 22/263 (8%)
Query: 9 QIGKGSFGSALLVRHK----HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV 64
+G+G FG L + K + VL K + + + +E+++ ++ + +V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAE---AIKKANGVHFPEEKLCKWLV----QLLMAL 117
E + +I+ Y + GD+ + A K + P K V Q+ + +
Sbjct: 72 RLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELL 175
++L +HRD+ N ++ +++++ L+K + + + + + ++ PE +
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190
Query: 176 ADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRG 233
+ + +KSD+WS G ++E+ + + F + ++N++ + P+P G
Sbjct: 191 QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP---EGCPSR 247
Query: 234 LVKSMLR---KNPEFRPSAAELL 253
L K M R NP+ RPS +EL+
Sbjct: 248 LYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 49/255 (19%), Positives = 109/255 (42%), Gaps = 11/255 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
++ ++ IGKG FG +L + +K +K ++ A ++ E +++ +R+
Sbjct: 5 SKELKLGATIGKGEFGDVML--GDYRGQKVAVKCLK---DDSTAAQAFLAEASVMTTLRH 59
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P +V+ ++ + I+ Y G + + ++ + + + + + YL
Sbjct: 60 PNLVQLLGVVLQGN-PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP-SYMCPELLADIP 179
+ +HRD+ N+ ++ D ++ DFGLAK P + PE L +
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALREKK 175
Query: 180 YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+ +KSD+WS G ++E+ S + + ++ ++ + K P ++K
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235
Query: 239 LRKNPEFRPSAAELL 253
+P RP+ +L
Sbjct: 236 WELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 49/211 (23%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 10 IGKGSFGSALLVR----HKHERKKYVLKKIRLARQ--TDRARRSAHQEMELISRV-RNPF 62
+G+G FG ++ K + K+ V +++ + T++ EME++ + ++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--KANGVHF-------PEEKLC-KWLV- 111
I+ + + G + +I+ Y G++ E ++ + G+ + P+E++ K LV
Sbjct: 83 IINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 112 ---QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG--- 165
Q+ + YL + +HRD+ N+ +T + +++ DFGLA+ + + D
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201
Query: 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M PE L D Y +SD+WS G ++E+
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 54/254 (21%), Positives = 116/254 (45%), Gaps = 16/254 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E ++++++G G FG + + + K +K ++ + +A +E L+ +++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHD 61
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V + V K + II Y G + + +K G KL + Q+ + Y+
Sbjct: 62 KLVRLY-AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADI 178
+ +HRD++ +N+ ++ ++ DFGLA+ +I D+ ++ G + PE I
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEA---I 176
Query: 179 PYGS---KSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
+GS KSD+WS G +YE+ + K + +++ + + P +
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236
Query: 235 VKSMLRKNPEFRPS 248
+K+ ++ E RP+
Sbjct: 237 MKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 44/209 (21%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 9 QIGKGSFGSALLVRHKH---ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65
++G+G+FG L + + K ++ L T AR+ +E EL++ +++ IV+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIK---------------KANGVHFPEEKLCKWL 110
+ + G + ++ Y + GD+ + ++ +A G ++
Sbjct: 72 FYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG-ELGLSQMLHIA 129
Query: 111 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP 167
Q+ + YL + H +HRD+ N + + +++GDFG+++ + S D + +
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 168 SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M PE + + ++SD+WS G ++E+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 10 IGKGSFGSAL------LVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPF 62
+G+G FG + + + + ++ V K+ TD+ EMEL+ + ++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 63 IVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKA---------NGVHFPEEKLC-KWLV 111
I+ ++G YV I+ Y G++ E ++ + PEE+L K LV
Sbjct: 80 IINLLGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 112 ----QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVG 165
Q+ + YL + +HRD+ N+ +T D +++ DFGLA+ + D +S
Sbjct: 138 SCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGR 197
Query: 166 TP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
P +M PE L D Y +SD+WS G ++E+
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 34/156 (21%), Positives = 74/156 (47%), Gaps = 4/156 (2%)
Query: 102 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159
+K+ + ++ + YL+AN +HRD+ N + D +++GDFG+ + + D
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 160 -ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINK 217
+ +M PE L D + + SD+WS G ++E++ + ++ + ++ + +
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
Query: 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
+ P L++ + NP+ RPS E++
Sbjct: 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 74/315 (23%), Positives = 123/315 (39%), Gaps = 70/315 (22%)
Query: 5 EVLEQIGKG--SFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
E+L IG+G + L R+K + +++I L T+ E+ + +P
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHF----PEEKLCKWLVQLLMALN 118
IV Y+ +++ + ++ + G + I HF E + L +L AL+
Sbjct: 61 IVPYRATFIADN-ELWVVTSFMAYGSAKDLI----CTHFMDGMSELAIAYILQGVLKALD 115
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT-PSY-------M 170
Y+H +HR VK S+I ++ D + L +I+ VV P Y +
Sbjct: 116 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL 175
Query: 171 CPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---QALINKINKSIVAPLPT 225
PE+L Y +KSDI+S+G E++ FK DM Q L+ K+N ++ L T
Sbjct: 176 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK--DMPATQMLLEKLNGTVPCLLDT 233
Query: 226 --------------------------------------------VYSGAFRGLVKSMLRK 241
+S F V+ L++
Sbjct: 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQR 293
Query: 242 NPEFRPSAAELLCHP 256
NP+ RPSA+ LL H
Sbjct: 294 NPDARPSASTLLNHS 308
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 8 EQIGKGSFGSALLVR-HKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEY 66
++IG G FG LL H+ K V+ K A T + QE++ + +P +++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA------LNYL 120
+E Y+ +++ +C GD+ ++ G+ ++ + V MA L +L
Sbjct: 61 LGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGM---VAQMAQKDVLQRMACEVASGLLWL 116
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELL-- 175
H +H D+ N LT D +++GD+GLA +D ++ PEL+
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 176 -------ADIPYGSKSDIWSLGCCVYEMS 197
D KS+IWSLG ++E+
Sbjct: 177 RGQDLLPKDQT--KKSNIWSLGVTMWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 3/103 (2%)
Query: 97 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156
P + L ++++ + + YL + + +HRD+ N L + + + DFGL+K + S
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165
Query: 157 DDL--ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
D P ++ E LAD Y + SD+W+ G ++E+
Sbjct: 166 GDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 57/251 (22%), Positives = 106/251 (42%), Gaps = 9/251 (3%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQ--TDRARRSAHQEMELISRVRNPFIVEYK 67
IG G FG K +K V I+ + T++ R+ E ++ + + I+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL- 71
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
+ V K II Y E G + + ++ +G F +L L + + YL + +H
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS----YMCPELLADIPYGSK 183
RD+ NI + + + ++ DFGL+++L D + + PE +A + S
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190
Query: 184 SDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242
SD+WS G ++E MS + + ++ IN P P A L+ +++
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQD 250
Query: 243 PEFRPSAAELL 253
RP +++
Sbjct: 251 RARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 4/154 (2%)
Query: 104 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 163
+ L W VQ+ ++YL ++HRD+ N+ + +++ DFGLA++L D+
Sbjct: 109 QDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 168
Query: 164 VGTP---SYMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSI 219
G +M E + + +SD+WS G V+E M+ + + + + + K
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228
Query: 220 VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
P P + + ++ + E RP EL+
Sbjct: 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 34/124 (27%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 138
II + G + + +K G P KL + Q+ + ++ + +HRD++ +NI ++
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 136
Query: 139 RDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGS---KSDIWSLGCC 192
++ DFGLA+ +I D+ ++ G + PE I +GS KSD+WS G
Sbjct: 137 ASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEA---INFGSFTIKSDVWSFGIL 192
Query: 193 VYEM 196
+ E+
Sbjct: 193 LMEI 196
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 106 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 165
L W VQ+ + YL ++HRD+ N+ + +++ DFGLA++L D+ + G
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
Query: 166 TP---SYMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVA 221
+M E + + +SD+WS G ++E M+ + + + + + K
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 230
Query: 222 PLPTVYS-GAFRGLVKSML---RKNPEFRPSAAEL 252
P P + + + +VK + P+F+ AAE
Sbjct: 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 7/90 (7%)
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS--- 168
Q+ +++L + + +HRDV N+ LT + ++ DFGLA+ +++D ++ VV +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND--SNYVVKGNARLP 277
Query: 169 --YMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M PE + D Y +SD+WS G ++E+
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 33/141 (23%), Positives = 63/141 (44%), Gaps = 4/141 (2%)
Query: 111 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP 167
+Q+ + YL ++ +H+D+ NI + +++ D GL++ + S D + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 168 SYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTV 226
+M PE + + S SDIWS G ++E+ S + F Q +I + K + P
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSED 250
Query: 227 YSGAFRGLVKSMLRKNPEFRP 247
L+ ++ P RP
Sbjct: 251 CPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 61/256 (23%), Positives = 112/256 (43%), Gaps = 8/256 (3%)
Query: 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ--TDRARRSAHQEMELISRVRNPFI 63
+ + IG G FG R K KK + I+ + +D+ R E ++ + +P I
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123
+ + V K V II Y E G + + +++ +G F +L L + + YL
Sbjct: 68 I-RLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM 125
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS---YMCPELLADIPY 180
+ +HRD+ NI + + ++ DFGL++ L + + G + PE +A +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 181 GSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
S SD+WS G ++E MS + + Q +I + P P A L+
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCW 245
Query: 240 RKNPEFRPSAAELLCH 255
+K+ RP+ ++++
Sbjct: 246 QKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 8 EQIGKGSFGSALL--VRHKHE-------------RKKYVLKKIRLARQTDRARRSAHQEM 52
E++G+G FG L V + + R V KI AR +E+
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 53 ELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI-------KKANGVHFPEEK 105
+++SR+++P I+ V++ +C+I Y E GD+ + + K+ NG
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDP-LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 106 LCKWLV----------QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155
C + Q+ + YL + + +HRD+ N + + I++ DFG+++ L
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 156 SDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+ D + V +M E + + + SD+W+ G ++E+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 61/265 (23%), Positives = 111/265 (41%), Gaps = 26/265 (9%)
Query: 10 IGKGSFGSALLVRHKHE--RKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEY 66
IG+G+FG L R K + R +K+++ D R A E+E++ ++ +P I+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNIINL 73
Query: 67 KDSWVEKGCYVCIIIGYCEGG--------------DMAEAIKKANGVHFPEEKLCKWLVQ 112
+ +G Y+ + I Y G D A AI + ++L +
Sbjct: 74 LGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK---MLISDDLASSVVGTPSY 169
+ ++YL +HRD+ NI + + ++ DFGL++ + + + V +
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV---RW 189
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYS 228
M E L Y + SD+WS G ++E+ S + L K+ + P
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 249
Query: 229 GAFRGLVKSMLRKNPEFRPSAAELL 253
L++ R+ P RPS A++L
Sbjct: 250 DEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 36/151 (23%), Positives = 73/151 (48%), Gaps = 7/151 (4%)
Query: 50 QEMELISRVRNPFIVE-YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 108
E +++ ++R+P +++ Y +E+ Y I+ + G + E ++ G +L
Sbjct: 50 AEAQIMKKLRHPKLIQLYAVCTLEEPIY--IVTELMKYGSLLEYLQGGAGRALKLPQLID 107
Query: 109 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP- 167
Q+ + YL A + +HRD+ N+ + + ++ DFGLA+ +I +D+ + G
Sbjct: 108 MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKF 166
Query: 168 --SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+ PE + KSD+WS G + E+
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 28/219 (12%)
Query: 5 EVLEQIGKGSFGSALLVRH----KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
E + IG+G+FG R +E V K+ + + +E L++ +
Sbjct: 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH 67
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK-------------KANGVHFPEEKL- 106
P IV+ G +C++ Y GD+ E ++ ++ L
Sbjct: 68 PNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 107 CKWLVQLLMALN------YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL- 159
QL +A YL +HRD+ N + + +++ DFGL++ + S D
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 160 -ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
AS P +M PE + Y ++SD+W+ G ++E+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 88 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 147
D+ I + + + E L + Q+ +++L + + +HRD+ NI LT + ++ D
Sbjct: 198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICD 257
Query: 148 FGLAKMLISDDLASSVVGTP----SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
FGLA+ I +D V G +M PE + + Y +SD+WS G ++E+
Sbjct: 258 FGLARD-IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 34/155 (21%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 104 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LAS 161
E L + Q+ + +L + +HRD+ NI L+ + +++ DFGLA+ + D +
Sbjct: 174 EDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 233
Query: 162 SVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDM-QALINKINKS 218
P +M PE + D Y ++SD+WS G ++E+ S + + + + ++
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293
Query: 219 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
P + ++ + + +P+ RP+ + L+
Sbjct: 294 TRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 44/202 (21%), Positives = 85/202 (42%), Gaps = 24/202 (11%)
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL---N 118
FI++ D + +I+ YC G + E + K EK + +L MA+
Sbjct: 86 FIIDIVDDL----PRLSLILEYCTRGYLREVLDK--------EKDLSFKTKLDMAIDCCK 133
Query: 119 YLHANHIL----HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 174
L+ + ++++ + +T + +++ GL K+L S V Y ++
Sbjct: 134 GLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKM 191
Query: 175 LADI--PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAF 231
L DI Y K DI+SLG ++E+ K F+ + + + I + LP
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI 251
Query: 232 RGLVKSMLRKNPEFRPSAAELL 253
+ +V++ + RP+ E+L
Sbjct: 252 KCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 53/248 (21%), Positives = 100/248 (40%), Gaps = 39/248 (15%)
Query: 7 LEQIGKGSFGSA----LLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+E++G+ FG L E+ + V K + R E + SR+++P
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAE----------------------AIKKANGVH 100
IV V K + +I YC D+ E ++ A+ VH
Sbjct: 70 IVCLLGV-VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 101 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158
+ Q+ + +L ++H++H+D+ N+ + ++++ D GL + + + D
Sbjct: 129 I--------VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 159 -LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKIN 216
L + + +M PE + + SDIWS G ++E+ S + + Q +I I
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
Query: 217 KSIVAPLP 224
V P P
Sbjct: 241 NRQVLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 10/124 (8%)
Query: 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 138
I+ Y G + + +K G +L Q+ + YL + + +HRD+ NI +
Sbjct: 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG 137
Query: 139 RDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGS---KSDIWSLGCC 192
+ ++ DFGLA++ I DD ++ G P + PE YG KSD+WS G
Sbjct: 138 ENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEA---ANYGRFTIKSDVWSFGIL 193
Query: 193 VYEM 196
+ E+
Sbjct: 194 LTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 57/257 (22%), Positives = 103/257 (40%), Gaps = 25/257 (9%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYK 67
E +GKG+FG K + K +A +T + +++ +S R + +Y
Sbjct: 1 ELLGKGNFGEVF--------KGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR--ILKQYD 50
Query: 68 DSWVEKGCYVC-------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+ K VC I++ GGD ++K ++L K+ + + YL
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYL 109
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS----YMCPELLA 176
+ + +HRD+ N + + +++ DFG+++ DD S G + PE L
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEALN 167
Query: 177 DIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235
Y S+SD+WS G ++E S + Q ++ K P ++
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227
Query: 236 KSMLRKNPEFRPSAAEL 252
+ PE RP +EL
Sbjct: 228 QRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 55/265 (20%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 10 IGKGSFGSAL--LVRHKHERKKYVLKKIR-LARQTDRARRSAHQEMELISRV-RNPFIVE 65
IG+G+FG + +++ + +K ++ A + D R E+E++ ++ +P I+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKLGHHPNIIN 67
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH----FPEE----------KLCKWLV 111
+ +G Y+ I I Y G++ + ++K+ + F +E +L ++
Sbjct: 68 LLGACENRG-YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK---MLISDDLASSVVGTPS 168
+ + YL +HRD+ N+ + + ++ DFGL++ + + + V
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV---R 183
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVY 227
+M E L Y +KSD+WS G ++E+ S + L K+ + P
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNC 243
Query: 228 SGAFRGLVKSMLRKNPEFRPSAAEL 252
L++ R P RP A++
Sbjct: 244 DDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 104 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 163
E L + Q+ + +L + +HRD+ NI L+ + +++ DFGLA+ + D
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD------ 226
Query: 164 VGTPSY------------MCPELLADIPYGSKSDIWSLGCCVYEM 196
P Y M PE + D Y ++SD+WS G ++E+
Sbjct: 227 ---PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 43/235 (18%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN- 60
+++++L +G+G+FG + + +RK+Y KI R + R A E++ + +VR
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKI--VRNVPKYTRDAKIEIQFMEKVRQA 185
Query: 61 ------PFIVEYKDSWVEKGCYVCIII---GYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
P + + E G ++CI++ G C + + I K F L + +
Sbjct: 186 DPADRFPLMKIQRYFQNETG-HMCIVMPKYGPC----LLDWIMKHGP--FSHRHLAQIIF 238
Query: 112 QLLMALNYLHAN-HILHRDVKCSNIFL-TRDQDI---------------RLGDFGLAKML 154
Q +AL+Y H H++H D+K NI + T D + R+ D G
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--- 295
Query: 155 ISDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 207
D+ S ++V T Y PE++ + + +D+WS+GC +YE+ K + D
Sbjct: 296 -CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349
|
Length = 467 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 33/153 (21%), Positives = 68/153 (44%), Gaps = 10/153 (6%)
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPE 173
+ YL+A +HRD+ N + D +++GDFG+ + + D + +M PE
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232
L D + + SD+WS G ++E+++ + ++ + ++ + P
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 251
Query: 233 GLVKSMLRKNPEFRPSAAELL------CHPHLQ 259
L++ + NP+ RP+ E++ HP
Sbjct: 252 DLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 13/108 (12%)
Query: 102 PEEKLCK----------WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151
+E L K + Q+ + +L + +HRD+ NI L+ + +++ DFGLA
Sbjct: 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 226
Query: 152 KMLISDD--LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+ + D + P +M PE + D Y +SD+WS G ++E+
Sbjct: 227 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 27/94 (28%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 106 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 165
L + Q+ + +L + + +HRD+ N+ L + + +++ DFGLA+ ++ D S
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 166 T---PSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
T +M PE + D Y + SD+WS G ++E+
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 45/204 (22%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 8 EQIGKGSFGSALL--VRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65
++IG G FG LL + + V+K+++ A + + + Q+ + +++P I++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELK-ANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK---LCKWLVQLLMALNYLHA 122
VE Y+ ++ YCE GD+ + + H + L + ++ + ++H
Sbjct: 60 CLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS---VVGTPSYMCPELLADIP 179
++ LH D+ N FLT D +++GD+G+ +D + ++ PEL+ +
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 180 YG-------SKSDIWSLGCCVYEM 196
G S++W+LG ++E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 23/89 (25%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 111 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP 167
+Q+ ++YLH ++H+D+ N + + +++ D L++ L D L +
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 168 SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M E L + Y S SD+WS G ++E+
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 46/211 (21%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 8 EQIGKGSFGSALL--VRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF--- 62
++IG G FG +L V + + V+K++R S ++M+ + + P+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELR-------VSASVQEQMKFLEEAQ-PYRSL 52
Query: 63 ----IVEYKDSWVEKGCYVCIIIGYCEGGDMA---EAIKKANGVHFPEEKLCKWLVQLLM 115
+++ E Y+ +++ +C GD+ + +KA + L + ++ +
Sbjct: 53 QHSNLLQCLGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTP-SYMCP 172
L +LH N+ +H D+ N LT D +++GD+GL+ +D + + P ++ P
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171
Query: 173 ELLADI-------PYGSKSDIWSLGCCVYEM 196
EL+ ++ +S++WSLG ++E+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 55/264 (20%), Positives = 112/264 (42%), Gaps = 26/264 (9%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQ--TDRARRSAHQEMELISRV-RNPFIVEY 66
IG+G+FG L R K + + + I+ ++ + R E+E++ ++ +P I+
Sbjct: 3 IGEGNFGQVLKARIKKDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH----FPEE----------KLCKWLVQ 112
+ +G Y+ + I Y G++ + ++K+ + F +L +
Sbjct: 62 LGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK---MLISDDLASSVVGTPSY 169
+ ++YL +HRD+ NI + + ++ DFGL++ + + + V +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV---RW 177
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYS 228
M E L Y + SD+WS G ++E+ S + L K+ + P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237
Query: 229 GAFRGLVKSMLRKNPEFRPSAAEL 252
L++ R+ P RPS A++
Sbjct: 238 DEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 44/207 (21%), Positives = 83/207 (40%), Gaps = 16/207 (7%)
Query: 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQE--ME--LISRVRN 60
+L +G G+FG ++ V ++ + + + ME ++S+ +
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA-NGVHFPEEKLCKWLVQLLMAL-- 117
IV E+ I++ GGD+ +++ P K L+ +
Sbjct: 69 QNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 118 --NYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDDL---ASSVVGTPSY 169
YL NH +HRD+ N LT + ++ DFG+A+ + + +
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYEM 196
M PE D + SK+D+WS G ++E+
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 16/104 (15%)
Query: 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF------KAFDMQALINKIN 216
++GTP Y+ PELL P+G D W+LG C++E F + F N +N
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQ-----NILN 594
Query: 217 KSIVAPLP---TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 257
+ I P P S + ++ +L +P R EL HP
Sbjct: 595 RDI--PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 3/88 (3%)
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-S 168
Q+ + +L + + +HRD+ N+ + + +++ DFGLA+ ++ D S T P
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M PE + + Y + SD+WS G ++E+
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 33/158 (20%), Positives = 48/158 (30%), Gaps = 37/158 (23%)
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQ-------DIRLGDFGLAKMLISDDLASSVV 164
QL AL+YL ++H +V NI + R I+L D G +
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG--------------I 154
Query: 165 GTPSYMCPELLADIPY--------GSKS-----DIWSLGCCVYEM-SAQKAAFKAFDMQA 210
E + IP+ G S D WS G + E+ S +
Sbjct: 155 PITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
Query: 211 LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 248
P+P L+ +P RPS
Sbjct: 215 KERFYQDQHRLPMPD--CAELANLINQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 15/184 (8%)
Query: 79 IIIGYCEGGDMAEAIKKANGVHFPEEK-LCKWLVQLLMALNYLHANHILHRDVKCSNIFL 137
+++ Y + GD+ I+ H P K L + +Q+ + YL + +HRD+ N L
Sbjct: 74 VVLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML 131
Query: 138 TRDQDIRLGDFGLAKMLISDDLAS----SVVGTP-SYMCPELLADIPYGSKSDIWSLGCC 192
+++ DFGLA+ + + S + P +M E L + +KSD+WS G
Sbjct: 132 DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 191
Query: 193 VYEMSAQKAA----FKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 248
++E+ + A +FD + + + P ++ S PE RP+
Sbjct: 192 LWELMTRGAPPYPDVDSFD---ITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPT 248
Query: 249 AAEL 252
+EL
Sbjct: 249 FSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 36/165 (21%), Positives = 55/165 (33%), Gaps = 25/165 (15%)
Query: 103 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 162
EE++ +Q L AL LH NI LT D L G S
Sbjct: 16 EEEIWAVCLQCLGALRELHRQAKSG------NILLT--WDGLLKLDGSV--AFKTPEQSR 65
Query: 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP 222
P +M PE++ Y K+DI+SLG +YE + + + L + +
Sbjct: 66 P--DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP--YNEERELSAILEILLNGM 121
Query: 223 LPTVYSGA-----------FRGLVKSMLRKNPEFRPSAAELLCHP 256
F ++ + P+ R +A L H
Sbjct: 122 PADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 26/128 (20%), Positives = 53/128 (41%), Gaps = 13/128 (10%)
Query: 28 KKYVLKKIRLARQTDRARRSAHQEMELISRVRN--PFIVEYKDSWVEKGCYVCIIIGYCE 85
+ YVLK +R+ R ++L++R P ++ +S G +++ + E
Sbjct: 22 EDYVLKINP-SREKGADREREVAILQLLARKGLPVPKVLASGES---DGWSY-LLMEWIE 76
Query: 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 145
G + E +E + + L +LL L+ L + H D+ NI + + + +
Sbjct: 77 GETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGI 130
Query: 146 GDFGLAKM 153
D+ A
Sbjct: 131 IDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 36/147 (24%), Positives = 63/147 (42%), Gaps = 15/147 (10%)
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQD--------IRLGDFGLAKMLISDDLASSV 163
QL AL++L + H +V N+ L R++D I+L D G++ ++ ++
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER 167
Query: 164 VGTPSYMCPELLADIPYGS-KSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVA 221
+ ++ PE + + S +D WS G ++E+ S A D Q +
Sbjct: 168 I---PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQL 224
Query: 222 PLPTVYSGAFRGLVKSMLRKNPEFRPS 248
P P A L+ + P+FRPS
Sbjct: 225 PAPKWTELA--NLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 66/304 (21%), Positives = 122/304 (40%), Gaps = 59/304 (19%)
Query: 2 EQYEVLEQIGKGSFG-----------------SALLVRHKHERKKYVLKKIRLARQTDRA 44
+ +E++G+G FG A V K+ +D A
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPV--LVAVKVLRPDASDNA 62
Query: 45 RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV----CIIIGYCEGGDMAEAIKKA---- 96
R +E++++SR+ +P I + C V C+I+ Y E GD+ + ++K
Sbjct: 63 REDFLKEVKILSRLSDPNIAR-----LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117
Query: 97 -----NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151
N L Q+ + YL + + +HRD+ N + ++ I++ DFG++
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 152 KMLISDDLASSVVGTP----SYMCPELLADIPYGSKSDIWSLGCCVYE--MSAQKAAFKA 205
+ L S D V G +M E + + +KSD+W+ G ++E ++ ++
Sbjct: 178 RNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
Query: 206 FDMQALINKI-------NKSIVAPLPTVYSGAFRGLVKSML---RKNPEFRPSAAELLCH 255
Q +I + I P P + + + ML R++ E RP+ E+ H
Sbjct: 237 LTDQQVIENAGHFFRDDGRQIYLPRPP---NCPKDIYELMLECWRRDEEDRPTFREI--H 291
Query: 256 PHLQ 259
LQ
Sbjct: 292 LFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 40/170 (23%)
Query: 7 LEQIGKGSFGSALLVRHKHERKKYVLKK------------IRLARQTDRARRSAHQEMEL 54
++ I +G+ A + K V+K R+ R+ R RR E +
Sbjct: 1 MKLIKRGA--EAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRE--RTRR----EARI 52
Query: 55 ISR-----VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 109
+SR V P + V+ ++ I++ Y EG + + I N E +L +
Sbjct: 53 MSRARKAGVNVPAVYF-----VDPENFI-IVMEYIEGEPLKDLI---NSNGMEELELSR- 102
Query: 110 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159
+ L+ LH+ I+H D+ SN+ L I L DFGLA+ S DL
Sbjct: 103 EIGRLVGK--LHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE--FSKDL 147
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 610 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.55 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.53 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.43 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.42 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.96 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.89 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.78 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.43 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.42 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.39 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.38 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.32 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.27 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.08 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.9 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.75 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.55 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.36 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.27 | |
| PLN02236 | 344 | choline kinase | 96.22 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.15 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.79 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.49 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.4 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.37 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.36 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.31 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.21 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.09 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 92.78 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.21 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=455.17 Aligned_cols=285 Identities=32% Similarity=0.554 Sum_probs=252.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
.++|++++.||+|+||+||+|+.+++++.||+|++++...... ..+....|..||.+++||+||+++.+|++.+ .+|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~-kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE-KLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-eEEE
Confidence 3789999999999999999999999999999999987665443 4567889999999999999999999998765 8999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc-cccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDD 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~-~~~~ 158 (610)
|+||+.||.|...|++.+ .|+|+.++.|+.+|+.||.|||++|||||||||+||||+.+|+++|+|||+|+.. ....
T Consensus 103 Vld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999999999999866 7999999999999999999999999999999999999999999999999999964 4445
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
...++|||+.|||||++.+.+|+.++|+||||++||+|++|.+||.+.+...++++|........|..++.++++||+++
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L 260 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL 260 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence 67788999999999999999999999999999999999999999999999999999999887777888999999999999
Q ss_pred hcCCCCCCC----CHHHHhcCCCCCchhhhhcc--ccCCCCCCCCCCCCCCccccc
Q 007266 239 LRKNPEFRP----SAAELLCHPHLQPYVLGIHL--KLNGPRRNTFPLEWSDSNFKK 288 (610)
Q Consensus 239 L~~dP~~Rp----Sa~eiL~Hp~f~~~~~~~~~--~~~~p~~~~~~~~~~~s~~~~ 288 (610)
|..||++|. ++.+|-+||||....|..-. ++..|..+......+.++|+.
T Consensus 261 L~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~ 316 (357)
T KOG0598|consen 261 LKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDN 316 (357)
T ss_pred hccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccH
Confidence 999999995 79999999999998776533 333444444333444444443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-55 Score=459.45 Aligned_cols=256 Identities=32% Similarity=0.487 Sum_probs=225.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-----HHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-----ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-----~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
+.|.+.+.||+|+||.|-+|..+.+++.||||++........ ......+|++||++|+|||||+++++|... .+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-ds 250 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-DS 250 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-Cc
Confidence 579999999999999999999999999999999976543321 122357999999999999999999977655 47
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC---CCeeeeecccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKM 153 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~---g~vKL~DFGlak~ 153 (610)
.||||||++||+|.+.+-.++ .+.|...+.+++||+.||.|||++||+||||||+||||..+ ..+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 799999999999999998765 68899999999999999999999999999999999999877 6699999999999
Q ss_pred cccccccccccCCCcccCCccccCCCC---CCCccccccchhHHhhhhcCccccccCHHH-HHHHHhhccC---CCCCcc
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPY---GSKSDIWSLGCCVYEMSAQKAAFKAFDMQA-LINKINKSIV---APLPTV 226 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~y---t~ksDIWSLG~iLyeLltG~~PF~~~~~~~-l~~~I~~~~~---~~~p~~ 226 (610)
......+.+.||||.|.|||++....+ ..++|||||||+||-+++|.+||.+..... +.+.|.++.+ ++.+..
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 988889999999999999999987653 458899999999999999999998766554 6677766544 445667
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+++++++||++||.+||+.|||++|+|+||||+.
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 8999999999999999999999999999999984
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=462.52 Aligned_cols=276 Identities=61% Similarity=1.044 Sum_probs=263.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.+|+|+||.+++++++.+++.||+|++......+..++..++|+.+++++.|||||.++++|.++++++|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 78999999999999999999999999999999999999999998889999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
|+||+||+|.+.|++..+..|+|+.++.|+.||+.|+.|||+++|+|||||+.|||+++++.|+|+|||+|+.+...+ +
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 999999999999999888899999999999999999999999999999999999999999999999999999998887 8
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
..+++|||.||+||++.+.+|+.++||||||||+|||++-+++|++.++..++.+|......|+|..++.+++.||+.||
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l 242 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSML 242 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCchhhhhccccCCCCCCC
Q 007266 240 RKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNT 276 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~~~~~~~~~~~~p~~~~ 276 (610)
..+|+.||++.++|.+|.+++++.............+
T Consensus 243 ~~~P~~RPsa~~LL~~P~l~~~~~~~~~~~~~~~~~~ 279 (426)
T KOG0589|consen 243 RKNPEHRPSALELLRRPHLLRYLVESQELETSIELPT 279 (426)
T ss_pred hcCCccCCCHHHHhhChhhhhHHHhhhccccccccCC
Confidence 9999999999999999999998866655444433333
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=447.80 Aligned_cols=257 Identities=33% Similarity=0.596 Sum_probs=239.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++.+.++.||+|+.|+||+|+|+.+++.+|+|.+. ........+++.+|+++++.++|||||.++++|+.++..++|+|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 36678899999999999999999999999999994 44555667889999999999999999999999998775699999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||+||+|..+++..+ .++|..+..++.+++.||.|||. ++||||||||+||||+..|+|||||||.++.+... +.
T Consensus 158 EYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence 9999999999999865 68999999999999999999996 89999999999999999999999999999998766 78
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc-----CHHHHHHHHhhccCCCCCcc-cchHHHHH
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-----DMQALINKINKSIVAPLPTV-YSGAFRGL 234 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~-----~~~~l~~~I~~~~~~~~p~~-~s~~l~~L 234 (610)
.+++||..|||||.+.+..|+.++||||||+.|.||++|+.||... +..+++..|..+..+.+|.. +|++|++|
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 9999999999999999999999999999999999999999999774 78889999999888888986 99999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
|..||++||.+||++.|+|+|||+..+.
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=462.13 Aligned_cols=253 Identities=30% Similarity=0.558 Sum_probs=236.3
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+|+..+.||+|||+.||.+++..+|+.||+|++.+.. ......+.+.+||+|.+.|+|||||++++.|. +..++|||.
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE-Ds~nVYivL 97 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE-DSNNVYIVL 97 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee-cCCceEEEE
Confidence 5999999999999999999999999999999997644 34556788999999999999999999999665 556999999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
|+|..++|.++++++. .|+|.+++.|++||+.||.|||+++|||||||..||||+.+.+|||+|||||..+..+ +..
T Consensus 98 ELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 9999999999999655 8999999999999999999999999999999999999999999999999999998755 678
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
.+.||||.|+|||++....++..+||||+|||||.|+.|+|||+..+..+.+++|....+. +|..+|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~-~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS-MPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-cccccCHHHHHHHHHHhc
Confidence 8999999999999999999999999999999999999999999999999999999877654 788999999999999999
Q ss_pred CCCCCCCCHHHHhcCCCCC
Q 007266 241 KNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f~ 259 (610)
.||.+|||+++||.|+||.
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred CCcccCCCHHHHhcCHhhh
Confidence 9999999999999999994
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-53 Score=425.10 Aligned_cols=261 Identities=28% Similarity=0.504 Sum_probs=232.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|+.+..+|+|+||+||+|+++++|+.||||++.-+..++...+...||+++|++++|+|+|.++++|.... .+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-klhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-KLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-eeEEE
Confidence 89999999999999999999999999999999999888888888888999999999999999999999987654 89999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-cccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~~~ 159 (610)
+|||+. ++.+.+.... ..++++.++.+++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+. ..+.
T Consensus 80 FE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 999975 5555565533 358999999999999999999999999999999999999999999999999999987 6777
Q ss_pred cccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc-------------
Q 007266 160 ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT------------- 225 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~------------- 225 (610)
.+.++.|.||+|||++.+ ..|+..+|||++||++.||++|.+.|.+....+++..|......-+|.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 888999999999998876 889999999999999999999999999998888777775543322111
Q ss_pred -----------------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 226 -----------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 226 -----------------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
.++..+.+|+++||..||.+|++.+|+|.|+||+.+...
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence 245578899999999999999999999999999877655
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=447.33 Aligned_cols=284 Identities=29% Similarity=0.504 Sum_probs=250.4
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+||||.||+|+.+.+|..||+|+++++.... ...+.+..|..+|....+|+||+++.+|++.. ++||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~-~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE-YLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC-eeEE
Confidence 579999999999999999999999999999999998776543 34566888999999999999999999998765 9999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc--
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-- 157 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-- 157 (610)
||||++||++..+|.+.+ .|+|+.++.|+.+++.||+.||+.|||||||||+|+|||..|++||+|||||..+...
T Consensus 219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999999999876 7999999999999999999999999999999999999999999999999998654210
Q ss_pred --------------------c--------------------------ccccccCCCcccCCccccCCCCCCCccccccch
Q 007266 158 --------------------D--------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGC 191 (610)
Q Consensus 158 --------------------~--------------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~ 191 (610)
+ +..+.+|||.|||||++.+..|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0 112358999999999999999999999999999
Q ss_pred hHHhhhhcCccccccCHHHHHHHHhh---ccCCCCCcccchHHHHHHHHhhcCCCCCCC---CHHHHhcCCCCCchhhhh
Q 007266 192 CVYEMSAQKAAFKAFDMQALINKINK---SIVAPLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 192 iLyeLltG~~PF~~~~~~~l~~~I~~---~~~~~~p~~~s~~l~~LI~kmL~~dP~~Rp---Sa~eiL~Hp~f~~~~~~~ 265 (610)
||||||.|.+||.+.+..+.+.+|.. .+..|....++.++++||.+||. ||++|. +++||..||||+...|.-
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 99999999999999999999998854 34455556689999999999999 999995 599999999999988887
Q ss_pred ccccCCCCCCCCCCCCCCccccc
Q 007266 266 HLKLNGPRRNTFPLEWSDSNFKK 288 (610)
Q Consensus 266 ~~~~~~p~~~~~~~~~~~s~~~~ 288 (610)
-.....|..+...-+.+..+|++
T Consensus 456 l~~~~apfvP~v~~~~DT~yFdd 478 (550)
T KOG0605|consen 456 LREMPAPFVPQVNSELDTQYFDD 478 (550)
T ss_pred hhcCCCCCCCCCCCccccccccc
Confidence 77777777777766777777764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-52 Score=416.35 Aligned_cols=258 Identities=27% Similarity=0.534 Sum_probs=238.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||.|+||.|.+++++.+|..||+|++.+... ..+..+..++|..+|+.+.||+++.+.+.|.+.+ ++|+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-NLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-eEEE
Confidence 4789999999999999999999999999999999976542 3345677899999999999999999999988765 8999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||++||.|..++++.+ .|+|..++.++.||+.||+|||+++|++|||||+|||||.+|++||+|||+|+.....
T Consensus 122 vmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 999999999999999876 7999999999999999999999999999999999999999999999999999987544
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
.-+.||||.|+|||++...+|+.++|+|+|||++|||++|.+||.+.+...++++|...... +|..++.++++||+++|
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-FPSYFSSDAKDLLKKLL 276 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-CCcccCHHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999999999999999887664 78899999999999999
Q ss_pred cCCCCCC-----CCHHHHhcCCCCCchhhh
Q 007266 240 RKNPEFR-----PSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 240 ~~dP~~R-----pSa~eiL~Hp~f~~~~~~ 264 (610)
++|-.+| ....+|.+||||+...|.
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccccHH
Confidence 9999999 367899999999986654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-52 Score=443.77 Aligned_cols=268 Identities=30% Similarity=0.530 Sum_probs=241.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~L 79 (610)
++|.+.+.||.|+|++|++|+++.+++.||||++.+.....+ ..+.+.+|-.+|.+| +||.||+++..|++.. .+|+
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-sLYF 151 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-SLYF 151 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-ceEE
Confidence 689999999999999999999999999999999976554332 345678899999999 8999999999988765 7999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|+||+.+|+|.++|++.+ .|+|..++.|+.||+.||+|||++|||||||||+||||+.||+++|+|||.|+.+.....
T Consensus 152 vLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999999999976 799999999999999999999999999999999999999999999999999998743321
Q ss_pred --------------cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc
Q 007266 160 --------------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT 225 (610)
Q Consensus 160 --------------~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~ 225 (610)
..++|||..|.+||++.+...+..+|||+||||||.|+.|.+||.+.+...++++|....+. +|.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~-fp~ 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE-FPE 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc-CCC
Confidence 14589999999999999999999999999999999999999999999999999999877654 788
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhhhccccCCCC
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPR 273 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~~~~~~~~p~ 273 (610)
.+++.+++||+++|..||.+|++++||.+||||....|..-+....|.
T Consensus 309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~ 356 (604)
T KOG0592|consen 309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPK 356 (604)
T ss_pred CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCc
Confidence 999999999999999999999999999999999998777655555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=428.80 Aligned_cols=257 Identities=32% Similarity=0.602 Sum_probs=238.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+.+|.+.+.||.|+||+||+++++.++..||||.+.+.....+..+.+..|+.||+.|+|||||.++++...+ +++|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-DFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-CeEEEE
Confidence 4689999999999999999999999999999999998887888888999999999999999999999976554 599999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC------CCeeeeeccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD------QDIRLGDFGLAKML 154 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~------g~vKL~DFGlak~~ 154 (610)
||||+||+|.++|++++ .++|..++.|+.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999876 78999999999999999999999999999999999999875 34899999999999
Q ss_pred ccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc--cCCCCCcccchHHH
Q 007266 155 ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS--IVAPLPTVYSGAFR 232 (610)
Q Consensus 155 ~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~--~~~~~p~~~s~~l~ 232 (610)
....+..+.||+|.|||||++....|+.|+|+||+|+|||+|++|++||...+..+++..+.+. ....++..++....
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence 9999999999999999999999999999999999999999999999999999999998888654 34556677888899
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+|+...|+.++..|.+..+-+.|+++..
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhccc
Confidence 9999999999999999999999988864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=425.35 Aligned_cols=255 Identities=38% Similarity=0.671 Sum_probs=235.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeee-eEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKD-SWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~-~~~~~~~~~~LV 80 (610)
.+|+|+++||+|.||.||+|++..+|..+|.|.+.....+...++.+..|+.+|++|+|||||++++ .|.+++..++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3599999999999999999999999999999999988888888999999999999999999999999 666666669999
Q ss_pred EeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--eecccCCCCceEecCCCCeeeeeccccccc
Q 007266 81 IGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHA--NH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs--~g--IiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
||||++|+|.+.|+. .....++|..++.++.||+.||.++|+ .. |+||||||.||||+.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999974 345679999999999999999999999 45 999999999999999999999999999998
Q ss_pred cccc-ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC-cccchHHH
Q 007266 155 ISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-TVYSGAFR 232 (610)
Q Consensus 155 ~~~~-~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p-~~~s~~l~ 232 (610)
.... ...+++|||.||+||.+.+.+|+.++||||+||++|||+...+||.+.+...+..+|.++..+++| ..+|..++
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~ 258 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLR 258 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHH
Confidence 6654 567899999999999999999999999999999999999999999999999999999999998899 78999999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.||.-|+.+||+.||+. +|+++..
T Consensus 259 ~li~~ci~vd~~~RP~t-----~~~v~di 282 (375)
T KOG0591|consen 259 ELINMCIAVDPEQRPDT-----VPYVQDI 282 (375)
T ss_pred HHHHHHccCCcccCCCc-----chHHHHH
Confidence 99999999999999986 5555443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=439.48 Aligned_cols=258 Identities=25% Similarity=0.437 Sum_probs=234.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~L 79 (610)
|++|.+++.||.|.||.||+|+.+.++..||||.++.....-+ ...-.||++.|++|+ |||||++++++.+.+..+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 6899999999999999999999999999999999986665532 334568999999999 99999999999988879999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|||||+ .+|+++++.+ +..|+|+.++.|++||+.||+|+|.+|++||||||+||||.....|||+|||+|+...+...
T Consensus 88 VfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 999994 7999999987 67899999999999999999999999999999999999999888999999999999999999
Q ss_pred cccccCCCcccCCcccc-CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc-------------
Q 007266 160 ASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT------------- 225 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~------------- 225 (610)
.+.++.|+||+|||++. ...|+.++|||++|||++|+++-++.|.|.+..+++.+|...++.|...
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 99999999999999865 5668999999999999999999999999999999999998766655211
Q ss_pred ----------------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 226 ----------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 226 ----------------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.++.++.+||.+||..||++||||.|+|+||||+.-
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 256788999999999999999999999999999863
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=427.27 Aligned_cols=256 Identities=30% Similarity=0.580 Sum_probs=232.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc---HHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT---DRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~---~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~ 77 (610)
.+|++.+.||+|+||+|+++.+..++..||+|++...... ....+.+.+|+.+++.+. ||||+++++++.... .+
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-~~ 95 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-KI 95 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-eE
Confidence 5899999999999999999999999999999987654211 233456779999999999 999999999887665 59
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-CCeeeeeccccccc-c
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKML-I 155 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-g~vKL~DFGlak~~-~ 155 (610)
|+|||||.||+|.++|.+.+ .+.|..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++... .
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred EEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 99999999999999999844 78999999999999999999999999999999999999999 99999999999988 5
Q ss_pred cccccccccCCCcccCCccccCCC-C-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCccc-chHHH
Q 007266 156 SDDLASSVVGTPSYMCPELLADIP-Y-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY-SGAFR 232 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~-y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~-s~~l~ 232 (610)
.+....+.|||+.|+|||++.+.. | +.++||||+||+||.|++|..||...+...++.+|..... .+|..+ |.+++
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-KIPSYLLSPEAR 252 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-cCCCCcCCHHHH
Confidence 677889999999999999999988 8 5899999999999999999999999999999999876644 367777 99999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+||.+||..||.+|+++.+|+.||||+..
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 99999999999999999999999999863
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=436.92 Aligned_cols=256 Identities=26% Similarity=0.550 Sum_probs=239.5
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccc-cccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA-RQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~-~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
-|++.+.||.|+.|.|-+|+|..+|+.+|||++.+. ...+.....+.+||.||+-|.|||++.++++|..+ .++|+|.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-QHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-ceEEEEE
Confidence 488999999999999999999999999999999766 34444556788999999999999999999998765 4899999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.||.|++++.+++ .|+|.++..|++||+.|+.|+|..+|+||||||+|+||+..++|||+|||+|.....+.+..
T Consensus 92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 9999999999999876 79999999999999999999999999999999999999999999999999999988888999
Q ss_pred cccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 162 SVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
+.||.|.|+|||++.|.+| +.++||||+|||||.|++|.+||.+.+...++.++..+.. .+|..++.++++||.+||.
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~ml~ 248 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRRMLD 248 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHHHhc
Confidence 9999999999999999999 7899999999999999999999999999999999988765 4889999999999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCchh
Q 007266 241 KNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+||.+|+|.+||+.|||++.+.
T Consensus 249 VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 249 VDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred cCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=437.39 Aligned_cols=289 Identities=27% Similarity=0.474 Sum_probs=251.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|.++++||+|.||+|+++..+.+++.||||.+++... .....+.+..|..|+...+ ||+++.++.+|+... ++|
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~-~l~ 445 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE-HLF 445 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-eEE
Confidence 5799999999999999999999999999999999987653 2334577888999988875 999999999988765 899
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-cc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~ 157 (610)
+||||+.||+|..+++.. .|+|..++.|+.+|+.||+|||++||||||||.+|||||.+|++||+|||+|+... ..
T Consensus 446 fvmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 999999999965544432 69999999999999999999999999999999999999999999999999999865 56
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
..+.++||||.|||||++.+..|+.++|+|+|||+||||+.|..||.+.+.+++++.|..... ..|..+|.++.+++++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAIMRR 601 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHHHHH
Confidence 678899999999999999999999999999999999999999999999999999999976654 3688899999999999
Q ss_pred hhcCCCCCCCC-----HHHHhcCCCCCchhhhh--ccccCCCCCCCCCCCCCCcccccccCCCc
Q 007266 238 MLRKNPEFRPS-----AAELLCHPHLQPYVLGI--HLKLNGPRRNTFPLEWSDSNFKKTRFMEP 294 (610)
Q Consensus 238 mL~~dP~~RpS-----a~eiL~Hp~f~~~~~~~--~~~~~~p~~~~~~~~~~~s~~~~~~~~~~ 294 (610)
||.+||++|.. +.+|..||||+...|.. ...+..|.++...-.-+-++|++....+.
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~ 665 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEK 665 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCC
Confidence 99999999964 68999999999877654 23445666666666666777776554443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=426.35 Aligned_cols=256 Identities=27% Similarity=0.483 Sum_probs=230.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~~LV 80 (610)
+.|+.+++||+|.||.||++++..+|+.||+|+++.+...+.......+||.||++|+|||||++.+...+. .+.+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 568899999999999999999999999999999999888888788899999999999999999999998887 6789999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
+|||+ -+|.-++.. .+..|++.+++.||+||+.||+|||++||+|||||.+|||||.+|.+||+|||||+.+....
T Consensus 197 FeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred Eeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 99996 588877765 56789999999999999999999999999999999999999999999999999999775544
Q ss_pred ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc------------
Q 007266 159 LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT------------ 225 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~------------ 225 (610)
..+..+.|.||+|||++.| ..|+.++|+||+||||.||+.|++.|.+.+..+++.+|.+.-..|...
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 4677889999999998876 469999999999999999999999999999999999887654433211
Q ss_pred ----------------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 226 ----------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 226 ----------------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
.++..+.+|+..||..||.+|.||.++|+|+||.
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 2456788999999999999999999999999994
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=412.51 Aligned_cols=259 Identities=30% Similarity=0.460 Sum_probs=231.7
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee----cCcEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE----KGCYVC 78 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~----~~~~~~ 78 (610)
+|..++.||+|+||.|+.+.++.+|+.||||++.....+....+...||+++|+.++|+|||.+++.+.. .-..+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 4666899999999999999999999999999998888888888899999999999999999999998875 235789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc--
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-- 156 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-- 156 (610)
+|+|++ +.+|.+.|+... .|++++++.+++||+.||+|+|+.||+||||||.|+|++.++++||||||+|+....
T Consensus 103 iV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred EehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 999999 679999999864 599999999999999999999999999999999999999999999999999998863
Q ss_pred -ccccccccCCCcccCCcccc-CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC-----------
Q 007266 157 -DDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL----------- 223 (610)
Q Consensus 157 -~~~~~~~vGTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~----------- 223 (610)
+...+.++.|.||+|||++. ...|+.++||||+||||.||++|++.|.|.+...+++.|....+.|.
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 55667899999999999764 67799999999999999999999999999998888877766554441
Q ss_pred -------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 224 -------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 224 -------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
....++.+.+|+.+||..||.+|+|++|+|+||||.++...
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 11356789999999999999999999999999999987543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=394.05 Aligned_cols=257 Identities=30% Similarity=0.530 Sum_probs=230.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|..++.||+|.||.||++++..+|+.||||+++.....+.....+.|||+.|+.++|+|||.++++|...+ .+.||
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-~l~lV 79 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-NLSLV 79 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-ceEEE
Confidence 57999999999999999999999999999999999988777666677899999999999999999999987665 67899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
+||++ .+|...|+... ..|+..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+++.+......
T Consensus 80 fEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 80 FEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 99995 69999998754 57999999999999999999999999999999999999999999999999999998766543
Q ss_pred c-cccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcc------------
Q 007266 161 S-SVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV------------ 226 (610)
Q Consensus 161 ~-~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~------------ 226 (610)
. ..+.|.||+|||++.| ..|+..+||||+|||+.||+.|.+.|.+.+..+++.+|...+..|.+..
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 3 3489999999998776 5699999999999999999999999999999999999987766664333
Q ss_pred ---------------cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 227 ---------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 227 ---------------~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+.++.+|+.+||.+||.+|+++.|+|.|+||..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 2456789999999999999999999999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=407.32 Aligned_cols=255 Identities=35% Similarity=0.603 Sum_probs=221.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc-EEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-YVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~-~~~LVm 81 (610)
+|...+.||+|+||.||++.+.++|..+|||.+..... .. .+.+.+|+.+|.+++|||||++++....... .++++|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~-~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS-PT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccc-hh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 57788999999999999999999999999999986622 22 6678999999999999999999996444443 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-CCCeeeeeccccccccc----
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLIS---- 156 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-~g~vKL~DFGlak~~~~---- 156 (610)
||+.||+|.+++++.++ .|+|..++.+.+||+.||.|||++|||||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999999877 7999999999999999999999999999999999999999 79999999999987763
Q ss_pred ccccccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccc-cCHHHHHHHHh-hccCCCCCcccchHHHH
Q 007266 157 DDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKA-FDMQALINKIN-KSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~-~~~~~l~~~I~-~~~~~~~p~~~s~~l~~ 233 (610)
........||+.|||||++..+.. ..++|||||||++.||+||.+||.. ......+-.+. ....+.+|..+|.++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~ 254 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKD 254 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 223456899999999999996333 3499999999999999999999997 44444444443 33355788899999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
||.+||.+||++||||+++|.|||++.
T Consensus 255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 255 FLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 999999999999999999999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=419.94 Aligned_cols=260 Identities=34% Similarity=0.590 Sum_probs=240.4
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|.+.+.||+|.||.||+++.+.+.+.||||.+.+....++..+.+.+|++|++.|+|||||.++++|.. ...+|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEE
Confidence 899999999999999999999999999999999999988888888999999999999999999999997754 4589999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
.|||.| +|..++...+ .++|+.++.+++|++.||.|||+++|+|||+||.||||...|.+|+||||+|+...... +
T Consensus 80 te~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 999987 9999998865 79999999999999999999999999999999999999999999999999999876544 4
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....-|||.|||||++.+.+|+..+|+||||||+|||+.|++||.......+...|...... .|...+..|.+|++.+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-PPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-CcccccHHHHHHHHHHh
Confidence 55678999999999999999999999999999999999999999999999999999877654 45589999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCchhhhh
Q 007266 240 RKNPEFRPSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~~~~~~ 265 (610)
.+||.+|.+..+++.|||.+.-+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~~~~ 261 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKINIA 261 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhhhhh
Confidence 99999999999999999998755433
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=395.20 Aligned_cols=256 Identities=29% Similarity=0.494 Sum_probs=235.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
|+|++.+.||+|.|+.|+++.+..+|+.+|+|++.........-+.+.+|+.|.+.|+|||||++.+.+.+.+ +.|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~-~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc-eeEEEE
Confidence 5789999999999999999999999999999999887777667788999999999999999999999987665 889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~DFGlak~~~~~~ 158 (610)
|+++|++|..-|.++. .++|..+..+++||+++|.|+|.+||||||+||+|+||-... -+||+|||+|..+....
T Consensus 90 e~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred ecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 9999999988776653 689999999999999999999999999999999999996543 49999999999998777
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC---CCCCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~---~~~p~~~s~~l~~LI 235 (610)
.....+|||.|||||++...+|+..+|||+.|||||.|+.|.+||.+.+...+++.|..+.+ .+.+..+++++++||
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence 88899999999999999999999999999999999999999999999999999999987654 335567899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
++||..||.+|+|+.|+|+|||+..
T Consensus 248 rrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHhccChhhhccHHHHhCCchhcc
Confidence 9999999999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=417.51 Aligned_cols=252 Identities=29% Similarity=0.542 Sum_probs=229.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
..|.....||+|+.|.||.++...+++.||||.+....+.. .+.+.+|+.+|+..+|+|||.++++|...+ .+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-eLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGD-ELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccc-eeEEEE
Confidence 46888999999999999999999999999999998766554 467899999999999999999999998774 799999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||++||+|.+.+... .++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.... ..
T Consensus 350 Eym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred eecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 999999999999875 58999999999999999999999999999999999999999999999999998876554 67
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC--CCCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--~~~p~~~s~~l~~LI~km 238 (610)
.+.+|||+|||||++....|+.++||||||+++.||+-|++||-..+...-+..|..... ...+..+|.+|++||.+|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 789999999999999999999999999999999999999999987776666666654433 335778999999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCC
Q 007266 239 LRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~ 259 (610)
|+.|+++|++|.|+|+||||+
T Consensus 507 L~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred hhcchhcCCCHHHHhcChhhh
Confidence 999999999999999999995
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=401.53 Aligned_cols=268 Identities=28% Similarity=0.467 Sum_probs=235.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||.|.-|+||+|+...++..+|+|++.+.... .....++..|.+||+.++||+++.++..|..+ .+.|++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-KYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-ceeEEE
Confidence 5688899999999999999999999999999999876544 33456788899999999999999999987655 599999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc----
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---- 156 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~---- 156 (610)
||||.||+|..+.+++.+..|+++.++.|+.+++.||+|||-.|||+|||||+||||..+|+|.|.||.|+.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998643200
Q ss_pred -------------------------------c----------------------cccccccCCCcccCCccccCCCCCCC
Q 007266 157 -------------------------------D----------------------DLASSVVGTPSYMCPELLADIPYGSK 183 (610)
Q Consensus 157 -------------------------------~----------------------~~~~~~vGTp~Y~APEvl~~~~yt~k 183 (610)
. ....+++||-.|+|||++.+..++.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 01235789999999999999999999
Q ss_pred ccccccchhHHhhhhcCccccccCHHHHHHHHhhccC-CCCCcccchHHHHHHHHhhcCCCCCCCC----HHHHhcCCCC
Q 007266 184 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-APLPTVYSGAFRGLVKSMLRKNPEFRPS----AAELLCHPHL 258 (610)
Q Consensus 184 sDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~-~~~p~~~s~~l~~LI~kmL~~dP~~RpS----a~eiL~Hp~f 258 (610)
+|||.||++||||+.|..||++.+..+.+.+|..... .+....++..+++||+++|.+||.+|.. |+||.+||||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccc
Confidence 9999999999999999999999998888877765443 3333468899999999999999999988 9999999999
Q ss_pred CchhhhhccccC
Q 007266 259 QPYVLGIHLKLN 270 (610)
Q Consensus 259 ~~~~~~~~~~~~ 270 (610)
+...|.+.....
T Consensus 396 ~gVnWaLir~~~ 407 (459)
T KOG0610|consen 396 EGVNWALIRCAR 407 (459)
T ss_pred cCCChhheeccC
Confidence 998888554433
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=398.44 Aligned_cols=256 Identities=27% Similarity=0.495 Sum_probs=227.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++.+.||+|+||.||+|++..+++.||+|.+..... .....+.+.+|+.+|++++||||+++++.+... ..+|+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-NRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-CEEEE
Confidence 5789999999999999999999999999999999975432 223446688999999999999999999988765 48899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||+.|++|.+++.... .++++.++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 96 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999999999998754 6899999999999999999999999999999999999999999999999999876433
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+.... ...+..++..+++||++||
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLL 250 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHh
Confidence 335689999999999999999999999999999999999999999988888887776543 3467778999999999999
Q ss_pred cCCCCCCCC-----HHHHhcCCCCCchh
Q 007266 240 RKNPEFRPS-----AAELLCHPHLQPYV 262 (610)
Q Consensus 240 ~~dP~~RpS-----a~eiL~Hp~f~~~~ 262 (610)
+.||.+|++ +++++.||||....
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 999999986 79999999998643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=394.27 Aligned_cols=253 Identities=29% Similarity=0.533 Sum_probs=221.4
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
+.||+|+||.||+|++..+++.||||++..... .......+.+|+.++++++||||+.+++.+... ..+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-DRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-CEEEEEEeCCCC
Confidence 479999999999999999999999999975432 223345677899999999999999999987655 488999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-ccccccccC
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVG 165 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~vG 165 (610)
++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 80 GELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 99999998754 689999999999999999999999999999999999999999999999999876322 233445789
Q ss_pred CCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCC
Q 007266 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 245 (610)
Q Consensus 166 Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~ 245 (610)
|+.|+|||++.+..|+.++|||||||++|||++|..||...+...+...+.... ..++..++.++.+||++||+.||++
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999999999999999999999999988887777765543 3467789999999999999999999
Q ss_pred CC-----CHHHHhcCCCCCchhhh
Q 007266 246 RP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 246 Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
|| ++.++++||||+...+.
T Consensus 237 R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 237 RLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred cCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99 89999999999875444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=390.39 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=226.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.++++++||||+++++.+.+. ..+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-RFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-CeEEEE
Confidence 589999999999999999999999999999999875432 223456688999999999999999999877654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||+.|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--c
Confidence 99999999999998754 6899999999999999999999999999999999999999999999999999875432 3
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+.... ..++..++..+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcC
Confidence 35689999999999999999999999999999999999999999988888777776543 34566789999999999999
Q ss_pred CCCCCCCC-----HHHHhcCCCCCchhh
Q 007266 241 KNPEFRPS-----AAELLCHPHLQPYVL 263 (610)
Q Consensus 241 ~dP~~RpS-----a~eiL~Hp~f~~~~~ 263 (610)
.||.+|++ ++++++||||+...+
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccCCCH
Confidence 99999995 999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=392.59 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=227.4
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~~~L 79 (610)
++.|+.++.|++|.||.||+++|+.+++.||+|+++.....+...-.-.+||.+|.+++|||||.+.++....+ +.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 46799999999999999999999999999999999877755554445679999999999999999999877543 56999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
|||||+ -+|..++.... .+|.+.+++-++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+...-
T Consensus 155 VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 999996 58988887754 579999999999999999999999999999999999999999999999999999986553
Q ss_pred ccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc------------
Q 007266 159 LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT------------ 225 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~------------ 225 (610)
.....+.|.||+|||++.+. .|+.++|+||+|||+.||+++.+.|.+....+++.+|......|...
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 45678999999999988765 58999999999999999999999999999999999987765544211
Q ss_pred -------------------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 226 -------------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 226 -------------------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+++...+|++.+|.+||.+|.||.|+|+|.||..
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 13467889999999999999999999999999976
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=397.45 Aligned_cols=259 Identities=29% Similarity=0.504 Sum_probs=221.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|..++||||+++++.|... .++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-NYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CeEEEE
Confidence 589999999999999999999999999999999975432 223445678899999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
||||.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+.+|.++|+|||+++.+....
T Consensus 80 ~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred ECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999999998754 68999999999999999999999999999999999999999999999999987542211
Q ss_pred -------------------------------------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCc
Q 007266 159 -------------------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 201 (610)
Q Consensus 159 -------------------------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~ 201 (610)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 1123579999999999999999999999999999999999999
Q ss_pred cccccCHHHHHHHHhhcc---CCCCCcccchHHHHHHHHhhcCCCCCCCC---HHHHhcCCCCCchhhh
Q 007266 202 AFKAFDMQALINKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEFRPS---AAELLCHPHLQPYVLG 264 (610)
Q Consensus 202 PF~~~~~~~l~~~I~~~~---~~~~p~~~s~~l~~LI~kmL~~dP~~RpS---a~eiL~Hp~f~~~~~~ 264 (610)
||...+....+..+.... ..+....+++.+++||.+||. +|.+|++ ++++|.||||....+.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 999888777766664321 122233578999999999997 9999987 9999999999876443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=384.54 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=221.2
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|++++.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|+||+.+++.|...+ .+|+||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-eEEEEE
Confidence 489999999999999999999999999999998754322 223345778999999999999999999876654 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 99999999988876555568999999999999999999999999999999999999999999999999998764444445
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHH---HHHhhccCCCCCcccchHHHHHHHHh
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALI---NKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~---~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
..+||+.|+|||++.+..|+.++|||||||++|+|++|..||......... ...........+..++..+.+||++|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999876532222 22222233345667899999999999
Q ss_pred hcCCCCCCCC-----HHHHhcCCCCCchh
Q 007266 239 LRKNPEFRPS-----AAELLCHPHLQPYV 262 (610)
Q Consensus 239 L~~dP~~RpS-----a~eiL~Hp~f~~~~ 262 (610)
|+.||++||+ ++++++||||+...
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 9999999997 99999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=397.80 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=221.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.++.+++|+||+++++.+.+. ..+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-LNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CeEEEE
Confidence 689999999999999999999999999999999975432 223445688899999999999999999987655 488999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
||||.||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 80 MEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999999998754 68999999999999999999999999999999999999999999999999987543211
Q ss_pred ----------------------------------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccc
Q 007266 159 ----------------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 204 (610)
Q Consensus 159 ----------------------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~ 204 (610)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 1134689999999999999999999999999999999999999999
Q ss_pred ccCHHHHHHHHhhc---cCCCCCcccchHHHHHHHHhhcCCCCC---CCCHHHHhcCCCCCchhhhh
Q 007266 205 AFDMQALINKINKS---IVAPLPTVYSGAFRGLVKSMLRKNPEF---RPSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 205 ~~~~~~l~~~I~~~---~~~~~p~~~s~~l~~LI~kmL~~dP~~---RpSa~eiL~Hp~f~~~~~~~ 265 (610)
+.+..+.+.++... ...+....+++++++||.+|+. +|.+ ||+++||++||||+...+..
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 98888888777542 1122223478999999999886 4544 58999999999999865443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=396.90 Aligned_cols=260 Identities=27% Similarity=0.502 Sum_probs=221.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH------------HHHHHHHHHHHHHhcCCCceeeeee
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR------------ARRSAHQEMELISRVRNPFIVEYKD 68 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~------------~~~~l~~Ei~iL~~L~HpnIV~l~~ 68 (610)
+++|++++.||+|.||.|-+|++..+++.||||++.+...... ..+...+||.||++|.|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 5899999999999999999999999999999999975433211 2367899999999999999999999
Q ss_pred eEeec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeee
Q 007266 69 SWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 147 (610)
Q Consensus 69 ~~~~~-~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~D 147 (610)
+.-+. ...+|||+|||..|.+...-.. ...|++.+++.|++.++.||+|||.+|||||||||+|+||+.+|.|||+|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 75433 3589999999998887543221 12389999999999999999999999999999999999999999999999
Q ss_pred ccccccc------ccccccccccCCCcccCCccccCC---CC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhh
Q 007266 148 FGLAKML------ISDDLASSVVGTPSYMCPELLADI---PY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK 217 (610)
Q Consensus 148 FGlak~~------~~~~~~~~~vGTp~Y~APEvl~~~---~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~ 217 (610)
||.+... ..++.....+|||.|+|||.+.++ .| +.+.|||||||.||-|+.|+.||-+....+++.+|..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9998866 222334458999999999998763 33 6789999999999999999999999999999999976
Q ss_pred ccC-CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 218 SIV-APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 218 ~~~-~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
... .|....+...+++||++||++||++|++..+|..|||+....
T Consensus 334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 543 333334789999999999999999999999999999997653
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=392.83 Aligned_cols=259 Identities=32% Similarity=0.544 Sum_probs=225.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|++..+++.||||++....... .....+.+|+.++..++|+||+++++.+.+. .++|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-EHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-CeEEEE
Confidence 58999999999999999999999999999999997543322 3445688999999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|||+.|++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 80 MEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999998763 68999999999999999999999999999999999999999999999999997654332
Q ss_pred ----------------------------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHH
Q 007266 159 ----------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA 210 (610)
Q Consensus 159 ----------------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~ 210 (610)
.....+||+.|+|||++.+..++.++|||||||+||+|++|..||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2345689999999999999999999999999999999999999999888777
Q ss_pred HHHHHhh---ccCCCCCcccchHHHHHHHHhhcCCCCCCCC-HHHHhcCCCCCchhhh
Q 007266 211 LINKINK---SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-AAELLCHPHLQPYVLG 264 (610)
Q Consensus 211 l~~~I~~---~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpS-a~eiL~Hp~f~~~~~~ 264 (610)
...++.. ....+....++..+++||.+||. ||.+|++ ++++|+||||+...+.
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence 7766654 22222333469999999999997 9999999 9999999999875443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=395.08 Aligned_cols=258 Identities=25% Similarity=0.513 Sum_probs=226.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCC-eEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHER-KKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~-~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|++++.||+|+||.||+|.+..++ ..||+|.+..... .....+.+.+|+.+++.++||||+++++++... ..+|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEE
Confidence 368999999999999999999987655 7899999865432 223445688999999999999999999988665 4889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999999999998754 6899999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+..... ..|..++..++++|++|
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~ 262 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKHLMKKL 262 (340)
T ss_pred -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHH
Confidence 3457899999999999998899999999999999999999999999888888887766543 35777899999999999
Q ss_pred hcCCCCCCC-----CHHHHhcCCCCCchhhh
Q 007266 239 LRKNPEFRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 239 L~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
|+.||.+|+ +++++++||||....+.
T Consensus 263 l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 263 LSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred cccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999995 89999999999875443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=396.66 Aligned_cols=258 Identities=27% Similarity=0.482 Sum_probs=218.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++.+..+++.||||++..... .......+.+|++++++++|||||+++++|.+. .++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-QYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CeeEEE
Confidence 589999999999999999999999999999999865432 233446688999999999999999999987655 489999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|||+.||+|.+++.... .+++..++.|+.||+.||+|||++||+||||||+||||+.++.++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 80 MEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999999998654 68999999999999999999999999999999999999999999999999986321100
Q ss_pred ----------------------------------------------ccccccCCCcccCCccccCCCCCCCccccccchh
Q 007266 159 ----------------------------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC 192 (610)
Q Consensus 159 ----------------------------------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~i 192 (610)
.....+||+.|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0113579999999999999999999999999999
Q ss_pred HHhhhhcCccccccCHHHHHHHHhhc---cCCCCCcccchHHHHHHHHhhcCCCCCC---CCHHHHhcCCCCCchhh
Q 007266 193 VYEMSAQKAAFKAFDMQALINKINKS---IVAPLPTVYSGAFRGLVKSMLRKNPEFR---PSAAELLCHPHLQPYVL 263 (610)
Q Consensus 193 LyeLltG~~PF~~~~~~~l~~~I~~~---~~~~~p~~~s~~l~~LI~kmL~~dP~~R---pSa~eiL~Hp~f~~~~~ 263 (610)
||||++|.+||.+.+..+.+..+... ...+....++.++++||.+||. +|.+| +++.+++.||||....+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999988877776666432 2222233578999999999998 67765 59999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=381.46 Aligned_cols=254 Identities=28% Similarity=0.514 Sum_probs=214.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++++..+++.||+|++..........+.+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-GKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-CEEEEEE
Confidence 589999999999999999999999999999999976655555566788999999999999999999987654 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||+.++.+..+.... ..++++.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 80 EYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999887666544332 368999999999999999999999999999999999999999999999999998764322 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC-------------------
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------------------- 220 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~------------------- 220 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 3346799999999999998999999999999999999999999988765444333222110
Q ss_pred -CC-----------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 221 -AP-----------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 221 -~~-----------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.+ ....++..+.+||++||+.||++|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 011367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=388.50 Aligned_cols=257 Identities=23% Similarity=0.449 Sum_probs=223.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|++..+++.||+|++...... ......+.+|+.++..++||||+++++.+... .++|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-EYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-CEEEEE
Confidence 5799999999999999999999999999999999754322 22345678899999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence 99999999999998654 689999999999999999999999999999999999999999999999999976543 34
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc---CCCCC----cccchHHHH
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLP----TVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~---~~~~p----~~~s~~l~~ 233 (610)
...+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.+..+.+..+.... ..+.. ..++.++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 56789999999999999999999999999999999999999999988877766654321 11111 146899999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
||.+||..+|.+||+++++++||||....+
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=380.77 Aligned_cols=256 Identities=29% Similarity=0.445 Sum_probs=215.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-CCeEEEEEEEccccccHHHHHHHHHHHHHHHhc---CCCceeeeeeeEee----c
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-ERKKYVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVE----K 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIV~l~~~~~~----~ 73 (610)
++|++++.||+|+||.||+|++.. ++..||+|.+............+.+|+.+++.+ .||||+++++.+.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999864 578899999876544333334456677777665 69999999998752 3
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
+..+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999996 6999999876555689999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC----------
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---------- 223 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---------- 223 (610)
...........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+..+......+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 6555555667899999999999988999999999999999999999999998887776666643322111
Q ss_pred ----------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 224 ----------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 224 ----------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
...++..+++||.+||+.||++||++.|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 12357788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=395.16 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=218.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
.+|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+|++++|+||+++++.|... ..+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CEEEEE
Confidence 479999999999999999999999999999999865332 222345678999999999999999999988665 589999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--- 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--- 157 (610)
||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999998754 6899999999999999999999999999999999999999999999999997532100
Q ss_pred -----------------------------------------cccccccCCCcccCCccccCCCCCCCccccccchhHHhh
Q 007266 158 -----------------------------------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196 (610)
Q Consensus 158 -----------------------------------------~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeL 196 (610)
......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 011245899999999999999999999999999999999
Q ss_pred hhcCccccccCHHHHHHHHhhc---cCCCCCcccchHHHHHHHHhhcCCCCCCC---CHHHHhcCCCCCchhh
Q 007266 197 SAQKAAFKAFDMQALINKINKS---IVAPLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQPYVL 263 (610)
Q Consensus 197 ltG~~PF~~~~~~~l~~~I~~~---~~~~~p~~~s~~l~~LI~kmL~~dP~~Rp---Sa~eiL~Hp~f~~~~~ 263 (610)
++|..||.+.+..+....+... ...+....++.++.+||.+|+ .+|.+|+ ++.++++||||+...+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 9999999988876665555332 122223457899999999977 5999999 9999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=394.45 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=218.7
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.++++++|+||+++++.+.+. ..+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-CEEEEEE
Confidence 69999999999999999999999999999999975432 233456788999999999999999999988765 4899999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc----
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---- 157 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~---- 157 (610)
|||.||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999998754 6899999999999999999999999999999999999999999999999997543100
Q ss_pred --------------------------------------------cccccccCCCcccCCccccCCCCCCCccccccchhH
Q 007266 158 --------------------------------------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCV 193 (610)
Q Consensus 158 --------------------------------------------~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iL 193 (610)
......+||+.|+|||++.+..|+.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 012346899999999999999999999999999999
Q ss_pred HhhhhcCccccccCHHHHHHHHhh---ccCCCCCcccchHHHHHHHHhhcC--CCCCCCCHHHHhcCCCCCchhhh
Q 007266 194 YEMSAQKAAFKAFDMQALINKINK---SIVAPLPTVYSGAFRGLVKSMLRK--NPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 194 yeLltG~~PF~~~~~~~l~~~I~~---~~~~~~p~~~s~~l~~LI~kmL~~--dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
|||++|..||...+.......+.. ....+....++.++.+||.+||.. ++..|++++++++||||+...+.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 999999999988776665555432 122233345899999999997755 44459999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=394.89 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=219.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
.+|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.++++++|+|||++++.|... ..+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-CEEEEE
Confidence 379999999999999999999999999999999975432 223456788999999999999999999988765 489999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--- 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--- 157 (610)
||||.||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 80 ~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 80 MDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999999998754 6899999999999999999999999999999999999999999999999997532100
Q ss_pred ---------------------------------------------cccccccCCCcccCCccccCCCCCCCccccccchh
Q 007266 158 ---------------------------------------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC 192 (610)
Q Consensus 158 ---------------------------------------------~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~i 192 (610)
......+||+.|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 01124589999999999999999999999999999
Q ss_pred HHhhhhcCccccccCHHHHHHHHhhc---cCCCCCcccchHHHHHHHHhhcCCCCCCCC---HHHHhcCCCCCchhh
Q 007266 193 VYEMSAQKAAFKAFDMQALINKINKS---IVAPLPTVYSGAFRGLVKSMLRKNPEFRPS---AAELLCHPHLQPYVL 263 (610)
Q Consensus 193 LyeLltG~~PF~~~~~~~l~~~I~~~---~~~~~p~~~s~~l~~LI~kmL~~dP~~RpS---a~eiL~Hp~f~~~~~ 263 (610)
||||++|.+||.+.+.......+... ...+....+++++.++|.+|+ .+|.+|++ ++++++||||+...+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 99999999999988776655555432 222333568999999999986 59999987 999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=386.07 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=222.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++.+.||+|+||.||++++..+++.||+|.+..... .......+.+|+.+++.++|+||+++++.+... ..+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-DNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CeEEEE
Confidence 589999999999999999999999999999999976543 233456788999999999999999999877654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|||++|++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 80 MEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred ECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999998753 368999999999999999999999999999999999999999999999999998764332
Q ss_pred ccccccCCCcccCCcccc------CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc---CCCCCcccch
Q 007266 159 LASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSG 229 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~------~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~---~~~~p~~~s~ 229 (610)
.....+||+.|+|||++. ...++.++|||||||++|+|++|..||........+..+.... ..+....++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223457999999999986 4567899999999999999999999999888777776664322 2222335789
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
.+.+||.+||. +|.+||+++++++||||+...+
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 99999999998 9999999999999999987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=380.91 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=214.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||.|+||.||++++..++..||+|.+...... .....+.+|+.++++++||||+++++++... ...|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTE-RCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEE
Confidence 68999999999999999999999999999999999754322 2234577899999999999999999987655 478999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
|||+.| +|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 82 FEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred EeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 999975 8999887643 357999999999999999999999999999999999999999999999999987653322 2
Q ss_pred cccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----------------
Q 007266 160 ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------- 222 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---------------- 222 (610)
....+|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 345678999999998865 568999999999999999999999999887766655543322111
Q ss_pred -------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 -------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 -------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....++.++++||++||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 012357789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=386.64 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=212.8
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVC 78 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~~ 78 (610)
+|++.+.||+|+||.||++++..++..||||.+............+.+|+.++++++||||+++++++.... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999998754444444456889999999999999999999876432 3589
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999999 568999987654 68999999999999999999999999999999999999999999999999997643221
Q ss_pred ----ccccccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC------------
Q 007266 159 ----LASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------------ 220 (610)
Q Consensus 159 ----~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~------------ 220 (610)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2245689999999999876 6789999999999999999999999987765443332211111
Q ss_pred ---------------CCC---CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 221 ---------------APL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 221 ---------------~~~---p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+. ...++..+.+||.+||+.||++||+++|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 000 11356788999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=383.84 Aligned_cols=248 Identities=30% Similarity=0.524 Sum_probs=218.1
Q ss_pred ecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCC
Q 007266 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 88 (610)
Q Consensus 10 LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Ggs 88 (610)
||+|+||.||++++..+++.||+|.+..... .......+.+|+.+|.+++||||+++++.+... ..+|+||||+.|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-EKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-CeEEEEEcCCCCCc
Confidence 7999999999999999999999999975432 233445678899999999999999999887654 58899999999999
Q ss_pred HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-ccccccccCCC
Q 007266 89 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTP 167 (610)
Q Consensus 89 L~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~vGTp 167 (610)
|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... .......+||+
T Consensus 80 L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 80 LFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 999998754 689999999999999999999999999999999999999999999999999876432 22344578999
Q ss_pred cccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCC
Q 007266 168 SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP 247 (610)
Q Consensus 168 ~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~Rp 247 (610)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+.... ..++..++..+++||.+||..||.+||
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence 9999999999999999999999999999999999999988888777776543 345677899999999999999999997
Q ss_pred ---CHHHHhcCCCCCch
Q 007266 248 ---SAAELLCHPHLQPY 261 (610)
Q Consensus 248 ---Sa~eiL~Hp~f~~~ 261 (610)
++.++|.||||...
T Consensus 237 ~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 237 GYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCCHHHHHcCCCcCCC
Confidence 58999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=389.12 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=216.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----c
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----C 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 75 (610)
+++|++++.||+|+||.||++.+..++..||+|.+............+.+|+.+++.++||||++++++|...+ .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999999999999999999765555555667889999999999999999999886543 3
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999965 66666643 47899999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-------------
Q 007266 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------- 222 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------- 222 (610)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 5445556789999999999999999999999999999999999999998776544433322111100
Q ss_pred ----------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 ----------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 ----------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.....+..+++||.+||..||++|||+.|+|+||||..+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 1112457889999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=386.05 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=228.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCc-eeeeeeeEeecCc----
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF-IVEYKDSWVEKGC---- 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~---- 75 (610)
|+.|+.+++||+|+||+||+|+++.+|+.||+|+++.....+.......+|+-+|+.++|+| ||.+++++...+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34678889999999999999999999999999999988765445566789999999999999 9999998876653
Q ss_pred -EEEEEEeecCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccc
Q 007266 76 -YVCIIIGYCEGGDMAEAIKKANG--VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 76 -~~~LVmEy~~GgsL~~~Ik~~~~--~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
.+++|+||++ .+|..++..... ..++...++.+++||+.||+|||++||+||||||.||||+.+|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 8899999994 699999987553 357889999999999999999999999999999999999999999999999999
Q ss_pred ccc-cccccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcc----
Q 007266 153 MLI-SDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV---- 226 (610)
Q Consensus 153 ~~~-~~~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~---- 226 (610)
... ........++|.+|+|||++.+. .|+..+||||+|||++||+++.+.|.+....+++..|......|....
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 875 33446778999999999998876 789999999999999999999999999999888888876554442111
Q ss_pred -------------------------cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 227 -------------------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 227 -------------------------~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.++...+++.+||+.+|.+|.|++.+|.||||+..-
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 123688999999999999999999999999998753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=390.48 Aligned_cols=253 Identities=27% Similarity=0.558 Sum_probs=233.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
.+|++.+.||+|.||.|-++.+...|+.||||.|+++...++ ..-.+.+||+||..|+|||||.++++|... ..+.||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-dKIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-DKIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-ceEEEE
Confidence 479999999999999999999999999999999998775443 445688999999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||..||.|+++|.+.+ .|+|..++.|++||+.|+.|+|.++++|||||.+|||||.++++||+|||++..+....+.
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 99999999999999876 7999999999999999999999999999999999999999999999999999999988899
Q ss_pred ccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
.++||+|-|++||++++.+| +..+|-|||||+||.|+.|..||.+.+...+...|..+-+...+ -+..+..||++||
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~--~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE--TPSDASGLIRWML 287 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC--CCchHHHHHHHHH
Confidence 99999999999999999999 67899999999999999999999999999999999877654322 3567889999999
Q ss_pred cCCCCCCCCHHHHhcCCCCC
Q 007266 240 RKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~ 259 (610)
.+||++|.|+++|-.|=|+.
T Consensus 288 mVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHWWVN 307 (668)
T ss_pred hcCcccchhHHHHhhhheee
Confidence 99999999999999998875
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=388.94 Aligned_cols=259 Identities=28% Similarity=0.464 Sum_probs=221.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..++|+||+++++.|... ..+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-RNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence 589999999999999999999999999999999975332 233456688899999999999999999987655 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
||||.||+|.+++.+.. .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 80 MEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999999998754 68999999999999999999999999999999999999999999999999987542110
Q ss_pred ----------------------------------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccc
Q 007266 159 ----------------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 204 (610)
Q Consensus 159 ----------------------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~ 204 (610)
.....+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 1124689999999999999999999999999999999999999999
Q ss_pred ccCHHHHHHHHhhcc---CCCCCcccchHHHHHHHHhhcCCCCCCC---CHHHHhcCCCCCchhhh
Q 007266 205 AFDMQALINKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 205 ~~~~~~l~~~I~~~~---~~~~p~~~s~~l~~LI~kmL~~dP~~Rp---Sa~eiL~Hp~f~~~~~~ 264 (610)
+.+....+..+.... ..+....++.++++||.+|+. ||.+|+ +++++++||||+...+.
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 988887777765421 122223478999999999874 999998 58999999999986544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=395.06 Aligned_cols=256 Identities=30% Similarity=0.545 Sum_probs=232.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~L 79 (610)
+.|++.+.||+|.||.||+|+++.+|+.+|+|.+.+..... .....+.+|+.||+++. |||||.+++.|.... .+++
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~~l 113 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SVYL 113 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eEEE
Confidence 47999999999999999999999999999999997655432 34567899999999998 999999999887665 8899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC----CCeeeeecccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD----QDIRLGDFGLAKMLI 155 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~----g~vKL~DFGlak~~~ 155 (610)
|||+|.||.|.+.|... .++|..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999999886 39999999999999999999999999999999999999754 469999999999988
Q ss_pred cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc---CCCCCcccchHHH
Q 007266 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSGAFR 232 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~---~~~~p~~~s~~l~ 232 (610)
........|||+.|+|||++.+.+|+..+||||+||++|.|++|.+||.+.........|.... ..+.+..++..++
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK 270 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence 7777889999999999999999999999999999999999999999999999888888887663 3445667899999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+||++||..||..|+++.++|+|||++..
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999998753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=382.70 Aligned_cols=253 Identities=30% Similarity=0.547 Sum_probs=220.1
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
+.||+|+||.||++++..+|..||+|++..... .......+.+|+.+++.++||||+++++.|... ..+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCC
Confidence 479999999999999999999999999975432 223345677899999999999999999987655 488999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cccccccC
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVG 165 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~~~~vG 165 (610)
++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......+|
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 80 GELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 99999887654 6899999999999999999999999999999999999999999999999998764222 23345689
Q ss_pred CCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCC
Q 007266 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 245 (610)
Q Consensus 166 Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~ 245 (610)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... ..+..+++++++||.+||+.||++
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999999999999999999999998888777776654332 356788999999999999999999
Q ss_pred CC-----CHHHHhcCCCCCchhhh
Q 007266 246 RP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 246 Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
|+ ++.++++|+||....+.
T Consensus 237 R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 237 RLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCCCHH
Confidence 98 89999999999875443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=381.46 Aligned_cols=257 Identities=25% Similarity=0.473 Sum_probs=222.0
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCc-eeeeeeeEeecCcEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPF-IVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~~~~LV 80 (610)
+|++++.||+|+||.||+|++..+++.||+|++..... .....+.+..|+.++..+.|++ |+.+++.+.. +..+|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence 69999999999999999999999999999999975432 2234456788999999998765 6677776654 4588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-cccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~~~ 159 (610)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ....
T Consensus 80 ~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 80 MEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999999997754 68999999999999999999999999999999999999999999999999987532 2223
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...++..+.... ...+..++..+.+||.+||
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l 236 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLL 236 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHh
Confidence 445689999999999999999999999999999999999999999998888888876544 3456778999999999999
Q ss_pred cCCCCCCCCH-----HHHhcCCCCCchhh
Q 007266 240 RKNPEFRPSA-----AELLCHPHLQPYVL 263 (610)
Q Consensus 240 ~~dP~~RpSa-----~eiL~Hp~f~~~~~ 263 (610)
..||.+|+++ +++++||||+...+
T Consensus 237 ~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 237 TKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999999976 89999999987543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=384.90 Aligned_cols=252 Identities=30% Similarity=0.538 Sum_probs=219.1
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
+.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++.+... ..+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-DRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CEEEEEEeCCCC
Confidence 479999999999999999999999999975432 223345678899999999999999999877655 488999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-ccccccccC
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVG 165 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~vG 165 (610)
++|..++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus 80 g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 80 GELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 99999887654 689999999999999999999999999999999999999999999999999876432 223345689
Q ss_pred CCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCC
Q 007266 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 245 (610)
Q Consensus 166 Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~ 245 (610)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ..++..++.++.+||++||+.||.+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHHH
Confidence 999999999999999999999999999999999999999888777776665433 3467788999999999999999999
Q ss_pred CC-----CHHHHhcCCCCCchhh
Q 007266 246 RP-----SAAELLCHPHLQPYVL 263 (610)
Q Consensus 246 Rp-----Sa~eiL~Hp~f~~~~~ 263 (610)
|+ ++.++++||||....+
T Consensus 237 R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 237 RLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred cCCCCCCCHHHHhcCCCcCCCCH
Confidence 97 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=389.03 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=219.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----c
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----C 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 75 (610)
+++|++++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++.+...+ .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999999999999999999765555555667889999999999999999998876432 3
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+|+||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 5799999996 477777754 47899999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC-----------
Q 007266 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP----------- 224 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p----------- 224 (610)
........+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.+..+.+.++......+.+
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 555556678999999999999999999999999999999999999999988776666555432222111
Q ss_pred ------------------------------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 225 ------------------------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 225 ------------------------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
...+..+++||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 11245789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=372.70 Aligned_cols=255 Identities=31% Similarity=0.461 Sum_probs=213.3
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc---CCCceeeeeeeEeec----Cc
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVEK----GC 75 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIV~l~~~~~~~----~~ 75 (610)
+|++++.||+|+||.||+|++..+++.||+|.+............+.+|+.+++.+ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999876443322223355677766655 799999999987642 34
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 6899999997 589998887555568999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-------------
Q 007266 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------- 222 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------- 222 (610)
.........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+.++......+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 5444556789999999999999899999999999999999999999998877666555553321100
Q ss_pred -------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 -------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 -------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 112357788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=382.60 Aligned_cols=285 Identities=28% Similarity=0.514 Sum_probs=246.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
|++|+.+++||+|.||.|.+|+.+.+++.||||++++.....+ ....-..|-++|+..+||++..+..+|+..+ .+|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-rlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-RLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-eEEE
Confidence 7899999999999999999999999999999999986553322 2233456889999999999999999988765 8999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc-cccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDD 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~-~~~~ 158 (610)
||||.+||.|.-.+.+.. .|+|+..+.+-.+|+.||.|||+++||+||||.+|+||+++|+|||+|||+|+.- ....
T Consensus 246 VMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 999999999999888754 7999999999999999999999999999999999999999999999999999874 3345
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
...++||||.|+|||++.+..|+.++|+|.+||+||||++|.+||...+...+++.|.-... .+|..++++++.|+..+
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFPr~ls~eAktLLsGL 402 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-KFPRTLSPEAKTLLSGL 402 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-cCCccCCHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999999999999998876544 47889999999999999
Q ss_pred hcCCCCCCC-----CHHHHhcCCCCCchhhhhc--cccCCCCCCCCCCCCCCcccccc
Q 007266 239 LRKNPEFRP-----SAAELLCHPHLQPYVLGIH--LKLNGPRRNTFPLEWSDSNFKKT 289 (610)
Q Consensus 239 L~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~~~--~~~~~p~~~~~~~~~~~s~~~~~ 289 (610)
|.+||.+|. .|.||.+|+||....|.-. .++..|.++....+-+.+-|++.
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~E 460 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEE 460 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhh
Confidence 999999995 4899999999998877643 34455555544444444444443
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=388.91 Aligned_cols=257 Identities=26% Similarity=0.488 Sum_probs=220.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++++..+++.||+|.+...... ......+.+|+.+++.++||||+++++.+.. +..+|+|
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~lv 121 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLYMV 121 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEEEE
Confidence 5799999999999999999999999999999999653322 2233457789999999999999999987765 4589999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 9999999999998764 58999999999999999999999999999999999999999999999999998764332
Q ss_pred ccccccCCCcccCCccccCC----CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc---CCCCCcccchHH
Q 007266 159 LASSVVGTPSYMCPELLADI----PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSGAF 231 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~----~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~---~~~~p~~~s~~l 231 (610)
.....+||+.|+|||++.+. .++.++|||||||+||+|++|.+||.+.+....+..+.... ..+....++.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 23456899999999998653 47889999999999999999999999998887777775432 222233579999
Q ss_pred HHHHHHhhcCCCCC--CCCHHHHhcCCCCCchh
Q 007266 232 RGLVKSMLRKNPEF--RPSAAELLCHPHLQPYV 262 (610)
Q Consensus 232 ~~LI~kmL~~dP~~--RpSa~eiL~Hp~f~~~~ 262 (610)
++||++||+.+|.+ |++++++++||||+...
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 99999999999988 99999999999998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=387.17 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=218.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----c
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----C 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 75 (610)
+++|++++.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||+++++.|...+ .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47899999999999999999999999999999999766555556677889999999999999999999876433 3
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+|+||||+++ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 57899999965 67777654 48899999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-------------
Q 007266 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------- 222 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------- 222 (610)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 5555566789999999999999999999999999999999999999998877554443332211110
Q ss_pred ----------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 ----------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 ----------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.+...+..+++||.+||+.||++|||+.|+|+||||+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 1112356789999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=388.17 Aligned_cols=256 Identities=27% Similarity=0.486 Sum_probs=218.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++++..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+... ..+|+|
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~~lv 121 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-KYLYMV 121 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence 589999999999999999999999999999999865332 222345678899999999999999999987654 589999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
||||.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 9999999999999764 58999999999999999999999999999999999999999999999999998764332
Q ss_pred ccccccCCCcccCCccccCCC----CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc---CCCCCcccchHH
Q 007266 159 LASSVVGTPSYMCPELLADIP----YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSGAF 231 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~----yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~---~~~~p~~~s~~l 231 (610)
.....+||+.|+|||++.+.. ++.++|||||||+||+|++|..||.+.+....+..+.... ..+....++..+
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 234678999999999987543 7889999999999999999999999988877777775432 222233579999
Q ss_pred HHHHHHhhcCCCCC--CCCHHHHhcCCCCCch
Q 007266 232 RGLVKSMLRKNPEF--RPSAAELLCHPHLQPY 261 (610)
Q Consensus 232 ~~LI~kmL~~dP~~--RpSa~eiL~Hp~f~~~ 261 (610)
+++|.+||..++.+ |++++|+++||||+..
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999866544 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=383.08 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=224.0
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc----EEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC----YVC 78 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~----~~~ 78 (610)
.|+-.+++|.|+||.||.+....+++.+|||++..+..- -.+|+++|+++.|||||+++.+|..... +..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 478899999999999999999999999999999755432 3479999999999999999998875432 456
Q ss_pred EEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-CCeeeeecccccccc
Q 007266 79 IIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLI 155 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-g~vKL~DFGlak~~~ 155 (610)
+||||+. .+|.+.++. ..+..++.-.++.+++||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 8999995 699999984 234578999999999999999999999999999999999999987 889999999999999
Q ss_pred cccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC-----------
Q 007266 156 SDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL----------- 223 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~----------- 223 (610)
.++...+++.|+.|+|||++.+ ..|+.+.||||.||||.||+.|++.|.+.+..+++..|.+.++.|.
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 9999999999999999998876 5699999999999999999999999999998888887766554441
Q ss_pred -----------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 224 -----------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 224 -----------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
....++++.+|+.++|.++|.+|.++.|+|.||||+.....
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 22356789999999999999999999999999999886544
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=360.70 Aligned_cols=256 Identities=45% Similarity=0.884 Sum_probs=229.0
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++++.||+|++|.||++.+..+++.||+|.+..........+.+.+|++++++++|+|++++++.+...+..+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999999999999999976655555566788999999999999999999987766667899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~~ 161 (610)
|+.+++|.+++....+..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 999999999998755556899999999999999999999999999999999999999999999999999776432 2334
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+........+..++..+.+||.+||+.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK 240 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhcc
Confidence 56789999999999999999999999999999999999999998887777666666666566778899999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 007266 242 NPEFRPSAAELLCHPHL 258 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f 258 (610)
||+.||++.++++||||
T Consensus 241 ~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 241 RPEKRPSVKSILRQPYI 257 (257)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=382.03 Aligned_cols=253 Identities=28% Similarity=0.538 Sum_probs=218.9
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
+.||+|+||.||++.+..+++.||+|++..... .......+.+|++++..++||||+.+++.+... ..+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-CEEEEEEeCCCC
Confidence 479999999999999999999999999975432 223345677899999999999999999877655 488999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeeccccccccc-cccccccc
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVV 164 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~v 164 (610)
++|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++.... .......+
T Consensus 80 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 80 GELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 99999887654 68999999999999999999998 7999999999999999999999999999875432 22334568
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+.... ...+..++.++.+||++||+.||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHhhcCHH
Confidence 9999999999999999999999999999999999999999888877777765443 335677899999999999999999
Q ss_pred CCC-----CHHHHhcCCCCCchhhh
Q 007266 245 FRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 245 ~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
+|+ ++.++++||||....+.
T Consensus 237 ~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 237 QRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred HhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 997 99999999999875433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=384.01 Aligned_cols=258 Identities=29% Similarity=0.505 Sum_probs=225.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++...||.|..++||+|+....++.||||++.....+.. .+.+.+|+..|+.++||||++++.+|..+. .+|+||
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-~LWvVm 103 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS-ELWVVM 103 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc-eeEEee
Confidence 689999999999999999999999999999999998776655 678999999999999999999999998765 799999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--- 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--- 158 (610)
.||.+|++.++++..-...|+|..|..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 99999999999998766679999999999999999999999999999999999999999999999999765543221
Q ss_pred --ccccccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCccccccCHHHH-HHHHhhccCCCC--------Cc
Q 007266 159 --LASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL-INKINKSIVAPL--------PT 225 (610)
Q Consensus 159 --~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l-~~~I~~~~~~~~--------p~ 225 (610)
...+++|||+|||||++.. ..|+.|+||||||+...||+.|..||....+..+ +.++......+. ..
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k 263 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDK 263 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhh
Confidence 1267899999999999653 5699999999999999999999999988876554 455544433221 22
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.++..|+.+|..||++||.+||||.++|+|+||+..
T Consensus 264 ~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 264 KFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred hhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 367789999999999999999999999999999863
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=380.47 Aligned_cols=254 Identities=28% Similarity=0.531 Sum_probs=219.3
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHH---HhcCCCceeeeeeeEeecCcEEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELI---SRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL---~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
|++++.||+|+||.||++.+..+++.||||.+..... .....+.+.+|++++ +.++||||+++++++... ..+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-DHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-CEEEE
Confidence 7899999999999999999999999999999975432 122344566676655 567899999999987654 58899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DD 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~ 158 (610)
||||+.|++|...+... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ..
T Consensus 80 v~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 80 VMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999999888653 689999999999999999999999999999999999999999999999999875322 23
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ..+..++..+.+||.+|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~ 235 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRL 235 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999888888877765443 35667899999999999
Q ss_pred hcCCCCCCC-----CHHHHhcCCCCCchh
Q 007266 239 LRKNPEFRP-----SAAELLCHPHLQPYV 262 (610)
Q Consensus 239 L~~dP~~Rp-----Sa~eiL~Hp~f~~~~ 262 (610)
|+.||.+|| ++.++++||||+...
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 999999999 799999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=380.24 Aligned_cols=252 Identities=29% Similarity=0.512 Sum_probs=219.0
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+|+++.+++.||+|++..... .....+.+..|..++..+ +||||+++++.+... ..+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-DRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-CEEEEEEcCCC
Confidence 479999999999999999999999999975432 223345677888888876 699999999987654 58899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~v 164 (610)
|++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... .......+
T Consensus 80 ~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 80 GGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 999999988754 689999999999999999999999999999999999999999999999999876422 23344568
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...++..+..... ..+..++.++++||++||+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~ 236 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMTKNPT 236 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHH
Confidence 99999999999999999999999999999999999999999998888888765443 35667899999999999999999
Q ss_pred CCCCH------HHHhcCCCCCchhh
Q 007266 245 FRPSA------AELLCHPHLQPYVL 263 (610)
Q Consensus 245 ~RpSa------~eiL~Hp~f~~~~~ 263 (610)
+|+++ +++++||||+...+
T Consensus 237 ~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 237 MRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred HCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 99998 99999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=375.20 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=209.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|++..+++.||+|++....... ....+.+|+.+++.++||||+++++++... ...|+||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEE
Confidence 78999999999999999999999999999999997543322 223467899999999999999999987655 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
||+. ++|.+++.... ..++++.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 83 EYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred ECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 9995 68888887643 35899999999999999999999999999999999999999999999999998754322 233
Q ss_pred ccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccC-HHHHHHHHhhccCCC----------------
Q 007266 161 SSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAP---------------- 222 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~~~~~~~---------------- 222 (610)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ....+..+......+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 45678999999998865 457889999999999999999999998653 333333332111100
Q ss_pred ------CC---------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 223 ------LP---------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 223 ------~p---------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+ ..++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 0134678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=379.97 Aligned_cols=252 Identities=30% Similarity=0.514 Sum_probs=220.1
Q ss_pred EeEecccCceEEEEEEEe---CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 7 LEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
++.||+|+||.||++++. .+++.||+|++............+.+|+++|++++||||+++++.+... ..+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-GKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CEEEEEEcC
Confidence 468999999999999874 4788999999976544444445678899999999999999999987655 488999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASS 162 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~~~ 162 (610)
+.|++|.+++.+.. .++++.++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||+++..... .....
T Consensus 80 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 99999999997654 6899999999999999999999999999999999999999999999999998765433 23445
Q ss_pred ccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCC
Q 007266 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~d 242 (610)
.+||+.|+|||++.+..++.++|||||||+||+|++|..||...+.......+..... .++..++..+.+||.+||+.|
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhcC
Confidence 7899999999999998999999999999999999999999999888877777755433 456778999999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCchh
Q 007266 243 PEFRPS-----AAELLCHPHLQPYV 262 (610)
Q Consensus 243 P~~RpS-----a~eiL~Hp~f~~~~ 262 (610)
|++||+ +++++.||||+...
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 999999 78899999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=378.93 Aligned_cols=255 Identities=28% Similarity=0.526 Sum_probs=214.2
Q ss_pred CeEEEeEecccCceEEEEEEEe---CCCeEEEEEEEccccc--cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQ--TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~--~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~ 76 (610)
+|++++.||+|+||.||+|++. .+++.||+|++..... .....+.+.+|+.++..+ +|+||+.+++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE-AK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC-CE
Confidence 5999999999999999999875 4788999999875432 223345678899999999 589999999877654 57
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+.||+|.+++.... .++++.++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 899999999999999998754 689999999999999999999999999999999999999999999999999976533
Q ss_pred cc--ccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccC----HHHHHHHHhhccCCCCCcccch
Q 007266 157 DD--LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAPLPTVYSG 229 (610)
Q Consensus 157 ~~--~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~----~~~l~~~I~~~~~~~~p~~~s~ 229 (610)
.. .....+||+.|+|||++.+. .++.++|||||||+||+|++|..||.... ...+...+.. ...+.+..++.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIGP 236 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCH
Confidence 22 23456899999999998865 47899999999999999999999996432 2333333332 33456677899
Q ss_pred HHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCch
Q 007266 230 AFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPY 261 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~Rp-----Sa~eiL~Hp~f~~~ 261 (610)
.+++||.+||+.||++|| +++++++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=377.00 Aligned_cols=252 Identities=30% Similarity=0.504 Sum_probs=215.0
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHH-HHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEME-LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~-iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||++++..+++.||+|++...... ......+.+|.. +++.++||||+++++.+... ..+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCC
Confidence 4799999999999999999999999999754321 122233444544 56789999999999987655 58899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-ccccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~~~~~~~v 164 (610)
|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++... ........+
T Consensus 80 ~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 80 GGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 999999998754 68999999999999999999999999999999999999999999999999987542 223344568
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+++..+..... ..+..++..+.+||.+||+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhcCHH
Confidence 99999999999999999999999999999999999999999888888877765543 34556799999999999999999
Q ss_pred CCCCH----HHHhcCCCCCchhh
Q 007266 245 FRPSA----AELLCHPHLQPYVL 263 (610)
Q Consensus 245 ~RpSa----~eiL~Hp~f~~~~~ 263 (610)
+||++ .++++||||....+
T Consensus 237 ~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 237 KRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCCCH
Confidence 99987 69999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=399.03 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=220.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-C-----CceeeeeeeEeecCcE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-N-----PFIVEYKDSWVEKGCY 76 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-H-----pnIV~l~~~~~~~~~~ 76 (610)
+|+|++.||+|+||.|.+|.+..+++.||||+++.. ....++...|+.||..|+ | -|+|+++++|.-.+ +
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-H 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-c
Confidence 699999999999999999999999999999999733 344566778999999997 3 48999999887665 8
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC--CCeeeeeccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD--QDIRLGDFGLAKML 154 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~--g~vKL~DFGlak~~ 154 (610)
+|||+|.+ +.+|+++|+.+....|+...++.|+.||+.||.+||+.||||+|||||||||..- ..|||+|||.++..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 6799999999988899999999999999999999999999999999999999764 36999999999886
Q ss_pred ccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc---------
Q 007266 155 ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT--------- 225 (610)
Q Consensus 155 ~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~--------- 225 (610)
...-. +++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+++..|...+..|.+.
T Consensus 342 ~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~ 419 (586)
T KOG0667|consen 342 SQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH 419 (586)
T ss_pred CCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence 54433 8999999999999999999999999999999999999999999999998888886544332100
Q ss_pred -----------------------------------------------------ccchHHHHHHHHhhcCCCCCCCCHHHH
Q 007266 226 -----------------------------------------------------VYSGAFRGLVKSMLRKNPEFRPSAAEL 252 (610)
Q Consensus 226 -----------------------------------------------------~~s~~l~~LI~kmL~~dP~~RpSa~ei 252 (610)
.-...|.+||++||..||.+|+|+.|+
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa 499 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA 499 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence 001247899999999999999999999
Q ss_pred hcCCCCCch
Q 007266 253 LCHPHLQPY 261 (610)
Q Consensus 253 L~Hp~f~~~ 261 (610)
|+||||...
T Consensus 500 l~Hpfl~~~ 508 (586)
T KOG0667|consen 500 LNHPFLTGT 508 (586)
T ss_pred hcCcccccc
Confidence 999999853
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=378.48 Aligned_cols=253 Identities=27% Similarity=0.491 Sum_probs=219.6
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+|++..+++.||+|.+..... .....+.+..|++++..+ +||||+.++++|... ..+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-DRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CeEEEEEeCCC
Confidence 469999999999999999999999999975432 223345577888888866 799999999987655 47899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~v 164 (610)
|++|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 80 GGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 999999997654 689999999999999999999999999999999999999999999999999876432 23345578
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+...++..+..... ..+..++.++.+||++||+.||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHH
Confidence 99999999999999999999999999999999999999999998888888766543 35667899999999999999999
Q ss_pred CCC-------CHHHHhcCCCCCchhhh
Q 007266 245 FRP-------SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 245 ~Rp-------Sa~eiL~Hp~f~~~~~~ 264 (610)
+|+ +++++++||||....+.
T Consensus 237 ~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 237 KRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred HcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 999 99999999999875433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=369.60 Aligned_cols=259 Identities=27% Similarity=0.478 Sum_probs=221.1
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|++++.||+|+||.||++.+..+++.||+|++....... .....+.+|+.+++.++||||+.+++.+... ..+|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEE
Confidence 4899999999999999999999999999999997543322 2334567899999999999999999987655 4899999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence 99999999998876554569999999999999999999999999999999999999999999999999998764444444
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHh---hccCCCCCcccchHHHHHHHHh
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN---KSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~---~~~~~~~p~~~s~~l~~LI~km 238 (610)
..+|++.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+. .......+..++..+.+||.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 5689999999999999899999999999999999999999998776543332222 1222334566899999999999
Q ss_pred hcCCCCCCC-----CHHHHhcCCCCCchh
Q 007266 239 LRKNPEFRP-----SAAELLCHPHLQPYV 262 (610)
Q Consensus 239 L~~dP~~Rp-----Sa~eiL~Hp~f~~~~ 262 (610)
|..||.+|| +++++++||||....
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 999999999 999999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=377.95 Aligned_cols=254 Identities=31% Similarity=0.515 Sum_probs=217.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++++..++..||+|.+.... .....+.+.+|+++|++++||||+++++++...+ .+++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EEEEEe
Confidence 78999999999999999999999999999999997543 3445567899999999999999999999887654 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
||++|++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMA 159 (331)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-ccc
Confidence 9999999999998754 689999999999999999999986 699999999999999999999999999876533 234
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhh-----------------------
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK----------------------- 217 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~----------------------- 217 (610)
...+||+.|+|||++.+..++.++|||||||+||+|++|..||...+..++...+..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 556899999999999999999999999999999999999999976655444322211
Q ss_pred -----------------------ccCCCC-CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 218 -----------------------SIVAPL-PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 218 -----------------------~~~~~~-p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
...... ...++.++++||.+||+.||++|||+.++|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 111111 1246889999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=377.65 Aligned_cols=252 Identities=31% Similarity=0.533 Sum_probs=218.4
Q ss_pred EeEecccCceEEEEEEEe---CCCeEEEEEEEccccc--cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 7 LEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQ--TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~--~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++.||+|+||.||+|++. .+++.||+|.+..... .......+.+|+.+|+.++||||+++++.|..+ ..+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-GKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-CeEEEEE
Confidence 478999999999999875 4688999999875432 222334577899999999999999999987665 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~ 160 (610)
||+.|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred eCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999999999998754 688999999999999999999999999999999999999999999999999875432 2234
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
...+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.+....+..+.... ..++..++..+.+||.+||+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHcc
Confidence 45689999999999999889999999999999999999999999988887777776543 34677789999999999999
Q ss_pred CCCCCCC-----CHHHHhcCCCCCchh
Q 007266 241 KNPEFRP-----SAAELLCHPHLQPYV 262 (610)
Q Consensus 241 ~dP~~Rp-----Sa~eiL~Hp~f~~~~ 262 (610)
.||++|| ++++++.||||....
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999 899999999998643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=376.09 Aligned_cols=252 Identities=25% Similarity=0.486 Sum_probs=216.6
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+++++.+++.||+|.+...... ......+..|..++..+ +||||+++++.+... ..+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-EHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-CEEEEEECCCC
Confidence 4799999999999999999999999999754321 22334566788887754 899999999988765 48899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~v 164 (610)
|++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.... .......+
T Consensus 80 ~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 80 GGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 999999998754 689999999999999999999999999999999999999999999999999875322 22345678
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+.+.+.... ...+..++.++++||.+||+.||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~ 236 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-PHYPRWITKESKDILEKLFERDPT 236 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHccCCHH
Confidence 9999999999999999999999999999999999999999988888777775443 345667899999999999999999
Q ss_pred CCCCH-HHHhcCCCCCchhh
Q 007266 245 FRPSA-AELLCHPHLQPYVL 263 (610)
Q Consensus 245 ~RpSa-~eiL~Hp~f~~~~~ 263 (610)
+|+++ +++++||||+...+
T Consensus 237 ~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 237 RRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred HcCCChHHHHcCCCcCCCCH
Confidence 99997 58999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=375.92 Aligned_cols=257 Identities=26% Similarity=0.481 Sum_probs=221.5
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LV 80 (610)
+|++++.||+|+||.||++++..+++.||+|.+..... .....+.+..|..++..+. |++|+.+++.+... ..+|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-DRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-CEEEEE
Confidence 69999999999999999999999999999999975432 2223345667888888774 77888888876554 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-ccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~ 159 (610)
|||+.||+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 80 MEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999999999997754 689999999999999999999999999999999999999999999999999875432 223
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...++..+..... ..|..++.++.+||.+||
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~l 236 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLM 236 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCcCCHHHHHHHHHHc
Confidence 4467899999999999999999999999999999999999999999988888887765443 456778999999999999
Q ss_pred cCCCCCCCC-----HHHHhcCCCCCchhh
Q 007266 240 RKNPEFRPS-----AAELLCHPHLQPYVL 263 (610)
Q Consensus 240 ~~dP~~RpS-----a~eiL~Hp~f~~~~~ 263 (610)
+.||.+|++ ..++++||||+...+
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 237 TKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred ccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999997 489999999986543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=378.71 Aligned_cols=252 Identities=28% Similarity=0.503 Sum_probs=213.6
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||++++..+++.||+|++...... ....+.+.+|+.++..+ +||||++++++|... ..+|+|||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-SRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-CEEEEEEeCCC
Confidence 4799999999999999999999999999764432 23445678899999998 799999999987655 58899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc-cccccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~-~~~~~~~~~v 164 (610)
|++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. .........+
T Consensus 80 ~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 80 GGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 999999887654 6899999999999999999999999999999999999999999999999998753 2233445678
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC---------HHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---------MQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---------~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||.... ...+.+.+.. .....|..++..+.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li 236 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKASSVL 236 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999996321 1223333333 23446778899999999
Q ss_pred HHhhcCCCCCCCC------HHHHhcCCCCCchhh
Q 007266 236 KSMLRKNPEFRPS------AAELLCHPHLQPYVL 263 (610)
Q Consensus 236 ~kmL~~dP~~RpS------a~eiL~Hp~f~~~~~ 263 (610)
++||+.||.+|++ ++++++||||....+
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999987 799999999976443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=382.05 Aligned_cols=256 Identities=27% Similarity=0.488 Sum_probs=218.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|++..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+... .++|+|
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~~lv 121 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-RYLYMV 121 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEEE
Confidence 689999999999999999999999999999999865332 222345578899999999999999999987654 589999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
||||.||+|.++++.. .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 122 MEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 9999999999999764 58999999999999999999999999999999999999999999999999998764332
Q ss_pred ccccccCCCcccCCccccCCC----CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc---CCCCCcccchHH
Q 007266 159 LASSVVGTPSYMCPELLADIP----YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSGAF 231 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~----yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~---~~~~p~~~s~~l 231 (610)
.....+||+.|+|||++.+.. ++.++|||||||+||+|++|..||.+.+....+..+.... ..+....++..+
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 234678999999999987543 7899999999999999999999999998887777776432 223344689999
Q ss_pred HHHHHHhhcCCCCC--CCCHHHHhcCCCCCch
Q 007266 232 RGLVKSMLRKNPEF--RPSAAELLCHPHLQPY 261 (610)
Q Consensus 232 ~~LI~kmL~~dP~~--RpSa~eiL~Hp~f~~~ 261 (610)
++||.+||..++.+ |++++++++|+||+..
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=396.12 Aligned_cols=254 Identities=35% Similarity=0.591 Sum_probs=232.7
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
.|..++.||+|.||.||++.+..+++.||||++......++ .+.+.+|+.+|.+++++||.+++++|..+ ..++++||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g-~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKG-TKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeec-ccHHHHHH
Confidence 58889999999999999999999999999999987766554 46688999999999999999999998865 48999999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
||.||++.+.++..+ .+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+.... ...
T Consensus 92 y~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 999999999998754 56999999999999999999999999999999999999999999999999998876554 348
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
+++|||.|||||++.+..|+.++||||||++.|||++|.+||....+...+..|.+...+.+...++..+++||..||.+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k 249 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDK 249 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhc
Confidence 89999999999999999999999999999999999999999999888777777777777777778999999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCc
Q 007266 242 NPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f~~ 260 (610)
||+.||+|.++|+|+|++.
T Consensus 250 ~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 250 NPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CcccCcCHHHHhhhHHHHh
Confidence 9999999999999999875
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=370.60 Aligned_cols=262 Identities=25% Similarity=0.453 Sum_probs=233.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc------cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecC
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ------TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKG 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~------~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~ 74 (610)
+.|+..+.||.|..++|..+.++.+++.+|+|++..... ..+..+.-.+|+.||+++ .||+||++.+.|..+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~- 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD- 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc-
Confidence 468888999999999999999999999999999965332 223456677899999998 699999999987654
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
..+++|+|.|..|.|++++... ..++|...+.+|+||+.|+.|||.++|+||||||+|||++++.+|+|.|||+++.+
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 5889999999999999999875 47999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCcccCCccccC------CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc---CCCCCc
Q 007266 155 ISDDLASSVVGTPSYMCPELLAD------IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPT 225 (610)
Q Consensus 155 ~~~~~~~~~vGTp~Y~APEvl~~------~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~---~~~~p~ 225 (610)
...+.....||||+|.|||.+.+ ..|+..+|+|++|||||-|+.|.+||....+.-++..|..+. ..+.+.
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 98888889999999999998753 358889999999999999999999999888888888886654 455677
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhhhc
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIH 266 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~~~ 266 (610)
.++...++||.+||++||.+|+|++|+|.||||.+++..-.
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~ 294 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA 294 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence 78999999999999999999999999999999988765443
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=396.27 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=211.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-------C
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-------G 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-------~ 74 (610)
++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||+++++|... .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 47999999999999999999999999999999885432 1245799999999999999998876532 2
Q ss_pred cEEEEEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeecccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLA 151 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGla 151 (610)
.++++||||+. ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 36789999996 477777653 2334789999999999999999999999999999999999999765 6999999999
Q ss_pred cccccccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--------
Q 007266 152 KMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-------- 222 (610)
Q Consensus 152 k~~~~~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~-------- 222 (610)
+...........+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+....+.+..+......+
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 87765555567789999999998865 468999999999999999999999999887665555443321111
Q ss_pred --------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 --------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 --------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+|...+.++++||.+||++||.+|||+.|+|+||||+...
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 2334678999999999999999999999999999998754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=399.92 Aligned_cols=262 Identities=27% Similarity=0.540 Sum_probs=234.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG------- 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~------- 74 (610)
++|++.+.||+|+||.||++++..+++.||||.+............+.+|+.++..++|+||+++++.+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 6899999999999999999999999999999999877666666777889999999999999999988775432
Q ss_pred cEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
..+++||||+.+|+|.++++.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 2478999999999999999753 23468999999999999999999999999999999999999999999999999997
Q ss_pred ccccc---cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccch
Q 007266 153 MLISD---DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG 229 (610)
Q Consensus 153 ~~~~~---~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~ 229 (610)
..... ......+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+...++..+......+++..++.
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISP 271 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 65422 234567899999999999999999999999999999999999999999998888888877777778888999
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
++.+||.+||+.||.+||++.++|+|||++.+..
T Consensus 272 ~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 272 EMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 9999999999999999999999999999987543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=363.73 Aligned_cols=257 Identities=25% Similarity=0.455 Sum_probs=236.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++.+.||+|-||.||+++.+.++..||+|++.+..... ....++.+|++|...|+||||++++++|.+. ..+|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-KRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-ceeEE
Confidence 578999999999999999999999999999999997655322 2346789999999999999999999987765 48999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
++||..+|+|...++......|+|.....|++|++.||.|+|..+||||||||+|+|++..|.+||+|||.+.... ...
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~k 178 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNK 178 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCC
Confidence 9999999999999997666789999999999999999999999999999999999999999999999999986654 556
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
..+.|||..|.+||...+..++..+|+|++|++.||++.|.+||+.....+++.+|.+.... +|..++.++++||.+||
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-~p~~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-FPSTISGGAADLISRLL 257 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-CCcccChhHHHHHHHHh
Confidence 77899999999999999999999999999999999999999999999999999999876554 67899999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCc
Q 007266 240 RKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.++|.+|....|++.|||+..
T Consensus 258 ~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 258 VKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ccCccccccHHHHhhhHHHHh
Confidence 999999999999999999864
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=374.44 Aligned_cols=261 Identities=26% Similarity=0.481 Sum_probs=217.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++++..+++.||+|++..... .....+.+.+|+.++..++|+||+.+++.|... ..+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEE
Confidence 689999999999999999999999999999999975322 222345678899999999999999999987655 589999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc-
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL- 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~- 159 (610)
|||+.|++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 80 MDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999999997633 3689999999999999999999999999999999999999999999999999876543322
Q ss_pred -cccccCCCcccCCccccC-----CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc----CCCCCcccch
Q 007266 160 -ASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI----VAPLPTVYSG 229 (610)
Q Consensus 160 -~~~~vGTp~Y~APEvl~~-----~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~----~~~~p~~~s~ 229 (610)
....+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+.+..+.... ..+....++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 223579999999999863 457889999999999999999999999888777776664322 1122234789
Q ss_pred HHHHHHHHhhcCCCCC--CCCHHHHhcCCCCCchhhh
Q 007266 230 AFRGLVKSMLRKNPEF--RPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~--RpSa~eiL~Hp~f~~~~~~ 264 (610)
.+++||++||..+++. |+++.++++||||....+.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 9999999999765444 7899999999999875443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=373.60 Aligned_cols=253 Identities=25% Similarity=0.475 Sum_probs=217.0
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHh-cCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISR-VRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~-L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+|++..+++.||+|.+...... .........|..++.. ++||||+++++.+...+ .+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-NLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-EEEEEEeCCC
Confidence 4799999999999999999999999999754321 2223445667788876 48999999999877654 7899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~v 164 (610)
||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+
T Consensus 80 ~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 80 GGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 999999998754 689999999999999999999999999999999999999999999999999875322 22344568
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+.... ...+..++.++++||.+||+.||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~ 236 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPE 236 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHh
Confidence 9999999999999999999999999999999999999999988888877775543 335667899999999999999999
Q ss_pred CCCCHH-HHhcCCCCCchhhh
Q 007266 245 FRPSAA-ELLCHPHLQPYVLG 264 (610)
Q Consensus 245 ~RpSa~-eiL~Hp~f~~~~~~ 264 (610)
+|+++. ++++||||....+.
T Consensus 237 ~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 237 RRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred hcCCChHHHHcCcccCCCCHH
Confidence 999996 99999999886543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=372.06 Aligned_cols=252 Identities=25% Similarity=0.481 Sum_probs=216.1
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHh-cCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISR-VRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~-L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+|.+..+++.||+|.+...... ....+.+..|..++.. ++||||+++++.+... ..+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-EHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence 4799999999999999999999999999754322 2233445567777765 4899999999987654 58999999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~v 164 (610)
|++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+
T Consensus 80 gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 80 GGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 999999998754 689999999999999999999999999999999999999999999999999976432 23345678
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...++..+... ....+..++.++.+||.+||..||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~ 236 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDPT 236 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999999888888777554 3446777899999999999999999
Q ss_pred CCCCH-HHHhcCCCCCchhh
Q 007266 245 FRPSA-AELLCHPHLQPYVL 263 (610)
Q Consensus 245 ~RpSa-~eiL~Hp~f~~~~~ 263 (610)
+||++ .++++||||....+
T Consensus 237 ~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 237 KRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred HcCCChHHHHcCcccCCCCH
Confidence 99986 58889999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=373.72 Aligned_cols=252 Identities=29% Similarity=0.541 Sum_probs=218.9
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++..+ +||||+++++.+... ..+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-DRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence 479999999999999999999999999975432 223345577899999888 699999999987655 48899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-ccccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~~~~~~~v 164 (610)
|++|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++... ........+
T Consensus 80 ~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 80 GGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 999999988754 68999999999999999999999999999999999999999999999999987532 222344568
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+..... ..+..++..+.+||.+||..||.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHccCCHH
Confidence 99999999999999999999999999999999999999998888877777655433 35667899999999999999999
Q ss_pred CCCCH-----HHHhcCCCCCchhh
Q 007266 245 FRPSA-----AELLCHPHLQPYVL 263 (610)
Q Consensus 245 ~RpSa-----~eiL~Hp~f~~~~~ 263 (610)
+||++ .+++.||||....+
T Consensus 237 ~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 237 KRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred HcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999 99999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=375.68 Aligned_cols=253 Identities=29% Similarity=0.520 Sum_probs=213.1
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||++++..+++.||+|++..... .......+.+|+.++.++ +||||+++++++... ..+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCC
Confidence 479999999999999999999999999976532 233445678899888876 799999999987665 48899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-ccccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~~~~~~~v 164 (610)
|++|..++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++... ........+
T Consensus 80 ~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 80 GGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 999999887654 68999999999999999999999999999999999999999999999999987532 223344578
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc---------CHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---------DMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~---------~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||... ....+.+.+.. ....+|..++..+.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASVL 236 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHHHHH
Confidence 999999999999999999999999999999999999999521 12223333333 23346778899999999
Q ss_pred HHhhcCCCCCCCC------HHHHhcCCCCCchhhh
Q 007266 236 KSMLRKNPEFRPS------AAELLCHPHLQPYVLG 264 (610)
Q Consensus 236 ~kmL~~dP~~RpS------a~eiL~Hp~f~~~~~~ 264 (610)
++||+.||.+|++ ++++++||||+...+.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 9999999999998 5899999999875443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=372.63 Aligned_cols=261 Identities=25% Similarity=0.480 Sum_probs=219.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++++..+++.||+|.+..... .......+.+|+.++..++|+||+.+++.+... .+.|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-NYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence 689999999999999999999999999999999865322 222345578899999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc-
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL- 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~- 159 (610)
|||+.||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++........
T Consensus 80 ~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999999999998743 3689999999999999999999999999999999999999999999999999976644322
Q ss_pred -cccccCCCcccCCccccC-----CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc-CCCCC---cccch
Q 007266 160 -ASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLP---TVYSG 229 (610)
Q Consensus 160 -~~~~vGTp~Y~APEvl~~-----~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~-~~~~p---~~~s~ 229 (610)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||...+..+.+..+.... ..+.+ ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 234579999999999875 467889999999999999999999999888777777765432 11222 34689
Q ss_pred HHHHHHHHhhcCCCCC--CCCHHHHhcCCCCCchhhh
Q 007266 230 AFRGLVKSMLRKNPEF--RPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~--RpSa~eiL~Hp~f~~~~~~ 264 (610)
++++||.+||..++.+ |++++++++||||+...+.
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999976654 4799999999999875433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=371.78 Aligned_cols=261 Identities=26% Similarity=0.479 Sum_probs=219.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++++..+++.||+|.+..... .......+.+|+.++..++|+||+.+++.+... ..+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-NNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CEEEEE
Confidence 689999999999999999999999999999999864322 222344578899999999999999999987655 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|||+.||+|.+++.+.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 80 MDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999999999998743 368999999999999999999999999999999999999999999999999987653332
Q ss_pred ccccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC----CCCCcccch
Q 007266 159 LASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSG 229 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~----~~~p~~~s~ 229 (610)
.....+||+.|+|||++. ...++.++|||||||+||||++|..||...+....+.++..... ......++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223468999999999886 34578999999999999999999999999888888877754321 112345799
Q ss_pred HHHHHHHHhhcCCCCC--CCCHHHHhcCCCCCchhhh
Q 007266 230 AFRGLVKSMLRKNPEF--RPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~--RpSa~eiL~Hp~f~~~~~~ 264 (610)
++++||++||..++.+ |++++++++||||+...+.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 9999999999775554 6899999999999875443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=370.82 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=214.7
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHH-HHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEM-ELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei-~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+|++..+++.||+|.+..... .......+.+|. .+++.++||||+++++.+... ..+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence 479999999999999999999999999975432 122233444554 467889999999999877654 58899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-ccccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~~~~~~~v 164 (610)
|++|...+.... .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++... ........+
T Consensus 80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 80 GGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 999999887644 68999999999999999999999999999999999999999999999999987532 223345578
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+...++..+.... ...+...+..+.++|.+||+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~ 236 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHKDQR 236 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHh
Confidence 9999999999999999999999999999999999999999988888777776543 345667889999999999999999
Q ss_pred CCCCH----HHHhcCCCCCchhhh
Q 007266 245 FRPSA----AELLCHPHLQPYVLG 264 (610)
Q Consensus 245 ~RpSa----~eiL~Hp~f~~~~~~ 264 (610)
+|+++ .++++|+||....+.
T Consensus 237 ~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 237 RRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred hcCCCCCCHHHHhCCCCcCCCCHH
Confidence 99875 599999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.62 Aligned_cols=255 Identities=36% Similarity=0.716 Sum_probs=230.0
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|.+.+.||+|+||.||++.+..+++.|++|.+............+.+|+++++.++||||+++++.+... ...|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEE
Confidence 58999999999999999999999999999999976655566667789999999999999999999988765 47899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|+.|++|.+++....+..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 9999999999987645578999999999999999999999999999999999999999999999999988764432 234
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+......+.+..++..+.++|.+||+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence 56789999999999999999999999999999999999999998888787887777777777778899999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 007266 242 NPEFRPSAAELLCHPHL 258 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f 258 (610)
+|++||++.++++|||+
T Consensus 240 ~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 240 DYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CcccCcCHHHHhhCCCC
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=393.35 Aligned_cols=255 Identities=22% Similarity=0.432 Sum_probs=208.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC------CceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN------PFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H------pnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|.+..+++.||||+++... .....+..|+.+++.+.| .+++.++++|.....
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 57999999999999999999999999999999996432 222345567777777654 458888888877767
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCC-------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQ------------- 141 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g------------- 141 (610)
++|+||+++ |++|.+++.+.+ .+++..++.|+.||+.||.|||+ .|||||||||+||||+.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 899999998 789999887754 68999999999999999999998 5999999999999998765
Q ss_pred ---CeeeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc
Q 007266 142 ---DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS 218 (610)
Q Consensus 142 ---~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~ 218 (610)
.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+...
T Consensus 283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred CCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 49999999886432 2344678999999999999999999999999999999999999999887765554444322
Q ss_pred cCCCC---------------------------C--------------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 007266 219 IVAPL---------------------------P--------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 257 (610)
Q Consensus 219 ~~~~~---------------------------p--------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~ 257 (610)
..... + ...+..+.+||.+||++||++|||++|+|+|||
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 11100 0 011355779999999999999999999999999
Q ss_pred CCchhhh
Q 007266 258 LQPYVLG 264 (610)
Q Consensus 258 f~~~~~~ 264 (610)
|+.+...
T Consensus 441 ~~~~~~~ 447 (467)
T PTZ00284 441 VLKYYPE 447 (467)
T ss_pred ccccCCc
Confidence 9876543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=378.23 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=213.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 76 (610)
++|++++.||.|+||.||++.+..+++.||+|++............+.+|+.+|++++|+||++++++|.... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 6899999999999999999999999999999999765444444566789999999999999999998775332 35
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|++++++ |++|.++++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred EEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 78999998 78998888643 689999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------ 223 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~------------ 223 (610)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+.
T Consensus 171 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07878 171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248 (343)
T ss_pred --CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence 2445789999999999876 5689999999999999999999999988766555444432111110
Q ss_pred ------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 224 ------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 224 ------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
....++.+.+||.+||..||.+|||+.|+|.||||..+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 11245678899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=374.13 Aligned_cols=252 Identities=31% Similarity=0.503 Sum_probs=213.3
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHH-HHHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQE-MELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~E-i~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+|++..+++.||+|++...... ......+..| ..+++.++||||+++++.+... ..+|+||||+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-CeEEEEEeCCC
Confidence 4799999999999999999999999999754321 1122233334 4457889999999999887655 47899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~v 164 (610)
|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+
T Consensus 80 ~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 80 GGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 999999998754 688999999999999999999999999999999999999999999999999875432 23345678
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+++..+..... ..+..++..+.++|.+||+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p~ 236 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDRT 236 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-CCCCCCCHHHHHHHHHHcccCHH
Confidence 99999999999999999999999999999999999999999888888777755433 34557899999999999999999
Q ss_pred CCCCHH----HHhcCCCCCchhh
Q 007266 245 FRPSAA----ELLCHPHLQPYVL 263 (610)
Q Consensus 245 ~RpSa~----eiL~Hp~f~~~~~ 263 (610)
+|+++. ++++|+||..+.+
T Consensus 237 ~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 237 KRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred HCCCCCCCHHHHhcCcccCCCCH
Confidence 999865 8999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.94 Aligned_cols=254 Identities=28% Similarity=0.517 Sum_probs=215.0
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.++.++ +||||+.+++.+... ..+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-SRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-CEEEEEEeCCC
Confidence 4799999999999999999999999999765432 33456688999999888 699999999977655 58899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-ccccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~~~~~~~v 164 (610)
|++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+
T Consensus 80 ~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 80 GGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 999999887654 68999999999999999999999999999999999999999999999999987532 233345678
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc------C-HHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF------D-MQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~------~-~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
||+.|+|||++.+..++.++|||||||+||+|++|..||... . ...+...+. ......|..++..+.++|.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999532 2 223333333 33445677889999999999
Q ss_pred hhcCCCCCCCC------HHHHhcCCCCCchhhhh
Q 007266 238 MLRKNPEFRPS------AAELLCHPHLQPYVLGI 265 (610)
Q Consensus 238 mL~~dP~~RpS------a~eiL~Hp~f~~~~~~~ 265 (610)
||..||.+|++ .+++++||||+...+..
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~ 270 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence 99999999987 57999999999865543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=374.73 Aligned_cols=250 Identities=32% Similarity=0.515 Sum_probs=211.9
Q ss_pred ecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhc---CCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRV---RNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 10 LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L---~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
||+|+||.||++++..+++.||+|++...... ......+..|..++..+ +||||+.+++.|... ..+|+||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-SDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-CeEEEEEcCCC
Confidence 79999999999999999999999998643321 22233455677777665 699999999887655 47899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~v 164 (610)
|++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||+++.... .......+
T Consensus 80 ~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 80 GGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 999999988654 689999999999999999999999999999999999999999999999999876432 23345678
Q ss_pred CCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCC
Q 007266 165 GTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 243 (610)
Q Consensus 165 GTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP 243 (610)
||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+...++..+...........++..+.+||++||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence 99999999998754 48999999999999999999999999988888887776554433334579999999999999999
Q ss_pred CCCC----CHHHHhcCCCCCchh
Q 007266 244 EFRP----SAAELLCHPHLQPYV 262 (610)
Q Consensus 244 ~~Rp----Sa~eiL~Hp~f~~~~ 262 (610)
.+|| ++.++++||||....
T Consensus 238 ~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 238 QHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HHCCCCCCCHHHHhcCccccCCC
Confidence 9998 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.44 Aligned_cols=252 Identities=29% Similarity=0.500 Sum_probs=213.9
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHH-HHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEME-LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~-iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||++++..+|+.||+|++...... ......+.+|.. +++.++||||+++++.+... ..+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-EKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-CEEEEEEcCCC
Confidence 4699999999999999999999999999754322 222334445554 56789999999999887655 47899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cccccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVV 164 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~~~~~~v 164 (610)
|++|..++.... .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .......+
T Consensus 80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 80 GGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 999999887644 689999999999999999999999999999999999999999999999999875422 23345678
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+++..+..... ..+..++..+.++|.+||+.+|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCCCCHHHHHHHHHHhccCHH
Confidence 99999999999999999999999999999999999999999888888777765433 23446889999999999999999
Q ss_pred CCCCH----HHHhcCCCCCchhh
Q 007266 245 FRPSA----AELLCHPHLQPYVL 263 (610)
Q Consensus 245 ~RpSa----~eiL~Hp~f~~~~~ 263 (610)
+||++ .+++.||||....+
T Consensus 237 ~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 237 RRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred hcCCCCCCHHHHhcCCCcCCCCH
Confidence 99876 69999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=371.91 Aligned_cols=257 Identities=26% Similarity=0.484 Sum_probs=220.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCC-CceeeeeeeEeecCcEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~H-pnIV~l~~~~~~~~~~~~LV 80 (610)
+|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+..|+.++..+.| ++|+.+++.+.. ...+|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence 58899999999999999999999999999999975432 22334557788899988865 566677776654 4589999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
|||+.||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..... ..
T Consensus 80 ~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 80 MEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 99999999999998754 6899999999999999999999999999999999999999999999999998764322 23
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+..... ..|..++..+.+|+.+||
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l 236 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-SYPKSLSKEAVSICKGLM 236 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHc
Confidence 3456799999999999999999999999999999999999999999888888877765443 356778999999999999
Q ss_pred cCCCCCCCC-----HHHHhcCCCCCchhh
Q 007266 240 RKNPEFRPS-----AAELLCHPHLQPYVL 263 (610)
Q Consensus 240 ~~dP~~RpS-----a~eiL~Hp~f~~~~~ 263 (610)
+.+|.+|++ .+++++||||+...+
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 237 TKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred ccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 999999997 589999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=358.46 Aligned_cols=252 Identities=36% Similarity=0.635 Sum_probs=215.3
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
|++++.||+|+||+||++++..+++.||+|.+..............+|+.++++++|+||+++++.+... ...++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-NYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-SEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-ccccccccc
Confidence 8999999999999999999999999999999987766665555566799999999999999999988764 578899999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc-cccccccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASS 162 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~-~~~~~~~~ 162 (610)
+.+++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||.+... ........
T Consensus 80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999998544 6899999999999999999999999999999999999999999999999998753 23344566
Q ss_pred ccCCCcccCCcccc-CCCCCCCccccccchhHHhhhhcCccccccC---HHHHHHHHhhcc-CCC--CCcccchHHHHHH
Q 007266 163 VVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSI-VAP--LPTVYSGAFRGLV 235 (610)
Q Consensus 163 ~vGTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---~~~l~~~I~~~~-~~~--~p~~~s~~l~~LI 235 (610)
..+++.|+|||++. +..++.++|||||||++|+|++|..||.... ............ ... .....+..+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 78999999999998 7888999999999999999999999999873 333333222211 111 1112247999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCC
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.+||+.||++||++.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=380.92 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=216.2
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVC 78 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~~ 78 (610)
+|++++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++|+||+++++.+...+ ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999999999999999998755444445567889999999999999999999876554 2689
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+. ++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9999995 68888886543 68999999999999999999999999999999999999999999999999997653322
Q ss_pred --ccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--------------
Q 007266 159 --LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-------------- 221 (610)
Q Consensus 159 --~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-------------- 221 (610)
.....++++.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 23445789999999998774 4789999999999999999999999988766665554332111
Q ss_pred -----------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 222 -----------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 222 -----------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
......+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 1123357889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=368.74 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=214.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||+|+||.||++++..++..||+|.+...... .....+.+|+.++++++||||+++++.+..+ ...|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTD-KSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEE
Confidence 68999999999999999999999999999999998754432 2234567899999999999999999987665 478999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
|||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 83 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 83 FEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 999975 8888887643 358999999999999999999999999999999999999999999999999987643322 2
Q ss_pred cccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----------------
Q 007266 160 ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------- 222 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---------------- 222 (610)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 334578999999998865 457899999999999999999999998877655554443221110
Q ss_pred -------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 223 -------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 223 -------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
....++.++++||.+||+.||.+|||++|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 112367889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=362.98 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=219.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|+|++.+++.+... ..+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-CEEEEEE
Confidence 488999999999999999999999999999998754332 22334567899999999999999999987665 4889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.|++|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 99999999999876555569999999999999999999999999999999999999999999999999987654443334
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH---HHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---ALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~---~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
..+|++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+........+..++..+++||.+|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 568999999999999999999999999999999999999999865321 12222222222334567889999999999
Q ss_pred hcCCCCCCCC-----HHHHhcCCCCCchh
Q 007266 239 LRKNPEFRPS-----AAELLCHPHLQPYV 262 (610)
Q Consensus 239 L~~dP~~RpS-----a~eiL~Hp~f~~~~ 262 (610)
|+.||++||| ++|+++||||....
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 9999999999 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=378.69 Aligned_cols=252 Identities=30% Similarity=0.493 Sum_probs=211.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+++++.++|+||+++++.|... ..+|+||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-GEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-CeEEEEE
Confidence 57889999999999999999999999999999986433 334456788999999999999999999987654 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
||++|++|.+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ...
T Consensus 152 e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 152 EFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred ecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 99999998642 24578889999999999999999999999999999999999999999999999875432 223
Q ss_pred ccccCCCcccCCccccC-----CCCCCCccccccchhHHhhhhcCccccccC---HHHHHHHHhhccCCCCCcccchHHH
Q 007266 161 SSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~-----~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---~~~l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
...+||..|+|||++.. ..++.++|||||||+||+|++|..||.... ...+...+........+..++.+++
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR 305 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence 45689999999998743 234568999999999999999999997433 2233333433444455667899999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+||.+||..||++||++.|+|+||||...
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 99999999999999999999999999764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=362.24 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=210.7
Q ss_pred ecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCC
Q 007266 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 88 (610)
Q Consensus 10 LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Ggs 88 (610)
||+|+||.||++++..+|+.||+|.+....... .....+..|++++++++||||+++++.+.. +..+|+||||+.|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence 799999999999999999999999986533222 223345679999999999999999987765 458899999999999
Q ss_pred HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccccccCCCc
Q 007266 89 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS 168 (610)
Q Consensus 89 L~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~ 168 (610)
|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.............|++.
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 99988766555689999999999999999999999999999999999999999999999999877654444445679999
Q ss_pred ccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH----HHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 169 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM----QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 169 Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~----~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+...........++.++++||.+||+.||+
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 9999999988899999999999999999999999976532 223333322222222346899999999999999999
Q ss_pred CCCCH----HHHhcCCCCCchh
Q 007266 245 FRPSA----AELLCHPHLQPYV 262 (610)
Q Consensus 245 ~RpSa----~eiL~Hp~f~~~~ 262 (610)
+||++ ++++.||||+...
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred hCCCCccchhhhhcChhhcCCC
Confidence 99999 7788999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=415.22 Aligned_cols=281 Identities=28% Similarity=0.477 Sum_probs=244.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|+|++.||+|+||.|.+|+++.+++.||+|++.+-..... .-.-|..|..+|..-+.+.|+.++.+|++.. ++|+|
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~-~LYlV 153 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER-YLYLV 153 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc-ceEEE
Confidence 689999999999999999999999999999999976332211 1234788999999999999999999988665 99999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|||+.||+|..++.+.. .++|+.++.|+.+|+.||.-||+.|+|||||||+||||+..|+|||+|||.|-.+..+.
T Consensus 154 MdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999999999999876 79999999999999999999999999999999999999999999999999987765443
Q ss_pred ccccccCCCcccCCcccc----C-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc---cCCCCCcccchH
Q 007266 159 LASSVVGTPSYMCPELLA----D-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS---IVAPLPTVYSGA 230 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~----~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~---~~~~~p~~~s~~ 230 (610)
.....+|||.|++||++. + +.|+..+|+|||||+||||+.|..||......+.+.+|... +..|-...+|.+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 456789999999999884 3 56899999999999999999999999999999999999654 333323569999
Q ss_pred HHHHHHHhhcCCCCCCCC---HHHHhcCCCCCchhhhhccccCCCCCCCCCCCCCCccc
Q 007266 231 FRGLVKSMLRKNPEFRPS---AAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF 286 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpS---a~eiL~Hp~f~~~~~~~~~~~~~p~~~~~~~~~~~s~~ 286 (610)
+++||.++|. +|+.|.. ++++.+||||....|........|..+.+..+-+.++|
T Consensus 312 akdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 312 AKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred HHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence 9999999886 5778877 99999999999988876666677877888777888887
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=390.58 Aligned_cols=256 Identities=29% Similarity=0.512 Sum_probs=226.5
Q ss_pred CeEEEeEecccCceEEEEEEEeCC-CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHE-RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~-~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||++++.|... ..+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEE
Confidence 499999999999999999999877 7889999775432 33445678899999999999999999988765 4889999
Q ss_pred eecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 82 GYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||+.||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999999988642 23468999999999999999999999999999999999999999999999999998764332
Q ss_pred --ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHH
Q 007266 159 --LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 159 --~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~ 236 (610)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+......+.+..++..+++||.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 304 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLD 304 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999888888888777666778889999999999
Q ss_pred HhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 237 SMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+||..||+.||+++++|.|+|++..
T Consensus 305 ~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 305 PLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHhccChhhCcCHHHHHhCHHHHHH
Confidence 9999999999999999999998754
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=350.06 Aligned_cols=255 Identities=39% Similarity=0.689 Sum_probs=229.8
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++++.||.|+||.||.+++..++..+++|.+............+.+|+.++++++|+||+++++.+.+. ..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-NTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-CeEEEEEE
Confidence 69999999999999999999999999999999987665666667788999999999999999999988765 58899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|+.|++|.+++....+..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9999999999987645578999999999999999999999999999999999999999999999999987764333 344
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+......+.+..++..+.++|.+||..
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 56799999999999988889999999999999999999999999888888877776666666677899999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 007266 242 NPEFRPSAAELLCHPHL 258 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f 258 (610)
+|.+||++.++|+|+|+
T Consensus 240 ~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 240 DPEKRPTADEVLDQPLL 256 (256)
T ss_pred CcccCCCHHHHhhCcCC
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=349.58 Aligned_cols=255 Identities=37% Similarity=0.694 Sum_probs=229.1
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++++.||+|+||.||++.+..+++.+|+|.+............+.+|+.++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence 6999999999999999999999999999999998765555566788999999999999999999997765 458899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeecccccccccccccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~~~~~~~~~ 161 (610)
|+.|++|.+++....+..+++..+..++.|++.+|.|||++|++|+||||+||+++.++ .++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999999876555689999999999999999999999999999999999998654 57999999998775554455
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+......+.+..++..+.++|.+||..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence 57889999999999988899999999999999999999999999888777777776666667778999999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 007266 242 NPEFRPSAAELLCHPHL 258 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f 258 (610)
+|++|||+.|+|+||||
T Consensus 240 ~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 240 DPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ChhhCCCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=377.26 Aligned_cols=249 Identities=26% Similarity=0.485 Sum_probs=219.9
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeE-EEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKK-YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~-vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
..+.+.||.|+||+||++... |.. ||+|.+..........+.|.+|+.+|.+++|||||++++++.+....++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 445667999999999999875 445 99999987766666678899999999999999999999998776546899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCCCCceEecCCC-Ceeeeecccccccccc-cc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g-IiHRDLKPeNILL~~~g-~vKL~DFGlak~~~~~-~~ 159 (610)
|+.+|+|.+++.......++...+..|+.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++..... ..
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 999999999998743457999999999999999999999999 99999999999999998 9999999999887654 34
Q ss_pred cccccCCCcccCCcccc--CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHh-hccCCCCCcccchHHHHHHH
Q 007266 160 ASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN-KSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~--~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~-~~~~~~~p~~~s~~l~~LI~ 236 (610)
.....||+.|||||++. ...|+.++||||||++|+||++|..||.+.........+. ......+|..++..+..||.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~ 280 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLME 280 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 44589999999999999 6699999999999999999999999999998766655554 55666678889999999999
Q ss_pred HhhcCCCCCCCCHHHHhc
Q 007266 237 SMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~ 254 (610)
.||..||..||+..+++.
T Consensus 281 ~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 281 RCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HhCCCCCCcCCCHHHHHH
Confidence 999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=371.28 Aligned_cols=253 Identities=17% Similarity=0.371 Sum_probs=211.1
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+|..+ +|||||++++++...+.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 68999999999999999999863 345689999987433 233445688999999999 89999999998887777
Q ss_pred EEEEEEeecCCCCHHHHHHHhC----------------------------------------------------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN---------------------------------------------------------- 97 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~---------------------------------------------------------- 97 (610)
.+++||||++||+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 7899999999999999987532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---ccccccCCCcccCC
Q 007266 98 --GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCP 172 (610)
Q Consensus 98 --~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~AP 172 (610)
...++++.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+++.|+||
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 1247888999999999999999999999999999999999999999999999997653221 12234567889999
Q ss_pred ccccCCCCCCCccccccchhHHhhhh-cCccccccCHH-HHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHH
Q 007266 173 ELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 250 (610)
Q Consensus 173 Evl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~-~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~ 250 (610)
|++.+..|+.++|||||||+||||++ |..||.+.... .+...+........+..++..+.+||.+||+.||++||++.
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 325 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFS 325 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999999999999999996 99999876543 33344444444455677899999999999999999999999
Q ss_pred HHhcC
Q 007266 251 ELLCH 255 (610)
Q Consensus 251 eiL~H 255 (610)
++++.
T Consensus 326 el~~~ 330 (338)
T cd05102 326 ALVEI 330 (338)
T ss_pred HHHHH
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=361.29 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=211.4
Q ss_pred ecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCC
Q 007266 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 88 (610)
Q Consensus 10 LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Ggs 88 (610)
||+|+||+||++.+..+++.||+|.+....... ...+.+..|+.+++.++|+||+.+.+.+... ..+|+||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-TDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-CeEEEEEeCCCCCC
Confidence 799999999999999999999999987543322 2345677899999999999999998877654 57899999999999
Q ss_pred HHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccccccC
Q 007266 89 MAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVG 165 (610)
Q Consensus 89 L~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~~~vG 165 (610)
|.+.+... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......|
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 99887542 23468999999999999999999999999999999999999999999999999987654332 2345689
Q ss_pred CCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH----HHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM----QALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 166 Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~----~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
|+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+... ....+..++..+.+|+.+||+.
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999976542 2222222222 2234567899999999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCchhhh
Q 007266 242 NPEFRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 242 dP~~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
||++|| +++++++||||+...+.
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 999999 88999999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=381.42 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=203.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.+|++++.||+|+||.||+|.+..+++.||+|... ...+.+|+++|++++|||||++++.|... ...|+||
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYN-KFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-CeeEEEE
Confidence 57999999999999999999999999999999653 22467899999999999999999987654 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc--cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--DL 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--~~ 159 (610)
||+. ++|..++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ..
T Consensus 163 e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred ecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 9994 78988887654 6899999999999999999999999999999999999999999999999999754222 22
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC-------HHHHHHHHhhccC------------
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------MQALINKINKSIV------------ 220 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-------~~~l~~~I~~~~~------------ 220 (610)
....+||+.|+|||++.+..|+.++|||||||+||+|++|..||.... ....+..+.....
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 345689999999999999999999999999999999999998764321 1111111111000
Q ss_pred ---------------CC--C-----CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 221 ---------------AP--L-----PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 221 ---------------~~--~-----p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+ . ...++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00 0 0124568899999999999999999999999999976
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=370.60 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=215.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|++++++++|+||++++++|...+ .+|+||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-EEEEEE
Confidence 68999999999999999999999999999999887543 3344567889999999999999999999887654 889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
||+.|++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMA 159 (333)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-hcc
Confidence 9999999999998754 689999999999999999999985 799999999999999999999999999876532 233
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHH-------------------------
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI------------------------- 215 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I------------------------- 215 (610)
...+|++.|+|||++.+..++.++|||||||++|+|++|..||.......+...+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 4568999999999999988999999999999999999999999765443332111
Q ss_pred -------------------hhccCCCCC-cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 216 -------------------NKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 216 -------------------~~~~~~~~p-~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
........+ ..++.++++||.+||++||++||++.|++.||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 111111111 136788999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.84 Aligned_cols=255 Identities=29% Similarity=0.551 Sum_probs=225.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++.+..+++.||+|.+..... .....+.+.+|++++++++||||+++++.+... ..+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-SNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CeEEEE
Confidence 589999999999999999999999999999999865432 223456788999999999999999999987655 478999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||+.|++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|.||||+.++.++|+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence 99999999999998764 6899999999999999999999999999999999999999999999999999876444 3
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
...+|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... ..+++..++..++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHHHHcc
Confidence 4567999999999998888899999999999999999999999888876666666533 334667789999999999999
Q ss_pred CCCCCCC-----CHHHHhcCCCCCchh
Q 007266 241 KNPEFRP-----SAAELLCHPHLQPYV 262 (610)
Q Consensus 241 ~dP~~Rp-----Sa~eiL~Hp~f~~~~ 262 (610)
.||.+|+ +++++++||||+...
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999 999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=348.47 Aligned_cols=256 Identities=42% Similarity=0.711 Sum_probs=230.3
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee-cCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~-~~~~~~LVm 81 (610)
+|++++.||.|+||.||++.+..++..||+|.+..........+.+.+|+.++++++|+||+++++.+.. .+...|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 6999999999999999999999999999999997666666667778999999999999999999998764 345789999
Q ss_pred eecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 82 GYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLH-----ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLH-----s~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
||+.+++|.+++... ....+++..++.++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999753 2346899999999999999999999 999999999999999999999999999999877
Q ss_pred ccccc-cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 155 ISDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 155 ~~~~~-~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
..... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+...+...+........+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE 240 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 54443 44568999999999999888999999999999999999999999998888888888777777778889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
++.+||+.+|++||++.++|+|||+
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.56 Aligned_cols=254 Identities=30% Similarity=0.525 Sum_probs=219.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH---HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD---RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~---~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
+.|++.+.||+|+||.||++.+..+++.||+|.+....... .....+.+|++++++++||||+++++.+...+ .++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-eEE
Confidence 57999999999999999999999999999999987543322 23456889999999999999999999887654 899
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+|+||+.|++|.+++.... .+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999999999998754 68999999999999999999999999999999999999999999999999987653321
Q ss_pred c----cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHh-hccCCCCCcccchHHHH
Q 007266 159 L----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN-KSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ~----~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~-~~~~~~~p~~~s~~l~~ 233 (610)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .......+..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 1 134578899999999999889999999999999999999999998766555444433 23344567778999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
+|.+||..+|++||++.++|+|+||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.56 Aligned_cols=255 Identities=42% Similarity=0.810 Sum_probs=227.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++++.||+|+||.||++.+..+++.||+|.+............+.+|+.++++++|+||+++++.+... ...|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-GNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-CeEEEEEe
Confidence 69999999999999999999999999999999976554555556789999999999999999999987654 58899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|+.|++|.+.+.......+++..+..|+.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....... ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 9999999999987555568999999999999999999999999999999999999999999999999987654332 223
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+......+.+..++..+.++|.+||+.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence 45689999999999988899999999999999999999999998888888777776666667778899999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 007266 242 NPEFRPSAAELLCHPHL 258 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f 258 (610)
+|.+||++.++|.||||
T Consensus 240 ~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 240 NPRDRPSVNSILEKNFI 256 (256)
T ss_pred ChhhCcCHHHHhhCcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=357.69 Aligned_cols=260 Identities=26% Similarity=0.470 Sum_probs=221.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|++.+.||+|+||.||++.+..+++.||+|.+....... .....+.+|+.+|++++|+|++.+.+.+..+ ...|+||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-DALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-CEEEEEE
Confidence 4889999999999999999999999999999987543322 2334577899999999999999999887655 4899999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.+++|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 99999999998876555579999999999999999999999999999999999999999999999999987654433344
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc---cCCCCCcccchHHHHHHHHh
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS---IVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~---~~~~~p~~~s~~l~~LI~km 238 (610)
...|+..|+|||++.+..++.++|||||||++|+|++|..||.+.........+... .....+..++..+.+|+.+|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 568999999999999889999999999999999999999999887654443333221 12234556888999999999
Q ss_pred hcCCCCCCCC-----HHHHhcCCCCCchhh
Q 007266 239 LRKNPEFRPS-----AAELLCHPHLQPYVL 263 (610)
Q Consensus 239 L~~dP~~RpS-----a~eiL~Hp~f~~~~~ 263 (610)
|+.||++||+ +.+++.|+||..+-+
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 9999999999 899999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=392.25 Aligned_cols=255 Identities=33% Similarity=0.567 Sum_probs=227.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+.|+|++.||.|+||.||++.++.++-..|.|+|. ....+..+.+.-||+||..+.||+||++++.|+..+ .+||++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-kLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-KLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc--ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-ceEEEE
Confidence 35788999999999999999999998889999886 344555677888999999999999999999988765 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc-ccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~-~~~~~~~ 160 (610)
|||.||.+..++-..+ ..|.|.+|..+++|++.||.|||+++|||||||..|||++-+|+|+|+|||.+.. .......
T Consensus 109 EFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 9999999999888754 4799999999999999999999999999999999999999999999999998644 3333456
Q ss_pred ccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--CCcccchHHHH
Q 007266 161 SSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--~p~~~s~~l~~ 233 (610)
.+++|||+|||||+++ +.+|++++||||||+.|.||..+.+|....+....+-+|.+...+. .|..|+..|.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 7899999999999875 5789999999999999999999999999999988888887765443 37789999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|+++||.+||..||+++++|+||||+.
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCccccc
Confidence 999999999999999999999999984
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=360.45 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=215.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||.|+||.||++.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecC-CeEEEE
Confidence 579999999999999999999999999999999987543322 233467899999999999999999988655 478999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus 83 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 83 FEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred Eeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 99996 58988887643 368999999999999999999999999999999999999999999999999987643222 2
Q ss_pred cccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----------------
Q 007266 160 ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------- 222 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---------------- 222 (610)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+......+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 334577899999998865 457889999999999999999999999887766555443321111
Q ss_pred -------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 223 -------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 223 -------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
....++..+++||.+||+.||.+|||++|+|+||||+.+-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 01236778999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=358.95 Aligned_cols=262 Identities=29% Similarity=0.502 Sum_probs=224.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+++++.+.|+||+++++.+... ...|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-TYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-CEEEEE
Confidence 58999999999999999999999999999999997654332 3456788999999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|||+.|++|.+++....+..+++..++.++.||+.||.|||++|++|+||||+||||+.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 999999999999987655679999999999999999999999999999999999999999999999999987543211
Q ss_pred ----------------------------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHH
Q 007266 159 ----------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA 210 (610)
Q Consensus 159 ----------------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~ 210 (610)
.....+||..|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1123578999999999998889999999999999999999999999888776
Q ss_pred HHHHHhhcc-CCCCCcccchHHHHHHHHhhcCCCCCCCC----HHHHhcCCCCCchhhh
Q 007266 211 LINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPS----AAELLCHPHLQPYVLG 264 (610)
Q Consensus 211 l~~~I~~~~-~~~~p~~~s~~l~~LI~kmL~~dP~~RpS----a~eiL~Hp~f~~~~~~ 264 (610)
.+..+.... ..+....++..++++|.+||..||+.||+ ++++|+||||+...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~ 298 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA 298 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence 666554322 22223337899999999999999999999 9999999999875443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=344.91 Aligned_cols=255 Identities=28% Similarity=0.519 Sum_probs=219.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||.|+||.||++.+..++..+++|.+....... ....+.+|+++++.++|+|++++++.+... ...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG-DELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-CEEEEEE
Confidence 68999999999999999999999899999999987554443 556789999999999999999999987654 5889999
Q ss_pred eecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~-~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
||+.|++|.+++..... ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999986432 468999999999999999999999999999999999999999999999999987764332
Q ss_pred ---ccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC-----cccch
Q 007266 159 ---LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-----TVYSG 229 (610)
Q Consensus 159 ---~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p-----~~~s~ 229 (610)
.....+|+..|++||++... .++.++|+|||||++|+|++|..||...+....+..+........+ ..++.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 22445789999999998776 7889999999999999999999999887766555555443322222 25678
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.+.+||.+||..||++||++.+++.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=375.12 Aligned_cols=263 Identities=27% Similarity=0.460 Sum_probs=232.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
++.|...++||+||||.||.++.+.+|+.||+|++.+.+...+ ......+|..||.+++.++||.+-.+|...+ .+|+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-~LCl 262 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-ALCL 262 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-ceEE
Confidence 4678999999999999999999999999999999976665433 3345778999999999999999988876554 8999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|+..|+||+|..+|-+.++..|+|..++.|+.+|+.||++||..+||+|||||+|||||+.|+|+|.|+|+|..+.....
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 99999999999999888878899999999999999999999999999999999999999999999999999999887777
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHH---HHHHHhhccCCCCCcccchHHHHHHH
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA---LINKINKSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~---l~~~I~~~~~~~~p~~~s~~l~~LI~ 236 (610)
....+||.+|||||++.+..|+...|+|||||+||||+.|..||+...... .+.+.........+..+|+++++|++
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~ 422 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCE 422 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHH
Confidence 777799999999999999999999999999999999999999998654322 23333344455578899999999999
Q ss_pred HhhcCCCCCCC-----CHHHHhcCCCCCchhhh
Q 007266 237 SMLRKNPEFRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 237 kmL~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
.+|++||.+|. .++++.+||||+...+.
T Consensus 423 ~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 423 GLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred HHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 99999999996 57899999999986554
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=359.82 Aligned_cols=247 Identities=26% Similarity=0.441 Sum_probs=195.6
Q ss_pred EeEecccCceEEEEEEEeC--CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEEEEEEee
Q 007266 7 LEQIGKGSFGSALLVRHKH--ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGY 83 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~--~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~~LVmEy 83 (610)
.+.||+|+||.||+|+++. +++.||+|.+...... ..+.+|+.+|++++||||+++++.|... +..+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 4689999999999999764 6789999998654332 2367899999999999999999988643 4578999999
Q ss_pred cCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe----cCCCCeeeeeccccc
Q 007266 84 CEGGDMAEAIKKAN-------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGDFGLAK 152 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~-------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL----~~~g~vKL~DFGlak 152 (610)
+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 95 58888876421 2358999999999999999999999999999999999999 455789999999998
Q ss_pred cccccc----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCH---------HHHHHHHhhc
Q 007266 153 MLISDD----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------QALINKINKS 218 (610)
Q Consensus 153 ~~~~~~----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~---------~~l~~~I~~~ 218 (610)
...... .....+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||..... ...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 754321 2345689999999999876 4589999999999999999999999964321 1122222111
Q ss_pred cCCC-------------------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 219 IVAP-------------------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 219 ~~~~-------------------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
...+ .....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1000 011134578899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=351.71 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=210.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++++.||.|+||.||++.+..++..||+|.+............+.+|+.+++.++||||+++++.+..+ ..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-SRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-CeEEEEEe
Confidence 59999999999999999999999999999999976544444445678899999999999999999988764 47899999
Q ss_pred ecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 83 YCEGGDMAEAIKKAN-GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~-~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
|+. ++|.+++.... +..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 997 58888886533 2468999999999999999999999999999999999999999999999999987653222 22
Q ss_pred ccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC-------------------
Q 007266 161 SSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------------------- 220 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~------------------- 220 (610)
....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 345778999999988654 578899999999999999999999987654433322211100
Q ss_pred ---------CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 221 ---------APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 221 ---------~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
......++.++.+||.+||+.||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.29 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=210.9
Q ss_pred EEEeEeccc--CceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 5 EVLEQIGKG--SFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 5 ~ilk~LG~G--~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+++++||+| +||+||++.+..+|+.||+|.+..........+.+.+|+.+++.++||||++++++|..++ ..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-EEEEEEe
Confidence 357899999 7899999999999999999999876655566677889999999999999999999887654 7899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-----
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD----- 157 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~----- 157 (610)
|+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999999998754446899999999999999999999999999999999999999999999999865443211
Q ss_pred ---cccccccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC------------
Q 007266 158 ---DLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------------ 220 (610)
Q Consensus 158 ---~~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~------------ 220 (610)
......+++..|+|||++.+ ..|+.++|||||||++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 11223467788999999876 4689999999999999999999999987654433322211110
Q ss_pred ---------------------------------CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 221 ---------------------------------APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 221 ---------------------------------~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+....+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112356789999999999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=343.38 Aligned_cols=251 Identities=42% Similarity=0.810 Sum_probs=223.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++.+.||.|+||.||++.+..+++.||+|.++.... ....+.+.+|+.+++.++|+||+++++.+... ..+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-GHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEe
Confidence 69999999999999999999999999999999875433 33456788899999999999999999987655 58899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|+.+++|.+++....+..++++.+..|+.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9999999999976555568999999999999999999999999999999999999999999999999987654332 334
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+......+.+..++..+++||.+||+.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence 56799999999999988899999999999999999999999999888887777777766677888999999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 007266 242 NPEFRPSAAELLCH 255 (610)
Q Consensus 242 dP~~RpSa~eiL~H 255 (610)
||++||++.+++.-
T Consensus 239 ~P~~Rp~~~~il~~ 252 (255)
T cd08219 239 NPRSRPSATTILSR 252 (255)
T ss_pred CcccCCCHHHHhhc
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.81 Aligned_cols=254 Identities=33% Similarity=0.586 Sum_probs=224.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||.|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++|+||+++++.+.+. ..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEE
Confidence 589999999999999999999999999999999875532 33345678999999999999999999987765 5899999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
||+.+++|.+++... .+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||+++..... ...
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999999999999864 6899999999999999999999999999999999999999999999999999876543 233
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcc-cchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV-YSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~-~s~~l~~LI~kmL 239 (610)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+........+.. ++..+.++|.+||
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 456789999999999988899999999999999999999999988776666666665555555555 8899999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCc
Q 007266 240 RKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
..+|++||+++++++||||+.
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred hCChhhCcCHHHHhhChhhcC
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=350.24 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=212.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||+|.+..........+.+.+|+.+++++.|+|++++++.+... ...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-RKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-CEEEEEE
Confidence 689999999999999999999999999999999875543333345678999999999999999999987755 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||++++.|..++.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred eccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9999988887776533 68999999999999999999999999999999999999999999999999998764433 23
Q ss_pred ccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC-------------------
Q 007266 161 SSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------------------- 220 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~------------------- 220 (610)
....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+.....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34578899999999865 5578999999999999999999999987765444333321100
Q ss_pred -CCC----------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 221 -APL----------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 221 -~~~----------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.+. ...++..+.+||.+||+.+|++||++.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 12357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=346.40 Aligned_cols=253 Identities=30% Similarity=0.504 Sum_probs=219.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-------HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-------DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-------~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 75 (610)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++||||+++++.+... .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-D 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-C
Confidence 588999999999999999999989999999988654332 12345688999999999999999999987665 4
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
+.++||||+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 7889999999999999998754 68999999999999999999999999999999999999999999999999988764
Q ss_pred ccc-------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccc
Q 007266 156 SDD-------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYS 228 (610)
Q Consensus 156 ~~~-------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s 228 (610)
... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+....+..+........+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS 237 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccC
Confidence 221 1123568899999999998889999999999999999999999998877655555555555556677889
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
..+.++|.+||+.||.+||++.++++||||
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=373.24 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=237.5
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
|.+.+.||+|.|++|-+++|.-+|..||||++.+...+......+.+|++.|+-+.|||||+++++. +....+|+|+|.
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-cccceEEEEEEe
Confidence 7788999999999999999999999999999998888887778899999999999999999999975 445589999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec-CCCCeeeeeccccccccccccccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASS 162 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~-~~g~vKL~DFGlak~~~~~~~~~~ 162 (610)
-+||+|+++|.++.. .+.|+.+++|+.||+.|+.|+|+.++|||||||+||.+. +-|-|||.|||++..+.+.....+
T Consensus 99 GD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred cCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 999999999988653 689999999999999999999999999999999999765 568899999999999988888899
Q ss_pred ccCCCcccCCccccCCCCC-CCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 163 VVGTPSYMCPELLADIPYG-SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~~yt-~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
.||+..|.|||++.+..|+ .++||||||||||-|++|++||+..+..+.+..|....+. .|..++.++++||..||..
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-vPshvS~eCrdLI~sMLvR 256 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-VPSHVSKECRDLIQSMLVR 256 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-CchhhhHHHHHHHHHHHhc
Confidence 9999999999999999995 5899999999999999999999999988999888877665 7899999999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCchhh
Q 007266 242 NPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
||.+|.+.++|..|+|+++...
T Consensus 257 dPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 257 DPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred CchhhccHHHHhccccccCCCC
Confidence 9999999999999999997543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=364.05 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=217.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 76 (610)
++|++++.||+|+||.||++.+..+++.||||.+............+.+|+.++++++|+||++++++|.... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 6899999999999999999999999999999998755444455566788999999999999999999876443 35
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
.|+||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 96 ~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred EEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 799999995 588888865 389999999999999999999999999999999999999999999999999987655
Q ss_pred ccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC-------------
Q 007266 157 DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------- 223 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~------------- 223 (610)
........+++.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+......+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 4444566789999999999999999999999999999999999999988776555444432211110
Q ss_pred -----------------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 224 -----------------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 224 -----------------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
+...+..+++||.+||+.||.+||++.|+|.||||+.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 1124567899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=348.57 Aligned_cols=254 Identities=27% Similarity=0.499 Sum_probs=216.0
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++.+.||.|+||.||+|.+..++..||+|.+............+.+|+.++++++|+||+++++.+... ...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-SGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-CeeEEEec
Confidence 69999999999999999999999999999999986655455556788999999999999999999987664 58899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--cc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LA 160 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~~ 160 (610)
|+ |++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99 999999997644 468999999999999999999999999999999999999999999999999988765433 23
Q ss_pred ccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-----------------
Q 007266 161 SSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------- 222 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----------------- 222 (610)
....|+..|+|||++.+. .++.++|||||||++|+|++|.++|.+......+..+......+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 456789999999988654 46899999999999999999999998776555554443322111
Q ss_pred ------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 223 ------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 223 ------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
.....+..+.+||.+||..+|++||+++++|+||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1123568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=346.52 Aligned_cols=252 Identities=27% Similarity=0.549 Sum_probs=221.2
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+|++.+.||.|+||.||++.+..+++.||+|.+....... ...+.+.+|++++++++||||+++++.+.. +...|+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence 5999999999999999999999999999999997544322 455778999999999999999999988764 45889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.|++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 80 DLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred eCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 9999999999998753 68999999999999999999999999999999999999999999999999988765544445
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH---HHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---QALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~---~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
...|+..|+|||++....++.++|+|||||++|+|++|..||...+. ..+.... .......+..++..+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ-ETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh-ccccccCcccCcHHHHHHHHHH
Confidence 67789999999999988899999999999999999999999987763 3333333 3244556777899999999999
Q ss_pred hcCCCCCCCCH--HHHhcCCCC
Q 007266 239 LRKNPEFRPSA--AELLCHPHL 258 (610)
Q Consensus 239 L~~dP~~RpSa--~eiL~Hp~f 258 (610)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.80 Aligned_cols=255 Identities=47% Similarity=0.857 Sum_probs=231.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++.+.||.|+||.||++.+..++..||+|.+............+.+|+++++.++|+|++++++.+... ...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence 69999999999999999999999999999999987666666677789999999999999999999988765 58899999
Q ss_pred ecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 83 YCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
|++|++|.+++.... +..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999999998753 3579999999999999999999999999999999999999999999999999987764443 3
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+......+++..++..+.++|.+||
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 44568899999999999888999999999999999999999999988888888877777777788889999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCC
Q 007266 240 RKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f 258 (610)
..+|++||++.++|+||||
T Consensus 240 ~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 240 QKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=354.78 Aligned_cols=254 Identities=33% Similarity=0.550 Sum_probs=215.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|++++++++||||+++++.+..++ .+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-EISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-EEEEEe
Confidence 58999999999999999999999999999999986443 3344566889999999999999999999887654 889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
||++|++|.+++++.. .+++..+..++.||+.||.|||+ ++++||||||+|||++.++.++|+|||++..... ...
T Consensus 79 ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~ 155 (308)
T cd06615 79 EHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMA 155 (308)
T ss_pred eccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc-ccc
Confidence 9999999999998754 68999999999999999999997 5999999999999999999999999999876532 234
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc---------------------
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI--------------------- 219 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~--------------------- 219 (610)
...+|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 56789999999999988889999999999999999999999997655444333221110
Q ss_pred ---------------CCCCC-cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 220 ---------------VAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 220 ---------------~~~~p-~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
....+ ..++.++++||.+||..+|++||++.++++||||..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00111 136788999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=351.38 Aligned_cols=253 Identities=27% Similarity=0.479 Sum_probs=208.8
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++++.||+|+||.||++++..+|+.||+|.+............+.+|+.++++++|+||+++++++... ..+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-KKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-CceEEEEe
Confidence 69999999999999999999999999999999976544433345577899999999999999999988655 47899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~~ 161 (610)
|+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus 80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 80 YCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 996 58888877643 36899999999999999999999999999999999999999999999999998765332 2233
Q ss_pred cccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCcc-ccccCHHHHHHHHhhccCC------------------
Q 007266 162 SVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVA------------------ 221 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~P-F~~~~~~~l~~~I~~~~~~------------------ 221 (610)
...+++.|+|||++.+. .++.++|||||||++|+|++|..| |.+.+..+.+..+......
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 45788999999988764 478999999999999999998877 4555554444443221110
Q ss_pred ----------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 222 ----------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 222 ----------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.....++.++++||.+||+.||.+|||++++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=400.94 Aligned_cols=260 Identities=32% Similarity=0.562 Sum_probs=220.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~~L 79 (610)
+++|++++.||+|+||.||+|++..++..||+|.+............+.+|+.+|++|.|||||++++.|... ...+||
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 4789999999999999999999999999999999987666666667789999999999999999999988754 457899
Q ss_pred EEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CeecccCCCCceEecCC----------
Q 007266 80 IIGYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHAN-------HILHRDVKCSNIFLTRD---------- 140 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~-------gIiHRDLKPeNILL~~~---------- 140 (610)
||||+.+++|.++|.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 999999999999997531 23689999999999999999999995 49999999999999642
Q ss_pred -------CCeeeeecccccccccccccccccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCccccccCH-HH
Q 007266 141 -------QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QA 210 (610)
Q Consensus 141 -------g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~-~~ 210 (610)
+.+||+|||++............+||+.|+|||++.+ ..++.++||||||||||+|++|..||...+. ..
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q 251 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence 3489999999987655555566789999999999864 4588999999999999999999999976543 33
Q ss_pred HHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 211 LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 211 l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
++..+...... ....++..+.+||..||..+|.+||++.|+|.|+|++..
T Consensus 252 li~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 252 LISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 44444333222 224578899999999999999999999999999999754
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.73 Aligned_cols=251 Identities=27% Similarity=0.502 Sum_probs=212.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||+|.+.... .......+.+|++++++++||||+++++.+...+ ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-RISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-EEEEEE
Confidence 58999999999999999999999999999999986543 3344566889999999999999999999887654 788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+++++|..+. .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~ 151 (279)
T cd06619 79 EFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAK 151 (279)
T ss_pred ecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-ccc
Confidence 999999996542 4789999999999999999999999999999999999999999999999999765432 344
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH-------HHHHHHHhhccCCCC-CcccchHHHH
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-------QALINKINKSIVAPL-PTVYSGAFRG 233 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~-------~~l~~~I~~~~~~~~-p~~~s~~l~~ 233 (610)
..+||..|+|||++.+..++.++|+|||||++|+|++|..||..... ......+........ ...++.++++
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 56899999999999998999999999999999999999999965321 122222222222222 3347889999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
||.+||+.+|++||+++++++||||+..
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.59 Aligned_cols=252 Identities=31% Similarity=0.527 Sum_probs=216.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||.|+||.||++.+..+++.+++|.+...... ..+.+.+|+.++++++||||+++++.+... ..+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRR-DKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeC-CEEEEEE
Confidence 6899999999999999999999999999999999754333 456788999999999999999999987654 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||+.|++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 80 EYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred eCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999999999987752 368999999999999999999999999999999999999999999999999987654332 23
Q ss_pred ccccCCCcccCCccccCC---CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC----CCCcccchHHHH
Q 007266 161 SSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~---~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~----~~p~~~s~~l~~ 233 (610)
....++..|+|||++.+. .++.++|+|||||++|+|++|.+||...+.......+...... ..+..++.++.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 456789999999998776 7889999999999999999999999887655544444333111 123456788999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPH 257 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~ 257 (610)
||.+||..+|..||++.+++.|+|
T Consensus 239 li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=354.68 Aligned_cols=258 Identities=30% Similarity=0.467 Sum_probs=215.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~~~L 79 (610)
+++|++++.||.|+||.||++.+..+++.||+|.+............+.+|+.++++++|+||+++++.+.... ..+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 57899999999999999999999999999999999755443332334567999999999999999999887543 46899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||||+. ++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 999996 48888887643 468999999999999999999999999999999999999999999999999998764332
Q ss_pred ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC--------------
Q 007266 159 LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-------------- 223 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~-------------- 223 (610)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 2233456888999998865 5578999999999999999999999998887776665543221110
Q ss_pred ---------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 224 ---------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 224 ---------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
...++..+.+||.+||+.||++|||+.++|.||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0124788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=345.81 Aligned_cols=253 Identities=26% Similarity=0.504 Sum_probs=214.1
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecC-----cE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~-----~~ 76 (610)
.|++.+.||+|+||.||++.+..+++.||+|.+...... ...+.+|+.++.++ +|+|++++++.+...+ ..
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 588999999999999999999999999999998754332 24577899999998 6999999999887532 46
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+.+++|.+++.......+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 89999999999999999875555789999999999999999999999999999999999999999999999999876532
Q ss_pred c-cccccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc-CCCCCcccch
Q 007266 157 D-DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSG 229 (610)
Q Consensus 157 ~-~~~~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~-~~~~p~~~s~ 229 (610)
. .......|++.|+|||++. +..|+.++|||||||++|+|++|..||...........+.... ....+..++.
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 243 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCH
Confidence 2 2234567999999999986 3457889999999999999999999998766554444433322 2223345788
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.+.+||.+||..+|.+||++.+++.||||
T Consensus 244 ~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=349.26 Aligned_cols=253 Identities=22% Similarity=0.403 Sum_probs=220.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCC-----eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHER-----KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~-----~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 75 (610)
+++|++++.||+|+||.||++.+...+ ..||+|.+.... .......+.+|+.++.+++||||+++++.+... .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-Q 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-C
Confidence 368999999999999999999987655 689999886443 334456788999999999999999999987654 4
Q ss_pred EEEEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANG--------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~--------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
..|++|||+++++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 78899999999999999976421 3578999999999999999999999999999999999999999
Q ss_pred Ceeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhh
Q 007266 142 DIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINK 217 (610)
Q Consensus 142 ~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~ 217 (610)
.++|+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987653322 2334567889999999988889999999999999999997 9999999988888888877
Q ss_pred ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 218 ~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+.+..++.++.+|+.+||+.||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77777788899999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.87 Aligned_cols=252 Identities=31% Similarity=0.578 Sum_probs=216.0
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc----HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT----DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~----~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
+|++.+.||+|+||.||++.+ .+++.+|+|.+...... ......+.+|+.++++++|+||+++++.+.+. ...|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEE
Confidence 689999999999999999986 47889999998754322 23446688999999999999999999987765 5899
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc--
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-- 156 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-- 156 (610)
+||||+.|++|.+++.+.. .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 79 IFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999998754 689999999999999999999999999999999999999999999999999876422
Q ss_pred -----ccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhh--ccCCCCCcccch
Q 007266 157 -----DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK--SIVAPLPTVYSG 229 (610)
Q Consensus 157 -----~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~--~~~~~~p~~~s~ 229 (610)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.. ......+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 1123346789999999999998899999999999999999999999987665444333322 233456777899
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.+.++|.+||..+|++||++.++|.||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.45 Aligned_cols=257 Identities=33% Similarity=0.580 Sum_probs=217.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+.|++++.||+|+||.||++++..++..+++|.+... .....+.+.+|+.+++.++|+|++++++.+..++ .+|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-KLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-eEEEEE
Confidence 4699999999999999999999999999999998643 3344566888999999999999999999887654 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
||+.|++|..++.+.. ..+++..+..++.||+.+|.|||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus 89 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 89 EFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred ecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 9999999998886543 36899999999999999999999999999999999999999999999999988654322 223
Q ss_pred ccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--CCCcccchHHHH
Q 007266 161 SSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~--~~p~~~s~~l~~ 233 (610)
....+++.|+|||++. ...++.++|||||||++|+|++|.+||...+......++...... ..+..++.++.+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence 4567889999999885 345788999999999999999999999887765555555433222 234567889999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
||.+||..+|++||+++++++||||....
T Consensus 248 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 99999999999999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=344.64 Aligned_cols=256 Identities=29% Similarity=0.529 Sum_probs=208.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHH-HHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMEL-ISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~i-L~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++.+..+|+.||||.+.......... .+..|+.+ ++.++||||+++++.+...+ .+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREG-DVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCC-cEEEE
Confidence 58999999999999999999999999999999997654443333 34456554 66778999999999887554 78999
Q ss_pred EeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 81 IGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|||++ ++|.+++... ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 6888887642 234689999999999999999999998 9999999999999999999999999998876443
Q ss_pred cccccccCCCcccCCccccC----CCCCCCccccccchhHHhhhhcCccccccC--HHHHHHHHhhccCCCC-CcccchH
Q 007266 158 DLASSVVGTPSYMCPELLAD----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPL-PTVYSGA 230 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~----~~yt~ksDIWSLG~iLyeLltG~~PF~~~~--~~~l~~~I~~~~~~~~-p~~~s~~ 230 (610)
.......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.... ...+... ........ ...++.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VEEPSPQLPAEKFSPE 236 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH-HhcCCCCCCccccCHH
Confidence 33344678999999998864 456889999999999999999999997532 2233322 22222223 2357899
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+.++|.+||..+|++||++.+++.||||+..
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 9999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=346.50 Aligned_cols=251 Identities=28% Similarity=0.512 Sum_probs=210.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-DKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEEEEEE
Confidence 478889999999999999999999999999999875432 2234578899999999999999999988765 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||+++++|.+++...+ .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 86 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 86 EFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred eccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 9999999999997754 68999999999999999999999999999999999999999999999999987653221 23
Q ss_pred ccccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC-C-C--CcccchHHHH
Q 007266 161 SSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-P-L--PTVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-~-~--p~~~s~~l~~ 233 (610)
....|++.|+|||++. ...++.++|+|||||++|+|++|..||...........+...... + . ...++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 4568999999999874 455788999999999999999999998765543333222222111 1 1 1246788999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPH 257 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~ 257 (610)
+|.+||..+|++||+++++++|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=340.80 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=217.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc---cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ---TDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCY 76 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~---~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~ 76 (610)
+++|++.+.||+|+||.||++.+..++..||||.+..... .....+.+.+|+.+++++.||||+++++.+.+. +..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 4689999999999999999999999999999998864332 233456788999999999999999999987654 357
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+++||||+.|++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 889999999999999998754 589999999999999999999999999999999999999999999999999876532
Q ss_pred cc----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc-CCCCCcccchHH
Q 007266 157 DD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAF 231 (610)
Q Consensus 157 ~~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~-~~~~p~~~s~~l 231 (610)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|..||...+....+..+.... ....+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 21 1234578999999999988889999999999999999999999998776555444443332 333566788899
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
.++|.+||. +|+.||+++++++|||+.
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 999999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.24 Aligned_cols=254 Identities=25% Similarity=0.482 Sum_probs=214.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEee-----cCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE-----KGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~-----~~~ 75 (610)
..|++.+.||.|+||.||++.+..+++.+|+|.+.... .....+..|+.++.++ +|+||+++++.|.. .+.
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 46899999999999999999999999999999886432 2334578899999998 69999999998863 245
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+|++|||+.+++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 78999999999999999987655578999999999999999999999999999999999999999999999999987653
Q ss_pred cc-cccccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC-CCCcccc
Q 007266 156 SD-DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYS 228 (610)
Q Consensus 156 ~~-~~~~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-~~p~~~s 228 (610)
.. ......+|++.|+|||++. ...++.++|||||||++|+|++|..||...........+...... .....++
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS 252 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence 22 2234567999999999876 346788999999999999999999999876654444433333222 2234578
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
..+.+||.+||..||.+||++.|+|+||||
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.49 Aligned_cols=255 Identities=36% Similarity=0.747 Sum_probs=223.8
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++.+.||+|+||.||++.+..++..+|+|.+..........+.+.+|+.+++.++|+||+++++.+.. +...|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence 6999999999999999999999999999999997654444455678899999999999999999997765 458899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC-eeeeeccccccccccc-cc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-IRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~-vKL~DFGlak~~~~~~-~~ 160 (610)
|+.+++|.+++....+..+++..+..++.||+.||.|||+++++|+||||+||+++.++. ++|+|||.+....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999998765556899999999999999999999999999999999999998865 6999999987764332 22
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+......+.+..++..++++|.+||.
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 34568999999999988889999999999999999999999999887777776666655555666788999999999999
Q ss_pred CCCCCCCCHHHHhcCCCC
Q 007266 241 KNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f 258 (610)
.+|++||++.++++||||
T Consensus 240 ~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 240 VSPRDRPSITSILKRPFL 257 (257)
T ss_pred cChhhCcCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=345.58 Aligned_cols=256 Identities=33% Similarity=0.565 Sum_probs=220.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||.|+||.||++.+..+++.+|+|.+...... .....+.+|+++++.+.||||+++++.+... ..+++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEE
Confidence 5799999999999999999999999999999998765433 4456688999999999999999999988766 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
||+.|++|.+++.... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||.+....... .
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~ 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-A 156 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-h
Confidence 9999999999998753 478999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc-----CHHHHHHHHhhccCCCCCcc-cchHHHHH
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-----DMQALINKINKSIVAPLPTV-YSGAFRGL 234 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~-----~~~~l~~~I~~~~~~~~p~~-~s~~l~~L 234 (610)
....++..|+|||.+.+..++.++|||||||++|+|++|..||... ...+....+........+.. ++.+++++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 2378899999999999989999999999999999999999999754 23444444444443344444 88999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
|.+||..||++||++.+++.||||+.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=348.47 Aligned_cols=256 Identities=32% Similarity=0.570 Sum_probs=220.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||.|+||.||++.+..++..||+|.+... .....+.+.+|++++++++|+||+++++.+... ...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-NKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-CeEEEEe
Confidence 6799999999999999999999989999999998643 333446688999999999999999999988765 4889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
||+.|++|.+++.+.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 82 EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999999987643 36899999999999999999999999999999999999999999999999988664332 223
Q ss_pred ccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--CCCcccchHHHH
Q 007266 161 SSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~--~~p~~~s~~l~~ 233 (610)
....|++.|+|||++. ...++.++|||||||++|+|++|.+||...+....+..+...... ..+..++..+.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 4567999999999875 345678999999999999999999999988876666666544322 235568899999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+|.+||+.+|.+||++.++|+||||...
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 241 FLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=345.31 Aligned_cols=254 Identities=30% Similarity=0.524 Sum_probs=216.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
-|++++.||.|+||.||++.+..++..+++|.+.... ....+.+.+|+++++.++|+|++++++.+...+ ..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-EEEEEEE
Confidence 4788999999999999999999999999999986432 334566888999999999999999999887654 7899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~~ 161 (610)
|+.+++|..++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred ecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999999998876532 36899999999999999999999999999999999999999999999999998664322 2234
Q ss_pred cccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC--CCCCcccchHHHHH
Q 007266 162 SVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGL 234 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--~~~p~~~s~~l~~L 234 (610)
...|++.|+|||++. +..++.++|||||||++|+|++|.+||...+.......+..... ...+..++..+++|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 567999999999874 45578899999999999999999999998876666555544332 22355688999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|.+||+.||.+||+++++++||||..
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEec
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.50 Aligned_cols=253 Identities=34% Similarity=0.608 Sum_probs=219.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc---cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ---TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~---~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+|+..+.||+|+||.||++.+..++..|++|.+..... .....+.+.+|+.+++.++|+||+++++.+... ..+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-CeEEE
Confidence 58899999999999999999998899999999865442 234556789999999999999999999976544 58899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
++||+.|++|.+++.+.. .+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 999999999999998754 589999999999999999999999999999999999999999999999999887654444
Q ss_pred cccccCCCcccCCccccCCC-CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhh-ccCCCCCcccchHHHHHHHH
Q 007266 160 ASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK-SIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~-yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~-~~~~~~p~~~s~~l~~LI~k 237 (610)
.....|++.|++||.+.... ++.++|+|||||++|+|++|..||...........+.. ......+..++..+.++|.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 45677999999999987766 89999999999999999999999987775555555444 33344566789999999999
Q ss_pred hhcCCCCCCCCHHHHhcCCCC
Q 007266 238 MLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f 258 (610)
||..+|.+||++.++|.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=339.32 Aligned_cols=256 Identities=33% Similarity=0.588 Sum_probs=226.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|++|.||++.+..+++.|++|++...... .....+.+|+.++.+++|+|++++++.+... ...++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEE
Confidence 5799999999999999999999999999999998765443 4456788999999999999999999988765 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
||+.|++|.+++.... .+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999998753 68999999999999999999999 99999999999999999999999999998876543322
Q ss_pred -ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc---CHHHHHHHHhhccCCCCCcc-cchHHHHHH
Q 007266 161 -SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVAPLPTV-YSGAFRGLV 235 (610)
Q Consensus 161 -~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~---~~~~l~~~I~~~~~~~~p~~-~s~~l~~LI 235 (610)
....++..|+|||.+....++.++|+|||||++|+|++|..||... ...+....+........+.. ++..+.++|
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 3567889999999999888999999999999999999999999877 55566666666555566666 899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||..+|+.||++.++++||||+.+
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.74 Aligned_cols=257 Identities=28% Similarity=0.526 Sum_probs=217.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++++++|+||+++++.+... ..+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-GAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-CeEEEEE
Confidence 58999999999999999999999999999999987543 333446788999999999999999999987765 4889999
Q ss_pred eecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 82 GYCEGGDMAEAIKKAN-GVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~-~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||+.|++|..++.... ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++..... ..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~ 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SL 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC-Cc
Confidence 9999999999887631 2368999999999999999999997 5999999999999999999999999999876532 23
Q ss_pred cccccCCCcccCCccccCC------CCCCCccccccchhHHhhhhcCccccccCHHHHHHH---HhhccCCCCCcccchH
Q 007266 160 ASSVVGTPSYMCPELLADI------PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK---INKSIVAPLPTVYSGA 230 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~------~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~---I~~~~~~~~p~~~s~~ 230 (610)
....++++.|+|||++.+. .++.++|||||||++|+|++|..||........... +........+..++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 4456789999999998543 357899999999999999999999976654444333 3334444566678999
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+.+||.+||+.+|++||+++++++||||...
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=341.95 Aligned_cols=255 Identities=31% Similarity=0.526 Sum_probs=215.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc---cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ---TDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~---~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~ 77 (610)
..|++.+.||+|+||.||++.+..++..|++|.+..... .......+.+|+.++++++||||+++++.+... +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 369999999999999999999999999999999865432 223446688999999999999999999987653 4678
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
+++|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 99999999999999998754 5899999999999999999999999999999999999999999999999998754321
Q ss_pred ----cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc-CCCCCcccchHHH
Q 007266 158 ----DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFR 232 (610)
Q Consensus 158 ----~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~-~~~~p~~~s~~l~ 232 (610)
.......++..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ....+..++..++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence 11223568899999999998889999999999999999999999998776555444443322 2334666788999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
++| .||..+|++||+++|+++||||+
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=343.97 Aligned_cols=255 Identities=28% Similarity=0.509 Sum_probs=214.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecC----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKG----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~----~~ 76 (610)
++|++.+.||+|+||.||++.+..+++.+|+|.+..... ....+.+|+.+++++ +|||++++++.+...+ ..
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 679999999999999999999999999999999864322 234567899999998 7999999999887543 46
Q ss_pred EEEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
+|+||||+.|++|.++++.. .+..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 89999999999999988642 2346899999999999999999999999999999999999999999999999998765
Q ss_pred cccc-ccccccCCCcccCCccccCC-----CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--CCcc
Q 007266 155 ISDD-LASSVVGTPSYMCPELLADI-----PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTV 226 (610)
Q Consensus 155 ~~~~-~~~~~vGTp~Y~APEvl~~~-----~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--~p~~ 226 (610)
.... ......|+..|+|||++... .++.++|||||||++|+|++|.+||...+.......+....... .+..
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEK 258 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccc
Confidence 4332 23346789999999987643 36789999999999999999999998877655555554433222 2445
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
++..+.+||.+||+.+|++||++.++++||||+
T Consensus 259 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 778899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=344.26 Aligned_cols=254 Identities=28% Similarity=0.528 Sum_probs=212.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEee----cCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE----KGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~----~~~~ 76 (610)
++|++++.||+|+||.||++.+..+++.+|+|.+...... ...+.+|+.+++.+ +|+||+++++.+.. .+..
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch---HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 6899999999999999999999999999999987643222 24577899999999 69999999998753 3457
Q ss_pred EEEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
+++||||++|++|.+++... ....+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||++...
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 89999999999999988632 2346899999999999999999999999999999999999999999999999998765
Q ss_pred cccc-ccccccCCCcccCCccccC-----CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC--CCCCcc
Q 007266 155 ISDD-LASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTV 226 (610)
Q Consensus 155 ~~~~-~~~~~vGTp~Y~APEvl~~-----~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--~~~p~~ 226 (610)
.... ......|++.|+|||++.. ..++.++|||||||++|+|++|..||........+..+..... ...+..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL 254 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCC
Confidence 4332 2344579999999998753 4578899999999999999999999987765444433332221 123455
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
++..+.+||.+||+.||++||++.|+|+|+||
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=341.01 Aligned_cols=250 Identities=28% Similarity=0.522 Sum_probs=217.9
Q ss_pred ecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCC
Q 007266 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 88 (610)
Q Consensus 10 LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Ggs 88 (610)
||.|+||.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++.+... ..+|+||||+.|++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-KYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-CccEEEEecCCCCc
Confidence 79999999999999988999999999754432 33456789999999999999999999977654 57899999999999
Q ss_pred HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccccccCCCc
Q 007266 89 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS 168 (610)
Q Consensus 89 L~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~ 168 (610)
|.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++............+|++.
T Consensus 80 L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 80 LWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 999998754 589999999999999999999999999999999999999999999999999987655444445688999
Q ss_pred ccCCccccCCCCCCCccccccchhHHhhhhcCccccccC--HHHHHHHHhh-ccCCCCCcccchHHHHHHHHhhcCCCCC
Q 007266 169 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINK-SIVAPLPTVYSGAFRGLVKSMLRKNPEF 245 (610)
Q Consensus 169 Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~--~~~l~~~I~~-~~~~~~p~~~s~~l~~LI~kmL~~dP~~ 245 (610)
|++||++.+..++.++|+|||||++|+|++|..||.... .......+.. ......+...+..++++|.+||+.+|++
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 237 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence 999999988889999999999999999999999998776 6666666553 3344456667899999999999999999
Q ss_pred CCC-----HHHHhcCCCCCchh
Q 007266 246 RPS-----AAELLCHPHLQPYV 262 (610)
Q Consensus 246 RpS-----a~eiL~Hp~f~~~~ 262 (610)
||+ ++|+++||||+++.
T Consensus 238 R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 238 RLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred CcCCcccCHHHHhcChhhhCCC
Confidence 999 99999999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=341.92 Aligned_cols=254 Identities=28% Similarity=0.533 Sum_probs=214.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc----HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT----DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~----~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ....+.+.+|++++++++|+||+++++.+... ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-SHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-CeEE
Confidence 589999999999999999999999999999999754421 22456788999999999999999999987655 4788
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeecccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~~~~~ 157 (610)
+||||+.|++|.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999998754 689999999999999999999999999999999999998776 4999999998766432
Q ss_pred c-----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHh----hccCCCCCcccc
Q 007266 158 D-----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN----KSIVAPLPTVYS 228 (610)
Q Consensus 158 ~-----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~----~~~~~~~p~~~s 228 (610)
. .....+|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+. .......+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 2234578999999999988889999999999999999999999997554322222221 122344566788
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
..+.++|.+||..+|++||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=339.75 Aligned_cols=254 Identities=30% Similarity=0.555 Sum_probs=214.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec-----Cc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK-----GC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~-----~~ 75 (610)
++|++.+.||.|+||.||+|.+..+++.+++|.+..... ..+.+.+|+.+++++ .|+||+++++.+... +.
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 689999999999999999999998999999999875433 235688999999999 799999999988753 34
Q ss_pred EEEEEEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
.+|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 6899999999999999987533 45789999999999999999999999999999999999999999999999999876
Q ss_pred cccc-cccccccCCCcccCCccccC-----CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC--Cc
Q 007266 154 LISD-DLASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PT 225 (610)
Q Consensus 154 ~~~~-~~~~~~vGTp~Y~APEvl~~-----~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--p~ 225 (610)
.... .......|+..|+|||++.. ..++.++|||||||+||+|++|..||...........+........ +.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE 242 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchh
Confidence 4322 22345678999999998753 3467899999999999999999999987665555555544332222 23
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.++..+++||.+||..||++|||+.+++.|||+
T Consensus 243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 478899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=362.88 Aligned_cols=248 Identities=29% Similarity=0.420 Sum_probs=200.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.+|++++.||+|+||.||++.+..++..||+|..... ....|+.++++++|+||+++++.+...+ ..|+||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGA-ITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCC-eeEEEE
Confidence 3699999999999999999999999999999975422 1346899999999999999999887654 788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||+++.........
T Consensus 137 e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 9995 68888887643 368999999999999999999999999999999999999999999999999997654444445
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcc-ccccCH----------HHHHHHHhhcc--CCCCC----
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA-FKAFDM----------QALINKINKSI--VAPLP---- 224 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~P-F~~~~~----------~~l~~~I~~~~--~~~~p---- 224 (610)
...||+.|+|||++.+..|+.++|||||||++|||+++..+ |..... ..+...+.... ...++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 67899999999999999999999999999999999975444 433211 11111111100 00000
Q ss_pred --------------------------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 225 --------------------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 225 --------------------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 134567778999999999999999999999999975
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.12 Aligned_cols=254 Identities=29% Similarity=0.467 Sum_probs=212.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++++.||.|+||.||++++..+++.||||.+............+.+|++++++++||||+++++.+... ...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-CcEEEEee
Confidence 58999999999999999999999999999999876554444445688999999999999999999987654 57899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|+. ++|.+++.......+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 995 689998877555678999999999999999999999999999999999999999999999999987654322 223
Q ss_pred cccCCCcccCCccccCCC-CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC------------------
Q 007266 162 SVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------ 222 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~-yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------------ 222 (610)
...+++.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+......+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 456788999999887644 5889999999999999999999998776544433332211110
Q ss_pred ----------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 ----------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 ----------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....++.+++++|.+||+.||.+||+++++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=352.87 Aligned_cols=253 Identities=27% Similarity=0.454 Sum_probs=218.4
Q ss_pred CCeEE-EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEee---cCcE
Q 007266 2 EQYEV-LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE---KGCY 76 (610)
Q Consensus 2 d~Y~i-lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~---~~~~ 76 (610)
++|.+ -++||-|-.|.|..|.++.+++.+|+|++.. .+ .+.+|+++.-.. .|||||.++++|.. ....
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---s~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---SP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---CH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56766 4689999999999999999999999998862 22 356788875554 69999999998753 2335
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeeecccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKM 153 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~DFGlak~ 153 (610)
+.+|||.++||.|+..|+.++...|+|.++..|++||..|+.|||+.+|.||||||+|+|....+ .+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 67999999999999999998888899999999999999999999999999999999999997654 599999999998
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC----HHHHHHHHhhc---cCCCCCcc
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKS---IVAPLPTV 226 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~----~~~l~~~I~~~---~~~~~p~~ 226 (610)
........+.|.||.|+|||++....|+...|+||+||+||.|++|.+||.... ...+..+|..+ +..+.+..
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 876677788999999999999999999999999999999999999999997553 23345555443 34445566
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+|+.++++|+++|..+|.+|.|+.++++|||+..+
T Consensus 294 VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 89999999999999999999999999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.94 Aligned_cols=251 Identities=29% Similarity=0.488 Sum_probs=209.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||+|++...... ....+.+|+.++++++||||+++++.+... ..+|+||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEE
Confidence 5799999999999999999999999999999998754322 234578899999999999999999988765 4788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 86 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 86 EYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 9999999999997654 68999999999999999999999999999999999999999999999999997654322 23
Q ss_pred ccccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc-CC---CCCcccchHHHH
Q 007266 161 SSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VA---PLPTVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~-~~---~~p~~~s~~l~~ 233 (610)
....|++.|+|||.+. ...++.++|+|||||++|+|++|..||...........+.... .. .....++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 4567899999999874 4457889999999999999999999997655433332222211 11 112347889999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPH 257 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~ 257 (610)
||.+||..+|++||+++++|+|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=348.04 Aligned_cols=253 Identities=28% Similarity=0.499 Sum_probs=217.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.+|++++.||+|+||.||++.+..++..|++|.+...... ..+.+.+|+.+++.+.|+|++++++.|... ...|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-CEEEEee
Confidence 5899999999999999999999999999999998754433 235688999999999999999999987754 4889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||+.|++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred cccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 999999999998753 57999999999999999999999999999999999999999999999999987654332 23
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC--CCCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--~~~p~~~s~~l~~LI~km 238 (610)
....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..... .+.+..++..+.+||.+|
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence 345789999999999988889999999999999999999999987765444333322222 223556888999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|..+|++||++.++++||||..
T Consensus 254 l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 254 LDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred CcCCcccCcCHHHHhhChhhhc
Confidence 9999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.09 Aligned_cols=254 Identities=27% Similarity=0.477 Sum_probs=214.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..+++.||+|.+..........+.+.+|+++++++.|+||+++++.+.. +...++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence 57999999999999999999999999999999987655555556778999999999999999999998876 45889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||+.++.+..++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 80 EYVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred ecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9998877766555433 58999999999999999999999999999999999999999999999999988765443 3
Q ss_pred cccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC------------------
Q 007266 160 ASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------------------ 220 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~------------------ 220 (610)
....+++..|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+.....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 4457889999999999887 789999999999999999999999987665443333221100
Q ss_pred -------------CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 221 -------------APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 221 -------------~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
...+..++.++++||++||..+|++||++++++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01123358889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=346.82 Aligned_cols=259 Identities=28% Similarity=0.443 Sum_probs=215.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++.+.||+|+||.||++.+..+++.||+|.+..........+.+.+|++++++++|+||+++++.+... ...|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEE
Confidence 6899999999999999999999999999999999876554444456688999999999999999999988755 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-CCCeeeeecccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISD-D 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-~g~vKL~DFGlak~~~~~-~ 158 (610)
|||+. ++|.+++.......+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++...... .
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99995 58888887655556789999999999999999999999999999999999985 456999999999765322 1
Q ss_pred ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC---------------
Q 007266 159 LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--------------- 222 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--------------- 222 (610)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+.++......+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 2234577899999998865 457899999999999999999999998776655554433211110
Q ss_pred -------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 223 -------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 223 -------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
....++..+.++|.+||+.+|++||++.++|.||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 012467889999999999999999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.93 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=215.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~~~L 79 (610)
+++|++.+.||.|+||.||+|.+..+++.+|+|.+............+.+|+.++++++||||+++++++...+ ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46899999999999999999999999999999999766544444445678999999999999999999877652 58999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-c
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-D 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~ 158 (610)
||||+. ++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++...... .
T Consensus 84 v~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 84 VMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 999997 49999887644 26899999999999999999999999999999999999999999999999998876543 2
Q ss_pred ccccccCCCcccCCccccCCC-CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC-----------------
Q 007266 159 LASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----------------- 220 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~-yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~----------------- 220 (610)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||......+.+.++.....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 334467889999999887644 68899999999999999999999988776665555432211
Q ss_pred -------------CCCCcc-cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 221 -------------APLPTV-YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 221 -------------~~~p~~-~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
...+.. +++.+.+||++||+.+|++|||+.|+|.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 111222 57889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=346.60 Aligned_cols=257 Identities=30% Similarity=0.524 Sum_probs=219.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++.+..+++.||+|.+...... ......+.+|+++++.++||||+++++.+... .++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-RHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-CEEEEE
Confidence 5799999999999999999999999999999998754322 23445688999999999999999999887654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--- 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--- 157 (610)
|||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 80 MEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999999999997754 6899999999999999999999999999999999999999999999999998642110
Q ss_pred -------------cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC-CC-
Q 007266 158 -------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-AP- 222 (610)
Q Consensus 158 -------------~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~-~~- 222 (610)
.......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+....++...+..... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 011234678899999999888899999999999999999999999998888777777654422 11
Q ss_pred CCcccchHHHHHHHHhhcCCCCCCCC---HHHHhcCCCCCch
Q 007266 223 LPTVYSGAFRGLVKSMLRKNPEFRPS---AAELLCHPHLQPY 261 (610)
Q Consensus 223 ~p~~~s~~l~~LI~kmL~~dP~~RpS---a~eiL~Hp~f~~~ 261 (610)
....++..++++|.+||+.+|++||+ +.++|+||||...
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 22357889999999999999999997 8999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=337.56 Aligned_cols=251 Identities=33% Similarity=0.607 Sum_probs=217.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||.|+||.||++.+..++..|++|.+..... ...+.+|+.++++++|+||+++++.+... ..+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEE
Confidence 689999999999999999999998899999999864432 56788999999999999999999988765 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||+.+++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 78 EYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred ecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999999999997633 468999999999999999999999999999999999999999999999999988764433 23
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC--CCCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--~~~p~~~s~~l~~LI~km 238 (610)
....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..... ...+..++..+.++|.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 445688999999999988999999999999999999999999987765544433322221 123445788999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCC
Q 007266 239 LRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f 258 (610)
|+.||++||++.|+|.||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=335.27 Aligned_cols=254 Identities=36% Similarity=0.733 Sum_probs=228.2
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++.+.||+|+||.||++.+..+++.+|+|.+............+.+|+.++++++|+||+++++.+... ...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence 69999999999999999999999999999999987665555566788999999999999999999988765 58899999
Q ss_pred ecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 83 YCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 83 y~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|+.|++|.+++... ....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence 99999999998762 2246899999999999999999999999999999999999999999999999999876544 44
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
....+++.|++||.+.+..++.++|+||||+++|+|++|..||...+...+...+......+.+..++.+++++|.+||.
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence 45678999999999999899999999999999999999999999998888777777777677777899999999999999
Q ss_pred CCCCCCCCHHHHhcCCCC
Q 007266 241 KNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f 258 (610)
.+|++||++.++++||++
T Consensus 239 ~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 239 VKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.35 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=215.1
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc---HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT---DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~---~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+|++++.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|+||+++++.+.. +...++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence 699999999999999999999999999999999765543 3344567789999999999999999998876 458899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999 899999997643 368999999999999999999999999999999999999999999999999998764432
Q ss_pred ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC---------------
Q 007266 159 LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--------------- 222 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--------------- 222 (610)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.++|.+.+..+.+.++......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2334567889999998854 457899999999999999999999998777655555543321111
Q ss_pred ------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 223 ------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 223 ------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.....+..+.+||.+||..+|++||++.|+|.|+||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 11234678999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=346.34 Aligned_cols=254 Identities=29% Similarity=0.508 Sum_probs=219.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.+|++++.||.|+||.||++.+..+++.|++|.+...... ..+.+.+|+.+++.++|+|++.+++.+... ..+|+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVG-DELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecC-ceEEEEE
Confidence 4699999999999999999999999999999998754333 245678999999999999999999987654 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||+.|++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence 999999999988753 58999999999999999999999999999999999999999999999999987654433 23
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc--CCCCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI--VAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~--~~~~p~~~s~~l~~LI~km 238 (610)
....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.... ....+..++..+++||.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence 34578999999999998889999999999999999999999998877655544443322 2224556889999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCch
Q 007266 239 LRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
|..||.+||++.+++.||||+..
T Consensus 253 l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 253 LEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred hhcChhhCCCHHHHhhChHhhhc
Confidence 99999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=349.59 Aligned_cols=253 Identities=29% Similarity=0.510 Sum_probs=216.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.+|++++.||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++.+... ...|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEee
Confidence 5899999999999999999999999999999998754433 235688999999999999999999988654 4889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||++|++|.+++.+. .+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++....... ..
T Consensus 96 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred cccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 999999999999763 57999999999999999999999999999999999999999999999999987654332 23
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc--CCCCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI--VAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~--~~~~p~~~s~~l~~LI~km 238 (610)
....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.... ....+..++..+++||.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 34678999999999999889999999999999999999999998765433322222211 1223556788999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|..+|++||+++++|+||||+.
T Consensus 253 l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 253 LEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred ccCChhhCcCHHHHhcCchhcc
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=347.67 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=193.9
Q ss_pred EeEecccCceEEEEEEEeC--CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee-cCcEEEEEEee
Q 007266 7 LEQIGKGSFGSALLVRHKH--ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGY 83 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~--~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~-~~~~~~LVmEy 83 (610)
...||+|+||.||+|++.. ++..||+|.+...... ..+.+|+.+|++++||||+++++.+.. .+..+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3689999999999999764 5678999988654322 246789999999999999999998864 34578999999
Q ss_pred cCCCCHHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe----cCCCCeeeeeccccc
Q 007266 84 CEGGDMAEAIKKA-------NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGDFGLAK 152 (610)
Q Consensus 84 ~~GgsL~~~Ik~~-------~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL----~~~g~vKL~DFGlak 152 (610)
+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 5888877532 12358899999999999999999999999999999999999 456789999999998
Q ss_pred cccccc----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHH---------HHHHHHhhc
Q 007266 153 MLISDD----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---------ALINKINKS 218 (610)
Q Consensus 153 ~~~~~~----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~---------~l~~~I~~~ 218 (610)
...... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 754322 2345688999999999876 45789999999999999999999999643211 111111110
Q ss_pred cCC-------------------------------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 219 IVA-------------------------------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 219 ~~~-------------------------------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
... ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011234568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=343.69 Aligned_cols=257 Identities=27% Similarity=0.426 Sum_probs=210.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCc----E
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGC----Y 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~----~ 76 (610)
++|++.+.||+|+||.||++.+..+++.||+|.+............+.+|+.+++++. |+||+++++.+...+. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5899999999999999999999999999999998765443333456788999999995 6999999998775443 4
Q ss_pred EEEEEeecCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-CCCeeeeeccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAK 152 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~---~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-~g~vKL~DFGlak 152 (610)
.|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7899999975 8888886532 246899999999999999999999999999999999999998 8899999999987
Q ss_pred ccccc-cccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--------
Q 007266 153 MLISD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-------- 222 (610)
Q Consensus 153 ~~~~~-~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~-------- 222 (610)
..... .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 65322 12233467889999998865 457899999999999999999999998776555444332211100
Q ss_pred -------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 223 -------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 223 -------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
....++.++.+||.+||..||.+||++.|+|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0123678899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=344.77 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=208.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC------
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG------ 74 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~------ 74 (610)
+++|++++.||+|+||.||++.+..+++.||||.+............+.+|+.++++++||||+++++.+...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 57899999999999999999999999999999998654433333345668999999999999999999876433
Q ss_pred -cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 75 -CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 75 -~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
...++||||+. ++|.+.+.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 35799999995 58888887643 3689999999999999999999999999999999999999999999999999876
Q ss_pred ccccc-----ccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-----
Q 007266 154 LISDD-----LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----- 222 (610)
Q Consensus 154 ~~~~~-----~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----- 222 (610)
..... .....+++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 53322 12345678899999987664 47889999999999999999999998877554443332211000
Q ss_pred -------------C-------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 -------------L-------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 -------------~-------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
. +...+..+.+||.+||..||.+||+++++|+||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 11135677899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=344.14 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=212.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||+|.+..........+.+.+|+++++.++||||+++++.+.. +...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence 58999999999999999999999899999999987655444445668899999999999999999998765 45889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||++++.|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred ecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9999998888776543 58999999999999999999999999999999999999999999999999987654332 23
Q ss_pred ccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC------------------
Q 007266 161 SSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA------------------ 221 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~------------------ 221 (610)
....++..|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34678999999998875 44688999999999999999999999876654443333211000
Q ss_pred ------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 222 ------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 222 ------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.....++..+.+||.+||..+|++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0122467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=340.38 Aligned_cols=250 Identities=17% Similarity=0.278 Sum_probs=215.3
Q ss_pred CCeEEEeEecccCceEEEEEEEe---CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||.||++.+. ..+..||+|.+..... ......+.+|+.++.+++||||+++++.+... ...|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-NTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-CCcE
Confidence 57999999999999999999875 3466899999875432 33445688999999999999999999987654 5789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.+++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+||||+.++.++|+|||.+.......
T Consensus 83 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999998743 368999999999999999999999999999999999999999999999999876543222
Q ss_pred ccc--cccCCCcccCCccccCCCCCCCccccccchhHHhhh-hcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 159 LAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMS-AQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~--~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLl-tG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
... ...++..|+|||++.+..++.++|||||||++|+|+ +|..||.+....++...+......+.+..++..+.+++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLM 241 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 111 234567899999999999999999999999999976 59999999888888888877766677888999999999
Q ss_pred HHhhcCCCCCCCCHHHHhc
Q 007266 236 KSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~ 254 (610)
.+||+.+|.+||++++|++
T Consensus 242 ~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 242 LDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHcCCCchhCCCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=363.27 Aligned_cols=248 Identities=29% Similarity=0.473 Sum_probs=202.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeC--CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH--ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~--~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
.+|++++.||+|+||.||++.... .+..||+|.+.... ...+|+++|++++|||||++++.|... ..+|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWK-STVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeC-CEEEE
Confidence 369999999999999999997653 56789999876331 245799999999999999999987655 47899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||||+. ++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.++|+|||+++......
T Consensus 164 v~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EehhcC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 999995 68888885433 68999999999999999999999999999999999999999999999999997654332
Q ss_pred --ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH---HHHHHHHhhcc--------------
Q 007266 159 --LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---QALINKINKSI-------------- 219 (610)
Q Consensus 159 --~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~---~~l~~~I~~~~-------------- 219 (610)
.....+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+... ...+..+....
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 12356899999999999999999999999999999999999999976531 11111111100
Q ss_pred ------------C--CCCC-----cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 220 ------------V--APLP-----TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 220 ------------~--~~~p-----~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
. ...+ ..++.++.+||++||..||++||++.|+|.||||..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0 0011 134668899999999999999999999999999975
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.93 Aligned_cols=253 Identities=32% Similarity=0.581 Sum_probs=216.3
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++.+.||+|+||.||++.+..+++.|++|.+..........+.+.+|+.+++.++|+||+++++.+.. ...+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence 6999999999999999999999899999999998766555567789999999999999999999997654 457899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc---
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--- 159 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~--- 159 (610)
|+.+++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 80 YCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred cCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999998743 578999999999999999999999999999999999999999999999999887644322
Q ss_pred --cccccCCCcccCCccccCCC---CCCCccccccchhHHhhhhcCccccccC-HHHHHHHHhhccCCCCCcc--cchHH
Q 007266 160 --ASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTV--YSGAF 231 (610)
Q Consensus 160 --~~~~vGTp~Y~APEvl~~~~---yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~~~~~~~~p~~--~s~~l 231 (610)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|..||...+ .......+........+.. ++..+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 22357889999999998766 8899999999999999999999997653 3333333333333334443 48899
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.++|.+||+.+|.+||++.+++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=342.39 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=206.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++.+.||.|+||.||++.+..+++.||+|.+....... ....+.+|+.++++++|+||+++++++... ...|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTK-KTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecC-CeEEEE
Confidence 579999999999999999999999899999999987543222 223466899999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
|||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus 82 ~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred EecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 999975 99998876543 68999999999999999999999999999999999999999999999999987543221 1
Q ss_pred cccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccC-HHHHHHHHhhccCCC---------------
Q 007266 160 ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAP--------------- 222 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~~~~~~~--------------- 222 (610)
.....++..|+|||++.+ ..++.++||||+||++|+|++|..||.... ..+....+......+
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 223457889999998865 558899999999999999999999997654 333332221111000
Q ss_pred --------------CCcccc--hHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 --------------LPTVYS--GAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 --------------~p~~~s--~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....++ ..+.++|.+||+.+|++||++.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 001233 778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=339.50 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=208.2
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeec-CcEEEEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEK-GCYVCIII 81 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~-~~~~~LVm 81 (610)
|++++.||+|+||.||++.+..+++.||+|.+.......... ...+|+.++.++. |+|++++++.+.+. +..+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 789999999999999999999999999999987544333222 3457888898885 99999999988765 14789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+. ++|.+.+.... ..+++..++.++.||+.||.|||++|++||||||+||+++. +.++|+|||++..........
T Consensus 80 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 80 ELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred ecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 9996 58888887643 36899999999999999999999999999999999999999 999999999998765544445
Q ss_pred cccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC------------------
Q 007266 162 SVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------ 222 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------------ 222 (610)
...+++.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 5678999999997654 556889999999999999999999998877665554443211110
Q ss_pred ----------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 ----------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 ----------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....++..+.+||.+||.++|++||+++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=369.83 Aligned_cols=259 Identities=24% Similarity=0.464 Sum_probs=239.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.-|.+++.||+|.|+.|.++++..++..||||.+.+...+......+.+|+++|+.|+|||||+++.+..... .+|+||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~-~lylV~ 134 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA-TLYLVM 134 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-eeEEEE
Confidence 3599999999999999999999999999999999988888888888999999999999999999999776554 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.+|.+++++.+.+ .+.+..++.++.|++.+++|||+++|+|||||.+||||+.+.++||+|||++..+....+..
T Consensus 135 eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred EeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence 9999999999999876 56789999999999999999999999999999999999999999999999999999888999
Q ss_pred cccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 162 SVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
++||++.|+|||++.+..| +..+|+||+|++||.|+.|.+||.+.+...+..+...... .+|..++-++.+||++||.
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~-rIp~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY-RIPFYMSCDCEDLLRKFLV 291 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee-cccceeechhHHHHHHhhc
Confidence 9999999999999999988 7799999999999999999999999988777776655543 3678899999999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCchhhh
Q 007266 241 KNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
++|.+|++.+++..|.|+......
T Consensus 292 l~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred cCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999875544
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=342.54 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=212.7
Q ss_pred ecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCC
Q 007266 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 88 (610)
Q Consensus 10 LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Ggs 88 (610)
||+|+||.||+|.+..+++.||+|.+...... ......+.+|+++|+.++|||++++++.+... ..+|+||||++|++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-DDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-CeEEEEEecCCCCc
Confidence 79999999999999999999999998754322 22344567899999999999999999887655 47899999999999
Q ss_pred HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccccccCCCc
Q 007266 89 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS 168 (610)
Q Consensus 89 L~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~ 168 (610)
|.+++.......+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.............++..
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 99999876555789999999999999999999999999999999999999999999999999877654444455678899
Q ss_pred ccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH----HHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 169 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM----QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 169 Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~----~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+ .......+..+++.+.++|.+||+.||.
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-ccccccCCccCCHHHHHHHHHHccCChh
Confidence 9999999888899999999999999999999999976543 2222222 2223345667899999999999999999
Q ss_pred CCC-----CHHHHhcCCCCCchh
Q 007266 245 FRP-----SAAELLCHPHLQPYV 262 (610)
Q Consensus 245 ~Rp-----Sa~eiL~Hp~f~~~~ 262 (610)
+|| ++.+++.||||..+.
T Consensus 239 ~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 239 KRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred HccCCCcccHHHHHhChhhhcCC
Confidence 999 999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.14 Aligned_cols=253 Identities=33% Similarity=0.576 Sum_probs=224.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++.+.||+|++|.||++.+..+++.|++|.+............+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEe
Confidence 69999999999999999999999999999999987766555667899999999999999999999987654 58899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc-cc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-AS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-~~ 161 (610)
|+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........ ..
T Consensus 80 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred cCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999998753 689999999999999999999999999999999999999999999999999987654332 23
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...++..|+|||.+.+..++.++|||+||+++|+|++|..||...+.......+........+..++..++++|.+||..
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQK 237 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhC
Confidence 46789999999999888889999999999999999999999987776555555555555667778899999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 007266 242 NPEFRPSAAELLCHPHL 258 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f 258 (610)
+|++||++.+++.||||
T Consensus 238 ~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 238 DPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ChhhCcCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=342.36 Aligned_cols=255 Identities=31% Similarity=0.571 Sum_probs=222.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
..|+.++.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++++.|+||+++++.+... ...|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-TKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEEE
Confidence 35888999999999999999999999999999987543 234456788999999999999999999987665 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||+.|++|.+++... .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 82 e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999999999998753 58999999999999999999999999999999999999999999999999987654333 23
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+........+..++..+.++|.+||+
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 34578899999999988889999999999999999999999999887766666555544555566788899999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCch
Q 007266 241 KNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+|++||++.++++|+||...
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cCcccCcCHHHHHhChHhhhc
Confidence 999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.42 Aligned_cols=252 Identities=21% Similarity=0.373 Sum_probs=217.4
Q ss_pred eEEEeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc-----
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC----- 75 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~----- 75 (610)
|++.+.||+|+||.||++.+..+ +..||+|.+............+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999998753 4789999998665555556778999999999999999999998765432
Q ss_pred EEEEEEeecCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKA----NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~----~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGla 151 (610)
..+++|||+.+++|..++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 478999999999999998543 2236899999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCccc
Q 007266 152 KMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVY 227 (610)
Q Consensus 152 k~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~ 227 (610)
+....... .....++..|+|||.+.+..++.++|||||||++|||++ |.+||.+....+++..+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence 86543321 112345678999999988889999999999999999998 99999988888888888777777778889
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+..+.++|.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 241 LDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=325.04 Aligned_cols=258 Identities=28% Similarity=0.518 Sum_probs=226.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|...++||+|.||+||++++..+++.||+|.++.+..++.......+|+.+|+.++|.|||++++....+ ..+.+|
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-kkltlv 79 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLV 79 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-ceeEEe
Confidence 6789999999999999999999999999999999998888777677789999999999999999999976544 478899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
+|||. .+|..++...++ .++.+.++.++.|++.||.++|+++++||||||.|+||+.+|++||+|||+++.+.-.- .
T Consensus 80 fe~cd-qdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 80 FEFCD-QDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHHhh-HHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 99994 688888887654 68999999999999999999999999999999999999999999999999998875432 3
Q ss_pred cccccCCCcccCCccccCCC-CCCCccccccchhHHhhh-hcCccccccCHHHHHHHHhhccCCCCCcc-----------
Q 007266 160 ASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMS-AQKAAFKAFDMQALINKINKSIVAPLPTV----------- 226 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~-yt~ksDIWSLG~iLyeLl-tG~~PF~~~~~~~l~~~I~~~~~~~~p~~----------- 226 (610)
.+..+.|.+|++|.++.+.. |+...|+||.|||+.|+. .|.+.|.+.+..+++.+|......+....
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 55678899999999988765 799999999999999997 68999999999999999877654432111
Q ss_pred -----------------cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 227 -----------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 227 -----------------~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
++..-++|+.++|..+|.+|++|+++|+||||..+
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 22346799999999999999999999999999764
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.63 Aligned_cols=248 Identities=19% Similarity=0.365 Sum_probs=215.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+. ++..||+|.+..... ..+.+.+|+.++++++|+||+++++.+... ...+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 80 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKE-EPIYIIT 80 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEE
Confidence 68999999999999999999865 556799998764332 245688999999999999999999887654 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
||+.+++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999999876556789999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......+....++.++.++|.+|
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 240 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 123345678999999988889999999999999999998 9999998888888887776666666667899999999999
Q ss_pred hcCCCCCCCCHHHHhc
Q 007266 239 LRKNPEFRPSAAELLC 254 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~ 254 (610)
|..+|++||++++++.
T Consensus 241 l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 241 WKEKAEERPTFDYLQS 256 (261)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=341.32 Aligned_cols=251 Identities=20% Similarity=0.396 Sum_probs=218.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|.+++.||+|+||.||++.+.. ++..||+|.+..... ......+.+|+++|+.+.|+||+++++.+... ..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-DP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CC
Confidence 578999999999999999998754 357899999865433 33456789999999999999999999987765 57
Q ss_pred EEEEEeecCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCee
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 144 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vK 144 (610)
.|+||||+.|++|.+++...+ ...+++..+..++.||+.||.|||++|++||||||+|||++.++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 899999999999999997642 13478999999999999999999999999999999999999999999
Q ss_pred eeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccC
Q 007266 145 LGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIV 220 (610)
Q Consensus 145 L~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~ 220 (610)
|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.....
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999987653322 2234456788999999999999999999999999999998 9999998888888888877666
Q ss_pred CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 221 APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 221 ~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
...+..++..+.+||.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6667789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=336.46 Aligned_cols=247 Identities=22% Similarity=0.405 Sum_probs=216.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++.+.||+|+||.||++... +..+|+|.+.... ..+.+.+|+.++++++|+|++++++.+...+...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 468999999999999999999764 6789999886432 2345788999999999999999999877777788999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||+.+++|.+++++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--Q 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--C
Confidence 99999999999998766556899999999999999999999999999999999999999999999999998764322 2
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...+...+...+........+..++..+.++|.+||
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 33455678999999998889999999999999999997 99999988888887777766666667788999999999999
Q ss_pred cCCCCCCCCHHHHhcC
Q 007266 240 RKNPEFRPSAAELLCH 255 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~H 255 (610)
+.+|++|||+.+++++
T Consensus 237 ~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 237 HLDAATRPSFLQLREQ 252 (256)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=340.91 Aligned_cols=253 Identities=19% Similarity=0.370 Sum_probs=217.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEe----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHK----HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
+++|++.+.||+|+||.||++.+. .++..+++|.+.... .......+.+|+.++++++||||+++++.+... ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-QP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-Cc
Confidence 468999999999999999999864 355789999987433 334446688999999999999999999987654 47
Q ss_pred EEEEEeecCCCCHHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN---------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~---------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
.|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 899999999999999986432 12478999999999999999999999999999999999999999
Q ss_pred Ceeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhh
Q 007266 142 DIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINK 217 (610)
Q Consensus 142 ~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~ 217 (610)
.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.......+.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999997754332 2334456778999999988889999999999999999998 9999998888777887777
Q ss_pred ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 218 ~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+.+..++..+.++|.+||+.||.+||++.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66666778889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=344.00 Aligned_cols=254 Identities=29% Similarity=0.540 Sum_probs=215.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||+|++.... .......+.+|+++++.++||||+++++.+... ..+|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEE
Confidence 57999999999999999999999999999999886543 234456788999999999999999999988766 4889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
||+.+++|.+++.+.+ .+++..+..++.|++.+|.|||+ +|++||||||+||+++.++.++|+|||++...... ..
T Consensus 83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IA 159 (284)
T ss_pred ecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-cc
Confidence 9999999999988754 68999999999999999999997 69999999999999999999999999998654322 23
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH-----------HHHHHHhhccCCCCCcc-cc
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-----------ALINKINKSIVAPLPTV-YS 228 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~-----------~l~~~I~~~~~~~~p~~-~s 228 (610)
...+|+..|+|||++.+..++.++|||||||++|+|++|..||...... +....+.......++.. ++
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 4568999999999998888999999999999999999999999865431 23333333322223333 77
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
..+.+||.+||+.||++||++.|+++|+||..
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 89999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=328.58 Aligned_cols=254 Identities=34% Similarity=0.592 Sum_probs=223.0
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~~~LVm 81 (610)
+|.+.+.||+|++|.||++.+..++..|++|.+..........+.+.+|+.++++++|+||+++++.+.... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 589999999999999999999999999999999876655556678999999999999999999999877652 5788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999999998765 789999999999999999999999999999999999999999999999999987755543
Q ss_pred -cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC-HHHHHHHHh-hccCCCCCcccchHHHHHHH
Q 007266 160 -ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKIN-KSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 160 -~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~-~~~~~~~p~~~s~~l~~LI~ 236 (610)
.....++..|++||.+.+..++.++|||||||++|+|++|..||...+ .......+. .......+..++..++++|.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 455688999999999988889999999999999999999999998776 222233332 23445567778999999999
Q ss_pred HhhcCCCCCCCCHHHHhcCCCC
Q 007266 237 SMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
+||..+|++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=353.00 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=215.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~ 77 (610)
++|++++.||+|+||.||++++..+++.||||.+............+.+|+.+++.++|+||+++++.+.... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 6899999999999999999999999999999998765444444456778999999999999999999776432 358
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|+|+||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 99999995 68998887643 6899999999999999999999999999999999999999999999999999876433
Q ss_pred -cccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--------------
Q 007266 158 -DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-------------- 221 (610)
Q Consensus 158 -~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-------------- 221 (610)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 33445678999999998765 45889999999999999999999999876543333322211100
Q ss_pred ----------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 222 ----------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 222 ----------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
.....++..+.+||.+||+.+|++||+++++|+||||..+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0123468889999999999999999999999999999875433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=372.84 Aligned_cols=249 Identities=29% Similarity=0.526 Sum_probs=219.3
Q ss_pred EecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCC
Q 007266 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 88 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Ggs 88 (610)
+||+|.||+||.++|..+....|||.+... +.+..+-++.||.+.++|+|.|||++++++.+++ ++-|+||-+.||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCCCc
Confidence 699999999999999999999999998633 3344566999999999999999999999976555 8889999999999
Q ss_pred HHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-CCCeeeeecccccccccc-ccccccc
Q 007266 89 MAEAIKKANGVHF--PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISD-DLASSVV 164 (610)
Q Consensus 89 L~~~Ik~~~~~~l--se~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-~g~vKL~DFGlak~~~~~-~~~~~~v 164 (610)
|..+++...+ ++ +|..+..|.+||++||.|||++.|||||||-+||||+. .|.+||.|||-++.+..- ....++.
T Consensus 659 LSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 659 LSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9999987654 45 89999999999999999999999999999999999975 688999999999887543 4577899
Q ss_pred CCCcccCCccccCC--CCCCCccccccchhHHhhhhcCcccccc--CHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 165 GTPSYMCPELLADI--PYGSKSDIWSLGCCVYEMSAQKAAFKAF--DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 165 GTp~Y~APEvl~~~--~yt~ksDIWSLG~iLyeLltG~~PF~~~--~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
||..|||||++..+ .|+.++|||||||.+.||.||++||... ....++..-.....+++|..++.++++||.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 99999999999765 4899999999999999999999999754 3444555445556788999999999999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCch
Q 007266 241 KNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+|.+||+|.++|..||++.-
T Consensus 818 pd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCcccCccHHHhccCcccccC
Confidence 999999999999999999863
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=351.13 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=211.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~ 77 (610)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+.++++++|+||+++++.+.... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 689999999999999999999999999999999864322 234456778999999999999999998765432 358
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|+|+||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99999996 5888877653 6899999999999999999999999999999999999999999999999998765332
Q ss_pred c----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----------
Q 007266 158 D----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------- 222 (610)
Q Consensus 158 ~----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---------- 222 (610)
. .....+|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 2 1234578999999998754 568899999999999999999999998766544333221111100
Q ss_pred --------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 223 --------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 223 --------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
....++.++.+||.+||+.+|++||++.++++||||..+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 012357789999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=346.12 Aligned_cols=253 Identities=21% Similarity=0.387 Sum_probs=212.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeE--EEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKK--YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~--vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~ 77 (610)
+++|++.+.||+|+||.||+|.+..++.. +++|.+... ........+.+|+.++.++ +|+||+++++.+... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-CCc
Confidence 46899999999999999999999877754 567766432 2334456788899999999 899999999987655 478
Q ss_pred EEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCe
Q 007266 78 CIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 143 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~v 143 (610)
|+||||+.+++|.+++.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 99999999999999997642 1357899999999999999999999999999999999999999999
Q ss_pred eeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCC
Q 007266 144 RLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAP 222 (610)
Q Consensus 144 KL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~ 222 (610)
+|+|||++.............++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCC
Confidence 9999999864322111222234567999999988889999999999999999998 999999888877777776555555
Q ss_pred CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 223 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 223 ~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+..++..+.+||.+||+.+|++||+++++|.+
T Consensus 244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.97 Aligned_cols=250 Identities=19% Similarity=0.336 Sum_probs=218.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.+|.+.+.||+|+||.||++.+..++..||+|.+.... .....+.+|+++++.++|+||+++++.+... ..++++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCC-CCcEEEE
Confidence 46899999999999999999999999999999886432 2345688899999999999999999987655 4788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc-
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA- 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~- 160 (610)
||+.+++|.+++.......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999999999998755556899999999999999999999999999999999999999999999999998776443221
Q ss_pred -ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 161 -SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 -~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+........+..++..+.++|.+|
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 241 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRAC 241 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 12234567999999999899999999999999999998 9999999888888888877666667778899999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||++||++.++++.
T Consensus 242 l~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 242 WQWNPSDRPSFAEIHQA 258 (263)
T ss_pred ccCCcccCCCHHHHHHH
Confidence 99999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=358.69 Aligned_cols=251 Identities=27% Similarity=0.543 Sum_probs=221.3
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
|.++++||+|+||.||++.|+.+|+.+|||++....+- +.+..|+.||++++.|++|+++++|+... .+||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDL----QEIIKEISIMQQC~S~yVVKYYGSYFK~s-DLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDL----QEIIKEISIMQQCKSKYVVKYYGSYFKHS-DLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchH----HHHHHHHHHHHHcCCchhhhhhhhhccCC-ceEeehhh
Confidence 56789999999999999999999999999999766543 44778999999999999999999998665 68999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASS 162 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~~~ 162 (610)
|..|++.++++-++ .+|+|+.+..+++..+.||+|||...-||||||..||||+.+|+.||+|||.+..+... ...++
T Consensus 110 CGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 110 CGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred cCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 99999999998754 57999999999999999999999999999999999999999999999999999876533 24568
Q ss_pred ccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--CCCcccchHHHHHHHHhhc
Q 007266 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~--~~p~~~s~~l~~LI~kmL~ 240 (610)
++|||.|||||++....|+.++||||||+...||..|++||.+..+...+..|.....+ .-|..||.+|-+||+.||.
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 89999999999999999999999999999999999999999877654444333322221 2356799999999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCc
Q 007266 241 KNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f~~ 260 (610)
++|++|-||-++++|||++.
T Consensus 269 K~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 269 KKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred CCHHHHHHHHHHhhhhhhcC
Confidence 99999999999999999974
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.68 Aligned_cols=251 Identities=20% Similarity=0.371 Sum_probs=206.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeC----------------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH----------------ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~----------------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~ 65 (610)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 489999999999999999998643 34579999987543 3344567889999999999999999
Q ss_pred eeeeEeecCcEEEEEEeecCCCCHHHHHHHhC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Q 007266 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-----------------GVHFPEEKLCKWLVQLLMALNYLHANHILHR 128 (610)
Q Consensus 66 l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~-----------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHR 128 (610)
+++.+...+ ..|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 84 LLGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999887654 6899999999999999986532 1246788899999999999999999999999
Q ss_pred cCCCCceEecCCCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh--cCccc
Q 007266 129 DVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA--QKAAF 203 (610)
Q Consensus 129 DLKPeNILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt--G~~PF 203 (610)
||||+||||+.++.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|+|++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999999999999999999997653332 2234456788999999998899999999999999999986 67788
Q ss_pred cccCHHHHHHHHhhc-------cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 204 KAFDMQALINKINKS-------IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 204 ~~~~~~~l~~~I~~~-------~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
...+..+.+..+... .....+..++..+.+||.+||+.||++|||+.+|.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 877766655544221 112234567889999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.24 Aligned_cols=242 Identities=17% Similarity=0.248 Sum_probs=209.3
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEee--c-CcEEEEEEee
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVE--K-GCYVCIIIGY 83 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~--~-~~~~~LVmEy 83 (610)
..||+|++|.||++.. +|+.||||.+....... ...+.+.+|+.+|++++|||||++++++.+ . ..++++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999987 68899999997654333 334678899999999999999999998876 2 3478999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeeccccccccccccccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 162 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~ 162 (610)
+.||+|.+++.+.. .+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..... ...
T Consensus 104 ~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFK 179 (283)
T ss_pred CCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--ccc
Confidence 99999999998754 689999999999999999999984 9999999999999999999999999998865432 234
Q ss_pred ccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhh-ccCCCCCcccchHHHHHHHHhh
Q 007266 163 VVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK-SIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~-~~~~~~p~~~s~~l~~LI~kmL 239 (610)
.+|+..|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+++..+.. ....+.+..++..+.+||.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 678999999999976 6789999999999999999999999999888887777643 3344456578999999999999
Q ss_pred cCCCCCCCCHHHHhcC
Q 007266 240 RKNPEFRPSAAELLCH 255 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~H 255 (610)
+.||++|||++++++.
T Consensus 260 ~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 260 SHDSIKRPNIKEILYN 275 (283)
T ss_pred cCCcccCcCHHHHHHH
Confidence 9999999999999864
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=369.48 Aligned_cols=248 Identities=27% Similarity=0.375 Sum_probs=202.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
..|.+.+.||+|+||.||++.+..+++.||||.... ..+.+|+++|++|+|+|||++++++...+ ..|+||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGG-LTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECC-EEEEEE
Confidence 369999999999999999999999999999996432 23567999999999999999999876654 788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--- 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--- 158 (610)
||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.++|+|||+++......
T Consensus 240 e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 240 PKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9995 68888887643 368999999999999999999999999999999999999999999999999997653321
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc--------CHHHHHHHHhhccC--CCC-----
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF--------DMQALINKINKSIV--APL----- 223 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~--------~~~~l~~~I~~~~~--~~~----- 223 (610)
.....+||+.|+|||++.+..++.++|||||||+||||++|..++... ....+.+.+..... ...
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223467999999999999999999999999999999999887654221 11222222221110 000
Q ss_pred --------------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 224 --------------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 224 --------------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
...++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0134568899999999999999999999999999974
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=325.50 Aligned_cols=251 Identities=35% Similarity=0.654 Sum_probs=217.7
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+.+++++.|+|++++++.+... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEe
Confidence 58999999999999999999998999999999976544 3456788999999999999999999987665 57889999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 162 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~ 162 (610)
|+.|++|.+++.... ..+++..+..++.||+.+|.|||++|++||||+|+||+++.++.++|+|||++...........
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 999999999998753 3689999999999999999999999999999999999999999999999999887654433456
Q ss_pred ccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcc--cchHHHHHHHHhhc
Q 007266 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV--YSGAFRGLVKSMLR 240 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~--~s~~l~~LI~kmL~ 240 (610)
..++..|++||++.+..++.++|+|||||+||+|++|..||...+.......+........+.. ++..+.++|.+||+
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 7889999999999888889999999999999999999999988755554444443333333333 48899999999999
Q ss_pred CCCCCCCCHHHHhcCCC
Q 007266 241 KNPEFRPSAAELLCHPH 257 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~ 257 (610)
.||.+|||+.++|.|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=346.50 Aligned_cols=255 Identities=31% Similarity=0.566 Sum_probs=219.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
.|++++.||+|+||.||++.+..++..||+|.+...... ...+.+.+|+.++++++|+||+++++.+... ...|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKG-TKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccC-CceEEEEE
Confidence 477788999999999999999989999999998754332 3456789999999999999999999987654 47899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|+.|++|.+++... .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 83 YLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred ccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 99999999988653 68999999999999999999999999999999999999999999999999987654332 223
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+........+..++..+.++|.+||+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 45688999999999998899999999999999999999999987766655555544444445566788999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCchh
Q 007266 242 NPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+|++||++.++++||||..+.
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 240 DPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred CcccCcCHHHHHHhHHHHHHh
Confidence 999999999999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.46 Aligned_cols=255 Identities=30% Similarity=0.505 Sum_probs=209.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LV 80 (610)
..|+++++||.||.+.||+|..- +...||+|++.....++.....+.+|++.|.+|+ |.+||+++++-.. +.++|+|
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEE
Confidence 36999999999999999999875 4457777877777777778889999999999995 8999999997665 4599999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|||- ..+|..+|++.... ++.-.++.|.+|||.++.++|.+||||-||||.|+|+- .|.+||+|||+|.....+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred eecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 9997 47999999987654 34348899999999999999999999999999999986 6889999999999876554
Q ss_pred -ccccccCCCcccCCccccCCC-----------CCCCccccccchhHHhhhhcCccccccC-HHHHHHHHhhc-cCCCCC
Q 007266 159 -LASSVVGTPSYMCPELLADIP-----------YGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKS-IVAPLP 224 (610)
Q Consensus 159 -~~~~~vGTp~Y~APEvl~~~~-----------yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~~~-~~~~~p 224 (610)
...+.+||+.||+||.+.+.. .+.++||||||||||+|+.|++||.... ...-+..|... ...++|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 456789999999999886443 4578999999999999999999998653 22223333221 112334
Q ss_pred cccch-HHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 225 TVYSG-AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 225 ~~~s~-~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
..-+. ++.++++.||..||++||+..++|+|||++.+
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 33333 39999999999999999999999999999874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.31 Aligned_cols=256 Identities=29% Similarity=0.475 Sum_probs=209.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC------
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG------ 74 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~------ 74 (610)
+++|++++.||.|+||.||++.+..+++.+|+|.+......+.....+.+|+++++.++|+||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47999999999999999999999999999999998755443333345678999999999999999998876443
Q ss_pred -cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 75 -CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 75 -~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
..+|+||||+. ++|...+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 35799999996 4777777653 33699999999999999999999999999999999999999999999999999976
Q ss_pred cccccc------------cccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC
Q 007266 154 LISDDL------------ASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV 220 (610)
Q Consensus 154 ~~~~~~------------~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~ 220 (610)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 533221 1234678899999987654 578999999999999999999999988776655554432111
Q ss_pred CC----------------------C-------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 221 AP----------------------L-------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 221 ~~----------------------~-------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.+ . ...++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 10 0 01234678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=330.52 Aligned_cols=246 Identities=23% Similarity=0.443 Sum_probs=218.5
Q ss_pred eEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeec
Q 007266 8 EQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
+.||+|+||.||++.+... +..|++|.+....... ..+.+.+|+.++..++|+|++++++.+.. +..+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEec
Confidence 4799999999999999876 8899999997655444 46678999999999999999999998776 56889999999
Q ss_pred CCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 85 EGGDMAEAIKKAN-------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 85 ~GgsL~~~Ik~~~-------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
.|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999998751 247899999999999999999999999999999999999999999999999999876543
Q ss_pred c---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 D---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
. ......+++.|+|||++....++.++|||||||++|+|++ |..||.......+...+........+..++.++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE 238 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence 2 2345678889999999988889999999999999999998 69999999888888888776666778888999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+|.+||..+|.+||++.+++++
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=338.04 Aligned_cols=252 Identities=19% Similarity=0.393 Sum_probs=216.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC-----CeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE-----RKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~-----~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++ +|+||+++++.+...+
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG- 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC-
Confidence 5799999999999999999998754 3789999987543 334445688999999999 7999999999876554
Q ss_pred EEEEEEeecCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 76 YVCIIIGYCEGGDMAEAIKKA--------------NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~--------------~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
.++++|||+.+++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 789999999999999999752 234689999999999999999999999999999999999999999
Q ss_pred Ceeeeecccccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhh
Q 007266 142 DIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINK 217 (610)
Q Consensus 142 ~vKL~DFGlak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~ 217 (610)
.++|+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......++...+..
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 249 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987543321 122334568999999998899999999999999999997 9999999888888888777
Q ss_pred ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 218 ~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
......+..++..+.+|+.+||..||++|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 250 GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66666677788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=331.91 Aligned_cols=254 Identities=29% Similarity=0.529 Sum_probs=217.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc---ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR---QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~---~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~ 77 (610)
.+|++.+.||+|+||.||++.+..++..||+|.+.... ........+.+|++++++++|+||+++++.+... +..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875432 2234456788999999999999999999987654 3468
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
+++|||+.|++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 89999999999999998654 5899999999999999999999999999999999999999999999999999765321
Q ss_pred ----cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc-cCCCCCcccchHHH
Q 007266 158 ----DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS-IVAPLPTVYSGAFR 232 (610)
Q Consensus 158 ----~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~-~~~~~p~~~s~~l~ 232 (610)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+... .....|..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence 1123457899999999999888899999999999999999999999887665555554432 23446778999999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
++|.+||. +|..||++.+++.|||+
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=334.65 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=214.0
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc---CCCceeeeeeeEeecCc----E
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVEKGC----Y 76 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIV~l~~~~~~~~~----~ 76 (610)
|++.+.||+|+||.||++++..+++.||+|.+............+.+|+.+++++ +|+|++++++.+...+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998899999999986554443344566788777666 59999999999876543 4
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
++++|||+. ++|.+++.......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 889999996 4899988775544689999999999999999999999999999999999999999999999999987655
Q ss_pred ccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--------------
Q 007266 157 DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-------------- 222 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~-------------- 222 (610)
........++..|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+.++......+
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 444445678899999999999899999999999999999999999999887766666554321110
Q ss_pred ------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 ------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 ------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....++..+.++|.+||+.||.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 011245778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=341.90 Aligned_cols=253 Identities=20% Similarity=0.364 Sum_probs=213.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCe--EEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERK--KYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~--~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~ 77 (610)
.++|++.+.||+|+||.||++.+..++. .+++|.+... ......+.+.+|+.++.++ +||||+++++.+... ..+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~ 78 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-GYL 78 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-Ccc
Confidence 3789999999999999999999887664 4688877632 2333445688999999999 799999999987655 478
Q ss_pred EEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCe
Q 007266 78 CIIIGYCEGGDMAEAIKKANG--------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 143 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~--------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~v 143 (610)
|+||||+.+++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999999999999976321 248899999999999999999999999999999999999999999
Q ss_pred eeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCC
Q 007266 144 RLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAP 222 (610)
Q Consensus 144 KL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~ 222 (610)
||+|||++..............+..|+|||++.+..++.++|||||||++|+|++ |..||.......+...+.......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 9999999864322111122233457999999998889999999999999999997 999999988888888887766666
Q ss_pred CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 223 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 223 ~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+..++..+++||.+||+.+|.+||+++++++.
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=346.91 Aligned_cols=252 Identities=29% Similarity=0.542 Sum_probs=215.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.++++++|+||+++++.+... .+.|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-DELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-CeEEEEEe
Confidence 4566778999999999999999999999999886432 33456688999999999999999999987655 58899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|+.|++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ...
T Consensus 100 ~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 100 FLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 99999999988643 58999999999999999999999999999999999999999999999999987543222 234
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC--CcccchHHHHHHHHhh
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSML 239 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--p~~~s~~l~~LI~kmL 239 (610)
..+|++.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+........ ...++..+.++|.+||
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 256 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence 46789999999999988899999999999999999999999988777666655544433322 2357889999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCc
Q 007266 240 RKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
..||.+|||++++|+||||..
T Consensus 257 ~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 257 VREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred cCChhHCcCHHHHhhChhhhc
Confidence 999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.98 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=214.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeE----EEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKK----YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~----vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
.+|++++.||+|+||.||++.+..++.. ||+|.+... ......+.+.+|+.+++.++||||+++++.+... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cc
Confidence 5799999999999999999998766553 899998643 3334456788999999999999999999987654 46
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++|+||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 79999999999999998743 35889999999999999999999999999999999999999999999999999876433
Q ss_pred ccc---ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 DLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~~~---~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.....+...+......+.+..++..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 242 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 221 22334668999999999999999999999999999987 99999988877776666666666667778899999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+|.+||..+|.+||++.+++.+
T Consensus 243 li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 243 IMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=335.02 Aligned_cols=253 Identities=19% Similarity=0.347 Sum_probs=217.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCC-----eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHER-----KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~-----~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 75 (610)
.++|++++.||+|+||.||++.+...+ ..||+|.+.... .......+.+|+.+++.++|+||+++++.+... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-Q 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-C
Confidence 368999999999999999999987543 789999986443 233345688999999999999999999987665 5
Q ss_pred EEEEEEeecCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeee
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN--------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 147 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~--------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~D 147 (610)
..|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 7899999999999999997532 12468889999999999999999999999999999999999999999999
Q ss_pred ccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCC
Q 007266 148 FGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPL 223 (610)
Q Consensus 148 FGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~ 223 (610)
||+++...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL 242 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCC
Confidence 99987654332 1234457789999999988889999999999999999998 9999998888888877776656667
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+..++..+.+||.+||+.+|++|||+.+++..
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 77889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=348.71 Aligned_cols=257 Identities=30% Similarity=0.447 Sum_probs=220.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVC 78 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~~ 78 (610)
+|++.+.||.|+||.||+|++..+++.||||.+..........+.+.+|+.+++.++|+||+++++.+...+ ..+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999989999999999765544455567889999999999999999999877654 4789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||.|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999996 58988887644 78999999999999999999999999999999999999999999999999998765442
Q ss_pred ----ccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC----------
Q 007266 159 ----LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---------- 223 (610)
Q Consensus 159 ----~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---------- 223 (610)
......+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 24456789999999999887 789999999999999999999999998887766665544322111
Q ss_pred --------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 224 --------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 224 --------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
...++..+.+||.+||+.+|++||+++++|.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 122577899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=332.12 Aligned_cols=247 Identities=21% Similarity=0.397 Sum_probs=212.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.... +..+|+|.+...... ...+.+|+.+|++++||||+++++.+... ...|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-KPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccC-CCEEEEE
Confidence 579999999999999999998754 567999987644332 24578899999999999999999977654 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc-
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA- 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~- 160 (610)
||+.|++|.+++....+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++........
T Consensus 79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999999999976433 5899999999999999999999999999999999999999999999999998765332221
Q ss_pred -ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 161 -SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 -~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+........+...+..+.+||.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 12345567999999998889999999999999999999 9999999888888888877655556777889999999999
Q ss_pred hcCCCCCCCCHHHHhc
Q 007266 239 LRKNPEFRPSAAELLC 254 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~ 254 (610)
|+.+|++||+++++++
T Consensus 238 ~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 238 WHEKPEGRPTFAELLR 253 (256)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=336.74 Aligned_cols=258 Identities=31% Similarity=0.547 Sum_probs=215.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~~LV 80 (610)
++|++++.||.|++|.||++.+..+++.||+|.+...... .....+.+|++++++++||||+++++.|... ...+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5899999999999999999999999999999998754332 3456688999999999999999999988653 4478999
Q ss_pred EeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
|||++|++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999999999887542 23468999999999999999999999999999999999999999999999999987653222
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc-----CHHHHHHHHhhccCCCCC------ccc
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-----DMQALINKINKSIVAPLP------TVY 227 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~-----~~~~l~~~I~~~~~~~~p------~~~ 227 (610)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||... ...++...+.......++ ..+
T Consensus 160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238 (287)
T ss_pred -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence 23456888999999999999999999999999999999999999865 233444443332211111 235
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
++.+.+||.+||..+|.+|||+.|++.||||...
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 7789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=338.84 Aligned_cols=257 Identities=18% Similarity=0.364 Sum_probs=215.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++++.||+|+||.||++.++. .+..||+|.+..... ......+.+|+.+++.++|+||+++++.+... ..
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-QP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CC
Confidence 589999999999999999997653 345799998764432 23334577899999999999999999987655 47
Q ss_pred EEEEEeecCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN--------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~--------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
.|+||||+.+|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence 899999999999999997632 123467788999999999999999999999999999999999999999999
Q ss_pred ccccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCC
Q 007266 149 GLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLP 224 (610)
Q Consensus 149 Glak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p 224 (610)
|+++....... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+........+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99876533221 122345678999999998889999999999999999998 79999988888877777666556667
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhc------CCCCCc
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLC------HPHLQP 260 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~------Hp~f~~ 260 (610)
..++..+.++|.+||+.||++||++.++++ ||||.+
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 778899999999999999999999999986 777765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.94 Aligned_cols=254 Identities=30% Similarity=0.571 Sum_probs=220.8
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
-|++++.||.|+||.||++.+..++..||+|.+..... ......+.+|+.++.+++||||+++++.+... ...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-CeEEEEEE
Confidence 37889999999999999999998999999998864433 33446788999999999999999999987665 57899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|+.|++|.+++... .+++..+..++.||+.+|.|||++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 83 ~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999999998753 58999999999999999999999999999999999999999999999999987654332 223
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+........+..++..+.++|.+||..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 45788999999999888888999999999999999999999988777666666655544445667889999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCch
Q 007266 242 NPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 242 dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+|.+||++.++++||||...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=350.89 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=213.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee---cCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---KGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~---~~~~~~ 78 (610)
++|++.+.||+|+||.||++.+..++..||+|.+............+.+|+.+|++++||||+++++.+.. ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57999999999999999999999999999999987654444445667889999999999999999987753 235789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 9999995 68998887643 58999999999999999999999999999999999999999999999999987653322
Q ss_pred -----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC-----------
Q 007266 159 -----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----------- 221 (610)
Q Consensus 159 -----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~----------- 221 (610)
.....+|+..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 2234588999999998865 45889999999999999999999999877654433322211110
Q ss_pred --------------CC-----CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 222 --------------PL-----PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 222 --------------~~-----p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.. ....+..+.++|++||+.+|++||++.++|.||||+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00 12357899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=353.23 Aligned_cols=253 Identities=19% Similarity=0.398 Sum_probs=211.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|.+.. +++.||+|++..... ......+.+|+.++.++ +|+||+++++.+...+.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 489999999999999999997543 457899999875432 33345678899999999 79999999998887777
Q ss_pred EEEEEEeecCCCCHHHHHHHhCC---------------------------------------------------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANG--------------------------------------------------------- 98 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~--------------------------------------------------------- 98 (610)
.++++|||+.|++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 89999999999999999864321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---ccccccCCCcccCCc
Q 007266 99 --VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPE 173 (610)
Q Consensus 99 --~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APE 173 (610)
..++++.+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.... ......++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 257899999999999999999999999999999999999999999999999998753322 122345677899999
Q ss_pred cccCCCCCCCccccccchhHHhhhh-cCccccccCHH-HHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHH
Q 007266 174 LLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 251 (610)
Q Consensus 174 vl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~-~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~e 251 (610)
++.+..++.++|||||||+||+|++ |..||.+.... .+...+........+..++.++.+++.+||+.+|++||++.|
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 325 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSE 325 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999999999999997 99999875433 333444444444456678899999999999999999999999
Q ss_pred HhcC
Q 007266 252 LLCH 255 (610)
Q Consensus 252 iL~H 255 (610)
+++|
T Consensus 326 ll~~ 329 (337)
T cd05054 326 LVEI 329 (337)
T ss_pred HHHH
Confidence 9987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=366.68 Aligned_cols=251 Identities=28% Similarity=0.533 Sum_probs=215.6
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
|.-++.||.|+||.||.+++..+.+.||||++.... +..+.+..+..|+.+|++++|||+|.|.++|.... ..|+|||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-TAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-hHHHHHH
Confidence 556788999999999999999999999999998655 45667888999999999999999999999887654 6789999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 162 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~ 162 (610)
||- |+-.+++.-.. .++-|..|..|+.+.+.||.|||+++.||||||..||||+..|.|||+|||.|... ....+
T Consensus 107 YCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---~PAns 181 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---APANS 181 (948)
T ss_pred HHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---Cchhc
Confidence 995 56666664422 37899999999999999999999999999999999999999999999999998764 45778
Q ss_pred ccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC-CCCCcccchHHHHHHHHh
Q 007266 163 VVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-APLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 163 ~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~-~~~p~~~s~~l~~LI~km 238 (610)
++|||+|||||++. .+.|+-++||||||+...||...++|+-..+...-+.-|-.... .-....||..|++||..|
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 261 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHH
Confidence 99999999999875 46799999999999999999999999766654444444444333 333456999999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|++-|.+|||++++|.|+|+..
T Consensus 262 LqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 262 LQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HhhCcccCCcHHHHhhcchhcc
Confidence 9999999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.93 Aligned_cols=252 Identities=20% Similarity=0.315 Sum_probs=215.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++.+.||+|+||.||++.+.. ++..||+|.+..... ......+.+|+.+++.++|+||+++++.+.+.+ .
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-P 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-C
Confidence 479999999999999999999987 778899998864332 333456888999999999999999999877655 6
Q ss_pred EEEEEeecCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKANG-----VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~-----~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~DF 148 (610)
.++||||+.|++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 7899999999999999976532 2589999999999999999999999999999999999998765 4899999
Q ss_pred ccccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCC
Q 007266 149 GLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLP 224 (610)
Q Consensus 149 Glak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p 224 (610)
|+++....... ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+...+........+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP 243 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 99987633221 112234567999999998889999999999999999996 99999988888877777666556667
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..++..+.+++.+||+.+|++||++.++|+|
T Consensus 244 ~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 244 KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7889999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=329.89 Aligned_cols=253 Identities=34% Similarity=0.615 Sum_probs=216.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|++++++++|+|++++++.+... ...++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~l 79 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNI 79 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEE
Confidence 4789999999999999999999999999999999875332 333466788999999999999999999988765 47899
Q ss_pred EEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
||||+.|++|.+++... ....+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999999998752 2346899999999999999999999999999999999999999999999999998765433
Q ss_pred c-ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC--HHHHHHHHhhccCCCCCc-ccchHHHH
Q 007266 158 D-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPLPT-VYSGAFRG 233 (610)
Q Consensus 158 ~-~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~--~~~l~~~I~~~~~~~~p~-~~s~~l~~ 233 (610)
. ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.... ..++.+.+......+.+. .++..+.+
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 2 2334578999999999998889999999999999999999999996543 345555555555555555 68889999
Q ss_pred HHHHhhcCCCCCCCCHHHHhc
Q 007266 234 LVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+|.+||..+|++||++.++++
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=336.48 Aligned_cols=252 Identities=20% Similarity=0.356 Sum_probs=213.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++.+.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++.+... ..
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~ 83 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QP 83 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CC
Confidence 579999999999999999998753 35679999886432 223445688999999999999999999987544 47
Q ss_pred EEEEEeecCCCCHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKANG--------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~--------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
.++||||+.+++|.+++..... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 8899999999999999975321 23577889999999999999999999999999999999999999999999
Q ss_pred ccccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCC
Q 007266 149 GLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLP 224 (610)
Q Consensus 149 Glak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p 224 (610)
|++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+........+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP 243 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 99876533221 122356788999999998889999999999999999998 79999988888877777666555667
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..++..+.++|.+||+.||++||++.|++.+
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 244 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.67 Aligned_cols=252 Identities=21% Similarity=0.374 Sum_probs=214.0
Q ss_pred eEEEeEecccCceEEEEEEEeCCCe--EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-----CcE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERK--KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GCY 76 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~--~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~ 76 (610)
|.+.+.||+|+||.||++.+..++. .+|+|.+..........+.+.+|+++++.++|+||+++++.+... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999887665 689999876655556667788999999999999999999876532 125
Q ss_pred EEEEEeecCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKA----NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~----~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
.+++|||+.+++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 68999999999999987532 22358999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccc
Q 007266 153 MLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYS 228 (610)
Q Consensus 153 ~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s 228 (610)
....... .....+++.|++||++.+..++.++|||||||++|+|++ |..||.+.....+...+......+.+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 7543321 123346678999999999999999999999999999998 899999888878777777665555666788
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..+.++|.+||+.||++|||+.+++++
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 241 DGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.94 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=210.3
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|++++.||.|++|.||++.+..++..||||.+...... .....+.+|+.++++++|+||+++++.+...+ ..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTEN-KLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-cEEEEEe
Confidence 599999999999999999999999999999999765432 22345678999999999999999999887654 7889999
Q ss_pred ecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 83 YCEGGDMAEAIKKAN-GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~-~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
|+.+ +|.+++.... ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9975 8888887543 2468999999999999999999999999999999999999999999999999987653321 22
Q ss_pred ccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-----------------
Q 007266 161 SSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------- 222 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----------------- 222 (610)
....+++.|++||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 345678999999988654 56889999999999999999999998877655555443221111
Q ss_pred -----------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 -----------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 -----------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....++..++++|.+||+.||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 012357789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.08 Aligned_cols=243 Identities=21% Similarity=0.356 Sum_probs=211.6
Q ss_pred EecccCceEEEEEEE--eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 9 QIGKGSFGSALLVRH--KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d--~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
.||+|+||.||++.. ..++..+|+|++..........+.+.+|+.+++.+.|+||+++++.+. +...++||||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence 689999999999965 456789999998766655666778999999999999999999998764 3467899999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc----ccc
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASS 162 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~----~~~ 162 (610)
++|.+++.... .+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||++........ ...
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 80 GPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999997654 689999999999999999999999999999999999999999999999999977643321 122
Q ss_pred ccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
..++..|+|||.+....++.++|||||||++|||++ |..||.......+...+......+.+..++.++.+||.+||+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 334578999999988889999999999999999997 9999998888888888887776777888999999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 007266 242 NPEFRPSAAELLCH 255 (610)
Q Consensus 242 dP~~RpSa~eiL~H 255 (610)
||++||++++|...
T Consensus 238 ~p~~Rp~~~~i~~~ 251 (257)
T cd05116 238 GVDERPGFAVVELR 251 (257)
T ss_pred CchhCcCHHHHHHH
Confidence 99999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=335.36 Aligned_cols=253 Identities=30% Similarity=0.565 Sum_probs=221.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~L 79 (610)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++++. |+||+++++.+... ...++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-ENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-ceEEE
Confidence 589999999999999999999999999999999875332 2333466888999999998 99999999977554 57899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||||+.+++|.+++.+.. .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999999998764 68999999999999999999999999999999999999999999999999987654322
Q ss_pred --------------------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc
Q 007266 159 --------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS 218 (610)
Q Consensus 159 --------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~ 218 (610)
......|+..|+|||++....++.++|||||||++++|++|..||...+....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~- 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK- 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-
Confidence 12345688999999999888899999999999999999999999998876666666543
Q ss_pred cCCCCCcccchHHHHHHHHhhcCCCCCCCCH----HHHhcCCCC
Q 007266 219 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA----AELLCHPHL 258 (610)
Q Consensus 219 ~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa----~eiL~Hp~f 258 (610)
.....+..++..+.+||.+||+.+|.+||++ +++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 3445677789999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=347.19 Aligned_cols=258 Identities=26% Similarity=0.452 Sum_probs=215.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe----EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK----KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~----~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
..|++++.||+|.||.||+|..++++. .||||++....+.........+|+.+++.|+|||+|.+..+|...+..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 579999999999999999997665433 7899999866544444456789999999999999999999999877789
Q ss_pred EEEEeecCCCCHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC----CCeeeeeccc
Q 007266 78 CIIIGYCEGGDMAEAIKKA---NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD----QDIRLGDFGL 150 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~---~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~----g~vKL~DFGl 150 (610)
++++||.+ -+|+++|+-+ ....++...++.+++||+.|+.|||++-|+||||||.|||+..+ |.|||+|||+
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999996 5999998742 23468999999999999999999999999999999999999988 8899999999
Q ss_pred cccccccc----ccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccC---------HHHHHHHHh
Q 007266 151 AKMLISDD----LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFD---------MQALINKIN 216 (610)
Q Consensus 151 ak~~~~~~----~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~---------~~~l~~~I~ 216 (610)
++.+...- ....++.|.||+|||++.+. .|+.+.|||++|||+.||++-.+.|.+.. ..+++.+|.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 99875432 24567899999999998775 58999999999999999999999997653 234556665
Q ss_pred hccCCCCCcc------------------------------------cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 217 KSIVAPLPTV------------------------------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 217 ~~~~~~~p~~------------------------------------~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
..+..|.... -++...+|+.+||++||.+|+|++++|+|+||..
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 5444332111 1233678999999999999999999999999975
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=332.52 Aligned_cols=251 Identities=22% Similarity=0.378 Sum_probs=216.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||.||++.+... ...||+|.+.... .......+.+|+.++++++||||+++++.+... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-RPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-CceE
Confidence 5799999999999999999998754 4579999886543 334455688899999999999999999977654 5789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.+++|.+++....+ .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 82 IITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 99999999999999987543 68999999999999999999999999999999999999999999999999998764211
Q ss_pred ---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHH
Q 007266 159 ---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234 (610)
Q Consensus 159 ---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~L 234 (610)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+......+.+..++..+.+|
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1112345578999999998889999999999999999987 999998888888888887666666677889999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcC
Q 007266 235 VKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~H 255 (610)
+.+||+.+|++||++.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=337.01 Aligned_cols=253 Identities=27% Similarity=0.426 Sum_probs=210.8
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
|++++.||.|++|.||++.+..+|..||+|++............+.+|+.+++.++|+|++++++.+... ...|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEec
Confidence 7889999999999999999999999999999976554433445678899999999999999999987655 588999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASS 162 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~~ 162 (610)
+. ++|.+++.......+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 95 689999887554568999999999999999999999999999999999999999999999999987643221 2233
Q ss_pred ccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--------------------
Q 007266 163 VVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-------------------- 221 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-------------------- 221 (610)
..+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+......
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 4678899999988664 5788999999999999999999999877654443333221110
Q ss_pred --------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 222 --------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 222 --------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.....++..+.++|.+||+.+|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=341.40 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=209.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|+.++.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. |+||+++++.+... ...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-GDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-CcEEEE
Confidence 5788889999999999999999999999999998755433 34456888999999996 99999999987765 467899
Q ss_pred EeecCCCCHHHHH---HHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 81 IGYCEGGDMAEAI---KKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 81 mEy~~GgsL~~~I---k~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
|||+. ++|.++. .......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99985 4655543 222334799999999999999999999985 999999999999999999999999999977654
Q ss_pred ccccccccCCCcccCCccccCC---CCCCCccccccchhHHhhhhcCccccccCH-HHHHHHHhhccCCC----CCcccc
Q 007266 157 DDLASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAP----LPTVYS 228 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~~---~yt~ksDIWSLG~iLyeLltG~~PF~~~~~-~~l~~~I~~~~~~~----~p~~~s 228 (610)
........|++.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+....... .+..++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 4444456789999999998776 688999999999999999999999986542 11222222211111 123478
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.++.+||.+||+.+|++||++++++.||||+.+.
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 8999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=330.54 Aligned_cols=244 Identities=22% Similarity=0.377 Sum_probs=208.4
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 87 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Gg 87 (610)
+.||+|+||.||++.+..+++.||+|.+... ........+.+|++++++++||||+++++.+... ...|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCeEEEEeeccCC
Confidence 4699999999999999999999999988643 2344556788999999999999999999987665 4788999999999
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc---ccc
Q 007266 88 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS---SVV 164 (610)
Q Consensus 88 sL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~---~~v 164 (610)
+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......... ...
T Consensus 79 ~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 79 DFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999997643 358999999999999999999999999999999999999999999999999987643221111 112
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 243 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP 243 (610)
++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+......+.+..++..+.+||.+||+.+|
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 2456999999998889999999999999999997 999998877777666666655556677889999999999999999
Q ss_pred CCCCCHHHHhc
Q 007266 244 EFRPSAAELLC 254 (610)
Q Consensus 244 ~~RpSa~eiL~ 254 (610)
++||++.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=330.47 Aligned_cols=254 Identities=33% Similarity=0.608 Sum_probs=214.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++.+.||+|+||.||++++..+++.||||.+.... ........+.+|+.+++.++||||+++++.+...+ ..++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~ 79 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-ELNI 79 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-eEEE
Confidence 478999999999999999999999999999999886533 23444566889999999999999999999887654 7889
Q ss_pred EEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
||||+.+++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999999888642 2235899999999999999999999999999999999999999999999999998775433
Q ss_pred c-ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC--HHHHHHHHhhccCCCCC-cccchHHHH
Q 007266 158 D-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPLP-TVYSGAFRG 233 (610)
Q Consensus 158 ~-~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~--~~~l~~~I~~~~~~~~p-~~~s~~l~~ 233 (610)
. ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.... .......+......+.+ ..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 2 2234578899999999988889999999999999999999999996543 34455555444333333 457889999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+|.+||..+|++||++.++++.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=337.71 Aligned_cols=250 Identities=25% Similarity=0.465 Sum_probs=203.2
Q ss_pred EecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHH---HhcCCCceeeeeeeEeecCcEEEEEEeec
Q 007266 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELI---SRVRNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL---~~L~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
.||+|+||.||++.+..+++.+|+|.+........ ....+.+|..++ ...+|+||+.+++.+...+ ..|+||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-KLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-eEEEEEecC
Confidence 48999999999999999999999999875443222 122234444433 3447999999988876554 788999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccccccc
Q 007266 85 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVV 164 (610)
Q Consensus 85 ~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~v 164 (610)
.|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 80 ~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~ 156 (279)
T cd05633 80 NGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV 156 (279)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcC
Confidence 9999999988654 6899999999999999999999999999999999999999999999999998765332 223457
Q ss_pred CCCcccCCcccc-CCCCCCCccccccchhHHhhhhcCccccccCH--HHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 165 GTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM--QALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 165 GTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~--~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
|++.|+|||++. +..++.++||||+||++|+|++|..||..... ..............++..++.+++++|++||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 999999999886 45688999999999999999999999975432 122223323334456677899999999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCchh
Q 007266 242 NPEFRP-----SAAELLCHPHLQPYV 262 (610)
Q Consensus 242 dP~~Rp-----Sa~eiL~Hp~f~~~~ 262 (610)
||.+|+ +++++++||||+.+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCCC
Confidence 999999 699999999998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=332.55 Aligned_cols=247 Identities=19% Similarity=0.386 Sum_probs=213.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+. ++..+|+|.+....... +.+.+|+.++++++|+|++++++.+.. ...|++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~ 79 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVT 79 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEE
Confidence 68999999999999999999765 55679999987644432 458899999999999999999987643 3578999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999999875555689999999999999999999999999999999999999999999999999976543321
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+.+..++..+.+||.+|
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQC 239 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 122345568999999988889999999999999999998 9999998888888888776666667778899999999999
Q ss_pred hcCCCCCCCCHHHHhc
Q 007266 239 LRKNPEFRPSAAELLC 254 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~ 254 (610)
|..+|++|||+++++.
T Consensus 240 l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 240 WKKDPEERPTFEYLQS 255 (260)
T ss_pred cccCcccCcCHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=332.97 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=210.7
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc--------HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT--------DRARRSAHQEMELISRVRNPFIVEYKDSWVEKG 74 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~--------~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~ 74 (610)
+|.+.+.||.|+||.||++.+..+++.+|+|.+...... ....+.+.+|+.+++.++|+|++++++.+...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 689999999999999999999989999999988643211 11245688899999999999999999977654
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
...++||||+.|++|.+++...+ .+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 57889999999999999998754 6899999999999999999999999999999999999999999999999998764
Q ss_pred cccc---ccccccCCCcccCCccccCCC--CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhh-ccCCCC----C
Q 007266 155 ISDD---LASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK-SIVAPL----P 224 (610)
Q Consensus 155 ~~~~---~~~~~vGTp~Y~APEvl~~~~--yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~-~~~~~~----p 224 (610)
.... ......|+..|+|||++.... ++.++|+|||||++|+|++|..||...+.......+.. ...... .
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 3221 123456889999999987654 78999999999999999999999976655443333221 112222 2
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
..++..+.++|.+||..+|+.||+++++|+||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2468899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=333.62 Aligned_cols=247 Identities=19% Similarity=0.370 Sum_probs=212.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..+ ..||+|++...... .+.+.+|+.++++++|+||+++++.+.. ...|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~ 79 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVT 79 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEE
Confidence 5899999999999999999988655 45999998754432 2457889999999999999999987643 4578999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
||+.+++|.+++....+..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999999875555689999999999999999999999999999999999999999999999999976543322
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+......+.+..++..+.+||.+|
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 239 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 223456678999999998899999999999999999999 8999998887777777766555556667899999999999
Q ss_pred hcCCCCCCCCHHHHhc
Q 007266 239 LRKNPEFRPSAAELLC 254 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~ 254 (610)
|+.+|++||++.+++.
T Consensus 240 l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 240 WRKEPEERPTFEYLQA 255 (262)
T ss_pred ccCCcccCCCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.41 Aligned_cols=252 Identities=21% Similarity=0.388 Sum_probs=207.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC-----CeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE-----RKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~-----~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||++++... +..||+|.+...... .....+.+|+.+++.+ +|+|||++++++...+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~- 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGG- 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC-
Confidence 4799999999999999999987543 357999999754433 3456688999999999 8999999999887654
Q ss_pred EEEEEEeecCCCCHHHHHHHhC----------------------------------------------------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN---------------------------------------------------------- 97 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~---------------------------------------------------------- 97 (610)
.+|+|||||.+|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 7889999999999999986431
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---cccccc
Q 007266 98 ----------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVV 164 (610)
Q Consensus 98 ----------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---~~~~~v 164 (610)
...++++.+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...... ......
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 1247889999999999999999999999999999999999999999999999997653322 112234
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHH-HHHhhccCCCCCcccchHHHHHHHHhhcCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALI-NKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~-~~I~~~~~~~~p~~~s~~l~~LI~kmL~~d 242 (610)
++..|+|||++.+..++.++|||||||++|+|++ |..||........+ ..+........+..++.++.++|.+||+.|
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 355 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLE 355 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCC
Confidence 5567999999998899999999999999999997 99999876544333 333333344455667899999999999999
Q ss_pred CCCCCCHHHHhcC
Q 007266 243 PEFRPSAAELLCH 255 (610)
Q Consensus 243 P~~RpSa~eiL~H 255 (610)
|.+||++.++++.
T Consensus 356 p~~RPs~~~l~~~ 368 (374)
T cd05106 356 PTERPTFSQISQL 368 (374)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=335.28 Aligned_cols=252 Identities=26% Similarity=0.463 Sum_probs=205.6
Q ss_pred EecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHH---HHHHhcCCCceeeeeeeEeecCcEEEEEEeec
Q 007266 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEM---ELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei---~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
.||+|+||.||++.+..+++.||+|.+....... .....+..|. .+++...||||+.+++.+... ..+|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecC
Confidence 4899999999999999999999999987543221 1112233343 445556899999999877655 4789999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccccccc
Q 007266 85 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVV 164 (610)
Q Consensus 85 ~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~v 164 (610)
.|++|.+++.... .+++..++.|+.||+.||.|||+++|+||||||+||+++.++.++|+|||++...... .....+
T Consensus 80 ~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~ 156 (278)
T cd05606 80 NGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV 156 (278)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcC
Confidence 9999999987644 6899999999999999999999999999999999999999999999999998765432 234568
Q ss_pred CCCcccCCccccC-CCCCCCccccccchhHHhhhhcCcccccc---CHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 165 GTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 165 GTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~---~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
|+..|+|||++.+ ..++.++||||+||++|+|++|..||... ........+ .......+..++..+.++|.+||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHHhh
Confidence 9999999999875 46899999999999999999999999876 333332222 223344666789999999999999
Q ss_pred CCCCCCC-----CHHHHhcCCCCCchhhhh
Q 007266 241 KNPEFRP-----SAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 241 ~dP~~Rp-----Sa~eiL~Hp~f~~~~~~~ 265 (610)
.+|.+|+ ++.++++||||....+..
T Consensus 236 ~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred cCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 9999999 999999999998865444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=331.06 Aligned_cols=247 Identities=20% Similarity=0.402 Sum_probs=215.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+. +++.||+|.+...... ...+.+|+.++++++|+||+++++.+. ....|++|
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~ 79 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIIT 79 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEE
Confidence 57999999999999999999865 5678999998754443 245788999999999999999998753 34688999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
||+.+++|.+++....+..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999999999876666789999999999999999999999999999999999999999999999999976543221
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....++..|+|||++....++.++|||||||++|+|++ |.+||.+.+..+....+......+.+..++.++.++|.+|
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLC 239 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 223455678999999998889999999999999999998 9999998888887777776666667778899999999999
Q ss_pred hcCCCCCCCCHHHHhc
Q 007266 239 LRKNPEFRPSAAELLC 254 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~ 254 (610)
|..+|++||++++++.
T Consensus 240 l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 240 WKEKPEERPTFEYLRS 255 (260)
T ss_pred ccCChhhCCCHHHHHH
Confidence 9999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=337.47 Aligned_cols=250 Identities=22% Similarity=0.426 Sum_probs=215.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|.+.+.||+|+||.||++.+.. ++..+|+|.+.... ......+.+|+.+++++.|+||+++++.+... ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-Cc
Confidence 479999999999999999998632 45678999886432 34456788999999999999999999987654 57
Q ss_pred EEEEEeecCCCCHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeee
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN-----------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 145 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~-----------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL 145 (610)
.++||||+.+++|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 899999999999999997543 124899999999999999999999999999999999999999999999
Q ss_pred eeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCC
Q 007266 146 GDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA 221 (610)
Q Consensus 146 ~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~ 221 (610)
+|||+++...... ......++..|+|||++.+..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999997653322 1233456778999999998889999999999999999998 99999988888888888777666
Q ss_pred CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 222 PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 222 ~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
..+..++..+.+|+.+||+.||.+||++.+++.
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 677788999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.96 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=212.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 76 (610)
++|++++.||+|+||.||++.+..+++.||+|++..........+.+.+|+.++++++|+||+++++.+.... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 6899999999999999999999999999999999765444444566889999999999999999999875432 34
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
.|++++++ |++|.++++.. .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 77888887 78998888653 589999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-------------- 221 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-------------- 221 (610)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 173 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred --cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 2345678999999998866 56788999999999999999999999876654443333221110
Q ss_pred ----------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 222 ----------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 222 ----------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
......+..+.+||.+||+.||.+||++.++|+||||+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 00113577899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=363.96 Aligned_cols=281 Identities=28% Similarity=0.436 Sum_probs=227.1
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
|..++.||-|+||.|.+++..++...||+|.+++...-. ........|..||..-+++.||+++.+|++++ .+|+||+
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYFVMd 709 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFVMD 709 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEEEEe
Confidence 778999999999999999999999999999998654322 23445778999999999999999999998776 6889999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-----
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD----- 157 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~----- 157 (610)
|+.||+|..+|.+.+ .|.|+.++.|+.+|..|+++.|..|+|||||||+|||||.+|+|||+|||||.-+...
T Consensus 710 YIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999998876 7999999999999999999999999999999999999999999999999998754110
Q ss_pred ----c----------------------------------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhc
Q 007266 158 ----D----------------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ 199 (610)
Q Consensus 158 ----~----------------------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG 199 (610)
+ .....+||+.|+|||++....|+..+|+||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 0 11346899999999999999999999999999999999999
Q ss_pred CccccccCHHHHHHHH---hhccCCCCCcccchHHHHHHHHhhcCCCCCCC---CHHHHhcCCCCCchhhhhccccCCCC
Q 007266 200 KAAFKAFDMQALINKI---NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQPYVLGIHLKLNGPR 273 (610)
Q Consensus 200 ~~PF~~~~~~~l~~~I---~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~Rp---Sa~eiL~Hp~f~~~~~~~~~~~~~p~ 273 (610)
.+||-.....+.-.++ ...+..+....+|.++.+||.++ ..+++.|. .++|+..||||+...+....+...|.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApY 946 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPY 946 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccchHhhhhccCCc
Confidence 9999776543332222 23334455667899999999875 45678885 47889999999987655433434443
Q ss_pred CCCCCCCCCCccccc
Q 007266 274 RNTFPLEWSDSNFKK 288 (610)
Q Consensus 274 ~~~~~~~~~~s~~~~ 288 (610)
.+...-.-+.+||+.
T Consensus 947 IP~ItHptDTSNFdp 961 (1034)
T KOG0608|consen 947 IPRITHPTDTSNFDP 961 (1034)
T ss_pred CccccCCCccccCCc
Confidence 333333345555544
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=329.80 Aligned_cols=247 Identities=18% Similarity=0.359 Sum_probs=213.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+. +++.||+|.+...... .+.+.+|+.++++++|+||+++++.+... ...|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 80 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLE-EPIYIVT 80 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecC-CCeeeee
Confidence 57999999999999999999875 4568999998754432 34578899999999999999999976554 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.|++|.+++....+..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++....... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence 999999999999876555789999999999999999999999999999999999999999999999999987653221 1
Q ss_pred cccC---CCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 162 SVVG---TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 162 ~~vG---Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
...| +..|+|||++.+..++.++|||||||++|+|++ |..||.+.....+...+......+.+..++..+.+++.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 2222 357999999998899999999999999999998 999999988888887777665556677789999999999
Q ss_pred hhcCCCCCCCCHHHHhc
Q 007266 238 MLRKNPEFRPSAAELLC 254 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~ 254 (610)
||+.+|++||++.+++.
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.23 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=218.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||.|+||.||++.+.. +..+++|.+..... .....+.+|+.+++.++|+||+++++.+... ..+++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVG-EPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecC-CCeEEEE
Confidence 468999999999999999999987 88999999875432 2345688999999999999999999977654 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc-c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-A 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-~ 160 (610)
||+.+++|.+++....+..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 999999999999876556789999999999999999999999999999999999999999999999999977543321 2
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....++..|++||++.+..++.++|||||||++|+|++ |..||...+..+.+..+......+.+..+++.+.++|.+||
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 241 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECW 241 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHc
Confidence 23345678999999998889999999999999999998 89999988888888888776666777889999999999999
Q ss_pred cCCCCCCCCHHHHhcC
Q 007266 240 RKNPEFRPSAAELLCH 255 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~H 255 (610)
+.||.+|||+.++++.
T Consensus 242 ~~~p~~Rpt~~~l~~~ 257 (261)
T cd05148 242 AAEPEDRPSFKALREE 257 (261)
T ss_pred CCCchhCcCHHHHHHH
Confidence 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=330.85 Aligned_cols=249 Identities=25% Similarity=0.488 Sum_probs=208.0
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHH-HHhcCCCceeeeeeeEeecCcEEEEEEeec
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMEL-ISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~i-L~~L~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
++.||.|+||.||+|.+..+++.||+|.+...... ......+..|..+ ....+|+|++++++.+.. +..+|+||||+
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 79 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYL 79 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEecc
Confidence 36799999999999999999999999998754322 1222234445444 445589999999998765 45889999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccccccc
Q 007266 85 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVV 164 (610)
Q Consensus 85 ~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~v 164 (610)
.|++|.++++... .+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCC
Confidence 9999999998754 689999999999999999999999999999999999999999999999999876432 33457
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC---CCCCcccchHHHHHHHHhhcC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~---~~~p~~~s~~l~~LI~kmL~~ 241 (610)
|++.|++||.+.+..++.++||||||+++|+|++|..||...+.......+..... ......++..+.++|.+||+.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 88999999999888889999999999999999999999998887777766644322 223345789999999999999
Q ss_pred CCCCCC---CHHHHhcCCCCCch
Q 007266 242 NPEFRP---SAAELLCHPHLQPY 261 (610)
Q Consensus 242 dP~~Rp---Sa~eiL~Hp~f~~~ 261 (610)
+|++|| +++|+|.||||...
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhcC
Confidence 999999 55899999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=354.31 Aligned_cols=252 Identities=20% Similarity=0.365 Sum_probs=208.1
Q ss_pred CCeEEEeEecccCceEEEEEEE-----eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRH-----KHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d-----~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||+|.+ ..++..||+|++...... ...+.+.+|+.+|..+ +|||||++++++...+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 4799999999999999999974 345678999998644332 3345688999999999 8999999999876654
Q ss_pred EEEEEEeecCCCCHHHHHHHhC----------------------------------------------------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN---------------------------------------------------------- 97 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~---------------------------------------------------------- 97 (610)
..++|||||.||+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 7889999999999999987532
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc---
Q 007266 98 ---------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--- 159 (610)
Q Consensus 98 ---------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~--- 159 (610)
...++++.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 12478899999999999999999999999999999999999999999999999976543221
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHH-HHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~-~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+........+...+.++.+||.+
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 352 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS 352 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence 122345667999999999999999999999999999997 89999876533 3444444444444556678899999999
Q ss_pred hhcCCCCCCCCHHHHhcC
Q 007266 238 MLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~H 255 (610)
||+.||++||++.++++.
T Consensus 353 cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 353 CWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.88 Aligned_cols=253 Identities=19% Similarity=0.356 Sum_probs=217.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCC-----CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHE-----RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~-----~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 75 (610)
+.+|++++.||+|+||.||++.+..+ +..||+|.+..... ....+.+.+|+.++..++||||+++++.+...+
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~- 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ- 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-
Confidence 35688999999999999999988653 57899999875432 344566889999999999999999999876554
Q ss_pred EEEEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
..++++||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 6889999999999999986321 12478899999999999999999999999999999999999999
Q ss_pred Ceeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhh
Q 007266 142 DIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINK 217 (610)
Q Consensus 142 ~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~ 217 (610)
.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987653322 2234456789999999988889999999999999999997 8999999888888888888
Q ss_pred ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 218 ~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+.+..++..+.+|+.+||+.+|.+||++++|+..
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 77777788899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.92 Aligned_cols=286 Identities=26% Similarity=0.452 Sum_probs=240.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~L 79 (610)
-+|..+.+||+|+||.|.++..+.+.+.||||+++++...+. ..+--..|-++|.-.. -|++++++..|+.- ..+|+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-DRLyF 427 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-DRLYF 427 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-hheee
Confidence 468899999999999999999999999999999986553221 1222345667776654 46777777766654 48899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-c
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-D 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~ 158 (610)
||||+.||+|...|++.+ .|.|..+..|+.+|+.||-+||++|||+||||.+||||+.+|+|||+|||+++.-..+ .
T Consensus 428 VMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 999999999999999876 7899999999999999999999999999999999999999999999999999875433 3
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
...++||||.|+|||++...+|+.++|+||+||+||||+.|++||.+.+..++++.|...... .|..+|.++.++++.+
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-yPKslSkEAv~ickg~ 584 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-YPKSLSKEAVAICKGL 584 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-CcccccHHHHHHHHHH
Confidence 567899999999999999999999999999999999999999999999999999999876554 6888999999999999
Q ss_pred hcCCCCCCCC-----HHHHhcCCCCCchhhhhc--cccCCCCCCCCCCCCCCcccccccC
Q 007266 239 LRKNPEFRPS-----AAELLCHPHLQPYVLGIH--LKLNGPRRNTFPLEWSDSNFKKTRF 291 (610)
Q Consensus 239 L~~dP~~RpS-----a~eiL~Hp~f~~~~~~~~--~~~~~p~~~~~~~~~~~s~~~~~~~ 291 (610)
|.+.|.+|.. -.+|-.||||+...|... ..+..|.++.....-+.+||++...
T Consensus 585 ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft 644 (683)
T KOG0696|consen 585 LTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFT 644 (683)
T ss_pred hhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHh
Confidence 9999999964 378899999998766532 2334555555555666677766433
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=331.32 Aligned_cols=248 Identities=19% Similarity=0.377 Sum_probs=213.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+.. +..+|+|.+...... ...+.+|+.++++++||||+++++++... ..+|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-RPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccC-CCcEEEE
Confidence 579999999999999999997754 456999988754332 24588999999999999999999987654 4689999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc-
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA- 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~- 160 (610)
||+.+++|.+++..... .+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++........
T Consensus 79 e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999999999987433 6899999999999999999999999999999999999999999999999998765433221
Q ss_pred -ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 161 -SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 -~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+........+...+..+++++.+|
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC 237 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 12335567999999988889999999999999999998 9999998888777777776665556777899999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|..+|.+||++.+++.+
T Consensus 238 l~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 238 WHEKAEERPTFQQLLSS 254 (256)
T ss_pred cCCCcccCCCHHHHHHh
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=340.75 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=204.4
Q ss_pred CeEEEeEecccCceEEEEEEEeC--CCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKH--ERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVC 78 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~--~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~~ 78 (610)
+|++++.||+|+||.||++.+.. ++..||+|.+.... ........+.+|+.++++++||||+++++.+... +..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 59999999999999999999988 89999999998643 1122234577899999999999999999988765 25789
Q ss_pred EEEeecCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC----CCCeeeeecccc
Q 007266 79 IIIGYCEGGDMAEAIKKAN---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR----DQDIRLGDFGLA 151 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~---~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~----~g~vKL~DFGla 151 (610)
+||||++ ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 47777775422 236899999999999999999999999999999999999999 889999999998
Q ss_pred ccccccc----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHH---------HHHHHhh
Q 007266 152 KMLISDD----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA---------LINKINK 217 (610)
Q Consensus 152 k~~~~~~----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~---------l~~~I~~ 217 (610)
....... .....++++.|+|||++.+ ..++.++|||||||+||+|++|.+||.+..... .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 8653322 1234578999999998766 457899999999999999999999997654321 1111100
Q ss_pred c------------------------c-CCCCC-----------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 218 S------------------------I-VAPLP-----------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 218 ~------------------------~-~~~~p-----------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
. . ....+ ...+..+.++|.+||+.||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 0 00011 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=334.46 Aligned_cols=254 Identities=32% Similarity=0.551 Sum_probs=216.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC---CCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR---NPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~~~ 78 (610)
+.|++++.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.+++++. |||++++++.+... ...|
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-~~~~ 78 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-PRLW 78 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-CEEE
Confidence 3589999999999999999999999999999998754332 33456788999999986 99999999987654 5889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.|++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999999998653 68999999999999999999999999999999999999999999999999987764332
Q ss_pred -ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc-ccchHHHHHH
Q 007266 159 -LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT-VYSGAFRGLV 235 (610)
Q Consensus 159 -~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~-~~s~~l~~LI 235 (610)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+.......++. .++.++.++|
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV 235 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHH
Confidence 2334578999999998864 457899999999999999999999998887665554443333333333 3788999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+||+.||++||++.+++.|+||+.
T Consensus 236 ~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 236 AACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred HHHcCCCcccCcCHHHHhhChHhhc
Confidence 9999999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=328.81 Aligned_cols=248 Identities=27% Similarity=0.520 Sum_probs=214.3
Q ss_pred ecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCC
Q 007266 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 88 (610)
Q Consensus 10 LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Ggs 88 (610)
||.|+||.||++.+..+++.+++|.+..... .......+.+|+.++++++|+||+++++.+.. +...|++|||+.|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence 6999999999999998999999999865433 23445678899999999999999999987754 458899999999999
Q ss_pred HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---------c
Q 007266 89 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---------L 159 (610)
Q Consensus 89 L~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---------~ 159 (610)
|.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 80 LASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999998755 68999999999999999999999999999999999999999999999999987653321 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcc--cchHHHHHHHH
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV--YSGAFRGLVKS 237 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~--~s~~l~~LI~k 237 (610)
.....++..|++||.+....++.++|+|||||++|+|++|..||...........+..... ..+.. ++..+.++|.+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 236 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISK 236 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHH
Confidence 2345788899999999888899999999999999999999999998888777777655322 23333 48999999999
Q ss_pred hhcCCCCCCCCH---HHHhcCCCCCch
Q 007266 238 MLRKNPEFRPSA---AELLCHPHLQPY 261 (610)
Q Consensus 238 mL~~dP~~RpSa---~eiL~Hp~f~~~ 261 (610)
||+.+|.+||++ .++|+||||...
T Consensus 237 ~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 237 LLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HhcCCHhhcCCCccHHHHhcCccccCC
Confidence 999999999999 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.07 Aligned_cols=253 Identities=30% Similarity=0.536 Sum_probs=217.1
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|...+.||.|++|.||++.+..+++.+++|.+.... ....+.+.+|+.+++.++|+|++++++.+... ...|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-DELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-CeEEEEEe
Confidence 4666789999999999999999999999999886432 23345688999999999999999999987654 57899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|+.|++|.+++.. . .+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 97 ~~~~~~L~~~~~~-~--~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-T--RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9999999999887 2 58999999999999999999999999999999999999999999999999887543322 223
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC--CcccchHHHHHHHHhh
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSML 239 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--p~~~s~~l~~LI~kmL 239 (610)
...|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+........ +..++..+.+||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 46799999999999988899999999999999999999999988777766666655433222 2237889999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCch
Q 007266 240 RKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
..+|++||++.++++||||+..
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred ccChhhCcCHHHHccCcccccC
Confidence 9999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.74 Aligned_cols=250 Identities=19% Similarity=0.359 Sum_probs=213.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe----EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK----KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~----~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||++.+..++. .||+|.+... ........+.+|+.+++.+.|+||+.+++.+... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--TV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--Cc
Confidence 589999999999999999999877665 4899988643 3334456788999999999999999999987643 46
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++++||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 79999999999999997643 36899999999999999999999999999999999999999999999999999876433
Q ss_pred cc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 DL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
.. .....+++.|+|||++.+..++.++|||||||++|||++ |..||.......+...+......+.+..++..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHH
Confidence 21 122344678999999998899999999999999999988 99999988877777777666556667778999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+|.+||..||+.||++.+++..
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=346.17 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=214.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 76 (610)
++|++++.||+|+||.||++.+..++..||+|.+............+.+|+.+|++++|+||+++++.+...+ ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 6899999999999999999999999999999998655444555567889999999999999999999886543 24
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+ |++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 68999999 78999888753 689999999999999999999999999999999999999999999999999876533
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-------------- 221 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-------------- 221 (610)
. .....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+......
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 171 E--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred C--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 2 334578999999998876 45788999999999999999999999877655444433221110
Q ss_pred ----------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 222 ----------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 222 ----------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.....++..+.++|.+||+.||.+||++.+++.||||+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 01234677899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=374.67 Aligned_cols=248 Identities=28% Similarity=0.523 Sum_probs=211.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeee-eEeec-----Cc
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKD-SWVEK-----GC 75 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~-~~~~~-----~~ 75 (610)
+++|.+.|.+|||+.||+|++...+..||+|.+... ++...+.+++|+.+|++|. |+|||.|++ ..... ..
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 678999999999999999999988899999998755 6677888999999999996 999999999 33322 24
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEecCCCCeeeeecccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
.++|+||||.||.|-+++.++....|+|.++.+|++|+++|+.+||..+ |||||||-|||||..+|++||||||.++.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 6789999999999999998766667999999999999999999999997 99999999999999999999999998865
Q ss_pred cccccc----------cccccCCCcccCCccc---cCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC
Q 007266 154 LISDDL----------ASSVVGTPSYMCPELL---ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV 220 (610)
Q Consensus 154 ~~~~~~----------~~~~vGTp~Y~APEvl---~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~ 220 (610)
...... .-...-|+.|+|||++ .+.+.++|+|||+|||+||-|+....||.......++ ...+.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl---ng~Y~ 272 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL---NGNYS 272 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE---ecccc
Confidence 422210 1123578999999975 5788899999999999999999999999987543332 23334
Q ss_pred CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 221 APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 221 ~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.|....++..+.+||+.||+.||++||++.|++.+
T Consensus 273 ~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 273 FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 44456899999999999999999999999999865
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=357.20 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=223.9
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
-+.||.|-||+||-++++.+|+.||||+|.+.+...+....+.+|+.||+++.||.||.+-..|.. .+.+++|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl~- 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKLH- 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhhc-
Confidence 368999999999999999999999999998877766667889999999999999999998877654 458999999995
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeeecccccccccccccccc
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDDLASSV 163 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~DFGlak~~~~~~~~~~~ 163 (610)
|++.+.|-......|+|...+.++.||+.||.|||-+||+|+||||+||||.... .+||||||+|+.+.......+.
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV 726 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV 726 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence 5777766555555799999999999999999999999999999999999997653 5999999999999988889999
Q ss_pred cCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc-CHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCC
Q 007266 164 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 242 (610)
Q Consensus 164 vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~-~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~d 242 (610)
+|||.|+|||++....|+...|+||+|||+|.-+.|..||... +..++++.-..-.....+..++.++.+||..+|++.
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVk 806 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVK 806 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999754 444555444333444456678999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCchh
Q 007266 243 PEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 243 P~~RpSa~eiL~Hp~f~~~~ 262 (610)
-.+|.|.++.|.|||+|.+-
T Consensus 807 m~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 807 MRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHhcchHhhccchhhhcch
Confidence 99999999999999999874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=333.65 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=215.1
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
|++.+.||.|++|.||++.+..+++.+++|.+............+.+|+.++++++|+||+++++.+... ...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEec
Confidence 7889999999999999999999999999999876655545566788999999999999999999987655 578899999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASS 162 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~~ 162 (610)
+.+ +|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 80 MDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred cCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 965 8888887643 468999999999999999999999999999999999999999999999999987765443 2334
Q ss_pred ccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-------------------
Q 007266 163 VVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------- 222 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------------- 222 (610)
..++..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+.+.++......+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5688899999998776 78999999999999999999999998877666655543322211
Q ss_pred ----------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 ----------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 ----------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....++.+++++|.+||+.||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.47 Aligned_cols=246 Identities=20% Similarity=0.383 Sum_probs=215.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||.|+||.||++... ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+.. +...|+||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~ 79 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVT 79 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEE
Confidence 68999999999999999999874 78899999975433 34668899999999999999999998776 45789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.+++|.++++......+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--~ 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--D 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--c
Confidence 99999999999987655568999999999999999999999999999999999999999999999999998763222 1
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
...++..|+|||++....++.++|||||||++|+|++ |..||......++...+........+..+++.+.++|.+||.
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhc
Confidence 3345567999999988889999999999999999997 999999988888887777665556677789999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q 007266 241 KNPEFRPSAAELLCH 255 (610)
Q Consensus 241 ~dP~~RpSa~eiL~H 255 (610)
.+|++||++.+++..
T Consensus 238 ~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 238 LDPAKRPTFKQLREQ 252 (256)
T ss_pred cChhhCcCHHHHHHH
Confidence 999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.44 Aligned_cols=253 Identities=28% Similarity=0.386 Sum_probs=203.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..++..||+|.+....... ....+.+|+.+++.++|+||+++++++... ...|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-CcHHHHHHHHHHHhcCCCCEeEEEEEEecC-CeEEEEE
Confidence 57999999999999999999999999999999986543322 223467899999999999999999987654 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
||+. ++|.+.+.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++..... ...
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 9995 67777776533 35789999999999999999999999999999999999999999999999998764322 123
Q ss_pred ccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCH-HHHHHHHhhccCCC----------------
Q 007266 161 SSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAP---------------- 222 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~-~~l~~~I~~~~~~~---------------- 222 (610)
....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+. .+.+..+......+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 34568999999999875 4578899999999999999999999976542 22222221100000
Q ss_pred ------CC---------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 ------LP---------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 ------~p---------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.+ ...+..+.++|.+||..||.+|||+.|+|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 0125678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=331.47 Aligned_cols=253 Identities=32% Similarity=0.506 Sum_probs=212.8
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEEEEEEe
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIG 82 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~~LVmE 82 (610)
|++++.||.|+||.||++.+..+++.+|+|.+............+.+|+.+++.++|+|++++++.+... +...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7899999999999999999999999999999987653444455678899999999999999999988766 368999999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--cc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LA 160 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~~ 160 (610)
|+. ++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 996 48988887643 368999999999999999999999999999999999999999999999999998764432 23
Q ss_pred ccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC----------------
Q 007266 161 SSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---------------- 223 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---------------- 223 (610)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+......+.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 34567889999998765 4578999999999999999999999988876665555433211110
Q ss_pred --------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 224 --------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 224 --------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
...++..+.++|.+||..+|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 11137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=337.02 Aligned_cols=256 Identities=31% Similarity=0.520 Sum_probs=211.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC------
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG------ 74 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~------ 74 (610)
+++|++.+.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46899999999999999999999999999999999765433333445778999999999999999999876533
Q ss_pred ---cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccc
Q 007266 75 ---CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151 (610)
Q Consensus 75 ---~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGla 151 (610)
..+|+|+||+.+ +|...+... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 378999999975 777777653 336899999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC------
Q 007266 152 KMLISDD--LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------ 222 (610)
Q Consensus 152 k~~~~~~--~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------ 222 (610)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 7764332 2223456888999998865 456889999999999999999999998777655554443321111
Q ss_pred -----------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 223 -----------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 223 -----------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....++..+.++|.+||..||.+||++.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=330.60 Aligned_cols=253 Identities=32% Similarity=0.591 Sum_probs=213.4
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++.+.||.|+||.||++++..++..+|||.+..... .......+.+|+.+++.++|+||+++++.+...+ ..++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~ 79 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNI 79 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-eEEE
Confidence 5789999999999999999999999999999998865432 2334467889999999999999999999887654 7889
Q ss_pred EEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
+|||+.|++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999999998742 2346899999999999999999999999999999999999999999999999998765433
Q ss_pred c-ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH--HHHHHHHhhccCCCC-CcccchHHHH
Q 007266 158 D-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM--QALINKINKSIVAPL-PTVYSGAFRG 233 (610)
Q Consensus 158 ~-~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~--~~l~~~I~~~~~~~~-p~~~s~~l~~ 233 (610)
. ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+... ......+......+. +..++..+++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 2 23346799999999999988899999999999999999999999975543 344444443333333 3457889999
Q ss_pred HHHHhhcCCCCCCCCHHHHhc
Q 007266 234 LVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+|.+||..||++|||+.+|++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.23 Aligned_cols=249 Identities=22% Similarity=0.397 Sum_probs=203.9
Q ss_pred CCe-EEEeEecccCceEEEEEEE----eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-Cc
Q 007266 2 EQY-EVLEQIGKGSFGSALLVRH----KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GC 75 (610)
Q Consensus 2 d~Y-~ilk~LG~G~fG~Vyla~d----~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~ 75 (610)
++| ++++.||+|+||+||++.. ..++..||+|.+.... .......+.+|+++|++++||||+++++.+... +.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 567 9999999999999988653 3467899999987543 233455688999999999999999999987654 35
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 689999999999999999764 58999999999999999999999999999999999999999999999999987654
Q ss_pred cccc----cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH---------------HHHHHHHh
Q 007266 156 SDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------------QALINKIN 216 (610)
Q Consensus 156 ~~~~----~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~---------------~~l~~~I~ 216 (610)
.... .....++..|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 3221 2233456679999999888899999999999999999999999854321 11111122
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
.....+.+..++..+.+++.+||+.+|+.||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22333446667899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=347.31 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=215.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc-----E
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-----Y 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~-----~ 76 (610)
++|++++.||.|+||.||++++..+++.||+|.+............+.+|+.+++++.|+|++++++.+...+. .
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 58999999999999999999999999999999987554444445667889999999999999999987765432 4
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+|+||+ |++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 95 ~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999999 67999998763 689999999999999999999999999999999999999999999999999976533
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------- 222 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------- 222 (610)
. .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+......+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred c--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 2 345678999999998765 467899999999999999999999998877666555543322111
Q ss_pred -----------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 -----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 -----------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
....++..+.+||.+||..+|++|||+.++|+||||+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 1123588999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=329.83 Aligned_cols=248 Identities=21% Similarity=0.412 Sum_probs=212.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.+|++.+.||+|+||.||++.+. ++..+|+|.+....... ..+.+|++++++++|+||+++++.+... ...|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEE
Confidence 47899999999999999999876 46689999886443322 3477899999999999999999977654 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc-
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA- 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~- 160 (610)
||++|++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 79 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred ecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999999986443 6899999999999999999999999999999999999999999999999998765432211
Q ss_pred -ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 161 -SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 -~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
....++..|+|||.+.+..++.++|||||||+||+|++ |..||...+..+....+........+..++..+.+++.+|
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 11223457999999999899999999999999999998 8999998888887877776666666777899999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|..+|++||++.++++.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=328.56 Aligned_cols=247 Identities=18% Similarity=0.357 Sum_probs=212.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..++ .+|+|.+...... .+.+.+|+.+++++.|+|++++++.+. ....|+||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEE
Confidence 67999999999999999999886554 5899987644332 345788999999999999999988764 34678999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
||+.+++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999999875555689999999999999999999999999999999999999999999999999976543321
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+......+.+..++..+.++|.+|
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence 123346678999999988889999999999999999998 9999998888777777776655566777899999999999
Q ss_pred hcCCCCCCCCHHHHhc
Q 007266 239 LRKNPEFRPSAAELLC 254 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~ 254 (610)
|..||++||+++++++
T Consensus 240 l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 240 WKKDPDERPTFEYIQS 255 (260)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=330.42 Aligned_cols=253 Identities=17% Similarity=0.307 Sum_probs=218.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeC----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++.+.||+|+||.||++.+.. ++..|++|.+.. .........+.+|+.++++++|+||+++++.+...+...
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 589999999999999999999986 357889998763 334455677889999999999999999999888767788
Q ss_pred EEEEeecCCCCHHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANG------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGla 151 (610)
+++++|+.+++|.+++..... ..+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 999999999999999976422 35899999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCccc
Q 007266 152 KMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVY 227 (610)
Q Consensus 152 k~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~ 227 (610)
+.+..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..++...+........+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINC 244 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcC
Confidence 86543321 223456678999999998889999999999999999998 99999988888887777766655566678
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
++.+.+++.+||..||++||++.++++.
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~~~~~~ 272 (280)
T cd05043 245 PDELFAVMACCWALDPEERPSFSQLVQC 272 (280)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=340.22 Aligned_cols=251 Identities=29% Similarity=0.516 Sum_probs=214.3
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
|+....||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++|||++++++.+... ...|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEec
Confidence 44566899999999999999999999999998654332 345688999999999999999999987765 478999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASS 162 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~~ 162 (610)
+++++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ....
T Consensus 100 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 100 LQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 9999999987653 58999999999999999999999999999999999999999999999999987653322 2345
Q ss_pred ccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC--CCCCcccchHHHHHHHHhhc
Q 007266 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--~~~p~~~s~~l~~LI~kmL~ 240 (610)
.+|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... ...+..++..+.++|.+||+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 6799999999999988899999999999999999999999987776666655543322 12234578899999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCc
Q 007266 241 KNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+|.+||++.++++||||..
T Consensus 257 ~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 257 REPQERATAQELLDHPFLLQ 276 (297)
T ss_pred CCcccCcCHHHHhhChhhcc
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.33 Aligned_cols=254 Identities=34% Similarity=0.605 Sum_probs=219.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+.|++.+.||+|+||.||++.+..++..|++|.+..... ....+.+|+++++.++|+|++++++.+... ...|+|+
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~ 94 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVM 94 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEE
Confidence 468899999999999999999998899999999975544 345678899999999999999999988766 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||++|++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 9999999999998754 368999999999999999999999999999999999999999999999999887654322 22
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC--CcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--p~~~s~~l~~LI~km 238 (610)
....+++.|++||++.+..++.++|+|||||++|+|++|..||...+.......+........ +..++..+.+||.+|
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence 345688999999999988899999999999999999999999998776655555443332222 233788999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|+.+|..||++.++|.|+||..
T Consensus 254 l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 254 LVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred hccChhhCcCHHHHhhChHhhc
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=337.37 Aligned_cols=253 Identities=29% Similarity=0.505 Sum_probs=215.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..++..||+|.+...... ..+.+.+|+.++++++|||++++++.+... ...|+|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLVG-DELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeeeC-CcEEEEE
Confidence 5899999999999999999999889999999998644332 345688999999999999999999988765 4788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||++|++|.+++.+. .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 999999999999764 57899999999999999999999999999999999999999999999999887654332 23
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc--CCCCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI--VAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~--~~~~p~~~s~~l~~LI~km 238 (610)
....|++.|++||.+.+..++.++|+|||||++|+|++|..||...+.......+.... ....+..++..++++|.+|
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 34578999999999988889999999999999999999999998776544433332211 1223445678899999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|..+|++||++.+++.|+||+.
T Consensus 253 l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 253 LEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred ccCChhhCcCHHHHhcCHHHhc
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=344.23 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=207.9
Q ss_pred EeEeccc--CceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeec
Q 007266 7 LEQIGKG--SFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 7 lk~LG~G--~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
...||+| +||+||++++..+++.||+|.+..........+.+.+|+.+++.++||||++++++|... ...|+||||+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-SWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-CceEEEEecc
Confidence 3467777 999999999999999999999987665666667899999999999999999999988765 4789999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc-----
Q 007266 85 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----- 159 (610)
Q Consensus 85 ~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~----- 159 (610)
.+++|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999999999876555689999999999999999999999999999999999999999999999986543321110
Q ss_pred ---cccccCCCcccCCccccCC--CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc-c--------------
Q 007266 160 ---ASSVVGTPSYMCPELLADI--PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS-I-------------- 219 (610)
Q Consensus 160 ---~~~~vGTp~Y~APEvl~~~--~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~-~-------------- 219 (610)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||...........+... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 1112356679999998764 4789999999999999999999999876544333222111 0
Q ss_pred -------------------------------CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 220 -------------------------------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 220 -------------------------------~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
..+.+..++..+.+||.+||+.||++|||+.|+|+||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 0111234677899999999999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.28 Aligned_cols=252 Identities=20% Similarity=0.393 Sum_probs=214.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-------ERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~ 73 (610)
++|.+.+.||+|+||.||++++.. +...+|+|.+.... .......+.+|+.+++++ +|+||+++++.+...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 579999999999999999998754 23469999987543 334455688899999999 799999999987665
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKANG--------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~~--------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
+ ..|+||||+.+++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+|||++.
T Consensus 97 ~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 97 G-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 4 78899999999999999976421 24789999999999999999999999999999999999999
Q ss_pred CCCeeeeecccccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHH
Q 007266 140 DQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKI 215 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I 215 (610)
++.++|+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 255 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 99999999999876543221 112234568999999998889999999999999999998 89999988888888877
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
........+..++.++.+||.+||..+|.+||++.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 256 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7766666777889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=362.36 Aligned_cols=284 Identities=24% Similarity=0.410 Sum_probs=247.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
.+++++..||-||||.|-+++.......+|+|++++... .....+.+..|-.||..++.|+||+++..|.+. .++|++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS-KYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-hhhhhh
Confidence 467788999999999999999877666799998876543 233456788999999999999999999998765 499999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
||-|-||.|+..+++++ .|.+...+.++..+++|++|||++|||+|||||+|++|+.+|.+||.|||+|+.+.....+
T Consensus 499 mEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 99999999999999876 7999999999999999999999999999999999999999999999999999999988888
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc-CCCCCcccchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~-~~~~p~~~s~~l~~LI~kmL 239 (610)
-++||||.|.|||++.+..++.++|.||||+++|||++|.+||.+.++...++.|.+++ ...+|..++..+.+||+++.
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999998765 46678999999999999999
Q ss_pred cCCCCCCCC-----HHHHhcCCCCCchhhhh-c-cccCCCCCCCCCCCCCCccccc
Q 007266 240 RKNPEFRPS-----AAELLCHPHLQPYVLGI-H-LKLNGPRRNTFPLEWSDSNFKK 288 (610)
Q Consensus 240 ~~dP~~RpS-----a~eiL~Hp~f~~~~~~~-~-~~~~~p~~~~~~~~~~~s~~~~ 288 (610)
..+|.+|.. +.+|-+|-||..+.|.- . ..+..|..+......+.++|+.
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~ 712 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDN 712 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccC
Confidence 999999975 79999999999887642 1 1234444444444444455544
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.81 Aligned_cols=249 Identities=20% Similarity=0.379 Sum_probs=216.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
.++|++.+.||+|+||.||++.+. ++..+|+|.+...... .+.+.+|+.++++++|+||+++++.+... ...++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEE-EPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecC-CceEEE
Confidence 378999999999999999999875 4577999998754433 34588899999999999999999976544 578999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc-
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL- 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~- 159 (610)
|||+++++|.+++....+..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999999876555789999999999999999999999999999999999999999999999999876543221
Q ss_pred -cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 160 -ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 160 -~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+......+..+......+.+...+..+.+++.+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 112334568999999998889999999999999999998 999999988888888887776666777789999999999
Q ss_pred hhcCCCCCCCCHHHHhc
Q 007266 238 MLRKNPEFRPSAAELLC 254 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~ 254 (610)
||..+|++||++++++.
T Consensus 240 ~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=325.75 Aligned_cols=242 Identities=21% Similarity=0.365 Sum_probs=208.6
Q ss_pred eEecccCceEEEEEEEeCCC---eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeec
Q 007266 8 EQIGKGSFGSALLVRHKHER---KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~---~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
+.||+|+||.||++.....+ ..+|+|.+...... ...+.+.+|+.+++.+.|+||+++++.+. +...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeC
Confidence 47999999999999886654 78999998765543 44567889999999999999999998764 34678999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc--c-
Q 007266 85 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--S- 161 (610)
Q Consensus 85 ~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~--~- 161 (610)
.+++|.+++.... .+++..+..++.||+.||.|||.+|++|+||||+|||++.++.++|+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999998754 6899999999999999999999999999999999999999999999999999876433211 1
Q ss_pred -cccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 162 -SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 162 -~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
...++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..++...+......+.+..++..++++|.+||
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 235 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW 235 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence 1123457999999998889999999999999999997 99999988888877777766666677788999999999999
Q ss_pred cCCCCCCCCHHHHhc
Q 007266 240 RKNPEFRPSAAELLC 254 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~ 254 (610)
..+|++||++.++++
T Consensus 236 ~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 236 KYRPEDRPTFSELES 250 (257)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.17 Aligned_cols=251 Identities=19% Similarity=0.367 Sum_probs=215.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
.+|.+.+.||+|+||.||++.+.. ++..+++|.+.... ....+.+.+|+.++++++|+||+++++.+... ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG-DP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-Cc
Confidence 479999999999999999998643 45568888875332 33445688999999999999999999987654 47
Q ss_pred EEEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 142 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~ 142 (610)
.++||||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 899999999999999997643 134899999999999999999999999999999999999999999
Q ss_pred eeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhc
Q 007266 143 IRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKS 218 (610)
Q Consensus 143 vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~ 218 (610)
++|+|||+++...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+.....+.+...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 9999999997654332 2334567889999999999899999999999999999998 99999888888888877776
Q ss_pred cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 219 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 219 ~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.....+..++..+.+||.+||+.+|++||++.++++.
T Consensus 242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 6666667789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=326.30 Aligned_cols=249 Identities=29% Similarity=0.500 Sum_probs=206.3
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
....||+|+||.||++.+..++..|++|.+.... ....+.+.+|+.+++.++|+||+++++.+... ...++|+||+.
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEEEEEecCC
Confidence 4568999999999999999999999999886443 23445788999999999999999999987655 58899999999
Q ss_pred CCCHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-CCCeeeeeccccccccccc-ccc
Q 007266 86 GGDMAEAIKKANGVHF--PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~l--se~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|++|.+++..... .+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++....... ...
T Consensus 89 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 167 (268)
T cd06624 89 GGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167 (268)
T ss_pred CCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence 9999999986422 34 88999999999999999999999999999999999976 6789999999987654322 233
Q ss_pred cccCCCcccCCccccCCC--CCCCccccccchhHHhhhhcCccccccCHHH--HHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 162 SVVGTPSYMCPELLADIP--YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA--LINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~--yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~--l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
...|++.|+|||++.... ++.++|+|||||++|+|++|..||....... ............++..++.++++||.+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 456899999999986543 7889999999999999999999997654222 222112223344567788999999999
Q ss_pred hhcCCCCCCCCHHHHhcCCCC
Q 007266 238 MLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f 258 (610)
||..+|.+||++.+++.||||
T Consensus 248 ~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.22 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=210.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 76 (610)
++|.+.+.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.+.|+||+++++++.... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6899999999999999999999999999999998765444444456789999999999999999999876442 24
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+|+||+. .+|..++. ..++++.+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 95 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred EEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 689999995 47766542 2589999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------- 222 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------- 222 (610)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+......+
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 2345678999999999876 468899999999999999999999999877555444433211100
Q ss_pred -----------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 -----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 -----------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
....++..+.+||.+||+.||++||+++++|.||||+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0123567899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.63 Aligned_cols=251 Identities=19% Similarity=0.374 Sum_probs=213.6
Q ss_pred CeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
+|++.+.||+|+||.||++.+.. ....+++|.+..... ......+.+|+.+++.+.||||+++++.+...+ ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG-PL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-Cc
Confidence 58999999999999999998864 235688888764333 334567889999999999999999999876554 68
Q ss_pred EEEEeecCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCce
Q 007266 78 CIIIGYCEGGDMAEAIKKAN----------------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 135 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~----------------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNI 135 (610)
+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 89999999999999986521 13578999999999999999999999999999999999
Q ss_pred EecCCCCeeeeecccccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHH
Q 007266 136 FLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQAL 211 (610)
Q Consensus 136 LL~~~g~vKL~DFGlak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l 211 (610)
|++.++.++|+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.....+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999876532221 223345678999999988889999999999999999998 9999999888888
Q ss_pred HHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 212 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 212 ~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+.+......+.+..++..+.+||.+||+.+|++||++++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 88877766666777889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=365.60 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=194.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCC-eEEEEEEE---------------ccccccHHHHHHHHHHHHHHHhcCCCceee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHER-KKYVLKKI---------------RLARQTDRARRSAHQEMELISRVRNPFIVE 65 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~-~~vAIK~i---------------~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~ 65 (610)
++|++++.||+|+||.||+|..+... ..+++|.+ ............+.+|+.+|++++|||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 58999999999999999999876432 22222211 011112234456889999999999999999
Q ss_pred eeeeEeecCcEEEEEEeecCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC
Q 007266 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 142 (610)
Q Consensus 66 l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~---~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~ 142 (610)
+++++...+ ..|+|++++. ++|.+++.... ........++.|+.||+.||.|||++|||||||||+||||+.++.
T Consensus 228 l~~~~~~~~-~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 228 IEEILRSEA-NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred EeEEEEECC-eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999876654 7889999994 57777765421 112346778899999999999999999999999999999999999
Q ss_pred eeeeeccccccccccc--ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcc-cccc--CH-HHHHHHHh
Q 007266 143 IRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA-FKAF--DM-QALINKIN 216 (610)
Q Consensus 143 vKL~DFGlak~~~~~~--~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~P-F~~~--~~-~~l~~~I~ 216 (610)
+||+|||+++.+.... .....+||+.|+|||++.+..|+.++|||||||+||||++|..+ |... .. ..+...+.
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 9999999998764332 23356899999999999999999999999999999999998754 4322 11 12221111
Q ss_pred hc---------------------cCCCC---------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 217 KS---------------------IVAPL---------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 217 ~~---------------------~~~~~---------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.. ..... ...++..+.++|.+||+.||.+|||+.|+|.||||...
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 00 00000 01245677889999999999999999999999999763
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=337.97 Aligned_cols=319 Identities=25% Similarity=0.463 Sum_probs=248.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|.++++||+|+|++|.+++++.+.+.||+|++++...+ ++..+-.+.|-.+..+. +||++|.++..|+.. ..++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-srlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-SRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-ceEE
Confidence 57899999999999999999999999999999999765433 33444566677666655 799999999877655 4888
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc-cccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~-~~~~ 157 (610)
+|.||++||+|.-.++++. +|+|++++.+..+|+.||.|||+.|||+||||..||||+..|++||+|+|+++. +...
T Consensus 328 fvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 9999999999998888765 799999999999999999999999999999999999999999999999999987 4556
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccc-------cCHHHHHHHHhhccCCCCCcccchH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA-------FDMQALINKINKSIVAPLPTVYSGA 230 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~-------~~~~~l~~~I~~~~~~~~p~~~s~~ 230 (610)
+..+++||||.|+|||++.+..|+..+|+|+|||+|+||+.|..||.- .+.++.+..+.-.....+|..+|-.
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvk 485 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVK 485 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehh
Confidence 788999999999999999999999999999999999999999999952 2334433333334445578899999
Q ss_pred HHHHHHHhhcCCCCCCC------CHHHHhcCCCCCchhhhhcc--ccCCCCCCCCCCCCCCcccccccCCCcchhc----
Q 007266 231 FRGLVKSMLRKNPEFRP------SAAELLCHPHLQPYVLGIHL--KLNGPRRNTFPLEWSDSNFKKTRFMEPEAIS---- 298 (610)
Q Consensus 231 l~~LI~kmL~~dP~~Rp------Sa~eiL~Hp~f~~~~~~~~~--~~~~p~~~~~~~~~~~s~~~~~~~~~~~~~~---- 298 (610)
+..+++..|.+||.+|. ...++..|+||+...|.+.. ....|.++...-+..-.+|+.....++.+..
T Consensus 486 as~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~ 565 (593)
T KOG0695|consen 486 ASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDE 565 (593)
T ss_pred hHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCCCCH
Confidence 99999999999999995 47899999999976665422 2234555544445555555544333321111
Q ss_pred cccchhhccccCCCCCCCCCCCcc
Q 007266 299 IHSNREKRQSFSNDRALNPSVSET 322 (610)
Q Consensus 299 ~~~~~~~~~s~~~~~~~~~~~~~~ 322 (610)
---.+.....|......||-..++
T Consensus 566 d~i~ridqsefegfeyinpl~ms~ 589 (593)
T KOG0695|consen 566 DAIKRIDQSEFEGFEYINPLLMST 589 (593)
T ss_pred HHHHhcchhhcCcceecchhhccc
Confidence 111222333455555666555443
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.94 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=211.0
Q ss_pred CCeEE-EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH------------HHHHHHHHHHHHHhcCCCceeeeee
Q 007266 2 EQYEV-LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR------------ARRSAHQEMELISRVRNPFIVEYKD 68 (610)
Q Consensus 2 d~Y~i-lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~------------~~~~l~~Ei~iL~~L~HpnIV~l~~ 68 (610)
++|.. .+.||.|+||.||++.+..+++.||+|++........ ....+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 57775 4779999999999999999999999999865433220 0124678999999999999999999
Q ss_pred eEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeec
Q 007266 69 SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 69 ~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
++... .+.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+||
T Consensus 88 ~~~~~-~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEG-DFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecC-CcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 87655 58899999996 58999987644 6899999999999999999999999999999999999999999999999
Q ss_pred ccccccccc---------------cccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHH
Q 007266 149 GLAKMLISD---------------DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALI 212 (610)
Q Consensus 149 Glak~~~~~---------------~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~ 212 (610)
|++...... .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998765411 112234678899999998764 4689999999999999999999999988876666
Q ss_pred HHHhhccCCCC---------------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 213 NKINKSIVAPL---------------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 213 ~~I~~~~~~~~---------------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
..+......+. ....+..+.++|.+||+.+|++||+++++|.||||+..-
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 55533221110 123477899999999999999999999999999998653
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=324.56 Aligned_cols=248 Identities=18% Similarity=0.367 Sum_probs=214.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++.+.||+|+||.||++.+. .+..+|+|.+.... ...+.+.+|+.++++++|+||+++++.+.. ...+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEE
Confidence 478999999999999999999754 45679999886432 234568889999999999999999988765 467899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc-
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL- 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~- 159 (610)
|||+.+++|.+++....+..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999999876556789999999999999999999999999999999999999999999999999876543221
Q ss_pred -cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 160 -ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 160 -~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
.....++..|+|||++....++.++|+|||||++|+|++ |..||.+.+...+...+......+.+..++.++.+++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 238 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHH
Confidence 122345677999999988889999999999999999998 999999988888888777766666677789999999999
Q ss_pred hhcCCCCCCCCHHHHhc
Q 007266 238 MLRKNPEFRPSAAELLC 254 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~ 254 (610)
||+.+|++||++.+++.
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 239 CWKNRPEERPTFEYIQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=331.24 Aligned_cols=250 Identities=19% Similarity=0.370 Sum_probs=213.1
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
.+|++.+.||+|+||.||++... .++..+++|.+.... ......+.+|+++++.+.|+||+++++.+... ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEG-RP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-Cc
Confidence 47899999999999999999753 246688999876433 34456789999999999999999999977654 57
Q ss_pred EEEEEeecCCCCHHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCe
Q 007266 77 VCIIIGYCEGGDMAEAIKKANG-------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 143 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~-------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~v 143 (610)
.+++|||+.+++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 8999999999999999976431 248899999999999999999999999999999999999999999
Q ss_pred eeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhcc
Q 007266 144 RLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSI 219 (610)
Q Consensus 144 KL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~ 219 (610)
+|+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 999999987653322 1223445788999999999999999999999999999998 999998888777777776665
Q ss_pred CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 220 VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 220 ~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
....+..++..+.+||.+||+.||.+||++++++.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55667778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.70 Aligned_cols=249 Identities=22% Similarity=0.410 Sum_probs=217.4
Q ss_pred eEEEeEecccCceEEEEEEEeCCC----eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHER----KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~----~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++.+.||.|+||.||++.+...+ ..||+|.+...... .....+.+|+.+++.++|+||+++++.+... ...|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEE
Confidence 467899999999999999998766 89999999655433 2456788999999999999999999988765 47899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
+|||+.|++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999875433389999999999999999999999999999999999999999999999999987654422
Q ss_pred cc--cccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHH
Q 007266 160 AS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 160 ~~--~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~ 236 (610)
.. ...+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+...+.+.+........+..++.++.+++.
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML 238 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 22 2336789999999988889999999999999999998 89999988888888888777666677778999999999
Q ss_pred HhhcCCCCCCCCHHHHhc
Q 007266 237 SMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~ 254 (610)
+||..+|++|||+.++++
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 239 QCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHCcCChhhCcCHHHHHh
Confidence 999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.58 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=211.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCC----------------eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHER----------------KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~----------------~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~ 65 (610)
++|++++.||+|+||.||++.+...+ ..||+|.+..... ......+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeE
Confidence 58999999999999999999887543 5689999875433 345667889999999999999999
Q ss_pred eeeeEeecCcEEEEEEeecCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceE
Q 007266 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN---------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 136 (610)
Q Consensus 66 l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~---------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNIL 136 (610)
+++.+..+ ...+++|||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 84 LLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99987665 57899999999999999997643 125899999999999999999999999999999999999
Q ss_pred ecCCCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh--cCccccccCHHHH
Q 007266 137 LTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA--QKAAFKAFDMQAL 211 (610)
Q Consensus 137 L~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt--G~~PF~~~~~~~l 211 (610)
++.++.++|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 9999999999999987654332 2334567788999999988889999999999999999987 7889987776666
Q ss_pred HHHHhhc-------cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 212 INKINKS-------IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 212 ~~~I~~~-------~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+..+... ...+.+..++.++.+||.+||+.||.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~ 293 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF 293 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence 6555332 1122345577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=334.31 Aligned_cols=252 Identities=19% Similarity=0.379 Sum_probs=215.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-------ERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~ 73 (610)
++|.+.+.||+|+||.||++++.. .+..||+|.+.... .......+.+|+.+++.+ +||||+++++.+...
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 579999999999999999998632 34579999886432 234456788999999999 899999999987655
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
...|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.
T Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 94 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 47899999999999999997642 134788899999999999999999999999999999999999
Q ss_pred CCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHH
Q 007266 140 DQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKI 215 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I 215 (610)
++.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 252 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 9999999999998764322 1223456678999999998889999999999999999997 89999999988888888
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
........+..++..+++||.+||..+|.+||++.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 253 KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 7666555677789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=334.13 Aligned_cols=253 Identities=29% Similarity=0.533 Sum_probs=213.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+.|++++.||+|+||.||++.+..+++.||+|.+.... ........+.+|+++++.++||||+++++.+...+ ..|+|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-TAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-eEEEE
Confidence 46899999999999999999999999999999986443 33344566889999999999999999999887654 78899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||+. |+|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..... .
T Consensus 94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---A 168 (307)
T ss_pred HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---C
Confidence 99996 57777776433 3689999999999999999999999999999999999999999999999999876432 2
Q ss_pred ccccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-CCcccchHHHHHHH
Q 007266 161 SSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLVK 236 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~-~p~~~s~~l~~LI~ 236 (610)
....+++.|+|||++. ...++.++|||||||++|+|++|.+||...+.......+....... .+..++..+.++|.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD 248 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHH
Confidence 3467889999999874 4567889999999999999999999998877665554444332222 23457889999999
Q ss_pred HhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 237 SMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+||..+|++||++.+++.||||..
T Consensus 249 ~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 249 SCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHhcCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.56 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=212.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||.|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||++++++|...+...|++|
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 58999999999999999999999999999999887544444445667899999999999999999999887667889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+ +++|.++++.. .+++..+..++.||+.||.|||++||+||||+|.|||++.++.++|+|||++..... ...
T Consensus 90 e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~ 163 (328)
T cd07856 90 ELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMT 163 (328)
T ss_pred ehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcC
Confidence 999 67898888653 578999999999999999999999999999999999999999999999999875432 234
Q ss_pred cccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc---------------------
Q 007266 162 SVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI--------------------- 219 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~--------------------- 219 (610)
...+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+....
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 5678899999998766 568999999999999999999999998765433222111110
Q ss_pred ----CCCC-----CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 220 ----VAPL-----PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 220 ----~~~~-----p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
..+. ...++..++++|.+||+.+|++||++++++.||||+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0011 12367889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.70 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=202.2
Q ss_pred CCeEEEeEe--cccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHh-cCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQI--GKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR-VRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~L--G~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.+ |.|+||.||++.++.++..+|+|.+........ |+.+... .+|+|++++++.|...+ .+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~-~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLK-GHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCC-eeE
Confidence 467777777 999999999999999999999999875432211 2222222 27999999999887765 889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeecccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~~~~~ 157 (610)
+||||+.|++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999999999998754 789999999999999999999999999999999999999998 9999999998765322
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHH-----HHHHHhhccCCCCCcccchHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA-----LINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~-----l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
....|+..|+|||++.+..++.++|||||||++|+|++|..||....... +.... ......+..++..+.
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNAN 238 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHH
Confidence 34578999999999999899999999999999999999999997554322 22222 222234557899999
Q ss_pred HHHHHhhcCCCCCCCC-HHHHhcCCCCC
Q 007266 233 GLVKSMLRKNPEFRPS-AAELLCHPHLQ 259 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpS-a~eiL~Hp~f~ 259 (610)
+||.+||+.+|.+|++ ++++|+||||.
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcCCccc
Confidence 9999999999999996 69999999996
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=335.46 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=213.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-------ERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~ 73 (610)
++|.+.+.||+|+||.||++++.. ....+|+|.+.... .......+.+|+.+++++ .||||+++++.+...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 479999999999999999998642 34578999887433 334456688899999999 699999999987654
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
..+|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 91 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 91 -GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 47899999999999999997642 134889999999999999999999999999999999999999
Q ss_pred CCCeeeeecccccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHH
Q 007266 140 DQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKI 215 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I 215 (610)
++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 249 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999976543221 122234467999999998889999999999999999998 89999998888888887
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
........+..++.++++||.+||..+|++||++.++++.
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 250 REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7665555677788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=330.17 Aligned_cols=250 Identities=20% Similarity=0.340 Sum_probs=211.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe----EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK----KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~----~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||++....++. .+++|.+... ........+..|+.++.++.||||+++++.+. +...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCcc
Confidence 689999999999999999999977665 4777777532 22233456778888999999999999999764 3457
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++++||+.+|+|.+++.... ..+++..+..|+.||+.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 78999999999999997643 36899999999999999999999999999999999999999999999999999865433
Q ss_pred c---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 D---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+......+.+..++..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM 242 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence 2 1233456778999999998899999999999999999998 99999988877766666655555556677889999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
++.+||..||++||++.|+++.
T Consensus 243 li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 243 VMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.01 Aligned_cols=254 Identities=30% Similarity=0.447 Sum_probs=207.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG------- 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~------- 74 (610)
.+|++.+.||.|+||.||++.+..+++.||+|++..... ...+.+.+|++++++++||||+++++.+...+
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 589999999999999999999999999999999865443 33456888999999999999999998765432
Q ss_pred ------cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-CCCeeeee
Q 007266 75 ------CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGD 147 (610)
Q Consensus 75 ------~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-~g~vKL~D 147 (610)
...|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999996 5898888643 5899999999999999999999999999999999999985 45689999
Q ss_pred ccccccccccc----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC-
Q 007266 148 FGLAKMLISDD----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA- 221 (610)
Q Consensus 148 FGlak~~~~~~----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~- 221 (610)
||++....... .....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99987653221 1223468889999998654 56788999999999999999999999876654443333221100
Q ss_pred -------------------------C---CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 222 -------------------------P---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 222 -------------------------~---~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+ ....++.++.+||.+||+.||.+||++.++|.||||+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 112467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=325.74 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=214.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe---EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK---KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~---~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
.+|++.+.||+|+||.||++.+..++. .||+|.+.... .......+..|+.+++.+.||||+++++.+... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-RPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-CceE
Confidence 579999999999999999999987654 69999886443 344556789999999999999999999987654 4788
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 82 IITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999997643 368999999999999999999999999999999999999999999999999987653322
Q ss_pred cc----cccc--CCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHH
Q 007266 159 LA----SSVV--GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231 (610)
Q Consensus 159 ~~----~~~v--GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l 231 (610)
.. .... ++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+......+.+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 240 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL 240 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence 11 1111 2357999999999899999999999999999886 999999888888888877666666677789999
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+++.+||..+|.+||++.+++..
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 241 HQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.12 Aligned_cols=253 Identities=19% Similarity=0.397 Sum_probs=209.9
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||+|.+. .+++.||||.++..... .....+.+|+.+|.++ +||||+++++.+...+.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 58999999999999999999853 46789999999754333 3345688899999999 68999999998887777
Q ss_pred EEEEEEeecCCCCHHHHHHHhCC---------------------------------------------------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANG--------------------------------------------------------- 98 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~--------------------------------------------------------- 98 (610)
.+++|||||.+|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 88999999999999999875321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---ccccccCCC
Q 007266 99 --------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP 167 (610)
Q Consensus 99 --------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp 167 (610)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......+++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 236788899999999999999999999999999999999999999999999987653221 112234567
Q ss_pred cccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHH-HHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCC
Q 007266 168 SYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 245 (610)
Q Consensus 168 ~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~-~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~ 245 (610)
.|+|||++.+..++.++|||||||++|+|++ |..||...... .....+......+.+..++..+.+++..||+.+|++
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~ 325 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 325 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999998899999999999999999996 99999765432 334444444444556667889999999999999999
Q ss_pred CCCHHHHhcC
Q 007266 246 RPSAAELLCH 255 (610)
Q Consensus 246 RpSa~eiL~H 255 (610)
||++.++++|
T Consensus 326 Rps~~eil~~ 335 (343)
T cd05103 326 RPTFSELVEH 335 (343)
T ss_pred CcCHHHHHHH
Confidence 9999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.12 Aligned_cols=252 Identities=26% Similarity=0.433 Sum_probs=205.3
Q ss_pred Eeccc--CceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 9 QIGKG--SFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 9 ~LG~G--~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
.||+| ++|.||++++..+++.||+|++..........+.+.+|+.+++.++|+||++++++|...+ ..|++|||+.+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-ELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-eEEEEEeccCC
Confidence 34444 5566788888889999999999876555566678999999999999999999999887654 78999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--------
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-------- 158 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-------- 158 (610)
++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 999999987655578999999999999999999999999999999999999999999999999887553221
Q ss_pred ccccccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCccccccCHHHH-HHHHhhcc----------------
Q 007266 159 LASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL-INKINKSI---------------- 219 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l-~~~I~~~~---------------- 219 (610)
......++..|+|||++.+ ..|+.++||||+||++|+|++|..||........ .+++....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 2234567889999999876 4588999999999999999999999987654332 22222110
Q ss_pred ----------------CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 220 ----------------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 220 ----------------~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.......++.++.+||.+||+.||++|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 001122346788999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=325.95 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=213.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCC---eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHER---KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~---~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||.||++.+..++ ..+|+|.+..... ......+.+|+.++++++||||+++++.+... ...|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-KPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccE
Confidence 57999999999999999999987544 3799998865433 34456788999999999999999999987654 5789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||++|++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999998753 368999999999999999999999999999999999999999999999999997654322
Q ss_pred c----cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 L----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ~----~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
. .....++..|++||++.+..++.++|+|||||++|+|++ |..||......+....+......+.+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ 240 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence 1 111233567999999998889999999999999999886 99999988877777777766555666678899999
Q ss_pred HHHHhhcCCCCCCCCHHHHhc
Q 007266 234 LVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~ 254 (610)
++.+||+.+|..||++.++++
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHcccCchhCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.24 Aligned_cols=257 Identities=24% Similarity=0.418 Sum_probs=209.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCC--CeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEee---cCcE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHE--RKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE---KGCY 76 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~--~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~---~~~~ 76 (610)
+|++.+.||+|+||.||++++..+ +..||+|.+............+.+|+.+++++ +||||+++++.+.. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 599999999999999999999887 88999999875444444455678899999999 59999999986542 2246
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|++++|+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 789999985 68999887543 689999999999999999999999999999999999999999999999999976542
Q ss_pred cc-----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC---------
Q 007266 157 DD-----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--------- 221 (610)
Q Consensus 157 ~~-----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~--------- 221 (610)
.. .....+|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+......
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 1234679999999998765 56889999999999999999999999877654444332221110
Q ss_pred ---------------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 222 ---------------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 222 ---------------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.....++..+.+||.+||+.||.+||++.+++.||||+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 01123577899999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=327.15 Aligned_cols=252 Identities=29% Similarity=0.479 Sum_probs=211.1
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEEEe
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
|++.+.||+|+||.||++.+..+++.|+||.+....... ......+|+..++++. |+|++++++.+.. +...|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEe
Confidence 789999999999999999999899999999987544322 2233557999999999 9999999998876 458899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 162 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~ 162 (610)
|+ +++|.+++....+..+++..+..++.||+.+|.|||++|++|+||+|.||+++.++.++|+|||++...........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 99 78999998876545789999999999999999999999999999999999999999999999999987655444456
Q ss_pred ccCCCcccCCcccc-CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC------------------
Q 007266 163 VVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------------ 223 (610)
Q Consensus 163 ~vGTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~------------------ 223 (610)
..++..|+|||++. ...++.++|+|||||++++|++|.+||......+.+.++......+.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 77899999999875 44578999999999999999999999987766555444332211110
Q ss_pred -----------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 224 -----------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 224 -----------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
....+..+.+||.+||+.+|++||++.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 11225789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=326.46 Aligned_cols=254 Identities=39% Similarity=0.768 Sum_probs=215.5
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc---ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR---QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~---~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+|.+.+.||+|+||.||++.+...+..+++|.+.... ........+.+|+.++++++||||+++++.+.... ..++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-AFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-ceEE
Confidence 6999999999999999999998877766666654322 22223345678999999999999999999876554 6889
Q ss_pred EEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 80 IIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
||||+.+++|.+++.. .....+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999999998864 22346899999999999999999999999999999999999974 66999999998765332
Q ss_pred -cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHH
Q 007266 158 -DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 158 -~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~ 236 (610)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+........+..++.++.++|.
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 3344567899999999998888899999999999999999999999888777777776666555667778999999999
Q ss_pred HhhcCCCCCCCCHHHHhcCCCC
Q 007266 237 SMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
+||..+|++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.73 Aligned_cols=251 Identities=20% Similarity=0.337 Sum_probs=213.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++++.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++++++||||+++++.+... ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG-KP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-Cc
Confidence 589999999999999999999753 57889999987443 334456688999999999999999999977654 47
Q ss_pred EEEEEeecCCCCHHHHHHHhC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceE
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN--------------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 136 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~--------------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNIL 136 (610)
.|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 899999999999999997532 124788999999999999999999999999999999999
Q ss_pred ecCCCCeeeeecccccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHH
Q 007266 137 LTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALI 212 (610)
Q Consensus 137 L~~~g~vKL~DFGlak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~ 212 (610)
++.++.++|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+..
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999876533321 223345667999999998899999999999999999997 88899888888887
Q ss_pred HHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 213 NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 213 ~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
..+......+.+..++..+.+||.+||+.+|.+||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 243 YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 777766666667778899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=361.08 Aligned_cols=251 Identities=27% Similarity=0.501 Sum_probs=216.4
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEc--cccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cEEEEEEe
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIG 82 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~--~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~~~LVmE 82 (610)
.-..||+|+|-+||+|.|..+|-.||--.++ .-.+.....++|..|+.+|+.|+|||||+++++|.+.. ..+.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3578999999999999999999998854433 23345566789999999999999999999999999754 35779999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecccCCCCceEecCC-CCeeeeecccccccccccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN--HILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~--gIiHRDLKPeNILL~~~-g~vKL~DFGlak~~~~~~~ 159 (610)
.+..|+|..++++.. .++...++.|++|||.||.|||++ -|||||||++||||+.+ |.|||+|+|||.......
T Consensus 124 L~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 999999999999976 678999999999999999999999 59999999999999875 889999999999876544
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC-HHHHHHHHhhccCCCC-CcccchHHHHHHHH
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPL-PTVYSGAFRGLVKS 237 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~~~~~~~~-p~~~s~~l~~LI~k 237 (610)
..+.+|||.|||||++. ..|++.+||||||+||+||+|+..||.... ...++.++..+..+.. ...-.+++++||.+
T Consensus 201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek 279 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK 279 (632)
T ss_pred cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence 55599999999999987 789999999999999999999999998765 5556666666554332 22336799999999
Q ss_pred hhcCCCCCCCCHHHHhcCCCCCch
Q 007266 238 MLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
||.. ...|+|+.|+|.||||+..
T Consensus 280 Cl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 280 CLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HhcC-chhccCHHHHhhChhhccc
Confidence 9999 9999999999999999863
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=351.84 Aligned_cols=245 Identities=22% Similarity=0.441 Sum_probs=217.4
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
+.+++.||+|-||.||++... ....||+|.+........ .+.+|+++|++|+|+|||++++++...+ .+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~---~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPE---AFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChh---HHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEe
Confidence 345788999999999999885 344899999987655543 4779999999999999999999887655 79999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 163 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~ 163 (610)
+..|+|.++++...+..+...+...|+.||++|++||+++++|||||-..|||++.+..+||+|||+|+....+.+....
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99999999999877778999999999999999999999999999999999999999999999999999955444432222
Q ss_pred cC--CCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 164 VG--TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 164 vG--Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
-+ ...|.|||.+....++.+||||||||+|+||+| |+.||.+....++++.+..+..-+.|..+++++-+++..||.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~ 442 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWH 442 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhh
Confidence 22 235899999999999999999999999999986 899999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHh
Q 007266 241 KNPEFRPSAAELL 253 (610)
Q Consensus 241 ~dP~~RpSa~eiL 253 (610)
.+|++|||.+.+.
T Consensus 443 ~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 443 EDPEDRPTFETLR 455 (468)
T ss_pred CCcccCCCHHHHH
Confidence 9999999998654
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=329.04 Aligned_cols=251 Identities=20% Similarity=0.391 Sum_probs=206.4
Q ss_pred CeEEEeEecccCceEEEEEEE----eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRH----KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d----~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~ 77 (610)
-|++++.||+|+||.||+++. ..++..||+|.+.... .......+.+|+.+++.+.|+|++++++.+... +...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 368999999999999999984 4578899999986443 334456789999999999999999999988765 3578
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++||||++|++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999997643 35899999999999999999999999999999999999999999999999999875433
Q ss_pred c----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc---------------CHHHHHHHHhhc
Q 007266 158 D----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---------------DMQALINKINKS 218 (610)
Q Consensus 158 ~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~---------------~~~~l~~~I~~~ 218 (610)
. ......++..|+|||++.+..++.++|||||||++|+|+++..|+... ........+...
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 2 123456777899999998888999999999999999999987654211 111222223333
Q ss_pred cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 219 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 219 ~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
...+.+..++..+.+||.+||+.+|++||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 3445566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=327.02 Aligned_cols=246 Identities=22% Similarity=0.407 Sum_probs=205.5
Q ss_pred eEecccCceEEEEEEEeCCCe--EEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeec
Q 007266 8 EQIGKGSFGSALLVRHKHERK--KYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~--~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
+.||+|+||.||++.+..++. .+++|.+... ......+.+.+|++++.++ +||||+++++.+...+ ..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-CceEEEEeC
Confidence 468999999999999988775 4678877632 2333445688999999999 7999999999876654 789999999
Q ss_pred CCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccc
Q 007266 85 EGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 150 (610)
Q Consensus 85 ~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGl 150 (610)
.+++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997632 12478999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccch
Q 007266 151 AKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSG 229 (610)
Q Consensus 151 ak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~ 229 (610)
+..............+..|+|||++....++.++|||||||++|+|++ |..||.+.+..+....+........+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence 864322111122234567999999988889999999999999999996 9999998888887877766555556667889
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 230 AFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
++.+|+.+||..||.+||++.+++..
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHH
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=323.97 Aligned_cols=251 Identities=20% Similarity=0.349 Sum_probs=214.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe---EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK---KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~---~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|+..+.||+|+||.||++.+..++. .+|+|.+.... .....+.+.+|++++++++|+|++++++.+... ...|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-KPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-CCcE
Confidence 478999999999999999999986554 79999886543 233456788999999999999999999987655 4788
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.+++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 83 IITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999997643 368999999999999999999999999999999999999999999999999987654322
Q ss_pred cc----ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 LA----SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ~~----~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
.. .....+..|+|||++.+..++.++|||||||++|+|++ |..||...+..++...+......+.+..++..+.+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 11 11223457999999988889999999999999999987 99999888888888888766666666678899999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
|+.+||+.+|+.||++.++++.
T Consensus 242 li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 242 LMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.14 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=212.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec-CcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK-GCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~-~~~~~L 79 (610)
++|++.+.||+|+||.||++.+..+++.+|+|.+............+.+|+.++.++ +|+||+++++++... +..+|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 689999999999999999999998999999998865443334445677899999999 999999999987654 447899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 87 VFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred Eecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 999996 5999988764 68899999999999999999999999999999999999999999999999987654322
Q ss_pred -----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC-----------
Q 007266 159 -----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----------- 221 (610)
Q Consensus 159 -----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~----------- 221 (610)
....++|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+...++......
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 2234678999999998765 45788999999999999999999999876655444333221110
Q ss_pred -------------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 222 -------------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 222 -------------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.....++.++.+||.+||+.||.+|||+.++++|||++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0112267889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=324.11 Aligned_cols=245 Identities=20% Similarity=0.360 Sum_probs=211.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++|||++++++.+... ..++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEE
Confidence 35799999999999999999864 67889999986432 234678899999999999999999987654 36899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||+.|++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~ 154 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--V 154 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--C
Confidence 99999999999998765556899999999999999999999999999999999999999999999999998754321 2
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+........+..++..+.++|.+||
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHc
Confidence 23344568999999988889999999999999999997 99999998888887777766555556678999999999999
Q ss_pred cCCCCCCCCHHHHhcC
Q 007266 240 RKNPEFRPSAAELLCH 255 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~H 255 (610)
+.+|+.||++++++..
T Consensus 235 ~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 235 ETEPKKRPSFHKLREK 250 (254)
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.78 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=215.3
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
.+.||+|+|+.|--+.+..++..||||++.+.. ...+..+.+|++++.++ .|+||+++++.| +++..+|+|||-+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefF-Edd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFF-EDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHh-cccceEEEEEeccc
Confidence 367999999999999999999999999998653 34566789999999998 599999999965 55568999999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC---eeeeecccccccccc-----
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISD----- 157 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~---vKL~DFGlak~~~~~----- 157 (610)
||.|...|.++. .|+|..+.++.++|+.||++||.+||.||||||+|||...... ||||||.+.......
T Consensus 160 GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 160 GGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred CchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999999999876 8999999999999999999999999999999999999876544 899999987543211
Q ss_pred ---cccccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccC---------------HHHHHHH
Q 007266 158 ---DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---------------MQALINK 214 (610)
Q Consensus 158 ---~~~~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---------------~~~l~~~ 214 (610)
....+.||+..|||||+.. ...|+.++|+||||||||.|++|.+||.+.= +..+++.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1233568999999999753 3458999999999999999999999997541 5678888
Q ss_pred HhhccCCC---CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 215 INKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 215 I~~~~~~~---~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
|..+.+.. -+..+|.++++||..+|..++..|.++.++++|||++.....
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 87776543 244589999999999999999999999999999999875433
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=358.17 Aligned_cols=239 Identities=29% Similarity=0.577 Sum_probs=212.5
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
-++-||.|+.|.||+++.. ++.||||+++. .-.-+|+-|++|+|||||.++++|.... .+|||||||.
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEfCa 195 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEFCA 195 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCc-eeEEeeeccc
Confidence 4677999999999999874 67999998762 2234788899999999999999987665 5789999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccccccC
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 165 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vG 165 (610)
.|-|.++++... .+..+.+..|..+|+.|+.|||.++|||||||.-||||..+..|||+|||-++.+.......+++|
T Consensus 196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaG 273 (904)
T KOG4721|consen 196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAG 273 (904)
T ss_pred cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhh
Confidence 999999999755 789999999999999999999999999999999999999999999999999998866666678999
Q ss_pred CCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHH-hhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 166 Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I-~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
|..|||||++...+.++++|||||||+|+||+||..||++-+...++--+ ...+.-+.|..+++.|+-||+.||+..|.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR 353 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR 353 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999999999999999988866655433 33455678899999999999999999999
Q ss_pred CCCCHHHHhcCCCC
Q 007266 245 FRPSAAELLCHPHL 258 (610)
Q Consensus 245 ~RpSa~eiL~Hp~f 258 (610)
.||+..+||.|--+
T Consensus 354 NRPSFrqil~HldI 367 (904)
T KOG4721|consen 354 NRPSFRQILLHLDI 367 (904)
T ss_pred CCccHHHHHHHHhh
Confidence 99999999999544
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=320.60 Aligned_cols=244 Identities=23% Similarity=0.368 Sum_probs=209.3
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 87 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Gg 87 (610)
+.||+|+||.||++.+.. ++.||+|.+...... .....+.+|+++++++.|+||+++++.+... ...++||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-QPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-CCeEEEEEcCCCC
Confidence 479999999999999987 999999998755443 4556789999999999999999999987655 4788999999999
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc---cccc
Q 007266 88 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA---SSVV 164 (610)
Q Consensus 88 sL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~---~~~v 164 (610)
+|.+++.... ..+++..+..++.|++.+|.|||++|++||||||+|||++.++.++|+|||++......... ....
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9999997643 36889999999999999999999999999999999999999999999999998765422111 1223
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 243 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP 243 (610)
++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......+.+..++..+.++|.+||..+|
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 4567999999988889999999999999999998 899999888777777776655555677789999999999999999
Q ss_pred CCCCCHHHHhcC
Q 007266 244 EFRPSAAELLCH 255 (610)
Q Consensus 244 ~~RpSa~eiL~H 255 (610)
.+||++.|+++.
T Consensus 237 ~~Rp~~~ell~~ 248 (251)
T cd05041 237 ENRPSFSEIYNE 248 (251)
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=322.25 Aligned_cols=245 Identities=20% Similarity=0.382 Sum_probs=209.2
Q ss_pred eEecccCceEEEEEEEeC-CCe--EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeec
Q 007266 8 EQIGKGSFGSALLVRHKH-ERK--KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~-~~~--~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
+.||+|+||.||++.+.. ++. .||||.+...... ...+.+.+|+.++++++|+||+++++.+.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEec
Confidence 468999999999999865 333 6899999765544 556678899999999999999999998876 6889999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc----cc
Q 007266 85 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LA 160 (610)
Q Consensus 85 ~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~----~~ 160 (610)
++++|.+++.......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999999987543468999999999999999999999999999999999999999999999999998764322 12
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhh-ccCCCCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINK-SIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~-~~~~~~p~~~s~~l~~LI~km 238 (610)
....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. ......+..++..+.+++.+|
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence 23457788999999999899999999999999999998 9999988877777666653 223334556789999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.+|++||++.++++.
T Consensus 238 l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 238 WAHNPADRPTFAALREF 254 (257)
T ss_pred CCCCcccCCCHHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=325.68 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=215.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe----EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK----KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~----~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
.+|++++.||+|+||.||++.+..++. .+|+|.+..... ......+.+|+.++++++|+||+++++.+.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS--SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--Cce
Confidence 579999999999999999999876654 588998765433 3445678899999999999999999998775 478
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++||||+.+++|.+++..... .+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||+++.....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 899999999999999987433 5899999999999999999999999999999999999999999999999999876433
Q ss_pred ccc---ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 DLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~~~---~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
... ....++..|+|||.+....++.++|||||||++|+|++ |..||.+....++...+......+.+..++..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 211 11223567999999988889999999999999999998 99999999888888888776666677778899999
Q ss_pred HHHHhhcCCCCCCCCHHHHhc
Q 007266 234 LVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~ 254 (610)
++.+||..+|..||++.++++
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=319.93 Aligned_cols=245 Identities=35% Similarity=0.604 Sum_probs=215.7
Q ss_pred ecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCC
Q 007266 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 88 (610)
Q Consensus 10 LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Ggs 88 (610)
||.|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|+||+++++.+.. +...|+||||+.+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence 79999999999999988999999998765432 2345678899999999999999999988754 458899999999999
Q ss_pred HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cccccccCCC
Q 007266 89 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTP 167 (610)
Q Consensus 89 L~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~~~~vGTp 167 (610)
|.+++.... .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++.
T Consensus 80 L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 80 LFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999998754 6899999999999999999999999999999999999999999999999998776443 2345567899
Q ss_pred cccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCC
Q 007266 168 SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP 247 (610)
Q Consensus 168 ~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~Rp 247 (610)
.|++||.+.+..++.++|+|||||++|+|++|..||...+.......+.. .....+..++..+.++|++||..||+.||
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence 99999999888888999999999999999999999988887666666655 34557777899999999999999999999
Q ss_pred CH---HHHhcCCCC
Q 007266 248 SA---AELLCHPHL 258 (610)
Q Consensus 248 Sa---~eiL~Hp~f 258 (610)
++ +++++||||
T Consensus 237 ~~~~~~~l~~~~~f 250 (250)
T cd05123 237 GSGGAEEIKAHPFF 250 (250)
T ss_pred CcccHHHHHhCCCC
Confidence 99 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=328.76 Aligned_cols=256 Identities=27% Similarity=0.497 Sum_probs=212.5
Q ss_pred CeEEEeEecccCceEEEEEEEe---CCCeEEEEEEEccccc--cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQ--TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~--~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~ 76 (610)
.|++.+.||.|+||.||+|.+. .+|..||+|.+..... .....+.+.+|+.+++++ +|+||+.+++.+..+ ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD-TK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC-Ce
Confidence 4899999999999999999985 3788999999875332 122345678899999999 589999998877654 58
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+.|++|.+++.... .+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 899999999999999998754 689999999999999999999999999999999999999999999999999877543
Q ss_pred cc--ccccccCCCcccCCccccCC--CCCCCccccccchhHHhhhhcCccccccC----HHHHHHHHhhccCCCCCcccc
Q 007266 157 DD--LASSVVGTPSYMCPELLADI--PYGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAPLPTVYS 228 (610)
Q Consensus 157 ~~--~~~~~vGTp~Y~APEvl~~~--~yt~ksDIWSLG~iLyeLltG~~PF~~~~----~~~l~~~I~~~~~~~~p~~~s 228 (610)
.. ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||.... ...+...+.. ...+.+..++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMS 236 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCC
Confidence 32 22346789999999998753 46789999999999999999999997432 2333333322 2334566789
Q ss_pred hHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCchh
Q 007266 229 GAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPYV 262 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~Rp-----Sa~eiL~Hp~f~~~~ 262 (610)
..+.+|+.+||+.||++|| ++++++.||||+...
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.85 Aligned_cols=243 Identities=21% Similarity=0.355 Sum_probs=206.6
Q ss_pred EecccCceEEEEEEEe--CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 9 QIGKGSFGSALLVRHK--HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~--~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
.||+|+||.||++.+. ..+..||+|.+.... .....+.+.+|+.++++++|+||+++++.+.. ...++||||+.|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCC
Confidence 4899999999999775 345679999886543 34445678899999999999999999997643 367899999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc----ccc
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASS 162 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~----~~~ 162 (610)
++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ ...
T Consensus 79 ~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 79 GPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999987533 3689999999999999999999999999999999999999999999999999876543321 111
Q ss_pred ccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
..++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+........+..++.++.++|.+||..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 233568999999988889999999999999999996 9999999888888877777666667778899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 007266 242 NPEFRPSAAELLCH 255 (610)
Q Consensus 242 dP~~RpSa~eiL~H 255 (610)
+|++||++.++++.
T Consensus 238 ~~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 KWEDRPNFAKVEER 251 (257)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=336.75 Aligned_cols=252 Identities=19% Similarity=0.381 Sum_probs=214.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC-------CeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE-------RKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~-------~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~ 73 (610)
.+|++.+.||+|+||.||+|++... +..||+|.+... ......+.+.+|+++++++ +||||+++++.+...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3799999999999999999987532 236899987643 3334456788999999999 799999999987765
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
+ .++++|||+.+++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.
T Consensus 91 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 91 G-PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 4 7899999999999999997632 124778889999999999999999999999999999999999
Q ss_pred CCCeeeeecccccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHH
Q 007266 140 DQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKI 215 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I 215 (610)
++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||+||+|++ |..||.+.+..+....+
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 249 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999999876543221 122334567999999999999999999999999999998 89999999988888888
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
........+..++.++.+||.+||+.+|++||++.+++.+
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 250 KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7766666677788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.40 Aligned_cols=248 Identities=28% Similarity=0.524 Sum_probs=211.1
Q ss_pred EEEeEecccCceEEEEEEEe----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 5 EVLEQIGKGSFGSALLVRHK----HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
.+.+.||.|+||.||+|... ..+..|+||.+.. .......+.+.+|++++++++||||+++++.+...+ ..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-PLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-SEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccc-ccccc
Confidence 57899999999999999998 3567899999954 344445678899999999999999999999988444 58899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--- 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--- 157 (610)
+||+.+|+|.+++.......+++..+..|+.||+.||.|||+++++|+||++.|||++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999874557999999999999999999999999999999999999999999999999999876322
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~ 236 (610)
.......+...|+|||.+.+..++.++||||||++||||++ |..||...+..++...+......+.+..++..+.++|.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ 239 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence 12334567778999999988889999999999999999999 78999999999988888777777778889999999999
Q ss_pred HhhcCCCCCCCCHHHHhc
Q 007266 237 SMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~ 254 (610)
.||..+|++||++.++++
T Consensus 240 ~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHT-SSGGGS--HHHHHH
T ss_pred HHcCCChhhCcCHHHHHh
Confidence 999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=326.96 Aligned_cols=252 Identities=32% Similarity=0.466 Sum_probs=212.6
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
|++.+.||.|+||.||++.+..+++.||+|.+............+.+|+.++++++|+|++++++.+... ...++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence 7889999999999999999999999999999986653444445678899999999999999999987765 588999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASS 162 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~~ 162 (610)
+. ++|.+++.+.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 97 58999998753 368999999999999999999999999999999999999999999999999987764332 2334
Q ss_pred ccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC------------------
Q 007266 163 VVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------------ 223 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~------------------ 223 (610)
..++..|+|||.+.+. .++.++|||||||++|+|++|.+||........+.++......+.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 5677889999998766 788999999999999999999999988776655554432211110
Q ss_pred ----------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 224 ----------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 224 ----------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
...++..+.++|.+||..||++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 11236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=321.98 Aligned_cols=246 Identities=19% Similarity=0.318 Sum_probs=205.8
Q ss_pred eEecccCceEEEEEEEeC---CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeec
Q 007266 8 EQIGKGSFGSALLVRHKH---ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~---~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
+.||+|+||.||++.+.. .+..+|+|.+... ......+.+.+|+.+++.++||||+++++.+...+...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998764 3457999987532 233345678899999999999999999998776666788999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-----c
Q 007266 85 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----L 159 (610)
Q Consensus 85 ~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-----~ 159 (610)
.+++|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 80 KHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999997643 246788889999999999999999999999999999999999999999999987653321 1
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+........+..++..+.+++.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 123456778999999988889999999999999999998 5778888777777776665555555667889999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|..+|++||++.+++..
T Consensus 239 l~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 239 WHPKPEMRPTFSELVSR 255 (262)
T ss_pred cCCChhhCCCHHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=328.96 Aligned_cols=257 Identities=27% Similarity=0.490 Sum_probs=209.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++.+.||+|+||.||++.+..+++.||||.+........ ...+.+|+.++.++ .|+||+++++.+... ...|+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVKCYGYFITD-SDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-HHHHHHHHHHHHhccCCCchHhhheeeecC-CeEEE
Confidence 4789999999999999999999998899999999975443333 34455677766666 499999999988765 47899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
||||+. ++|.+++..... .+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++.......
T Consensus 92 v~e~~~-~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EeeccC-cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 999984 578887766433 78999999999999999999997 599999999999999999999999999987664433
Q ss_pred ccccccCCCcccCCccccCCC----CCCCccccccchhHHhhhhcCccccccCH-HHHHHHHhhccCCCC--CcccchHH
Q 007266 159 LASSVVGTPSYMCPELLADIP----YGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAPL--PTVYSGAF 231 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~----yt~ksDIWSLG~iLyeLltG~~PF~~~~~-~~l~~~I~~~~~~~~--p~~~s~~l 231 (610)
......++..|+|||++.+.. ++.++|||||||++|+|++|..||..... .+.+..+........ ...++.++
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHH
Confidence 334456888999999987553 78899999999999999999999976432 233444333322222 23478899
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||.+||..||.+||++++++.||||+.+
T Consensus 250 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.68 Aligned_cols=248 Identities=22% Similarity=0.455 Sum_probs=212.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.+|++.+.||+|+||.||++.+.. +..+|+|.+....... ..+.+|+++++++.|||++++++.+... ...|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTER-SPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccC-CceEEEE
Confidence 579999999999999999998764 6689999886544332 3578899999999999999999987654 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
||+.|++|.+++.... ..++++.+..++.|++.+|.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999997643 2589999999999999999999999999999999999999999999999999876543321
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||.......+...+........+...+..+.+|+.+|
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 122345678999999988889999999999999999998 9999998888888877766555445667889999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.+|++||++.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 238 WKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cccChhhCCCHHHHHHh
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.28 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=213.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|.+.+.||+|+||.||++.+... ...||||...... .....+.+.+|+.+++++.|+||+++++.+.. ...|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcE
Confidence 5789999999999999999988654 3468899886443 24455678999999999999999999997754 3578
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.+++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||+++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999997643 358999999999999999999999999999999999999999999999999987654332
Q ss_pred c--cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 159 L--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~--~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
. .....++..|+|||.+....++.++|||||||++|+|++ |..||......+....+......+.+..++..+.++|
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 2 112334567999999988889999999999999999885 9999998887777777777666667788899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcC
Q 007266 236 KSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~H 255 (610)
.+||..+|++||++.+++.+
T Consensus 242 ~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 242 TKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=331.55 Aligned_cols=252 Identities=19% Similarity=0.373 Sum_probs=210.1
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||++.+. .++..+|+|.+..... ....+.+.+|+.+++++ +|+||+++++.+... .
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIG-G 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-C
Confidence 47999999999999999999863 3456899998865432 34456788999999999 799999999987655 4
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
..|+||||+.+++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+++...
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 78999999999999999986544458999999999999999999999999999999999999999999999999987654
Q ss_pred ccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHH-HhhccCCCCCcccchH
Q 007266 156 SDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINK-INKSIVAPLPTVYSGA 230 (610)
Q Consensus 156 ~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~-I~~~~~~~~p~~~s~~ 230 (610)
... ......++..|+|||++.+..++.++||||+||++|+|++ |..||........+.. +........+...+..
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHH
Confidence 322 1223456788999999999899999999999999999998 9999987765544433 3333333445667899
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+.+|+.+||..+|++||++.+++..
T Consensus 273 ~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 273 IYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=347.54 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=209.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC-----CeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE-----RKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~-----~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||++.+... +..||||++.... .....+.+.+|+++|.++. |||||+++++|... .
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-~ 114 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-G 114 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-C
Confidence 5788999999999999999987532 3579999996543 3344567889999999996 99999999988655 4
Q ss_pred EEEEEEeecCCCCHHHHHHHhC----------------------------------------------------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN---------------------------------------------------------- 97 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~---------------------------------------------------------- 97 (610)
.+|+|||||.+|+|.+++.+..
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 7899999999999999886531
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 98 ------------------------------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 98 ------------------------------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 12478889999999999999999999999999999999999999
Q ss_pred Ceeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHH-HHHHHHh
Q 007266 142 DIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQ-ALINKIN 216 (610)
Q Consensus 142 ~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~-~l~~~I~ 216 (610)
.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .....+.
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~ 354 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence 99999999998653322 1223457788999999999899999999999999999996 99999875433 3444555
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.....+.+..++..+.++|.+||+.+|++||++.++.+.
T Consensus 355 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 554555667789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=371.34 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=208.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
|++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++.+... ...|+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-~~lyL 79 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-DPVYY 79 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-CEEEE
Confidence 6899999999999999999999999999999999975432 334556788999999999999999999987654 58899
Q ss_pred EEeecCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccc
Q 007266 80 IIGYCEGGDMAEAIKKAN---------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 150 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~---------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGl 150 (610)
||||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999999986421 12356678899999999999999999999999999999999999999999999
Q ss_pred cccccccc-------------------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHH
Q 007266 151 AKMLISDD-------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 211 (610)
Q Consensus 151 ak~~~~~~-------------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l 211 (610)
++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 97652110 11235799999999999999999999999999999999999999987654443
Q ss_pred HHHHhhccC--CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 212 INKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 212 ~~~I~~~~~--~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
......... ......++..+.+++.+||+.||++|++..+.|.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 322111111 11123578899999999999999999877666543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=385.12 Aligned_cols=254 Identities=30% Similarity=0.512 Sum_probs=223.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+++....||.|.||.||-+.+.++|...|+|.+............+.+|+.+|..|+|||+|+++++-...+ .++|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-kv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-KVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-HHHHHHH
Confidence 456677899999999999999999999999999876655566677899999999999999999999876554 7889999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc----
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---- 158 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---- 158 (610)
||+||+|.+++.... ..+|...+.|..|++.||.|||++|||||||||+||||+.+|-+|++|||.|..+....
T Consensus 1315 yC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 999999999997633 57888889999999999999999999999999999999999999999999997764432
Q ss_pred -ccccccCCCcccCCccccCCC---CCCCccccccchhHHhhhhcCccccccCHH-HHHHHHhhccCCCCCcccchHHHH
Q 007266 159 -LASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 -~~~~~vGTp~Y~APEvl~~~~---yt~ksDIWSLG~iLyeLltG~~PF~~~~~~-~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
......|||.|||||++.+.. ...+.|||||||++.||+||+.||...+.. .++..+..+..+++|..+|.+.++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 234679999999999997643 578999999999999999999999877644 455666677788899999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
||..||+.||+.|+++.|+|.|-|-+
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhccc
Confidence 99999999999999999999998765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=365.48 Aligned_cols=149 Identities=30% Similarity=0.562 Sum_probs=134.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
|++|++++.||+|+||.||++.+..+++.||||++.... ........+.+|+.++..++|+||+++++.+... .++||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-NNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-CEEEE
Confidence 689999999999999999999999999999999997543 2334456788999999999999999999877654 58999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
||||+.|++|.+++...+ .+++..++.|+.||+.||.|||.+|||||||||+||||+.++.++|+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999998654 68999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=331.44 Aligned_cols=249 Identities=29% Similarity=0.512 Sum_probs=213.0
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
...||+|+||.||++.+..++..||+|++.... ......+.+|+.+++.++|+|++++++.+... ...|+||||+.+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-CEEEEEEecCCC
Confidence 457999999999999999999999999886432 23456688999999999999999999987665 588999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccccccC
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVG 165 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~~~vG 165 (610)
++|.+++... .+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......|
T Consensus 102 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 102 GALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 9999987543 58999999999999999999999999999999999999999999999999887653322 2334678
Q ss_pred CCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--CCcccchHHHHHHHHhhcCCC
Q 007266 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSMLRKNP 243 (610)
Q Consensus 166 Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--~p~~~s~~l~~LI~kmL~~dP 243 (610)
++.|+|||++.+..++.++|+||+||++|+|++|..||.+.........+....... ....++..+.++|.+||..+|
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 999999999988888999999999999999999999998877666655554433222 233578899999999999999
Q ss_pred CCCCCHHHHhcCCCCCch
Q 007266 244 EFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 244 ~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||++.++|.||||...
T Consensus 259 ~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 259 AQRATAAELLKHPFLAKA 276 (292)
T ss_pred ccCcCHHHHhcChHHhcc
Confidence 999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.76 Aligned_cols=256 Identities=26% Similarity=0.462 Sum_probs=215.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++.+.+..||.|..|.|++++.+.+|...|||.++.....++.. ++...+.++.+. .+|+||+++++|..+. .++|.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~k-RILmDldvv~~s~dcpyIV~c~GyFi~n~-dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENK-RILMDLDVVLKSHDCPYIVQCFGYFITNT-DVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHH-HHHHhhhHHhhccCCCeeeeeeeEEeeCc-hHHHH
Confidence 45667889999999999999999999999999998776665544 455566665555 4999999999998765 57788
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||.+ +.-+..+++. -..+++|..+-.+..-++.||.||..+ ||||||+||+|||||..|+|||||||++..+....-
T Consensus 170 MelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 170 MELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9988 3344555554 334799999999999999999999865 999999999999999999999999999988877776
Q ss_pred cccccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccC-HHHHHHHHhhccCCCCCc--ccchHHHH
Q 007266 160 ASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPT--VYSGAFRG 233 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~~~~~~~~p~--~~s~~l~~ 233 (610)
.+...|.+.|||||.+. ...|+..+||||||+.|+||+||..||.+.+ ..+.+.++.....+.++. .+|+.|++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~ 327 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQS 327 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHH
Confidence 77788999999999885 3468999999999999999999999999865 456677776655544443 38999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
|++.||++|+.+||.+.++|+|||+..|
T Consensus 328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 328 FVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHhhcCcccCcchHHHhcCcceeec
Confidence 9999999999999999999999999765
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.66 Aligned_cols=251 Identities=22% Similarity=0.378 Sum_probs=206.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC--------------CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE--------------RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYK 67 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~--------------~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~ 67 (610)
++|++.+.||+|+||.||+|.+... ...||+|.+.... .......+.+|++++++++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4899999999999999999987543 2358999987543 344556788999999999999999999
Q ss_pred eeEeecCcEEEEEEeecCCCCHHHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe
Q 007266 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL 137 (610)
Q Consensus 68 ~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~----------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL 137 (610)
+.+... ...++||||+.+++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||+
T Consensus 84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 84 GVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 987655 47899999999999999986532 1236889999999999999999999999999999999999
Q ss_pred cCCCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh--cCccccccCHHHHH
Q 007266 138 TRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA--QKAAFKAFDMQALI 212 (610)
Q Consensus 138 ~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt--G~~PF~~~~~~~l~ 212 (610)
+.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+..
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 999999999999987653322 1223355678999999998889999999999999999987 77889887766655
Q ss_pred HHHhh-------ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 213 NKINK-------SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 213 ~~I~~-------~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
..+.. ......+..++..+.+||.+||+.||++||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 54422 1122335567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=330.00 Aligned_cols=252 Identities=29% Similarity=0.538 Sum_probs=212.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|..++.||+|+||.||++++..++..+|+|.+.... ........+.+|++++++++|+|++++++++.... ..|+||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-TAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-eEEEEE
Confidence 4788899999999999999999999999999986543 23344567889999999999999999999877654 788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.| +|.+.+.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..... ..
T Consensus 105 e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~ 179 (317)
T cd06635 105 EYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---AN 179 (317)
T ss_pred eCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cc
Confidence 99965 7877776533 3689999999999999999999999999999999999999999999999999865432 33
Q ss_pred cccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC-CCCCcccchHHHHHHHH
Q 007266 162 SVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-APLPTVYSGAFRGLVKS 237 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~-~~~p~~~s~~l~~LI~k 237 (610)
...|++.|+|||++. ...++.++|||||||++|+|++|..||...+.......+..... ......++..+++||.+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 259 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 259 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHH
Confidence 467899999999874 45678999999999999999999999988776665555544332 33344678899999999
Q ss_pred hhcCCCCCCCCHHHHhcCCCCCc
Q 007266 238 MLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
||+.+|.+||++.++++|+|+..
T Consensus 260 ~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 260 CLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HccCCcccCcCHHHHHhChhhhc
Confidence 99999999999999999999843
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.05 Aligned_cols=251 Identities=22% Similarity=0.435 Sum_probs=206.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeC----------------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH----------------ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~----------------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~ 65 (610)
++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 479999999999999999986542 34578999987443 3344567889999999999999999
Q ss_pred eeeeEeecCcEEEEEEeecCCCCHHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceE
Q 007266 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 136 (610)
Q Consensus 66 l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~---------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNIL 136 (610)
+++.+...+ ..|+||||+.+++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 84 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 84 LLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecCC-ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999876554 78999999999999999976421 24678899999999999999999999999999999999
Q ss_pred ecCCCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh--cCccccccCHHHH
Q 007266 137 LTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA--QKAAFKAFDMQAL 211 (610)
Q Consensus 137 L~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt--G~~PF~~~~~~~l 211 (610)
++.++.++|+|||+++...... ......+++.|++||+..+..++.++|||||||++|||++ |..||...+..+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999999987653322 1223345678999999888889999999999999999998 7889987765555
Q ss_pred HHHHhh-------ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 212 INKINK-------SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 212 ~~~I~~-------~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+..... ....+.+..++..+.+||.+||+.||++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 443311 1223445667899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=316.51 Aligned_cols=244 Identities=20% Similarity=0.341 Sum_probs=207.1
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 87 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~Gg 87 (610)
+.||+|+||.||++.+. ++..+|+|.+.... .......+.+|+.++++++||||+++++.+... ...++||||+.|+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-QPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-CccEEEEECCCCC
Confidence 47999999999999864 67899999886443 333445688999999999999999999987655 4789999999999
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc--ccccC
Q 007266 88 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVG 165 (610)
Q Consensus 88 sL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~--~~~vG 165 (610)
+|.+++.... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++.++|+|||++......... ....+
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9999987643 35899999999999999999999999999999999999999999999999998754322211 12244
Q ss_pred CCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 166 Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
+..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+|+.+||..+|+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 567999999998889999999999999999998 9999998887777777766655556677899999999999999999
Q ss_pred CCCCHHHHhcC
Q 007266 245 FRPSAAELLCH 255 (610)
Q Consensus 245 ~RpSa~eiL~H 255 (610)
+||++.++++.
T Consensus 237 ~Rp~~~~l~~~ 247 (250)
T cd05085 237 NRPKFSELQKE 247 (250)
T ss_pred cCCCHHHHHHH
Confidence 99999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=328.22 Aligned_cols=252 Identities=28% Similarity=0.539 Sum_probs=211.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|..++.||+|+||.||++++..++..|++|.+..... .......+.+|+.+++.++|+|++++++.+... ...|+||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 100 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVM 100 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEE
Confidence 36677899999999999999999999999999875433 333445688899999999999999999988765 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+. ++|.+++.... ..+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++.... ...
T Consensus 101 e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~ 175 (313)
T cd06633 101 EYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PAN 175 (313)
T ss_pred ecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCC
Confidence 9995 57887776543 368999999999999999999999999999999999999999999999999986532 234
Q ss_pred cccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC-CCCcccchHHHHHHHH
Q 007266 162 SVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAFRGLVKS 237 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-~~p~~~s~~l~~LI~k 237 (610)
...|+..|+|||++. ...++.++|||||||++|+|++|..||...+.......+...... .....++..+++||.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 567899999999974 355788999999999999999999999887765555554433222 2234577889999999
Q ss_pred hhcCCCCCCCCHHHHhcCCCCCc
Q 007266 238 MLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
||+.+|.+||++.+++.||||+.
T Consensus 256 ~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 256 CLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HccCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.24 Aligned_cols=252 Identities=17% Similarity=0.383 Sum_probs=211.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++++.||+|+||.||+++.+. +.+.+++|.+.... .....+.+.+|++++++++|+||+++++.+.. ...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCc
Confidence 579999999999999999999764 34678999875432 23345678999999999999999999997654 457
Q ss_pred EEEEEeecCCCCHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANG-------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 149 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~-------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFG 149 (610)
.|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 8999999999999999976441 158999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc--ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhh-ccCCCCCc
Q 007266 150 LAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINK-SIVAPLPT 225 (610)
Q Consensus 150 lak~~~~~~--~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~-~~~~~~p~ 225 (610)
++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ...++.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCC
Confidence 987543222 2234466778999999988888999999999999999998 8899987776666666653 23344566
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.++..+.++|.+||+.+|.+||++.+++.+
T Consensus 243 ~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 243 GCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.80 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=208.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee----cCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE----KGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~----~~~~~ 77 (610)
++|+|.+.||.|||+.||++++..++..||+|++.... .+..+...+|++..++++|||++++++.... .....
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 58999999999999999999999999999999998665 3456778999999999999999998886542 33468
Q ss_pred EEEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEecCCCCeeeeecccccc
Q 007266 78 CIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
||++.|...|+|.+.|.. .++..++|.++..|+.+|+.||++||+.. ++||||||.|||+.+++.++|+|||.++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999874 34457999999999999999999999998 99999999999999999999999998865
Q ss_pred ccccc----------ccccccCCCcccCCccccCCC---CCCCccccccchhHHhhhhcCccccccCHHH---HHHHHhh
Q 007266 154 LISDD----------LASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA---LINKINK 217 (610)
Q Consensus 154 ~~~~~----------~~~~~vGTp~Y~APEvl~~~~---yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~---l~~~I~~ 217 (610)
..-.- .......|..|+|||++.-.. .++++|||||||+||+|+.|..||+..-.+. .+.....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA 258 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence 42110 011245788999999987543 5789999999999999999999997431100 0001122
Q ss_pred ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 218 ~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....|....+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 33444555699999999999999999999999999976
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.98 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=202.9
Q ss_pred CCeEEEeEecccCceEEEEEEE----eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee-cCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRH----KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d----~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~-~~~~ 76 (610)
++|++++.||+|+||.||++.. ..++..||+|.+... .....+.+.+|++++++++||||+++++.+.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4799999999999999999974 457889999998643 23445678899999999999999999987653 3456
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 889999999999999997643 3589999999999999999999999999999999999999999999999999986543
Q ss_pred ccc----cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH----------------HHHHHHh
Q 007266 157 DDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ----------------ALINKIN 216 (610)
Q Consensus 157 ~~~----~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~----------------~l~~~I~ 216 (610)
... .....++..|+|||++.+..++.++|||||||++|||++|..++...... .+.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 221 11223344699999999888999999999999999999987665432211 1112222
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.....+.+..++..+.+||.+||..+|++|||+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 223334456688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=323.64 Aligned_cols=258 Identities=28% Similarity=0.525 Sum_probs=212.6
Q ss_pred CeEEEeEecccCceEEEEEEEe---CCCeEEEEEEEcccccc--HHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQT--DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~~--~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~ 76 (610)
+|++.+.||+|+||.||++++. .++..||+|.+...... ......+.+|+.++.++ +|+||+++++.+... ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~-~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD-TK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC-CE
Confidence 5899999999999999999865 36788999998754322 23345678999999999 599999999887554 57
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
.|+||||+.|++|.+++.... .+++..++.++.||+.+|.|||+.|++||||||.||+++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 899999999999999987643 689999999999999999999999999999999999999999999999999876543
Q ss_pred cc--ccccccCCCcccCCccccCCC--CCCCccccccchhHHhhhhcCccccccC----HHHHHHHHhhccCCCCCcccc
Q 007266 157 DD--LASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAPLPTVYS 228 (610)
Q Consensus 157 ~~--~~~~~vGTp~Y~APEvl~~~~--yt~ksDIWSLG~iLyeLltG~~PF~~~~----~~~l~~~I~~~~~~~~p~~~s 228 (610)
.. ......|+..|++||.+.+.. ++.++||||||+++|+|++|..||...+ ...+...+.. ...+.+..++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKTMS 236 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCcccC
Confidence 32 223457899999999987655 6789999999999999999999996432 2233333322 2345667788
Q ss_pred hHHHHHHHHhhcCCCCCCCC---HHHHhcCCCCCchhhh
Q 007266 229 GAFRGLVKSMLRKNPEFRPS---AAELLCHPHLQPYVLG 264 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpS---a~eiL~Hp~f~~~~~~ 264 (610)
..+.++|.+||+.||++||| +.++|+||||+...+.
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 99999999999999999998 5788999999886654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.78 Aligned_cols=252 Identities=19% Similarity=0.347 Sum_probs=212.7
Q ss_pred eEEEeEecccCceEEEEEEEeC---CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----c
Q 007266 4 YEVLEQIGKGSFGSALLVRHKH---ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----C 75 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~---~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 75 (610)
|.+.+.||+|+||.||++.... ++..||||.+..........+.+.+|++++++++||||+++++.+.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6789999999999999998754 5789999999876666666777889999999999999999999876432 1
Q ss_pred EEEEEEeecCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN----GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~----~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGla 151 (610)
..+++++|+.+++|.+++.... ...+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3478999999999998875321 124789999999999999999999999999999999999999999999999998
Q ss_pred ccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCccc
Q 007266 152 KMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVY 227 (610)
Q Consensus 152 k~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~ 227 (610)
+...... ......+++.|++||.+.+..++.++|||||||++|+|++ |.+||.+.+...+...+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 8654322 1223345678999999999889999999999999999998 99999988887777777655444455567
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+..+.+++.+||+.+|+.||++.+++.+
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=319.41 Aligned_cols=252 Identities=34% Similarity=0.649 Sum_probs=215.3
Q ss_pred CeEEEeEecccCceEEEEEEEeC-CCeEEEEEEEcccc--------ccHHHHHHHHHHHHHHHh-cCCCceeeeeeeEee
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKH-ERKKYVLKKIRLAR--------QTDRARRSAHQEMELISR-VRNPFIVEYKDSWVE 72 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~-~~~~vAIK~i~~~~--------~~~~~~~~l~~Ei~iL~~-L~HpnIV~l~~~~~~ 72 (610)
.|++.+.||+|+||.||++.+.. +++.+|+|.+.... ........+.+|+.++.+ ++|+||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48999999999999999999987 78899999886432 223344567789988875 799999999998776
Q ss_pred cCcEEEEEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeecc
Q 007266 73 KGCYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFG 149 (610)
Q Consensus 73 ~~~~~~LVmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFG 149 (610)
. ...+++|||++|++|.+++.. .....+++..++.++.||+.||.|||+ .|++|+||+|+|||++.++.++|+|||
T Consensus 81 ~-~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 N-DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred C-CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 5 488999999999999998854 233468999999999999999999996 689999999999999999999999999
Q ss_pred cccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc-ccc
Q 007266 150 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT-VYS 228 (610)
Q Consensus 150 lak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~-~~s 228 (610)
++.............|+..|++||.+.+..++.++|+|||||++|+|++|.+||...+.......+......+.+. .++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 9987655544456778999999999998889999999999999999999999999888777777766655554444 678
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..+.++|.+||+.||+.||++.|+..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.24 Aligned_cols=252 Identities=28% Similarity=0.533 Sum_probs=211.8
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|..++.||+|+||.||++++..++..+|+|.+.... ........+.+|+++++.++|+|++++++++... ...++||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 94 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVM 94 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEEE
Confidence 5778899999999999999999999999999987532 2334445678899999999999999999988765 4788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+. ++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..... ..
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~ 169 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---AN 169 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---cc
Confidence 9996 58887776533 3689999999999999999999999999999999999999999999999999876543 23
Q ss_pred cccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC-CCCCcccchHHHHHHHH
Q 007266 162 SVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-APLPTVYSGAFRGLVKS 237 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~-~~~p~~~s~~l~~LI~k 237 (610)
...|++.|+|||++. ...++.++|||||||++|+|++|..||...+.......+..... ......++..+.+||++
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHH
Confidence 457899999999874 34578899999999999999999999987765554444433322 22344688899999999
Q ss_pred hhcCCCCCCCCHHHHhcCCCCCc
Q 007266 238 MLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
||..+|++||+++++++|||+..
T Consensus 250 cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HhhCCcccCCCHHHHhhCccccc
Confidence 99999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=318.82 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=206.4
Q ss_pred eEecccCceEEEEEEEeCCC------eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 8 EQIGKGSFGSALLVRHKHER------KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~------~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+.||+|+||.||++.+.... ..+|+|.+..... ......+.+|+.+++.++||||+++++.+...+ ..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-PQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-CeEEEE
Confidence 46999999999999986543 6899998864322 233456888999999999999999999876554 789999
Q ss_pred eecCCCCHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-----Ceeeeecccc
Q 007266 82 GYCEGGDMAEAIKKAN-----GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-----DIRLGDFGLA 151 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~-----~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-----~vKL~DFGla 151 (610)
||+.|++|.+++.... ...+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999997532 23478999999999999999999999999999999999999887 8999999998
Q ss_pred cccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCccc
Q 007266 152 KMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVY 227 (610)
Q Consensus 152 k~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~ 227 (610)
+....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+........+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence 76543321 223356788999999999899999999999999999998 99999888777777766555555566778
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+..+.+||.+||..+|.+||+++++++.
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 266 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQEI 266 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 9999999999999999999999999753
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=325.44 Aligned_cols=250 Identities=18% Similarity=0.335 Sum_probs=211.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe----EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK----KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~----~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||++.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++.+... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP--TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--Cc
Confidence 578999999999999999999987775 468888764332 33344678999999999999999999987643 46
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++++||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 78999999999999997643 35899999999999999999999999999999999999999999999999999875432
Q ss_pred cc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 DL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+......+.+..++..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 21 223445678999999998899999999999999999987 99999888777666666655555566678889999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
++.+||..+|+.||++++++..
T Consensus 243 li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=315.03 Aligned_cols=236 Identities=19% Similarity=0.270 Sum_probs=195.2
Q ss_pred eEecccCceEEEEEEEeCCC----------eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 8 EQIGKGSFGSALLVRHKHER----------KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~----------~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
+.||+|+||.||++.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++.+.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR--DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec--CCc
Confidence 47999999999999998776 35777876543322 4668899999999999999999998876 457
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-------Ceeeeeccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-------DIRLGDFGL 150 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-------~vKL~DFGl 150 (610)
++||||+.+++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999987543 689999999999999999999999999999999999999887 799999999
Q ss_pred ccccccccccccccCCCcccCCccccCC--CCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCccc
Q 007266 151 AKMLISDDLASSVVGTPSYMCPELLADI--PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVY 227 (610)
Q Consensus 151 ak~~~~~~~~~~~vGTp~Y~APEvl~~~--~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~ 227 (610)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+............. .+...
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~ 229 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPMPD 229 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCCCC
Confidence 876543 3345677889999999876 78999999999999999998 6888877754444333332222 22233
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
...+.++|.+||..+|.+||++.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=370.09 Aligned_cols=254 Identities=34% Similarity=0.604 Sum_probs=205.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec--------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-------- 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-------- 73 (610)
.+|+.++.||+||||.||+|+++-+|..||||+|.... +......+.+|+.+|.+|+|||||+|+.+|.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 57888999999999999999999999999999999877 666677899999999999999999999988621
Q ss_pred ---------------------------------------------------------------------C----------
Q 007266 74 ---------------------------------------------------------------------G---------- 74 (610)
Q Consensus 74 ---------------------------------------------------------------------~---------- 74 (610)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 007266 75 -------------------------------CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123 (610)
Q Consensus 75 -------------------------------~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~ 123 (610)
..+||=||||+..+|.++|.++.... .-..++++++||++||.|+|++
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC
Confidence 14789999999888888887753111 4788999999999999999999
Q ss_pred CeecccCCCCceEecCCCCeeeeecccccccc-------------------cccccccccCCCcccCCccccCCC---CC
Q 007266 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-------------------SDDLASSVVGTPSYMCPELLADIP---YG 181 (610)
Q Consensus 124 gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-------------------~~~~~~~~vGTp~Y~APEvl~~~~---yt 181 (610)
|||||||||.||||+.++.|||+|||+|+... .....+..+||..|+|||++.+.. |+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999998721 001234579999999999997655 99
Q ss_pred CCccccccchhHHhhhhcCcccc-ccCHHHHHHHHhhccCCCC---CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 007266 182 SKSDIWSLGCCVYEMSAQKAAFK-AFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 257 (610)
Q Consensus 182 ~ksDIWSLG~iLyeLltG~~PF~-~~~~~~l~~~I~~~~~~~~---p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~ 257 (610)
.|+||||||+|++||+. ||. .+.....+..+.....+.. ...--+.-..+|.+||+.||.+||||.|+|++.|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l 873 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSEL 873 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence 99999999999999974 353 2333334444443222211 1112234567999999999999999999999999
Q ss_pred CCc
Q 007266 258 LQP 260 (610)
Q Consensus 258 f~~ 260 (610)
|.+
T Consensus 874 lpp 876 (1351)
T KOG1035|consen 874 LPP 876 (1351)
T ss_pred CCc
Confidence 974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=352.27 Aligned_cols=257 Identities=27% Similarity=0.529 Sum_probs=228.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEee----cCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE----KGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~----~~~~ 76 (610)
+.|+|++.||+|.+|.||+++++.+++.+|+|++......++ .+..|.+||+.. +|||++.++++|.- .++.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de---EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE---EIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH---HHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 468999999999999999999999999999999987766554 356688888876 69999999998873 3568
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|||||||.||+..++++...+..+.|+.+..|++.++.||.|||.+.+||||||-.|||++.+|.|||+|||++..+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999999999987788999999999999999999999999999999999999999999999999999987755
Q ss_pred c-cccccccCCCcccCCccccCC-----CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC--Ccccc
Q 007266 157 D-DLASSVVGTPSYMCPELLADI-----PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYS 228 (610)
Q Consensus 157 ~-~~~~~~vGTp~Y~APEvl~~~-----~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--p~~~s 228 (610)
. ....+.+|||.|||||++.+. .|+..+|+||||++..||.-|.+|+-+..+...+..|.....+.+ |..|+
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs 255 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWS 255 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHH
Confidence 4 356788999999999999754 478899999999999999999999988877776666665554433 67799
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+|.+||..||.+|.++||+..++|.|||+...
T Consensus 256 ~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 256 KKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred HHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 999999999999999999999999999999853
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=333.18 Aligned_cols=252 Identities=27% Similarity=0.525 Sum_probs=208.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC--C---c-eeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN--P---F-IVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H--p---n-IV~l~~~~~~~~~ 75 (610)
++|++++.+|+|.||.|..+.+..++..||||+++.. ....+...-|+++|++|.+ | + +|.+.+ |++-.+
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~-wFdyrg 164 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRD-WFDYRG 164 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh-hhhccC
Confidence 5899999999999999999999999999999998733 2344556779999999942 2 2 455555 455556
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC----------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---------------- 139 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~---------------- 139 (610)
+.|||+|.+ |.+++++++.++..+|+-.+++.+.+||+.++++||+.+++|-||||+|||+..
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 899999999 789999999988889999999999999999999999999999999999999952
Q ss_pred ----CCCeeeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHH---HH
Q 007266 140 ----DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA---LI 212 (610)
Q Consensus 140 ----~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~---l~ 212 (610)
+.+|+|+|||.|+... +...+.+.|..|+|||++.+.+++..+||||+||||+||++|...|+..+..+ ++
T Consensus 244 r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred ccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 3358999999998643 33477899999999999999999999999999999999999999998776444 55
Q ss_pred HHHhhccCCCC-----------------Ccc-------------------------cchHHHHHHHHhhcCCCCCCCCHH
Q 007266 213 NKINKSIVAPL-----------------PTV-------------------------YSGAFRGLVKSMLRKNPEFRPSAA 250 (610)
Q Consensus 213 ~~I~~~~~~~~-----------------p~~-------------------------~s~~l~~LI~kmL~~dP~~RpSa~ 250 (610)
++|.+.....+ +.. --.++.+||++||.+||.+|+|+.
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 55543221110 000 012477999999999999999999
Q ss_pred HHhcCCCCCc
Q 007266 251 ELLCHPHLQP 260 (610)
Q Consensus 251 eiL~Hp~f~~ 260 (610)
|+|.||||..
T Consensus 402 EAL~HpFF~~ 411 (415)
T KOG0671|consen 402 EALSHPFFAR 411 (415)
T ss_pred HHhcCHHhhc
Confidence 9999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=349.61 Aligned_cols=242 Identities=27% Similarity=0.464 Sum_probs=209.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++...+|.|+|+.|-.+.+..+++.+++|++..... ...+|+.++... +||||+++.+.+.+ +.+.|+|
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v 394 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLV 394 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecC-Cceeeee
Confidence 579999999999999999999999999999999976522 134577666655 69999999998754 5589999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe-cCCCCeeeeecccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL-~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||++.|+.+.+.+.... .....+..|+.||+.++.|||++|||||||||+|||+ +..|+++|+|||.++....+
T Consensus 395 ~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 99999999999887753 3337888899999999999999999999999999999 68899999999999887655
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH-HHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~-~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
..+.|-|..|+|||++....|+.++||||||++||+|++|..||...... ++..+|.. .+....+|..+++||.+|
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~---~~~s~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM---PKFSECVSDEAKDLLQQL 546 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC---CccccccCHHHHHHHHHh
Confidence 44567889999999999999999999999999999999999999877665 44554433 233478999999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCC
Q 007266 239 LRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f 258 (610)
|++||.+|+++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 99999999999999999999
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=314.88 Aligned_cols=229 Identities=25% Similarity=0.368 Sum_probs=192.9
Q ss_pred cCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCCHHHH
Q 007266 13 GSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 92 (610)
Q Consensus 13 G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~ 92 (610)
|.||.||+|++..+++.||+|.+..... ..+|...+....||||+++++.+... ...|+||||+.|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999975431 23455555666799999999987655 588999999999999999
Q ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccccccCCCcccCC
Q 007266 93 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCP 172 (610)
Q Consensus 93 Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~AP 172 (610)
+.+.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....++..|+||
T Consensus 76 l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aP 151 (237)
T cd05576 76 ISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAP 151 (237)
T ss_pred HHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCC
Confidence 98754 5899999999999999999999999999999999999999999999999987655332 2345667889999
Q ss_pred ccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCH---
Q 007266 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA--- 249 (610)
Q Consensus 173 Evl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa--- 249 (610)
|++.+..++.++|+||+||++|+|++|..||...... +........+..++..+++||.+||+.||++|+++
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 9998888999999999999999999999887654321 11112223566789999999999999999999985
Q ss_pred --HHHhcCCCC
Q 007266 250 --AELLCHPHL 258 (610)
Q Consensus 250 --~eiL~Hp~f 258 (610)
+++++||||
T Consensus 227 ~~~~~~~h~~~ 237 (237)
T cd05576 227 GVEDIKSHPFF 237 (237)
T ss_pred chHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.33 Aligned_cols=252 Identities=23% Similarity=0.421 Sum_probs=208.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeC----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~ 76 (610)
++|++++.||+|+||.||++.... ++..||+|.+...... .....+.+|+++++.+.|+||+++++++... +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 478999999999999999998653 4789999999755443 4456789999999999999999999876542 447
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
.++||||+.+++|.+++..... .+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 8999999999999999976432 589999999999999999999999999999999999999999999999999987652
Q ss_pred ccc----cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC---------------HHHHHHHHhh
Q 007266 157 DDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---------------MQALINKINK 217 (610)
Q Consensus 157 ~~~----~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---------------~~~l~~~I~~ 217 (610)
... .....++..|++||.+.+..++.++|||||||++|+|++|..||.... ...+...+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 211 112344567999999988889999999999999999999999986532 2222333333
Q ss_pred ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 218 ~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+.+..++.++.+|+.+||..+|.+||++.|++..
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 44444556678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.13 Aligned_cols=239 Identities=20% Similarity=0.320 Sum_probs=196.3
Q ss_pred eEecccCceEEEEEEEeCCCe-------EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 8 EQIGKGSFGSALLVRHKHERK-------KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~-------~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+.||+|+||.||++.+...+. .+++|.+.... ....+.+.+|+.+++.+.|||++++++.+...+ ..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-ESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-CcEEE
Confidence 469999999999999866443 38888775332 233456888999999999999999999887654 67899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC--------eeeeeccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--------IRLGDFGLAK 152 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~--------vKL~DFGlak 152 (610)
|||+.+|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999986443 6899999999999999999999999999999999999988765 6999999886
Q ss_pred ccccccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhc-CccccccCHHHHHHHHhhccCCCCCcccchH
Q 007266 153 MLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPTVYSGA 230 (610)
Q Consensus 153 ~~~~~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG-~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~ 230 (610)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++| .+||...+.......... ....+...+.+
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (258)
T cd05078 157 TVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQLPAPKWTE 231 (258)
T ss_pred ccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--cccCCCCCcHH
Confidence 5432 234578899999999876 4578999999999999999998 577777665554433322 23455567789
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+.+||.+||+.||++|||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHh
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.14 Aligned_cols=244 Identities=23% Similarity=0.411 Sum_probs=194.6
Q ss_pred eEecccCceEEEEEEEeC--CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKH--ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~--~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||++.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+... ..+|+||||+.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-IPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-CceEEEEEeCC
Confidence 369999999999997543 34578888776433 334445678899999999999999999987755 47899999999
Q ss_pred CCCHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc---
Q 007266 86 GGDMAEAIKKANG---VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--- 159 (610)
Q Consensus 86 GgsL~~~Ik~~~~---~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~--- 159 (610)
+++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999999976432 2356888999999999999999999999999999999999999999999999865433221
Q ss_pred cccccCCCcccCCcccc-------CCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCC-----CCCcc
Q 007266 160 ASSVVGTPSYMCPELLA-------DIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA-----PLPTV 226 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~-------~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~-----~~p~~ 226 (610)
.....++..|+|||++. ...++.++|||||||++|+|++ |..||......+....+...... ..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 22345667899999874 3456789999999999999998 88899887766655554333221 23446
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
++..+.+++..|+ .||++||+++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=339.15 Aligned_cols=252 Identities=20% Similarity=0.390 Sum_probs=209.7
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~ 75 (610)
++|.+.+.||+|+||.||+|++. .++..||+|++...... ...+.+.+|+++|.++. |||||++++.+...+
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~- 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG- 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC-
Confidence 46888999999999999999864 35568999999754333 33456889999999997 999999999887655
Q ss_pred EEEEEEeecCCCCHHHHHHHhCC---------------------------------------------------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANG--------------------------------------------------------- 98 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~--------------------------------------------------------- 98 (610)
.+++|||||.+|+|.+++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 78999999999999999975321
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 99 ---------------------------------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 99 ---------------------------------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
..+++..+..|+.||+.||.|||+.||+||||||+|||++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 23677888999999999999999999999999999999999
Q ss_pred CCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHH-HHH
Q 007266 140 DQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQAL-INK 214 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l-~~~ 214 (610)
++.++|+|||+++...... .....++++.|+|||++.+..++.++|||||||++|||++ |..||......+. ...
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~ 354 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA 354 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence 9999999999998653222 1223467889999999998889999999999999999998 8999987654443 344
Q ss_pred HhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 215 INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 215 I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+......+.+..++.++.+||.+||..+|..||++.+|++.
T Consensus 355 ~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 355 IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44444445667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=313.36 Aligned_cols=244 Identities=20% Similarity=0.373 Sum_probs=194.8
Q ss_pred eEecccCceEEEEEEEeC--CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKH--ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~--~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||++.... ++..+|+|.++..... .....+.+|+.++++++||||+++++.+.+. ..+++||||+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-TPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CCcEEEEECCC
Confidence 469999999999998653 4567999988755433 3334688899999999999999999987655 46889999999
Q ss_pred CCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc---
Q 007266 86 GGDMAEAIKKAN---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--- 159 (610)
Q Consensus 86 GgsL~~~Ik~~~---~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~--- 159 (610)
+++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999997532 23467788889999999999999999999999999999999999999999999876433321
Q ss_pred cccccCCCcccCCccccCC-------CCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCC-----CCCcc
Q 007266 160 ASSVVGTPSYMCPELLADI-------PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA-----PLPTV 226 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~-------~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~-----~~p~~ 226 (610)
.....|+..|+|||++.+. .++.++|||||||++|+|++ |..||......+........... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 2235678889999988642 35789999999999999996 99999877766554433222111 12234
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
.+..+.+++..|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=318.11 Aligned_cols=248 Identities=19% Similarity=0.254 Sum_probs=191.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHH---------HHHHHHHHHHHHhcCCCceeeeeee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRA---------RRSAHQEMELISRVRNPFIVEYKDS 69 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~---------~~~l~~Ei~iL~~L~HpnIV~l~~~ 69 (610)
++|++.+.||+|+||.||++.+..+ +..+|+|+.......... ......++..+..+.|+|++.+++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5899999999999999999998877 667777765433321110 0112234445667789999999986
Q ss_pred EeecCc---EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeee
Q 007266 70 WVEKGC---YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 146 (610)
Q Consensus 70 ~~~~~~---~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~ 146 (610)
+..... +.+++++++ ..++.+.+.... .+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 654432 456788887 457777776543 46889999999999999999999999999999999999999999999
Q ss_pred eccccccccccc--------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH-HH-------
Q 007266 147 DFGLAKMLISDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QA------- 210 (610)
Q Consensus 147 DFGlak~~~~~~--------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~-~~------- 210 (610)
|||+++...... ......||+.|+|||++.+..++.++|||||||+||+|++|..||.+... ..
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999997653221 12335799999999999999999999999999999999999999987732 22
Q ss_pred -HHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 211 -LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 211 -l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
.+..+..... .....+..+.++++.|+..+|++||+++++++
T Consensus 249 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 DFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2222222111 23346789999999999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.97 Aligned_cols=247 Identities=24% Similarity=0.452 Sum_probs=213.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++..+...||+|.||+||++++-. .||||++.....++...+.|.+|+.+|++-+|.||+-+.+++...+ + .||.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-~-AIiT 466 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-L-AIIT 466 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-e-eeee
Confidence 456788999999999999999864 5999999999999999999999999999999999999999887665 3 8999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc---cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---DD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~---~~ 158 (610)
.+|+|.+|+.+|.... ..|....++.|++||+.|+.|||.++|||||||..||||..++.|||+||||+..... ..
T Consensus 467 qwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred hhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 9999999999997644 4699999999999999999999999999999999999999999999999999876422 12
Q ss_pred ccccccCCCcccCCccccC---CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----CCcccchHH
Q 007266 159 LASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----LPTVYSGAF 231 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~---~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----~p~~~s~~l 231 (610)
-.....|...|||||++.. .+|+..+||||||||+|||++|..||.......++..+..+...+ ....++.++
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m 625 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM 625 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence 2334567789999999874 468999999999999999999999999777666666665553332 233467799
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhc
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
++|+..||.+++++||...+||.
T Consensus 626 k~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 626 KRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHhcCcccCccHHHHHH
Confidence 99999999999999999999986
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=311.44 Aligned_cols=239 Identities=19% Similarity=0.249 Sum_probs=192.4
Q ss_pred eEecccCceEEEEEEEeC------------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc
Q 007266 8 EQIGKGSFGSALLVRHKH------------ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~------------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 75 (610)
+.||+|+||.||++.... ....+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 468999999999998532 22358888875432 233456888999999999999999999877554
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC-------eeeeec
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-------IRLGDF 148 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~-------vKL~DF 148 (610)
..++||||+++++|..++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 6789999999999998887643 36899999999999999999999999999999999999987664 899999
Q ss_pred ccccccccccccccccCCCcccCCcccc-CCCCCCCccccccchhHHhhh-hcCccccccCHHHHHHHHhhccCCCCCcc
Q 007266 149 GLAKMLISDDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMS-AQKAAFKAFDMQALINKINKSIVAPLPTV 226 (610)
Q Consensus 149 Glak~~~~~~~~~~~vGTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLl-tG~~PF~~~~~~~l~~~I~~~~~~~~p~~ 226 (610)
|++..... .....++..|+|||++. +..++.++|||||||++|+|+ .|..||......+......... .....
T Consensus 157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~ 231 (262)
T cd05077 157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC--MLVTP 231 (262)
T ss_pred CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc--cCCCC
Confidence 99865432 23456888999999886 566899999999999999997 6899988766544433222211 22333
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+.++.+||.+||+.||++||++.+||++
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 56789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.65 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=224.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 76 (610)
.+|.-+..+|.|+- .|..+.|.-.++.||+|++.....+....+...+|..++..++|+|||.++..|.... ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 47888999999999 7889999999999999999877777777788999999999999999999999887543 35
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+ ..+|.+.+.. .++-+.+..+++|++.|++|||+.||+||||||+||++..++.+||.|||+++....
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 88999999 4699988884 578999999999999999999999999999999999999999999999999988776
Q ss_pred ccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcc----------
Q 007266 157 DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV---------- 226 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~---------- 226 (610)
+-..+.++.|..|.|||++.+..|...+||||+||++.||++|...|.+.+..+++.++......+-+..
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 6678889999999999999999999999999999999999999999999998888888766544442111
Q ss_pred -------------------------------cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 227 -------------------------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 227 -------------------------------~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
-...+++|+.+||..||++|++++++|+|||++-
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 1235889999999999999999999999999983
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=313.29 Aligned_cols=238 Identities=21% Similarity=0.275 Sum_probs=192.1
Q ss_pred EecccCceEEEEEEEeCC------------------------CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCcee
Q 007266 9 QIGKGSFGSALLVRHKHE------------------------RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV 64 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~~~------------------------~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV 64 (610)
.||+|+||.||++....+ ...|++|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999875321 2358888876432 23345678899999999999999
Q ss_pred eeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---
Q 007266 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ--- 141 (610)
Q Consensus 65 ~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g--- 141 (610)
++++++...+ ..++||||+++++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGS-ENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCC-ceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 9999877654 7889999999999999887633 3689999999999999999999999999999999999998654
Q ss_pred ----CeeeeecccccccccccccccccCCCcccCCccccC-CCCCCCccccccchhHHhh-hhcCccccccCHHHHHHHH
Q 007266 142 ----DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKI 215 (610)
Q Consensus 142 ----~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeL-ltG~~PF~~~~~~~l~~~I 215 (610)
.++|+|||++...... ....++..|+|||++.+ ..++.++|||||||++||| ++|..||............
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 3899999987653222 23467888999998865 5688999999999999998 5799999877655544333
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
... ...+...+..+.++|.+||+.+|++||++.++|++
T Consensus 235 ~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred Hhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222 23444566789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=328.68 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=199.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+.|.--..||+|+||.||++...++ ..||||.+....... ...|.+|+.+|.+++|||+|+++++|.+.+...+||+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 3566678999999999999987654 899999776544432 3349999999999999999999999887764588999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCCCceEecCCCCeeeeeccccccccc-c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH---ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-D 157 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g---IiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~ 157 (610)
||+..|+|.+++.......++|....+|+.+++.||+|||... ||||||||+|||||.+...||+|||+|+.... .
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 9999999999998654337899999999999999999999963 99999999999999999999999999976544 3
Q ss_pred cccccc-cCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC---HHHHHH----HH-----hhccCCCCC
Q 007266 158 DLASSV-VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALIN----KI-----NKSIVAPLP 224 (610)
Q Consensus 158 ~~~~~~-vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---~~~l~~----~I-----~~~~~~~~p 224 (610)
...... .||.+|++||++..+..+.++||||||++|.||++|+.+..... ...+.. .+ .......+.
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~ 311 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK 311 (361)
T ss_pred cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence 222223 89999999999998899999999999999999999998876432 111222 11 111111122
Q ss_pred -cccc-----hHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 225 -TVYS-----GAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 225 -~~~s-----~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..++ ..+..+...|++.+|..||++.|++..
T Consensus 312 ~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 312 EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 2222 235578899999999999999997543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.14 Aligned_cols=257 Identities=29% Similarity=0.483 Sum_probs=212.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-------C
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-------G 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-------~ 74 (610)
..|+.+.+||+|.||.||+|+.+++++.||+|++..............+|+++|..|+|+|++.+++.+... .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 357778899999999999999999999999998765544444445577999999999999999988876532 2
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
..+|+||.+|+ .+|.-++... ...|+..+|+.++.+|+.||.|+|++.|+|||+|++|+||+.+|.+||+|||+++.+
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 35899999996 5888888653 357999999999999999999999999999999999999999999999999999776
Q ss_pred cccc-----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC------CC
Q 007266 155 ISDD-----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------AP 222 (610)
Q Consensus 155 ~~~~-----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~------~~ 222 (610)
...+ .....+.|.+|++||.+.+ ..|+.+.|||..||||.||.++.+.|.+...+..+..|..... ||
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 4332 2344577999999997764 6799999999999999999999999999988877777644221 11
Q ss_pred ---------------CCc-------------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 223 ---------------LPT-------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 223 ---------------~p~-------------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
++. .-.+++.+|+.+||..||.+|+.++++|+|.||-.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 111 11346789999999999999999999999999953
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.78 Aligned_cols=244 Identities=21% Similarity=0.382 Sum_probs=194.5
Q ss_pred eEecccCceEEEEEEEeCCC--eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHER--KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~--~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||++....++ ..+++|.+..... ....+.+.+|+.+++.++||||+++++.+... ...|+||||+.
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-IPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCC-CccEEEEecCC
Confidence 36999999999999765433 3566777654332 33456788999999999999999999987754 47899999999
Q ss_pred CCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---cc
Q 007266 86 GGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LA 160 (610)
Q Consensus 86 GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---~~ 160 (610)
+++|.+++.+.. ...+++..++.++.||+.||.|||+++++||||||+|||++.++.++|+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999999997642 2346778889999999999999999999999999999999999999999999986432221 22
Q ss_pred ccccCCCcccCCccccC-------CCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhcc-----CCCCCccc
Q 007266 161 SSVVGTPSYMCPELLAD-------IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSI-----VAPLPTVY 227 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~-------~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~-----~~~~p~~~ 227 (610)
...+++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..+.... ....+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 35678899999998753 245779999999999999986 678898777766666543332 12234457
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+..+.+++..|| .+|++||+++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.67 Aligned_cols=250 Identities=20% Similarity=0.390 Sum_probs=217.8
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCe---E-EEEEEEcc-ccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERK---K-YVLKKIRL-ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~---~-vAIK~i~~-~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
+-.+.+.||+|+||.||++..+..+. . ||+|.... ..........+.+|+++|++++|||||+++|+..... .+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-Pl 236 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-PL 236 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-cc
Confidence 44567999999999999999886432 3 89999876 3356677888999999999999999999999877554 78
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
+||||+|.||+|.+++++... .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++.....
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 899999999999999998654 5899999999999999999999999999999999999999999999999998765422
Q ss_pred ccccccc-CCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHH-hhccCCCCCcccchHHHHH
Q 007266 158 DLASSVV-GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGL 234 (610)
Q Consensus 158 ~~~~~~v-GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I-~~~~~~~~p~~~s~~l~~L 234 (610)
......+ -...|+|||.+...-|+.++||||+||+++|+++ |..||.+....++..+| .....-+.+...+..+..+
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 2222122 3457999999999999999999999999999988 88899999999999999 6677777888899999999
Q ss_pred HHHhhcCCCCCCCCHHHHhc
Q 007266 235 VKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~ 254 (610)
+.+|+..+|++||++.++.+
T Consensus 396 ~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHhccCChhhccCHHHHHH
Confidence 99999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=342.28 Aligned_cols=249 Identities=23% Similarity=0.437 Sum_probs=220.8
Q ss_pred CeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
+-+..+.||+|+||+||+++... ....||||.++.. ........|+||+++|..++|||||++++.+.+++ .+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGD-PL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-ee
Confidence 45678899999999999998754 3467999999744 44446778999999999999999999999987665 78
Q ss_pred EEEEeecCCCCHHHHHHHhC--------CCC----CCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeee
Q 007266 78 CIIIGYCEGGDMAEAIKKAN--------GVH----FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 145 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~--------~~~----lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL 145 (610)
|+|+|||..|||.++|+... +.. |+..+...|+.||+.|++||-++++|||||-..|+||..+-.|||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 89999999999999997532 223 889999999999999999999999999999999999999999999
Q ss_pred eeccccccccccccccc---ccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCC
Q 007266 146 GDFGLAKMLISDDLASS---VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA 221 (610)
Q Consensus 146 ~DFGlak~~~~~~~~~~---~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~ 221 (610)
+|||+++..-..++... ..-...|||||.+..+.|+.+|||||+||+|+|+++ |..||.+...++.++.|..+...
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL 724 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLL 724 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcc
Confidence 99999998766654332 233458999999999999999999999999999975 99999999999999999999999
Q ss_pred CCCcccchHHHHHHHHhhcCCCCCCCCHHHHh
Q 007266 222 PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253 (610)
Q Consensus 222 ~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL 253 (610)
+.|..++.++.+|+..||+.+|.+||+..||=
T Consensus 725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 725 SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 99999999999999999999999999999983
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=291.35 Aligned_cols=241 Identities=35% Similarity=0.619 Sum_probs=209.8
Q ss_pred CceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCCHHHHH
Q 007266 14 SFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI 93 (610)
Q Consensus 14 ~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~I 93 (610)
+||.||++.+..+++.+|+|.+........ .+.+.+|++++++++|+|++++++.+... ...++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHH
Confidence 689999999998899999999976544332 56789999999999999999999987665 4788999999999999999
Q ss_pred HHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccccccCCCcccCCc
Q 007266 94 KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173 (610)
Q Consensus 94 k~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APE 173 (610)
.... .+++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+.............++..|++||
T Consensus 79 ~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 79 KKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred Hhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 8754 38999999999999999999999999999999999999999999999999998876554556678999999999
Q ss_pred cccCCCCCCCccccccchhHHhhhhcCccccc-cCHHHHHHHHhhccCCCCCcc--cchHHHHHHHHhhcCCCCCCCCHH
Q 007266 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA-FDMQALINKINKSIVAPLPTV--YSGAFRGLVKSMLRKNPEFRPSAA 250 (610)
Q Consensus 174 vl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~-~~~~~l~~~I~~~~~~~~p~~--~s~~l~~LI~kmL~~dP~~RpSa~ 250 (610)
.+.+..++.++|||+||+++++|++|..||.. .+.....+.+........... ++..+.+++.+||..+|++||++.
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 236 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE 236 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence 99888889999999999999999999999987 566666665554443333322 888999999999999999999999
Q ss_pred HHhcCCCC
Q 007266 251 ELLCHPHL 258 (610)
Q Consensus 251 eiL~Hp~f 258 (610)
++++||||
T Consensus 237 ~~~~~~~~ 244 (244)
T smart00220 237 EALQHPFF 244 (244)
T ss_pred HHhhCCCC
Confidence 99999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.79 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=217.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-----HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-----DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-----~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|-++.+||+|||+.||++.|....+.||+|+-.....- ....+...+|..|.+.|.||.||+++++|.-+...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4788899999999999999999999999999987654422 11234567899999999999999999999988889
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecccCCCCceEecC---CCCeeeeecccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN--HILHRDVKCSNIFLTR---DQDIRLGDFGLA 151 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~--gIiHRDLKPeNILL~~---~g~vKL~DFGla 151 (610)
+|-|+|||+|.+|..+++.+. .++|..++.|+.||+.||.||... -|||-||||.||||.. -|.|||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 999999999999999999865 789999999999999999999987 6999999999999964 378999999999
Q ss_pred ccccccc--------ccccccCCCcccCCccccCC----CCCCCccccccchhHHhhhhcCcccccc-CHHHHHHH--Hh
Q 007266 152 KMLISDD--------LASSVVGTPSYMCPELLADI----PYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINK--IN 216 (610)
Q Consensus 152 k~~~~~~--------~~~~~vGTp~Y~APEvl~~~----~yt~ksDIWSLG~iLyeLltG~~PF~~~-~~~~l~~~--I~ 216 (610)
++...+. +.+...||.||++||.+.-. ..+.++||||+|||+|..+.|+.||... ..+++++. |.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9875442 44567899999999976432 2588999999999999999999999754 34444433 22
Q ss_pred hc--cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 217 KS--IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 217 ~~--~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+. ...|....++.++++||++||++.-++|....++-+||||.+.+
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 22 22334456899999999999999999999999999999998744
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=319.51 Aligned_cols=255 Identities=27% Similarity=0.471 Sum_probs=206.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-----C---CceeeeeeeEee-
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-----N---PFIVEYKDSWVE- 72 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-----H---pnIV~l~~~~~~- 72 (610)
.+|.++++||+|-|++||+|.|..+.+.||+|+.+-.. ...+....||++|+++. | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 48999999999999999999999999999999987433 33456789999999984 2 479999999874
Q ss_pred --cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEec-----------
Q 007266 73 --KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLT----------- 138 (610)
Q Consensus 73 --~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~----------- 138 (610)
++.++|+|+|++ |.+|..+|++.+-..++...++.|++|||.||.|||.. ||||-||||+||||.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 456899999999 89999999998888899999999999999999999987 999999999999994
Q ss_pred --------------------------------------------------------------------------------
Q 007266 139 -------------------------------------------------------------------------------- 138 (610)
Q Consensus 139 -------------------------------------------------------------------------------- 138 (610)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------CC----------------------------------------------------CCe
Q 007266 139 -----------------------RD----------------------------------------------------QDI 143 (610)
Q Consensus 139 -----------------------~~----------------------------------------------------g~v 143 (610)
+. -.+
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 00 015
Q ss_pred eeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC------HHHHHHHH--
Q 007266 144 RLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD------MQALINKI-- 215 (610)
Q Consensus 144 KL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~------~~~l~~~I-- 215 (610)
||+|||.|+... .....-+.|..|+|||++.+..|+..+||||++|+++||+||...|.... .++-+..|
T Consensus 394 KIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E 471 (590)
T KOG1290|consen 394 KIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME 471 (590)
T ss_pred EEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence 778888877753 23455688999999999999999999999999999999999999995331 11111111
Q ss_pred -----------------------------hhccCCCCCc----------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 007266 216 -----------------------------NKSIVAPLPT----------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256 (610)
Q Consensus 216 -----------------------------~~~~~~~~p~----------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp 256 (610)
.+...|++.. .-..+|.+||.-||+.+|++||||.++|+||
T Consensus 472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP 551 (590)
T KOG1290|consen 472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP 551 (590)
T ss_pred HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence 1122222211 1234688999999999999999999999999
Q ss_pred CCCchh
Q 007266 257 HLQPYV 262 (610)
Q Consensus 257 ~f~~~~ 262 (610)
|+.+..
T Consensus 552 wLn~~~ 557 (590)
T KOG1290|consen 552 WLNPVA 557 (590)
T ss_pred cccCCC
Confidence 998753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.17 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=210.0
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHH-HhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELI-SRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL-~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
.+-++.||.|+||+|++..|+.+|+..|||.|+......+ ..++..|.... +.-++||||+++++.+.++ ..||.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~EG-dcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-DCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-ceeeeHH
Confidence 3456789999999999999999999999999987665333 34566677654 4557999999999988776 5789999
Q ss_pred ecCCCCHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 83 YCEGGDMAEAIKK---ANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 83 y~~GgsL~~~Ik~---~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
.++ .+|..+.+. .....++|+.+..|..-.+.||+||... +||||||||+||||+..|.|||||||++..+...-
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 994 576655432 2334799999999999999999999876 99999999999999999999999999998887665
Q ss_pred ccccccCCCcccCCcccc--CCCCCCCccccccchhHHhhhhcCccccccCH-HHHHHHHhhccCCCC-----CcccchH
Q 007266 159 LASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAPL-----PTVYSGA 230 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~--~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~-~~l~~~I~~~~~~~~-----p~~~s~~ 230 (610)
-.+.-.|...|||||.+. +..|+.++|+||||+.|||++||..|+..++. .+++..+..+..+.+ ...++..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~ 302 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS 302 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence 556678999999999885 34689999999999999999999999998763 333333333322211 1237889
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+..+|.-||.+|-..||.+.+++.+||...+.
T Consensus 303 ~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 303 MVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 99999999999999999999999999998764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=337.77 Aligned_cols=244 Identities=31% Similarity=0.499 Sum_probs=198.0
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVC 78 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~~~ 78 (610)
|..-+.||+||||.||+++++.+|+.||||.++... .....+...+|+++|++++|+|||+++++-.+.. ..-.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 455678999999999999999999999999998644 3345677889999999999999999998643322 2456
Q ss_pred EEEeecCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC--CC--eeeeecccccc
Q 007266 79 IIIGYCEGGDMAEAIKKA-NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD--QD--IRLGDFGLAKM 153 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~-~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~--g~--vKL~DFGlak~ 153 (610)
+|||||.||+|..++.+- +...|+|..+..++..+..||.|||++||+||||||.||++-.. |. .||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999999752 33579999999999999999999999999999999999998643 33 79999999999
Q ss_pred cccccccccccCCCcccCCcccc-CCCCCCCccccccchhHHhhhhcCccccccCHH-----HHHHHHhhc---------
Q 007266 154 LISDDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-----ALINKINKS--------- 218 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~-----~l~~~I~~~--------- 218 (610)
+..+....+++||+.|.+||++. ...|+..+|+||+||++|+++||..||...... -++..+.+.
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~ 253 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ 253 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence 99888999999999999999998 588999999999999999999999999644321 222222111
Q ss_pred ----------cCCCCCcccchH----HHHHHHHhhcCCCCCCCC
Q 007266 219 ----------IVAPLPTVYSGA----FRGLVKSMLRKNPEFRPS 248 (610)
Q Consensus 219 ----------~~~~~p~~~s~~----l~~LI~kmL~~dP~~RpS 248 (610)
..-|.|...+.. +-..+..||..+|.+|..
T Consensus 254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 111223334443 446777888899999973
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=335.88 Aligned_cols=253 Identities=23% Similarity=0.273 Sum_probs=178.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCC----CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEe-----
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHE----RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWV----- 71 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~----~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~----- 71 (610)
+++|++.+.||+|+||.||++.+..+ +..||+|++......+. ...| .+....+.++..++..|.
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 47899999999999999999999988 89999998753221111 1111 112222222322222211
Q ss_pred ecCcEEEEEEeecCCCCHHHHHHHhCC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCC
Q 007266 72 EKGCYVCIIIGYCEGGDMAEAIKKANG------------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCS 133 (610)
Q Consensus 72 ~~~~~~~LVmEy~~GgsL~~~Ik~~~~------------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPe 133 (610)
..+..+++||||+.+++|.+++..... ....+..+..++.||+.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 344578999999999999999875321 01124557789999999999999999999999999
Q ss_pred ceEecC-CCCeeeeecccccccccc--cccccccCCCcccCCccccCC----------------------CCCCCccccc
Q 007266 134 NIFLTR-DQDIRLGDFGLAKMLISD--DLASSVVGTPSYMCPELLADI----------------------PYGSKSDIWS 188 (610)
Q Consensus 134 NILL~~-~g~vKL~DFGlak~~~~~--~~~~~~vGTp~Y~APEvl~~~----------------------~yt~ksDIWS 188 (610)
||||+. ++.+||+|||+++.+... ......++++.|+|||++... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 578999999999865322 234567899999999966422 2445679999
Q ss_pred cchhHHhhhhcCccccccCHHHHHHHHhhcc-----------CCC----------CCcccchHHHHHHHHhhcCCCCCCC
Q 007266 189 LGCCVYEMSAQKAAFKAFDMQALINKINKSI-----------VAP----------LPTVYSGAFRGLVKSMLRKNPEFRP 247 (610)
Q Consensus 189 LG~iLyeLltG~~PF~~~~~~~l~~~I~~~~-----------~~~----------~p~~~s~~l~~LI~kmL~~dP~~Rp 247 (610)
|||+||||+++..++... ...+..+.... ... .........++||.+||++||++||
T Consensus 365 lGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 999999999877654422 11111111100 000 0011223456899999999999999
Q ss_pred CHHHHhcCCCCCch
Q 007266 248 SAAELLCHPHLQPY 261 (610)
Q Consensus 248 Sa~eiL~Hp~f~~~ 261 (610)
|+.++|+||||+..
T Consensus 443 ta~e~L~Hpff~~~ 456 (566)
T PLN03225 443 SAKAALAHPYFDRE 456 (566)
T ss_pred CHHHHhCCcCcCCC
Confidence 99999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=300.52 Aligned_cols=254 Identities=25% Similarity=0.438 Sum_probs=214.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecC-cEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKG-CYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~-~~~~ 78 (610)
.++|++++.+|+|.|+.||.+.+..+++.++||++++. ..+.+.+|++||..|. |||||.+++...+.. ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 37899999999999999999999999999999999743 3456889999999996 999999999877654 3456
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-CCeeeeecccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-g~vKL~DFGlak~~~~~ 157 (610)
+|+||++..+...+.. .|+.-.++.++.||+.||.|+|++||+|||+||.|++|+.. ..++|+|+|+|..+...
T Consensus 112 LiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999999988887765 47888999999999999999999999999999999999975 46999999999998877
Q ss_pred cccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccc-cccCHHHHHHHHhhccCCC-------------
Q 007266 158 DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAF-KAFDMQALINKINKSIVAP------------- 222 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF-~~~~~~~l~~~I~~~~~~~------------- 222 (610)
...+..+.+..|--||++-+- .|+...|+|||||+|..|+..+-|| .+.+..+++-+|.+.+...
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 767777889999999988764 5799999999999999999887775 5666666555553322111
Q ss_pred -----------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 223 -----------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 223 -----------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
....+++++.+||.++|..|-.+|+||.|++.||||.+....
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 111256899999999999999999999999999999886544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.61 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=209.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC------CceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN------PFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H------pnIV~l~~~~~~~~~ 75 (610)
.+|.+....|+|-|++|..|.+..-|+.||||+|+... ...+.=..|++||++|+. .|++.++..|...+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn- 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN- 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc-
Confidence 48999999999999999999999999999999998433 233345679999999963 47888988887654
Q ss_pred EEEEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeecccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN-GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKM 153 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~-~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~ 153 (610)
++|||+|-+ ..+|.+++++.+ +..|.-..++.|+.||+.||.+|...||+|.||||.|||++... .+||||||.|..
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 899999999 579999999854 35678899999999999999999999999999999999998765 489999999987
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-----------
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------- 222 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----------- 222 (610)
....+ ...+..+..|.|||++.|.+|++..|+||+||+||||++|+..|.+.....++..........
T Consensus 587 ~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~ 665 (752)
T KOG0670|consen 587 ASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK 665 (752)
T ss_pred ccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence 65554 456677889999999999999999999999999999999999999887665554332211000
Q ss_pred ------------------------------CC------------------cccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 223 ------------------------------LP------------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 223 ------------------------------~p------------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
-| ..+-.+|++||.+||..||++|.+..|+|.
T Consensus 666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00 001135889999999999999999999999
Q ss_pred CCCCCc
Q 007266 255 HPHLQP 260 (610)
Q Consensus 255 Hp~f~~ 260 (610)
||||+.
T Consensus 746 HpFi~~ 751 (752)
T KOG0670|consen 746 HPFITE 751 (752)
T ss_pred CCcccC
Confidence 999973
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.43 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=218.0
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEEEEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCII 80 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~~LV 80 (610)
+.-+.||.|+||+||.+.|..+|+.||+|++....++-...+.+.+|+++|...+|.|++..++..+... ..+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999999999999999999877776667788999999999999999999888765443 235678
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
+|.+ ..+|..+|..-. .++.++++-+++||+.||+|||+.||+||||||.|+|++.++.+||||||+++....++
T Consensus 136 TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 8888 468888876543 79999999999999999999999999999999999999999999999999999865544
Q ss_pred ccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc------------
Q 007266 159 LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT------------ 225 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~------------ 225 (610)
.+...+.|..|+|||++++. .|+.++||||+|||+.||+..+..|...+..+.++.|...+..|..+
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 34556889999999998765 58999999999999999999999999999888888877665554211
Q ss_pred ---------------------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhhh
Q 007266 226 ---------------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 226 ---------------------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~~ 265 (610)
.-..+...++.+||..||++|++.++++.|+|+.......
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~ 353 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRF 353 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceee
Confidence 1123577899999999999999999999999997754443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=322.60 Aligned_cols=259 Identities=20% Similarity=0.282 Sum_probs=188.6
Q ss_pred CCeEEEeEecccCceEEEEEEEe----------------CCCeEEEEEEEccccccHH------------HHHHHHHHHH
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK----------------HERKKYVLKKIRLARQTDR------------ARRSAHQEME 53 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~----------------~~~~~vAIK~i~~~~~~~~------------~~~~l~~Ei~ 53 (610)
++|++.++||+|+||.||++... ..++.||||.+........ ..+....|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 68999999999999999998652 2456799999865432211 1122345777
Q ss_pred HHHhcCCCce-----eeeeeeEeec-------CcEEEEEEeecCCCCHHHHHHHhCC----------------------C
Q 007266 54 LISRVRNPFI-----VEYKDSWVEK-------GCYVCIIIGYCEGGDMAEAIKKANG----------------------V 99 (610)
Q Consensus 54 iL~~L~HpnI-----V~l~~~~~~~-------~~~~~LVmEy~~GgsL~~~Ik~~~~----------------------~ 99 (610)
++.+++|.++ +.++++|... ....|+||||+.+++|.+++....+ .
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7778876654 5566655421 2357899999999999998864211 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccccc--ccCCCcccCCccccC
Q 007266 100 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS--VVGTPSYMCPELLAD 177 (610)
Q Consensus 100 ~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~--~vGTp~Y~APEvl~~ 177 (610)
.+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++........... ..+|+.|+|||++..
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 245678899999999999999999999999999999999999999999999976543322222 345899999998754
Q ss_pred CC--------------------CC--CCccccccchhHHhhhhcCc-cccccCHHH-----------HHHHHh-hccCCC
Q 007266 178 IP--------------------YG--SKSDIWSLGCCVYEMSAQKA-AFKAFDMQA-----------LINKIN-KSIVAP 222 (610)
Q Consensus 178 ~~--------------------yt--~ksDIWSLG~iLyeLltG~~-PF~~~~~~~-----------l~~~I~-~~~~~~ 222 (610)
.. |+ ...||||+||++|+|++|.. ||.+..... .+..+. ......
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~ 464 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS 464 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc
Confidence 22 22 24799999999999999876 665422111 011111 111222
Q ss_pred CCcccchHHHHHHHHhhcCCC---CCCCCHHHHhcCCCCCc
Q 007266 223 LPTVYSGAFRGLVKSMLRKNP---EFRPSAAELLCHPHLQP 260 (610)
Q Consensus 223 ~p~~~s~~l~~LI~kmL~~dP---~~RpSa~eiL~Hp~f~~ 260 (610)
.....++..++||.+||..+| .+|+|++|+|+||||.+
T Consensus 465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 344578999999999999866 68999999999999965
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=336.76 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=216.5
Q ss_pred CeEEEeEecccCceEEEEEEEeCCC-----eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHER-----KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~-----~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
.-++.+.||+|+||.||.+....-. ..||||.+..... ......|.+|..+|++++|||||++++++++. ...
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-GPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-CCc
Confidence 3567899999999999999887632 2499999875543 34456799999999999999999999999984 477
Q ss_pred EEEEeecCCCCHHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKA-----NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~-----~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
+|++|||+||+|..+|++. ....++...+..++.||+.|++||+++++|||||-..|+||+....|||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 8999999999999999875 13468999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-cccccCC--CcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccc
Q 007266 153 MLISDDL-ASSVVGT--PSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYS 228 (610)
Q Consensus 153 ~~~~~~~-~~~~vGT--p~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s 228 (610)
.+...++ .....+. ..|||||.+.++.++.++|||||||+|+|+++ |..||.+.+..+++.....+..-+.|..++
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP 930 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCP 930 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCC
Confidence 5543332 2222222 47999999999999999999999999999986 899999999999988666666777899999
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+.+.+||..||+.+|++||+...|++
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=320.58 Aligned_cols=255 Identities=30% Similarity=0.541 Sum_probs=220.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|+++..+|.|.||.||+++++.+++..|+|+++.....+- ..+.+|+-+++.++|||||.|+++|.... .+||+|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~--~~iqqei~~~~dc~h~nivay~gsylr~d-klwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF--SGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc--cccccceeeeecCCCcChHHHHhhhhhhc-CcEEEE
Confidence 689999999999999999999999999999999987665443 45789999999999999999999998665 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
|||.||+|++...-.+ .++|.++.+++++.+.||+|||++|-+|||||-.|||+++.|++|++|||.+..+... ...
T Consensus 92 EycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred EecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 9999999999876544 8999999999999999999999999999999999999999999999999987665332 345
Q ss_pred ccccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----CCcccchHHHH
Q 007266 161 SSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----LPTVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----~p~~~s~~l~~ 233 (610)
.+++|||.|||||+.. .+.|...+|||++|+...|+..-++|.....+...+....+....+ -+..+++.|.+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 6899999999999864 5679999999999999999988888855555444444444444333 25569999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
|++.+|.++|++||+++.+|.|||+..-
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999999764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=308.77 Aligned_cols=245 Identities=23% Similarity=0.402 Sum_probs=217.5
Q ss_pred EEeEecccCceEEEEEEEeCC--C--eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 6 VLEQIGKGSFGSALLVRHKHE--R--KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~--~--~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+.++||.|-||.||.+....- | -.||||..+.+-.. ...+.|.+|.-+|++++|||||++++.+.+. ..||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e~--P~Wivm 469 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ--PMWIVM 469 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeecc--ceeEEE
Confidence 457899999999999987642 2 35889988654433 4478899999999999999999999998765 589999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
|.+.-|.|..+++.+.. .|+...+..|++||+.+|.|||+.++|||||-..|||+.....|||+|||+++.+..+.+..
T Consensus 470 EL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred ecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 99999999999998543 68999999999999999999999999999999999999999999999999999987776555
Q ss_pred cccCC--CcccCCccccCCCCCCCccccccchhHHhhh-hcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 162 SVVGT--PSYMCPELLADIPYGSKSDIWSLGCCVYEMS-AQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 162 ~~vGT--p~Y~APEvl~~~~yt~ksDIWSLG~iLyeLl-tG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
...|. .-|||||.++-+.++.++|+|.|||||+|++ .|..||.+-...+.+-.|.++...|.|..+++.+..|+.+|
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKC 628 (974)
T ss_pred ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHH
Confidence 44444 3699999999999999999999999999986 59999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCHHHHhc
Q 007266 239 LRKNPEFRPSAAELLC 254 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~ 254 (610)
|.++|.+||...+|..
T Consensus 629 WayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 629 WAYEPSKRPRFTEIKA 644 (974)
T ss_pred hccCcccCCcHHHHHH
Confidence 9999999999988864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=327.44 Aligned_cols=237 Identities=18% Similarity=0.254 Sum_probs=187.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
.|...+.||+|+||.||++.+..++..||+|.+...... ...|++++++++|||||++++++...+ ..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~-~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEK-GAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCC-CCEEEEe
Confidence 455677899999999999999999999999988643321 224688999999999999999887654 6889999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH---ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLH---s~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|++||+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 9999999999953 789999999999999999999 6699999999999999998887775 665543321
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC-----HHHHHHHHhh-----ccCC-------C
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-----MQALINKINK-----SIVA-------P 222 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-----~~~l~~~I~~-----~~~~-------~ 222 (610)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..+....... .... .
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 223478999999999999999999999999999999999999985321 1111111000 0000 1
Q ss_pred CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 223 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 223 ~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+.....++.+++.+||+.||++||++.|+++.
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 111223357789999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=307.06 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=223.6
Q ss_pred eEEEeEecccCceEEEEEEEeCCCe---EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERK---KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~---~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
..|.++||.|.||.||.++.+..++ .||||.++ ....++++..|..|+.||.++.|||||.+.++.. +...+.||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK-~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-ks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-KSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeec-cCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-cCceeEEE
Confidence 4688999999999999999987654 69999996 5566778888999999999999999999999765 45578899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
.|||+.|+|..+|+++.+ .|...++.-+++.|+.|++||-++|+|||||-..|||++.+-..|++|||+++.+..+.
T Consensus 709 TEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 999999999999998776 49999999999999999999999999999999999999999999999999999875443
Q ss_pred ccccccCC--CcccCCccccCCCCCCCccccccchhHHhh-hhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 159 LASSVVGT--PSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGT--p~Y~APEvl~~~~yt~ksDIWSLG~iLyeL-ltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
...+.-|. ..|.|||.+..+.++.++|+||+|++|+|. -.|..||.++..++.++.|..+..-|.|-.++..+..|+
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLM 867 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLM 867 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHH
Confidence 12222222 479999999999999999999999999995 469999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCHHHHhcC
Q 007266 236 KSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~H 255 (610)
..||++|=.+||...||+.+
T Consensus 868 ldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=298.86 Aligned_cols=249 Identities=23% Similarity=0.389 Sum_probs=212.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
...+.++||+|-||.|.+|.-. .+.+||+|+++..... ..++.|.+|+++|.+|+|||||.++++|..++ .+|+|+|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-PicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHHHHH
Confidence 4567899999999999999764 4789999999865543 44678999999999999999999999998765 7889999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc--
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-- 160 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~-- 160 (610)
|++.|+|.+++.++....+.-+....++.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-..+..
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999999999875434456667779999999999999999999999999999999999999999999987655532
Q ss_pred -ccccCCCcccCCccccCCCCCCCccccccchhHHhh--hhcCccccccCHHHHHHHHhhcc-------CCCCCcccchH
Q 007266 161 -SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM--SAQKAAFKAFDMQALINKINKSI-------VAPLPTVYSGA 230 (610)
Q Consensus 161 -~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeL--ltG~~PF~~~~~~~l~~~I~~~~-------~~~~p~~~s~~ 230 (610)
...+-...|||+|.+..+.++.++|+|+||+.|||+ ++...||.....++..+....-. ....|..++..
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~ 775 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQG 775 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHH
Confidence 234566789999999999999999999999999997 56788998887777766654322 23457778999
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+.+||.+|+..+-++||+.+++-.
T Consensus 776 lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 776 LYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHhchhhhcCCCHHHHHH
Confidence 999999999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=303.35 Aligned_cols=250 Identities=20% Similarity=0.361 Sum_probs=219.6
Q ss_pred CeEEEeEecccCceEEEEEEEeC-CCe--EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKH-ERK--KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~-~~~--~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+..+.++||+|.||+|+.+.... +|+ .||||.++...... .-..|.+|+.+|.+|.|+|+|++++...+. .+.+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q--p~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ--PAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc--hhhH
Confidence 44567899999999999998875 343 58999998766654 456799999999999999999999988763 5679
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|||.+.+|+|.+.+.+.....|....++.|+.||+.||.||.++++|||||-..||||-....|||+||||.+.+...+.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999999886666899999999999999999999999999999999999999988999999999998865543
Q ss_pred ccc----ccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHH
Q 007266 160 ASS----VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234 (610)
Q Consensus 160 ~~~----~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~L 234 (610)
... .-....|||||.+....++.++|+|++||.|+||++ |+-||.+.....++++|.....-+-|..+++.+.++
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~i 347 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQI 347 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHH
Confidence 222 123346999999999999999999999999999986 899999999999999998777777888999999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcC
Q 007266 235 VKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~H 255 (610)
++.||..+|.+||+...|...
T Consensus 348 mk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 348 MKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHhccCCccccccHHHHHHh
Confidence 999999999999999888644
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=265.74 Aligned_cols=218 Identities=27% Similarity=0.511 Sum_probs=180.2
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHh-cCCCceeeeeeeEeecCcEEEEEEe
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR-VRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
...+..||+|+||.|-+.+|..+|...|+|.++..-.++.. .++.+|+.+..+ ..+|++|.+++.++..+ .+||.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q-~r~L~dldi~~r~~~CPf~V~FyGa~~reg-dvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQ-KRLLMDLDIIMRTVDCPFTVHFYGALFREG-DVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHH-HHHHHhhhhhccCCCCCeEEEeehhhhccc-cEEEeHH
Confidence 34567899999999999999999999999999866655544 456677777655 57999999999988776 6889999
Q ss_pred ecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 83 YCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 83 y~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
.++ .+|..+.++ ..+..++|..+-+++..++.||.|||++ .+||||+||+||||+.+|.||+||||++..+...--
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 994 577766543 2345799999999999999999999998 999999999999999999999999999988765543
Q ss_pred cccccCCCcccCCcccc----CCCCCCCccccccchhHHhhhhcCcccccc-CHHHHHHHHhhccCCCCC
Q 007266 160 ASSVVGTPSYMCPELLA----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVAPLP 224 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~-~~~~l~~~I~~~~~~~~p 224 (610)
.+--.|...|||||.+. ...|+.++||||||+.|+||.++..||... ...+++..+.....+.+|
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 33467889999999875 347899999999999999999999999754 466667666666555444
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=291.39 Aligned_cols=245 Identities=20% Similarity=0.364 Sum_probs=219.7
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
.....+||-|-||.||.+..+.-.-.||||.++-+.+ ..+.|..|+.+|+.|+|||+|+++++|.... .+|||+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-PFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-PFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCC-CeEEEEec
Confidence 3457899999999999999999889999998874432 3567999999999999999999999987654 78999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 163 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~ 163 (610)
|-.|+|.+++++.+...++.-.+.+++.||..|++||..+++|||||-..|.|+..+..||++||||++....+.+. ..
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AH 423 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AH 423 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-cc
Confidence 99999999999888778888899999999999999999999999999999999999999999999999987655433 22
Q ss_pred cC---CCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 164 VG---TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 164 vG---Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
.| ..-|.|||-+....++.++|||+|||+|+|+.| |..||.+.+....+..+.+++.-.-|..+++....|+..||
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW 503 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACW 503 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence 22 236999999999999999999999999999975 99999999999999999999888899999999999999999
Q ss_pred cCCCCCCCCHHHHh
Q 007266 240 RKNPEFRPSAAELL 253 (610)
Q Consensus 240 ~~dP~~RpSa~eiL 253 (610)
+.+|.+||+.+|+-
T Consensus 504 ~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 504 NWSPSDRPSFAEIH 517 (1157)
T ss_pred cCCcccCccHHHHH
Confidence 99999999999884
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=304.46 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=189.0
Q ss_pred EeEecccCceE-EEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEEeec
Q 007266 7 LEQIGKGSFGS-ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 7 lk~LG~G~fG~-Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
-+.+|.|+-|+ ||++.. .|+.||||.+.. +....+.+|+..|+.. .|||||++++.-.+ ..+.||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQD-RQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccC-CceEEEEehHh
Confidence 35788998885 566655 688999997752 3445688999999988 49999999986543 45899999999
Q ss_pred CCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC---CC--Ceeeeecccccccccc
Q 007266 85 EGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQ--DIRLGDFGLAKMLISD 157 (610)
Q Consensus 85 ~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~---~g--~vKL~DFGlak~~~~~ 157 (610)
..+|.+++... ..........+.++.|++.||+|||+.+||||||||.||||+. ++ .++|.|||+|+.+..+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 57999999873 1111112456788999999999999999999999999999987 34 4899999999998654
Q ss_pred c----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhc-CccccccCHHHHHHHHhhccCCC--CCcccchH
Q 007266 158 D----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAP--LPTVYSGA 230 (610)
Q Consensus 158 ~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG-~~PF~~~~~~~l~~~I~~~~~~~--~p~~~s~~ 230 (610)
. ......||-+|+|||++....-+.++||+||||++|+.++| ..||...-.. .. .|..+...- +...-..+
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~-NIl~~~~~L~~L~~~~d~e 742 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QA-NILTGNYTLVHLEPLPDCE 742 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hh-hhhcCccceeeeccCchHH
Confidence 3 34567899999999999998888999999999999988775 8898754322 12 222222111 11111128
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+.+||.+||.++|..||+|.++|.||||=..
T Consensus 743 A~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 743 AKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 9999999999999999999999999999543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=246.52 Aligned_cols=212 Identities=39% Similarity=0.733 Sum_probs=187.1
Q ss_pred ecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCCH
Q 007266 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 89 (610)
Q Consensus 10 LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~GgsL 89 (610)
||.|++|.||++.+..+++.+++|.+....... ....+.+|+.+++.+.|++++++++.+... ...+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcH
Confidence 689999999999998889999999997654432 346788999999999999999999987765 578899999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-CCCeeeeeccccccccccc-ccccccCCC
Q 007266 90 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISDD-LASSVVGTP 167 (610)
Q Consensus 90 ~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-~g~vKL~DFGlak~~~~~~-~~~~~vGTp 167 (610)
.+++.... ..++++.+..++.+++.+|.|||++|++|+||+|.||+++. ++.++|+|||.+....... ......+..
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 99998752 35899999999999999999999999999999999999999 8999999999987654332 234466888
Q ss_pred cccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCC
Q 007266 168 SYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 246 (610)
Q Consensus 168 ~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~R 246 (610)
.|++||.+... .++.+.|+|++|++|++| ..+.+++.+||..+|++|
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccC
Confidence 99999999887 788999999999999999 688999999999999999
Q ss_pred CCHHHHhcCC
Q 007266 247 PSAAELLCHP 256 (610)
Q Consensus 247 pSa~eiL~Hp 256 (610)
|+++++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=295.83 Aligned_cols=248 Identities=24% Similarity=0.426 Sum_probs=213.9
Q ss_pred EEEeEecccCceEEEEEEEeC---C----CeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcE
Q 007266 5 EVLEQIGKGSFGSALLVRHKH---E----RKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~---~----~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~ 76 (610)
.+.+.||.|+||.|+++.-.. . ...||+|.+...... ...+.+..|+++|+.+. |+||+.+++++.. ++.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-CCc
Confidence 566799999999999997542 1 457999998766555 66778999999999995 9999999998877 568
Q ss_pred EEEEEeecCCCCHHHHHHHhC--------C------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN--------G------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 142 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~--------~------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~ 142 (610)
+++|+||+..|+|.++++... + ..++...+..+++||+.|++||++.++|||||-..||||..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 899999999999999998754 0 13889999999999999999999999999999999999999999
Q ss_pred eeeeeccccccccccccc--ccccCC--CcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccC-HHHHHHHHh
Q 007266 143 IRLGDFGLAKMLISDDLA--SSVVGT--PSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFD-MQALINKIN 216 (610)
Q Consensus 143 vKL~DFGlak~~~~~~~~--~~~vGT--p~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~-~~~l~~~I~ 216 (610)
+||+|||+|+.....+.. ....|+ ..|||||.+....|+.++||||+|++||||++ |..||.+.. ..++++.+.
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~ 536 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK 536 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh
Confidence 999999999865444332 222332 24999999999999999999999999999975 889999866 777888888
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
.+.....|..++.++.++++.|++.+|++||+..++..
T Consensus 537 ~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 537 EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 88888889999999999999999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.58 Aligned_cols=200 Identities=26% Similarity=0.420 Sum_probs=175.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHH------HHHHHHHHHHHHhcC---CCceeeeeeeEee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRA------RRSAHQEMELISRVR---NPFIVEYKDSWVE 72 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~------~~~l~~Ei~iL~~L~---HpnIV~l~~~~~~ 72 (610)
.+|..++.||.|+||.|++|.++.+...|+||.|.+.+.-... .-.+-.||.||..++ |+||+++++.| +
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF-E 639 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF-E 639 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-e
Confidence 4799999999999999999999999999999999766533221 123456999999998 99999999965 5
Q ss_pred cCcEEEEEEeec-CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccc
Q 007266 73 KGCYVCIIIGYC-EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151 (610)
Q Consensus 73 ~~~~~~LVmEy~-~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGla 151 (610)
++.++||+||-- +|-+|+++|..+. .++|..++.|++|++.|+++||++||||||||-+||.++.+|.+||+|||.+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 556899999965 5779999998765 6899999999999999999999999999999999999999999999999988
Q ss_pred cccccccccccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccc
Q 007266 152 KMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKA 205 (610)
Q Consensus 152 k~~~~~~~~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~ 205 (610)
... .......++||..|+|||++.+..| +..-|||+||++||-++....||.+
T Consensus 718 a~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 654 3456788999999999999999998 7789999999999999999998864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=249.01 Aligned_cols=216 Identities=32% Similarity=0.573 Sum_probs=185.9
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
|.+.+.||.|++|.||++.+..+++.+++|.+...... ...+.+.+|++.++.++|+|++++++.+... ...++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEec
Confidence 67889999999999999999988999999999865443 2456788999999999999999999987654 578899999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--ccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LAS 161 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~~~ 161 (610)
+.+++|.+++..... .+++..+..++.|++.+|.+||+++++|+||+|.||+++.++.++|+|||++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999987542 17899999999999999999999999999999999999999999999999988765442 335
Q ss_pred cccCCCcccCCccc-cCCCCCCCccccccchhHHhhhhcCccccc--cCHHHHHHHHhhccCCC
Q 007266 162 SVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSAQKAAFKA--FDMQALINKINKSIVAP 222 (610)
Q Consensus 162 ~~vGTp~Y~APEvl-~~~~yt~ksDIWSLG~iLyeLltG~~PF~~--~~~~~l~~~I~~~~~~~ 222 (610)
...++..|++||.+ ....++.++|+|+||+++++|++|..||.. .+...+.+.+......+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence 56788899999998 667788899999999999999999999987 44556777776665443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.90 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=195.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeC---CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH---ERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~---~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~ 77 (610)
+.|.++++||.|.|++||++.+.. .+..||+|.+.....-. .+.+|+++|..+. +.||+++.+.+. .++.+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~----ri~~El~~L~~~gG~~ni~~~~~~~r-nnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS----RILNELEMLYRLGGSDNIIKLNGCFR-NNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch----HHHHHHHHHHHhccchhhhcchhhhc-cCCee
Confidence 568899999999999999999987 78899999997655433 4788999999985 889999998654 55589
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-CCeeeeeccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLIS 156 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-g~vKL~DFGlak~~~~ 156 (610)
++|+||++.....+++.. ++-..++.+++.++.||.|+|.+|||||||||.|+|.+.. +.-.|+|||+|.....
T Consensus 111 ~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999998888864 6788999999999999999999999999999999999865 6789999999872100
Q ss_pred c-------c--------------------------------------ccccccCCCcccCCccccCC-CCCCCccccccc
Q 007266 157 D-------D--------------------------------------LASSVVGTPSYMCPELLADI-PYGSKSDIWSLG 190 (610)
Q Consensus 157 ~-------~--------------------------------------~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG 190 (610)
. . ..-...||++|+|||++..- ..+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 0 00123699999999988754 468899999999
Q ss_pred hhHHhhhhcCcccccc-CH-HHHHH------------------H--------------------------Hhhcc-----
Q 007266 191 CCVYEMSAQKAAFKAF-DM-QALIN------------------K--------------------------INKSI----- 219 (610)
Q Consensus 191 ~iLyeLltG~~PF~~~-~~-~~l~~------------------~--------------------------I~~~~----- 219 (610)
||+.-++++..||-.. +. ..+.+ + +....
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999997322 10 00000 0 00000
Q ss_pred CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 220 VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 220 ~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.......++..+.+|+.+||..||.+|+||+++|.||||.+.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 000011234578899999999999999999999999999853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=278.43 Aligned_cols=246 Identities=17% Similarity=0.304 Sum_probs=213.4
Q ss_pred EEEeEecccCceEEEEEEEeCCCe----EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERK----KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~----~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+..++||.|+||+||++...-.|+ +||||++.. ....+....+.+|+-+|.+|+|||++++++.+.... +-||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHH
Confidence 456899999999999998876555 688888863 344455567889999999999999999999887654 6789
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
++|+.+|.|.++++.+.. .+-......|.+||+.||.|||.++++||||-..|||+..-.++||.|||+++.+..++..
T Consensus 776 tq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 999999999999998543 6888999999999999999999999999999999999999999999999999998766532
Q ss_pred cc---ccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHH
Q 007266 161 SS---VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 161 ~~---~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~ 236 (610)
.. .---+.|||-|.+....|+.++||||+||.++|++| |..|+.+....++-+.+..+..-+.|..++-++.-++.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 22 122346889899999999999999999999999875 99999999998888888877777789999999999999
Q ss_pred HhhcCCCCCCCCHHHHhc
Q 007266 237 SMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~ 254 (610)
+||..|+..||+++++..
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999998865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=298.42 Aligned_cols=201 Identities=13% Similarity=0.146 Sum_probs=147.8
Q ss_pred hcCC-CceeeeeeeEee------cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Q 007266 57 RVRN-PFIVEYKDSWVE------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRD 129 (610)
Q Consensus 57 ~L~H-pnIV~l~~~~~~------~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRD 129 (610)
.+.| +||+.++++|.. ....+++++||+ +++|.++|... ...+++..++.|++||+.||.|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3344 466666666521 123567788887 67999999753 33699999999999999999999999999999
Q ss_pred CCCCceEecCC-------------------CCeeeeecccccccccc---------c--------ccccccCCCcccCCc
Q 007266 130 VKCSNIFLTRD-------------------QDIRLGDFGLAKMLISD---------D--------LASSVVGTPSYMCPE 173 (610)
Q Consensus 130 LKPeNILL~~~-------------------g~vKL~DFGlak~~~~~---------~--------~~~~~vGTp~Y~APE 173 (610)
|||+||||+.. +.+||+|||+++..... . .....+||++|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999654 44566666666532110 0 011246899999999
Q ss_pred cccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHh
Q 007266 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253 (610)
Q Consensus 174 vl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL 253 (610)
++.+..|+.++|||||||+||||++|.+||.... ..+..+......+..........+++.+||+.+|.+||++.|+|
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 9999999999999999999999999999876432 12222222222111112244567899999999999999999999
Q ss_pred cCCCCCch
Q 007266 254 CHPHLQPY 261 (610)
Q Consensus 254 ~Hp~f~~~ 261 (610)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=259.32 Aligned_cols=241 Identities=23% Similarity=0.387 Sum_probs=188.7
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHh--cCCCceeeeeeeEeecC---cEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVEKG---CYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIV~l~~~~~~~~---~~~ 77 (610)
+..+++.||+|.||.||+++.. |+.||||++... ..+...+|.+|++. |+|+||+.++++-..+. .++
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 5688999999999999999884 779999998622 12357788888875 59999999998754333 378
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecccCCCCceEecCCCCeeeeecc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN--------HILHRDVKCSNIFLTRDQDIRLGDFG 149 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~--------gIiHRDLKPeNILL~~~g~vKL~DFG 149 (610)
|||.+|.+.|+|+|++.+. .++-+.+.+++..++.||+|||-. .|.|||||..|||+.++|...|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999999984 689999999999999999999964 59999999999999999999999999
Q ss_pred ccccccccc-----ccccccCCCcccCCccccCCC----C--CCCccccccchhHHhhhhc----------Ccccccc--
Q 007266 150 LAKMLISDD-----LASSVVGTPSYMCPELLADIP----Y--GSKSDIWSLGCCVYEMSAQ----------KAAFKAF-- 206 (610)
Q Consensus 150 lak~~~~~~-----~~~~~vGTp~Y~APEvl~~~~----y--t~ksDIWSLG~iLyeLltG----------~~PF~~~-- 206 (610)
||-...... ..+..+||..|||||++...- + -..+||||||.+|+|++.. .+||.+.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 997764441 345679999999999986432 1 1468999999999999642 4677543
Q ss_pred ---CHHHHHHHHhh-ccCCCCCcccch-----HHHHHHHHhhcCCCCCCCCHHHHh
Q 007266 207 ---DMQALINKINK-SIVAPLPTVYSG-----AFRGLVKSMLRKNPEFRPSAAELL 253 (610)
Q Consensus 207 ---~~~~l~~~I~~-~~~~~~p~~~s~-----~l~~LI~kmL~~dP~~RpSa~eiL 253 (610)
+.+++...+.. ...+.+|..+.. .+-.|++.||..||.-|.||--+.
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 23344333322 233334444432 355789999999999999986554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=250.59 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=195.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|.|.|.+.||+|.||.+.+|+|+.++..+|+|.+...... ...|.+|..---.| .|.|||.-++.-++..++++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 6799999999999999999999999999999988754433 34588888765555 4889998887766666688899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC--CCeeeeeccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD--QDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~--g~vKL~DFGlak~~~~~~ 158 (610)
|||+..|+|...+... .+-|...+.++.||+.||.|||+.++||||||.+||||-+. ..|||||||+.+..+..
T Consensus 101 qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred eccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 9999999999988764 47899999999999999999999999999999999999643 46999999998764322
Q ss_pred ccccccCCCcccCCccccCC---C--CCCCccccccchhHHhhhhcCccccccC----HHHHHHHHhhccCCCCCc---c
Q 007266 159 LASSVVGTPSYMCPELLADI---P--YGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAPLPT---V 226 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~---~--yt~ksDIWSLG~iLyeLltG~~PF~~~~----~~~l~~~I~~~~~~~~p~---~ 226 (610)
....--+..|.+||++... . ....+|||.||+++|.+++|.+||+... ....+.+..+......|. .
T Consensus 177 -V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~ 255 (378)
T KOG1345|consen 177 -VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP 255 (378)
T ss_pred -ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc
Confidence 1122344579999976432 2 3668999999999999999999997432 222333344444444444 4
Q ss_pred cchHHHHHHHHhhcCCCCCC---CCHHHHhcCCCCC
Q 007266 227 YSGAFRGLVKSMLRKNPEFR---PSAAELLCHPHLQ 259 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~R---pSa~eiL~Hp~f~ 259 (610)
+++.+..+.++-|..++++| .++.......|..
T Consensus 256 fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 256 FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 78899999999999999999 5555555554543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=260.98 Aligned_cols=242 Identities=20% Similarity=0.343 Sum_probs=187.8
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHh--cCCCceeeeeeeEeec---CcEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVEK---GCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIV~l~~~~~~~---~~~~ 77 (610)
..++++.||+|.||.||+++.. ++.||||++.. .....+..|.+|.+. +.|+||+++++.-... ...+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 4567889999999999999874 58999999863 334567788888775 5799999999864322 2368
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CeecccCCCCceEecCCCCeeeeec
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN---------HILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~---------gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
+||++|.+.|+|.++++.+ .+++...++++..|+.||+|||.. .|+|||||..||||..|+...|+||
T Consensus 284 wLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 8999999999999999986 689999999999999999999974 5999999999999999999999999
Q ss_pred cccccccccc---ccccccCCCcccCCccccCCC-CC-----CCccccccchhHHhhhhcCc------------cccc--
Q 007266 149 GLAKMLISDD---LASSVVGTPSYMCPELLADIP-YG-----SKSDIWSLGCCVYEMSAQKA------------AFKA-- 205 (610)
Q Consensus 149 Glak~~~~~~---~~~~~vGTp~Y~APEvl~~~~-yt-----~ksDIWSLG~iLyeLltG~~------------PF~~-- 205 (610)
|+|..+.... .....+||..|||||++.+.- +. .+.||||+|.+|+||++... ||..
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998875432 344589999999999987643 22 36899999999999987543 2321
Q ss_pred ---cCHHHHHHHHhhcc-CCCCCcc-----cchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 206 ---FDMQALINKINKSI-VAPLPTV-----YSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 206 ---~~~~~l~~~I~~~~-~~~~p~~-----~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
-...++.+.+.... .+.+|.. .-..+++.+..||..|++-|.||.-+-+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 11233333332222 2223333 2446889999999999999999976643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=229.20 Aligned_cols=252 Identities=34% Similarity=0.542 Sum_probs=207.9
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHHHhcCCC-ceeeeeeeEeecCcEEEEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRNP-FIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL~~L~Hp-nIV~l~~~~~~~~~~~~LVm 81 (610)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +++.+.+.+.. ....++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEE
Confidence 789999999999999999987 7889999976665543 567799999999999988 79999998844 44578999
Q ss_pred eecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeeccccccccccc-
Q 007266 82 GYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~-~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~~~~~~- 158 (610)
+|+.|+++.+++..... ..+++..+..++.|++.++.|+|+.+++||||||+||+++..+ .++++|||+++......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977765421 2589999999999999999999999999999999999999988 69999999998654333
Q ss_pred ------ccccccCCCcccCCccccC---CCCCCCccccccchhHHhhhhcCccccccCH----HHHHHHHhhccCC----
Q 007266 159 ------LASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM----QALINKINKSIVA---- 221 (610)
Q Consensus 159 ------~~~~~vGTp~Y~APEvl~~---~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~----~~l~~~I~~~~~~---- 221 (610)
.....+||..|++||++.+ ..+....|+|++|+++++++.|..||..... ......+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 3467899999999999987 5788999999999999999999999887763 4555554444322
Q ss_pred CCCccc----chHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 222 PLPTVY----SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 222 ~~p~~~----s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
...... ...+.+++..++..+|..|.+..+...+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 111111 25789999999999999999999998885543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=243.93 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=198.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCC-eEEEEEEEccccccHHHHHHHHHHHHHHHhcCC----CceeeeeeeEeecCcEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHER-KKYVLKKIRLARQTDRARRSAHQEMELISRVRN----PFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~-~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H----pnIV~l~~~~~~~~~~~ 77 (610)
+|.+.+.||+|+||.||+|.+..++ ..+|+|........... .+..|+.++..+.. .++..+++.....+.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7999999999999999999998775 67888887654332211 47778888888862 57888887764445588
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-----Ceeeeeccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-----DIRLGDFGLAK 152 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-----~vKL~DFGlak 152 (610)
|+||+.+ |.+|.++.+......|+...+..++.|++.+|++||+.|++||||||+|+++.... .+.|+|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 8999999 89999988776667899999999999999999999999999999999999998653 59999999998
Q ss_pred --cccccc--------c-cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHh---hc
Q 007266 153 --MLISDD--------L-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN---KS 218 (610)
Q Consensus 153 --~~~~~~--------~-~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~---~~ 218 (610)
...... . ...+.||..|+++..+.+...+.+.|+||+++++.+|+.|..||.+........+.. ..
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 321111 1 234569999999999999999999999999999999999999997766332222222 11
Q ss_pred cCCC-CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 219 IVAP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 219 ~~~~-~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.... .....+.++..+...+-..+...+|.+..+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111 233456788888888888999999999888765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=227.81 Aligned_cols=160 Identities=24% Similarity=0.335 Sum_probs=131.1
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccccccCC
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT 166 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGT 166 (610)
|+|.+++...+ ..+++..++.|+.||+.||.|||+++ ||+|||++.++.+++ ||+++..... ...||
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 68999998643 36999999999999999999999999 999999999999999 9998765432 23789
Q ss_pred CcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH-HHHHHHHhhccCCC------CCcccch--HHHHHHHH
Q 007266 167 PSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAP------LPTVYSG--AFRGLVKS 237 (610)
Q Consensus 167 p~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~-~~l~~~I~~~~~~~------~p~~~s~--~l~~LI~k 237 (610)
+.|+|||++.+..|+.++|||||||++|||++|..||..... ...+..+....... .+..++. .+.++|.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999999999999999999999999999999976542 22333332222111 2233444 69999999
Q ss_pred hhcCCCCCCCCHHHHhcCCCCC
Q 007266 238 MLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
||..+|.+||++.|++.|+|+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=270.70 Aligned_cols=253 Identities=22% Similarity=0.350 Sum_probs=202.4
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEcc---ccccHHH-HHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRL---ARQTDRA-RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~---~~~~~~~-~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
...+.+|.|++|.|+.+......+.++.|..+. ....... ...+..|+.+-..+.|+|++..+..+++...... +
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~-~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ-S 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh-h
Confidence 346789999999999998888877777776652 2222222 2227778888889999999988877766654443 4
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--- 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--- 157 (610)
||||++ +|+.++.... .+....+..+++||+.||+|||++||.||||||+|++++.+|.+||+|||.+......
T Consensus 400 mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 999999 9999998753 6889999999999999999999999999999999999999999999999998775432
Q ss_pred --cccccccCCCcccCCccccCCCCC-CCccccccchhHHhhhhcCccccccCHHHHH-HHHhh-------ccCCCCCcc
Q 007266 158 --DLASSVVGTPSYMCPELLADIPYG-SKSDIWSLGCCVYEMSAQKAAFKAFDMQALI-NKINK-------SIVAPLPTV 226 (610)
Q Consensus 158 --~~~~~~vGTp~Y~APEvl~~~~yt-~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~-~~I~~-------~~~~~~p~~ 226 (610)
......+|+..|+|||++.+..|. ..+||||.|++++.|++|+.||+.....+.. ..... .....+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 245678999999999999999995 5799999999999999999999765433221 11111 111223344
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
++.+.+.+|.+||+.||.+|.|+++|++.+||+..
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 67889999999999999999999999999999863
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=237.31 Aligned_cols=252 Identities=18% Similarity=0.269 Sum_probs=215.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCC-----eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHER-----KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~-----~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++++..-.+-+|.||.||.+.....+ +.|.+|.+. ..-++.....+.+|.-++..+.|||+..+.+...+....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 35667778889999999999776533 234455553 334455667888999999999999999999999988888
Q ss_pred EEEEEeecCCCCHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKA------NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 150 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~------~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGl 150 (610)
.++++.+..-|+|..++... ....++-.++..++.||..|++|||++||||.||-..|.+|++.-.|||+|=.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 88999999999999999732 224577888999999999999999999999999999999999999999999999
Q ss_pred ccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcc
Q 007266 151 AKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTV 226 (610)
Q Consensus 151 ak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~ 226 (610)
++.+-+.++ ....-....||+||.+....|+.++|+|||||+|+||++ |+.|+...++.++...+..+.....|.+
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~N 522 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFN 522 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCC
Confidence 988755543 223334457999999999999999999999999999875 9999999999999999999988888999
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+++++..++.-||...|++||+.+|+..
T Consensus 523 CPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-27 Score=257.67 Aligned_cols=243 Identities=29% Similarity=0.500 Sum_probs=208.5
Q ss_pred EecccCceEEEEEEEe---CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEEEeec
Q 007266 9 QIGKGSFGSALLVRHK---HERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
.+|+|+||.|++++.. ..+..||+|...+.......+.....|..++..++ ||++|.+...|+.++ ..+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-KLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-chhHhhhhc
Confidence 3799999999998764 35778999988766544443335667888999987 999999998887665 788999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccccccc
Q 007266 85 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVV 164 (610)
Q Consensus 85 ~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~v 164 (610)
.||+|...+.+.. .+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++........ |
T Consensus 80 rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---c 154 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---C 154 (612)
T ss_pred ccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---c
Confidence 9999998887654 6889999999999999999999999999999999999999999999999999987655544 9
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 244 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~ 244 (610)
||..|||||+++ .+..++|+||+|+++++|++|..||.. ++...|.+.. ..+|..++..+++++..|+..+|.
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LEMPRELSAEARSLFRQLFKRNPE 227 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCCchhhhHHHHHHHHHHHhhCHH
Confidence 999999999998 667899999999999999999999998 5555555432 346888999999999999999999
Q ss_pred CCCC-----HHHHhcCCCCCchhhh
Q 007266 245 FRPS-----AAELLCHPHLQPYVLG 264 (610)
Q Consensus 245 ~RpS-----a~eiL~Hp~f~~~~~~ 264 (610)
.|.. +.|+++|+||+...+.
T Consensus 228 nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 228 NRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHhccCcchhHHHhccchheeeeHh
Confidence 9954 5899999999987665
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=238.39 Aligned_cols=182 Identities=19% Similarity=0.188 Sum_probs=139.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeC-CCeEEEEEEEccccc---cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKH-ERKKYVLKKIRLARQ---TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~-~~~~vAIK~i~~~~~---~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
+++|++.+.||+|+||+||+|++.. +++.+|||++..... .......+.+|+++|+++.|+|++..+..+ ..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 4789999999999999999999886 778889998753311 234456799999999999999999644322 24
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccC-CCCceEecCCCCeeeeecccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDV-KCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDL-KPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.|+|||||+|++|.. +.. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||+++.+.
T Consensus 93 ~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred cEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 689999999999963 211 11 1468899999999999999999999 9999999999999999999998654
Q ss_pred ccc---------ccccccCCCcccCCccccCCC------CCCCcccc-ccchhHHh
Q 007266 156 SDD---------LASSVVGTPSYMCPELLADIP------YGSKSDIW-SLGCCVYE 195 (610)
Q Consensus 156 ~~~---------~~~~~vGTp~Y~APEvl~~~~------yt~ksDIW-SLG~iLye 195 (610)
... .....++++.|+|||.+.-.. .+...|-| .-|=+.|.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDlg~~ 219 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKKVYN 219 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCEEEE
Confidence 332 113567899999999986432 22345666 44544443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=217.88 Aligned_cols=245 Identities=18% Similarity=0.250 Sum_probs=199.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
..|++++.||.|+||.+|++.+..+|+.||||+-......+. +..|.++.+.|.+-.-++-+..|..+..+-.+||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpq----L~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQ----LLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcc----hhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 479999999999999999999999999999998875555443 6779999999987655555555555666888999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~DFGlak~~~~~~ 158 (610)
+.+ |.+|.+++.-.. ..|+...+..++.|++.-++|+|.+++|||||||+|+|..-+. .+.|+|||+++.+....
T Consensus 91 dLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred ecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 999 899999987543 3699999999999999999999999999999999999986543 48999999998864322
Q ss_pred --------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH---HHHHHHhhcc----CCCC
Q 007266 159 --------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---ALINKINKSI----VAPL 223 (610)
Q Consensus 159 --------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~---~l~~~I~~~~----~~~~ 223 (610)
......||..|++-..+.+...+...|+-|+|++|.++..|..||++.... .-+++|..-. ...+
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~L 248 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVL 248 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHH
Confidence 234568999999988888888899999999999999999999999887533 3344443322 2224
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHH
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAEL 252 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~ei 252 (610)
...++.+|--.+..|-..--++-|.+.-+
T Consensus 249 C~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 249 CKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred hCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 55688999999999999888888886433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=224.51 Aligned_cols=243 Identities=19% Similarity=0.270 Sum_probs=202.2
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|++.++||.|.||+.|++.+.-+++.||||.-......+ .++.|....+.|. .+.|...+ +|-..+.+-.|||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vY-YFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVY-YFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCcee-eeccccchhhhhh
Confidence 5999999999999999999999999999999876554443 3778888888886 45666554 4555666778999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-----Ceeeeeccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-----DIRLGDFGLAKMLIS 156 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-----~vKL~DFGlak~~~~ 156 (610)
|.+ |.+|.+++.-. +..|+...+..++.|++.-++|+|++.+|+|||||+|+||..-+ .|.|+|||+|+.+..
T Consensus 104 dLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999 89999999864 45799999999999999999999999999999999999998654 389999999998754
Q ss_pred cc--------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC---HHHHHHHHhhccC----C
Q 007266 157 DD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIV----A 221 (610)
Q Consensus 157 ~~--------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---~~~l~~~I~~~~~----~ 221 (610)
.. ...+..||..||+=-.+.+...+...|+-|||-++++++-|.+||.+.. ..+-+++|..... .
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 32 2456789999999999999999999999999999999999999998764 4555666643322 2
Q ss_pred CCCcccchHHHHHHHHhhcCCCCCCCCHHHH
Q 007266 222 PLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 252 (610)
Q Consensus 222 ~~p~~~s~~l~~LI~kmL~~dP~~RpSa~ei 252 (610)
.+...++.+|...+...-..+..+-|.++-+
T Consensus 262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 262 VLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred HHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 2455688899999999999999999988644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-25 Score=251.87 Aligned_cols=221 Identities=30% Similarity=0.528 Sum_probs=176.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|..++.|..|+||.||+++|+.+.+.+|+ ++.+... . +.+ ++....+|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l--i----lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL--I----LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccch--h----hhc---cccccCCccee-----------------
Confidence 5789999999999999999999999999999 4432221 1 111 44455566555
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--- 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--- 158 (610)
|+-...++..+ .++.+. +.+++|||+.||+|||+||+|++|+.-|++|+.|||+.+......
T Consensus 136 -----gDc~tllk~~g--~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG--PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccCC--CCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444455433 444443 789999999999999999999999999999999999987642111
Q ss_pred -------------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc-cCCCC-
Q 007266 159 -------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS-IVAPL- 223 (610)
Q Consensus 159 -------------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~-~~~~~- 223 (610)
....+||||.|+|||++....|+..+|||+||+|+||++.|..||.+...++++..+... ..|+.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 123469999999999999999999999999999999999999999999999988776443 33332
Q ss_pred CcccchHHHHHHHHhhcCCCCCC---CCHHHHhcCCCCCchhhh
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFR---PSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~R---pSa~eiL~Hp~f~~~~~~ 264 (610)
...++.+++++|.++|+.+|..| ..+-++.+|+||+.+.+.
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 34478899999999999999999 578899999999987766
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=204.07 Aligned_cols=171 Identities=16% Similarity=0.224 Sum_probs=133.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHH------HHHHHHHHHhcCCCceeeeeeeEeecC
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRS------AHQEMELISRVRNPFIVEYKDSWVEKG 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~------l~~Ei~iL~~L~HpnIV~l~~~~~~~~ 74 (610)
.+|+++++||.|+||.||++.+ ++..+|+|.++....... .... +.+|+..+.++.|++|....+.+....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4799999999999999999755 466899999975543332 2222 679999999999999999888766432
Q ss_pred -------cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeee
Q 007266 75 -------CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 147 (610)
Q Consensus 75 -------~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~D 147 (610)
...++||||++|.+|.++. .++++ .+.+|+.+|..||.+|++||||||+||+++.+| ++|+|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP------EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh------hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3578999999999998763 23443 456999999999999999999999999999988 99999
Q ss_pred cccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhh
Q 007266 148 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196 (610)
Q Consensus 148 FGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeL 196 (610)
||.......+.... .++....|+.++|+|+|||.+..+
T Consensus 178 fg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 178 LSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHH
Confidence 99886553222111 134455677899999999977755
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=198.15 Aligned_cols=141 Identities=15% Similarity=0.143 Sum_probs=110.0
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHH------------------------HHHHHHHHHHHHhcCCCc
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRA------------------------RRSAHQEMELISRVRNPF 62 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~------------------------~~~l~~Ei~iL~~L~Hpn 62 (610)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+++|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999997 8999999999765321111 123346999999998776
Q ss_pred eeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCeecccCCCCceEecCCC
Q 007266 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL-HANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 63 IV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yL-Hs~gIiHRDLKPeNILL~~~g 141 (610)
+....... ... .+|||||++|+++...+... ..++++.+..++.||+.+|.|| |+.||+||||||+|||++ ++
T Consensus 81 v~~p~~~~-~~~--~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPIL-LKS--HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEEE-ecC--CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 63322211 122 27999999988776554332 2689999999999999999999 799999999999999998 57
Q ss_pred Ceeeeeccccccc
Q 007266 142 DIRLGDFGLAKML 154 (610)
Q Consensus 142 ~vKL~DFGlak~~ 154 (610)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=190.89 Aligned_cols=143 Identities=15% Similarity=0.112 Sum_probs=112.6
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH------------------------HHHHHHHHHHHHHHhcCCC
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD------------------------RARRSAHQEMELISRVRNP 61 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~------------------------~~~~~l~~Ei~iL~~L~Hp 61 (610)
+.+.||+|+||.||+|.+. +|+.||||+++...... .....+.+|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3678999999999999987 89999999998653210 0122346789999999998
Q ss_pred ceeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCC
Q 007266 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRD 140 (610)
Q Consensus 62 nIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~ 140 (610)
++......+... .|+||||++|+++...+.... .++++.+..++.|++.+|.+||+ +||+||||||+|||++ +
T Consensus 80 ~i~~p~~~~~~~---~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 80 GVPVPEPILLKK---NVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCCceEEEecC---CEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence 875433333222 379999999886544322222 57889999999999999999999 9999999999999998 8
Q ss_pred CCeeeeecccccccc
Q 007266 141 QDIRLGDFGLAKMLI 155 (610)
Q Consensus 141 g~vKL~DFGlak~~~ 155 (610)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-21 Score=201.08 Aligned_cols=235 Identities=21% Similarity=0.279 Sum_probs=149.7
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCC---C-------ceeeeeee---
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRN---P-------FIVEYKDS--- 69 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~H---p-------nIV~l~~~--- 69 (610)
+...+.||.|+++.||.|.|..+++.+|+|+........ ...+.+.+|.-....+.+ | .++-.++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 567899999999999999999999999999987655322 245566666644444322 1 11111111
Q ss_pred -----EeecCc--------EEEEEEeecCCCCHHHHHH---HhCCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Q 007266 70 -----WVEKGC--------YVCIIIGYCEGGDMAEAIK---KANGVH--FPEEKLCKWLVQLLMALNYLHANHILHRDVK 131 (610)
Q Consensus 70 -----~~~~~~--------~~~LVmEy~~GgsL~~~Ik---~~~~~~--lse~~i~~i~~QLl~aL~yLHs~gIiHRDLK 131 (610)
++..+. ..+++|.-+ .++|.+++. ...... +.......+..|++..+++||..|++|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 111111 235677777 568877754 222111 1122223444899999999999999999999
Q ss_pred CCceEecCCCCeeeeecccccccccccccccccCCCcccCCccccC--------CCCCCCccccccchhHHhhhhcCccc
Q 007266 132 CSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD--------IPYGSKSDIWSLGCCVYEMSAQKAAF 203 (610)
Q Consensus 132 PeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~--------~~yt~ksDIWSLG~iLyeLltG~~PF 203 (610)
|+|+|++.+|.+.|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||++||.|.||..||
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence 99999999999999999987654433221 345578999997643 35788999999999999999999999
Q ss_pred cccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCC
Q 007266 204 KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 246 (610)
Q Consensus 204 ~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~R 246 (610)
........... ...... .+++.++.||..||+.||++|
T Consensus 251 ~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 251 GLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 85532211111 112233 789999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=189.71 Aligned_cols=187 Identities=19% Similarity=0.145 Sum_probs=140.5
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc--cHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ--TDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~--~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LV 80 (610)
+.+...|++|+||+||++.. .+..++.+.+..... ...+...+.+|+++|++|. |++++.++++ ...|++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lv 76 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLD 76 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEE
Confidence 34678999999999997765 667788776654443 2223446889999999995 4778888774 235899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccC-CCCceEecCCCCeeeeecccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDV-KCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDL-KPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|||+.|.+|.+.+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||++........
T Consensus 77 meyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 77 RSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999999999754321 1 1357889999999999999999999 79999999999999999999986443221
Q ss_pred --------------cccccCCCcccCCccccCC-CCC-CCccccccchhHHhhhhcCcccccc
Q 007266 160 --------------ASSVVGTPSYMCPELLADI-PYG-SKSDIWSLGCCVYEMSAQKAAFKAF 206 (610)
Q Consensus 160 --------------~~~~vGTp~Y~APEvl~~~-~yt-~ksDIWSLG~iLyeLltG~~PF~~~ 206 (610)
..-...++.|+.|+..... ..+ ...++++.|+-+|.|+|+..++-+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0012357788888854332 222 5678999999999999999887543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-21 Score=203.18 Aligned_cols=246 Identities=23% Similarity=0.335 Sum_probs=177.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCe-----------------------------------EEEEEEEcccc---ccH
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERK-----------------------------------KYVLKKIRLAR---QTD 42 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~-----------------------------------~vAIK~i~~~~---~~~ 42 (610)
+|+|+|.+.||+|.-+.||.++-..++. ..|||.+.--. .+.
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 5789999999999999999987765321 23455442111 111
Q ss_pred HHHHHHHHHH--------------HHHHh--------cCCCceeeeeeeEeec--------------------------C
Q 007266 43 RARRSAHQEM--------------ELISR--------VRNPFIVEYKDSWVEK--------------------------G 74 (610)
Q Consensus 43 ~~~~~l~~Ei--------------~iL~~--------L~HpnIV~l~~~~~~~--------------------------~ 74 (610)
...+...+|. ...+. -.|||||.++..|.+. +
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 1223333332 11111 2599999998887632 2
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC--C--Ceeeeeccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD--Q--DIRLGDFGL 150 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~--g--~vKL~DFGl 150 (610)
..+|+||..+ ..+|.+++..+ ..+....+-++.|+++|+.|||.+||.|||+|.+||||.-+ + .+.|+|||+
T Consensus 316 ~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 316 KTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred ceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 3588999887 46999999765 56888889999999999999999999999999999998543 3 378899997
Q ss_pred ccccccc----cc---cccccCCCcccCCccccCCCC------CCCccccccchhHHhhhhcCccccccCHHHHH-HHHh
Q 007266 151 AKMLISD----DL---ASSVVGTPSYMCPELLADIPY------GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALI-NKIN 216 (610)
Q Consensus 151 ak~~~~~----~~---~~~~vGTp~Y~APEvl~~~~y------t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~-~~I~ 216 (610)
|-.-..- .+ ....-|.-..||||+....+- -.++|.|+.|.+.||+++...||.......+- ....
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 7432111 11 122357778999999865431 25899999999999999999999874432221 1133
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHH
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 250 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~ 250 (610)
+...+.+|..+++.+++|+..+|+.||.+|+++.
T Consensus 472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 4556778999999999999999999999998853
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-22 Score=226.33 Aligned_cols=235 Identities=22% Similarity=0.302 Sum_probs=175.7
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc--HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT--DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~--~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+|...+.||.+.|=+|.++++..+ .|+||++-+.... -....+...|++ ...+++||.+++... ...+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHH
Confidence 477889999999999999998654 4888988543321 112222333444 455689999998775 3445577899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc--cccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML--ISDD 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~--~~~~ 158 (610)
-+|+ ..+|++.|..+. -+..-+.+.|+.||+.||..+|..||+|+|||.+||||+.-..+.|+||..-+.. ..++
T Consensus 100 Rqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 100 RQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9999 569999998765 4677788899999999999999999999999999999999999999999976552 1221
Q ss_pred ------ccccccCCCcccCCccccC----------CC-CCCCccccccchhHHhhhh-cCcccccc-----------CHH
Q 007266 159 ------LASSVVGTPSYMCPELLAD----------IP-YGSKSDIWSLGCCVYEMSA-QKAAFKAF-----------DMQ 209 (610)
Q Consensus 159 ------~~~~~vGTp~Y~APEvl~~----------~~-yt~ksDIWSLG~iLyeLlt-G~~PF~~~-----------~~~ 209 (610)
+..+-..-.+|+|||.+.. .+ .+.+.||||+||+++||++ |.++|.-. +.+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE 256 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence 1122223347999997643 12 5678999999999999976 68888532 122
Q ss_pred HHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 210 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 210 ~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.++++| -+..+++||..|++.||.+|.+|++.|+.
T Consensus 257 ~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 257 QLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 222222 23478999999999999999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.1e-20 Score=181.79 Aligned_cols=137 Identities=18% Similarity=0.209 Sum_probs=108.1
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-----CCCceeeeeeeEeecC--cE-
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-----RNPFIVEYKDSWVEKG--CY- 76 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-----~HpnIV~l~~~~~~~~--~~- 76 (610)
.-.+.||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ .||||+++++++..+. .+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3467899999999995 7766666 58988754322 345689999999999 5799999999887763 24
Q ss_pred EEEEEee--cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH-HHHHHCCeecccCCCCceEecCC----CCeeeeecc
Q 007266 77 VCIIIGY--CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL-NYLHANHILHRDVKCSNIFLTRD----QDIRLGDFG 149 (610)
Q Consensus 77 ~~LVmEy--~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL-~yLHs~gIiHRDLKPeNILL~~~----g~vKL~DFG 149 (610)
+.+|||| +.+++|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4478999 5579999999763 36666 36688888887 99999999999999999999753 369999955
Q ss_pred cc
Q 007266 150 LA 151 (610)
Q Consensus 150 la 151 (610)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=211.06 Aligned_cols=231 Identities=22% Similarity=0.308 Sum_probs=169.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC---CCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR---NPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~~~ 78 (610)
+.|.|-+.||+|+||+||+|.+.+ |+.||+|+-.....-+--+ =.+++.+|+ -+.|..+..+++-.+ ..+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~-~S~ 770 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQN-ASV 770 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCC-cce
Confidence 579999999999999999999987 9999999887655332211 122333333 233444444333333 356
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-------CCeeeeecccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-------QDIRLGDFGLA 151 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-------g~vKL~DFGla 151 (610)
+|+||.+-|+|.+++.. ...++|..+..|+.||+..+++||.+||||+||||+|+||... --++|+|||.+
T Consensus 771 lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 89999999999999984 3478999999999999999999999999999999999999643 23999999988
Q ss_pred ccc---ccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc---
Q 007266 152 KML---ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT--- 225 (610)
Q Consensus 152 k~~---~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~--- 225 (610)
..+ .........++|-.+-++|+..|.++++.+|.|.|..++|-|+.|+. ++ ...+..+....
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y----------~q-~~~g~~~~~~~~~~ 917 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY----------ME-VKNGSSWMVKTNFP 917 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH----------HH-hcCCcceeccccch
Confidence 654 22335667889999999999999999999999999999999999974 22 22222232222
Q ss_pred -ccchH-HHHHHHHhhcCCCCCCCCHHHH
Q 007266 226 -VYSGA-FRGLVKSMLRKNPEFRPSAAEL 252 (610)
Q Consensus 226 -~~s~~-l~~LI~kmL~~dP~~RpSa~ei 252 (610)
.+..+ +-.|+..||..|-..=|...+|
T Consensus 918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 918 RYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred hhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 23222 3467888888333222444444
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-20 Score=204.58 Aligned_cols=177 Identities=30% Similarity=0.481 Sum_probs=140.1
Q ss_pred EEEEEEeecCCCCHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKK-ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~-~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
++||.|++|...+|.++|.. ..+...+...+..|+.|+..|++| +|.+|||+||.||++..++.+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 68999999999999999973 333456788999999999999999 99999999999999999999999999998776
Q ss_pred cccc-------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcc
Q 007266 155 ISDD-------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTV 226 (610)
Q Consensus 155 ~~~~-------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~ 226 (610)
.... .....+||.+||+||++.+..|+.++|||+||+||+||+. =...|. ....+..+..+..++....
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHHhh
Confidence 5444 3456799999999999999999999999999999999987 222222 2223333333333322111
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
-.+.-.+|+.+||...|.+||++.+.-.|.|+
T Consensus 484 d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 484 DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 12344589999999999999988877777765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-19 Score=180.98 Aligned_cols=145 Identities=16% Similarity=0.144 Sum_probs=112.5
Q ss_pred eEEEeEecccCceEEEEEE-EeCCCeEEEEEEEcccccc----------------------HHHHHHHHHHHHHHHhcCC
Q 007266 4 YEVLEQIGKGSFGSALLVR-HKHERKKYVLKKIRLARQT----------------------DRARRSAHQEMELISRVRN 60 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~-d~~~~~~vAIK~i~~~~~~----------------------~~~~~~l~~Ei~iL~~L~H 60 (610)
|++.+.||+|+||.||+|. +..+|+.||+|.++..... ......+.+|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7789999999999999999 6678999999999754311 0112346789999999975
Q ss_pred CceeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCCCCceEecC
Q 007266 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTR 139 (610)
Q Consensus 61 pnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g-IiHRDLKPeNILL~~ 139 (610)
. ++.+...+... ..++||||+.|.+|........ .+.+..+..++.||+.+|.+||.+| |+||||||+||+++
T Consensus 110 ~-~i~~p~~~~~~--~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 110 A-GVPVPKPIAWR--RNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred c-CCCCCeeeEec--CceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 3 22222222222 2479999999988876553322 4667778899999999999999999 99999999999999
Q ss_pred CCCeeeeeccccccc
Q 007266 140 DQDIRLGDFGLAKML 154 (610)
Q Consensus 140 ~g~vKL~DFGlak~~ 154 (610)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.4e-18 Score=166.12 Aligned_cols=137 Identities=24% Similarity=0.284 Sum_probs=111.4
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEcccccc------HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT------DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~------~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++.||+|++|.||++.+ .+..+++|+....... ......+.+|+.++..+.|++++.....+... ...++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv 77 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-ENFIIV 77 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-CCCEEE
Confidence 36799999999999987 6678999976543221 11234578899999999998877655554444 356799
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
|||++|++|.+++.... . ....++.+|+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999987532 2 7889999999999999999999999999999999 78899999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-20 Score=209.00 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=208.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-ERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~L 79 (610)
..|.+.+.||+|+|+.|-++.+.. ....+|.|.+...............|..+-+.+. |.|++.+++...... ..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-SYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-cccc
Confidence 468999999999999999998865 4456777777655544445555667888888887 999999999876554 7789
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCCCCceEecCCC-Ceeeeeccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH-ANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLIS- 156 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLH-s~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~~~~- 156 (610)
+++|..|+++.+-+........+......++.|+..+|.|+| ..++.||||||+|.+++..+ .+++.|||+|..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999999884323325778888999999999999999 99999999999999999999 999999999988755
Q ss_pred cc---ccccccC-CCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHH--HHHhh--ccCCCCCccc
Q 007266 157 DD---LASSVVG-TPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALI--NKINK--SIVAPLPTVY 227 (610)
Q Consensus 157 ~~---~~~~~vG-Tp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~--~~I~~--~~~~~~p~~~ 227 (610)
.. .....+| ++.|+|||...+..| ....|+||+|+++..|++|..||......... ..+.. ......+..+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 22 3345688 999999999988654 77899999999999999999998755433211 11111 1134456678
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+....+++.++|..+|..|.+.+++-.++|+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 889999999999999999999999999999976
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-18 Score=166.37 Aligned_cols=138 Identities=20% Similarity=0.180 Sum_probs=108.9
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH--------------------HHHHHHHHHHHHHHhcCCCc-
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD--------------------RARRSAHQEMELISRVRNPF- 62 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~--------------------~~~~~l~~Ei~iL~~L~Hpn- 62 (610)
|.+.+.||.|+||.||++.+. +|+.||||.++...... .....+.+|+.++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999875 78999999876543110 11223678899999997764
Q ss_pred -eeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 63 -IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 63 -IV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
++..++ .+..++||||++|++|.++... .....++.+|+.++.++|..||+||||||+||+|+.++
T Consensus 96 ~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPID-----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceee-----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 333332 1245899999999998765321 34567889999999999999999999999999999999
Q ss_pred Ceeeeecccccccc
Q 007266 142 DIRLGDFGLAKMLI 155 (610)
Q Consensus 142 ~vKL~DFGlak~~~ 155 (610)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=159.94 Aligned_cols=132 Identities=27% Similarity=0.293 Sum_probs=103.6
Q ss_pred EecccCceEEEEEEEeCCCeEEEEEEEccccc-c-----HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-T-----DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~-----~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
.||+|+||.||++.. .+..+++|....... . ......+.+|++++..+.|+++......+... ...++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-DNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-CCCEEEEE
Confidence 389999999999984 567899998653221 1 11235678899999999887654333333333 35679999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
|++|++|.+++.... . .++.||+.+|.+||+.|++|+|++|.||+++ ++.++|+|||++..
T Consensus 78 ~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998876532 0 7899999999999999999999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-18 Score=173.36 Aligned_cols=242 Identities=17% Similarity=0.285 Sum_probs=195.7
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+..++-+|.....|..|+++.+.+ -++.|++..........+.|..|.-.|+-+.||||+++++.+.... .+.++..
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-nlv~isq 267 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-NLVIISQ 267 (448)
T ss_pred hhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-CceEeee
Confidence 344566788888999999988643 5667888776666666778999999999999999999999987764 6779999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEecCCCCeee--eeccccccccccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRL--GDFGLAKMLISDD 158 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~~~g~vKL--~DFGlak~~~~~~ 158 (610)
|+..|+|+..+....+...+..++.+|+..|+.|+.|||+.. |----|....|+|+.+-..+| +|--++-.
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 999999999999877777889999999999999999999973 334468899999998877665 44332211
Q ss_pred ccccccCCCcccCCccccCCCC---CCCccccccchhHHhhhhcCccccccCHHHHHHHH-hhccCCCCCcccchHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPY---GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGL 234 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~y---t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I-~~~~~~~~p~~~s~~l~~L 234 (610)
.....-.|.||+||.+...+- -.++|+|||.++|+||.|...||......+.--+| ..++...+|..++.....|
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 112234688999999876653 35899999999999999999999988876665555 4556677899999999999
Q ss_pred HHHhhcCCCCCCCCHHHHh
Q 007266 235 VKSMLRKNPEFRPSAAELL 253 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL 253 (610)
++-|+..||.+||..+.++
T Consensus 422 m~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHhcCCCCcCCCcceeh
Confidence 9999999999999887664
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.3e-17 Score=181.81 Aligned_cols=137 Identities=22% Similarity=0.198 Sum_probs=107.3
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccc-cc-----cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA-RQ-----TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~-~~-----~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
|...+.||+|+||.||++..... .+++|+.... .. .....+.+.+|++++..+.|++++.....+... ...
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~ 411 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-EEK 411 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-CCC
Confidence 45678999999999999887543 3444432211 11 112235688999999999999988766555543 356
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
++||||++|++|.+++. ....++.||+.+|.|||++|++||||||+|||+ .++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 79999999999998886 246789999999999999999999999999999 6788999999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=154.42 Aligned_cols=137 Identities=18% Similarity=0.227 Sum_probs=99.6
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHH----------------------HHHHHHHHHhcCCCc--
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS----------------------AHQEMELISRVRNPF-- 62 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~----------------------l~~Ei~iL~~L~Hpn-- 62 (610)
.+.||+|+||.||++.+. +++.||||.++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999987 7889999998754332211111 135666676665433
Q ss_pred eeeeeeeEeecCcEEEEEEeecCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCC
Q 007266 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAE-AIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRD 140 (610)
Q Consensus 63 IV~l~~~~~~~~~~~~LVmEy~~GgsL~~-~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~ 140 (610)
+.+.+.. ...++||||+.|+.+.. .+.... . ...++.++.+++.++.++|. +||+||||||+||+++ +
T Consensus 81 ~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 81 VPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCceEec-----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 3333322 13589999999854432 122211 1 16778999999999999999 9999999999999999 8
Q ss_pred CCeeeeeccccccc
Q 007266 141 QDIRLGDFGLAKML 154 (610)
Q Consensus 141 g~vKL~DFGlak~~ 154 (610)
+.++|+|||.+...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 89999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.8e-16 Score=156.41 Aligned_cols=137 Identities=22% Similarity=0.316 Sum_probs=105.2
Q ss_pred eEec-ccCceEEEEEEEeCCCeEEEEEEEccccc-----------cHHHHHHHHHHHHHHHhcCCCce--eeeeeeEeec
Q 007266 8 EQIG-KGSFGSALLVRHKHERKKYVLKKIRLARQ-----------TDRARRSAHQEMELISRVRNPFI--VEYKDSWVEK 73 (610)
Q Consensus 8 k~LG-~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-----------~~~~~~~l~~Ei~iL~~L~HpnI--V~l~~~~~~~ 73 (610)
..|| .||.|+||.+... +..+|||.+..... .......+.+|+.++..|.|+++ +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4687 8999999999774 67889998753211 11233567889999999988774 5555543333
Q ss_pred CcE---EEEEEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecc
Q 007266 74 GCY---VCIIIGYCEG-GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 149 (610)
Q Consensus 74 ~~~---~~LVmEy~~G-gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFG 149 (610)
... .++||||++| .+|.+++... .++++. +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 322 3599999997 6999888652 456553 5789999999999999999999999999999999999999
Q ss_pred cccc
Q 007266 150 LAKM 153 (610)
Q Consensus 150 lak~ 153 (610)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.2e-16 Score=140.56 Aligned_cols=132 Identities=19% Similarity=0.228 Sum_probs=108.9
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC--CceeeeeeeEeecCcEEEEEEee
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN--PFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H--pnIV~l~~~~~~~~~~~~LVmEy 83 (610)
+++.||.|.++.||++.... ..+++|....... ...+.+|+.+++.+.+ .++++++..+... +..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEe
Confidence 56889999999999999854 6889998865433 3457889999999976 4788877755443 578899999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCCCceEecCCCCeeeeecccccc
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN---HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~---gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
+.|+.+..+ +......++.+++.+|.+||.. +++|+||+|+||+++..+.++++|||++..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998877643 4566678899999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.6e-16 Score=179.85 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=207.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
++.+.+.+.+-.|+++.++.+.-..++...++|.......... ..+.+.++-.++-...+|.++.....+. .....++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCCCcch
Confidence 3678888999999999999998888887777776554332221 1233334444444455677776655533 3346789
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc---
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS--- 156 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~--- 156 (610)
+++|+.|++|...+...+ ..+++..+.++..++.+++|||...+.|||++|.|+|+..+|+.++.|||......-
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999999988765 578899999999999999999999999999999999999999999999984322100
Q ss_pred ------------------c-----------cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC
Q 007266 157 ------------------D-----------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 207 (610)
Q Consensus 157 ------------------~-----------~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~ 207 (610)
. ......+||+.|.+||.+.+...+..+|+|++|++++|.++|.+||+...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 01224589999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhccC-CC-CCcccchHHHHHHHHhhcCCCCCCCCHH---HHhcCCCCCchhhhh
Q 007266 208 MQALINKINKSIV-AP-LPTVYSGAFRGLVKSMLRKNPEFRPSAA---ELLCHPHLQPYVLGI 265 (610)
Q Consensus 208 ~~~l~~~I~~~~~-~~-~p~~~s~~l~~LI~kmL~~dP~~RpSa~---eiL~Hp~f~~~~~~~ 265 (610)
.+..++.|..... |+ .+...+.++++++..+|..+|.+|..+. ++-.|+||++..|..
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 9888887755432 22 3556899999999999999999998776 999999999876553
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-15 Score=167.65 Aligned_cols=198 Identities=22% Similarity=0.358 Sum_probs=155.8
Q ss_pred HHhcCCCceeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCe-ecccCCCC
Q 007266 55 ISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI-LHRDVKCS 133 (610)
Q Consensus 55 L~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gI-iHRDLKPe 133 (610)
|+.+.|.|+.++++..++. ...++|.+||..|+|.+.+.. ....+++--...+++.|+.||.|||.-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4578899999999998877 578899999999999999987 34568888889999999999999998855 99999999
Q ss_pred ceEecCCCCeeeeecccccccccc---cccccccCCCcccCCccccCCC-------CCCCccccccchhHHhhhhcCccc
Q 007266 134 NIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADIP-------YGSKSDIWSLGCCVYEMSAQKAAF 203 (610)
Q Consensus 134 NILL~~~g~vKL~DFGlak~~~~~---~~~~~~vGTp~Y~APEvl~~~~-------yt~ksDIWSLG~iLyeLltG~~PF 203 (610)
|.+++....+||.|||+....... .......-..-|.|||++.+.. .+.+.||||+|+++||+++..-||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765321 1111112334589999987642 356799999999999999999999
Q ss_pred ccc----CHHHHHHHHhh-ccCCCCCc-----ccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 204 KAF----DMQALINKINK-SIVAPLPT-----VYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 204 ~~~----~~~~l~~~I~~-~~~~~~p~-----~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
... +..+++.++.+ ......|. ...+++..+++.|+..+|..||+++++-.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 753 23455555555 22222222 23457889999999999999999988854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-15 Score=167.68 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=192.5
Q ss_pred CeEEEeEecc--cCceEEEEEEE--eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEE
Q 007266 3 QYEVLEQIGK--GSFGSALLVRH--KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~--G~fG~Vyla~d--~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~ 77 (610)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-............-.+|+...++++ |+|.+.....|... ...
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~-~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS-GIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC-Ccc
Confidence 4567788999 99999999999 778999999985444433332333446777767775 88999977766554 478
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH----HHHHHHHCCeecccCCCCceEecCC-CCeeeeeccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM----ALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAK 152 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~----aL~yLHs~gIiHRDLKPeNILL~~~-g~vKL~DFGlak 152 (610)
|+-+|+| |.+|..+..... ..+++..++..+.+... ||.++|+.+++|-|+||+||++..+ ...+++|||+..
T Consensus 194 fiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 8999999 578888776533 35889999999999999 9999999999999999999999999 789999999998
Q ss_pred ccccccccccc------cCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc-cCCCCCc
Q 007266 153 MLISDDLASSV------VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS-IVAPLPT 225 (610)
Q Consensus 153 ~~~~~~~~~~~------vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~-~~~~~p~ 225 (610)
.+....+.... -|..-|++||+..+ -++...|||+||.++.+-.+|...+....... +..+... +...+..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-ccccccccCchhhhc
Confidence 87766543322 46778999998766 45789999999999999988876654331100 1111111 1122333
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
..+..+...+..|++.+|..|++++.+++|+++..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 45667778999999999999999999999999874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.4e-13 Score=148.63 Aligned_cols=144 Identities=17% Similarity=0.197 Sum_probs=99.6
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccccHH--------------------------------HHH------HHH
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR--------------------------------ARR------SAH 49 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~--------------------------------~~~------~l~ 49 (610)
+.||.|++|.||+|+.. +|+.||||+.++...... ... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999875 689999999875421110 001 133
Q ss_pred HHHHHHHhc----CCCceeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 007266 50 QEMELISRV----RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM-ALNYLHANH 124 (610)
Q Consensus 50 ~Ei~iL~~L----~HpnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~-aL~yLHs~g 124 (610)
+|+..+.++ .|.+.|.+-..|.+-....++||||++|++|.++...... .+. ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 455444444 2333344433443323346899999999999887654211 122 3345566655 478899999
Q ss_pred eecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 125 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 125 IiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
++|+|+||.||+++.+|.++|+|||++..+..
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999977643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.6e-13 Score=152.20 Aligned_cols=148 Identities=16% Similarity=0.319 Sum_probs=100.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc--------------------------------HHHHHHHH
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT--------------------------------DRARRSAH 49 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~--------------------------------~~~~~~l~ 49 (610)
..|+. +.||.|++|.||+|+.+.+|+.||||++++.... ++..+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 7899999999999999888999999999854211 01222333
Q ss_pred HHHHHH------Hhc----CCCceeeeeeeEeecCcEEEEEEeecCCCCHHHH--HHHhCC--CCCCHHHHHHHHHHHHH
Q 007266 50 QEMELI------SRV----RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA--IKKANG--VHFPEEKLCKWLVQLLM 115 (610)
Q Consensus 50 ~Ei~iL------~~L----~HpnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~--Ik~~~~--~~lse~~i~~i~~QLl~ 115 (610)
+|+.++ .++ .+.+.+.+-..|.+-....+|||||++|+.+.++ +...+. ..+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 444333 333 2333344334333323345799999999999874 333210 1244555555666654
Q ss_pred HHHHHHHCCeecccCCCCceEecCCC----Ceeeeecccccccccc
Q 007266 116 ALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKMLISD 157 (610)
Q Consensus 116 aL~yLHs~gIiHRDLKPeNILL~~~g----~vKL~DFGlak~~~~~ 157 (610)
..|++|+|+||.||+++.+| .++++|||++..+...
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 58999999999999999988 8999999999876443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-13 Score=150.80 Aligned_cols=248 Identities=26% Similarity=0.302 Sum_probs=186.0
Q ss_pred CCeEEEeEecccCceEEEEEEEe-CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~L 79 (610)
-+|..+..||.|.|+.|+.+... .++..|++|..............-..|+-+...+ -|.+++.+...|.... ..|+
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-~~~i 343 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-QGYI 343 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-cccC
Confidence 36788999999999999998755 5788899997765554444333445666666665 4889999988888765 5568
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-CCeeeeeccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-g~vKL~DFGlak~~~~~~ 158 (610)
=-|||+++++...+.-. ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+...+...
T Consensus 344 p~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred chhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 99999999887666332 268899999999999999999999999999999999999886 78899999988642211
Q ss_pred ccccccCCCccc--CCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHH
Q 007266 159 LASSVVGTPSYM--CPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 159 ~~~~~vGTp~Y~--APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~ 236 (610)
.....+.-++. +++.+....+..+.|+++||.-+++.++|.+.-.... ....|..+.....+. ...++..+.+
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~~~-~~~~~q~~~k 495 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNLPG-LKLQLQVLLK 495 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecccccCCCc-hHHhhhhhhh
Confidence 11222333344 5666677788999999999999999999876433221 122233333333333 3488999999
Q ss_pred HhhcCCCCCCCCHHHHhcCCCC
Q 007266 237 SMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
.|+..++..|+.+.++..|.-|
T Consensus 496 v~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 496 VMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhcCCccccchhhhhhcccchh
Confidence 9999999999999999888655
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3e-13 Score=139.72 Aligned_cols=202 Identities=25% Similarity=0.428 Sum_probs=145.9
Q ss_pred HHhcCCCceeeeeeeEeecC----cEEEEEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC--Cee
Q 007266 55 ISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHAN--HIL 126 (610)
Q Consensus 55 L~~L~HpnIV~l~~~~~~~~----~~~~LVmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs~--gIi 126 (610)
|-++.|.|||+++.+|.+.. ....+++||+..|+|.+++++ .....+.....++|+.||+.||.|||+. -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44567899999999886543 357799999999999999975 2345688999999999999999999998 699
Q ss_pred cccCCCCceEecCCCCeeeeecccccc-----cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCc
Q 007266 127 HRDVKCSNIFLTRDQDIRLGDFGLAKM-----LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 201 (610)
Q Consensus 127 HRDLKPeNILL~~~g~vKL~DFGlak~-----~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~ 201 (610)
|+++.+.-|++..+|-||+.---.... ...........+-++|.+||.=.....+.++|||++|++..+|..|..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 999999999999888888742111000 000111223456789999998777778889999999999999988765
Q ss_pred cccc-cCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 202 AFKA-FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 202 PF~~-~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
--.. ......-..|..... ..-.+.-+++|.+||+-.|..||++.++|.||.+=.
T Consensus 281 q~tnseS~~~~ee~ia~~i~----~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIANVII----GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ccCCCcceeehhhhhhhhee----eccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 3211 111111111111110 011233468999999999999999999999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1e-12 Score=124.24 Aligned_cols=129 Identities=19% Similarity=0.169 Sum_probs=95.7
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
++.|+.|.++.||++... +..|++|........ ...+.+|+.+++.+.+.++++.+-.+... ..++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCC
Confidence 578999999999999864 778999987543321 12356789999888665555433323222 24699999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCe-----ecccCCCCceEecCCCCeeeeecccccc
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI-----LHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gI-----iHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
.++... . .....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 76 ~~l~~~--~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 887643 0 1123457899999999999985 9999999999998 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=8e-12 Score=123.47 Aligned_cols=139 Identities=14% Similarity=0.167 Sum_probs=100.1
Q ss_pred EeEecccCceEEEEEEEeC------CCeEEEEEEEcccccc--------------------HHHHHHHH----HHHHHHH
Q 007266 7 LEQIGKGSFGSALLVRHKH------ERKKYVLKKIRLARQT--------------------DRARRSAH----QEMELIS 56 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~------~~~~vAIK~i~~~~~~--------------------~~~~~~l~----~Ei~iL~ 56 (610)
...||.|--+.||.+.... .+..+|||+.+..... ......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998654 3578999988642210 01122333 8999998
Q ss_pred hcCC--CceeeeeeeEeecCcEEEEEEeecCCCCHH-HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCeecccCCC
Q 007266 57 RVRN--PFIVEYKDSWVEKGCYVCIIIGYCEGGDMA-EAIKKANGVHFPEEKLCKWLVQLLMALNYL-HANHILHRDVKC 132 (610)
Q Consensus 57 ~L~H--pnIV~l~~~~~~~~~~~~LVmEy~~GgsL~-~~Ik~~~~~~lse~~i~~i~~QLl~aL~yL-Hs~gIiHRDLKP 132 (610)
++.. -++...++. . .-+|||||+.|..+. ..++.. .++++.+..++.|++.+|..| |..||||+||++
T Consensus 82 rl~~~Gv~vP~pi~~--~---~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL--K---KHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe--c---CCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 8853 344444432 2 236899999765443 223332 456677888899999999999 899999999999
Q ss_pred CceEecCCCCeeeeeccccccc
Q 007266 133 SNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 133 eNILL~~~g~vKL~DFGlak~~ 154 (610)
.|||+. ++.+.|+|||.+...
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeC
Confidence 999997 578999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.4e-11 Score=134.50 Aligned_cols=180 Identities=21% Similarity=0.304 Sum_probs=135.2
Q ss_pred eEecccCceEEE-EEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCC
Q 007266 8 EQIGKGSFGSAL-LVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 8 k~LG~G~fG~Vy-la~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
...+-++.+ +| .+..+.++.+|.|........ .....+.+-++.|+.++||||+.|++.+...+ .+|||+|-+.
T Consensus 18 e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV~- 92 (690)
T KOG1243|consen 18 EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERVR- 92 (690)
T ss_pred ccccCCCcc-cccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeeccc-
Confidence 333344444 33 355667788888888765444 44456778889999999999999999987766 7899999994
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCCCCceEecCCCCeeeeeccccccccccc-cccccc
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH-ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVV 164 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLH-s~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~~~v 164 (610)
.|..++++. ....+..-++||+.||.+|| +.+++|++|.-..|+++..|+.||++|-++....... ......
T Consensus 93 -Pl~~~lk~l-----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~ 166 (690)
T KOG1243|consen 93 -PLETVLKEL-----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLY 166 (690)
T ss_pred -cHHHHHHHh-----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccch
Confidence 788888874 37888999999999999997 5699999999999999999999999999876532221 112222
Q ss_pred CCCcccCCccccCCCCCCCccccccchhHHhhhhcC
Q 007266 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQK 200 (610)
Q Consensus 165 GTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~ 200 (610)
---.|..|+.+.... -..|.|-|||++++++.|.
T Consensus 167 ~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 167 LIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 222456666543322 4579999999999999983
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.3e-10 Score=110.89 Aligned_cols=145 Identities=23% Similarity=0.275 Sum_probs=105.1
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEcccc------ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR------QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~------~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
.+..|-+|+-+.|+++.. .|+.++||.-.... +..-......+|+++|.++.--.|.--.-+|.+. ..-.|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-YGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-CCCeE
Confidence 578899999999998876 57777777432211 1223456788999999987532222111112222 23468
Q ss_pred EEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC---eeeeecccccc
Q 007266 80 IIGYCEG-GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKM 153 (610)
Q Consensus 80 VmEy~~G-gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~---vKL~DFGlak~ 153 (610)
+|||++| .++.+++..........+....++..|-..|.-||.++|||+||..+||+|..+|. +.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999987 47888887654444455555899999999999999999999999999999988764 58999999854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.7e-10 Score=113.15 Aligned_cols=142 Identities=13% Similarity=0.188 Sum_probs=103.6
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC--ceeeeeeeEeecC--cEEEEEEe
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP--FIVEYKDSWVEKG--CYVCIIIG 82 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIV~l~~~~~~~~--~~~~LVmE 82 (610)
++.||.|.++.||++...+ |..+++|........ .....+.+|+++++.+.+. ++.+++......+ ...++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 4678999999999998743 578999987654331 1234578899999998753 3455555433221 25679999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA---------------------------------------- 122 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs---------------------------------------- 122 (610)
|++|.++.+.+.. ..++++....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999988765432 146677777777788877777773
Q ss_pred ----------------CCeecccCCCCceEecC--CCCeeeeecccccc
Q 007266 123 ----------------NHILHRDVKCSNIFLTR--DQDIRLGDFGLAKM 153 (610)
Q Consensus 123 ----------------~gIiHRDLKPeNILL~~--~g~vKL~DFGlak~ 153 (610)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-09 Score=105.18 Aligned_cols=131 Identities=24% Similarity=0.310 Sum_probs=92.8
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEc-cccccHH-----HHHHHHHHHHHHHhcCCC--ceeeeeeeEeecCcEEEE
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIR-LARQTDR-----ARRSAHQEMELISRVRNP--FIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~-~~~~~~~-----~~~~l~~Ei~iL~~L~Hp--nIV~l~~~~~~~~~~~~L 79 (610)
..+++|+-+.+|.+... |..+++|.=- +....+. ......+|+.+|.++.-- +...+++ ++.+ ...|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD~~-~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VDPD-NGLI 76 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--EcCC-CCEE
Confidence 46889999999999553 3345555332 2222222 235567899999887532 2222333 3333 4469
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
+|||++|..|.+.+... ...++..+-.-+.-||.+||+|+||.++||++..++ +.++|||++..
T Consensus 77 ~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999888764 145677777888889999999999999999997554 99999999875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-10 Score=128.57 Aligned_cols=148 Identities=19% Similarity=0.296 Sum_probs=115.3
Q ss_pred HHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeecccccccccc-c---------ccccccCCCcccCCccccCCCCC
Q 007266 113 LLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-D---------LASSVVGTPSYMCPELLADIPYG 181 (610)
Q Consensus 113 Ll~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~---------~~~~~vGTp~Y~APEvl~~~~yt 181 (610)
.+.||.|+|.. ++||+.|.|++|.++..|..||+.|+++...... + +.....-...|.|||++.....+
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~ 187 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNT 187 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccc
Confidence 34899999976 9999999999999999999999999987654331 1 11122445679999999998889
Q ss_pred CCccccccchhHHhhh-hcCccccccCHHHHHHHHhh---ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 007266 182 SKSDIWSLGCCVYEMS-AQKAAFKAFDMQALINKINK---SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 257 (610)
Q Consensus 182 ~ksDIWSLG~iLyeLl-tG~~PF~~~~~~~l~~~I~~---~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~ 257 (610)
.++|+||+||++|-+. .|+..+.+......+..-.. .........++.++++-|.++|..++..||++.+++.-||
T Consensus 188 ~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~f 267 (700)
T KOG2137|consen 188 PASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPF 267 (700)
T ss_pred ccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccc
Confidence 9999999999999999 67766665543222222211 1122234668899999999999999999999999999999
Q ss_pred CCc
Q 007266 258 LQP 260 (610)
Q Consensus 258 f~~ 260 (610)
|++
T Consensus 268 f~D 270 (700)
T KOG2137|consen 268 FSD 270 (700)
T ss_pred cCC
Confidence 986
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.4e-09 Score=116.92 Aligned_cols=214 Identities=18% Similarity=0.287 Sum_probs=155.7
Q ss_pred ceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee---cCcEEEEEEeecCC-CCHH
Q 007266 15 FGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---KGCYVCIIIGYCEG-GDMA 90 (610)
Q Consensus 15 fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~---~~~~~~LVmEy~~G-gsL~ 90 (610)
-.+.|++....+|..|++|.+...+.... .....-+++++++.|.|+|++.++|.. .+..+++|++|..+ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 45789999999999999999943322211 122345788999999999999998873 34578899999875 5777
Q ss_pred HHHHH-------------hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 91 EAIKK-------------ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 91 ~~Ik~-------------~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++.-. ..+...+|+.+|.|+.||..||.+||+.|+.-+-|.|.+||++.+..|+|..-|+...+..+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 76521 12456789999999999999999999999999999999999998877888766655554433
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcc-cc-ccCHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA-FK-AFDMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~P-F~-~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
. + |.+.+ -.+-|.=.||.+++.|.+|..- +. ...+..-+..| -..++.+++++|
T Consensus 447 ~------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I--------~~~yS~D~rn~v 502 (655)
T KOG3741|consen 447 P------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI--------TTTYSTDLRNVV 502 (655)
T ss_pred C------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh--------hhhhhHHHHHHH
Confidence 2 0 11111 2467888999999999999643 11 11222213332 345788999999
Q ss_pred HHhhcCCCCCCCCHHHHhcC
Q 007266 236 KSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~H 255 (610)
..+...++++ -+..+++.|
T Consensus 503 ~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhcCccc-ccHHHHHHH
Confidence 9999999987 677777765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.2e-08 Score=105.82 Aligned_cols=135 Identities=17% Similarity=0.096 Sum_probs=92.6
Q ss_pred EEEEEEEeCCCeEEEEEEEccccccHHHH---------HHHHHHHHHHHhcC-----CCceeeeeeeEeec-CcEEEEEE
Q 007266 17 SALLVRHKHERKKYVLKKIRLARQTDRAR---------RSAHQEMELISRVR-----NPFIVEYKDSWVEK-GCYVCIII 81 (610)
Q Consensus 17 ~Vyla~d~~~~~~vAIK~i~~~~~~~~~~---------~~l~~Ei~iL~~L~-----HpnIV~l~~~~~~~-~~~~~LVm 81 (610)
.|+.+. -.|+.|.||............ ..+.+|...+.+|. .|..|-+...-... ....+|||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 355543 367789999664322111111 13678888887763 34444332111111 23467999
Q ss_pred eecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-------CCCeeeeecccccc
Q 007266 82 GYCEGG-DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-------DQDIRLGDFGLAKM 153 (610)
Q Consensus 82 Ey~~Gg-sL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-------~g~vKL~DFGlak~ 153 (610)
|+++|. +|.+++........++.....++.+|+..+.-||.+||+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999886 8999886432234567788899999999999999999999999999999985 35789999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.5e-08 Score=99.61 Aligned_cols=127 Identities=20% Similarity=0.244 Sum_probs=83.2
Q ss_pred EEEEEEEeCCCeEEEEEEEccccc------------------------cHHHHHHHHHHHHHHHhcCCC--ceeeeeeeE
Q 007266 17 SALLVRHKHERKKYVLKKIRLARQ------------------------TDRARRSAHQEMELISRVRNP--FIVEYKDSW 70 (610)
Q Consensus 17 ~Vyla~d~~~~~~vAIK~i~~~~~------------------------~~~~~~~l~~Ei~iL~~L~Hp--nIV~l~~~~ 70 (610)
.||.|... +|..+|+|..+.... .........+|.+.|.++..- ++...++
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~-- 77 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD-- 77 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE--
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE--
Confidence 38888764 577999998864221 111335677899999999765 3444443
Q ss_pred eecCcEEEEEEeecC--CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCeecccCCCCceEecCCCCeeeee
Q 007266 71 VEKGCYVCIIIGYCE--GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY-LHANHILHRDVKCSNIFLTRDQDIRLGD 147 (610)
Q Consensus 71 ~~~~~~~~LVmEy~~--GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~y-LHs~gIiHRDLKPeNILL~~~g~vKL~D 147 (610)
...+ +|||||++ |..+..+... .++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|
T Consensus 78 ~~~~---~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 78 YNRN---VIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp EETT---EEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--
T ss_pred EeCC---EEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEe
Confidence 2332 59999998 6556543332 22356677888889886655 579999999999999999877 899999
Q ss_pred ccccccc
Q 007266 148 FGLAKML 154 (610)
Q Consensus 148 FGlak~~ 154 (610)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.4e-08 Score=105.75 Aligned_cols=236 Identities=15% Similarity=0.254 Sum_probs=154.3
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEe-------ecCcEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWV-------EKGCYVC 78 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~-------~~~~~~~ 78 (610)
.+.||+|+-+.+|-+-...+ .+-|+.....-... .+.+..|... .||-+ .+--.|- ..+..+-
T Consensus 16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~-----aqk~a~la~~p~~p~~-~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQ-----AQKVAELAATPDAPLL-NYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CccccCCccceeeecchhhc---hhheeecCCCchHH-----HHHHHHhccCCCCcch-hhhhcccHHHhhCCCccceeE
Confidence 46799999999998755432 34466653332211 1223344443 34432 2211121 2223366
Q ss_pred EEEeecCCCC-HHHHH----HHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 79 IIIGYCEGGD-MAEAI----KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 79 LVmEy~~Ggs-L~~~I----k~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
++|..+.|.. +..++ +++....+.+.-+.+..+.|+.+...||.+|.+-+|+.++|+|+.+++.|.|+|-..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 8888887652 22322 223344678999999999999999999999999999999999999999999988654433
Q ss_pred cccccccccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhc-CccccccCHH-----HHHHHHh------
Q 007266 154 LISDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQ-----ALINKIN------ 216 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG-~~PF~~~~~~-----~l~~~I~------ 216 (610)
-..+...-..+|.+.|.+||+-. +..-+...|.|.||++|++|+.| ..||.+.... -.-..|.
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 33444556779999999999654 44456789999999999998876 8999764210 0000111
Q ss_pred ----hccCCC-----CCcccchHHHHHHHHhhcC--CCCCCCCHHH
Q 007266 217 ----KSIVAP-----LPTVYSGAFRGLVKSMLRK--NPEFRPSAAE 251 (610)
Q Consensus 217 ----~~~~~~-----~p~~~s~~l~~LI~kmL~~--dP~~RpSa~e 251 (610)
.....+ ....+++.+..|..+|+.. ++.-|||++-
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111111 1234677889999999875 4678999854
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.7e-08 Score=97.16 Aligned_cols=106 Identities=23% Similarity=0.310 Sum_probs=81.2
Q ss_pred HHHHHHHHHHHhcC-----CCceeeeeeeEeecCcEEEEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Q 007266 46 RSAHQEMELISRVR-----NPFIVEYKDSWVEKGCYVCIIIGYCEGG-DMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119 (610)
Q Consensus 46 ~~l~~Ei~iL~~L~-----HpnIV~l~~~~~~~~~~~~LVmEy~~Gg-sL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~y 119 (610)
....+|...+..|. -|..|.+...-.......++|+|+++|. +|.+++.... .++......++.++...+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 35677877776663 3444443322111123458999999884 7999998744 26778889999999999999
Q ss_pred HHHCCeecccCCCCceEecCCC---Ceeeeecccccc
Q 007266 120 LHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKM 153 (610)
Q Consensus 120 LHs~gIiHRDLKPeNILL~~~g---~vKL~DFGlak~ 153 (610)
||.+||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 799999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.9e-08 Score=100.81 Aligned_cols=136 Identities=22% Similarity=0.233 Sum_probs=103.0
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc--------------------HHHHHHHHHHHHHHHhcCCC--c
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT--------------------DRARRSAHQEMELISRVRNP--F 62 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~--------------------~~~~~~l~~Ei~iL~~L~Hp--n 62 (610)
.+...||-|--+.||.|.+. .|..+|||.=+....+ ...+..+.+|.++|.+|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35689999999999999987 6788999965432211 12456678999999999654 4
Q ss_pred eeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC
Q 007266 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 142 (610)
Q Consensus 63 IV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~ 142 (610)
+.+-++. +.-++||||++|..|...- ++.+....++..|+.-+.-+-..||||+|+.+-|||++.+|.
T Consensus 173 VP~P~~~-----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW-----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc-----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 5555442 2456999999997775422 245566667777777777777899999999999999999999
Q ss_pred eeeeecccccc
Q 007266 143 IRLGDFGLAKM 153 (610)
Q Consensus 143 vKL~DFGlak~ 153 (610)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999986543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.2e-07 Score=88.77 Aligned_cols=141 Identities=11% Similarity=0.130 Sum_probs=99.3
Q ss_pred cccCceEEEEEEEeCCCeEEEEEEEc-ccccc---HHHHHHHHHHHHHHHhcCCC--ceeeeeeeEee--c-CcEEEEEE
Q 007266 11 GKGSFGSALLVRHKHERKKYVLKKIR-LARQT---DRARRSAHQEMELISRVRNP--FIVEYKDSWVE--K-GCYVCIII 81 (610)
Q Consensus 11 G~G~fG~Vyla~d~~~~~~vAIK~i~-~~~~~---~~~~~~l~~Ei~iL~~L~Hp--nIV~l~~~~~~--~-~~~~~LVm 81 (610)
|+||-+.|+..... |+.|-+|... .-..+ +.....+.+|+..|.+|..- ++.+....-.. . ....+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56899999998653 3356677654 11111 22345688999999887532 23333311111 1 23467899
Q ss_pred eecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC--eeeeecccccc
Q 007266 82 GYCEG-GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKM 153 (610)
Q Consensus 82 Ey~~G-gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~--vKL~DFGlak~ 153 (610)
|-+.| .+|.+++.+..-...++.....++.++...|.-||+.|+.|+|+.+.|||++.+|. +.++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 58888886643335678888899999999999999999999999999999987777 99999986654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-08 Score=113.98 Aligned_cols=244 Identities=20% Similarity=0.272 Sum_probs=171.3
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCc-eeeeeeeEeecCcEEEEEEee
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF-IVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~~~~LVmEy 83 (610)
.....+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+.+++.+.. +.+.+++|+|
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~-E~~~~i~~~i 315 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDG-EDYLWIPMRI 315 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCc-ccccchhhhh
Confidence 33455789999999999987776555 5555422 22445789999999999 7777776544 4588999999
Q ss_pred cCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccccc
Q 007266 84 CEGG-DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 162 (610)
Q Consensus 84 ~~Gg-sL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~ 162 (610)
+.++ +-...+... ...|-+-++..+++.-+.+|+|||+.--+||| ||+.. ++..+..||+....+.......+
T Consensus 316 ~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t 389 (829)
T KOG0576|consen 316 CSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRT 389 (829)
T ss_pred hcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccccccc
Confidence 9887 222222110 11244555666777888899999999889999 88655 57899999999888776666778
Q ss_pred ccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC--C-cccchHHH-HHHHHh
Q 007266 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--P-TVYSGAFR-GLVKSM 238 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--p-~~~s~~l~-~LI~km 238 (610)
..+|+.++|||+.....+....|.|++|+--.+|.-|.+|-..- ......+..+...+. . ..++..+. ++...|
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~ 467 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPC 467 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccccCCcccc
Confidence 89999999999999999999999999999888888887775431 011111111110000 0 11222223 478889
Q ss_pred hcCCCCCCCCHHHHhcCCCCCchhhhh
Q 007266 239 LRKNPEFRPSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~~~~~~ 265 (610)
+..-|..|+...+++-|.+|..--+++
T Consensus 468 ~~g~P~~pkv~mgacfsKvfngCpl~i 494 (829)
T KOG0576|consen 468 LNGLPPTPKVHMGACFSKVFNGCPLRI 494 (829)
T ss_pred cCCCCCCCcchhhHHHHHHhccCcccc
Confidence 999999999999999888776543333
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.9e-06 Score=86.64 Aligned_cols=139 Identities=17% Similarity=0.248 Sum_probs=88.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH-HH------HHHHHHHHHHHhcCC---CceeeeeeeEe
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-AR------RSAHQEMELISRVRN---PFIVEYKDSWV 71 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~-~~------~~l~~Ei~iL~~L~H---pnIV~l~~~~~ 71 (610)
.+|.+++.+-......|.+..- +|+.+++|..+......+ .. ....+++..+.++.. -.+..++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 3678888888888777766654 568899998764332111 00 112334444444422 22222111111
Q ss_pred e----cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeee
Q 007266 72 E----KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 147 (610)
Q Consensus 72 ~----~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~D 147 (610)
- -....++||||++|..|.+... +++ .+...|..+|.-||+.|++|+|..|.|++++.+ .++++|
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID 177 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID 177 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence 1 1124568999999988876532 233 244667788999999999999999999999855 499999
Q ss_pred cccccc
Q 007266 148 FGLAKM 153 (610)
Q Consensus 148 FGlak~ 153 (610)
|+..+.
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-06 Score=85.05 Aligned_cols=141 Identities=21% Similarity=0.274 Sum_probs=82.0
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC--ceeeeeeeEe--ecCcEEEEEEe
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP--FIVEYKDSWV--EKGCYVCIIIG 82 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIV~l~~~~~--~~~~~~~LVmE 82 (610)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... .+..++.... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999998765 48889987643 3445677888888887533 2344444222 22335789999
Q ss_pred ecCCCCHHH----------------HHHH---h--CCCCCCHHH---------HHHH------------HHHHHH-HHHH
Q 007266 83 YCEGGDMAE----------------AIKK---A--NGVHFPEEK---------LCKW------------LVQLLM-ALNY 119 (610)
Q Consensus 83 y~~GgsL~~----------------~Ik~---~--~~~~lse~~---------i~~i------------~~QLl~-aL~y 119 (610)
+++|..+.. .+.. . ....+.... .... +..+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999988877 1111 1 001111100 0000 111222 2333
Q ss_pred HHH-------CCeecccCCCCceEec-CCCCeeeeecccccc
Q 007266 120 LHA-------NHILHRDVKCSNIFLT-RDQDIRLGDFGLAKM 153 (610)
Q Consensus 120 LHs-------~gIiHRDLKPeNILL~-~~g~vKL~DFGlak~ 153 (610)
++. ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 3699999999999999 556677999997754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.3e-09 Score=123.04 Aligned_cols=262 Identities=16% Similarity=0.105 Sum_probs=184.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCC-eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee-cCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHER-KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~-~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~-~~~~~~ 78 (610)
|+.|++.=-+|.|.++..-..+.+.++ +.-+-|........+-.++.+..|..-++...|+++.....-... .+...|
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~ 1307 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEY 1307 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHH
Confidence 355666666666655543333333332 111222222222333344555666666677789988876554332 233567
Q ss_pred EEEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-----CeecccCCCCceEecCCCCeeeeecccc
Q 007266 79 IIIGYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHAN-----HILHRDVKCSNIFLTRDQDIRLGDFGLA 151 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~-----gIiHRDLKPeNILL~~~g~vKL~DFGla 151 (610)
.+++||.+|.+...|-+.- ...+.+.-+.....+.+.+..-+|+. -.+|++||+.|.+|..+..++++++|+.
T Consensus 1308 ~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLd 1387 (2724)
T KOG1826|consen 1308 IRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLD 1387 (2724)
T ss_pred HHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccc
Confidence 8999999999999987531 22344555555555557777777765 3899999999999999999999999999
Q ss_pred cccc-cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchH
Q 007266 152 KMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGA 230 (610)
Q Consensus 152 k~~~-~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~ 230 (610)
+... ........++++.|+.|++.....++.++|||..|+.+|++..|..+|...-...+...+.......++...+++
T Consensus 1388 KIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgd 1467 (2724)
T KOG1826|consen 1388 KIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGD 1467 (2724)
T ss_pred cccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCc
Confidence 9443 334566788999999999999999998999999999999999999988766555555555544445566667777
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
...+...+|-.....||.-...+..+++...+
T Consensus 1468 aNve~~~~Ll~K~~~rp~q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1468 ANVEALHRLLWKYMERPGQYISLSRDHFAVGL 1499 (2724)
T ss_pred ccHHHHHHHHHHhhhcchhhhhcccccccccc
Confidence 77788888888888999999999888886543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4e-07 Score=102.13 Aligned_cols=144 Identities=20% Similarity=0.230 Sum_probs=92.5
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccccH--------------------------------HHHHHHH------
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD--------------------------------RARRSAH------ 49 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~--------------------------------~~~~~l~------ 49 (610)
+.|+.++-|.||.|+.+. |+.||||+.++.-... +..+.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578899999999999875 9999999987543211 1112222
Q ss_pred HHHHHHHhc----CCCceeeeeeeEeecCcEEEEEEeecCCCCHHHHH--HHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 007266 50 QEMELISRV----RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI--KKANGVHFPEEKLCKWLVQLLMALNYLHAN 123 (610)
Q Consensus 50 ~Ei~iL~~L----~HpnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~I--k~~~~~~lse~~i~~i~~QLl~aL~yLHs~ 123 (610)
+|..-+.++ .+..-+.+-..|.+-...-.++|||++|-.+.+.. +.. .++...+...+.++. +..+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHHHHHHHHHHHH--HHHHHhc
Confidence 333333333 23333334444433223446999999999998874 442 344333322222221 2333348
Q ss_pred CeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 124 gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|++|.|.+|.||+++.+|.+.+.|||+...+...
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999998776443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.3e-06 Score=86.42 Aligned_cols=135 Identities=19% Similarity=0.191 Sum_probs=79.4
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCce--eeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI--VEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnI--V~l~~~~~~~~~~~~LVmEy~~ 85 (610)
..||+|..+.||+. .+..+++|....... ...+.+|.++++.+..-.+ .+.++ +.+.+...++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~-~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFD-LVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEE-EEecCCeeeeeeeecC
Confidence 67899999999984 244677888764332 2236789999988764333 33333 3344456778999999
Q ss_pred CCC-HH--------------HHH----HHhCC-----CCCCHHHHHHHHHH----------HHHH-HHHHHH----CCee
Q 007266 86 GGD-MA--------------EAI----KKANG-----VHFPEEKLCKWLVQ----------LLMA-LNYLHA----NHIL 126 (610)
Q Consensus 86 Ggs-L~--------------~~I----k~~~~-----~~lse~~i~~i~~Q----------Ll~a-L~yLHs----~gIi 126 (610)
|.+ +. ..+ .+-.. ..++. ....+..+ +... ..+|.. ..++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 964 21 111 11111 11110 01111111 1111 122221 2578
Q ss_pred cccCCCCceEecCCCCeeeeecccccc
Q 007266 127 HRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 127 HRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
|+|+.|.||+++.++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.42 E-value=7.9e-07 Score=105.12 Aligned_cols=204 Identities=20% Similarity=0.240 Sum_probs=150.0
Q ss_pred HHHHHHHHHHHhcCCCceeeeeeeEeecCc---EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007266 46 RSAHQEMELISRVRNPFIVEYKDSWVEKGC---YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122 (610)
Q Consensus 46 ~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~---~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs 122 (610)
....-|+..+.++.|+|++.++.+-.+... ...+..+||.+.++...+...+ ..+.+..+.+..+++.||.|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence 334456677888899999999887665432 2335668999999999988765 67899999999999999999999
Q ss_pred CCeecccCCCC---ceEecCCCCeeee--ecccccccccccccccccCCCcccCCccccCCCCCCC--ccccccchhHHh
Q 007266 123 NHILHRDVKCS---NIFLTRDQDIRLG--DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK--SDIWSLGCCVYE 195 (610)
Q Consensus 123 ~gIiHRDLKPe---NILL~~~g~vKL~--DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~k--sDIWSLG~iLye 195 (610)
....|.-|.-. +-..+.++.+.+. ||+..+.+..............+.++|......+..+ .|+|++|..+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 96655554444 3334455666666 9998888776666666777778889998877666444 799999999999
Q ss_pred hhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 196 MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 196 LltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+..|..+-.... ... ..++........+++.+|+.-+.++|+++.+++.|+|+...
T Consensus 385 ~~~~~~i~~~~~---~~~-------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKSA---VPV-------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCccccccc---chh-------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 988765322111 111 11122222377889999999999999999999999998753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.2e-06 Score=85.20 Aligned_cols=139 Identities=15% Similarity=0.146 Sum_probs=92.1
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHH----------------------HHHHHHHHHHHHhcCCC--
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRA----------------------RRSAHQEMELISRVRNP-- 61 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~----------------------~~~l~~Ei~iL~~L~Hp-- 61 (610)
+...|+.|-.+.||+|.. .++..+|+|+++.....-.. ..-...|+.-|+++..-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 355788888999999976 46789999998754432111 01123466666665322
Q ss_pred ceeeeeeeEeecCcEEEEEEeecCCCC-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecC
Q 007266 62 FIVEYKDSWVEKGCYVCIIIGYCEGGD-MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTR 139 (610)
Q Consensus 62 nIV~l~~~~~~~~~~~~LVmEy~~Ggs-L~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~ 139 (610)
.+.+-+.. . .-.|||||+...- -.-.|+. ..+..+....+..+++..+.-|-. .|+||+||..-|||+.
T Consensus 131 rvP~Pi~~--~---~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 131 RVPEPIAF--R---NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH- 201 (268)
T ss_pred CCCCceee--c---CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence 22222221 1 1258999995431 1111222 234444788888999999988877 8999999999999998
Q ss_pred CCCeeeeeccccccc
Q 007266 140 DQDIRLGDFGLAKML 154 (610)
Q Consensus 140 ~g~vKL~DFGlak~~ 154 (610)
++.+.|+|||-+...
T Consensus 202 ~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 DGEPYIIDVSQAVTI 216 (268)
T ss_pred CCeEEEEECcccccc
Confidence 889999999987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.6e-05 Score=75.74 Aligned_cols=172 Identities=17% Similarity=0.147 Sum_probs=107.1
Q ss_pred HHHHHHHHhcCC-CceeeeeeeEeecCcEEEEEEeecCCCCHHHH---HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--
Q 007266 49 HQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA---IKKANGVHFPEEKLCKWLVQLLMALNYLHA-- 122 (610)
Q Consensus 49 ~~Ei~iL~~L~H-pnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~---Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-- 122 (610)
..|.-+|+.+.+ +++++++|++ | -++|.||...+++... +.. ...-++....+++.+|+..+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G--~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---G--RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---C--CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 458888888876 6999999976 2 2579999987766421 111 1135799999999999999999998
Q ss_pred -CCeecccCCCCceEecCCCCeeeeeccccccccccc--ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhc
Q 007266 123 -NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ 199 (610)
Q Consensus 123 -~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG 199 (610)
..+...|++++|+-++.+|++|++|...+....... .....+.+ ...... .|..|.-...-..+.+
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~~~~~l~~~~c~~----------~~DC~~-~dC~s~c~~~~~~C~~ 148 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVEDKLDEILSERSCES----------DEDCTF-FDCRSFCDLSEGRCSG 148 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcchhHHhhhhccccCCCC----------CCCcCc-CCccCccCCCcCcCCC
Confidence 468889999999999999999999999775543211 10011111 001101 1222211111222233
Q ss_pred CccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 200 KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 200 ~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
.. ...+.......+........|..+.+++..++..|.+
T Consensus 149 ~~--~~~Nl~~vC~~l~~~lL~~~p~~l~~~L~~lL~~C~~ 187 (188)
T PF12260_consen 149 QN--ENNNLQAVCQKLLDYLLHGPPSELQEELQKLLQECAN 187 (188)
T ss_pred cc--ccCcHHHHHHHHHHHhcCCCCHHHHHHHHHHHHHhcC
Confidence 22 2344555555555444444466677778888887754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.5e-05 Score=77.06 Aligned_cols=138 Identities=14% Similarity=0.097 Sum_probs=79.7
Q ss_pred eEecccCc-eEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSF-GSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~f-G~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
..|-.|.. ..||++... +..+++|...... ...+.+|+++++.+. +-.+.++++..... ...++|||+++
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~ 75 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVP 75 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeC
Confidence 44555666 788999653 3577788765332 234667888888874 33344555544333 45679999999
Q ss_pred CCCHHHHH----------------HHhCC-----CCCCHH---HHHHHHH-------------------HHHHHHHHHH-
Q 007266 86 GGDMAEAI----------------KKANG-----VHFPEE---KLCKWLV-------------------QLLMALNYLH- 121 (610)
Q Consensus 86 GgsL~~~I----------------k~~~~-----~~lse~---~i~~i~~-------------------QLl~aL~yLH- 121 (610)
|.+|.... .+-.. ..+... .+..... .+...+..|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 98776432 11011 111100 0000000 0111122221
Q ss_pred ------HCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 122 ------ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 122 ------s~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12599999999999999877788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.2e-05 Score=87.03 Aligned_cols=143 Identities=19% Similarity=0.265 Sum_probs=91.5
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccccc-----------------------------HHHHHHHHHHHHHHH--
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-----------------------------DRARRSAHQEMELIS-- 56 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-----------------------------~~~~~~l~~Ei~iL~-- 56 (610)
+.||.-+.|.|++|+.+. |+.||||+-++.-.. ++..+.+.+|+..++
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578899999999999876 999999987643322 122233334443332
Q ss_pred --------hcCCCc---eeeeeeeEeecCcEEEEEEeecCCCCHHHH--HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 007266 57 --------RVRNPF---IVEYKDSWVEKGCYVCIIIGYCEGGDMAEA--IKKANGVHFPEEKLCKWLVQLLMALNYLHAN 123 (610)
Q Consensus 57 --------~L~Hpn---IV~l~~~~~~~~~~~~LVmEy~~GgsL~~~--Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~ 123 (610)
.+.|-+ -|.+-.+|.+-...-.|+||||+|..+.+. |.+. .++...+..-+.+... +-|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH--HHHHhc
Confidence 223434 222333333333356799999999877654 4554 3566644433333222 233356
Q ss_pred CeecccCCCCceEecC----CCCeeeeeccccccccc
Q 007266 124 HILHRDVKCSNIFLTR----DQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 124 gIiHRDLKPeNILL~~----~g~vKL~DFGlak~~~~ 156 (610)
|++|.|=+|.||+++. ++.+.+.|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999994 56799999999877643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.9e-05 Score=90.57 Aligned_cols=148 Identities=17% Similarity=0.332 Sum_probs=90.2
Q ss_pred EEeEecccCceEEEEEEEeCCC--eEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCce--eeeeeeEeecC--cEEE
Q 007266 6 VLEQIGKGSFGSALLVRHKHER--KKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFI--VEYKDSWVEKG--CYVC 78 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~--~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnI--V~l~~~~~~~~--~~~~ 78 (610)
.++.|+.|.+..+|++.....+ ..+++|+....... .....+.+|+++|+.+. |.++ .+++..+.+.. ...|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3678899999999999765433 46778876433221 12345789999999995 5554 45555443321 3567
Q ss_pred EEEeecCCCCHHH--------------------HHHHhCCC--------------CCCHHHHHHHHHH------------
Q 007266 79 IIIGYCEGGDMAE--------------------AIKKANGV--------------HFPEEKLCKWLVQ------------ 112 (610)
Q Consensus 79 LVmEy~~GgsL~~--------------------~Ik~~~~~--------------~lse~~i~~i~~Q------------ 112 (610)
+||||++|..+.+ .+..-... .+-..++..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999999865321 11111000 0112344333332
Q ss_pred ---HHHHHHHHHH-----------CCeecccCCCCceEecCC-CC-eeeeeccccccc
Q 007266 113 ---LLMALNYLHA-----------NHILHRDVKCSNIFLTRD-QD-IRLGDFGLAKML 154 (610)
Q Consensus 113 ---Ll~aL~yLHs-----------~gIiHRDLKPeNILL~~~-g~-vKL~DFGlak~~ 154 (610)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|+||.++..-
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233556633 249999999999999853 33 578999998764
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.4e-05 Score=73.16 Aligned_cols=129 Identities=19% Similarity=0.212 Sum_probs=91.2
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.+.||+|.+|.||++... |..+|+|+-+.+. .+..+..|+++|..+.--++-+-+..| .. .++.|||+.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~y-g~---~~i~me~i~ 95 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFY-GE---DFIRMEYID 95 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEe-ch---hhhhhhhhc
Confidence 4678999999999999874 4588888776443 345688899999998876665544322 12 235699999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC-CCceEecCCCCeeeeecccccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVK-CSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLK-PeNILL~~~g~vKL~DFGlak~ 153 (610)
|..|.++.... . ++-+..+++.---|-..||-|..|. |..++|..++++.|+||.-|+.
T Consensus 96 G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98998766431 1 2223445555455677899999987 5555555666999999998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00035 Score=69.63 Aligned_cols=128 Identities=23% Similarity=0.305 Sum_probs=89.6
Q ss_pred CCeEEEeEecccCc-eEEEEEEEeCCCeEEEEEEEcc---ccc-------c--H-------HHHHHHHHHHHHHHhcC--
Q 007266 2 EQYEVLEQIGKGSF-GSALLVRHKHERKKYVLKKIRL---ARQ-------T--D-------RARRSAHQEMELISRVR-- 59 (610)
Q Consensus 2 d~Y~ilk~LG~G~f-G~Vyla~d~~~~~~vAIK~i~~---~~~-------~--~-------~~~~~l~~Ei~iL~~L~-- 59 (610)
++++.++.||.|.- |.||+++. .|+.||+|+++. ... . + ....-|..|.+...+|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 46899999999999 99999987 677999999321 110 0 0 12245677877766664
Q ss_pred -CCce--eeeeeeEeecC-----------------cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Q 007266 60 -NPFI--VEYKDSWVEKG-----------------CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119 (610)
Q Consensus 60 -HpnI--V~l~~~~~~~~-----------------~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~y 119 (610)
+.++ |+++++..-.. ....||.||+.... .+..+. +.+|++-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHH
Confidence 4455 88888764221 13457888876533 123333 4677778888
Q ss_pred HHHCCeecccCCCCceEecCCCCeeeeecccc
Q 007266 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151 (610)
Q Consensus 120 LHs~gIiHRDLKPeNILL~~~g~vKL~DFGla 151 (610)
+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999983 2489999964
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00021 Score=71.62 Aligned_cols=139 Identities=13% Similarity=0.186 Sum_probs=81.1
Q ss_pred EeEecccCceEEEEEEEeC-CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCcee-eeeeeEeecCcEEEEEEeec
Q 007266 7 LEQIGKGSFGSALLVRHKH-ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV-EYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~-~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV-~l~~~~~~~~~~~~LVmEy~ 84 (610)
++.|..|-...+|++.... .++.|++|......... -...+|+.+++.+....++ +++.. .. + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~---~d~~~E~~~~~~l~~~gl~P~v~~~-~~-~---~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI---IDRERELRIHKLLSKHGLAPKLYAT-FQ-N---GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce---ecHHHHHHHHHHHHhCCCCCeEEEE-eC-C---cEEEEee
Confidence 5778889999999997543 35688889765332111 1124688888888543333 33332 22 2 3799999
Q ss_pred CCCCHHH--------------HHHHhCC--CC----------CC-HHHHHHHHHHH----------------------H-
Q 007266 85 EGGDMAE--------------AIKKANG--VH----------FP-EEKLCKWLVQL----------------------L- 114 (610)
Q Consensus 85 ~GgsL~~--------------~Ik~~~~--~~----------ls-e~~i~~i~~QL----------------------l- 114 (610)
+|.++.. .+.+-.. .. .. .+.+..|...+ .
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 9976521 1111000 00 11 12333332211 1
Q ss_pred --HHHH-HHHH----CCeecccCCCCceEecC-CCCeeeeecccccc
Q 007266 115 --MALN-YLHA----NHILHRDVKCSNIFLTR-DQDIRLGDFGLAKM 153 (610)
Q Consensus 115 --~aL~-yLHs----~gIiHRDLKPeNILL~~-~g~vKL~DFGlak~ 153 (610)
..|. .+.. .+++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 1111 36999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00012 Score=73.96 Aligned_cols=74 Identities=11% Similarity=0.082 Sum_probs=44.5
Q ss_pred EeEecccCceE-EEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC---ceeeeeeeEee--cCcEEEEE
Q 007266 7 LEQIGKGSFGS-ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP---FIVEYKDSWVE--KGCYVCII 80 (610)
Q Consensus 7 lk~LG~G~fG~-Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp---nIV~l~~~~~~--~~~~~~LV 80 (610)
++.|+.||... ||++. ..+++|..... .....+.+|.++|..+... .+..+++.... .....+++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 46788777774 88872 25677765431 1234588899999887532 22233322111 11245789
Q ss_pred EeecCCCCH
Q 007266 81 IGYCEGGDM 89 (610)
Q Consensus 81 mEy~~GgsL 89 (610)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0011 Score=66.08 Aligned_cols=130 Identities=18% Similarity=0.242 Sum_probs=87.3
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEcccc--------------ccHHHHHHHHHHHHHHHhcC------CCceeee
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR--------------QTDRARRSAHQEMELISRVR------NPFIVEY 66 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~--------------~~~~~~~~l~~Ei~iL~~L~------HpnIV~l 66 (610)
...||+|+.=.||.--+ +....||+..... ......+...+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 45799999998876533 3345678887665 01112344556666555554 7788899
Q ss_pred eeeEeecCcEEEEEEeecCC------CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC
Q 007266 67 KDSWVEKGCYVCIIIGYCEG------GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD 140 (610)
Q Consensus 67 ~~~~~~~~~~~~LVmEy~~G------gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~ 140 (610)
++.. +.+....+|+|.+.. .+|.++++.. .+++ .+ ...|-.-.+||-+++|+.+||+|.||++...
T Consensus 83 ~G~v-eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFV-ETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEE-ecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEec
Confidence 9965 445566788887642 4688888653 3555 33 3344455668899999999999999999754
Q ss_pred C----Ceeeee
Q 007266 141 Q----DIRLGD 147 (610)
Q Consensus 141 g----~vKL~D 147 (610)
. .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 3 366777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0016 Score=68.43 Aligned_cols=30 Identities=23% Similarity=0.282 Sum_probs=25.8
Q ss_pred CeecccCCCCceEecCCCCeeeeecccccc
Q 007266 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 124 gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
++||+|+.|.|||++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 899999999999998665558999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0012 Score=69.48 Aligned_cols=142 Identities=16% Similarity=0.154 Sum_probs=79.6
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC--ceeeeeee-----EeecCcEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP--FIVEYKDS-----WVEKGCYV 77 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIV~l~~~-----~~~~~~~~ 77 (610)
..++.++.|....+|++.. . +..+++|+...... . +.+..|++++..|... ++.+++.. +...++..
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~-~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVK-A---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eeccccCCccccceEEEEe-C-CCcEEEEEecCCCC-H---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 3467788888889999864 2 33677887754221 1 2244566777666321 12333221 11123467
Q ss_pred EEEEeecCCCCHH-----------HHHH---H-hCCCC--------CC-HHHH-H-----------HHHHHHHHHHHHHH
Q 007266 78 CIIIGYCEGGDMA-----------EAIK---K-ANGVH--------FP-EEKL-C-----------KWLVQLLMALNYLH 121 (610)
Q Consensus 78 ~LVmEy~~GgsL~-----------~~Ik---~-~~~~~--------ls-e~~i-~-----------~i~~QLl~aL~yLH 121 (610)
+++++|++|..+. ..+. . ..+.. ++ +... . .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999985431 1111 1 01100 00 0000 0 00112333455554
Q ss_pred H-------CCeecccCCCCceEecCCCCeeeeeccccc
Q 007266 122 A-------NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 122 s-------~gIiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
. .++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3 589999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0013 Score=66.99 Aligned_cols=135 Identities=13% Similarity=0.206 Sum_probs=77.4
Q ss_pred EecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceee-eeeeEeecCcEEEEEEeecCCC
Q 007266 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE-YKDSWVEKGCYVCIIIGYCEGG 87 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~-l~~~~~~~~~~~~LVmEy~~Gg 87 (610)
.+..|-.+.+|++. .++..+++|......... .. ...+|..+++.+....+++ ++.. ..+ ++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~-~r~~E~~~l~~l~~~g~~P~~i~~--~~~---~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GV-DRQREYQILQALSALGLAPKPILV--NEH---WLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cC-cHHHHHHHHHHHHhcCCCCceEEE--eCC---EEEEEeccCc
Confidence 45668888999987 456678888654321111 01 2467888888886433332 2222 222 5899999987
Q ss_pred CHHH--------------HHHHhCC-----CCCC-HHHHHHHHHHH---------HHHHHHHHH--------CCeecccC
Q 007266 88 DMAE--------------AIKKANG-----VHFP-EEKLCKWLVQL---------LMALNYLHA--------NHILHRDV 130 (610)
Q Consensus 88 sL~~--------------~Ik~~~~-----~~ls-e~~i~~i~~QL---------l~aL~yLHs--------~gIiHRDL 130 (610)
.+.. .+.+-.. ..++ .+.+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 1222111 1111 12222332222 111222222 25899999
Q ss_pred CCCceEecCCCCeeeeecccccc
Q 007266 131 KCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 131 KPeNILL~~~g~vKL~DFGlak~ 153 (610)
.|.||+++.++ +.|+||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 88999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0018 Score=68.12 Aligned_cols=78 Identities=10% Similarity=0.018 Sum_probs=52.1
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC---CceeeeeeeEeec--CcEEEEE
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN---PFIVEYKDSWVEK--GCYVCII 80 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H---pnIV~l~~~~~~~--~~~~~LV 80 (610)
-.+.||.|..+.||.+.... + .+++|..+ ... ....+..|...|+.|.. -.+.++++.+... .+..+||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMAR-SFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEec-ccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 46789999999999996533 3 46667643 211 12357889999988753 3455666544322 2457899
Q ss_pred EeecCCCCH
Q 007266 81 IGYCEGGDM 89 (610)
Q Consensus 81 mEy~~GgsL 89 (610)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00011 Score=77.63 Aligned_cols=135 Identities=23% Similarity=0.292 Sum_probs=95.7
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH--------------------HHHHHHHHHHHHHhcC-CCc
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR--------------------ARRSAHQEMELISRVR-NPF 62 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~--------------------~~~~l~~Ei~iL~~L~-Hpn 62 (610)
|.+.+.||-|--+.||.+.+. .|...++|.-+..+.+-. .+-...+|+..|+.|. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456789999999999999885 467788886554332211 1223557888888884 333
Q ss_pred -eeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 63 -IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 63 -IV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
+.+.++ .+.-|+|||++.|..|.+.-+- +.+..+...|+.-+.-|-.+|+||+|+.=-||++..++
T Consensus 173 pVPkpiD-----~~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 173 PVPKPID-----HNRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCccc-----ccceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 333333 2356799999999988764432 12234455566666778899999999999999999999
Q ss_pred Ceeeeeccccc
Q 007266 142 DIRLGDFGLAK 152 (610)
Q Consensus 142 ~vKL~DFGlak 152 (610)
.++++||--+.
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999998543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0017 Score=67.68 Aligned_cols=139 Identities=19% Similarity=0.237 Sum_probs=81.7
Q ss_pred EeEecccCceEEEEEEEeC------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCcee-eeeeeEeecCcEEEE
Q 007266 7 LEQIGKGSFGSALLVRHKH------ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV-EYKDSWVEKGCYVCI 79 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV-~l~~~~~~~~~~~~L 79 (610)
++.|..|-...||++.... .++.|++|+....... .....+|.+++..+....+. +++..+ .+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~-~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIF-PN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEe-CC----Cc
Confidence 5677778888999997643 2578989987543221 12346788888887543333 334332 22 25
Q ss_pred EEeecCCCCHHH--------------HHHHhCC--CC--------CC--HHHHHHH------------------------
Q 007266 80 IIGYCEGGDMAE--------------AIKKANG--VH--------FP--EEKLCKW------------------------ 109 (610)
Q Consensus 80 VmEy~~GgsL~~--------------~Ik~~~~--~~--------ls--e~~i~~i------------------------ 109 (610)
|+||++|..+.. .+.+-.. .. ++ +..+..|
T Consensus 75 v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (302)
T cd05156 75 IEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELS 154 (302)
T ss_pred hhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHH
Confidence 899999876632 1111000 00 00 1111111
Q ss_pred --HHHHHHHHHHHHH---------CCeecccCCCCceEecCC----CCeeeeecccccc
Q 007266 110 --LVQLLMALNYLHA---------NHILHRDVKCSNIFLTRD----QDIRLGDFGLAKM 153 (610)
Q Consensus 110 --~~QLl~aL~yLHs---------~gIiHRDLKPeNILL~~~----g~vKL~DFGlak~ 153 (610)
..++...+..|-. ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 155 ~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 155 LFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 1122223334432 268999999999999985 8899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.003 Score=69.28 Aligned_cols=79 Identities=11% Similarity=0.103 Sum_probs=52.4
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEcccc----cc-HHHHHHHHHHHHHHHhcC---CCceeeeeeeEeecCcEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR----QT-DRARRSAHQEMELISRVR---NPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~----~~-~~~~~~l~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~~~ 78 (610)
.+.||.|.+..||++.+..+++.++||.-.... .. ....+....|.+.|..+. -.++.+++.+ + ....+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D-~~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D-EELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C-CCCCE
Confidence 578999999999999987555689999754211 10 123345677888888763 2345555543 2 23467
Q ss_pred EEEeecCCCC
Q 007266 79 IIIGYCEGGD 88 (610)
Q Consensus 79 LVmEy~~Ggs 88 (610)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998744
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0024 Score=66.25 Aligned_cols=140 Identities=16% Similarity=0.148 Sum_probs=80.8
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC--ceeeeeee-----EeecCcEEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP--FIVEYKDS-----WVEKGCYVCI 79 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIV~l~~~-----~~~~~~~~~L 79 (610)
++.|..|....+|++.. .+..+++|.... .. ...+..|+.++..+.+. .+.+.+.. +...++..++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 66788888889999865 334688898753 11 23466677777777432 23333321 1122335689
Q ss_pred EEeecCCCCHHH-----------HHHH---h-CCCCC------CHHHHHH------------HHHHHHHHHHHHHH----
Q 007266 80 IIGYCEGGDMAE-----------AIKK---A-NGVHF------PEEKLCK------------WLVQLLMALNYLHA---- 122 (610)
Q Consensus 80 VmEy~~GgsL~~-----------~Ik~---~-~~~~l------se~~i~~------------i~~QLl~aL~yLHs---- 122 (610)
|++|++|..+.. .+.+ . ..... ....... ....+..++.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999999876421 1110 0 00000 0000000 11112334444443
Q ss_pred ---CCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 123 ---NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 123 ---~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
.++||+|+.|.|||++.++.+.|+||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999877678999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0012 Score=73.33 Aligned_cols=161 Identities=22% Similarity=0.247 Sum_probs=108.6
Q ss_pred HHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Q 007266 48 AHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127 (610)
Q Consensus 48 l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiH 127 (610)
+.--..+++.+.|+|...+++.-........+|||++ +.+|++.++.+... .++ ++ .+|+.|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~--~~s--------~~-------~~~~~~ 90 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK--DES--------LL-------AHGVLH 90 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc--hhh--------hc-------ccccce
Confidence 4456788899999999999986655555688999999 67999988875411 111 11 233332
Q ss_pred ccCCCCceEecCCCCeeeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC
Q 007266 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 207 (610)
Q Consensus 128 RDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~ 207 (610)
- || +.++| -++.. ..+..| .++|||++|.++.++..|...|....
T Consensus 91 ~-----~~-------~~~td-~~~t~------~~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 91 L-----NI-------IYITD-HFLTK------YPSPIG----------------PKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred e-----hh-------hhccc-ccccc------CCCCCC----------------cchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 2 22 22233 00000 011111 39999999999999999998888777
Q ss_pred HHHHHHHHhhccCCCCC-----------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 208 MQALINKINKSIVAPLP-----------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 208 ~~~l~~~I~~~~~~~~p-----------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
..+....+.+-...+.. ..++..+..+.++|+-..|..||...++.+|+-|...
T Consensus 136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 66666666554333211 1245667889999999999999999999999888765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0045 Score=64.55 Aligned_cols=30 Identities=27% Similarity=0.402 Sum_probs=25.5
Q ss_pred CeecccCCCCceEecCCCC-eeeeecccccc
Q 007266 124 HILHRDVKCSNIFLTRDQD-IRLGDFGLAKM 153 (610)
Q Consensus 124 gIiHRDLKPeNILL~~~g~-vKL~DFGlak~ 153 (610)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.012 Score=62.82 Aligned_cols=148 Identities=17% Similarity=0.228 Sum_probs=80.3
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC--ceeeeeeeEeecC-cEEEEEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP--FIVEYKDSWVEKG-CYVCIII 81 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIV~l~~~~~~~~-~~~~LVm 81 (610)
.+++.+-.|---.+|...+. ++.+++. .......-.......+|+.+|+.+.-- .....++.+.+.. ...|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34455533434445555443 7778777 322222333445677888888887531 1222233333322 3568999
Q ss_pred eecCCCCHHHH------------------HHHhC----------C--CCCCHHHHHHHHHHH--------------HHHH
Q 007266 82 GYCEGGDMAEA------------------IKKAN----------G--VHFPEEKLCKWLVQL--------------LMAL 117 (610)
Q Consensus 82 Ey~~GgsL~~~------------------Ik~~~----------~--~~lse~~i~~i~~QL--------------l~aL 117 (610)
+|++|..+.+. |..-. + ..+...++..+..+. ....
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99998433211 11100 0 001112222222222 1223
Q ss_pred HHHHHC--------CeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 118 NYLHAN--------HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 118 ~yLHs~--------gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+|+.+ .++|+|+.+.||+|+.++.+-|+||+++..-.
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 344433 48999999999999999999999999987643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.028 Score=59.16 Aligned_cols=30 Identities=13% Similarity=0.207 Sum_probs=27.8
Q ss_pred CeecccCCCCceEecCCCCeeeeecccccc
Q 007266 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 124 gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
++||+|+.++|||++.++.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.082 Score=55.07 Aligned_cols=29 Identities=24% Similarity=0.419 Sum_probs=25.6
Q ss_pred CCeecccCCCCceEecCCCCeeeeeccccc
Q 007266 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 123 ~gIiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
.++||+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.06 Score=57.49 Aligned_cols=139 Identities=14% Similarity=0.201 Sum_probs=79.3
Q ss_pred EeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCcee-eeeeeEeecCcEEEEEEe
Q 007266 7 LEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV-EYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV-~l~~~~~~~~~~~~LVmE 82 (610)
++.|..|=...+|++..... +..|++++...... ...+ -.+|..+++.+..-++- ++++.+ ..+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~Id-R~~E~~il~~l~~~gl~P~~l~~~-~~G----~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVID-RERELQAIKYLSAAGFGAKLLGVF-GNG----MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEec-hHHHHHHHHHHHhcCCCCceeEEe-CCc----Eeeh
Confidence 55565588888999975432 34788887754322 1111 24688888887644443 344433 332 5899
Q ss_pred ecCCCCHHH--------------HHHHhCCCCC-------CHHHHHHHHHHHH----------------------HHHHH
Q 007266 83 YCEGGDMAE--------------AIKKANGVHF-------PEEKLCKWLVQLL----------------------MALNY 119 (610)
Q Consensus 83 y~~GgsL~~--------------~Ik~~~~~~l-------se~~i~~i~~QLl----------------------~aL~y 119 (610)
|++|..|.. .+++-....+ ....+..|+.++- .-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998876521 1222111111 1334444443321 11112
Q ss_pred HH----HC----CeecccCCCCceEecC-CCCeeeeecccccc
Q 007266 120 LH----AN----HILHRDVKCSNIFLTR-DQDIRLGDFGLAKM 153 (610)
Q Consensus 120 LH----s~----gIiHRDLKPeNILL~~-~g~vKL~DFGlak~ 153 (610)
+. .. -++|.|+.+.|||++. ++.++++||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 21 11 2899999999999975 46899999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.026 Score=60.74 Aligned_cols=140 Identities=11% Similarity=0.170 Sum_probs=82.0
Q ss_pred EEeEecccCceEEEEEEEeC----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCcee-eeeeeEeecCcEEEEE
Q 007266 6 VLEQIGKGSFGSALLVRHKH----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV-EYKDSWVEKGCYVCII 80 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV-~l~~~~~~~~~~~~LV 80 (610)
-+..|-.|-.-.+|++.... .++.|++|...... ....+ -.+|+.+++.+...++- ++++.+ ..+ .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~-~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRF-PNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEE-CCc----eE
Confidence 35566668888999987432 24678889775432 12222 25688888887644333 344433 332 58
Q ss_pred EeecCCCCHHH--------------HHHHhCCC-------CCCHHHHHHHHHHHH-----------------HHHHHH--
Q 007266 81 IGYCEGGDMAE--------------AIKKANGV-------HFPEEKLCKWLVQLL-----------------MALNYL-- 120 (610)
Q Consensus 81 mEy~~GgsL~~--------------~Ik~~~~~-------~lse~~i~~i~~QLl-----------------~aL~yL-- 120 (610)
.+|++|.+|.. .+.+-... ....+.+..|+.++. ..+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 99998876631 11111111 112344445543321 111112
Q ss_pred --H----HCCeecccCCCCceEecC-CCCeeeeecccccc
Q 007266 121 --H----ANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKM 153 (610)
Q Consensus 121 --H----s~gIiHRDLKPeNILL~~-~g~vKL~DFGlak~ 153 (610)
. ...++|+|+++.|||++. ++.+.|+||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 226899999999999986 46799999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.019 Score=62.02 Aligned_cols=139 Identities=15% Similarity=0.193 Sum_probs=93.6
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccc----------------------cHH--HHHHHHHHHHHHHhcCCC
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ----------------------TDR--ARRSAHQEMELISRVRNP 61 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~----------------------~~~--~~~~l~~Ei~iL~~L~Hp 61 (610)
|-.+|..|--+.||.|... +|..+|||++..+-. ++. ..--+..|++-|.+|+.-
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4578889999999998765 566799998753211 111 111245677788888654
Q ss_pred ceeeeeeeEeecCcEEEEEEeecCCCCHH--HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCCCCceEec
Q 007266 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMA--EAIKKANGVHFPEEKLCKWLVQLLMALNYLH-ANHILHRDVKCSNIFLT 138 (610)
Q Consensus 62 nIV~l~~~~~~~~~~~~LVmEy~~GgsL~--~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLH-s~gIiHRDLKPeNILL~ 138 (610)
.|. +-.-..-.+ -.|||+++.+ +=+ -.|+. ..++...+..+-.|++.-+.-|- ..++||.||.=-|+|+-
T Consensus 227 GIP-~PePIlLk~--hVLVM~FlGr-dgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIP-CPEPILLKN--HVLVMEFLGR-DGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred CCC-CCCceeeec--ceEeeeeccC-CCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 432 222212222 3589999953 322 12332 35788889999899998888775 56999999999999875
Q ss_pred CCCCeeeeecccccc
Q 007266 139 RDQDIRLGDFGLAKM 153 (610)
Q Consensus 139 ~~g~vKL~DFGlak~ 153 (610)
+|.+.|+|.+-+-.
T Consensus 300 -dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVE 313 (520)
T ss_pred -CCEEEEEEcccccc
Confidence 78899999886543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.032 Score=60.46 Aligned_cols=75 Identities=12% Similarity=0.103 Sum_probs=47.1
Q ss_pred EecccCceEEEEEEEeCCCeEEEEEEEcccc-----ccHHHHHHHHHHHHHHHhcC--CCceee-eeeeEeecCcEEEEE
Q 007266 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLAR-----QTDRARRSAHQEMELISRVR--NPFIVE-YKDSWVEKGCYVCII 80 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-----~~~~~~~~l~~Ei~iL~~L~--HpnIV~-l~~~~~~~~~~~~LV 80 (610)
.||.|....||++.+..+++.++||.-.... .-.-..++..-|...|+... .|..|+ ++. + +.....+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~-D~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F-DTEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E-ccccceeh
Confidence 5799999999999986444689999654211 11222344556777777664 354444 433 2 33355699
Q ss_pred EeecCC
Q 007266 81 IGYCEG 86 (610)
Q Consensus 81 mEy~~G 86 (610)
||++..
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.015 Score=57.67 Aligned_cols=30 Identities=30% Similarity=0.533 Sum_probs=21.7
Q ss_pred CeecccCCCCceEe-cCCCCeeeeecccccc
Q 007266 124 HILHRDVKCSNIFL-TRDQDIRLGDFGLAKM 153 (610)
Q Consensus 124 gIiHRDLKPeNILL-~~~g~vKL~DFGlak~ 153 (610)
-++|+||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 69999999999999 7889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.067 Score=58.95 Aligned_cols=76 Identities=14% Similarity=0.139 Sum_probs=47.3
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccc--cH---HHHHHHHHHHHHHHhcC--C-CceeeeeeeEeecCcEE
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ--TD---RARRSAHQEMELISRVR--N-PFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~--~~---~~~~~l~~Ei~iL~~L~--H-pnIV~l~~~~~~~~~~~ 77 (610)
..+.||.|....||++.+. +..++||.-..... .. ....+...|+..|+.+. . .++.+++.+.. ...
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de---d~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR---TMA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC---CCC
Confidence 3678999999999999873 44688887652111 00 12233445677776654 2 35555655432 345
Q ss_pred EEEEeecCC
Q 007266 78 CIIIGYCEG 86 (610)
Q Consensus 78 ~LVmEy~~G 86 (610)
+++|||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 689999977
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.027 Score=61.70 Aligned_cols=77 Identities=12% Similarity=0.191 Sum_probs=49.8
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEcccc----ccHHHHHHHHHHHHHHHhcC--CCceee-eeeeEeecCcEEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR----QTDRARRSAHQEMELISRVR--NPFIVE-YKDSWVEKGCYVCI 79 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~----~~~~~~~~l~~Ei~iL~~L~--HpnIV~-l~~~~~~~~~~~~L 79 (610)
++.||.|.-..||++.+..+++.++||.-..-. .-.-..++..-|.++|+.+. .|..|+ ++. | +.....+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~--D~e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F--DSVMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E--CcHHhhH
Confidence 678999999999999985445678888653211 11223355666778887664 454444 443 2 3335568
Q ss_pred EEeecCC
Q 007266 80 IIGYCEG 86 (610)
Q Consensus 80 VmEy~~G 86 (610)
|||++..
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999964
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.043 Score=55.68 Aligned_cols=84 Identities=18% Similarity=0.244 Sum_probs=59.5
Q ss_pred HHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--CC
Q 007266 47 SAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA--NH 124 (610)
Q Consensus 47 ~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs--~g 124 (610)
.+..+..++.+++ .|+++... ++..+-++.|+|-.... ....++.-=+..|.-.|+ .+
T Consensus 104 ~y~nky~v~Armh--GilrL~ND---n~~~yGvIlE~Cy~~~i---------------~~~N~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND---NNYKYGVILERCYKIKI---------------NFSNFITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC---CCceeEEEEeeccCccc---------------chhHHHHHhHHHHHHhhccCCC
Confidence 4677888888874 58888753 55567799999942111 111222222456677784 38
Q ss_pred eecccCCCCceEecCCCCeeeeeccc
Q 007266 125 ILHRDVKCSNIFLTRDQDIRLGDFGL 150 (610)
Q Consensus 125 IiHRDLKPeNILL~~~g~vKL~DFGl 150 (610)
.+|+|-.|+||+-+..|.+||.|-+.
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999999774
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.22 Score=61.21 Aligned_cols=141 Identities=16% Similarity=0.225 Sum_probs=77.4
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-------CCCceeeee-eeE----ee-c
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-------RNPFIVEYK-DSW----VE-K 73 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-------~HpnIV~l~-~~~----~~-~ 73 (610)
++.|+ |..-.+|++.. .++..|++|+.+.... . ..+..|.++|..| ..|.+++-. +.+ .. .
T Consensus 30 ~~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~-~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 30 ATPLD-GERDLNFRLTT-DDGADYILKIVNPSEP-R---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred EeecC-CcCCceEEEEe-CCCCeEEEEEcCCccc-h---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 35665 45677898864 4566899999876432 1 1233344455433 334444422 111 11 1
Q ss_pred C-cEEEEEEeecCCCCHHHH-------HHH--------------hC----CCCCCH-----------------HHHHHHH
Q 007266 74 G-CYVCIIIGYCEGGDMAEA-------IKK--------------AN----GVHFPE-----------------EKLCKWL 110 (610)
Q Consensus 74 ~-~~~~LVmEy~~GgsL~~~-------Ik~--------------~~----~~~lse-----------------~~i~~i~ 110 (610)
+ ...+.+++|++|..+.+. +.. .. ...+.| ...+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 256779999999877541 100 00 001111 1112233
Q ss_pred HHHHHHHHH-----HH--HCCeecccCCCCceEecCCC--Cee-eeecccccc
Q 007266 111 VQLLMALNY-----LH--ANHILHRDVKCSNIFLTRDQ--DIR-LGDFGLAKM 153 (610)
Q Consensus 111 ~QLl~aL~y-----LH--s~gIiHRDLKPeNILL~~~g--~vK-L~DFGlak~ 153 (610)
.+++..+.- |. ..++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 333333321 21 14799999999999999875 555 999998754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.032 Score=60.20 Aligned_cols=75 Identities=20% Similarity=0.348 Sum_probs=59.3
Q ss_pred ecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeeccc
Q 007266 72 EKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGL 150 (610)
Q Consensus 72 ~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGl 150 (610)
+++.|.|++|++- |++|. .++. -..+++..|+.+.+..+.-+... ..-|||+.-.||||+ +|+|.|+||-+
T Consensus 296 de~~y~yl~~kdh-gt~is-~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 296 DETLYLYLHFKDH-GTPIS-IIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CCceEEEEEEecC-Cceee-eeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeee
Confidence 4566888999986 55553 2322 24677888888888887777766 799999999999999 99999999999
Q ss_pred cccc
Q 007266 151 AKML 154 (610)
Q Consensus 151 ak~~ 154 (610)
++.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9853
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.45 Score=50.66 Aligned_cols=29 Identities=31% Similarity=0.311 Sum_probs=24.4
Q ss_pred CCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 123 ~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3789999999999995 4 588999998753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.27 Score=51.75 Aligned_cols=75 Identities=15% Similarity=0.134 Sum_probs=43.0
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC--C-CceeeeeeeEeecCcEEEEEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR--N-PFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~--H-pnIV~l~~~~~~~~~~~~LVm 81 (610)
+-.+.||.|....+|.+. .+++.+.+|.-.... ...+..|.+-|+.|. + -.+.+.+......+ ..+|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-DAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-CCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-CceEEE
Confidence 447789999999999987 677788889876222 234677888887773 3 33445555443333 458999
Q ss_pred eecCCC
Q 007266 82 GYCEGG 87 (610)
Q Consensus 82 Ey~~Gg 87 (610)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.27 Score=52.85 Aligned_cols=137 Identities=21% Similarity=0.272 Sum_probs=78.2
Q ss_pred EecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC---CCceee---e----eeeEeecCcEEE
Q 007266 9 QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR---NPFIVE---Y----KDSWVEKGCYVC 78 (610)
Q Consensus 9 ~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIV~---l----~~~~~~~~~~~~ 78 (610)
.|.. .-..||++...+. .+++|+.+.. ... ..+.-|+..|..|. .+-.++ + +...... .+.+
T Consensus 33 ~l~s-~eN~~f~~~~~~g--~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~-~r~a 104 (331)
T COG2334 33 GLNS-EENSNFRVQTEDG--RYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG-PRPA 104 (331)
T ss_pred cccc-ccCceEEEEecCC--CeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC-ceeE
Confidence 3444 4556888876543 3488988765 332 23556777777663 222222 1 1111111 4778
Q ss_pred EEEeecCCCCHHH-----HH----------HHh-CCC---------CCCHH----HH---------HHHHHHHHHHHHHH
Q 007266 79 IIIGYCEGGDMAE-----AI----------KKA-NGV---------HFPEE----KL---------CKWLVQLLMALNYL 120 (610)
Q Consensus 79 LVmEy~~GgsL~~-----~I----------k~~-~~~---------~lse~----~i---------~~i~~QLl~aL~yL 120 (610)
-|++|++|..+.. .+ ... .+. ...+. .. .....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999987762 11 000 000 11111 00 01223444445555
Q ss_pred HHC--------C--eecccCCCCceEecCCCC-eeeeecccccc
Q 007266 121 HAN--------H--ILHRDVKCSNIFLTRDQD-IRLGDFGLAKM 153 (610)
Q Consensus 121 Hs~--------g--IiHRDLKPeNILL~~~g~-vKL~DFGlak~ 153 (610)
.+. + +||+|+.|.|||++.+.. +.++|||.|+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 442 4 999999999999998886 89999998753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.057 Score=59.06 Aligned_cols=80 Identities=9% Similarity=0.102 Sum_probs=44.5
Q ss_pred EEeEecccCceEEEEEEEeCC-CeEEEEEEE-c-c-ccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 6 VLEQIGKGSFGSALLVRHKHE-RKKYVLKKI-R-L-ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~-~~~vAIK~i-~-~-~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.++.|..|-...+|++..... +..+.+|.+ . . ........+ -.+|+++++.+...++-+.+...+.. ++|.
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ 128 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ 128 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEec-cHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence 456676699999999975433 222222311 1 1 111111111 24688899988765555443333332 4899
Q ss_pred eecCCCCHH
Q 007266 82 GYCEGGDMA 90 (610)
Q Consensus 82 Ey~~GgsL~ 90 (610)
||++|..|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987663
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.78 E-value=2.2 Score=52.42 Aligned_cols=31 Identities=26% Similarity=0.275 Sum_probs=25.6
Q ss_pred CCeecccCCCCceEecCCC--Ce---eeeecccccc
Q 007266 123 NHILHRDVKCSNIFLTRDQ--DI---RLGDFGLAKM 153 (610)
Q Consensus 123 ~gIiHRDLKPeNILL~~~g--~v---KL~DFGlak~ 153 (610)
.++||.|+.+.|||++.+. .+ -|+|||.+..
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 5899999999999998653 33 7899997754
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.21 E-value=1.7 Score=48.48 Aligned_cols=76 Identities=17% Similarity=0.200 Sum_probs=45.1
Q ss_pred EEeEecccCceEEEEEEEeCC--------CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCcee-eeeeeEeecCcE
Q 007266 6 VLEQIGKGSFGSALLVRHKHE--------RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV-EYKDSWVEKGCY 76 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~--------~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV-~l~~~~~~~~~~ 76 (610)
-++.|..|-.-.+|++..... ++.|++++.-..... .. .-.+|..+++.+....|- ++++.+ . +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~--lI-dR~~E~~v~~~ls~~gi~P~l~~~f-~-g-- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE--LY-NPISEFEVYKTMSKYRIAPQLLNTF-S-G-- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc--ee-CHHHHHHHHHHHHHCCCCCceEEEe-C-C--
Confidence 467777788889999975422 457888876533221 11 123577777766543333 344433 2 2
Q ss_pred EEEEEeecCCCCH
Q 007266 77 VCIIIGYCEGGDM 89 (610)
Q Consensus 77 ~~LVmEy~~GgsL 89 (610)
+.|.+|++|..|
T Consensus 182 -g~I~efi~g~~l 193 (442)
T PTZ00296 182 -GRIEEWLYGDPL 193 (442)
T ss_pred -CEEEEeeCCccC
Confidence 357899988744
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 610 | ||||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-59 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-43 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-42 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-42 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-34 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-33 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-33 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-31 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-30 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-30 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-30 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-30 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-30 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-30 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-29 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-29 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-28 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-28 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-28 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-28 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-28 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-28 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-28 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-27 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-27 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-27 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-27 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-27 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-27 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-27 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-27 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-27 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-27 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-27 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-26 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-26 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-26 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-26 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-26 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-26 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-26 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-26 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-26 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-26 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-26 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-25 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-25 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-25 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-25 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-25 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-25 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-25 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-25 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-25 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-25 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-25 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-25 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-25 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-24 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-24 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-24 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-24 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-24 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-24 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-24 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-23 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-23 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-23 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-23 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-23 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-23 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-23 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-23 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-23 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-23 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-23 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-23 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-23 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-23 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-22 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-22 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-22 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-22 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-22 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-22 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-22 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-22 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-22 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-22 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-22 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-22 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-22 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-22 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-22 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-22 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-22 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-22 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-22 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-22 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-22 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-22 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-22 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-22 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-22 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-22 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-22 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-22 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-22 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-22 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-22 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-22 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-22 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-22 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-22 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-22 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-22 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-22 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-22 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-22 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-22 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-22 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-22 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-22 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-22 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-22 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-22 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-21 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-21 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-21 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-21 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-21 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-21 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-21 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-21 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-21 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-21 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-21 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-21 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-21 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-21 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-21 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-21 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-21 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-21 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-21 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-21 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-21 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-21 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-21 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-21 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-21 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-21 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-21 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-21 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-21 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-21 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-21 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-21 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-21 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-21 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-20 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-20 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-20 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-20 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-20 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-20 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-20 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-20 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-20 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-20 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-20 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-20 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-20 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-20 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-20 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-20 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-20 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-20 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-20 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-20 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-19 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-19 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-19 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-19 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-19 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-19 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-19 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-19 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-19 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-18 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-18 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-18 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-18 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-18 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-18 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-18 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-18 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-18 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-18 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-18 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-18 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-18 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-18 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-18 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-18 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-18 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-18 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-17 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-17 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-17 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-17 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-17 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-17 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-17 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-17 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-17 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-17 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-17 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-17 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-16 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-16 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-16 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-16 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-16 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-16 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-16 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-15 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-15 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-15 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-15 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-15 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-14 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-08 |
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 408 bits (1050), Expect = e-139
Identities = 105/263 (39%), Positives = 172/263 (65%), Gaps = 2/263 (0%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME+Y L++IG+GSFG A+LV+ + ++YV+K+I ++R + + R + +E+ +++ +++
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P IV+Y++S+ E G + I++ YCEGGD+ + I GV F E+++ W VQ+ +AL ++
Sbjct: 83 PNIVQYRESFEENGS-LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIP 179
H ILHRD+K NIFLT+D ++LGDFG+A++L S +LA + +GTP Y+ PE+ + P
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
Y +KSDIW+LGC +YE+ K AF+A M+ L+ KI P+ YS R LV +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261
Query: 240 RKNPEFRPSAAELLCHPHLQPYV 262
++NP RPS +L + +
Sbjct: 262 KRNPRDRPSVNSILEKGFIAKRI 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-132
Identities = 98/275 (35%), Positives = 147/275 (53%), Gaps = 9/275 (3%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
E YEVL IG GS+G +R K + K V K++ T+ ++ E+ L+ +++
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 61 PFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMAL 117
P IV Y D +++ + I++ YCEGGD+A I K + EE + + + QL +AL
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 118 NYLH-----ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMC 171
H + +LHRD+K +N+FL Q+++LGDFGLA++L D A + VGTP YM
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231
PE + + Y KSDIWSLGC +YE+ A F AF + L KI + +P YS
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIH 266
++ ML RPS E+L +P + + H
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-126
Identities = 65/275 (23%), Positives = 129/275 (46%), Gaps = 26/275 (9%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
++ +E IG G FG +H+ + K YV+K+++ + A +E++ ++++ +
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDH 63
Query: 61 PFIVEYKDSWVE---------------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 105
IV Y W K + I + +C+ G + + I+K G +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 106 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 165
+ Q+ ++Y+H+ +++RD+K SNIFL + +++GDFGL L +D + G
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183
Query: 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT 225
T YM PE ++ YG + D+++LG + E+ AF+ + +
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRDG---IISD 238
Query: 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260
++ + L++ +L K PE RP+ +E+L +
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-124
Identities = 85/275 (30%), Positives = 144/275 (52%), Gaps = 8/275 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVR 59
+ + + ++IG+G F + LKK+++ D +AR +E++L+ ++
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLVQLLMAL 117
+P +++Y S++E + I++ + GD++ IK K PE + K+ VQL AL
Sbjct: 91 HPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLA 176
++H+ ++HRD+K +N+F+T ++LGD GL + S A S+VGTP YM PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKA--FDMQALINKINKSIVAPLPT-VYSGAFRG 233
+ Y KSDIWSLGC +YEM+A ++ F ++ +L KI + PLP+ YS R
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 234 LVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 268
LV + +PE RP + L+
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 340 bits (873), Expect = e-113
Identities = 72/284 (25%), Positives = 133/284 (46%), Gaps = 28/284 (9%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ +E ++ +G+G FG ++K + Y +K+IRL + + AR +E++ ++++ +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEH 62
Query: 61 PFIVEYKDSWVEKGC-----------YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC-K 108
P IV Y ++W+EK Y+ I + C ++ + + + E +C
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 109 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV----- 163
+Q+ A+ +LH+ ++HRD+K SNIF T D +++GDFGL + D+ +V
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 164 --------VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 215
VGT YM PE + Y K DI+SLG ++E+ + + +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDV 240
Query: 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
PL T +V+ ML +P RP A ++ + +
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-109
Identities = 72/261 (27%), Positives = 120/261 (45%), Gaps = 9/261 (3%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-R 59
+ ++ L ++G GS+G VR K + + Y +K+ + + R E+ +V +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+P V + +W E G + + C G + + + G PE ++ +L L+AL +
Sbjct: 116 HPCCVRLEQAWEEGGI-LYLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAH 172
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
LH+ ++H DVK +NIFL +LGDFGL L + G P YM PELL
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-S 231
Query: 180 YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
YG+ +D++SLG + E+ + Q L + S R ++ M
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY---LPPEFTAGLSSELRSVLVMM 288
Query: 239 LRKNPEFRPSAAELLCHPHLQ 259
L +P+ R +A LL P L+
Sbjct: 289 LEPDPKLRATAEALLALPVLR 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-103
Identities = 69/282 (24%), Positives = 127/282 (45%), Gaps = 30/282 (10%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RN 60
++ LE+IG G FGS + + Y +K+ + ++A +E+ + + ++
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGV--HFPEEKLCKWLVQLLMALN 118
+V Y +W E ++ I YC GG +A+AI + + +F E +L L+Q+ L
Sbjct: 71 SHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 119 YLHANHILHRDVKCSNIFLTRDQDI-------------------RLGDFGLAKMLISDDL 159
Y+H+ ++H D+K SNIF++R ++GD G +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SS 186
Query: 160 ASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS 218
G ++ E+L + + K+DI++L V + + + D ++I +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG 243
Query: 219 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260
+ +P V S F L+K M+ +PE RPSA L+ H L
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 6e-99
Identities = 70/292 (23%), Positives = 131/292 (44%), Gaps = 37/292 (12%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+E + +G+G+FG + R+ + + Y +KKIR T+ + E+ L++ + +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQ 62
Query: 62 FIVEYKDSWVE------------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 109
++V Y +W+E K + I + YCE G + + I ++ ++ +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRL 121
Query: 110 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML--------------- 154
Q+L AL+Y+H+ I+HRD+K NIF+ +++++GDFGLAK +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 155 ISDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALIN 213
S D +S +GT Y+ E+L Y K D++SLG +EM + ++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK 239
Query: 214 KINK---SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262
K+ + +++ ++ +P RP A LL L
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 1e-82
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 23/286 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ Y ++++G+G F LV H+ Y LK+I Q DR A +E ++ +P
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHP 86
Query: 62 FIVEYKDSWVEK---GCYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLVQLLMA 116
I+ + + +++ + + G + I+ K G E+++ L+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS----------VVGT 166
L +HA HRD+K +NI L + L D G S T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 167 PSYMCPELLADIPY---GSKSDIWSLGCCVYEMSAQKAAFKAFDMQA--LINKINKSIVA 221
SY PEL + + ++D+WSLGC +Y M + + + + + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 222 PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH-LQPYVLGIH 266
P +S A L+ SM+ +P RP LL LQP G H
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 254 bits (649), Expect = 1e-79
Identities = 60/329 (18%), Positives = 120/329 (36%), Gaps = 73/329 (22%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY----------------VLKKIRLARQ---- 40
+ +E ++ +G+G FG ++K + Y V+++++ +
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 41 ------------------------------------TDRARRSAHQEMELISRVRNPFIV 64
+ + ++ + V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC-KWLVQLLMALNYLHAN 123
K + I + C ++ + + + + E +C +Q+ A+ +LH+
Sbjct: 125 GQLQPSSPKVY-LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV-------------VGTPSYM 170
++HRD+K SNIF T D +++GDFGL + D+ +V VGT YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 171 CPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGA 230
PE + Y K DI+SLG ++E+ + + +I + L T
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLFTQKYPQ 301
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
+V+ ML +P RP A +++ + +
Sbjct: 302 EHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-68
Identities = 65/260 (25%), Positives = 120/260 (46%), Gaps = 12/260 (4%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYK 67
+IG+GSF + + +++ + T R+ +E E++ +++P IV +
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 68 DSWV---EKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
DSW + + ++ G + +K+ + L W Q+L L +LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 125 --ILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 181
I+HRD+KC NIF+T +++GD GLA + A +V+GTP +M PE+ + Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE-KYD 207
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI--NKSIVAPLPTVYSGAFRGLVKSML 239
D+++ G C+ EM+ + + A I + + A V + +++ +
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 240 RKNPEFRPSAAELLCHPHLQ 259
R+N + R S +LL H Q
Sbjct: 268 RQNKDERYSIKDLLNHAFFQ 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-66
Identities = 77/343 (22%), Positives = 150/343 (43%), Gaps = 30/343 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-- 59
Y +L+QIG G V ++ ++ Y +K + L ++ S E+ +++++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+ I+ D + Y+ +++ C D+ +KK + + +L A++
Sbjct: 68 SDKIIRLYDYEITDQ-YIYMVM-ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHT 123
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLA 176
+H + I+H D+K +N + D ++L DFG+A + D + S VGT +YM PE +
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 177 DIP-----------YGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPL 223
D+ KSD+WSLGC +Y M+ K F+ + L I+ +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSD 283
P + + ++K L+++P+ R S ELL HP++Q +N + T E
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ----THPVNQMAKGT--TEEMK 296
Query: 284 SNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDS 326
+ + + + + + +S + N S S+T +
Sbjct: 297 YVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 339
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 7e-66
Identities = 69/279 (24%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR- 59
Y +L+QIG G V ++ ++ Y +K + L ++ S E+ +++++
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 60 -NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+ I+ D + Y+ +++ C D+ +KK + + +L A++
Sbjct: 86 HSDKIIRLYDYEITDQ-YIYMVM-ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVH 141
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELL 175
+H + I+H D+K +N + D ++L DFG+A + D + S VGT +YM PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 176 ADIP-----------YGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAP 222
D+ KSD+WSLGC +Y M+ K F+ + L I+ +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260
Query: 223 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
P + + ++K L+++P+ R S ELL HP++Q
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-64
Identities = 65/292 (22%), Positives = 116/292 (39%), Gaps = 31/292 (10%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN-P 61
+ V + +G F + ++Y LK RL + R+ QE+ + ++ P
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 62 FIVEYKDSWV-------EKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
IV++ + ++ C+G + K + + + K Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 115 MALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS---------- 162
A+ ++H I+HRD+K N+ L+ I+L DFG A + S
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 163 ---VVGTPSYMCPELL---ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN 216
TP Y PE++ ++ P G K DIW+LGC +Y + ++ F+ ++N
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG-- 264
Query: 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 268
P F L+++ML+ NPE R S AE++ ++ K
Sbjct: 265 -KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 6e-64
Identities = 74/344 (21%), Positives = 146/344 (42%), Gaps = 30/344 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR- 59
Y +L+QIG G V ++ ++ Y +K + L ++ S E+ +++++
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 60 -NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+ I+ D + Y+ +++ C D+ +KK + + +L A++
Sbjct: 114 HSDKIIRLYDYEITDQ-YIYMVM-ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVH 169
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELL 175
+H + I+H D+K +N + D ++L DFG+A + D + S VG +YM PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 176 ADIP-----------YGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAP 222
D+ KSD+WSLGC +Y M+ K F+ + L I+ +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288
Query: 223 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWS 282
P + + ++K L+++P+ R S ELL HP++Q + E
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ------THPVNQMAKGTTEEM 342
Query: 283 DSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDS 326
+ + + + + + +S + N S S+T +
Sbjct: 343 KYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 386
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-59
Identities = 75/265 (28%), Positives = 115/265 (43%), Gaps = 19/265 (7%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ ++G+GSFG ++ K + +KK+RL +E+ + + +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSS 109
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P IV + V +G +V I + EGG + + IK+ PE++ +L Q L L YL
Sbjct: 110 PRIVPLYGA-VREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYL 166
Query: 121 HANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDLAS------SVVGTPSYMCPE 173
H ILH DVK N+ L+ D L DFG A L D L + GT ++M PE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI--NKSIVAPLPTVYSGAF 231
++ P +K DIWS C + M + + L KI + +P +
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHP 256
++ LRK P R SA EL
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKV 311
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-57
Identities = 69/255 (27%), Positives = 118/255 (46%), Gaps = 12/255 (4%)
Query: 10 IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDS 69
+GKG++G R + + +K+I + R + H+E+ L +++ IV+Y S
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 70 WVEKGCYVCIIIGYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMALNYLHANHILHR 128
+ ++ I + GG ++ ++ G + E+ + + Q+L L YLH N I+HR
Sbjct: 88 -FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 129 DVKCSNIFL-TRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPE--LLADIPYGSKS 184
D+K N+ + T +++ DFG +K L + + GT YM PE YG +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 185 DIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRK 241
DIWSLGC + EM+ K F A+ K+ V P +P S + +
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 242 NPEFRPSAAELLCHP 256
+P+ R A +LL
Sbjct: 266 DPDKRACANDLLVDE 280
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-56
Identities = 82/257 (31%), Positives = 132/257 (51%), Gaps = 8/257 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E + LE+IGKGSFG +K +K I L D QE+ ++S+ +P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 80
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
++ +Y S++ K + II+ Y GG + ++ E ++ L ++L L+YLH
Sbjct: 81 YVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 136
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLADIPY 180
+ +HRD+K +N+ L+ +++L DFG+A L + ++ VGTP +M PE++ Y
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
SK+DIWSLG E++ + M+ L I K+ L YS + V++ L
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACL 255
Query: 240 RKNPEFRPSAAELLCHP 256
K P FRP+A ELL H
Sbjct: 256 NKEPSFRPTAKELLKHK 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-56
Identities = 72/261 (27%), Positives = 125/261 (47%), Gaps = 14/261 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELI 55
+E +E+ +GKG FG+ L R K + LK ++ A + RR E+E+
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR----EVEIQ 63
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
S +R+P I+ + V +I+ Y G + ++K + F E++ ++ +L
Sbjct: 64 SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELAN 120
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
AL+Y H+ ++HRD+K N+ L ++++ DFG + + + GT Y+ PE++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMI 179
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235
+ K D+WSLG YE K F+A Q +I++ P + R L+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-FPDFVTEGARDLI 238
Query: 236 KSMLRKNPEFRPSAAELLCHP 256
+L+ NP RP E+L HP
Sbjct: 239 SRLLKHNPSQRPMLREVLEHP 259
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 6e-56
Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 14/271 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEME-LISRVR 59
+ E L ++G G+ G +R + +K++R + + + +++ ++
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHD 82
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
P+IV+ +++ V I + AE +KK PE L K V ++ AL Y
Sbjct: 83 CPYIVQCFGTFITNTD-VFIAMELMGTC--AEKLKKRMQGPIPERILGKMTVAIVKALYY 139
Query: 120 LHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE----- 173
L H ++HRDVK SNI L I+L DFG++ L+ D G +YM PE
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKI--NKSIVAPLPTVYSGA 230
Y ++D+WSLG + E++ + +K ++ K+ + + P +SG
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
F+ VK L K+ RP +LL H ++ Y
Sbjct: 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-56
Identities = 83/305 (27%), Positives = 133/305 (43%), Gaps = 49/305 (16%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ +E + ++G G+ G V HK K I L R +E++++ +
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNS 90
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P+IV + ++ G + I + + +GG + + +KKA PE+ L K + ++ L YL
Sbjct: 91 PYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYL 147
Query: 121 HANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
H I+HRDVK SNI + +I+L DFG++ LI D +A+S VGT SYM PE L
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA----------------------------- 210
Y +SDIWS+G + EM+ + D +
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 211 -------------LINKINKSIVAPLPT-VYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
L++ I LP+ V+S F+ V L KNP R +L+ H
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326
Query: 257 HLQPY 261
++
Sbjct: 327 FIKRS 331
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-55
Identities = 76/264 (28%), Positives = 130/264 (49%), Gaps = 15/264 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++Y E+IG+G+ G+ ++ ++++ L +Q + E+ ++ +NP
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV Y DS++ G + +++ Y GG + + + + E ++ + L AL +LH
Sbjct: 78 NIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLADIPY 180
+N ++HRD+K NI L D ++L DFG + + S++VGTP +M PE++ Y
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIVAPL--PTVYSGAFRGLV 235
G K DIWSLG EM + + + ++AL I + L P S FR +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALY-LIATNGTPELQNPEKLSAIFRDFL 250
Query: 236 KSMLRKNPEFRPSAAELLCHPHLQ 259
L + E R SA ELL H L+
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-55
Identities = 79/262 (30%), Positives = 135/262 (51%), Gaps = 17/262 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +IG+GS G L R KH ++ +K + L +Q R E+ ++ ++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHF 102
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+VE S++ G + +++ + +GG + + + + V EE++ +L AL YLH
Sbjct: 103 NVVEMYKSYL-VGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH 158
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELLADIP 179
A ++HRD+K +I LT D ++L DFG + S D+ S+VGTP +M PE+++
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIVAPL--PTVYSGAFRGL 234
Y ++ DIWSLG V EM + + F +QA+ ++ S L S R
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPY--FSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDF 274
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
++ ML ++P+ R +A ELL HP
Sbjct: 275 LERMLVRDPQERATAQELLDHP 296
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-54
Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 13/271 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEME-LISRVR 59
+ E + ++G+G++G +RH + +K+IR + ++ +++ + V
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTVD 64
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGG--DMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
PF V + + +G V I + + + + PE+ L K V ++ AL
Sbjct: 65 CPFTVTFYGALFREGD-VWICMELMDTSLDKFYKQVIDKGQT-IPEDILGKIAVSIVKAL 122
Query: 118 NYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE--- 173
+LH+ ++HRDVK SN+ + +++ DFG++ L+ D G YM PE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN 182
Query: 174 -LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPLPT-VYSGA 230
L Y KSDIWSLG + E++ + + ++ + ++ + LP +S
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE 242
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
F L+KN + RP+ EL+ HP +
Sbjct: 243 FVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-54
Identities = 82/262 (31%), Positives = 134/262 (51%), Gaps = 17/262 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E ++VLE++G+GS+GS HK + +K++ + +E+ ++ + +P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII----KEISIMQQCDSP 84
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+Y S+ K + I++ YC G +++ I+ N E+++ L L L YLH
Sbjct: 85 HVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLH 142
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLADIPY 180
+HRD+K NI L + +L DFG+A L ++V+GTP +M PE++ +I Y
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTV-----YSGAFRGL 234
+DIWSLG EM+ K + M+A+ I + P PT +S F
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTN---PPPTFRKPELWSDNFTDF 258
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
VK L K+PE R +A +LL HP
Sbjct: 259 VKQCLVKSPEQRATATQLLQHP 280
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-54
Identities = 75/262 (28%), Positives = 135/262 (51%), Gaps = 13/262 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELI 55
+E ++V +GKGSF H + +K + A R + E+++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN----EVKIH 65
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
++++P I+E + + E YV +++ C G+M +K F E + ++ Q++
Sbjct: 66 CQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIIT 123
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPEL 174
+ YLH++ ILHRD+ SN+ LTR+ +I++ DFGLA L ++ GTP+Y+ PE+
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI 183
Query: 175 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
+G +SD+WSLGC Y + + F ++ +NK+ + +P+ S + L
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-MPSFLSIEAKDL 242
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
+ +LR+NP R S + +L HP
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHP 264
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 5e-54
Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 15/274 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR-VR 59
E + L +IG+G++GS + HK + +K+IR ++ +++++ R
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSD 79
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGG--DMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
P+IV++ + +G I + + + PEE L K + + AL
Sbjct: 80 CPYIVQFYGALFREGD-CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 118 NYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE--- 173
N+L N I+HRD+K SNI L R +I+L DFG++ L+ + G YM PE
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 174 -LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINK----SIVAPLPTVY 227
+ Y +SD+WSLG +YE++ + + ++ + + ++ K + +
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258
Query: 228 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
S +F V L K+ RP ELL HP + Y
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-54
Identities = 86/269 (31%), Positives = 140/269 (52%), Gaps = 24/269 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E +E++ ++G G+FG ++K K I + + E+E+++ +P
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYIVEIEILATCDHP 76
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+IV+ ++ + I+I +C GG + + + + E ++ Q+L ALN+LH
Sbjct: 77 YIVKLLGAYY-HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLH 134
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLA---- 176
+ I+HRD+K N+ +T + DIRL DFG++ + S +GTP +M PE++
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 177 -DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIVAPLPTV-----Y 227
D PY K+DIWSLG + EM+ + + M+ L+ KI KS PT+ +
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPH--HELNPMRVLL-KIAKS---DPPTLLTPSKW 248
Query: 228 SGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
S FR +K L KNPE RPSAA+LL HP
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHP 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-53
Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 58/312 (18%)
Query: 2 EQYEVLEQIGKG--SFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR 59
YE+L IGKG + L R+K + +++I L ++ E+ +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+P IV Y+ +++ + ++ + G + I E + L +L AL+Y
Sbjct: 85 HPNIVPYRATFI-ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--------DLASSVVGTPSYMC 171
+H +HR VK S+I ++ D + L +IS D V ++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 172 PELLA--DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKIN------------ 216
PE+L Y +KSDI+S+G E++ FK Q L+ K+N
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263
Query: 217 --------------------------------KSIVAPLPTVYSGAFRGLVKSMLRKNPE 244
S P +S F V+ L++NP+
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323
Query: 245 FRPSAAELLCHP 256
RPSA+ LL H
Sbjct: 324 ARPSASTLLNHS 335
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-53
Identities = 71/272 (26%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RN 60
+E++E +G G++G RH + +K + + + QE+ ++ + +
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHH 80
Query: 61 PFIVEYKDSWVEKGCYVC-----IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
I Y ++++K +++ +C G + + IK G EE + ++L
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPEL 174
L++LH + ++HRD+K N+ LT + +++L DFG++ L ++ +GTP +M PE+
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 175 LA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTV-- 226
+A D Y KSD+WSLG EM+ M+AL I ++ P P +
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRN---PAPRLKS 256
Query: 227 --YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+S F+ ++S L KN RP+ +L+ HP
Sbjct: 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-53
Identities = 72/298 (24%), Positives = 132/298 (44%), Gaps = 18/298 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELI 55
+Y +GKG F + ++ + K + Q ++ E+ +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIH 95
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+ + +V + + E +V +++ C + E K+ E + +L Q+++
Sbjct: 96 RSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVL 152
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPEL 174
YLH N ++HRD+K N+FL D ++++GDFGLA + D + GTP+Y+ PE+
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 212
Query: 175 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
L+ + + D+WS+GC +Y + K F+ ++ +I K+ +P + L
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASL 271
Query: 235 VKSMLRKNPEFRPSAAELLCHP----HLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKK 288
++ ML+ +P RP+ ELL P L I PR + P SN K
Sbjct: 272 IQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKP 329
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 57/261 (21%), Positives = 117/261 (44%), Gaps = 14/261 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELI 55
++ +++ +GKG FG+ L R K + LK ++ + RR E+E+
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR----EIEIQ 68
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
S +R+P I+ + + + +++ + G++ + ++K F E++ ++ +L
Sbjct: 69 SHLRHPNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELAD 125
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
AL+Y H ++HRD+K N+ + ++++ DFG + ++ GT Y+ PE++
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRTMCGTLDYLPPEMI 184
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235
+ K D+W G YE F + +I + P S + L+
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-FPPFLSDGSKDLI 243
Query: 236 KSMLRKNPEFRPSAAELLCHP 256
+LR +P R ++ HP
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHP 264
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-52
Identities = 69/262 (26%), Positives = 131/262 (50%), Gaps = 12/262 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E Y+ ++++G G++G LL R K + +K IR + + +E+ ++ + +P
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I++ D + +K +++ +GG++ + I F E + Q+L + YLH
Sbjct: 97 NIMKLYDFFEDKR-NYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH 153
Query: 122 ANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
++I+HRD+K N+ ++++D I++ DFGL+ + + +GT Y+ PE+L
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK- 212
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFRGL 234
Y K D+WS+G ++ + A F Q ++ K+ K V GA + L
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA-KDL 271
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
+K ML+ + + R SA + L HP
Sbjct: 272 IKQMLQFDSQRRISAQQALEHP 293
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-52
Identities = 66/262 (25%), Positives = 129/262 (49%), Gaps = 12/262 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+Y ++ +GKGSFG L + + +++Y +K I A ++ + +E+EL+ ++ +P
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I++ + + I+ GG++ + I K F E + + Q+ + Y+H
Sbjct: 82 NIMKLFEILEDSS-SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH 138
Query: 122 ANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
++I+HRD+K NI ++++D I++ DFGL+ + +GT Y+ PE+L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG- 197
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFRGL 234
Y K D+WS G +Y + + F + ++ ++ T+ A + L
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA-KDL 256
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
++ ML +P R +A + L HP
Sbjct: 257 IRKMLTFHPSLRITATQCLEHP 278
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 3e-52
Identities = 62/311 (19%), Positives = 116/311 (37%), Gaps = 49/311 (15%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISRV 58
+ + + +G+G+ + RHK + V I R D R E E++ ++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----EFEVLKKL 64
Query: 59 RNPFIVEYKDSWVEKGC-YVCIIIGYCEGGDMAEAI-KKANGVHFPEEKLCKWLVQLLMA 116
+ IV+ E + +I+ +C G + + + +N PE + L ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQD----IRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
+N+L N I+HR++K NI +D +L DFG A+ L D+ S+ GT Y+ P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 173 ELLADI--------PYGSKSDIWSLGCCVYEMSAQKAAFKAFDM----QALINKINK--- 217
++ YG+ D+WS+G Y + F+ F+ + ++ KI
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 218 -----------------SIVAPLPTVYSGAFRGLVKS----MLRKNPEFRPSAAELLCHP 256
S P+ S + L+ +L + E +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 257 HLQPYVLGIHL 267
+ H
Sbjct: 305 SDILHRGNSHH 315
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-52
Identities = 63/262 (24%), Positives = 122/262 (46%), Gaps = 14/262 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELI 55
+Y +GKG F + ++ + K + Q ++ E+ +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIH 69
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+ + +V + + E +V +++ C + E K+ E + +L Q+++
Sbjct: 70 RSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVL 126
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPEL 174
YLH N ++HRD+K N+FL D ++++GDFGLA + D + GTP+Y+ PE+
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 186
Query: 175 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
L+ + + D+WS+GC +Y + K F+ ++ +I K+ +P + L
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASL 245
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
++ ML+ +P RP+ ELL
Sbjct: 246 IQKMLQTDPTARPTINELLNDE 267
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-52
Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 24/277 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ YE+ E IG G+ +++K +K+I L + +E++ +S+ +P
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQCHHP 73
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA------NGVHFPEEKLCKWLVQLLM 115
IV Y S+V + +++ GG + + IK E + L ++L
Sbjct: 74 NIVSYYTSFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS------SVVGTPSY 169
L YLH N +HRDVK NI L D +++ DFG++ L + + + VGTP +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 170 MCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKS--------I 219
M PE++ + Y K+DIWS G E++ A + + M+ L+ +
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 220 VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ Y +FR ++ L+K+PE RP+AAELL H
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-51
Identities = 69/263 (26%), Positives = 127/263 (48%), Gaps = 13/263 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVRN 60
++Y+ +GKGSFG +L + K ++ +K I + + + S +E++L+ ++ +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P I++ + + +KG Y ++ GG++ + I F E + + Q+L + Y+
Sbjct: 86 PNIMKLYEFFEDKG-YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYM 142
Query: 121 HANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
H N I+HRD+K N+ ++ +D IR+ DFGL+ + +GT Y+ PE+L
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 202
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFRG 233
Y K D+WS G +Y + + F + ++ K+ K V A +
Sbjct: 203 -TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA-KD 260
Query: 234 LVKSMLRKNPEFRPSAAELLCHP 256
L++ ML P R SA + L H
Sbjct: 261 LIRKMLTYVPSMRISARDALDHE 283
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-50
Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 19/264 (7%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSA-HQEMELISRVRN 60
+ + L +IG GSFG+ R + +KK+ + + + +E+ + ++R+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P ++Y+ ++ + +++ YC G ++ ++ E ++ L L YL
Sbjct: 114 PNTIQYRGCYL-REHTAWLVMEYCLGS-ASDLLEVHKKP-LQEVEIAAVTHGALQGLAYL 170
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA---D 177
H+++++HRDVK NI L+ ++LGDFG A ++ A+S VGTP +M PE++ +
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDE 227
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTV----YSGAFR 232
Y K D+WSLG E++ +K + M AL I ++ P + +S FR
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQN---ESPALQSGHWSEYFR 283
Query: 233 GLVKSMLRKNPEFRPSAAELLCHP 256
V S L+K P+ RP++ LL H
Sbjct: 284 NFVDSCLQKIPQDRPTSEVLLKHR 307
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 9e-50
Identities = 76/270 (28%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLAR--QTDRARRSAHQEMELI 55
E ++ + +G+GSF + +L R ++Y +L+K + + + R E +++
Sbjct: 29 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR----ERDVM 84
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
SR+ +PF V+ ++ + + + Y + G++ + I+K F E + +++
Sbjct: 85 SRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVS 141
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCP 172
AL YLH I+HRD+K NI L D I++ DFG AK+L + A+S VGT Y+ P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232
ELL + SD+W+LGC +Y++ A F+A + + KI K P + R
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-FPEKFFPKAR 260
Query: 233 GLVKSMLRKNPEFRP------SAAELLCHP 256
LV+ +L + R L HP
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 69/262 (26%), Positives = 125/262 (47%), Gaps = 14/262 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ + +E +G G+F LV+ + K + LK I+ + + E+ ++ ++++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS--LENEIAVLKKIKHE 66
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV +D E + +++ GG++ + I + + E+ + Q+L A+ YLH
Sbjct: 67 NIVTLED-IYESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH 123
Query: 122 ANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
N I+HRD+K N+ +LT +++ I + DFGL+KM + + S+ GTP Y+ PE+LA
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGIMSTACGTPGYVAPEVLAQK 182
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRGL 234
PY D WS+G Y + F L KI + + A +
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA-KDF 241
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
+ +L K+P R + + L HP
Sbjct: 242 ICHLLEKDPNERYTCEKALSHP 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-49
Identities = 70/266 (26%), Positives = 134/266 (50%), Gaps = 16/266 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
+ +E+L IGKGSFG +V+ +K Y + K + + R+ +E++++
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER--NEVRNVFKELQIMQG 71
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+ +PF+V S+ ++ + +++ GGD+ +++ VHF EE + ++ +L+MAL
Sbjct: 72 LEHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMAL 128
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
+YL I+HRD+K NI L + + DF +A ML + +++ GT YM PE+ +
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 178 IP---YGSKSDIWSLGCCVYEMSAQKAAF---KAFDMQALINKINKSIVAPLPTVYSGAF 231
Y D WSLG YE+ + + + + +++ ++V P+ +S
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-TYPSAWSQEM 247
Query: 232 RGLVKSMLRKNPEFR-PSAAELLCHP 256
L+K +L NP+ R +++ P
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFP 273
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-49
Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 23/273 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAH-----------Q 50
E Y + ++G G++G LL + K+ + +K I+ ++ +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 51 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 110
E+ L+ + +P I++ D + E Y ++ + EGG++ E I + F E +
Sbjct: 96 EISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIM 152
Query: 111 VQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTP 167
Q+L + YLH ++I+HRD+K NI ++ I++ DFGL+ D +GT
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 168 SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APL 223
Y+ PE+L Y K D+WS G +Y + F + Q +I K+ K
Sbjct: 213 YYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ A + L+K ML + R +A E L
Sbjct: 272 KNISDEA-KELIKLMLTYDYNKRCTAEEALNSR 303
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-49
Identities = 66/262 (25%), Positives = 129/262 (49%), Gaps = 12/262 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+Y ++ +GKGSFG L + + +++Y +K I A ++ + +E+EL+ ++ +P
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I++ + + I+ GG++ + I K F E + + Q+ + Y+H
Sbjct: 82 NIMKLFEILEDSS-SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH 138
Query: 122 ANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
++I+HRD+K NI ++++D I++ DFGL+ + +GT Y+ PE+L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG- 197
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFRGL 234
Y K D+WS G +Y + + F + ++ ++ T+ A + L
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA-KDL 256
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
++ ML +P R +A + L HP
Sbjct: 257 IRKMLTFHPSLRITATQCLEHP 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-48
Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 11/262 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ Y+V E++GKG+F HK ++ K I + + R + +E + ++++P
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV DS E+ + ++ GG++ E I + E + Q+L ++ Y H
Sbjct: 66 NIVRLHDSIQEES-FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH 122
Query: 122 ANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
+N I+HR++K N+ ++ + ++L DFGLA + + GTP Y+ PE+L
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFRGL 234
PY DIW+ G +Y + F D L +I TV A + L
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-KSL 241
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
+ SML NP+ R +A + L P
Sbjct: 242 IDSMLTVNPKKRITADQALKVP 263
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 59/297 (19%), Positives = 112/297 (37%), Gaps = 49/297 (16%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISRV 58
+ + + +G+G+ + RHK + V I R D R E E++ ++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----EFEVLKKL 64
Query: 59 RNPFIVEYKDSWVEKGC-YVCIIIGYCEGGDMAEAI-KKANGVHFPEEKLCKWLVQLLMA 116
+ IV+ E + +I+ +C G + + + +N PE + L ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQD----IRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
+N+L N I+HR++K NI +D +L DFG A+ L D+ S+ GT Y+ P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 173 ELLADI--------PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--- 221
++ YG+ D+WS+G Y + F+ F+ ++ I+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 222 ---------------------PLPTVYSGAFRGLVKS----MLRKNPEFRPSAAELL 253
P+ S + L+ +L + E +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 7e-48
Identities = 68/263 (25%), Positives = 126/263 (47%), Gaps = 16/263 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +EV ++G+G+ + K +K Y LK ++ R E+ ++ R+ +P
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT----EIGVLLRLSHP 108
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I++ K+ + E + +++ GG++ + I + ++ E + Q+L A+ YLH
Sbjct: 109 NIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLH 165
Query: 122 ANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
N I+HRD+K N+ + T D +++ DFGL+K++ L +V GTP Y PE+L
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKA-FDMQALINKINKSIV----APLPTVYSGAFRG 233
YG + D+WS+G Y + F Q + +I V A +
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA-KD 284
Query: 234 LVKSMLRKNPEFRPSAAELLCHP 256
LV+ ++ +P+ R + + L HP
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHP 307
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-47
Identities = 71/267 (26%), Positives = 118/267 (44%), Gaps = 14/267 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
+ +GKG FG + + K Y L+K R+ ++ A A E +++ +
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA--MALNEKQILEK 240
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
V + F+V ++ K +C+++ GGD+ I FPE + + ++ L
Sbjct: 241 VNSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
LH I++RD+K NI L IR+ D GLA + VGT YM PE++ +
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGL 234
Y D W+LGC +YEM A ++ F+ + ++ + + +S R L
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419
Query: 235 VKSMLRKNPEFR-----PSAAELLCHP 256
+L K+P R SA E+ HP
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHP 446
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 67/309 (21%), Positives = 126/309 (40%), Gaps = 38/309 (12%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN-P 61
+ + +G G+ G+ + R + + +K+I + A +E++L+ P
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSF-----ADREVQLLRESDEHP 78
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
++ Y + + + I I C + E +++ + L Q L +LH
Sbjct: 79 NVIRYFCT-EKDRQFQYIAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 122 ANHILHRDVKCSNIFLTRDQD-----IRLGDFGLAKMLISDDLA----SSVVGTPSYMCP 172
+ +I+HRD+K NI ++ + DFGL K L + S V GT ++ P
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 173 ELLADIP---YGSKSDIWSLGCCVYEMSAQKAAF--KAFDMQA--LINKINKSIVAPLPT 225
E+L++ DI+S GC Y + ++ + K+ QA L+ + + P
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSN 285
R L++ M+ +P+ RPSA +L HP + ++ F + SD
Sbjct: 256 E-DVIARELIEKMIAMDPQKRPSAKHVLKHPFFW----------SLEKQLQFFQDVSD-R 303
Query: 286 FKKTRFMEP 294
+K P
Sbjct: 304 IEKESLDGP 312
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-47
Identities = 79/338 (23%), Positives = 140/338 (41%), Gaps = 18/338 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ Y+V E++GKG+F HK ++ K I + + R + +E + ++++P
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV DS E+ + ++ GG++ E I + E + Q+L ++ Y H
Sbjct: 89 NIVRLHDSIQEES-FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH 145
Query: 122 ANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
+N I+HR++K N+ ++ + ++L DFGLA + + GTP Y+ PE+L
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRGL 234
PY DIW+ G +Y + F D L +I TV A + L
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-KSL 264
Query: 235 VKSMLRKNPEFRPSAAELLCHPHLQ---PYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRF 291
+ SML NP+ R +A + L P + IH + F + K
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFN---ARRKLKGA-I 320
Query: 292 MEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLSS 329
+ + + + R + PS + +S +
Sbjct: 321 LTTMIATRNLSNLGRNLLNKKEQGPPSTIKESSESSQT 358
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-47
Identities = 72/263 (27%), Positives = 121/263 (46%), Gaps = 12/263 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+Y++ E++GKG+F ++Y I + + R + +E + +++P
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV DS E+G + +I GG++ E I ++ E + Q+L A+ + H
Sbjct: 71 NIVRLHDSISEEG-HHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH 127
Query: 122 ANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLAD 177
++HR++K N+ ++ + ++L DFGLA + + A GTP Y+ PE+L
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRG 233
PYG D+W+ G +Y + F D L +I TV A +
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA-KD 246
Query: 234 LVKSMLRKNPEFRPSAAELLCHP 256
L+ ML NP R +AAE L HP
Sbjct: 247 LINKMLTINPSKRITAAEALKHP 269
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-47
Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 24/275 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
+ +E+L+ IG+G+F +V+ K + Y ++ K + ++ + + E +++
Sbjct: 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE--ERDVLVN 117
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+I + ++ ++ Y+ +++ Y GGD+ + K G P E +L +++MA+
Sbjct: 118 GDRRWITQLHFAFQDEN-YLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAI 175
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELL 175
+ +H +HRD+K NI L R IRL DFG L +D + VGTP Y+ PE+L
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 176 -------ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVY 227
YG + D W+LG YEM + F A KI + LP V
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295
Query: 228 ---SGAFRGLVKSMLRKNPEFR---PSAAELLCHP 256
R ++ +L PE R A + HP
Sbjct: 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 174 bits (441), Expect = 9e-47
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 15/296 (5%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+E+ E++G G FG L H+ ++ +K+ R + + R E++++ ++ +P
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMKKLNHPN 73
Query: 63 IVEYKD-----SWVEKGCYVCIIIGYCEGGDMAEAI-KKANGVHFPEEKLCKWLVQLLMA 116
+V ++ + + + YCEGGD+ + + + N E + L + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
L YLH N I+HRD+K NI L ++ D G AK L +L + VGT Y+ PE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233
LL Y D WS G +E F + + VY
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 234 LVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKT 289
+ S + P LQ L + +R T P + F+
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCM-----LMWHQRQRGTDPQNPNVGCFQAL 304
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-46
Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 22/273 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
E +E+L+ IG+G+FG +V+ K+ K + +L K + ++ + A E +++
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE--ERDVLVN 130
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+ +I ++ + + +++ Y GGD+ + K PEE +L ++++A+
Sbjct: 131 GDSKWITTLHYAFQDDN-NLYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYLAEMVIAI 188
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELL 175
+ +H H +HRD+K NI + + IRL DFG L+ D +S VGTP Y+ PE+L
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 176 ADIP-----YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLP---TV 226
+ YG + D WSLG C+YEM + F A + KI N P T
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
Query: 227 YSGAFRGLVKSMLRKNPEFR---PSAAELLCHP 256
S + L++ ++ R + HP
Sbjct: 309 VSENAKDLIRRLICSREH-RLGQNGIEDFKKHP 340
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 63/309 (20%), Positives = 122/309 (39%), Gaps = 56/309 (18%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKI---RLARQTDRARRSAHQEMELISRV 58
++Y + IG+GS+G + R +K + ++ + + E+ L+ ++
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK----------------------- 95
+P I + + E Y+C+++ C GG + + +
Sbjct: 86 HHPNIARLYEVY-EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 96 ---------------ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD 140
+ E+ + + Q+ AL+YLH I HRD+K N + +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 141 QD--IRLGDFGLAKMLISDDLA-----SSVVGTPSYMCPELL--ADIPYGSKSDIWSLGC 191
+ I+L DFGL+K + ++ GTP ++ PE+L + YG K D WS G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 192 CVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRP 247
++ + F + I+++ + + A R L+ ++L +N + R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLA-RDLLSNLLNRNVDERF 323
Query: 248 SAAELLCHP 256
A L HP
Sbjct: 324 DAMRALQHP 332
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 14/262 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ Y + IG+GS+G + K R + KKI D R QE+E++ + +P
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR--FKQEIEIMKSLDHP 66
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I+ +++ E + +++ C GG++ E + F E + + +L A+ Y H
Sbjct: 67 NIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH 123
Query: 122 ANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
++ HRD+K N FLT D ++L DFGLA + + VGTP Y+ P++L
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG- 182
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFRGL 234
YG + D WS G +Y + F A ++ KI + V A L
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA-ESL 241
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
++ +L K+P+ R ++ + L H
Sbjct: 242 IRRLLTKSPKQRITSLQALEHE 263
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-46
Identities = 75/265 (28%), Positives = 129/265 (48%), Gaps = 16/265 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKI---RLARQTDRARRSAHQEMELISRV 58
+ + ++G G+FG LV + + V+K I R ++ E+E++ +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA----EIEVLKSL 77
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI--KKANGVHFPEEKLCKWLVQLLMA 116
+P I++ + + E + I++ CEGG++ E I +A G E + + + Q++ A
Sbjct: 78 DHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 117 LNYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
L Y H+ H++H+D+K NI F I++ DFGLA++ SD+ +++ GT YM PE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAF 231
+ K DIWS G +Y + F ++ + K A +
Sbjct: 197 VFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHP 256
L+K ML K+PE RPSAA++L H
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHE 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-46
Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 34/278 (12%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKI---RLARQTDRARRSAH---QEMELI 55
++Y + + +G G+ G L + KK ++ I + A + R A E+E++
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
++ +P I++ K+ + + Y I++ EGG++ + + E + Q+L+
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLL 250
Query: 116 ALNYLHANHILHRDVKCSNIFLT---RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
A+ YLH N I+HRD+K N+ L+ D I++ DFG +K+L L ++ GTP+Y+ P
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 173 ELLADI---PYGSKSDIWSLGCCVYEM-------SAQKAAFKAFDMQALINKINKSIVA- 221
E+L + Y D WSLG ++ S + +L ++I
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR------TQVSLKDQITSGKYNF 364
Query: 222 ---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
V A LVK +L +P+ R + E L HP
Sbjct: 365 IPEVWAEVSEKA-LDLVKKLLVVDPKARFTTEEALRHP 401
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 12/261 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+Y + E +G+G FG +K Y+ K ++ + TD+ +E+ +++ R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQV--LVKKEISILNIARHR 61
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I+ +S+ E + +I + G D+ E I + E ++ ++ Q+ AL +LH
Sbjct: 62 NILHLHESF-ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH 119
Query: 122 ANHILHRDVKCSNIFLT--RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
+++I H D++ NI R I++ +FG A+ L D + P Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRGLV 235
+ +D+WSLG VY + + F A Q +I I + + A V
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA-MDFV 238
Query: 236 KSMLRKNPEFRPSAAELLCHP 256
+L K + R +A+E L HP
Sbjct: 239 DRLLVKERKSRMTASEALQHP 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 81/269 (30%), Positives = 134/269 (49%), Gaps = 19/269 (7%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRH---KHERKKYVLKKIRLARQTDRARRSAHQEME--LI 55
E +E+L +GKG +G VR + K + +K ++ A A+ +AH + E ++
Sbjct: 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 56 SRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
V++PFIV+ ++ K + +I+ Y GG++ +++ F E+ C +L ++
Sbjct: 76 EEVKHPFIVDLIYAFQTGGK---LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEI 130
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCP 172
MAL +LH I++RD+K NI L ++L DFGL K I D + + GT YM P
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232
E+L + D WSLG +Y+M F + + I+KI K + LP + R
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEAR 249
Query: 233 GLVKSMLRKNPEFR-----PSAAELLCHP 256
L+K +L++N R A E+ HP
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHP 278
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 81/272 (29%), Positives = 133/272 (48%), Gaps = 27/272 (9%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKK---Y---VLKKIRLARQTDRARRSAHQEME- 53
Q+E+L+ +G+GSFG LV+ Y VLKK L R +ME
Sbjct: 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-----VRDRVRTKMER 77
Query: 54 -LISRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 110
++ V +PFIV+ ++ K + +I+ + GGD+ + K V F EE + +L
Sbjct: 78 DILVEVNHPFIVKLHYAFQTEGK---LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYL 132
Query: 111 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSY 169
+L +AL++LH+ I++RD+K NI L + I+L DFGL+K I + A S GT Y
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG 229
M PE++ + +D WS G ++EM F+ D + + I K+ + +P S
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSP 251
Query: 230 AFRGLVKSMLRKNPEFR-----PSAAELLCHP 256
+ L++ + ++NP R E+ H
Sbjct: 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 76/271 (28%), Positives = 133/271 (49%), Gaps = 22/271 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
E YEV++ IG+G+FG LVRHK RK Y +L K + +++D A +E ++++
Sbjct: 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAF 125
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+P++V+ ++ + Y+ +++ Y GGD+ + PE+ + ++++AL
Sbjct: 126 ANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLAL 181
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--DLASSVVGTPSYMCPELL 175
+ +H+ +HRDVK N+ L + ++L DFG + + + VGTP Y+ PE+L
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 176 ----ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI---NKSIVAPLPTVYS 228
D YG + D WS+G +YEM F A + +KI S+ P S
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301
Query: 229 GAFRGLVKSMLRKNPEFR---PSAAELLCHP 256
+ L+ + L + E R E+ H
Sbjct: 302 KEAKNLICAFL-TDREVRLGRNGVEEIKRHL 331
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 78/268 (29%), Positives = 129/268 (48%), Gaps = 23/268 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN- 60
+ YEV E IG GS+ HK ++ +K I D+++R +E+E++ R
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQH 75
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P I+ KD + + G YV ++ +GG++ + I + F E + L + + YL
Sbjct: 76 PNIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYL 132
Query: 121 HANHILHRDVKCSNI-FLTRDQD---IRLGDFGLAKMLISDD-LASSVVGTPSYMCPELL 175
HA ++HRD+K SNI ++ + IR+ DFG AK L +++ L + T +++ PE+L
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---QALINKINKSIV----APLPTVYS 228
Y + DIWSLG +Y M F + ++ +I +V
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 229 GAFRGLVKSMLRKNPEFRPSAAELLCHP 256
A + LV ML +P R +AA +L HP
Sbjct: 253 TA-KDLVSKMLHVDPHQRLTAALVLRHP 279
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 78/265 (29%), Positives = 132/265 (49%), Gaps = 15/265 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
M ++ L+ +GKG+FG +LVR K + Y +L+K + + + A E ++
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT--ESRVLQN 61
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
R+PF+ K ++ +C ++ Y GG++ + + F EE+ + +++ AL
Sbjct: 62 TRHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSAL 118
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA 176
YLH+ +++RD+K N+ L +D I++ DFGL K ISD + GTP Y+ PE+L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236
D YG D W LG +YEM + F D + L I + P S + L+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLA 237
Query: 237 SMLRKNPEFR-----PSAAELLCHP 256
+L+K+P+ R A E++ H
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHR 262
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-45
Identities = 40/282 (14%), Positives = 87/282 (30%), Gaps = 40/282 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHER-----KKYVLKKIRLARQTDRARRSAHQEMELIS 56
+ V +G+G+F +K+VLK + A + Q ME +
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI--GTQLMERLK 122
Query: 57 RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG---DMAEAIKKANGVHFPEEKLCKWLVQL 113
+++ + + + ++ G + K P+ + + +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS-VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 114 LMALNYLHANHILHRDVKCSNIFLTR-----------DQDIRLGDFGLA---KMLISDDL 159
L + +H I+H D+K N L + L D G + K+ +
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI 219
++ T + C E+L++ P+ + D + + VY M + +
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL--- 298
Query: 220 VAPLPTVYSGAFRG-----LVKSMLRKNPEFRPSAAELLCHP 256
+ ML + +LL
Sbjct: 299 -------FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-45
Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 22/273 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRA-------RRSAHQEMEL 54
E YE E +G+G HK K+Y +K I + + R + +E+++
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 55 ISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+ +V P I++ KD++ E + ++ + G++ + + + V E++ K + L
Sbjct: 77 LRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRAL 133
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
L + LH +I+HRD+K NI L D +I+L DFG + L + V GTPSY+ PE
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 174 LLADI------PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APL 223
++ YG + D+WS G +Y + A F ++ I
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ LV L P+ R +A E L HP
Sbjct: 254 DDYSDTV-KDLVSRFLVVQPQKRYTAEEALAHP 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-45
Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 34/278 (12%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKI---RLARQTDRARRSAH---QEMELI 55
++Y + + +G G+ G L + KK +K I + A + R A E+E++
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
++ +P I++ K+ + + Y I++ EGG++ + + E + Q+L+
Sbjct: 70 KKLNHPCIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLL 125
Query: 116 ALNYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
A+ YLH N I+HRD+K N+ ++++D I++ DFG +K+L L ++ GTP+Y+ P
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 173 ELLADI---PYGSKSDIWSLGCCVYEM-------SAQKAAFKAFDMQALINKINKSIVA- 221
E+L + Y D WSLG ++ S + +L ++I
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR------TQVSLKDQITSGKYNF 239
Query: 222 ---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
V A LVK +L +P+ R + E L HP
Sbjct: 240 IPEVWAEVSEKA-LDLVKKLLVVDPKARFTTEEALRHP 276
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-45
Identities = 79/269 (29%), Positives = 126/269 (46%), Gaps = 23/269 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEME---L 54
+ L+ IGKGSFG LL RHK E Y VL+K + ++ + H E L
Sbjct: 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEK----HIMSERNVL 92
Query: 55 ISRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
+ V++PF+V S+ +K + ++ Y GG++ +++ F E + + +
Sbjct: 93 LKNVKHPFLVGLHFSFQTADK---LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAE 147
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMC 171
+ AL YLH+ +I++RD+K NI L I L DFGL K I S+ GTP Y+
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207
Query: 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231
PE+L PY D W LG +YEM F + + + + I + L + +
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSA 266
Query: 232 RGLVKSMLRKNPEFR----PSAAELLCHP 256
R L++ +L+K+ R E+ H
Sbjct: 267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-45
Identities = 68/268 (25%), Positives = 121/268 (45%), Gaps = 16/268 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKI---RLARQTDRARRSAHQEMELISRV 58
+ YE+ E IGKG F ++ +++ +K + + + +E + +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI--KKANGVHFPEEKLCKWLVQLLMA 116
++P IVE +++ G + ++ + +G D+ I + G + E ++ Q+L A
Sbjct: 84 KHPHIVELLETYSSDG-MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 117 LNYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLA-SSVVGTPSYMCP 172
L Y H N+I+HRDVK + +++ ++LG FG+A L L VGTP +M P
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYS 228
E++ PYG D+W G ++ + + F + L I K +
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISE 261
Query: 229 GAFRGLVKSMLRKNPEFRPSAAELLCHP 256
A + LV+ ML +P R + E L HP
Sbjct: 262 SA-KDLVRRMLMLDPAERITVYEALNHP 288
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 9e-45
Identities = 72/264 (27%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
++ +++L +G GSFG L+R +H + Y VLKK + R + E ++S
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH--TNDERLMLSI 62
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
V +PFI+ ++ + + +I+ Y EGG++ ++K+ FP + ++ +AL
Sbjct: 63 VTHPFIIRMWGTFQDAQ-QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLAL 119
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
YLH+ I++RD+K NI L ++ I++ DFG AK + D+ ++ GTP Y+ PE+++
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST 177
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237
PY D WS G +YEM A F + KI + + P ++ + L+
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-FPPFFNEDVKDLLSR 236
Query: 238 MLRKNPEFR-----PSAAELLCHP 256
++ ++ R ++ HP
Sbjct: 237 LITRDLSQRLGNLQNGTEDVKNHP 260
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 67/267 (25%), Positives = 129/267 (48%), Gaps = 16/267 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR----QTDRARRSAHQEMELISR 57
+ YE+ E++G G F R K K+Y K I+ R + +R +E+ ++
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+R+P I+ D + E V +I+ GG++ + + + E++ ++L Q+L +
Sbjct: 65 IRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGV 121
Query: 118 NYLHANHILHRDVKCSNI-FLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
+YLH+ I H D+K NI L ++ I+L DFG+A + + + ++ GTP ++ PE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSG 229
++ P G ++D+WS+G Y + + + F Q + I+
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 230 AFRGLVKSMLRKNPEFRPSAAELLCHP 256
A + ++ +L K+P+ R + A+ L H
Sbjct: 242 A-KDFIRRLLVKDPKRRMTIAQSLEHS 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 62/282 (21%), Positives = 129/282 (45%), Gaps = 11/282 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ Y++LE++G G+FG K + +V K I D+ E+ +++++ +P
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--VKNEISIMNQLHHP 108
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
++ D++ E + +I+ + GG++ + I A E ++ ++ Q L ++H
Sbjct: 109 KLINLHDAF-EDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 122 ANHILHRDVKCSNIFLT--RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
+ I+H D+K NI + +++ DFGLA L D++ T + PE++ P
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRGLV 235
G +D+W++G Y + + + F D + + + +V A + +
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA-KDFI 285
Query: 236 KSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTF 277
K++L+K P R + + L HP L+ + ++ R N
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKI 327
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-44
Identities = 72/270 (26%), Positives = 127/270 (47%), Gaps = 17/270 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
+ + +G+G FG + K K Y L K RL ++ A E +++++
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ--GAMVEKKILAK 241
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH--FPEEKLCKWLVQLLM 115
V + FIV ++ K +C+++ GGD+ I + + F E + + Q++
Sbjct: 242 VHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPEL 174
L +LH +I++RD+K N+ L D ++R+ D GLA L + GTP +M PEL
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 175 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAF 231
L Y D ++LG +YEM A + F+A + ++ + ++ P +S A
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 232 RGLVKSMLRKNPEFR-----PSAAELLCHP 256
+ +++L+K+PE R S L HP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 20/266 (7%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEME---L 54
+E + + + +GKGSFG L K + + LKK + D +E L
Sbjct: 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD----VECTMVEKRVL 71
Query: 55 ISRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
+PF+ ++ E + ++ Y GGD+ I+ + F + + +
Sbjct: 72 SLAWEHPFLTHMFCTFQTKEN---LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAE 126
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMC 171
+++ L +LH+ I++RD+K NI L +D I++ DFG+ K + D ++ GTP Y+
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 186
Query: 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231
PE+L Y D WS G +YEM ++ F D + L + I P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEA 245
Query: 232 RGLVKSMLRKNPEFR-PSAAELLCHP 256
+ L+ + + PE R ++ HP
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHP 271
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 64/271 (23%), Positives = 128/271 (47%), Gaps = 16/271 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ----EMELISR 57
+ Y+ E++G G F R K +Y K I+ R R + + E+ ++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+++P ++ + + E V +I+ GG++ + + + EE+ ++L Q+L +
Sbjct: 71 IQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGV 127
Query: 118 NYLHANHILHRDVKCSNI-FLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
YLH+ I H D+K NI L R+ I++ DFGLA + + ++ GTP ++ PE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSG 229
++ P G ++D+WS+G Y + + + F Q + ++ +
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260
A + ++ +L K+P+ R + + L HP ++P
Sbjct: 248 A-KDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 64/267 (23%), Positives = 118/267 (44%), Gaps = 16/267 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ----EMELISR 57
+ Y++ E++G G F R K +Y K I+ + R + + E+ ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
V + ++ D + E V +I+ GG++ + + + EE+ ++ Q+L +
Sbjct: 72 VLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGV 128
Query: 118 NYLHANHILHRDVKCSNI-FLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
NYLH I H D+K NI L ++ I+L DFGLA + ++ GTP ++ PE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSG 229
++ P G ++D+WS+G Y + + + F Q + I
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 230 AFRGLVKSMLRKNPEFRPSAAELLCHP 256
A + ++ +L K R + E L HP
Sbjct: 249 A-KDFIRKLLVKETRKRLTIQEALRHP 274
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 77/348 (22%), Positives = 142/348 (40%), Gaps = 19/348 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIR----LARQTDRARRSAHQEMELISR 57
+ Y++ E++G G F R K +Y K I+ A + R +E+ ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
V +P I+ D + E V +I+ GG++ + + + EE+ ++ Q+L +
Sbjct: 72 VLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGV 128
Query: 118 NYLHANHILHRDVKCSNI-FLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
NYLH I H D+K NI L ++ I+L DFGLA + ++ GTP ++ PE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSG 229
++ P G ++D+WS+G Y + + + F Q + I
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLE--WSDSNFK 287
A + ++ +L K R + E L HP + P + N + + +K
Sbjct: 249 A-KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWK 307
Query: 288 KTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQ-DSLSSTLRGR 334
+ + + + K+ L S+TE+ + L R
Sbjct: 308 LSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPR 355
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 64/251 (25%), Positives = 127/251 (50%), Gaps = 15/251 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAH--QEMELI 55
++Q++ ++ +G GSFG +LV+HK Y +L K ++ + ++ H E ++
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL----KQIEHTLNEKRIL 95
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
V PF+V+ + S+ + + +++ Y GG+M +++ F E + Q+++
Sbjct: 96 QAVNFPFLVKLEFSFKDNS-NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVL 152
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
YLH+ +++RD+K N+ + + I++ DFG AK + ++ GTP + PE++
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEII 210
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235
Y D W+LG +YEM+A F A + KI V P+ +S + L+
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-FPSHFSSDLKDLL 269
Query: 236 KSMLRKNPEFR 246
+++L+ + R
Sbjct: 270 RNLLQVDLTKR 280
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-44
Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQE-------- 51
QY + ++IGKGS+G L ++++ Y VL K +L RQ RR +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 52 ------MELISR-------VRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKAN 97
+E + + + +P +V+ + + ++ ++ G + E
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK- 132
Query: 98 GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-S 156
E++ + L+ + YLH I+HRD+K SN+ + D I++ DFG++ S
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 157 DDLASSVVGTPSYMCPELLADI--PY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALIN 213
D L S+ VGTP++M PE L++ + G D+W++G +Y + F + L +
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 214 KINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
KI + P + + L+ ML KNPE R E+ HP
Sbjct: 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 24/270 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEME---L 54
+ + L +GKGSFG +L K + Y +LKK + + D +E L
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----VECTMVEKRVL 74
Query: 55 ISRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
+ PF+ + + +++ + ++ Y GGD+ I++ F E + +
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAE 129
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMC 171
+ + L +L + I++RD+K N+ L + I++ DFG+ K I D + GTP Y+
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 189
Query: 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231
PE++A PYG D W+ G +YEM A +A F+ D L I + V P S
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEA 248
Query: 232 RGLVKSMLRKNPEFR-----PSAAELLCHP 256
+ K ++ K+P R ++ H
Sbjct: 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHA 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 40/300 (13%), Positives = 80/300 (26%), Gaps = 44/300 (14%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRL-ARQTDRARRSAHQEMELISRVRNP 61
+ +++E + G LVR + + LK + A + H+ +R+
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 62 FIVE----------------------------YKDSWVEKGCYVCIIIGYCEGGDMAEAI 93
E D V + + + +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181
Query: 94 KKANGVHFPEEKLCKWLV--QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151
E L ++ QL+ L + ++H N+F+ D + LGD
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 152 KMLISDDLASSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCVYEM--------SAQKA 201
+ +Y E L + + + W LG +Y +
Sbjct: 242 W--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 202 AFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
++ +L S+ T + L+ L + R E + P
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-43
Identities = 58/265 (21%), Positives = 121/265 (45%), Gaps = 11/265 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ Y++ E++G G+FG V + + K + ++D+ +E++ +S +R+P
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET--VRKEIQTMSVLRHP 214
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V D++ E + +I + GG++ E + + E++ +++ Q+ L ++H
Sbjct: 215 TLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH 272
Query: 122 ANHILHRDVKCSNI-FLTRDQD-IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
N+ +H D+K NI F T+ + ++L DFGL L GT + PE+ P
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFRGLV 235
G +D+WS+G Y + + + F + + + + + + +
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG-KDFI 391
Query: 236 KSMLRKNPEFRPSAAELLCHPHLQP 260
+ +L +P R + + L HP L P
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTP 416
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 2 EQYEVL-EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ Y++ + +G G G L H+ +K LK + + +AR+ E++ +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQ----EVDHHWQASG 80
Query: 61 -PFIVE----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
P IV Y++ K C + II+ EGG++ I++ F E + + + +
Sbjct: 81 GPHIVCILDVYENMHHGKRC-LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 116 ALNYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
A+ +LH+++I HRDVK N+ + ++++D ++L DFG AK + L + TP Y+ P
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAP 198
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--------PLP 224
E+L Y D+WSLG +Y + F + QA+ + + I
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258
Query: 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
V A + L++ +L+ +P R + + + HP
Sbjct: 259 EVSEDA-KQLIRLLLKTDPTERLTITQFMNHP 289
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 64/298 (21%), Positives = 122/298 (40%), Gaps = 45/298 (15%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHER------KKYVLKKIRLARQTDRARRSAH----- 49
+ Y ++ + +G F +L ++ +K +L+K R +++ + S
Sbjct: 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 50 --QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH------F 101
E+++I+ ++N + + + V II Y E + + + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 102 PEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160
P + + + +L + +Y+H +I HRDVK SNI + ++ ++L DFG ++ ++ +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 161 SSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCVYEMSAQKAAFKA-FDMQALINKINK 217
S GT +M PE ++ G+K DIWSLG C+Y M F + L N I
Sbjct: 209 GS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267
Query: 218 -------------------SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ + +K LRKNP R ++ + L H
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED-IDFLKLFLRKNPAERITSEDALKHE 324
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 77/266 (28%), Positives = 132/266 (49%), Gaps = 16/266 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
M ++E L+ +GKG+FG +LV+ K + Y +LKK + + + A E ++
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA--HTLTENRVLQN 204
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
R+PF+ K S+ +C ++ Y GG++ + + F E++ + +++ AL
Sbjct: 205 SRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSAL 261
Query: 118 NYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELL 175
+YLH+ +++RD+K N+ L +D I++ DFGL K I D + GTP Y+ PE+L
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235
D YG D W LG +YEM + F D + L I + P + L+
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLL 380
Query: 236 KSMLRKNPEFR----PS-AAELLCHP 256
+L+K+P+ R A E++ H
Sbjct: 381 SGLLKKDPKQRLGGGSEDAKEIMQHR 406
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 65/272 (23%), Positives = 123/272 (45%), Gaps = 21/272 (7%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR------QTDRARRSAHQEMELI 55
++Y+ + IG+G H+ ++ +K + + Q + R + +E ++
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 56 SRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+V P I+ DS E ++ ++ G++ + + + V E++ + LL
Sbjct: 154 RQVAGHPHIITLIDS-YESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLL 210
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 174
A+++LHAN+I+HRD+K NI L + IRL DFG + L + + GTP Y+ PE+
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 175 L------ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLP 224
L YG + D+W+ G ++ + A F ++ I +
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
S + L+ +L+ +PE R +A + L HP
Sbjct: 331 DRSSTV-KDLISRLLQVDPEARLTAEQALQHP 361
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 74/276 (26%), Positives = 136/276 (49%), Gaps = 25/276 (9%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRH---KHERKKYVLKKIRLARQTDRARRSAHQEME---L 54
+E +E+L+ +G G++G LVR K Y +K ++ A +A+ + H E L
Sbjct: 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 55 ISRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
++PF+V ++ K + +I+ Y GG++ + + F E ++ ++ +
Sbjct: 113 EHIRQSPFLVTLHYAFQTETK---LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGE 167
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--DLASSVVGTPSYM 170
+++AL +LH I++RD+K NI L + + L DFGL+K ++D + A GT YM
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 171 CPELLADIPYG-SKS-DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPT 225
P+++ G K+ D WSLG +YE+ + F + +I++ I+ P P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287
Query: 226 VYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 256
S + L++ +L K+P+ R A E+ H
Sbjct: 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-43
Identities = 71/272 (26%), Positives = 127/272 (46%), Gaps = 26/272 (9%)
Query: 2 EQYEVLEQ-IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ Y+V Q +G G G L + +K ++K+ LK ++ +ARR E+EL R
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARR----EVELHWRASQ 113
Query: 61 -PFIVE----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
P IV Y++ + + C + I++ +GG++ I+ F E + + + +
Sbjct: 114 CPHIVRIVDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 116 ALNYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
A+ YLH+ +I HRDVK N+ + ++ + ++L DFG AK S + ++ TP Y+ P
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--------PLP 224
E+L Y D+WSLG +Y + F + A+ + I
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292
Query: 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
V + L++++L+ P R + E + HP
Sbjct: 293 EVSEEV-KMLIRNLLKTEPTQRMTITEFMNHP 323
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 74/328 (22%), Positives = 132/328 (40%), Gaps = 36/328 (10%)
Query: 2 EQYEVL---EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
+ Y++ + +G+GSF HK + + +K I R + +E+ +
Sbjct: 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-----KRMEANTQKEITALKLC 62
Query: 59 RN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
P IV+ + + + +++ GG++ E IKK HF E + + +L+ A+
Sbjct: 63 EGHPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAV 119
Query: 118 NYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDD-LASSVVGTPSYMCPE 173
+++H ++HRD+K N+ F + + I++ DFG A++ D+ + T Y PE
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 174 LLADIPYGSKSDIWSLGCCVYEM-------SAQKAAFKAFDMQALINKINKSIV----AP 222
LL Y D+WSLG +Y M + + ++ KI K
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 223 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWS 282
V A + L++ +L +P R + L + LQ L P
Sbjct: 240 WKNVSQEA-KDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAV 298
Query: 283 DSNFKKTRFMEPEAISIHSNREKRQSFS 310
+ K T F A N+ KR+ F
Sbjct: 299 HTCVKAT-FH---AF----NKYKREGFC 318
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 67/269 (24%), Positives = 124/269 (46%), Gaps = 11/269 (4%)
Query: 2 EQYEVL-EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR- 59
Y + +++G+G F K ++Y K ++ R+ R E+ ++ +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
P ++ + + E + +I+ Y GG++ E + + + Q+L + Y
Sbjct: 88 CPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 120 LHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 176
LH N+I+H D+K NI L+ DI++ DFG+++ + ++GTP Y+ PE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFR 232
P + +D+W++G Y + + F D Q I++ V +V A
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA-T 265
Query: 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
++S+L KNPE RP+A L H LQ +
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 5/255 (1%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
Y +L+ IGKG+F L RH ++ +K I + + + +E+ ++ + +P
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
IV+ + E + +I+ Y GG++ + + +G E++ Q++ A+ Y H
Sbjct: 76 IVKLFEVI-ETEKTLYLIMEYASGGEVFDYLVA-HG-RMKEKEARSKFRQIVSAVQYCHQ 132
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY-G 181
I+HRD+K N+ L D +I++ DFG + + G P Y PEL Y G
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 182 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241
+ D+WSLG +Y + + F +++ L ++ + +P S L+K L
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVL 251
Query: 242 NPEFRPSAAELLCHP 256
NP R + +++
Sbjct: 252 NPIKRGTLEQIMKDR 266
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 76/271 (28%), Positives = 126/271 (46%), Gaps = 25/271 (9%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEME---L 54
++ +E + +GKGSFG +L R K Y VLKK + + D E L
Sbjct: 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD----VECTMTEKRIL 77
Query: 55 ISRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
+PF+ + + ++ + ++ + GGD+ I+K+ F E + + +
Sbjct: 78 SLARNHPFLTQLFCCFQTPDR---LFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAE 132
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMC 171
++ AL +LH I++RD+K N+ L + +L DFG+ K I + ++ GTP Y+
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192
Query: 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231
PE+L ++ YG D W++G +YEM A F+A + L I V PT
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDA 251
Query: 232 RGLVKSMLRKNPEFR------PSAAELLCHP 256
G++KS + KNP R +L HP
Sbjct: 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 7e-42
Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 18/269 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIR----LARQTDRARRSAHQEMELIS 56
M + V IG+G FG R K Y +K + +Q + + + L+S
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 57 RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
PFIV ++ + I+ GGD+ + + F E + + ++++
Sbjct: 248 TGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILG 304
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 176
L ++H +++RD+K +NI L +R+ D GLA S + VGT YM PE+L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQ 363
Query: 177 D-IPYGSKSDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVAPLPTVYSGAFR 232
+ Y S +D +SLGC ++++ + F+ D + V LP +S R
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELR 422
Query: 233 GLVKSMLRKNPEFR-----PSAAELLCHP 256
L++ +L+++ R A E+ P
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESP 451
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 61/258 (23%), Positives = 114/258 (44%), Gaps = 10/258 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVRN 60
+ E+IG GSFG+ V V +K + +E+ ++ R+R+
Sbjct: 37 CDLNIKEKIGAGSFGT---VHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI-KKANGVHFPEEKLCKWLVQLLMALNY 119
P IV + + + I+ Y G + + K E + + +NY
Sbjct: 94 PNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 120 LHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-SVVGTPSYMCPELLA 176
LH + I+HR++K N+ + + +++ DFGL+++ S L+S S GTP +M PE+L
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTVYSGAFRGLV 235
D P KSD++S G ++E++ + + + Q + K +P + ++
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 236 KSMLRKNPEFRPSAAELL 253
+ P RPS A ++
Sbjct: 273 EGCWTNEPWKRPSFATIM 290
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 59/263 (22%), Positives = 114/263 (43%), Gaps = 13/263 (4%)
Query: 2 EQYEV--LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR 59
Y V E +G G FG K K I+ D+ E+ +++++
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE--VKNEISVMNQLD 144
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+ +++ D++ E + +++ Y +GG++ + I + E ++ Q+ + +
Sbjct: 145 HANLIQLYDAF-ESKNDIVLVMEYVDGGELFDRII-DESYNLTELDTILFMKQICEGIRH 202
Query: 120 LHANHILHRDVKCSNI-FLTRDQD-IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
+H +ILH D+K NI + RD I++ DFGLA+ + GTP ++ PE++
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY 262
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRG 233
+D+WS+G Y + + + F + +N I + A +
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA-KE 321
Query: 234 LVKSMLRKNPEFRPSAAELLCHP 256
+ +L K +R SA+E L HP
Sbjct: 322 FISKLLIKEKSWRISASEALKHP 344
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-41
Identities = 33/296 (11%), Positives = 71/296 (23%), Gaps = 50/296 (16%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRAR----RSAHQEMELISRV 58
+G+ + L + + + + + + + L+ +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 59 RNPFIV-------------------------EYKDSWVEKGCYVCIIIGYCEGGDMAEAI 93
+N + + E +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 94 --KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151
+ + +Q++ L LH ++H ++ +I L + + L F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 152 KMLISDDLASSVVGTPSYMCPELLAD-----------IPYGSKSDIWSLGCCVYEMSAQK 200
D + + PEL A D W+LG +Y +
Sbjct: 254 VR---DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 201 AAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
I +S R L++ LR E R + + P
Sbjct: 311 LPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 76/324 (23%), Positives = 135/324 (41%), Gaps = 21/324 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLK---KIRLARQTDRARRSAHQ---EMEL 54
++Y + +G G+FG K + K+ V+K K ++ + E+ +
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 55 ISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+SRV + I++ D + +G + ++ + G D+ I + + E QL+
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HP-RLDEPLASYIFRQLV 140
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 174
A+ YL I+HRD+K NI + D I+L DFG A L L + GT Y PE+
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 175 LADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233
L PY G + ++WSLG +Y + ++ F + + ++ + P P + S
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHP-PYLVSKELMS 253
Query: 234 LVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFME 293
LV +L+ PE R + +L+ P + V R P +S +E
Sbjct: 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKP----ESGVLSAASLE 309
Query: 294 PEAISIHSNREKRQSFSNDRALNP 317
S+ S+ + Q +
Sbjct: 310 MGNRSL-SDVAQAQELCGGEGHHH 332
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 76/280 (27%), Positives = 128/280 (45%), Gaps = 34/280 (12%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEME---L 54
++ +++L IG+GS+ LLVR K + Y V+KK + D + E
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED----IDWVQTEKHVF 63
Query: 55 ISRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
+PF+V + + + +I Y GGD+ +++ PEE + +
Sbjct: 64 EQASNHPFLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAE 118
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMC 171
+ +ALNYLH I++RD+K N+ L + I+L D+G+ K + D S+ GTP+Y+
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178
Query: 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---------DMQALINKINKSIVAP 222
PE+L YG D W+LG ++EM A ++ F L I + +
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R 237
Query: 223 LPTVYSGAFRGLVKSMLRKNPEFR------PSAAELLCHP 256
+P S ++KS L K+P+ R A++ HP
Sbjct: 238 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 39/310 (12%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME+YE + +IG+GS+G R++ + +KK + ++ A +E+ ++ ++++
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P +V + + K + ++ YC+ + + + PE + Q L A+N+
Sbjct: 62 PNLVNLLEVFRRKRR-LHLVFEYCDH-TVLHELDR-YQRGVPEHLVKSITWQTLQAVNFC 118
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLADI 178
H ++ +HRDVK NI +T+ I+L DFG A++L D V T Y PE L+ D
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG-----AFRG 233
YG D+W++GC E+ + + + I K++ +P F G
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 234 -------------------------LVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 268
L+K L +P R + +LL H PY I
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH----PYFENIREI 294
Query: 269 LNGPRRNTFP 278
+ + + P
Sbjct: 295 EDLAKEHDKP 304
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 76/280 (27%), Positives = 128/280 (45%), Gaps = 34/280 (12%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEME---L 54
++ +++L IG+GS+ LLVR K + Y V+KK + D + E
Sbjct: 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED----IDWVQTEKHVF 106
Query: 55 ISRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
+PF+V + + + +I Y GGD+ +++ PEE + +
Sbjct: 107 EQASNHPFLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAE 161
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMC 171
+ +ALNYLH I++RD+K N+ L + I+L D+G+ K + D S+ GTP+Y+
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---------DMQALINKINKSIVAP 222
PE+L YG D W+LG ++EM A ++ F L I + +
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R 280
Query: 223 LPTVYSGAFRGLVKSMLRKNPEFR------PSAAELLCHP 256
+P S ++KS L K+P+ R A++ HP
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 63/292 (21%), Positives = 119/292 (40%), Gaps = 43/292 (14%)
Query: 2 EQYEVLEQ-IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ Y++ E +G+G+ + ++Y +K I R+R +E+E++ + +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQG 69
Query: 61 -PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
++E + + E+ ++ GG + I K HF E + + + AL++
Sbjct: 70 HRNVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDF 126
Query: 120 LHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKML--------ISDDLASSVVGTPS 168
LH I HRD+K NI +Q +++ DF L + IS + G+
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 169 YMCPELL-----ADIPYGSKSDIWSLGCCVY-----------EMSAQKAAFKAFDMQALI 212
YM PE++ Y + D+WSLG +Y + + A
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 213 NKINKSIVA--------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
N + +SI + A + L+ +L ++ + R SAA++L HP
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAA-KDLISKLLVRDAKQRLSAAQVLQHP 297
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-40
Identities = 69/268 (25%), Positives = 117/268 (43%), Gaps = 20/268 (7%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEME---L 54
+ + L +GKGSFG +L K + Y +LKK + + D +E L
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----VECTMVEKRVL 395
Query: 55 ISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+ PF+ + + + ++ Y GGD+ I++ F E + ++
Sbjct: 396 ALPGKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIA 452
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPE 173
+ L +L + I++RD+K N+ L + I++ DFG+ K I + GTP Y+ PE
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233
++A PYG D W+ G +YEM A +A F+ D L I + V P S
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVA 571
Query: 234 LVKSMLRKNPEFR-----PSAAELLCHP 256
+ K ++ K+P R ++ H
Sbjct: 572 ICKGLMTKHPGKRLGCGPEGERDIKEHA 599
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 68/288 (23%), Positives = 128/288 (44%), Gaps = 35/288 (12%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME+YE L +G+GS+G + R+K + +KK + ++ A +E++L+ ++R+
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+V + +K ++ + + + + ++ + + K+L Q++ + +
Sbjct: 84 ENLVNLLEVCKKKKR-WYLVFEFVDH-TILDDLEL-FPNGLDYQVVQKYLFQIINGIGFC 140
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLADI 178
H+++I+HRD+K NI +++ ++L DFG A+ L ++ V T Y PE L+ D+
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG-----AFRG 233
YG D+W++GC V EM + F + I + +P F G
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 234 -------------------------LVKSMLRKNPEFRPSAAELLCHP 256
L K L +P+ RP AELL H
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 69/289 (23%), Positives = 128/289 (44%), Gaps = 21/289 (7%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVR 59
++ EV E +G+G+FG V R K V +K+I ++ R++ E+ +SRV
Sbjct: 7 YKEIEVEEVVGRGAFGV---VCKAKWRAKDVAIKQIE----SESERKAFIVELRQLSRVN 59
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI-KKANGVHFPEEKLCKWLVQLLMALN 118
+P IV+ + + VC+++ Y EGG + + ++ W +Q +
Sbjct: 60 HPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 119 YLHA---NHILHRDVKCSNIFLTRDQD-IRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 174
YLH+ ++HRD+K N+ L +++ DFG A + ++ G+ ++M PE+
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEV 174
Query: 175 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPLPTVYSGAFR 232
Y K D++S G ++E+ ++ F ++ ++ PL
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 233 GLVKSMLRKNPEFRPSAAELLCH-PHLQPYVLGIHLKLNGPRRNTFPLE 280
L+ K+P RPS E++ HL Y G L P +++ P
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 34/296 (11%), Positives = 76/296 (25%), Gaps = 45/296 (15%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRAR----RSAHQEMELISRV 58
+G+ + L + + + + + + + L+ +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 59 RNPFIV--------------------------EYKDSWVEKGCYVCIIIGYCEGGDMAEA 92
+N + +D WV + E
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS-RFFLYPRMQSNLQTFGEV 197
Query: 93 IKKANGVH--FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 150
+ + H + +Q++ L LH ++H ++ +I L + + L F
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 151 AKMLISDDLAS--SVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAF 203
+ ++ P +L D W+LG +Y +
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 204 KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
I +P R L++ LR E R + + P +
Sbjct: 318 TDDAALGGSEWI-FRSCKNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-39
Identities = 65/273 (23%), Positives = 125/273 (45%), Gaps = 18/273 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELI 55
+ Y + + +G G+FG + H+ K +K KIR + +R E++ +
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNL 65
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
R+P I++ +++ Y GG++ + I K +G E + + Q+L
Sbjct: 66 KLFRHPHIIKLYQVI-STPTDFFMVMEYVSGGELFDYICK-HG-RVEEMEARRLFQQILS 122
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
A++Y H + ++HRD+K N+ L + ++ DFGL+ M+ + + G+P+Y PE++
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182
Query: 176 ADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
+ Y G + DIWS G +Y + F + L KI + +P + + L
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YIPEYLNRSVATL 241
Query: 235 VKSMLRKNPEFRPSAAELLCHP----HLQPYVL 263
+ ML+ +P R + ++ H L Y+
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 4e-39
Identities = 71/382 (18%), Positives = 139/382 (36%), Gaps = 62/382 (16%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN- 60
+ +G GS G+ + + + + +K++ + A E++L++ +
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDH 68
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK-----ANGVHFPEEKLCKWLVQLLM 115
P ++ Y S ++ I + C ++ + ++ N E L Q+
Sbjct: 69 PNVIRYYCS-ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 116 ALNYLHANHILHRDVKCSNIFLT-------------RDQDIRLGDFGLAKMLISDDLA-- 160
+ +LH+ I+HRD+K NI ++ + I + DFGL K L S +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 161 ---SSVVGTPSYMCPELLADI-------PYGSKSDIWSLGCCVYEM-SAQKAAFKA-FDM 208
++ GT + PELL + DI+S+GC Y + S K F +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 209 QALINKIN---KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 265
++ I + + L+ M+ +P RP+A ++L HP
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW------ 300
Query: 266 HLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQD 325
++ F L+ SD + P A+ + + + +T D
Sbjct: 301 ----PKSKKLEFLLKVSD-RLEIENRDPPSALLMKFDAGSDFVIPSGDW-TVKFDKTFMD 354
Query: 326 SLSSTLRGRAFGNYMNQKFKEL 347
+L + Y + K +L
Sbjct: 355 NL------ERYRKYHSSKLMDL 370
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 67/263 (25%), Positives = 122/263 (46%), Gaps = 12/263 (4%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISRVR 59
+Y + + +G+GS+G V + +LKK +L R + +E++L+ R+R
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLR 64
Query: 60 NPFIVEYKDSW-VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+ +++ D E+ + +++ YC G M E + FP + + QL+ L
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA---KMLISDDLASSVVGTPSYMCPELL 175
YLH+ I+H+D+K N+ LT +++ G+A +DD + G+P++ PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 176 ADI-PY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233
+ + G K DIWS G +Y ++ F+ ++ L I K A +P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA-IPGDCGPPLSD 242
Query: 234 LVKSMLRKNPEFRPSAAELLCHP 256
L+K ML P R S ++ H
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHS 265
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 76/292 (26%), Positives = 118/292 (40%), Gaps = 37/292 (12%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARR---SAHQEMEL--- 54
+YE + +IG G++G+ R H LK +R+ S +E+ L
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 55 ISRVRNPFIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 110
+ +P +V D S ++ V ++ + + D+ + KA P E + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 111 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYM 170
Q L L++LHAN I+HRD+K NI +T ++L DFGLA++ + VV T Y
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 171 CPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------NKSI---V 220
PE+L Y + D+WS+GC EM +K F + KI +
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246
Query: 221 APLP----------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
LP + L+ ML NP R SA L H
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 56/265 (21%), Positives = 116/265 (43%), Gaps = 16/265 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
+E +++++ +G+G++G L ++ + ++ R + ++ E+ +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKM 61
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+ + +V++ E + + YC GG++ + I+ G PE ++ QL+ +
Sbjct: 62 LNHENVVKFYGHRREGN-IQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGV 118
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---DDLASSVVGTPSYMCPEL 174
YLH I HRD+K N+ L ++++ DFGLA + + L + + GT Y+ PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 175 LADIPY-GSKSDIWSLGCCVYEMSAQKAAF-KAFDMQALINKINKSIVAPLPTVY-SGAF 231
L + D+WS G + M A + + + D + + P A
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHP 256
L+ +L +NP R + ++
Sbjct: 239 LALLHKILVENPSARITIPDIKKDR 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 86/343 (25%), Positives = 151/343 (44%), Gaps = 21/343 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKI-RLARQTDRARRSAHQEMELISRVR 59
++Y+ ++ IG G+FG A L+R K ++ +K I R A + +R E+ +R
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLR 74
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+P IV +K+ + ++ II+ Y GG++ E I A F E++ + QLL ++Y
Sbjct: 75 HPNIVRFKEVILTPT-HLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSY 131
Query: 120 LHANHILHRDVKCSNIFLTRDQ--DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
H+ I HRD+K N L +++ DFG +K + S VGTP+Y+ PE+L
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 178 IPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-----PLPTVYSGAF 231
Y G +D+WS G +Y M F+ + K + I++ P S
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHP----HLQPYVLGIHLKLNGPRRNTFPLEWSDSNFK 287
L+ + +P R S E+ H +L ++ + + P++ D+ +
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQ 311
Query: 288 KTR-FMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLSS 329
P + + + D ++ SE+E D SS
Sbjct: 312 IISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSS 354
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 35/290 (12%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMEL---IS 56
+QYE + +IG+G++G R ++V LK++R+ + S +E+ + +
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 57 RVRNPFIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
+P +V D S ++ + ++ + + D+ + K P E + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
LL L++LH++ ++HRD+K NI +T I+L DFGLA++ +SVV T Y P
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI----------------- 215
E+L Y + D+WS+GC EM +K F+ + KI
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 216 --NKSIVAPLPTVYSGAFRG-------LVKSMLRKNPEFRPSAAELLCHP 256
++ + L+ L NP R SA L HP
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 39/289 (13%)
Query: 1 MEQYEVLEQIGKGSFGSALLV-RHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRV 58
ME+Y+ LE++G+G++G +V + K + + V LK+IRL + + +A +E+ L+ +
Sbjct: 20 MEKYQKLEKVGEGTYG---VVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+P IV D + C + ++ + E D+ + + + N + ++ +L QLL +
Sbjct: 77 HHPNIVSLIDVIHSERC-LTLVFEFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVA 133
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLA 176
+ H + ILHRD+K N+ + D ++L DFGLA+ I + V T Y P+ L+
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------NKSI---VAPLPTV 226
Y + DIWS+GC EM K F + KI N V LP
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 227 YSGAFRG-------------------LVKSMLRKNPEFRPSAAELLCHP 256
F+ L+ +ML +P R SA + + HP
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 50/270 (18%), Positives = 107/270 (39%), Gaps = 25/270 (9%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSA-----HQEMELI 55
+ E +QIGKG FG R K V +K + L +E+ ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
S + +P IV+ +++ + GD+ + + ++ + +
Sbjct: 78 SNLNHPNIVKLYGLMHNP---PRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIAL 133
Query: 116 ALNYLHANH--ILHRDVKCSNIFLTRDQD-----IRLGDFGLAKMLISDDLASSVVGTPS 168
+ Y+ + I+HRD++ NIFL + ++ DFGL++ S S ++G
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSVSGLLGNFQ 191
Query: 169 YMCPELLA--DIPYGSKSDIWSLGCCVYEMSAQKAAFK---AFDMQALINKINKSIVAPL 223
+M PE + + Y K+D +S +Y + + F ++ + + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
P R +++ +P+ RP + ++
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 71/289 (24%), Positives = 127/289 (43%), Gaps = 40/289 (13%)
Query: 1 MEQYEVLEQIGKGSFGSALLV-RHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRV 58
ME+Y LE+IG+G++G +V + ++ + LKKIRL ++ + + +E+ ++ +
Sbjct: 1 MEKYHGLEKIGEGTYG---VVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
++ IV+ D K + ++ + + D+ + + G +L+QLL +
Sbjct: 58 KHSNIVKLYDVIHTKKR-LVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIA 114
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLA 176
Y H +LHRD+K N+ + R+ ++++ DFGLA+ I + + T Y P+ L+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------NKSI---VAPLPTV 226
Y + DIWS+GC EM F + +I N V LP
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK- 233
Query: 227 YSGAF-------------------RGLVKSMLRKNPEFRPSAAELLCHP 256
Y F L+ ML+ +P R +A + L H
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 56/265 (21%), Positives = 116/265 (43%), Gaps = 16/265 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY---VLKKIRLARQTDRARRSAHQEMELISR 57
+E +++++ +G+G++G L ++ + ++ R + ++ E+ +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKM 61
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+ + +V++ E + + YC GG++ + I+ G PE ++ QL+ +
Sbjct: 62 LNHENVVKFYGHRREGN-IQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGV 118
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---DDLASSVVGTPSYMCPEL 174
YLH I HRD+K N+ L ++++ DFGLA + + L + + GT Y+ PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 175 LADIPY-GSKSDIWSLGCCVYEMSAQKAAF-KAFDMQALINKINKSIVAPLPTVY-SGAF 231
L + D+WS G + M A + + + D + + P A
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHP 256
L+ +L +NP R + ++
Sbjct: 239 LALLHKILVENPSARITIPDIKKDR 263
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 57/269 (21%), Positives = 113/269 (42%), Gaps = 22/269 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
EQ E+ E IGKG FG V H + ++ I + R + ++ +E+ + R+
Sbjct: 32 FEQLEIGELIGKGRFGQ---VYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+V + + + II C+G + ++ + K + +++ + YL
Sbjct: 89 ENVVLFMGACMSPPHL-AIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA------SSVVGTPSYMCPEL 174
HA ILH+D+K N+F + + + DFGL + G ++ PE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 175 L---------ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT 225
+ +P+ SD+++LG YE+ A++ FK +A+I ++ + L
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ 265
Query: 226 V-YSGAFRGLVKSMLRKNPEFRPSAAELL 253
+ ++ E RP+ +L+
Sbjct: 266 IGMGKEISDILLFCWAFEQEERPTFTKLM 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 63/268 (23%), Positives = 115/268 (42%), Gaps = 23/268 (8%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSA--HQEMELISR 57
+ + E IG G FG V V +K R D ++ QE +L +
Sbjct: 6 FAELTLEEIIGIGGFGK---VYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+++P I+ + +++ C+++ + GG + + P + L W VQ+ +
Sbjct: 63 LKHPNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGM 118
Query: 118 NYLHANH---ILHRDVKCSNIFLTRDQD--------IRLGDFGLAKMLISDDLASSVVGT 166
NYLH I+HRD+K SNI + + + +++ DFGLA+ S G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGA 177
Query: 167 PSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPT 225
++M PE++ + SD+WS G ++E+ + F+ D + + P+P+
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 226 VYSGAFRGLVKSMLRKNPEFRPSAAELL 253
F L++ +P RPS +L
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNIL 265
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 35/261 (13%), Positives = 95/261 (36%), Gaps = 15/261 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVR 59
+Q L ++ + G + + + +K +++ + R R ++E +
Sbjct: 9 FKQLNFLTKLNENHSGE---LWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 60 NPFIVEYK-DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+P ++ + +I + G + + + + + K+ + + +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 119 YLHA--NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 176
+LH I + ++ + D R+ + S + P+++ PE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQ 181
Query: 177 DIPYGS---KSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTVYSGAFR 232
P + +D+WS ++E+ ++ F M+ + + + +P S
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241
Query: 233 GLVKSMLRKNPEFRPSAAELL 253
L+K + ++P RP ++
Sbjct: 242 KLMKICMNEDPAKRPKFDMIV 262
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 64/264 (24%), Positives = 119/264 (45%), Gaps = 17/264 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
Q V ++IG GSFG+ V +K + + T + ++ E+ ++ + R+
Sbjct: 23 DGQITVGQRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
I+ + + I+ +CEG + + + F +KL Q ++YL
Sbjct: 80 VNILLFM-GYSTAPQL-AIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYL 136
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM---LISDDLASSVVGTPSYMCPELLAD 177
HA I+HRD+K +NIFL D +++GDFGLA + G+ +M PE++
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 178 ---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAP-LPTVYSGAFR 232
PY +SD+++ G +YE+ + + + +I + + ++P L V S +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 233 GLVKSMLR---KNPEFRPSAAELL 253
+ + M K + RPS +L
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRIL 280
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 65/260 (25%), Positives = 126/260 (48%), Gaps = 15/260 (5%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELISR 57
Y + E +G+GSFG L H ++K LK ++ + R R E+ +
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKL 65
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+R+P I++ D + ++I Y GG++ + I + E++ ++ Q++ A+
Sbjct: 66 LRHPHIIKLYDVI-TTPTDIVMVIEYA-GGELFDYIVE-KK-RMTEDEGRRFFQQIICAI 121
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
Y H + I+HRD+K N+ L + ++++ DFGL+ ++ + + G+P+Y PE++
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING 181
Query: 178 IPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236
Y G + D+WS G +Y M + F + L K+N + +P S + L++
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY-VMPDFLSPGAQSLIR 240
Query: 237 SMLRKNPEFRPSAAELLCHP 256
M+ +P R + E+ P
Sbjct: 241 RMIVADPMQRITIQEIRRDP 260
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 1e-35
Identities = 75/287 (26%), Positives = 135/287 (47%), Gaps = 34/287 (11%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M++YE LE+IG+G++G+ +++ + LK++RL + SA +E+ L+ +++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
IV D + ++ +C+ D+ + NG E + +L QLL L +
Sbjct: 61 KNIVRLHDVLHSDKK-LTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFC 117
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLADI 178
H+ ++LHRD+K N+ + R+ +++L +FGLA+ I S+ V T Y P+ L
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 179 PYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKI-------NKSI---VAPLP--- 224
Y + D+WS GC E+ +A + F D+ + +I + + LP
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 225 ---------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ R L++++L+ NP R SA E L HP
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 66/262 (25%), Positives = 124/262 (47%), Gaps = 14/262 (5%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLK-----KIRLARQTDRARRSAHQEMELI 55
+ Y + + +G G+FG + +H+ K +K KIR + RR E++ +
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNL 70
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
R+P I++ + +++ Y GG++ + I K NG E++ + Q+L
Sbjct: 71 KLFRHPHIIKLYQVI-STPSDIFMVMEYVSGGELFDYICK-NG-RLDEKESRRLFQQILS 127
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
++Y H + ++HRD+K N+ L + ++ DFGL+ M+ + + G+P+Y PE++
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 187
Query: 176 ADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
+ Y G + DIWS G +Y + F + L KI I P + + L
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISL 246
Query: 235 VKSMLRKNPEFRPSAAELLCHP 256
+K ML+ +P R + ++ H
Sbjct: 247 LKHMLQVDPMKRATIKDIREHE 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 66/299 (22%), Positives = 131/299 (43%), Gaps = 27/299 (9%)
Query: 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYK 67
E +GKG FG A+ V H+ + V+K++ R + +R+ +E++++ + +P ++++
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 127
+ K + I Y +GG + IK +P + + + + YLH+ +I+H
Sbjct: 74 GV-LYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS---------------SVVGTPSYMCP 172
RD+ N + ++++ + DFGLA++++ + +VVG P +M P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM--QALINKINKSIVAPLPTVYSGA 230
E++ Y K D++S G + E+ + A + + + P +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPS 251
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKT 289
F + +PE RPS +L L+ + + L G LE D F +T
Sbjct: 252 FFPITVRCCDLDPEKRPSFVKL--EHWLET----LRMHLAGHLPLGPQLEQLDRGFWET 304
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 68/270 (25%), Positives = 114/270 (42%), Gaps = 20/270 (7%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ----EMELISRV 58
QY+V +G G FGS + +K + R +D E+ L+ +V
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 59 RN--PFIVEYKDSWVEKGCYVCIIIGYCEG-GDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+ ++ D W E+ +I+ E D+ + I + G EE + Q+L
Sbjct: 104 SSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITE-RG-ALQEELARSFFWQVLE 160
Query: 116 ALNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 174
A+ + H +LHRD+K NI + +++L DFG L+ D + + GT Y PE
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEW 219
Query: 175 LADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233
+ Y G + +WSLG +Y+M F+ +I + V S +
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVF-FRQRVSSECQH 272
Query: 234 LVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263
L++ L P RP+ E+ HP +Q +L
Sbjct: 273 LIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 63/272 (23%), Positives = 116/272 (42%), Gaps = 47/272 (17%)
Query: 2 EQYEVL-EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ Y+V + +G G G L + +K ++K+ LK ++ +ARR E+EL R
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARR----EVELHWRASQ 69
Query: 61 -PFIVE----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
P IV Y++ + + C + I++ +GG++ I+ F E + + + +
Sbjct: 70 CPHIVRIVDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 116 ALNYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
A+ YLH+ +I HRDVK N+ + ++ + ++L DFG A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------K 168
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--------PLP 224
E + Y D+WSLG +Y + F + A+ + I
Sbjct: 169 ETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
V + L++++L+ P R + E + HP
Sbjct: 228 EVSEEV-KMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 65/287 (22%), Positives = 121/287 (42%), Gaps = 35/287 (12%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME Y L+++G+G++ + + K LK+IRL + A +A +E+ L+ +++
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKH 59
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
IV D + + ++ Y + D+ + + G + +L QLL L Y
Sbjct: 60 ANIVTLHDIIHTEKS-LTLVFEYLDK-DLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYC 116
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LLADI 178
H +LHRD+K N+ + +++L DFGLA+ I + V T Y P+ LL
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------NKSI---VAPLPTVYS 228
Y ++ D+W +GC YEM+ + F ++ ++ I + + +
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 229 GAF-------------------RGLVKSMLRKNPEFRPSAAELLCHP 256
+ L+ +L+ R SA + + HP
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 67/292 (22%), Positives = 119/292 (40%), Gaps = 40/292 (13%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+++Y + ++G+G++G + +K+IRL + + +A +E+ L+ +++
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
I+E K + +I Y E D+ + + K + +L QL+ +N+
Sbjct: 93 RNIIELKSVIHHNHR-LHLIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFC 148
Query: 121 HANHILHRDVKCSNIFLTRDQD-----IRLGDFGLAKML-ISDDLASSVVGTPSYMCPE- 173
H+ LHRD+K N+ L+ +++GDFGLA+ I + + T Y PE
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI------------------ 215
LL Y + DIWS+ C EM + F + KI
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268
Query: 216 -----------NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
K++ L + L+ +ML +P R SA L HP
Sbjct: 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 58/259 (22%), Positives = 112/259 (43%), Gaps = 27/259 (10%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVRNP 61
QYEV I G G L ++ + V LK + + + A E + ++ V +P
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVVHP 139
Query: 62 FIV------EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
IV E+ D + Y I++ Y G + + + P + +L+++L
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILP 193
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
AL+YLH+ +++ D+K NI LT +Q ++L D G + + + GTP + PE++
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI---NSFGYLYGTPGFQAPEIV 249
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235
P +DI+++G + ++ + L P+ Y ++ L+
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED------DPVLKTY-DSYGRLL 301
Query: 236 KSMLRKNPEFRP-SAAELL 253
+ + +P R +A E+
Sbjct: 302 RRAIDPDPRQRFTTAEEMS 320
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 24/291 (8%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQ----EMELISRV 58
+Y + +GKG FG+ +R + +K I R + S E+ L+ +V
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 59 RN----PFIVEYKDSWVEKGCYVCIIIGY-CEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
P ++ D W E +++ D+ + I + G E + Q+
Sbjct: 92 GAGGGHPGVIRLLD-WFETQEGFMLVLERPLPAQDLFDYITE-KG-PLGEGPSRCFFGQV 148
Query: 114 LMALNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
+ A+ + H+ ++HRD+K NI + R +L DFG L+ D+ + GT Y P
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA-LLHDEPYTDFDGTRVYSPP 207
Query: 173 ELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231
E ++ Y + +WSLG +Y+M F+ +I ++ + P S
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAEL-HFPAHVSPDC 260
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWS 282
L++ L P RPS E+L P +Q + L + PL WS
Sbjct: 261 CALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPA--PLAWS 309
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 48/301 (15%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ +YE L +IG+G+FG RH+ +K LKK+ + + + +A +E++++ +++
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 61 PFIVEYKDSWVEKGCYVCIIIG-------YCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+V + K G +CE D+A + V F ++ + + L
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQML 133
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM------LISDDLASSVVGTP 167
L L Y+H N ILHRD+K +N+ +TRD ++L DFGLA+ + + VV T
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TL 192
Query: 168 SYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------NKSI 219
Y PE LL + YG D+W GC + EM + + Q + I +
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252
Query: 220 ---VAPLPTVYSGAFRG---------------------LVKSMLRKNPEFRPSAAELLCH 255
V L+ +L +P R + + L H
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312
Query: 256 P 256
Sbjct: 313 D 313
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 40/294 (13%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
Q++ LE++G G++ + +K LK+++L + +A +E+ L+ +++
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIREISLMKELKH 62
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCE---GGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
IV D + + ++ + + M + + QLL L
Sbjct: 63 ENIVRLYDVIHTENK-LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPE-LL 175
+ H N ILHRD+K N+ + + ++LGDFGLA+ I + SS V T Y P+ L+
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------------------- 215
Y + DIWS GC + EM K F + + + I
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241
Query: 216 -------------NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ + G + +L+ NP+ R SA + L HP
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR---ARRSAHQEMELISR 57
++YE L+ +G+G F + R K+ + +KKI+L +++ R+A +E++L+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+ +P I+ D++ K + ++ + E D+ IK N + + +++ L L
Sbjct: 69 LSHPNIIGLLDAFGHKSN-ISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGL 125
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS--DDLASSVVGTPSYMCPELL 175
YLH + ILHRD+K +N+ L + ++L DFGLAK S VV T Y PELL
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELL 184
Query: 176 ADIPYGSKS-----DIWSLGCCVYEMSAQKAAFKAFDMQALINKI-------NKSI---V 220
+G++ D+W++GC + E+ + + +I + +
Sbjct: 185 ----FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 221 APLP----------TVYSGAFRG-------LVKSMLRKNPEFRPSAAELLCHP 256
LP F L++ + NP R +A + L
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 64/262 (24%), Positives = 109/262 (41%), Gaps = 21/262 (8%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-----RARRSAHQEMELISRV 58
Y + +G+G G + LK + +D R +R A R+
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREAR----TAGRL 91
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+ P +V D G + + G D+A +++ + + Q+ AL+
Sbjct: 92 QEPHVVPIHDFGEIDGQLY-VDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALD 148
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLA 176
HA HRDVK NI ++ D L DFG+A + L + VGT YM PE +
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 177 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK-INKSIVAP---LPTVYSGAFR 232
+ ++DI++L C +YE ++ D +++ IN++I P P + AF
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGI-PVAFD 266
Query: 233 GLVKSMLRKNPEFR-PSAAELL 253
++ + KNPE R + +L
Sbjct: 267 AVIARGMAKNPEDRYVTCGDLS 288
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 75/307 (24%), Positives = 125/307 (40%), Gaps = 52/307 (16%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+Y L+ +G G G K+ +KKI L + A +E+++I R+ +
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-VKH-ALREIKIIRRLDHD 68
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCE------------GGDMAEAIKKANGVHFPEEKLCKW 109
IV+ + G + +G D+A +++ EE +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP---LLEEHARLF 125
Query: 110 LVQLLMALNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLISDDLASSV----V 164
+ QLL L Y+H+ ++LHRD+K +N+F+ T D +++GDFGLA+++ +
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 165 GTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFK------------------- 204
T Y P LL+ Y D+W+ GC EM K F
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 205 AFDMQALINKINKSIVA-------PLPTVYSGAFRG---LVKSMLRKNPEFRPSAAELLC 254
D Q L++ I I PL + G R ++ +L +P R +A E L
Sbjct: 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305
Query: 255 HPHLQPY 261
HP++ Y
Sbjct: 306 HPYMSIY 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 68/309 (22%), Positives = 128/309 (41%), Gaps = 55/309 (17%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA--RQTDRARRSAHQEMELISRV 58
+++Y+ L+ IG G+ G + +KK+ QT A+R A++E+ L+ V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKR-AYRELVLMKCV 81
Query: 59 RNPFIVEYKD-----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+ I+ + +E+ V I++ + ++ + I+ E++ L Q+
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQM 136
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + + + V T Y PE
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--------MQAL-------INKINKS 218
++ + Y DIWS+GC + EM F D ++ L + K+ +
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 219 IVA-----------PLPTVYSGAFRG---------------LVKSMLRKNPEFRPSAAEL 252
+ ++ L+ ML + R S E
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 253 LCHPHLQPY 261
L HP++ +
Sbjct: 317 LQHPYINVW 325
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 70/304 (23%), Positives = 127/304 (41%), Gaps = 47/304 (15%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M++++V G+G+FG+ L + K +KK+ + R Q M+ ++ + +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNR-ELQIMQDLAVLHH 78
Query: 61 PFIVEYKDSWVEKG------CYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLVQ 112
P IV+ + + G Y+ +++ Y + + V P + +L Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 113 LLMALNYLHAN--HILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLISDDLASSVVGTPSY 169
L+ ++ LH ++ HRD+K N+ + D ++L DFG AK L + + + + Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 170 MCPEL-LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--------MQAL-------IN 213
PEL + Y + DIWS+GC EM + F+ + ++ L +
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257
Query: 214 KINKSIVA---------PLPTVYSGAFRG-------LVKSMLRKNPEFRPSAAELLCHPH 257
K+N S P V+S L+ ++L+ PE R E LCHP+
Sbjct: 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317
Query: 258 LQPY 261
Sbjct: 318 FDEL 321
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 61/307 (19%), Positives = 121/307 (39%), Gaps = 59/307 (19%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ Y+++ ++G+G + + +K V+K ++ + + +R E++++ +R
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKR----EIKILENLRG 89
Query: 61 -PFIVEYKD---SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
P I+ D V + ++ + D + + + + ++ ++L A
Sbjct: 90 GPNIITLADIVKDPVSRTPA--LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKA 142
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
L+Y H+ I+HRDVK N+ + + +RL D+GLA+ + V + + PELL
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202
Query: 176 ADIPYGSKS-DIWSLGCCVYEMSAQKAAFKAF-------------------DMQALINKI 215
D S D+WSLGC + M +K F F D+ I+K
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260
Query: 216 NKSIV------------APLPTVYSGAFRG--------LVKSMLRKNPEFRPSAAELLCH 255
N + + + +LR + + R +A E + H
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 256 PHLQPYV 262
P+ V
Sbjct: 321 PYFYTVV 327
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 70/324 (21%), Positives = 121/324 (37%), Gaps = 78/324 (24%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP- 61
+Y ++ ++G G F + L + +V KI R +A E++L+ RV +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKD-MVNNTHVAMKI--VRGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 62 ----------FIVEYKDSWVEKGCY---VCIIIGYCE--GGDMAEAIKKANGVHFPEEKL 106
I++ D + KG V ++ E G ++ IKK P +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMV---FEVLGENLLALIKKYEHRGIPLIYV 133
Query: 107 CKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQD------IRLGDFGLAKMLISDDL 159
+ QLL+ L+Y+H I+H D+K N+ + I++ D G A D+
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEH 191
Query: 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA-------------- 205
++ + T Y PE+L P+G +DIWS C ++E+ F+
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 206 -----------------------FDMQALINKINKSIVAPLPTV----------YSGAFR 232
F+ + L+ I+K PL V +
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 233 GLVKSMLRKNPEFRPSAAELLCHP 256
+ ML+ +P R A L+ HP
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHP 335
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 61/264 (23%), Positives = 113/264 (42%), Gaps = 23/264 (8%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHER-KKYV-LKKIRLARQTD-----RARRSAHQEMELIS 56
Y++++++G G G + + + V +K I + + R R H S
Sbjct: 13 YKIVDKLGGG--GMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN----SS 66
Query: 57 RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
++ + IV D E CY +++ Y EG ++E I+ +G + + Q+L
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIES-HG-PLSVDTAINFTNQILDG 123
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPEL 174
+ + H I+HRD+K NI + ++ +++ DFG+AK L L + V+GT Y PE
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 175 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK-INKSIVAPLPTVYSG---A 230
+DI+S+G +YEM + F ++ K I S+ V +
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 231 FRGLVKSMLRKNPEFRP-SAAELL 253
++ K+ R + E+
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMK 267
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 75/380 (19%), Positives = 148/380 (38%), Gaps = 62/380 (16%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA--RQTDRARRSAHQEMELISRVR 59
++Y+ L+ IG G+ G + +KK+ QT A+R A++E+ L+ V
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKR-AYRELVLMKCVN 119
Query: 60 NPFIVEYKD-----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+ I+ + +E+ V +++ + ++ + I+ E++ L Q+L
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQML 174
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 174
+ +LH+ I+HRD+K SNI + D +++ DFGLA+ + + + V T Y PE+
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 175 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--------MQAL-------INKINKSI 219
+ + Y DIWS+GC + EM K F D ++ L + K+ ++
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 220 VA-----------PLPTVYSGAFRG---------------LVKSMLRKNPEFRPSAAELL 253
P ++ + L+ ML +P R S + L
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 254 CHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAI---SIHSNREKRQSFS 310
HP++ + + + + T E I ++S + +
Sbjct: 355 QHPYINVW----YDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVV 410
Query: 311 NDRALNPSVSETEQDSLSST 330
+ + +SL +
Sbjct: 411 KGQPSPSGAAVNSSESLPPS 430
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 75/298 (25%), Positives = 137/298 (45%), Gaps = 47/298 (15%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA--RQTDRARRSAHQEMELISRVR 59
+ Y +G G++GS K +K +KK+ + A+R A++E+ L+ ++
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF-AKR-AYRELLLLKHMQ 81
Query: 60 NPFIVEYKD-----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+ ++ D S + +++ + + D+ + + F EEK+ + Q+L
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL----KFSEEKIQYLVYQML 136
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE- 173
L Y+H+ ++HRD+K N+ + D ++++ DFGLA+ ++ VV T Y PE
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMTGYVV-TRWYRAPEV 194
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------------------MQALINK 214
+L+ + Y DIWS+GC + EM K FK D +Q L +K
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 215 INKSIVAPLP--------TVYSGA---FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
KS + LP ++ A L++ ML + + R +AA+ L HP +P+
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 76/299 (25%), Positives = 129/299 (43%), Gaps = 44/299 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+Y L IG+G++G + + +KKI +R +E++++ R R+
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-TLREIKILLRFRHE 85
Query: 62 FIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
I+ D +E+ V I+ E D+ + +K H + +C +L Q+L L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGL 141
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV----VGTPSYMCPE 173
Y+H+ ++LHRD+K SN+ L D+++ DFGLA++ D + V T Y PE
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 174 -LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------------------MQALIN 213
+L Y DIWS+GC + EM + + F + +IN
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 214 KINKSIVAPLP--------TVYSGAFRG---LVKSMLRKNPEFRPSAAELLCHPHLQPY 261
++ + LP ++ A L+ ML NP R + L HP+L+ Y
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-30
Identities = 64/298 (21%), Positives = 112/298 (37%), Gaps = 46/298 (15%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRL-ARQTDRARRSAHQEMELISRVRN 60
Y + IG GSFG + + +KK+ R +R E++++ ++ +
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDH 106
Query: 61 PFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLVQL 113
IV + + G Y+ +++ Y + + P + ++ QL
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDI-RLGDFGLAKMLISDDLASSVVGTPSYMCP 172
+L Y+H+ I HRD+K N+ L D + +L DFG AK L+ + S + + Y P
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 225
Query: 173 EL-LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--------MQAL-------INKIN 216
EL Y S D+WS GC + E+ + F ++ L I ++N
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285
Query: 217 -KSIVAPLPTV----YSGAFRG--------LVKSMLRKNPEFRPSAAELLCHPHLQPY 261
P + ++ FR L +L P R + E H
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 56/298 (18%), Positives = 104/298 (34%), Gaps = 57/298 (19%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEME--LISRV 58
+ E IGKG FG V R + V +K R RS +E E +
Sbjct: 42 RTIVLQESIGKGRFGE---VWRGKWRGEEVAVKIFS-----SREERSWFREAEIYQTVML 93
Query: 59 RNPFIVEYKDSWVEKGCYV---CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
R+ I+ + + + ++ Y E G + + + + E + K +
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTAS 150
Query: 116 ALNYLHANH--------ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-----DDLASS 162
L +LH I HRD+K NI + ++ + D GLA S D +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 163 VVGTPSYMCPELL------ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--------- 207
VGT YM PE+L ++DI+++G +E++ + + +
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 208 --MQALINKINKSIVA-----PLPTVYSG-----AFRGLVKSMLRKNPEFRPSAAELL 253
+ ++ K + +P + +++ N R +A +
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 61/306 (19%), Positives = 111/306 (36%), Gaps = 50/306 (16%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR----------ARRSAHQE 51
Y V I GS+G+ E +K++ R +R +E
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKR-VLRE 79
Query: 52 MELISRVRNPFIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 107
+ L++ +P I+ +D + ++ D+A+ I + + +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH-DQRIVISPQHIQ 137
Query: 108 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP 167
++ +L+ L+ LH ++HRD+ NI L + DI + DF LA+ +D + V
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 168 SYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD------------------- 207
Y PE ++ + D+WS GC + EM +KA F+
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 208 MQALINKINKSIVA---------PLPTVYSGA---FRGLVKSMLRKNPEFRPSAAELLCH 255
+ + + + V A L+ ML NP+ R S + L H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 256 PHLQPY 261
P+ +
Sbjct: 318 PYFESL 323
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 49/300 (16%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRL-ARQTDRARRSAHQEMELISRV 58
Y + IG GSFG + + V +KK+ R +R E++++ V
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE--VAIKKVLQDKRFKNR-------ELQIMRIV 89
Query: 59 RNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLV 111
++P +V+ K + G ++ +++ Y + A + P + ++
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQD-IRLGDFGLAKMLISDDLASSVVGTPSYM 170
QLL +L Y+H+ I HRD+K N+ L ++L DFG AK+LI+ + S + + Y
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208
Query: 171 CPEL-LADIPYGSKSDIWSLGCCVYEMSAQKAAFK---AFDMQALINKI----------- 215
PEL Y + DIWS GC + E+ + F D I K+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268
Query: 216 --NKSIVAPLPTV----YSGAFRG--------LVKSMLRKNPEFRPSAAELLCHPHLQPY 261
+ P + +S FR L+ +L P R +A E LCHP
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 60/302 (19%), Positives = 108/302 (35%), Gaps = 65/302 (21%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEME--LISRV 58
+Q ++++QIGKG +G V R + V +K S +E E +
Sbjct: 37 KQIQMVKQIGKGRYGE---VWMGKWRGEKVAVKVFF-----TTEEASWFRETEIYQTVLM 88
Query: 59 RNPFIVEY-------KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
R+ I+ + SW + + +I Y E G + + +K + + K
Sbjct: 89 RHENILGFIAADIKGTGSWTQ----LYLITDYHENGSLYDYLKSTT---LDAKSMLKLAY 141
Query: 112 QLLMALNYLHA--------NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-----DD 158
+ L +LH I HRD+K NI + ++ + D GLA IS D
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 159 LASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD----- 207
++ VGT YM PE+L +D++S G ++E++ + + +
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 208 ------MQALINKINKSIVA-----PLPTVYSG-----AFRGLVKSMLRKNPEFRPSAAE 251
+ + + P +S L+ NP R +A
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 252 LL 253
+
Sbjct: 322 VK 323
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 58/302 (19%), Positives = 109/302 (36%), Gaps = 65/302 (21%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMEL--ISRV 58
+LE +GKG +G V + + V +K R +S +E EL +
Sbjct: 8 RDITLLECVGKGRYGE---VWRGSWQGENVAVKIFS-----SRDEKSWFRETELYNTVML 59
Query: 59 RNPFIVEY-------KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
R+ I+ + + S + + +I Y E G + + ++ + ++
Sbjct: 60 RHENILGFIASDMTSRHSSTQ----LWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVL 112
Query: 112 QLLMALNYLHANH--------ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-----DD 158
+ L +LH I HRD+K NI + ++ + D GLA M D
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 159 LASSVVGTPSYMCPELLADIP------YGSKSDIWSLGCCVYEMSAQKAAFKAFD----- 207
+ VGT YM PE+L + + DIW+ G ++E++ + + +
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
Query: 208 ------MQALINKINKSIVA-----PLPTVYSG-----AFRGLVKSMLRKNPEFRPSAAE 251
+ K + +P + + L+K +NP R +A
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292
Query: 252 LL 253
+
Sbjct: 293 IK 294
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 66/298 (22%), Positives = 130/298 (43%), Gaps = 46/298 (15%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA--RQTDRARRSAHQEMELISRVR 59
E+Y+ L +G G++GS + +KK+ A+R ++E+ L+ ++
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKR-TYRELRLLKHMK 86
Query: 60 NPFIVEYKD-----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+ ++ D +E+ V ++ D+ +K ++ + + Q+L
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK---CQKLTDDHVQFLIYQIL 142
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE- 173
L Y+H+ I+HRD+K SN+ + D ++++ DFGLA+ + D + V T Y PE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEI 200
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------------------MQALINK 214
+L + Y DIWS+GC + E+ + F D ++ + ++
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 215 INKSIVAPLP--------TVYSGA---FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
++ + L V+ GA L++ ML + + R +AA+ L H + Y
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 66/307 (21%), Positives = 127/307 (41%), Gaps = 52/307 (16%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+++ +G+G++G HK + +KKI + A R +E++++ ++
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-TLREIKILKHFKHE 69
Query: 62 FIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
I+ + E V II + D+ I ++ + ++ Q L A+
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIS---TQMLSDDHIQYFIYQTLRAV 125
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV-----------VGT 166
LH ++++HRD+K SN+ + + D+++ DFGLA+++ +S V T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 167 PSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA-------------------- 205
Y PE +L Y D+WS GC + E+ ++ F
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 206 FDMQALINKINKSIVAPLP--------TVYSGAFRG---LVKSMLRKNPEFRPSAAELLC 254
D++ + + + + LP ++ L++ ML +P R +A E L
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 255 HPHLQPY 261
HP+LQ Y
Sbjct: 306 HPYLQTY 312
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 72/298 (24%), Positives = 132/298 (44%), Gaps = 46/298 (15%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA--RQTDRARRSAHQEMELISRVR 59
Y L+ +G G++G+ K +KK+ + A+R A++E+ L+ +R
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKR-AYRELRLLKHMR 82
Query: 60 NPFIVEYKD-----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
+ ++ D ++ +++ + D+ + +K E+++ + Q+L
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE---KLGEDRIQFLVYQML 138
Query: 115 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE- 173
L Y+HA I+HRD+K N+ + D ++++ DFGLA+ ++ VV T Y PE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMTGYVV-TRWYRAPEV 196
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------------------MQALINK 214
+L + Y DIWS+GC + EM K FK D +Q L +
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 215 INKSIVAPLP--------TVYSGA---FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
K+ + LP ++ + A L++ ML + E R +A E L HP+ +
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 34/272 (12%)
Query: 4 YEVLEQIGKGSFGS------ALLVRH---KHERKKYVLKKIRLARQTDRARRSAHQEMEL 54
YE+ E +G G R K VL+ LAR R +E +
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK------VLRA-DLARDPSFYLR-FRREAQN 65
Query: 55 ISRVRNPFIVEYKDSWVEKGCYVC---IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
+ + +P IV D+ + I++ Y +G + + + G ++ + +
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG-PMTPKRAIEVIA 123
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA----SSVVGTP 167
ALN+ H N I+HRDVK +NI ++ +++ DFG+A+ + + ++V+GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 168 SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAP--- 222
Y+ PE ++SD++SLGC +YE+ + F D + + + + P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSAR 242
Query: 223 LPTVYSGAFRGLVKSMLRKNPEFRP-SAAELL 253
+ S +V L KNPE R +AAE+
Sbjct: 243 HEGL-SADLDAVVLKALAKNPENRYQTAAEMR 273
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR--- 59
+YEVL+ IGKGSFG + H+ ++V K+ R R R A +E+ ++ +R
Sbjct: 98 RYEVLKVIGKGSFGQVVKAY-DHKVHQHVALKM--VRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 60 ---NPFIVEYKDSWVEKGCYVCIIIGYCE--GGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
++ +++ + ++C+ E ++ E IKK F + K+ +L
Sbjct: 155 KDNTMNVIHMLENFTFRN-HICMT---FELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 115 MALNYLHANHILHRDVKCSNIFLT--RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
L+ LH N I+H D+K NI L I++ DFG + + + + Y P
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYIQSRFYRAP 268
Query: 173 ELLADIPYGSKSDIWSLGCCVYEM 196
E++ YG D+WSLGC + E+
Sbjct: 269 EVILGARYGMPIDMWSLGCILAEL 292
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 71/394 (18%), Positives = 136/394 (34%), Gaps = 84/394 (21%)
Query: 2 EQYEVL-EQIGKGSFGSALLVRHKHER--KKYVLKKIRLARQTDRARRSAHQEMELISRV 58
+ +E ++G+G++G + K + K Y LK+I SA +E+ L+ +
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLREL 75
Query: 59 RNPFIVEYKDSWVEKG-CYVCIIIGYCEG------GDMAEAIKKANGVHFPEEKLCKWLV 111
++P ++ + ++ V ++ Y E + V P + L
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQD----IRLGDFGLAKMLISD-----DLASS 162
Q+L ++YLHAN +LHRD+K +NI + + +++ D G A++ S DL
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 163 VVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA---------------- 205
VV T Y PE LL Y DIW++GC E+ + F
Sbjct: 196 VV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254
Query: 206 ------------------------------FDMQALINKINKSIVAPLPTVYSGAFRGLV 235
F N + L+
Sbjct: 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 314
Query: 236 KSMLRKNPEFRPSAAELLCHPHLQ--PYVLGIHLKLNGPRRNTF-PLEWSDSNFKKTRFM 292
+ +L +P R ++ + + P+ P P + F + +
Sbjct: 315 QKLLTMDPIKRITSEQAMQDPYFLEDPL----------PTSDVFAGCQIPYPKREFLTEE 364
Query: 293 EPEAISIHSNREKRQSFSNDRALNPSVSETEQDS 326
EP+ N++++Q ++ ++ +
Sbjct: 365 EPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHT 398
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 64/330 (19%), Positives = 118/330 (35%), Gaps = 76/330 (23%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRL-ARQTDRARRSAHQEMELISRVR 59
++Y + + +G GSFG V K++ LKK+ R +R E++++ +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------ELDIMKVLD 58
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHF------------------ 101
+ I++ D + G + + H
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 102 --------------------PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL-TRD 140
P + ++ QL A+ ++H+ I HRD+K N+ + ++D
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 141 QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL-LADIPYGSKSDIWSLGCCVYEMSAQ 199
++L DFG AK LI + + + + + Y PEL L Y D+WS+GC E+
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 200 KAAFKAFDMQALINKINKSIVAP----------------LPTV----YSGAFRG------ 233
K F + +I + + P PT+ +
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 234 --LVKSMLRKNPEFRPSAAELLCHPHLQPY 261
L++ +LR P+ R + E + HP
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFFDHL 328
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 81/335 (24%), Positives = 136/335 (40%), Gaps = 86/335 (25%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-- 59
+ V+ ++G G+FG LL +H + KKY K+ R + RSA E +++ +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQH-IDNKKYYAVKV--VRNIKKYTRSAKIEADILKKIQND 91
Query: 60 ---NPFIVEYKDSWVEKGCYVCIIIGYCE--GGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
N IV+Y ++ ++C+I E G + E I + N F E + + +++L
Sbjct: 92 DINNNNIVKYHGKFMYYD-HMCLI---FEPLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 115 MALNYLHANHILHRDVKCSNIFLT-------------------------RDQDIRLGDFG 149
ALNYL + H D+K NI L + I+L DFG
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 150 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-- 207
A D S++ T Y PE++ ++ + SD+WS GC + E+ F+ +
Sbjct: 208 CA--TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 208 -----MQALINKINKSIVA------------------PLPTVYSG--------------- 229
M+++I I K+++ P S
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 230 -----AFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
F + S+L+ +P RPS AELL H L+
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/302 (18%), Positives = 103/302 (34%), Gaps = 65/302 (21%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++LE +G FG V +YV KI D+ E+ + +++
Sbjct: 24 MPLQLLEVKARGRFGC---VWKAQLLNEYVAVKI--FPIQDKQSWQNEYEVYSLPGMKHE 78
Query: 62 FIVEY-------KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLL 114
I+++ V+ +I + E G +++ +K +LC +
Sbjct: 79 NILQFIGAEKRGTSVDVDL----WLITAFHEKGSLSDFLKANV---VSWNELCHIAETMA 131
Query: 115 MALNYLHAN----------HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA---S 161
L YLH + I HRD+K N+ L + + DFGLA + A
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 162 SVVGTPSYMCPELL-----ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---------- 206
VGT YM PE+L + D++++G ++E++++ A
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 207 ---------DMQALI------NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 251
DMQ ++ + ++ + E R SA
Sbjct: 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 252 LL 253
+
Sbjct: 309 VG 310
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 71/365 (19%), Positives = 122/365 (33%), Gaps = 118/365 (32%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN- 60
+Y V+ ++G G F + L KK+V K+ + + +A E+ L+ VRN
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQG-KKFVAMKV--VKSAEHYTETALDEIRLLKSVRNS 93
Query: 61 -------PFIVEYKDSWVEK---GCYVCIIIGYCE--GGDMAEAIKKANGVHFPEEKLCK 108
+V+ D + G ++C++ E G + + I K+N P + K
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMV---FEVLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 109 WLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQ-------------------------- 141
+ Q+L L+YLH I+H D+K NI L+ ++
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 142 -----------------------DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
+++ D G A + + T Y E+L
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------------MQALINKINKSIVA---- 221
Y + +DIWS C +E++ F+ + L+ K+ + ++
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328
Query: 222 ------------------------PLPTVYSG------AFRGLVKSMLRKNPEFRPSAAE 251
L Y F + ML PE R +AAE
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388
Query: 252 LLCHP 256
L HP
Sbjct: 389 CLRHP 393
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 69/325 (21%), Positives = 122/325 (37%), Gaps = 78/325 (24%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+YE++ +G+G+FG + K V KI R + R +A E+ ++ +++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKEK 76
Query: 62 ------FIVEYKDSWVEKGCYVCIIIGYCE--GGDMAEAIKKANGVHFPEEKLCKWLVQL 113
V D + G ++CI E G + E +K+ N +P + QL
Sbjct: 77 DKENKFLCVLMSDWFNFHG-HMCIA---FELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 114 LMALNYLHANHILHRDVKCSNIFLT-------------------RDQDIRLGDFGLAKML 154
AL +LH N + H D+K NI ++ IR+ DFG A
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 191
Query: 155 ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD------- 207
+ +++V T Y PE++ ++ + D+WS+GC ++E F+ +
Sbjct: 192 -DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250
Query: 208 MQALINKINKSIVA-------------PLPTVYSGAFRG--------------------- 233
M+ ++ I ++ S
Sbjct: 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310
Query: 234 --LVKSMLRKNPEFRPSAAELLCHP 256
L++ ML +P R + AE L HP
Sbjct: 311 FDLMRRMLEFDPAQRITLAEALLHP 335
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++YE+ IGKGSFG + +++V KI + A E+ L+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAY-DRVEQEWVAIKI--IKNKKAFLNQAQIEVRLLELMNKH 110
Query: 62 ------FIVEYKDSWVEKGCYVCIIIGYCE--GGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+IV K ++ + ++C++ E ++ + ++ N K+ Q+
Sbjct: 111 DTEMKYYIVHLKRHFMFRN-HLCLV---FEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 114 LMALNYLHAN--HILHRDVKCSNIFLT--RDQDIRLGDFGLAKMLISDDLASSVVGTPSY 169
AL +L I+H D+K NI L + I++ DFG + + + Y
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFY 224
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYEM 196
PE+L +PY D+WSLGC + EM
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEM 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 66/325 (20%), Positives = 124/325 (38%), Gaps = 78/325 (24%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+YE+++ +G+G+FG + ++V KI + DR +A E++++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI--VKNVDRYCEAARSEIQVLEHLNTT 71
Query: 62 ------FIVEYKDSWVEKGCYVCIIIGYCE--GGDMAEAIKKANGVHFPEEKLCKWLVQL 113
V+ + + G ++CI+ E G + IK+ + F + + K Q+
Sbjct: 72 DPNSTFRCVQMLEWFEHHG-HICIV---FELLGLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 114 LMALNYLHANHILHRDVKCSNIFLT-------------------RDQDIRLGDFGLAKML 154
++N+LH+N + H D+K NI + DI++ DFG A
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TY 186
Query: 155 ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD------- 207
+ S++V T Y PE++ + + D+WS+GC + E F D
Sbjct: 187 DDEHH-STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245
Query: 208 MQALINKINKSIVA------------------------------PLPTVYSG------AF 231
M+ ++ + K ++ PL
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305
Query: 232 RGLVKSMLRKNPEFRPSAAELLCHP 256
L++ ML +P R + E L HP
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHP 330
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 71/338 (21%), Positives = 131/338 (38%), Gaps = 89/338 (26%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA--RQTDRARRSAHQEMELISRVR 59
+YE+++++GKG++G + + +KKI A TD A+R +E+ +++ +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD-AQR-TFREIMILTELS 66
Query: 60 N-PFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIK--KANGVHFPEEKLCKWLV-Q 112
IV + + Y ++ Y E D+ I+ VH +++V Q
Sbjct: 67 GHENIVNLLNVLRADNDRDVY--LVFDYMET-DLHAVIRANILEPVH------KQYVVYQ 117
Query: 113 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS---- 168
L+ + YLH+ +LHRD+K SNI L + +++ DFGL++ ++ ++ +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 169 ------------------YMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFK----- 204
Y PE LL Y D+WSLGC + E+ K F
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 205 --------------AFDMQALINKINKSIVAPLPTVYSGAFRG----------------- 233
D++++ + K+++ L
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297
Query: 234 ----------LVKSMLRKNPEFRPSAAELLCHPHLQPY 261
L+ +L+ NP R SA + L HP + +
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 45/229 (19%), Positives = 86/229 (37%), Gaps = 45/229 (19%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEME--LISR 57
++ ++LE IG+G +G+ V ++ V +K + R++ E +
Sbjct: 12 LDNLKLLELIGRGRYGA---VYKGSLDERPVAVKVF-----SFANRQNFINEKNIYRVPL 63
Query: 58 VRNPFIVEY-----KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
+ + I + + + + Y +++ Y G + + + C+
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEY-LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHS 119
Query: 113 LLMALNYLHANH---------ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--- 160
+ L YLH I HRD+ N+ + D + DFGL+ L + L
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 161 ------SSVVGTPSYMCPELLADI-------PYGSKSDIWSLGCCVYEM 196
S VGT YM PE+L + D+++LG +E+
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 68/350 (19%), Positives = 126/350 (36%), Gaps = 97/350 (27%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA--RQTDRARRSAHQEMELISRVR 59
+ Y + IG+GS+G L K+ K +KK+ D +R +E+ +++R++
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID-CKR-ILREITILNRLK 83
Query: 60 NPFIVEYKD-----SWVE-KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+ +I+ D ++ Y I++ + D+ + K + EE + L L
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELY--IVLEIADS-DLKKLFKT--PIFLTEEHIKTILYNL 138
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS----- 168
L+ N++H + I+HRD+K +N L +D +++ DFGLA+ + S+ + V
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 169 ------------------YMCPE-LLADIPYGSKSDIWSLGCCVYEM-----------SA 198
Y PE +L Y DIWS GC E+ +
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 199 QKAAFKAF------------------------------------DMQALINKINKSIVAP 222
+ F D++ + +
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318
Query: 223 LPTVYSGAFRGL-----------VKSMLRKNPEFRPSAAELLCHPHLQPY 261
P + ++SML+ NP R + + L HP+L+
Sbjct: 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
+++ ++ +G G+FG+ L + + K V K + +A + E +++ V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 59 RNPFIVE-YKDSWVEKGCYVC------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
NP + G +C +I G + + +++ + + + L W V
Sbjct: 75 DNPHVCRLL-------G--ICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCV 124
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-S 168
Q+ +NYL ++HRD+ N+ + Q +++ DFGLAK+L +++ G P
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M E + Y +SD+WS G V+E+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWEL 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 7 LEQIGKGSFGS---ALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVRNPF 62
L+Q+GKG+FGS + + V +KK++ + T+ R +E+E++ +++
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 103
Query: 63 IVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV+YK G + +I+ Y G + + ++K + KL ++ Q+ + YL
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLG 162
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS-----YMCPELLA 176
+HRD+ NI + + +++GDFGL K ++ D V P + PE L
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 177 DIPYGSKSDIWSLGCCVYEM 196
+ + SD+WS G +YE+
Sbjct: 222 ESKFSVASDVWSFGVVLYEL 241
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 7e-21
Identities = 67/356 (18%), Positives = 126/356 (35%), Gaps = 101/356 (28%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA--RQTDRARRSAHQEMELISRVR 59
++YE+ IG GS+G K E++ +KKI D +R +E+ +++R+
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID-CKR-ILREIAILNRLN 110
Query: 60 NPFIVEYKD----SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+ +V+ D VEK + +++ + D + + V+ E + L LL+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRT--PVYLTELHIKTLLYNLLV 167
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS------- 168
+ Y+H+ ILHRD+K +N + +D +++ DFGLA+ + + +S +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 169 ---------------------YMCPE-LLADIPYGSKSDIWSLGCCVYEM---------- 196
Y PE +L Y D+WS+GC E+
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 197 -SAQKAAFKAFDMQAL--------------------INKINKSIVAP----LPTVYSGAF 231
+ + F L +N I + P + +
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347
Query: 232 RGLVKSM----------------------LRK----NPEFRPSAAELLCHPHLQPY 261
+ ++ L++ NP R + E L HP +
Sbjct: 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 7 LEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
L+Q+GKG+FGS + + V K L T+ R +E+E++ +++ I
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 64 VEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
V+YK G + +I+ Y G + + ++K + KL ++ Q+ + YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS-----YMCPELLAD 177
+HRD+ NI + + +++GDFGL K ++ D V P + PE L +
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 178 IPYGSKSDIWSLGCCVYEM 196
+ SD+WS G +YE+
Sbjct: 192 SKFSVASDVWSFGVVLYEL 210
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 45/199 (22%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 7 LEQIGKGSFGS---ALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+ +G+G FG + V +K ++ +E+E++ + +
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHEN 84
Query: 63 IVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV+YK E G + +I+ + G + E + K N ++ K+ VQ+ ++YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLG 143
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPS---YMCPELLAD 177
+ +HRD+ N+ + + +++GDFGL K + +D + + S + PE L
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 178 IPYGSKSDIWSLGCCVYEM 196
+ SD+WS G ++E+
Sbjct: 204 SKFYIASDVWSFGVTLHEL 222
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 47/208 (22%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
+++ ++ +G G+FG+ L + + K V K + +A + E +++ V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 59 RNPFIVEYKDSWVEKGCY-VC------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
NP + +C +I G + + +++ + + + L W V
Sbjct: 75 DNPHVCR---------LLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCV 124
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-S 168
Q+ +NYL ++HRD+ N+ + Q +++ DFGLAK+L +++ G P
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M E + Y +SD+WS G V+E+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWEL 212
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 7 LEQIGKGSFGS---ALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+ +G+G FG + V +K ++ A + R QE++++ + +
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 63 IVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I++YK + G + +++ Y G + + + + + +L + Q+ + YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 151
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS-----YMCPELLA 176
A H +HRD+ N+ L D+ +++GDFGLAK + + V + PE L
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 177 DIPYGSKSDIWSLGCCVYEM 196
+ + SD+WS G +YE+
Sbjct: 211 EYKFYYASDVWSFGVTLYEL 230
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 48/199 (24%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 7 LEQIGKGSFGS---ALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+ Q+GKG+FGS V +K+++ D +R +E++++ + + F
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPD-QQRDFQREIQILKALHSDF 85
Query: 63 IVEYKD-SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV+Y+ S+ + +++ Y G + + +++ + +L + Q+ + YL
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLG 144
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP-SYMCPELLAD 177
+ +HRD+ NI + + +++ DFGLAK+L D + +P + PE L+D
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 178 IPYGSKSDIWSLGCCVYEM 196
+ +SD+WS G +YE+
Sbjct: 205 NIFSRQSDVWSFGVVLYEL 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 28/257 (10%), Positives = 63/257 (24%), Gaps = 40/257 (15%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRS-AHQEMELISRVRNPF 62
Y +L G ++ L + +SR+ P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
+ D V ++ + GG + E + P + + + L A + H
Sbjct: 93 VARVLD-VVHTRAGGLVVAEWIRGGSLQEVADTSPS---PVGAI-RAMQSLAAAADAAHR 147
Query: 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGS 182
+ S + ++ D D+ L M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA-------NP 181
Query: 183 KSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAP---LPTVYSGAFRGLV 235
+ DI +G +Y + + + + P + +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI-PFQISAVA 240
Query: 236 KSMLRKNPEFRPSAAEL 252
++ + R ++ L
Sbjct: 241 ARSVQGDGGIRSASTLL 257
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
+Q+ + +GKG FGS A L + K +K ++ +E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 59 RNPFIVE-----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA----NGVHFPEEKLCKW 109
+P + + + + +I+ + + GD+ + + N + P + L ++
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 110 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P 167
+V + + YL + + +HRD+ N L D + + DFGL++ + S D + P
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 168 -SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
++ E LAD Y SD+W+ G ++E+
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEI 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 43/202 (21%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 8 EQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV 64
+ +G G FG+ + + K V K+ + ++ ++ M I + + IV
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 65 E-YKDSWVEKGCYVC------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
G +C ++ Y G + + +++ + + L W VQ+ +
Sbjct: 79 RLL-------G--LCPGSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGM 128
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPEL 174
YL + ++HR++ N+ L +++ DFG+A +L DD P +M E
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 175 LADIPYGSKSDIWSLGCCVYEM 196
+ Y +SD+WS G V+E+
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWEL 210
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 51/268 (19%), Positives = 102/268 (38%), Gaps = 27/268 (10%)
Query: 5 EVLEQIGKGSFG---SALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E IG+G FG L+ + ++ +K + E ++ +P
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHP 86
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
++ + +++ Y + GD+ I+ + + L + +Q+ + YL
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS-----YMCPELLA 176
+ +HRD+ N L +++ DFGLA+ + + S T + +M E L
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 177 DIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLP-----TVYSGA 230
+ +KSD+WS G ++E M+ + + + + + P +Y
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE-- 263
Query: 231 FRGLVKSMLR---KNPEFRPSAAELLCH 255
ML+ E RPS +EL+
Sbjct: 264 ------VMLKCWHPKAEMRPSFSELVSR 285
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 46/256 (17%), Positives = 102/256 (39%), Gaps = 9/256 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ ++G G +G K +K ++ + +E ++ +++P
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276
Query: 62 FIVE-YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+V+ + II + G++ + +++ N L Q+ A+ YL
Sbjct: 277 NLVQLL--GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY--MCPELLADI 178
+ +HR++ N + + +++ DFGL++++ D + PE LA
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 179 PYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237
+ KSD+W+ G ++E + + + D+ + + K P L+++
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 454
Query: 238 MLRKNPEFRPSAAELL 253
+ NP RPS AE+
Sbjct: 455 CWQWNPSDRPSFAEIH 470
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 58/265 (21%), Positives = 104/265 (39%), Gaps = 25/265 (9%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E + EQIG+G+FG R + + +K R + QE ++ + +P
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHP 172
Query: 62 FIVEYKDSWVEKGCY-VC-------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
IV VC I++ +GGD ++ G + L + +
Sbjct: 173 NIVR---------LIGVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDA 222
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY---- 169
+ YL + +HRD+ N +T +++ DFG+++ +D + ++ G
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKW 281
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYS 228
PE L Y S+SD+WS G ++E S + + Q + K P P +
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341
Query: 229 GAFRGLVKSMLRKNPEFRPSAAELL 253
A L++ P RPS + +
Sbjct: 342 DAVFRLMEQCWAYEPGQRPSFSTIY 366
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 50/255 (19%), Positives = 107/255 (41%), Gaps = 9/255 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E + ++G+G FG V I+ + + + QE +++ ++R+
Sbjct: 184 ESLRLEVKLGQGCFGE---V-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+ E+ Y I+ Y G + + +K G + +L Q+ + Y+
Sbjct: 240 KLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY--MCPELLADIP 179
+ +HRD++ +NI + + ++ DFGLA+++ ++ + PE
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 180 YGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+ KSD+WS G + E + + + + +++++ + P P + L+
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 417
Query: 239 LRKNPEFRPSAAELL 253
RK PE RP+ L
Sbjct: 418 WRKEPEERPTFEYLQ 432
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 43/210 (20%), Positives = 85/210 (40%), Gaps = 25/210 (11%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSA-HQEMELISR 57
+ +LE++G GSFG + +K ++ + +E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 58 VRNPFIVE-YKDSWVEKGCYVC------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 110
+ + ++ Y G V ++ G + + ++K + HF L ++
Sbjct: 78 LDHRNLIRLY-------G--VVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYA 127
Query: 111 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP 167
VQ+ + YL + +HRD+ N+ L +++GDFGL + L +D + P
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 168 -SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
++ PE L + SD W G ++EM
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEM 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 52/272 (19%), Positives = 101/272 (37%), Gaps = 35/272 (12%)
Query: 5 EVLEQIGKGSFG---SALLVRHKHERKKYV----LKKIRLARQTDRARRSAHQEMELISR 57
E IG+G FG L +K + L +I E ++
Sbjct: 92 HFNEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKD 146
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+P ++ + +++ Y + GD+ I+ + + L + +Q+ +
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGM 205
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS-----YMCP 172
+L + +HRD+ N L +++ DFGLA+ + + S T + +M
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 173 ELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLP-----TV 226
E L + +KSD+WS G ++E M+ + + + + + P +
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325
Query: 227 YSGAFRGLVKSMLR---KNPEFRPSAAELLCH 255
Y ML+ E RPS +EL+
Sbjct: 326 YE--------VMLKCWHPKAEMRPSFSELVSR 349
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 18/211 (8%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
+ + +G+G FGS L + K +K ++L + R E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 59 RNPFIVE------YKDSWVEKGCYVCIIIGYCEGGDMAEAIKK----ANGVHFPEEKLCK 108
+P ++ S +I+ + + GD+ + H P + L K
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPM--VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 109 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT-- 166
++V + + + YL + LHRD+ N L D + + DFGL+K + S D
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 167 P-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
P ++ E LAD Y SKSD+W+ G ++E+
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 8e-17
Identities = 60/264 (22%), Positives = 106/264 (40%), Gaps = 24/264 (9%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
E+ E+ IG+G FG + + ++ +K + +D R QE + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQF 448
Query: 59 RNPFIVEYKDSWVEKGCY-VC------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
+P IV+ V II+ C G++ ++ L +
Sbjct: 449 DHPHIVK---------LIGVITENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAY 498
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG-TP-SY 169
QL AL YL + +HRD+ N+ ++ + ++LGDFGL++ + + G P +
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYS 228
M PE + + S SD+W G C++E + F+ +I +I P+P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 618
Query: 229 GAFRGLVKSMLRKNPEFRPSAAEL 252
L+ +P RP EL
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTEL 642
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 2e-16
Identities = 43/195 (22%), Positives = 89/195 (45%), Gaps = 12/195 (6%)
Query: 9 QIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65
++G G+FGS + K + + K ++ +E +++ ++ NP+IV
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAI-KVLK-QGTEKADTEEMMREAQIMHQLDNPYIV- 399
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
+ V + + +++ GG + + + P + + L Q+ M + YL +
Sbjct: 400 -RLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGT--P-SYMCPELLADIPYG 181
+HR++ N+ L ++ DFGL+K L +DD ++ P + PE + +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 182 SKSDIWSLGCCVYEM 196
S+SD+WS G ++E
Sbjct: 518 SRSDVWSYGVTMWEA 532
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 2e-16
Identities = 50/255 (19%), Positives = 107/255 (41%), Gaps = 9/255 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E + ++G+G FG V I+ + + + QE +++ ++R+
Sbjct: 267 ESLRLEVKLGQGCFGE---V-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+ E+ Y I+ Y G + + +K G + +L Q+ + Y+
Sbjct: 323 KLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY--MCPELLADIP 179
+ +HRD++ +NI + + ++ DFGLA+++ ++ + PE
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 180 YGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+ KSD+WS G + E + + + + +++++ + P P + L+
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 500
Query: 239 LRKNPEFRPSAAELL 253
RK PE RP+ L
Sbjct: 501 WRKEPEERPTFEYLQ 515
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
E+ E+ IG+G FG + + ++ +K + +D R QE + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 73
Query: 59 RNPFIVEYKDSWVEKGCY-VC------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
+P IV+ V II+ C G++ ++ L +
Sbjct: 74 DHPHIVK---------LIGVITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAY 123
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT-P-SY 169
QL AL YL + +HRD+ N+ ++ + ++LGDFGL++ + + G P +
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 170 MCPELLADIPYGSKSDIWSLGCCVYEM 196
M PE + + S SD+W G C++E+
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEI 210
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
E + +G+G FG + HK E+ +K + T + E ++ +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNL 70
Query: 59 RNPFIVEYKDSWVEKGCY-VC------IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 111
+P IV+ + II+ G++ +++ N L + +
Sbjct: 71 DHPHIVK---------LIGIIEEEPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSL 120
Query: 112 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-S 168
Q+ A+ YL + + +HRD+ NI + + ++LGDFGL++ I D+ T P
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK 179
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEM 196
+M PE + + + SD+W C++E+
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEI 207
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 39/204 (19%), Positives = 81/204 (39%), Gaps = 18/204 (8%)
Query: 5 EVLEQIGKGSFGS---ALLVRHKHERKKYV----LKKIRLARQTDRARRSAHQEMELISR 57
IGKG FG + + + L +I + + +E L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEY-IDQAQNRIQCAIKSLSRI----TEMQQVEAFLREGLLMRG 78
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+ +P ++ + +++ Y GD+ + I+ + + L + +Q+ +
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGM 137
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS-----YMCP 172
YL +HRD+ N L +++ DFGLA+ ++ + S + +
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 173 ELLADIPYGSKSDIWSLGCCVYEM 196
E L + +KSD+WS G ++E+
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWEL 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 43/229 (18%), Positives = 79/229 (34%), Gaps = 54/229 (23%)
Query: 2 EQYEVLEQIGKGSFGS-----ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELIS 56
E+ + ++G+GSFG A V + +K + + R R E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMK 83
Query: 57 RVRNPFIVEYKDSWVEKGCY--------VCIIIGYCEGGDM--------AEAIKKANGVH 100
+V +I+ GD+
Sbjct: 84 EFNCHHVVR---------LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 101 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160
K+ + ++ + YL+AN +HRD+ N + D +++GDFG+ + + D
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-- 192
Query: 161 SSVVGTPSY-------------MCPELLADIPYGSKSDIWSLGCCVYEM 196
Y M PE L D + + SD+WS G ++E+
Sbjct: 193 --------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 44/195 (22%), Positives = 90/195 (46%), Gaps = 12/195 (6%)
Query: 9 QIGKGSFGSAL--LVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE- 65
++G G+FGS + R + ++ +K ++ +E +++ ++ NP+IV
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 66 YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 125
V + + +++ GG + + + P + + L Q+ M + YL +
Sbjct: 76 IG---VCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 126 LHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGT--P-SYMCPELLADIPYG 181
+HRD+ N+ L ++ DFGL+K L +DD ++ P + PE + +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 182 SKSDIWSLGCCVYEM 196
S+SD+WS G ++E
Sbjct: 192 SRSDVWSYGVTMWEA 206
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 33/88 (37%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPE 173
+N+LH NH +HRD+K +NI L ++ DFGLA+ + S +VGT +YM PE
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 174 LLADIPY--G---SKSDIWSLGCCVYEM 196
G KSDI+S G + E+
Sbjct: 206 ------ALRGEITPKSDIYSFGVVLLEI 227
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 46/165 (27%)
Query: 51 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC-EGGDMA---EAIKKAN------GVH 100
E+E +S R+P +V +IG+C E +M + ++ N G
Sbjct: 85 EIETLSFCRHPHLVS--------------LIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 101 FPEEKLCKWLVQLLMA------LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154
P + W +L + L+YLH I+HRDVK NI L + ++ DFG++K
Sbjct: 131 LPTMSM-SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 155 ISDD---LASSVVGTPSYMCPELLADIPYGS------KSDIWSLG 190
D L++ V GT Y+ PE Y KSD++S G
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPE------YFIKGRLTEKSDVYSFG 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 45/204 (22%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 2 EQYEVLEQIGKGSFG---SALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISR 57
+ IG G FG +L +++ V +K ++ A T++ R E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQ 102
Query: 58 VRNPFIVE-YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
+ I+ + K + II Y E G + + +++ F +L L +
Sbjct: 103 FSHHNIIRLE--GVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAG 159
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPS---YMCP 172
+ YL + +HRD+ NI + + ++ DFGL+++L D + + G + P
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 173 ELLADIPYGSKSDIWSLGCCVYEM 196
E ++ + S SD+WS G ++E+
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEV 243
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 38/197 (19%), Positives = 87/197 (44%), Gaps = 8/197 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E ++ +++G G FG V K+ ++ + + + E ++ +++
Sbjct: 188 ESLKLEKKLGAGQFGE---V-WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+ ++ Y II + G + + +K G P KL + Q+ + ++
Sbjct: 244 KLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY--MCPELLADIP 179
+ +HRD++ +NI ++ ++ DFGLA+++ ++ + PE +
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 180 YGSKSDIWSLGCCVYEM 196
+ KSD+WS G + E+
Sbjct: 362 FTIKSDVWSFGILLMEI 378
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 58/264 (21%), Positives = 111/264 (42%), Gaps = 19/264 (7%)
Query: 2 EQYEVLEQIGKGSFG---SALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
+ + + IG G G L +K ++ A T+R RR E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQF 107
Query: 59 RNPFIVE-YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+P I+ V +G I+ Y E G + ++ + F +L L + +
Sbjct: 108 DHPNIIRLE--GVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGM 164
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPS---YMCPE 173
YL +HRD+ N+ + + ++ DFGL+++L D D A + G + PE
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 174 LLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232
+A + S SD+WS G ++E ++ + + + +I+ + + P P G
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP---MGCPH 281
Query: 233 GLVKSMLR---KNPEFRPSAAELL 253
L + ML K+ RP ++++
Sbjct: 282 ALHQLMLDCWHKDRAQRPRFSQIV 305
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 43/186 (23%), Positives = 81/186 (43%), Gaps = 11/186 (5%)
Query: 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 136
II + G++ + +++ N L Q+ A+ YL + +HRD+ N
Sbjct: 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 137 LTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCV 193
+ + +++ DFGL++ L++ D ++ G P + PE LA + KSD+W+ G +
Sbjct: 144 VGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 202
Query: 194 YE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSA 249
+E + + + D+ + + K P G + + M NP RPS
Sbjct: 203 WEIATYGMSPYPGIDLSQVYELLEKDYRMERPE---GCPEKVYELMRACWQWNPSDRPSF 259
Query: 250 AELLCH 255
AE+
Sbjct: 260 AEIHQA 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 50/287 (17%), Positives = 97/287 (33%), Gaps = 62/287 (21%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA-----RQTDRARRSAHQEMELIS 56
E E +G+G+F + L + + + S + ++S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 57 RVRNPFIVEYKDSWVEKGCY-VC-------IIIGYCEGGDMAEAIKKANGVHFPEEKLCK 108
++ + +V Y VC ++ + + G + +KK N +
Sbjct: 68 KLSHKHLVL---------NYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLE 117
Query: 109 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--------IRLGDFGLAKMLISDDLA 160
QL A+++L N ++H +V NI L R++D I+L D G++ ++ D
Sbjct: 118 VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-- 175
Query: 161 SSVVGTPSY------MCPELLAD-IPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALI 212
+ PE + + +D WS G ++E S A D Q +
Sbjct: 176 -------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 213 NKINKSIVAPLP---TVYSGAFRGLVKSMLR---KNPEFRPSAAELL 253
P P + + + P+ RPS ++
Sbjct: 229 QFYEDRHQLPAPKAAELAN--------LINNCMDYEPDHRPSFRAII 267
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 44/185 (23%), Positives = 84/185 (45%), Gaps = 12/185 (6%)
Query: 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 136
+ I+ Y G + ++ +G +L + + + +L ++ +HRD+ N
Sbjct: 78 IYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136
Query: 137 LTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCV 193
+ RD +++ DFG+ + + DD S VGT P + PE+ Y SKSD+W+ G +
Sbjct: 137 VDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195
Query: 194 YE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSA 249
+E S K + + ++ K+++ P A + + M + PE RP+
Sbjct: 196 WEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTF 252
Query: 250 AELLC 254
+LL
Sbjct: 253 QQLLS 257
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 62/264 (23%), Positives = 112/264 (42%), Gaps = 17/264 (6%)
Query: 2 EQYEVLEQIGKGSFG---SALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV 58
+ + +G G FG S L + +++ V K T++ RR E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRL-KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+P I+ + V K V I+ Y E G + ++K + F +L L + +
Sbjct: 104 DHPNIIRLE-GVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMK 161
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPS---YMCPEL 174
YL +HRD+ NI + + ++ DFGL ++L D + A + G + PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 175 LADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233
+A + S SD+WS G ++E MS + + Q +I +++ P P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP---MDCPAA 278
Query: 234 LVKSMLR---KNPEFRPSAAELLC 254
L + ML K+ RP +++
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVS 302
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 52/228 (22%), Positives = 96/228 (42%), Gaps = 48/228 (21%)
Query: 2 EQYEVLEQIGKGSFG---SALLVR-HKHERKKYV-LKKIRLARQTDRARRSAHQEMELIS 56
+ ++G+G+FG A + K V +K ++ A ++ AR+ +E EL++
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT 98
Query: 57 RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE--------AIKKANGVHFPEEKLCK 108
+++ IV + +G + ++ Y GD+ A A G L
Sbjct: 99 MLQHQHIVRFFGV-CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG- 156
Query: 109 WLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161
L QLL +A YL H +HRD+ N + + +++GDFG+++ + S D
Sbjct: 157 -LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD--- 212
Query: 162 SVVGTPSY-------------MCPELLADIPYGSKSDIWSLGCCVYEM 196
Y M PE + + ++SD+WS G ++E+
Sbjct: 213 -------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 46/225 (20%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 2 EQYEVLEQIGKGSFG---SALLVRHKHERKKYV--LKKIRLARQTDRARRSAHQEMELIS 56
+ ++G+G+FG A + K + +K ++ T AR+ +E EL++
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLT 72
Query: 57 RVRNPFIVEYKDSWVEKGCY--------VCIIIGYCEGGDMAE--------AIKKANGVH 100
+++ IV+ Y + ++ Y + GD+ + A+ +G
Sbjct: 73 NLQHEHIVK---------FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 101 FPEEKLCKWLVQLLMAL------NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154
+ L +A YL + H +HRD+ N + + +++GDFG+++ +
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 155 ISDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
S D T +M PE + + ++SD+WS G ++E+
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 43/200 (21%), Positives = 89/200 (44%), Gaps = 22/200 (11%)
Query: 9 QIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE 65
++G G+FG+ K + V K ++ + E ++ ++ NP+IV
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAV-KILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 66 -----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+S +++ E G + + +++ H ++ + + + Q+ M + YL
Sbjct: 83 MIGICEAES-------WMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYL 133
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGT--P-SYMCPELLA 176
++ +HRD+ N+ L ++ DFGL+K L +D + + P + PE +
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 177 DIPYGSKSDIWSLGCCVYEM 196
+ SKSD+WS G ++E
Sbjct: 194 YYKFSSKSDVWSFGVLMWEA 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 30/122 (24%), Positives = 61/122 (50%), Gaps = 2/122 (1%)
Query: 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 136
+ II Y E G + + +K +G+ KL Q+ + ++ + +HRD++ +NI
Sbjct: 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 137 LTRDQDIRLGDFGLAKMLISDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCVY 194
++ ++ DFGLA+++ ++ + P + PE + + KSD+WS G +
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 195 EM 196
E+
Sbjct: 202 EI 203
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 22/190 (11%)
Query: 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 136
+C++ + E G +++ ++ F E L + + + YL ++HRD+ N
Sbjct: 78 ICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 136
Query: 137 LTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCV 193
+ +Q I++ DFG+ + + DD +S GT P + PE+ + Y SKSD+WS G +
Sbjct: 137 VGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195
Query: 194 YE-MSAQKAAFKAFDMQALINKINKSIVAPLP-----TVYSGAFRGLVKSMLR---KNPE 244
+E S K ++ ++ I+ P VY M + PE
Sbjct: 196 WEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ--------IMNHCWRERPE 247
Query: 245 FRPSAAELLC 254
RP+ + LL
Sbjct: 248 DRPAFSRLLR 257
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 57/287 (19%), Positives = 103/287 (35%), Gaps = 55/287 (19%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKY-----VLKKIRLARQTDRARRSAHQEME 53
+ ++ +G G+FG + ++ L + +++ E
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEAL 85
Query: 54 LISRVRNPFIVEYKDSWVEKGCY-VC-------IIIGYCEGGDMAEAIKKANGVHFPEEK 105
+IS+ + IV C V I++ GGD+ +++
Sbjct: 86 IISKFNHQNIVR---------CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 106 LCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLI 155
L ++ LL +A YL NH +HRD+ N LT ++GDFG+A+ +
Sbjct: 137 LA--MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 156 SDDLASSVVGTPSY-----MCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQ 209
G + M PE + + SK+D WS G ++E S + + Q
Sbjct: 195 RASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252
Query: 210 ALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSAAELL 253
++ + P G + M + PE RP+ A +L
Sbjct: 253 EVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIIL 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 39/206 (18%), Positives = 75/206 (36%), Gaps = 29/206 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSA-HQEMELISRVRN 60
+Y + +IG GSFG L ++ +K + + + H E ++ ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQG 63
Query: 61 -PFIVEYKDSWVEKGCYVCIIIGYCEGGDMA----EAIKKANGVHFPEEKLCKWLVQLLM 115
I + E V ++ ++ E + F + + Q++
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVM-------ELLGPSLEDLFNFCSRKFSLKTVLLLADQMIS 116
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISD--------DLASSVV 164
+ Y+H+ + +HRDVK N + + + + DFGLAK ++
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 165 GTPSYMCPELLADIPYGSKSDIWSLG 190
GT Y I + D+ SLG
Sbjct: 177 GTARYASINTHLGIEQSRRDDLESLG 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 41/220 (18%), Positives = 84/220 (38%), Gaps = 28/220 (12%)
Query: 2 EQYEVLEQIGKGSFG--------SALLVRHKHERKKYVLK----KIRLARQTDRARRSA- 48
Q+++ + + G S L +++K+ LK RL + + +R+A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 49 HQEMELISRVRNPF---IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 105
++ ++ + I V + Y +++ G + A+ + E
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERS 160
Query: 106 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLGDFGLAK--------MLI 155
+ + +LL AL +LH N +H +V NIF+ + + L +G A +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLG-CCVY 194
+ S G ++ +L +SD+ SLG C +
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 42/222 (18%), Positives = 84/222 (37%), Gaps = 34/222 (15%)
Query: 2 EQYEVLEQIGKGSFG---SALLVRHKHERKKYV-----LKKIRLARQTDRARRSAHQEME 53
+E++G+ FG L + LK + R E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD----KAEGPLREEFRHEAM 64
Query: 54 LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE---------AIKKANGVHFPEE 104
L +R+++P +V V K + +I YC GD+ E + + +
Sbjct: 65 LRARLQHPNVVCLLGV-VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 105 KLCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157
L + + YL ++H++H+D+ N+ + ++++ D GL + + +
Sbjct: 124 ALE--PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 158 DLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
D + + +M PE + + SDIWS G ++E+
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 46/229 (20%), Positives = 92/229 (40%), Gaps = 45/229 (19%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLK---KIRLARQTDRARRSAHQEMELI 55
++ + + +G+G+FG A V ++ K + K+ T++ EME++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56 SRV-RNPFIVE-YKDSWVEKGCYVCIIIGYCEGGDM--------------AEAIKKANGV 99
+ ++ I+ + + +I+ Y G++ + I +
Sbjct: 95 KMIGKHKNIINLL--GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 100 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159
+ L QL + YL + +HRD+ N+ +T + +++ DFGLA+ + + D
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 211
Query: 160 ASSVVGTPSY------------MCPELLADIPYGSKSDIWSLGCCVYEM 196
Y M PE L D Y +SD+WS G ++E+
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 46/229 (20%), Positives = 91/229 (39%), Gaps = 45/229 (19%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLK---KIRLARQTDRARRSAHQEMELI 55
++ + + +G+G FG A V ++ K + K+ T++ EME++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 56 SRV-RNPFIVE-YKDSWVEKGCYVCIIIGYCEGGDM--------------AEAIKKANGV 99
+ ++ I+ + + +I+ Y G++ + I +
Sbjct: 141 KMIGKHKNIINLL--GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 100 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159
+ L QL + YL + +HRD+ N+ +T + +++ DFGLA+ + + D
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 257
Query: 160 ASSVVGTPSY------------MCPELLADIPYGSKSDIWSLGCCVYEM 196
Y M PE L D Y +SD+WS G ++E+
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 55/279 (19%), Positives = 102/279 (36%), Gaps = 39/279 (13%)
Query: 2 EQYEVLEQIGKGSFG---SALLVRHKHERKKY-----VLKKIRLARQTDRARRSAHQEME 53
+ ++ +G G+FG + ++ L + +++ E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEAL 126
Query: 54 LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+IS+ + IV + I++ GGD+ +++ L ++ L
Sbjct: 127 IISKFNHQNIVRCIGV-SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA--MLDL 183
Query: 114 L-MAL------NYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDDLASSV 163
L +A YL NH +HRD+ N LT ++GDFG+A+ +
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--YYR 241
Query: 164 VGTPSY-----MCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINK 217
G + M PE + + SK+D WS G ++E S + + Q ++ +
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
Query: 218 SIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSAAELL 253
P G + M + PE RP+ A +L
Sbjct: 302 GGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIIL 337
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 22/195 (11%)
Query: 71 VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDV 130
K + II Y G + +++ F ++L + + A+ YL + LHRD+
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146
Query: 131 KCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIW 187
N + +++ DFGL++ + DD +S VG+ P + PE+L + SKSDIW
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 188 SLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLP-----TVYSGAFRGLVKSMLR- 240
+ G ++E S K ++ F I + + P VY+ M
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT--------IMYSC 257
Query: 241 --KNPEFRPSAAELL 253
+ + RP+ LL
Sbjct: 258 WHEKADERPTFKILL 272
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 46/232 (19%), Positives = 93/232 (40%), Gaps = 52/232 (22%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVR-HKHERKKYV----LKKIRLARQTDRARRSAHQEME 53
++ ++ + +G+G+FG A K + V LK+ T R+ E++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELK 82
Query: 54 LISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM---------AEAIKKANGVHFPE 103
++ + + +V + + G + +I+ +C+ G++ K +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 104 EKLCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156
+ L L L+ + +L + +HRD+ NI L+ +++ DFGLA+ +
Sbjct: 143 DFLT--LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 157 DDLASSVVGTPSY------------MCPELLADIPYGSKSDIWSLGCCVYEM 196
D Y M PE + D Y +SD+WS G ++E+
Sbjct: 201 DP---------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 3/100 (3%)
Query: 100 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158
E L + Q+ + +L + +HRD+ NI L+ +++ DFGLA+ + D
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 159 -LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
+ P +M PE + D Y +SD+WS G ++E+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 49/238 (20%), Positives = 84/238 (35%), Gaps = 58/238 (24%)
Query: 2 EQYEVLEQIGKGSFG---SALLVR-HKHERKKYV----LKKIRLARQTDRARRSAHQEME 53
E + IG+G+FG A +E V LK+ + + +E
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAA 102
Query: 54 LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM----------------AEAIKKAN 97
L++ NP IV+ G +C++ Y GD+ +
Sbjct: 103 LMAEFDNPNIVKLLGV-CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 98 GVHFPEEKLCKWLVQLLMAL------NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151
V P QL +A YL +HRD+ N + + +++ DFGL+
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 152 KMLISDDLASSVVGTPSY-------------MCPELLADIPYGSKSDIWSLGCCVYEM 196
+ + S D Y M PE + Y ++SD+W+ G ++E+
Sbjct: 222 RNIYSAD----------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 42/234 (17%), Positives = 87/234 (37%), Gaps = 50/234 (21%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVR-HKHERKKYVLKKIRLARQTDRARRSAHQEMELISR 57
+ + + +G+G FG A V K+ + R E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 58 VRNPFIVE-YKDSWVEKGCYVCIIIGYCEGGDM----------------------AEAIK 94
V +P +++ Y + + +I+ Y + G + + ++
Sbjct: 83 VNHPHVIKLY--GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 95 KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154
+ L + Q+ + YL ++HRD+ NI + + +++ DFGL++ +
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 155 ISDDLASSVVGTPSY------------MCPELLADIPYGSKSDIWSLGCCVYEM 196
+D SY M E L D Y ++SD+WS G ++E+
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 17/85 (20%)
Query: 117 LNYLH--AN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMC 171
L YLH + I+HRDVK +NI L + + +GDFGLAK++ D + ++V GT ++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 172 PELLADIPYGS------KSDIWSLG 190
PE Y S K+D++ G
Sbjct: 204 PE------YLSTGKSSEKTDVFGYG 222
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 2e-12
Identities = 46/333 (13%), Positives = 81/333 (24%), Gaps = 94/333 (28%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV--- 58
E+ + E+IG+G FG H +K I + E++ +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 59 ------------RNPFIVEYKDSWVEKGCY-----------------------------V 77
R + +G Y +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIF 136
I++ + GG +++ L QL +L A+ HRD+ N+
Sbjct: 138 FIVLEFEFGG---IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 137 LTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 196
L + +L K SS + + I Y ++
Sbjct: 195 LKKTSLKKLHYTLNGK--------SSTIPSCGLQVSI----IDYTLSRLERDGIVVFCDV 242
Query: 197 SAQKAAF--------KAFDMQALINKINKSIVAPLPTVY--------------------- 227
S + F + + N P V
Sbjct: 243 SMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNT 302
Query: 228 --SGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258
+ ++ R F SA +LLC L
Sbjct: 303 PAMKQIKRKIQEFHRTMLNFS-SATDLLCQHSL 334
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 47/198 (23%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++ ++L+ IGKG FG ++ + K +K I+ D ++ E +++++R+
Sbjct: 193 KELKLLQTIGKGEFGD--VMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHS 246
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+ VE+ + I+ Y G + + ++ + L K+ + + A+ YL
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADI 178
N+ +HRD+ N+ ++ D ++ DFGL K + +S+ P + PE L +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK 361
Query: 179 PYGSKSDIWSLGCCVYEM 196
+ +KSD+WS G ++E+
Sbjct: 362 KFSTKSDVWSFGILLWEI 379
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 49/199 (24%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQEMELISRVRN 60
++ ++L+ IGKG FG V R V +K I+ D ++ E +++++R+
Sbjct: 21 KELKLLQTIGKGEFGD---VMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRH 73
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+V+ VE+ + I+ Y G + + ++ + L K+ + + A+ YL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLAD 177
N+ +HRD+ N+ ++ D ++ DFGL K + +S+ P + PE L +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 188
Query: 178 IPYGSKSDIWSLGCCVYEM 196
+ +KSD+WS G ++E+
Sbjct: 189 KKFSTKSDVWSFGILLWEI 207
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 42/220 (19%), Positives = 78/220 (35%), Gaps = 30/220 (13%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSA-HQEMELISRVRNP 61
++V IG+G FG L + V + + + E++ R P
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMN--SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP 93
Query: 62 -FIVEYKDSWVEKGCYVCIIIGYCEGGDMA---------------EAIKKANGVHFPEEK 105
I ++ + K V G + I +AN F +
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153
Query: 106 LCKWLVQLLMALNYLHANHILHRDVKCSNIFL-TRDQD-IRLGDFGLAKMLISD------ 157
+ + +++L L Y+H + +H D+K SN+ L ++ D + L D+GLA +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213
Query: 158 --DLASSVVGTPSYMCPELLADIPYGSKSDIWSLG-CCVY 194
D GT + + + + D+ LG C +
Sbjct: 214 AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ 253
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 51/231 (22%), Positives = 92/231 (39%), Gaps = 49/231 (21%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYVLK---KIRLARQTDRARRSAHQEMELI 55
++ + + +G+G+FG A + ++ V K K+ + T++ EME++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 56 SRVRN-PFIVE-YKDSWVEKGCYVCIIIGYCEGGDM---------AEAIKKANGVHFPEE 104
+ I+ + + +I+ Y G++ N H PEE
Sbjct: 129 KMIGKHKNIINLL--GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 105 KLCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157
+L L+ A YL + +HRD+ N+ +T D +++ DFGLA+ +
Sbjct: 187 QLS--SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 158 DLASSVVGTPSY------------MCPELLADIPYGSKSDIWSLGCCVYEM 196
D Y M PE L D Y +SD+WS G ++E+
Sbjct: 245 D---------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 39/219 (17%), Positives = 82/219 (37%), Gaps = 31/219 (14%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
Q+ + ++IG G FG L ++ +K +++ + E++ RV
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY---QENGPLFSELKFYQRVAKKD 94
Query: 63 IVEYKDSWVEKG------CYVCIIIGYCEG----------GDMAEAIKKANGVHFPEEKL 106
++ + Y + + G + I NG F + +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTV 153
Query: 107 CKWLVQLLMALNYLHANHILHRDVKCSNIFL-TRDQD-IRLGDFGLAKMLISD------- 157
+ +++L L Y+H N +H D+K +N+ L ++ D + L D+GL+ +
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 158 -DLASSVVGTPSYMCPELLADIPYGSKSDIWSLG-CCVY 194
+ GT + + + +SD+ LG C +
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 35/144 (24%), Positives = 59/144 (40%), Gaps = 33/144 (22%)
Query: 77 VCIIIGYCEGGDM------------AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
V +I YC GD+ + L + Q+ + +L + +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184
Query: 125 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY------------MCP 172
+HRDV N+ LT ++GDFGLA+ +++D +Y M P
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---------NYIVKGNARLPVKWMAP 235
Query: 173 ELLADIPYGSKSDIWSLGCCVYEM 196
E + D Y +SD+WS G ++E+
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEI 259
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 35/148 (23%), Positives = 63/148 (42%), Gaps = 37/148 (25%)
Query: 77 VCIIIGYCEGGDM----------------AEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+I YC GD+ + AI + + + E L + Q+ + +L
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY----------- 169
+ + +HRD+ NI LT + ++ DFGLA+ + +D +Y
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---------NYVVKGNARLPVK 212
Query: 170 -MCPELLADIPYGSKSDIWSLGCCVYEM 196
M PE + + Y +SD+WS G ++E+
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 40/206 (19%), Positives = 76/206 (36%), Gaps = 29/206 (14%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN-P 61
+ V ++IG G+FG L ++ + + +K L R H E ++ +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSR-APQLHLEYRFYKQLGSGD 65
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMA----EAIKKANGVHFPEEKLCKWLVQLLMAL 117
I + ++ ++ E + F + + +QL+ +
Sbjct: 66 GIPQVYYFGPCGKYNAMVL-------ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 118 NYLHANHILHRDVKCSNIFL-----TRDQDIRLGDFGLAKMLISDDLAS--------SVV 164
Y+H+ ++++RDVK N + Q I + DF LAK I + S+
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 165 GTPSYMCPELLADIPYGSKSDIWSLG 190
GT YM + D+ +LG
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALG 204
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 38/207 (18%), Positives = 66/207 (31%), Gaps = 29/207 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN- 60
Y+V +IG+GSFG + ++ +K E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAGC 65
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMA----EAIKKANGVHFPEEKLCKWLVQLLMA 116
I E V +I D+ E + G F + + Q+L
Sbjct: 66 TGIPNVYYFGQEGLHNVLVI-------DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 118
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQD-----IRLGDFGLAKMLISDDLAS--------SV 163
+ +H +++RD+K N + R I + DFG+ K ++
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178
Query: 164 VGTPSYMCPELLADIPYGSKSDIWSLG 190
GT YM + D+ +LG
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALG 205
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 38/205 (18%), Positives = 72/205 (35%), Gaps = 27/205 (13%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN- 60
++ + +IG GSFG L + ++ +K E ++ ++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKIYRILQGG 62
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMA----EAIKKANGVHFPEEKLCKWLVQLLMA 116
I + VE V ++ D+ E + + + Q++
Sbjct: 63 TGIPNVRWFGVEGDYNVLVM-------DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAK--------MLISDDLASSVVG 165
+ ++H+ LHRD+K N + + + + DFGLAK I ++ G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 166 TPSYMCPELLADIPYGSKSDIWSLG 190
T Y I + D+ SLG
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLG 200
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 39/222 (17%)
Query: 2 EQYEVLEQIGKGSFGS---ALLVRHKHERKKYV----LKKIRLARQTDRARRSAHQEMEL 54
+ + IG+G+FG A + K + +K+ + R E+E+
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARI--KKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEV 78
Query: 55 ISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM---------AEAIKKANGVHFPEE 104
+ ++ +P I+ E Y+ + I Y G++ E +
Sbjct: 79 LCKLGHHPNIINLL-GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 105 KLCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157
L QLL A +YL +HRD+ NI + + ++ DFGL++
Sbjct: 138 TLS--SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQ 192
Query: 158 DLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCVYEM 196
++ P +M E L Y + SD+WS G ++E+
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 39/152 (25%), Positives = 62/152 (40%), Gaps = 42/152 (27%)
Query: 78 CIIIGYCEGGDM------------AEAIKKANGVHFPEEKLCKWL--VQLL-MAL----- 117
+I YC GD+ + I+ N EE+ L LL A
Sbjct: 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 184
Query: 118 -NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY------- 169
+L +HRD+ N+ +T + +++ DFGLA+ ++SD +Y
Sbjct: 185 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS---------NYVVRGNAR 235
Query: 170 -----MCPELLADIPYGSKSDIWSLGCCVYEM 196
M PE L + Y KSD+WS G ++E+
Sbjct: 236 LPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 1e-06
Identities = 51/335 (15%), Positives = 83/335 (24%), Gaps = 134/335 (40%)
Query: 59 RNPFIVEYKDSWVEKGCY------------VCIIIG--YCEGGDMAEAIKKANGVHFPEE 104
+ F + W+ + I + D + IK
Sbjct: 179 KMDFKI----FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIH 228
Query: 105 KLCKWLVQLLMALNYLHANHILHRDV-----------KCSNIFLTRDQDI---------- 143
+ L +LL + Y + +L +V C + TR + +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVL-LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 144 --RLGDFG-----------LAKML--ISDDLASSVVGT-P---SYMCPELLADIPYGSKS 184
L L K L DL V+ T P S + E + D
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS-IIAESIRDGL----- 341
Query: 185 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN-- 242
W +K + L I S+ P Y F L S+ +
Sbjct: 342 ATWD-----N--------WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL--SVFPPSAH 386
Query: 243 -PEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFM--------- 292
P LL ++ W D +
Sbjct: 387 IPT------ILLS-------LI-----------------WFDVIKSDVMVVVNKLHKYSL 416
Query: 293 -----EPEAISIHS-NREKRQSFSNDRALNPSVSE 321
+ ISI S E + N+ AL+ S+ +
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 59/476 (12%), Positives = 120/476 (25%), Gaps = 141/476 (29%)
Query: 194 YEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSAA 250
+E + +K D +++ + V V+ M + E
Sbjct: 9 FETGEHQYQYK--D---ILSVFEDAFVDNFDCKD-------VQDMPKSILSKEEID---- 52
Query: 251 ELLCHPH--LQPYVLGIHLKLNGPRR-NTFPLEWSDSNFK------KTRFMEPEAISIHS 301
++ L L F E N+K KT +P ++
Sbjct: 53 HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY 112
Query: 302 NREKRQSFSNDRALNP-SVSETEQDSLSSTLRGRAFGNYMNQKFKELSIG---VVHEELG 357
++ + +++++ +VS + LR Q EL ++ LG
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQP---YLKLR---------QALLELRPAKNVLIDGVLG 160
Query: 358 VDMSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTH---IGSKR--DSLPI------S 406
+GKT + V + + Q + + +++
Sbjct: 161 -----------SGKTW-VA-LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 407 HNPGGKPSRPARRASLPLTTTRASESHYQPITCIMKSPDVS--------VNAPRIDKIAE 458
SR +++ L S + ++KS V +
Sbjct: 208 QIDPNWTSRSDHSSNIKLRI----HSIQAELRRLLKSKPYENCLLVLLNVQNAKA--WNA 261
Query: 459 FPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSI---TKDKCTIQVMDRTASRPNFVVH 515
F ++ C I T+ K + + + H
Sbjct: 262 F----------------------------NLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 516 TTHG-----------TIQNGSEFSEPNPATGVSS-HSSL--ESQHRRFDTSSF--QQRAE 559
+ + P + S+ ES T +
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353
Query: 560 ALEGLLEFSARLL----QQERFEELGVLLKPFGPEKVS-PRET--AIWLAKSFKET 608
L ++E S +L ++ F+ L V P P IW +
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVF-----PPSAHIPTILLSLIWFDVIKSDV 404
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 26/175 (14%), Positives = 48/175 (27%), Gaps = 43/175 (24%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP-- 61
+ + +L+ + E + + + H+ ++ P
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR--SIVDHYNIPKT 458
Query: 62 -----FIVEYKDSWVEKGCYVCIIIGY-CEGGDMAEAIKKANGV----HFPEEKLCK--- 108
I Y D Y IG+ + + E + V F E+K+
Sbjct: 459 FDSDDLIPPYLDQ------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 109 -W---------LVQLLMALNYLHANH---------ILHRDVKCS-NIFLTRDQDI 143
W L QL Y+ N IL K N+ ++ D+
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDL 567
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 610 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.67 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.2 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.34 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.26 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.06 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.17 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.39 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-62 Score=523.53 Aligned_cols=259 Identities=40% Similarity=0.793 Sum_probs=236.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
||+|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|++|+|||||+++++|.+. ..+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-GSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEE
Confidence 6899999999999999999999999999999999988777777788899999999999999999999988765 489999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
||||+||+|.++|....+..++|..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... ..
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999999999998876667899999999999999999999999999999999999999999999999999887543 34
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
..+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+++.+|......+.+..+|.++++||.+||
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L 261 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 55679999999999999999999999999999999999999999999999999999888777888899999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCc
Q 007266 240 RKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
++||++|||++|+|+||||+.
T Consensus 262 ~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 262 KRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp CSSGGGSCCHHHHHTSHHHHT
T ss_pred cCChhHCcCHHHHhcCHHhhc
Confidence 999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=506.27 Aligned_cols=259 Identities=29% Similarity=0.503 Sum_probs=233.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|+++|++|+|||||+++++|.+. ..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence 679999999999999999999999999999999975432 222346789999999999999999999988765 489999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--- 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--- 157 (610)
||||+||+|.++|++.+ .|+|..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999998865 6999999999999999999999999999999999999999999999999999986433
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
....+.|||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.+..+++.+|..... .+|..+++++++||.+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999999999999877654 4678899999999999
Q ss_pred hhcCCCCCCCCHHH------HhcCCCCCchhhh
Q 007266 238 MLRKNPEFRPSAAE------LLCHPHLQPYVLG 264 (610)
Q Consensus 238 mL~~dP~~RpSa~e------iL~Hp~f~~~~~~ 264 (610)
||++||++|||++| |++||||+.+.|.
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 99999999999887 6899999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-60 Score=502.31 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=229.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+.|++++.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|++++|||||+++++|...+ .+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 46999999999999999999999999999999997654332 345789999999999999999999987665 899999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
|||+||+|.+++.+. .++|+.++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... ...
T Consensus 151 Ey~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 151 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred eCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 999999999999763 5999999999999999999999999999999999999999999999999999876543 456
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--CCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--~p~~~s~~l~~LI~km 238 (610)
.+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+++..|....... .+..+|+++++||.+|
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 77899999999999999999999999999999999999999999999999998887765433 3456899999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|++||++|||++|+|+||||+.
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGG
T ss_pred cCCChhHCcCHHHHhcCHhhcC
Confidence 9999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-60 Score=487.67 Aligned_cols=255 Identities=26% Similarity=0.529 Sum_probs=213.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||+||+|+++.+|+.||||++....... .....+.+|+.+|++++|||||+++++|... ..+|+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-DEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEE
Confidence 478999999999999999999999999999999997654332 3346789999999999999999999988655 58899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||| +|+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 91 vmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 99999 689999998765 699999999999999999999999999999999999999999999999999988776666
Q ss_pred cccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
..+.+||+.|||||++.+..| +.++|||||||+||+|++|.+||.+.+...++..+..... .+|..+|+++++||.+|
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-TLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHH
Confidence 778899999999999998886 5799999999999999999999999999998888876653 46788999999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|++||++|||++|+|+||||+.
T Consensus 247 L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SCSSGGGSCCHHHHHHCHHHHT
T ss_pred ccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-59 Score=505.35 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=230.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+.|++++.||+|+||.||+|+++.+|+.||||++....... .+.+.+|+.+|++++|||||+++++|...+ .+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECC-EEEEEE
Confidence 46999999999999999999999999999999997654332 345889999999999999999999987665 899999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
|||+||+|.++++.. .|++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... ...
T Consensus 228 Ey~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 228 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp ECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred eCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 999999999999763 5999999999999999999999999999999999999999999999999999876543 456
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--CCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--~p~~~s~~l~~LI~km 238 (610)
.+.|||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+++..|....... .+..+|+++++||.+|
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 77899999999999999999999999999999999999999999999999988887765433 3457899999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|++||++|||++|+|+||||+.
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGG
T ss_pred cCCChhHCcCHHHHhcCHHhcC
Confidence 9999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-60 Score=493.37 Aligned_cols=259 Identities=30% Similarity=0.509 Sum_probs=225.3
Q ss_pred CCeEEEeEecccCceEEEEEEEe---CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++++.||+|+||+||+|++. .+++.||||++............+.+|+.+|++++|||||+++++|.+. ..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-GKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-TEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEE
Confidence 57999999999999999999985 3678999999976543333334578899999999999999999988765 4889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-c
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-D 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~ 157 (610)
||||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .
T Consensus 103 ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999998865 699999999999999999999999999999999999999999999999999987543 3
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
....+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+++..|..... +.|..+|+++++||.+
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRM 259 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHH
Confidence 456678999999999999999999999999999999999999999999999999998877654 4678899999999999
Q ss_pred hhcCCCCCCCC-----HHHHhcCCCCCchhhh
Q 007266 238 MLRKNPEFRPS-----AAELLCHPHLQPYVLG 264 (610)
Q Consensus 238 mL~~dP~~RpS-----a~eiL~Hp~f~~~~~~ 264 (610)
||++||++||| ++|+++||||+.+.+.
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 99999999998 5899999999986543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=477.33 Aligned_cols=253 Identities=25% Similarity=0.505 Sum_probs=222.7
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec---CcEEEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK---GCYVCII 80 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~~~LV 80 (610)
|++.+.||+|+||+||+|.+..++..||+|++..........+.+.+|+.+|++|+|||||+++++|... +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3778889999999999999999999999999987776777778899999999999999999999998652 4578999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEecC-CCCeeeeecccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~~-~g~vKL~DFGlak~~~~~ 157 (610)
||||+||+|.+++++.. .+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+... .
T Consensus 108 mEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-A 184 (290)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-T
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-C
Confidence 99999999999998865 6899999999999999999999998 999999999999985 7899999999998643 3
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc-CHHHHHHHHhhccCC-CCCcccchHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVA-PLPTVYSGAFRGLV 235 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~-~~~~l~~~I~~~~~~-~~p~~~s~~l~~LI 235 (610)
....+.+||+.|||||++.+ .|+.++|||||||+||||++|.+||.+. +...++..+...... ..+..+++++++||
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 45567899999999999875 6999999999999999999999999764 455566666554332 24556788999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+||++||++|||++|+|+||||+.
T Consensus 264 ~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-58 Score=484.94 Aligned_cols=251 Identities=31% Similarity=0.446 Sum_probs=219.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++.|++.+.||+|+||.||+|+++.+|+.||||+++.... ..+|+.+|++++|||||+++++|.+. ..+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREG-PWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEE
Confidence 3579999999999999999999999999999999976433 24699999999999999999988765 488999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeecccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~~~~~~~ 159 (610)
||||+||+|.++|++.+ .|++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999999998865 699999999999999999999999999999999999999988 599999999987654332
Q ss_pred ------cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC--CCCCcccchHH
Q 007266 160 ------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAF 231 (610)
Q Consensus 160 ------~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--~~~p~~~s~~l 231 (610)
....+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+...++.+|..... ..++..+++.+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 2346899999999999999999999999999999999999999998877777777765543 23567799999
Q ss_pred HHHHHHhhcCCCCCCCCHHHH-------------hcCCCCCch
Q 007266 232 RGLVKSMLRKNPEFRPSAAEL-------------LCHPHLQPY 261 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~ei-------------L~Hp~f~~~ 261 (610)
++||.+||++||.+|||+.|+ |+|||++.+
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 999999999999999999998 467777653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=485.13 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=227.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-----CcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~ 76 (610)
++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+++|+.|+|||||++++++... ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999987777767777889999999999999999999987542 357
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|||||||+ |+|.+++.+.+ .|++..++.|++||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 899999996 67999997654 799999999999999999999999999999999999999999999999999987643
Q ss_pred c-----cccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC------
Q 007266 157 D-----DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP------ 224 (610)
Q Consensus 157 ~-----~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p------ 224 (610)
. ....+.+||+.|||||++.+. .|+.++||||+||++|||++|.+||.+.+..+++..|......+..
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2 245678999999999998875 5699999999999999999999999999999888888654433221
Q ss_pred ------------------------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 225 ------------------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 225 ------------------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
..++.++++||.+||++||.+|||++|+|+||||+.+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 23578999999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=467.67 Aligned_cols=256 Identities=27% Similarity=0.488 Sum_probs=207.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC------ 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~------ 75 (610)
++|++++.||+|+||+||+|+++.+|+.||||++.... .+...+.+.+|+.+|++|+|||||+++++|...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 57999999999999999999999999999999997544 44556778999999999999999999999976543
Q ss_pred -----EEEEEEeecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecc
Q 007266 76 -----YVCIIIGYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 149 (610)
Q Consensus 76 -----~~~LVmEy~~GgsL~~~Ik~~~~-~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFG 149 (610)
++|||||||.||+|.+++..... ...++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 57999999999999999986542 124567789999999999999999999999999999999999999999999
Q ss_pred cccccccccc-------------cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC-HHHHHHHH
Q 007266 150 LAKMLISDDL-------------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKI 215 (610)
Q Consensus 150 lak~~~~~~~-------------~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I 215 (610)
+|+....... ..+.+||+.|||||++.+..|+.++|||||||+||||++ ||.... ....+..+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 9987654321 234689999999999999999999999999999999996 776432 22334444
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.....++.+...++.+.+||.+||+.||.+|||+.|+|+||||+.+
T Consensus 241 ~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 4433333344566788999999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=490.36 Aligned_cols=260 Identities=25% Similarity=0.449 Sum_probs=224.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc----cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ----TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~----~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
|++|++++.||+|+||.||+|+++.+|+.||||++.+... .........+++.+++.++|||||+++++|.+.+ .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~-~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-K 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS-E
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC-E
Confidence 5899999999999999999999999999999999975432 2222223344567778889999999999987654 8
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|||||||.||+|.++|.+.+ .|+|..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 267 lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999998865 699999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccCCCcccCCcccc-CCCCCCCccccccchhHHhhhhcCcccccc---CHHHHHHHHhhccCCCCCcccchHHH
Q 007266 157 DDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLltG~~PF~~~---~~~~l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
. ...+.|||+.|||||++. +..|+.++|||||||+||||++|.+||.+. +...+...+... ....|..+|++++
T Consensus 345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~~~p~~~S~~a~ 422 (689)
T 3v5w_A 345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPDSFSPELR 422 (689)
T ss_dssp C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CCCCCTTSCHHHH
T ss_pred C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CCCCCccCCHHHH
Confidence 3 456789999999999996 467999999999999999999999999764 344455555443 3456788999999
Q ss_pred HHHHHhhcCCCCCCCC-----HHHHhcCCCCCchhhhh
Q 007266 233 GLVKSMLRKNPEFRPS-----AAELLCHPHLQPYVLGI 265 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpS-----a~eiL~Hp~f~~~~~~~ 265 (610)
+||.+||++||.+|++ ++||++||||+.+.|..
T Consensus 423 dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp HHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred HHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 9999999999999998 89999999999877654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=460.56 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=206.9
Q ss_pred CCeEEEeEecccCceEEEEEEEe---CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||+||+|+++ .+++.||||.+..... ...+.+|+++|+.+ +|||||+++++|... .++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKN-DHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEET-TEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEEC-CEE
Confidence 57999999999999999999986 3578999999865432 23477899999998 699999999988765 589
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-CCeeeeeccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLIS 156 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-g~vKL~DFGlak~~~~ 156 (610)
|+|||||+||+|.++++ .+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+....
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999983 48999999999999999999999999999999999999877 7999999999976432
Q ss_pred c-----------------------------cccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCcccc-c
Q 007266 157 D-----------------------------DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFK-A 205 (610)
Q Consensus 157 ~-----------------------------~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~-~ 205 (610)
. ....+.+||++|+|||++.+. .|+.++||||+||++|||++|..||. +
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 2 123456899999999999876 48999999999999999999999984 4
Q ss_pred cCHHHHHHHHhhccC-----------------------------------------------------CCCCcccchHHH
Q 007266 206 FDMQALINKINKSIV-----------------------------------------------------APLPTVYSGAFR 232 (610)
Q Consensus 206 ~~~~~l~~~I~~~~~-----------------------------------------------------~~~p~~~s~~l~ 232 (610)
.+..+++..|..... ......+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 444444444322100 011235788999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+||++||++||.+|+|++|+|+||||++.
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=486.18 Aligned_cols=257 Identities=22% Similarity=0.429 Sum_probs=231.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.|+|||||+++++|.+. ..+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-SEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEE
Confidence 478999999999999999999999999999999997543 33456788999999999999999999988755 589999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC--CCeeeeeccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD--QDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~--g~vKL~DFGlak~~~~~~ 158 (610)
||||+||+|.++|.... ..|++..++.|+.||+.||+|||++||+||||||+||||+.+ |.+||+|||+|+.+....
T Consensus 233 ~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999999997543 369999999999999999999999999999999999999864 889999999999887777
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC---CCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---~p~~~s~~l~~LI 235 (610)
.....+||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.+..+++..|....... .+..+|.++++||
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 6778899999999999999999999999999999999999999999999999998887654332 2346899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
++||++||.+|||++|+|+||||++.
T Consensus 392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 392 RKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHccCChhHCcCHHHHhcCcCcCCC
Confidence 99999999999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=449.05 Aligned_cols=255 Identities=22% Similarity=0.424 Sum_probs=224.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|.+.+.||+|+||.||+|++.. ++..||||++... .....+.+.+|+++|++++|||||++++++.+.+ .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-P 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-E
Confidence 579999999999999999998753 5789999999743 3455677999999999999999999999887654 7
Q ss_pred EEEEEeecCCCCHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeee
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN-----------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 145 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~-----------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL 145 (610)
+|||||||+||+|.++|.+.+ ...|++..+..|+.||+.||.|||+++||||||||+||||+.++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 889999999999999997642 346999999999999999999999999999999999999999999999
Q ss_pred eeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCC
Q 007266 146 GDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA 221 (610)
Q Consensus 146 ~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~ 221 (610)
+|||+|+...... .....+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+++..+......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 249 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999998764443 2334679999999999999999999999999999999998 99999999999999999888777
Q ss_pred CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 222 PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 222 ~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+.|..+++++.+||.+||+.||++|||++|++ +|++.+
T Consensus 250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~ 287 (299)
T 4asz_A 250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL 287 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence 88899999999999999999999999999994 455543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=448.63 Aligned_cols=251 Identities=20% Similarity=0.374 Sum_probs=216.9
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|.+.+.||+|+||.||+|++. .++..||||++... .....+.|.+|+++|++++|||||++++++.+.+ .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-P 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-E
Confidence 46889999999999999999865 36889999999743 4455678999999999999999999999887654 7
Q ss_pred EEEEEeecCCCCHHHHHHHhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCe
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN-------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 143 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~-------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~v 143 (610)
+|||||||+||+|.+++++.. ...|++..+..|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 899999999999999997642 2358999999999999999999999999999999999999999999
Q ss_pred eeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhcc
Q 007266 144 RLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSI 219 (610)
Q Consensus 144 KL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~ 219 (610)
||+|||+++...... .....+||+.|||||++.+..|+.++|||||||+||||++ |..||.+.+..+++..+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998764433 2345789999999999999999999999999999999998 999999999999999998877
Q ss_pred CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 220 VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 220 ~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..+.|..+++++.+||.+||+.||++|||+.||+.+
T Consensus 278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 777888999999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=445.73 Aligned_cols=252 Identities=19% Similarity=0.370 Sum_probs=223.3
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
+++++++.||+|+||+||++... .+++.||||.+..... ....+.|.+|+.+|++++|||||++++++...+ .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-P 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC-E
Confidence 57899999999999999999863 4678999999975433 334567999999999999999999999887654 6
Q ss_pred EEEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 142 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~ 142 (610)
+|||||||++|+|.++|.... ...+++..+..|+.||+.||.|||+++||||||||+||||+.++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 889999999999999997532 135899999999999999999999999999999999999999999
Q ss_pred eeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhc
Q 007266 143 IRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKS 218 (610)
Q Consensus 143 vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~ 218 (610)
+||+|||+++.....+ .....+||+.|||||++.+..|+.++|||||||+||||++ |..||.+.+..+++..+...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~ 263 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 263 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998764433 3456789999999999999999999999999999999998 89999999999999999888
Q ss_pred cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 219 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 219 ~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
...+.|..++..+.+||.+||+.||++|||+.||+++
T Consensus 264 ~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 264 QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8888899999999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=442.05 Aligned_cols=248 Identities=23% Similarity=0.422 Sum_probs=208.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||+||++++. ..||||+++.........+.+.+|+.+|++++|||||++++++.+ ..+||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVm 110 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVT 110 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEE
Confidence 57889999999999999999754 359999998777777777889999999999999999999997643 3578999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---D 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~---~ 158 (610)
|||+||+|.+++.... ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+..... .
T Consensus 111 Ey~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp ECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999997643 36999999999999999999999999999999999999999999999999999875432 2
Q ss_pred ccccccCCCcccCCccccC---CCCCCCccccccchhHHhhhhcCccccccCHHH-HHHHHhhccCC----CCCcccchH
Q 007266 159 LASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA-LINKINKSIVA----PLPTVYSGA 230 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~---~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~-l~~~I~~~~~~----~~p~~~s~~ 230 (610)
.....+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+.+... +...+...... ..+..++..
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 3456799999999999864 458999999999999999999999998765444 44444443332 245668999
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+.+||.+||+.||++|||+.|++++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=445.85 Aligned_cols=253 Identities=19% Similarity=0.377 Sum_probs=222.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC-----CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC-CceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE-----RKKYVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~-----~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|.+... ++.||||.+.... .....+.+.+|+++|.++.| ||||+++++|...+.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 5899999999999999999998764 3689999997543 33445678999999999976 899999999887777
Q ss_pred EEEEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
.+|||||||+||+|.++|+... ...+++..+..|+.||+.||+|||+++||||||||+||||+.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 8899999999999999998632 23489999999999999999999999999999999999999999
Q ss_pred Ceeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccC-HHHHHHHHh
Q 007266 142 DIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFD-MQALINKIN 216 (610)
Q Consensus 142 ~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~-~~~l~~~I~ 216 (610)
.+||+|||+|+....+. .....+||+.|||||++.+..|+.++|||||||+||||++ |..||.+.+ ...+...+.
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~ 302 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 99999999998764432 2345789999999999999999999999999999999997 999999865 345566666
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.....+.|..+++++.+||.+||+.||++|||+.||++|
T Consensus 303 ~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 303 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 666777888999999999999999999999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=429.15 Aligned_cols=257 Identities=23% Similarity=0.454 Sum_probs=235.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++... ..+|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-KTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEE
Confidence 4689999999999999999999999999999999987776777778899999999999999999999987654 578999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred EECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 99999999999998765 6899999999999999999999999999999999999999999999999999877666666
Q ss_pred ccccCCCcccCCccccCCCCC-CCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPYG-SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt-~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+...+...+..... ..|..++.++.+||++||
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 249 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFL 249 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHC
Confidence 778999999999999888874 789999999999999999999999999988888876644 467778999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCch
Q 007266 240 RKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
..||.+|||++|+|+||||+..
T Consensus 250 ~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 250 VLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp CSSTTTSCCHHHHTTCTTTTTT
T ss_pred CCChhHCcCHHHHhcCHhhcCC
Confidence 9999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=426.19 Aligned_cols=260 Identities=29% Similarity=0.550 Sum_probs=231.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.+|+.++||||++++++|...+ .+|+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-EEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-EEEE
Confidence 5799999999999999999999999999999999975432 1123456789999999999999999999887654 7899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-ccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDD 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~~ 158 (610)
||||++||+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++... ...
T Consensus 83 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 999999999999998765 68999999999999999999999999999999999999999999999999998643 233
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+...+...+..... ..|..++.++++||.+|
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999998888888766543 46778999999999999
Q ss_pred hcCCCCCCC-----CHHHHhcCCCCCchhhh
Q 007266 239 LRKNPEFRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 239 L~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
|+.||.+|| +++|+++||||+...+.
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999999 99999999999986554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=432.34 Aligned_cols=261 Identities=28% Similarity=0.520 Sum_probs=227.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|++++.||+|+||.||+|+++.+++.||||++..... .....+.+.+|+.+|..+ +||||++++++|... ..+|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~ 100 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-DRLF 100 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-CEEE
Confidence 5799999999999999999999999999999999975432 222345678899999988 799999999988665 4789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-c
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-D 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~ 157 (610)
+|||||.||+|.+++.+.. .+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.... .
T Consensus 101 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 9999999999999998765 699999999999999999999999999999999999999999999999999986432 3
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
......+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..+++..|..... ..|..++..+.+||++
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~ 257 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILKS 257 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Confidence 345677999999999999999999999999999999999999999999999999988876644 3567799999999999
Q ss_pred hhcCCCCCCCCH------HHHhcCCCCCchhhhh
Q 007266 238 MLRKNPEFRPSA------AELLCHPHLQPYVLGI 265 (610)
Q Consensus 238 mL~~dP~~RpSa------~eiL~Hp~f~~~~~~~ 265 (610)
||+.||.+||++ +|+++||||+...+..
T Consensus 258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~ 291 (353)
T 3txo_A 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291 (353)
T ss_dssp HTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred HhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence 999999999998 9999999999865543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=431.57 Aligned_cols=284 Identities=27% Similarity=0.505 Sum_probs=235.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|++++.||+|+||.||+|+++.+++.||+|++....... ...+.+.+|..+|.++ +|||||+++++|... ..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-CEEE
Confidence 468999999999999999999999999999999998654332 3345578899999887 899999999988765 4889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc-ccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~-~~~ 157 (610)
+|||||.||+|..++.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.. ...
T Consensus 130 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 9999999999999998765 6999999999999999999999999999999999999999999999999999863 334
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc---------CHHHHHHHHhhccCCCCCcccc
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---------DMQALINKINKSIVAPLPTVYS 228 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~---------~~~~l~~~I~~~~~~~~p~~~s 228 (610)
......+||+.|+|||++.+..|+.++|||||||+||||++|.+||... ....+.+.+... ...+|..++
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s 286 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLS 286 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CCCCCTTSC
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-ccCCCCcCC
Confidence 4566789999999999999999999999999999999999999999643 233445555443 345677899
Q ss_pred hHHHHHHHHhhcCCCCCCCCH------HHHhcCCCCCchhhhhcc--ccCCCCCCCCCCCCCCccccc
Q 007266 229 GAFRGLVKSMLRKNPEFRPSA------AELLCHPHLQPYVLGIHL--KLNGPRRNTFPLEWSDSNFKK 288 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa------~eiL~Hp~f~~~~~~~~~--~~~~p~~~~~~~~~~~s~~~~ 288 (610)
.++++||++||+.||.+||++ +|+++||||+...|.... .+..|..+...-..+.++|+.
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~ 354 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS 354 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCH
T ss_pred HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcCh
Confidence 999999999999999999985 899999999987655422 233444444433444455543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=417.89 Aligned_cols=261 Identities=28% Similarity=0.533 Sum_probs=228.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|++++.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.++.++ +||||++++++|... ..+|
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-CEEE
Confidence 4689999999999999999999999999999999986543 344566788999999988 899999999988665 4889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-cc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~ 157 (610)
+||||+.||+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++... ..
T Consensus 87 lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999999998765 68999999999999999999999999999999999999999999999999998643 33
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccc---------cCHHHHHHHHhhccCCCCCcccc
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA---------FDMQALINKINKSIVAPLPTVYS 228 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~---------~~~~~l~~~I~~~~~~~~p~~~s 228 (610)
......+||+.|+|||++.+..|+.++|||||||+||+|++|..||.. .....+.+.+... ...+|..++
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s 243 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLS 243 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTTSC
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCCCC
Confidence 445678999999999999999999999999999999999999999975 2334455555543 334677899
Q ss_pred hHHHHHHHHhhcCCCCCCCCH------HHHhcCCCCCchhhhh
Q 007266 229 GAFRGLVKSMLRKNPEFRPSA------AELLCHPHLQPYVLGI 265 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa------~eiL~Hp~f~~~~~~~ 265 (610)
..+++||.+||+.||.+||++ +|+++||||+...+..
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~ 286 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 286 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence 999999999999999999995 8999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=416.09 Aligned_cols=259 Identities=26% Similarity=0.541 Sum_probs=231.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|... ..+|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-CEEEE
Confidence 47899999999999999999999999999999999754321 12345678899999999999999999988655 48899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||+.|++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .
T Consensus 84 v~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--V 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--C
T ss_pred EEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--c
Confidence 999999999999998754 689999999999999999999999999999999999999999999999999987533 3
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+....+..+.... ...|..++.++++||.+||
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL 238 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLI 238 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHh
Confidence 456799999999999999999999999999999999999999999999888888887654 3467789999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCCCCCchhhhh
Q 007266 240 RKNPEFRP-----SAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 240 ~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~~ 265 (610)
..||.+|+ +++++++||||+...+..
T Consensus 239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~ 269 (318)
T 1fot_A 239 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 269 (318)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred ccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence 99999999 999999999999876553
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=439.34 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=221.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----c
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----C 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 75 (610)
+++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.++|||||+++++|...+ .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 36899999999999999999999999999999999877667777788999999999999999999999986543 4
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 68999999975 57666643 48999999999999999999999999999999999999999999999999998876
Q ss_pred cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcc---------
Q 007266 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV--------- 226 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~--------- 226 (610)
........+||++|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..+++..|......+.+..
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 66667778999999999999999999999999999999999999999999998888887766544332111
Q ss_pred --------------------------------cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 227 --------------------------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 227 --------------------------------~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
.+.++++||.+||..||++|||++|+|+||||+.+...
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 15679999999999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=424.55 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=229.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH----HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~----~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||+|+++.+|+.||+|.+....... ...+.+.+|+.+|++++||||++++++|... ..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~ 90 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-TDV 90 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-CEE
Confidence 57999999999999999999999999999999997654321 1245688999999999999999999987654 588
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC----Ceeeeecccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKM 153 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g----~vKL~DFGlak~ 153 (610)
|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999997644 699999999999999999999999999999999999998877 799999999988
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchH
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGA 230 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~ 230 (610)
..........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..+........ +..++..
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 7666556778999999999999999999999999999999999999999999998888888876544322 2457899
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+++||.+||..||.+|||+.|+|+||||+...
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 99999999999999999999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=424.48 Aligned_cols=260 Identities=25% Similarity=0.478 Sum_probs=230.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|++++.||+|+||.||+|+++.+++.||||++...... ....+.+..|..++..+ +||||++++++|... ..+|
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-~~~~ 94 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLF 94 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-CEEE
Confidence 57999999999999999999999999999999999754311 12234577899999877 899999999988765 4789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-c
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-D 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~ 157 (610)
+||||+.||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.... .
T Consensus 95 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 9999999999999998765 689999999999999999999999999999999999999999999999999986432 3
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...++..+..... ..+..++.++++||.+
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDLLVK 251 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCcccCHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999999888888876543 4577799999999999
Q ss_pred hhcCCCCCCCCHH-HHhcCCCCCchhhh
Q 007266 238 MLRKNPEFRPSAA-ELLCHPHLQPYVLG 264 (610)
Q Consensus 238 mL~~dP~~RpSa~-eiL~Hp~f~~~~~~ 264 (610)
||..||.+||++. ++++||||+...+.
T Consensus 252 lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 252 LFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 9999999999998 99999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=405.94 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=221.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||+|+||.||+|++..+++.||+|++............+.+|+.++++++||||+++++++... ..+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEE
Confidence 6899999999999999999999999999999999987766666667788999999999999999999988765 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
|||++| +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 999975 6666666533 36999999999999999999999999999999999999999999999999999876433 33
Q ss_pred cccccCCCcccCCccccCCC-CCCCccccccchhHHhhhhcCcc-ccccCHHHHHHHHhhccCCC---------------
Q 007266 160 ASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVAP--------------- 222 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~-yt~ksDIWSLG~iLyeLltG~~P-F~~~~~~~l~~~I~~~~~~~--------------- 222 (610)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+......+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 45678999999999987766 79999999999999999977666 67777777776664432221
Q ss_pred -------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 223 -------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 223 -------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
....++..+++||.+||+.||++|||++|+|+||||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 122467899999999999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=422.39 Aligned_cols=261 Identities=25% Similarity=0.474 Sum_probs=231.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|++++.||+|+||.||+|+++.+++.||||++..... .....+.+.+|..+|..+ +||||++++++|... ..+|
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~ 97 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLY 97 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-SEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-CEEE
Confidence 5799999999999999999999999999999999975432 112345678899999988 799999999988665 4889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-cc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~ 157 (610)
+||||+.||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++... ..
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 9999999999999998765 68999999999999999999999999999999999999999999999999998643 23
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
......+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+...++..|..... ..|..++.++++||.+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 254 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKG 254 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999999998888876543 4677899999999999
Q ss_pred hhcCCCCCCC-----CHHHHhcCCCCCchhhhh
Q 007266 238 MLRKNPEFRP-----SAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 238 mL~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~~ 265 (610)
||..||.+|| +++++++||||+...+..
T Consensus 255 lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 255 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp HTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 9999999999 479999999999865543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=419.90 Aligned_cols=258 Identities=24% Similarity=0.481 Sum_probs=231.4
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||+|++..+++.||||++...... ....+.+.+|+.+|+.++||||+++++++... ..+|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEE
Confidence 47899999999999999999999999999999999754321 12345688999999999999999999988755 48899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||+.|++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999999999998765 6899999999999999999999999999999999999999999999999999876433
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+...++..+.... ...|..++..+.+||.+||
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL 273 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHS
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHh
Confidence 456799999999999999999999999999999999999999999999988888887664 3467789999999999999
Q ss_pred cCCCCCCCC-----HHHHhcCCCCCchhhh
Q 007266 240 RKNPEFRPS-----AAELLCHPHLQPYVLG 264 (610)
Q Consensus 240 ~~dP~~RpS-----a~eiL~Hp~f~~~~~~ 264 (610)
+.||.+||+ ++++++||||+...+.
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred hcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 999999998 9999999999976554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=425.13 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=216.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecC-cEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKG-CYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~-~~~~ 78 (610)
+++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.+. ||||+++++++...+ ..+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999999999999999999876666677778899999999997 999999999987543 4789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc--
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-- 156 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-- 156 (610)
+|||||+ ++|.++++.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 88 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9999997 5899999874 689999999999999999999999999999999999999999999999999976532
Q ss_pred --------------------ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHH
Q 007266 157 --------------------DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 215 (610)
Q Consensus 157 --------------------~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I 215 (610)
.......+||++|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 112345789999999999876 67899999999999999999999999999988888777
Q ss_pred hhccCCCCC----------------------------------------------cccchHHHHHHHHhhcCCCCCCCCH
Q 007266 216 NKSIVAPLP----------------------------------------------TVYSGAFRGLVKSMLRKNPEFRPSA 249 (610)
Q Consensus 216 ~~~~~~~~p----------------------------------------------~~~s~~l~~LI~kmL~~dP~~RpSa 249 (610)
......+.. ..++.++.+||.+||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 654433221 1567899999999999999999999
Q ss_pred HHHhcCCCCCchh
Q 007266 250 AELLCHPHLQPYV 262 (610)
Q Consensus 250 ~eiL~Hp~f~~~~ 262 (610)
+|+|+||||+.+.
T Consensus 324 ~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 324 NDALKHPFVSIFH 336 (388)
T ss_dssp HHHTTSTTTTTTC
T ss_pred HHHhCCHHHHHhc
Confidence 9999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=407.52 Aligned_cols=253 Identities=28% Similarity=0.506 Sum_probs=225.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+..+++.||+|.+....... .+.+.+|+.+++.++||||++++++|...+ .+|+||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~ 96 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVM 96 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECC-EEEEEE
Confidence 57999999999999999999999999999999997554433 356889999999999999999999887654 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 999999999999874 58999999999999999999999999999999999999999999999999988765433 34
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC--CCCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--~~~p~~~s~~l~~LI~km 238 (610)
...+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+..... ...+..++..+++||.+|
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 567899999999999999999999999999999999999999998887776666544332 334667899999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|+.||++|||++|+|+||||+.
T Consensus 254 l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGG
T ss_pred ccCChhHCcCHHHHhhChhhcc
Confidence 9999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=420.26 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=230.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++|||||++++++... ...|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEE
Confidence 479999999999999999999999999999999987766666677899999999999999999999987655 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~DFGlak~~~~~~ 158 (610)
|||.|++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.......
T Consensus 108 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 9999999999997654 689999999999999999999999999999999999998654 49999999998876555
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC---CCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---~p~~~s~~l~~LI 235 (610)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...++..+....... ....++.++++||
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 5667899999999999999999999999999999999999999999999888888876654322 2245799999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+||+.||.+||++.|+|+||||..
T Consensus 266 ~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=430.15 Aligned_cols=283 Identities=26% Similarity=0.457 Sum_probs=236.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|+++.+++.||+|++....... ...+.+.+|+.+++.++|||||+++++|.+. ..+|+|
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lV 147 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-RYLYMV 147 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEE
Confidence 68999999999999999999999999999999996432111 1123477899999999999999999988754 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus 148 ~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp ECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 9999999999999764 58999999999999999999999999999999999999999999999999998765443
Q ss_pred ccccccCCCcccCCccccCCC----CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc---cCCCCCcccchHH
Q 007266 159 LASSVVGTPSYMCPELLADIP----YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS---IVAPLPTVYSGAF 231 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~----yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~---~~~~~p~~~s~~l 231 (610)
.....+||+.|+|||++.+.. |+.++|||||||+||||++|.+||.+.+...++.+|... ...+....++.++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 345789999999999998765 789999999999999999999999999998888888653 2334445789999
Q ss_pred HHHHHHhhcCCCCC--CCCHHHHhcCCCCCchhhhh--ccccCCCCCCCCCCCCCCccccc
Q 007266 232 RGLVKSMLRKNPEF--RPSAAELLCHPHLQPYVLGI--HLKLNGPRRNTFPLEWSDSNFKK 288 (610)
Q Consensus 232 ~~LI~kmL~~dP~~--RpSa~eiL~Hp~f~~~~~~~--~~~~~~p~~~~~~~~~~~s~~~~ 288 (610)
++||.+||+.+|.+ |++++||++||||+...|.. ......|..+...-..+.++|+.
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~ 365 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 365 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCC
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCC
Confidence 99999999999988 99999999999999864332 22333444444444445555544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=421.61 Aligned_cols=261 Identities=27% Similarity=0.546 Sum_probs=227.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+|+.++|||||+++++|...+ .+|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-DMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEEE
Confidence 4789999999999999999999999999999999975432 1123456889999999999999999999887654 7899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||+.||+|.+++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.......
T Consensus 93 v~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp EECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 999999999999998754 699999999999999999999999999999999999999999999999999988766666
Q ss_pred cccccCCCcccCCccccC---CCCCCCccccccchhHHhhhhcCcccccc---CHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 160 ASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~---~~yt~ksDIWSLG~iLyeLltG~~PF~~~---~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||... ....+...+... ....+..++..+.+
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~p~~~s~~~~~ 249 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSAWSQEMVS 249 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-CCCCCTTSCHHHHH
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-ccCCCCcCCHHHHH
Confidence 778899999999999874 45899999999999999999999999743 344555554443 34567789999999
Q ss_pred HHHHhhcCCCCCCCC-HHHHhcCCCCCchhhhh
Q 007266 234 LVKSMLRKNPEFRPS-AAELLCHPHLQPYVLGI 265 (610)
Q Consensus 234 LI~kmL~~dP~~RpS-a~eiL~Hp~f~~~~~~~ 265 (610)
||.+||+.||.+||+ ++++++||||+...+..
T Consensus 250 li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~ 282 (384)
T 4fr4_A 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDA 282 (384)
T ss_dssp HHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred HHHHHhcCCHhHhcccHHHHHcChhhhcCCHHH
Confidence 999999999999998 99999999999876553
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=408.61 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=215.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||+|+||.||+|++. +++.||+|++............+.+|+.++++++||||+++++++... ..+|+|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-RCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-SCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-CEEEEE
Confidence 579999999999999999999985 588999999986655555567788999999999999999999987655 478899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
|||++| +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 98 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 999975 8888887643 35899999999999999999999999999999999999999999999999999876433 23
Q ss_pred cccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC--------------
Q 007266 160 ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-------------- 224 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p-------------- 224 (610)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+....+.+..+......+.+
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 445689999999999876 56899999999999999999999999887766666655443222211
Q ss_pred ---------------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 225 ---------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 225 ---------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
..++.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 23567899999999999999999999999999998643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=429.42 Aligned_cols=261 Identities=28% Similarity=0.548 Sum_probs=222.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+.++++|...+ .+|+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-EEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-EEEE
Confidence 3689999999999999999999999999999999975432 2233456788999999999999999999887654 7899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeeccccccccc-c
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-D 157 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~ 157 (610)
||||++|++|.+++.... .+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++.... .
T Consensus 226 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999999999998765 68999999999999999999998 9999999999999999999999999999986432 3
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
......+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+...+...+..... ..+..+++++.+||.+
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~ 382 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLSG 382 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999998888888766543 4677899999999999
Q ss_pred hhcCCCCCCC-----CHHHHhcCCCCCchhhhh
Q 007266 238 MLRKNPEFRP-----SAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 238 mL~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~~ 265 (610)
||+.||.+|| +++|+|+||||+...+..
T Consensus 383 ~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 383 LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 9999999999 999999999999876553
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=404.95 Aligned_cols=258 Identities=30% Similarity=0.431 Sum_probs=220.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH---HHHHHHHHHHHHHHhc---CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD---RARRSAHQEMELISRV---RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~---~~~~~l~~Ei~iL~~L---~HpnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|++..+++.||||++....... .....+.+|+.+++.+ .||||+++++++.....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 68999999999999999999999999999999997543211 1122355677776665 59999999998876543
Q ss_pred ----EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccc
Q 007266 76 ----YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 151 (610)
Q Consensus 76 ----~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGla 151 (610)
.+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 6889999996 59999998866556999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC--------
Q 007266 152 KMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-------- 223 (610)
Q Consensus 152 k~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~-------- 223 (610)
+...........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+......+.
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (308)
T 3g33_A 168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247 (308)
T ss_dssp TTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred cccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence 887666666778999999999999999999999999999999999999999999988887777754332211
Q ss_pred ------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 224 ------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 224 ------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
...++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 1246789999999999999999999999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=428.49 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=228.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+|+.++|||||+++++|.+. ...|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-GHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-SEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-CEEEEEE
Confidence 579999999999999999999999999999999987766666677899999999999999999999987654 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec---CCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT---RDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~---~~g~vKL~DFGlak~~~~~~ 158 (610)
|||.||+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 90 E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 90 DLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999999999998765 699999999999999999999999999999999999998 45789999999998765433
Q ss_pred -ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC---CCcccchHHHHH
Q 007266 159 -LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGL 234 (610)
Q Consensus 159 -~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---~p~~~s~~l~~L 234 (610)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...++..+....... ....+++++++|
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 3456789999999999999999999999999999999999999999999988888887654332 234689999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
|.+||+.||.+|||+.|+|+||||+..
T Consensus 248 i~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=420.44 Aligned_cols=261 Identities=29% Similarity=0.477 Sum_probs=223.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHH-HHhcCCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMEL-ISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~i-L~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|++++.||+|+||.||+|+++.+++.||||++...... ......+.+|..+ ++.++||||++++++|... ..+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-SEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-CEEE
Confidence 36899999999999999999999999999999999765432 2233456667776 5778999999999988765 4889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-cc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~ 157 (610)
+||||+.||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ..
T Consensus 116 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999999999998765 68999999999999999999999999999999999999999999999999998643 33
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..|..... ..+..++..+++||.+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 272 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEG 272 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-CCCSSSCHHHHHHHHH
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHHHH
Confidence 456678999999999999999999999999999999999999999999999888888876543 3567799999999999
Q ss_pred hhcCCCCCCCCH----HHHhcCCCCCchhhhh
Q 007266 238 MLRKNPEFRPSA----AELLCHPHLQPYVLGI 265 (610)
Q Consensus 238 mL~~dP~~RpSa----~eiL~Hp~f~~~~~~~ 265 (610)
||+.||.+||++ .++++||||+...|..
T Consensus 273 lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 273 LLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp HTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred HcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 999999999986 7999999999866543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=411.17 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=228.4
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
.++|++++.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+|+.++||||++++++|... ..+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM-EELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEE
Confidence 378999999999999999999999999999999987443 3345688999999999999999999988665 488999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC--CCCeeeeeccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~--~g~vKL~DFGlak~~~~~~ 158 (610)
||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999997642 36899999999999999999999999999999999999987 7899999999998876665
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC---cccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP---TVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p---~~~s~~l~~LI 235 (610)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...++..+......... ..++.++.+||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 566778999999999999988999999999999999999999999999988888888765543322 35789999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||..||.+|||+.|+|+||||+..
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999999999999999999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=401.33 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=218.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++... ...++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-RRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-CeEEEE
Confidence 6899999999999999999999999999999999987766666677889999999999999999999988765 478999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999998887644 6899999999999999999999999999999999999999999999999999876432 33
Q ss_pred cccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---------------
Q 007266 160 ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--------------- 223 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--------------- 223 (610)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 456789999999999876 6689999999999999999999999998887766655543221110
Q ss_pred ---------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 224 ---------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 224 ---------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
...++..+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 12467889999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=417.01 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=221.3
Q ss_pred CCeEEEeEeccc--CceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKG--SFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G--~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
++|++++.||+| +||.||+|++..+++.||||++..........+.+.+|+.+++.++|||||+++++|...+ .+|+
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~l 103 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWV 103 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC-EEEE
Confidence 589999999999 9999999999999999999999877777777788999999999999999999999887654 7899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc--
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-- 157 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-- 157 (610)
|||||+|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 999999999999998865557999999999999999999999999999999999999999999999999988654222
Q ss_pred ------cccccccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc----------
Q 007266 158 ------DLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---------- 219 (610)
Q Consensus 158 ------~~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~---------- 219 (610)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence 12334589999999999987 678999999999999999999999998765443333222111
Q ss_pred -----------------------------------CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 220 -----------------------------------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 220 -----------------------------------~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
..+.+..++..+++||.+||+.||.+|||++|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 1123455788999999999999999999999999999998643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=429.68 Aligned_cols=283 Identities=26% Similarity=0.443 Sum_probs=235.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|+++.+++.||+|++....... .....+.+|+.++..++||||++++++|.+. ..+|+|
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-~~~~lV 152 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-NNLYLV 152 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-SEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-CEEEEE
Confidence 68999999999999999999999999999999997432211 1123377899999999999999999988765 478999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
||||.||+|.+++.+.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus 153 ~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp ECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 99999999999998732 369999999999999999999999999999999999999999999999999997764433
Q ss_pred ccccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc----CCCCCcccch
Q 007266 159 LASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI----VAPLPTVYSG 229 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~----~~~~p~~~s~ 229 (610)
.....+||+.|+|||++. ...|+.++|||||||+||||++|.+||.+.+..+++.+|.... .+.....+++
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 311 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCH
Confidence 234579999999999986 5678999999999999999999999999999888888875432 1222345899
Q ss_pred HHHHHHHHhhcCCCCC--CCCHHHHhcCCCCCchhhhhccccCCCCCCCCCCCCCCccc
Q 007266 230 AFRGLVKSMLRKNPEF--RPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF 286 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~--RpSa~eiL~Hp~f~~~~~~~~~~~~~p~~~~~~~~~~~s~~ 286 (610)
++++||++||..+|++ |++++|+++||||+...|........|..+......+.++|
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~f 370 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNF 370 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCCCCCSSTTCCTTS
T ss_pred HHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCCCcCCCccchhhc
Confidence 9999999999998888 99999999999999876665444444444443333334444
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=408.57 Aligned_cols=257 Identities=25% Similarity=0.450 Sum_probs=226.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH----HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~----~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+|++++||||++++++|... ..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEE
Confidence 46999999999999999999999999999999997644321 1345688999999999999999999987654 578
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC----Ceeeeecccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKM 153 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g----~vKL~DFGlak~ 153 (610)
|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999999997643 689999999999999999999999999999999999999887 799999999988
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchH
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGA 230 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~ 230 (610)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+........ +..++..
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHH
Confidence 7655556678899999999999999999999999999999999999999999888887777765433222 2357889
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+++||.+||..||.+|||+.|+|+||||+..
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=392.81 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=231.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++... ...|+||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-CEEEEEE
Confidence 689999999999999999999999999999999987776777778899999999999999999999987654 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC---eeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~---vKL~DFGlak~~~~~~ 158 (610)
||+.|++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999999999998765 6899999999999999999999999999999999999987665 9999999998776665
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC---CCCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~---~~p~~~s~~l~~LI 235 (610)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...... +....+++++.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHH
Confidence 566788999999999999999999999999999999999999999999888888777655432 22346899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+||+.||++|||++|+|+||||+.
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 243 DSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp HHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred HHHcccChhhCCCHHHHhcCccccC
Confidence 9999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=399.92 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=215.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||+|+||.||+|++ .+++.||+|++..........+.+.+|+.++++++||||+++++++... ..+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEE
Confidence 78999999999999999999998 6789999999976554443445688999999999999999999988665 478999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
|||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 999975 9999887643 36899999999999999999999999999999999999999999999999999875432 23
Q ss_pred cccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----------------
Q 007266 160 ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------- 222 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---------------- 222 (610)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 345689999999999876 458999999999999999999999999988777666654322111
Q ss_pred ------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 223 ------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 223 ------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
....++..+.+||.+||+.||++|||++|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 12347889999999999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=425.45 Aligned_cols=261 Identities=26% Similarity=0.445 Sum_probs=224.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|+++.+++.||||++...... ....+.+.+|+.++..++||||++++++|.+. ..+|+|
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-~~~~lV 139 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-NYLYLV 139 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-SEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEE
Confidence 6899999999999999999999999999999999753321 11234478899999999999999999988765 489999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc-
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL- 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~- 159 (610)
|||+.||+|.+++.+.+ ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.......
T Consensus 140 mE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999999998753 3689999999999999999999999999999999999999999999999999987654432
Q ss_pred -cccccCCCcccCCcccc-------CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc----CCCCCccc
Q 007266 160 -ASSVVGTPSYMCPELLA-------DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI----VAPLPTVY 227 (610)
Q Consensus 160 -~~~~vGTp~Y~APEvl~-------~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~----~~~~p~~~ 227 (610)
....+||+.|+|||++. ...|+.++|||||||+||||++|..||.+.+..+++.+|.... ....+..+
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 298 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCC
Confidence 34579999999999987 4568999999999999999999999999999888888876421 12234578
Q ss_pred chHHHHHHHHhhcCCCCCC---CCHHHHhcCCCCCchhhhh
Q 007266 228 SGAFRGLVKSMLRKNPEFR---PSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~R---pSa~eiL~Hp~f~~~~~~~ 265 (610)
+.++++||++||. +|.+| ++++|+++||||+.+.|..
T Consensus 299 s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999999999999 99998 5999999999999876554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=426.00 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=204.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~ 77 (610)
++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++|||||++++++...+ ..+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999999999999999999876666667778999999999999999999999886432 478
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|+||||+ +++|.++++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 9999998 579999997643 6999999999999999999999999999999999999999999999999999875422
Q ss_pred c----------------------------ccccccCCCcccCCccc-cCCCCCCCccccccchhHHhhhh----------
Q 007266 158 D----------------------------LASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSA---------- 198 (610)
Q Consensus 158 ~----------------------------~~~~~vGTp~Y~APEvl-~~~~yt~ksDIWSLG~iLyeLlt---------- 198 (610)
. .....+||++|+|||++ .+..|+.++||||||||||||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 1 23456899999999976 56679999999999999999998
Q ss_pred -cCccccccCH--------------------HHHHHHHhhccCCC------------------------------CCccc
Q 007266 199 -QKAAFKAFDM--------------------QALINKINKSIVAP------------------------------LPTVY 227 (610)
Q Consensus 199 -G~~PF~~~~~--------------------~~l~~~I~~~~~~~------------------------------~p~~~ 227 (610)
|.++|.+.+. .+.+..|......+ ....+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7777866541 22333332221111 11235
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
+.++.+||.+||..||.+|||++|+|+||||+.+.+.
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 8899999999999999999999999999999986543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=414.16 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=216.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----c
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----C 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 75 (610)
+++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++...+ .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36899999999999999999999999999999999876666666778899999999999999999999887554 3
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+|+||||++| +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 78888863 58999999999999999999999999999999999999999999999999998776
Q ss_pred cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc----------
Q 007266 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT---------- 225 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~---------- 225 (610)
........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+......+.+.
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 5555567899999999999999999999999999999999999999999998887777776543332111
Q ss_pred -------------------------------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhhh
Q 007266 226 -------------------------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 226 -------------------------------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~~ 265 (610)
..+..+++||.+||+.||.+|||++|+|+||||+.+....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 329 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 329 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHH
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCcc
Confidence 1256899999999999999999999999999998765443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=408.28 Aligned_cols=246 Identities=20% Similarity=0.270 Sum_probs=196.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC---cEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~---~~~~ 78 (610)
++|.+.+.||+|+||+||++++ +|+.||||++..... .......|+.++.+++|||||++++++...+ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4799999999999999999987 689999999864322 1222345666677899999999999988764 3689
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecccCCCCceEecCCCCeeeeeccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN--------HILHRDVKCSNIFLTRDQDIRLGDFGL 150 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~--------gIiHRDLKPeNILL~~~g~vKL~DFGl 150 (610)
||||||+||+|.++++.. .++++.+..++.|++.||.|||++ +||||||||+||||+.++.+||+|||+
T Consensus 78 lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999999874 589999999999999999999987 999999999999999999999999999
Q ss_pred cccccccc-----ccccccCCCcccCCccccCC------CCCCCccccccchhHHhhhhcCcccccc-------------
Q 007266 151 AKMLISDD-----LASSVVGTPSYMCPELLADI------PYGSKSDIWSLGCCVYEMSAQKAAFKAF------------- 206 (610)
Q Consensus 151 ak~~~~~~-----~~~~~vGTp~Y~APEvl~~~------~yt~ksDIWSLG~iLyeLltG~~PF~~~------------- 206 (610)
++...... .....+||+.|||||++.+. .|+.++|||||||+||||++|.+||...
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98764432 12346899999999998764 3677999999999999999998766321
Q ss_pred --CHHHHHHHHhhcc-CCCCCcc-----cchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 207 --DMQALINKINKSI-VAPLPTV-----YSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 207 --~~~~l~~~I~~~~-~~~~p~~-----~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+...+.... ...+|.. .+..+.+||.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2334444443332 2334433 33578899999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=406.16 Aligned_cols=259 Identities=29% Similarity=0.517 Sum_probs=218.9
Q ss_pred CCeEEEeEecccCceEEEEEEEe---CCCeEEEEEEEccccc--cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQ--TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~--~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++++.||+|+||.||+|++. .+++.||+|++..... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 95 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-GK 95 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-SC
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-CE
Confidence 68999999999999999999986 5889999999976532 223345678899999999999999999988655 47
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 899999999999999998765 689999999999999999999999999999999999999999999999999976432
Q ss_pred -ccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 157 -DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 157 -~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+..... ..+..++..+++||
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li 252 (327)
T 3a62_A 174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEARDLL 252 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHH
T ss_pred CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHH
Confidence 2345567899999999999999999999999999999999999999999998888888766543 46677899999999
Q ss_pred HHhhcCCCCCCC-----CHHHHhcCCCCCchhhh
Q 007266 236 KSMLRKNPEFRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 236 ~kmL~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
.+||..||.+|| +++|+++||||+...+.
T Consensus 253 ~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp HHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred HHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 999999999999 89999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=400.55 Aligned_cols=256 Identities=26% Similarity=0.484 Sum_probs=217.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH------------------------HHHHHHHHHHHHHH
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD------------------------RARRSAHQEMELIS 56 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~------------------------~~~~~l~~Ei~iL~ 56 (610)
+++|++++.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999997543211 12356889999999
Q ss_pred hcCCCceeeeeeeEeec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCce
Q 007266 57 RVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 135 (610)
Q Consensus 57 ~L~HpnIV~l~~~~~~~-~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNI 135 (610)
+++||||+++++++... +..+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 99999999999988763 5688999999999999876543 3699999999999999999999999999999999999
Q ss_pred EecCCCCeeeeeccccccccccc-ccccccCCCcccCCccccCCC---CCCCccccccchhHHhhhhcCccccccCHHHH
Q 007266 136 FLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 211 (610)
Q Consensus 136 LL~~~g~vKL~DFGlak~~~~~~-~~~~~vGTp~Y~APEvl~~~~---yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l 211 (610)
|++.++.+||+|||+++...... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......+
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 99999999999999998764432 345678999999999998765 36789999999999999999999999888777
Q ss_pred HHHHhhccC-CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 212 INKINKSIV-APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 212 ~~~I~~~~~-~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
...+..... .+....++..+.+||.+||+.||++||++.|+|+||||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 777655432 233456899999999999999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=410.94 Aligned_cols=258 Identities=28% Similarity=0.501 Sum_probs=220.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc---HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT---DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~---~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++++.||+|+||.||+|.+..+++.||||++...... ....+.+.+|+.+++.++||||++++++|... ..+|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-GMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEE
Confidence 4799999999999999999999999999999999643211 11245688999999999999999999988765 4889
Q ss_pred EEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC---eeeeecccccc
Q 007266 79 IIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKM 153 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~---vKL~DFGlak~ 153 (610)
+|||||+|++|.+.+.+. .+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888653 2345899999999999999999999999999999999999987665 99999999987
Q ss_pred ccccc-ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC---cccch
Q 007266 154 LISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP---TVYSG 229 (610)
Q Consensus 154 ~~~~~-~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p---~~~s~ 229 (610)
..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.. ..++..+........+ ..++.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~ 261 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISE 261 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCH
Confidence 65443 3456789999999999999999999999999999999999999998754 4455555444333222 35789
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+++||.+||..||.+|||+.|+|+||||+..
T Consensus 262 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 99999999999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=402.69 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=214.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC------ 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~------ 75 (610)
++|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.+|++++|||||+++++|.+.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 58999999999999999999999999999999997544 33345678999999999999999999998865432
Q ss_pred --------------------------------------------------EEEEEEeecCCCCHHHHHHHhCC-CCCCHH
Q 007266 76 --------------------------------------------------YVCIIIGYCEGGDMAEAIKKANG-VHFPEE 104 (610)
Q Consensus 76 --------------------------------------------------~~~LVmEy~~GgsL~~~Ik~~~~-~~lse~ 104 (610)
++|+|||||+|++|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 48999999999999999986432 235667
Q ss_pred HHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-------------ccccccCCCcccC
Q 007266 105 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-------------LASSVVGTPSYMC 171 (610)
Q Consensus 105 ~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-------------~~~~~vGTp~Y~A 171 (610)
.++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... .....+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 799999999999999999999999999999999999999999999998765432 2345689999999
Q ss_pred CccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHH
Q 007266 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 251 (610)
Q Consensus 172 PEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~e 251 (610)
||++.+..++.++|||||||++|+|++|..|+... ......+............++.+.+||.+||+.||.+||+++|
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 322 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence 99999999999999999999999999998876432 2333333333333333456788999999999999999999999
Q ss_pred HhcCCCCCc
Q 007266 252 LLCHPHLQP 260 (610)
Q Consensus 252 iL~Hp~f~~ 260 (610)
+|+||||+.
T Consensus 323 ~l~~~~f~~ 331 (332)
T 3qd2_B 323 IIENAIFEN 331 (332)
T ss_dssp HHHSTTCCC
T ss_pred Hhhchhhhc
Confidence 999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=406.74 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=211.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|++++||||+++++++... ..+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 111 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLHLI 111 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEEEE
Confidence 4789999999999999999999999999999999987665555566788999999999999999999987665 488999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-----CCCeeeeecccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-----DQDIRLGDFGLAKMLI 155 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-----~g~vKL~DFGlak~~~ 155 (610)
|||++| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++...
T Consensus 112 ~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 999974 9999998755 6899999999999999999999999999999999999954 4459999999998764
Q ss_pred cc-cccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC---------
Q 007266 156 SD-DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP--------- 224 (610)
Q Consensus 156 ~~-~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p--------- 224 (610)
.. ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+......+..
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 33 234556889999999999874 4899999999999999999999999998887777766543322211
Q ss_pred --------------------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 225 --------------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 225 --------------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
..++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 1267899999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=418.07 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=215.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~ 77 (610)
++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.++||||+++++++...+ ..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 6899999999999999999999999999999999876666667778999999999999999999999887653 578
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|+||||++ ++|.++++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 99999996 59999998643 6999999999999999999999999999999999999999999999999999876433
Q ss_pred c-----------------------ccccccCCCcccCCccc-cCCCCCCCccccccchhHHhhhh-----------cCcc
Q 007266 158 D-----------------------LASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSA-----------QKAA 202 (610)
Q Consensus 158 ~-----------------------~~~~~vGTp~Y~APEvl-~~~~yt~ksDIWSLG~iLyeLlt-----------G~~P 202 (610)
. .....+||++|+|||++ .+..|+.++|||||||+||||++ |.++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 2 23668999999999986 56679999999999999999998 4555
Q ss_pred ccccC-----------------HHHHHHHHhhccCCCC------------------------------CcccchHHHHHH
Q 007266 203 FKAFD-----------------MQALINKINKSIVAPL------------------------------PTVYSGAFRGLV 235 (610)
Q Consensus 203 F~~~~-----------------~~~l~~~I~~~~~~~~------------------------------p~~~s~~l~~LI 235 (610)
|.+.+ ..+.+..|......+. ...+++++.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 55433 1223333322221111 134789999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
.+||+.||.+|||++|+|+||||+.+.+.
T Consensus 343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 99999999999999999999999986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=411.58 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=219.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 76 (610)
++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++...+ ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 5899999999999999999999999999999999776666667778999999999999999999999887553 34
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+ |++|.++++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 68999999 88999999873 689999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------- 222 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------- 222 (610)
.....+||++|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 181 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 181 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred --ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 3456789999999999877 679999999999999999999999999988877777665433221
Q ss_pred -----------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 -----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 -----------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
....+++.+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 1234688999999999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=416.59 Aligned_cols=256 Identities=25% Similarity=0.509 Sum_probs=223.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+|+.++||||+++++++... ..+|+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-TDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEE
Confidence 478999999999999999999999999999999997433211 1234688999999999999999999987765 47899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 87 v~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 99999 789999988765 689999999999999999999999999999999999999999999999999988776666
Q ss_pred cccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.....+...+... ....|..+++.+++||.+|
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHHHTT
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHHHHH
Confidence 778899999999999998876 68999999999999999999999887654444433322 2345777899999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCch
Q 007266 239 LRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
|+.||.+|||++|+++||||+..
T Consensus 243 L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SCSSGGGSCCHHHHTTCHHHHTT
T ss_pred cCCChhHCcCHHHHHhChhhccC
Confidence 99999999999999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=403.00 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=207.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
.++|++++.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.++++++||||+++++++... ..+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTE-NKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-TEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-CeEEEE
Confidence 36899999999999999999999999999999999754422 2234577899999999999999999987655 478999
Q ss_pred EeecCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 81 IGYCEGGDMAEAIKKAN----GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~----~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
|||++ ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 59999987642 13589999999999999999999999999999999999999999999999999987643
Q ss_pred c-cccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC------------
Q 007266 157 D-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------ 222 (610)
Q Consensus 157 ~-~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------ 222 (610)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 2 23456789999999999876 468999999999999999999999999988877776664322111
Q ss_pred ---------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 223 ---------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 223 ---------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
.+..++.++.+||.+||+.||++|||++|+|+||||+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 12246789999999999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=387.92 Aligned_cols=255 Identities=25% Similarity=0.458 Sum_probs=226.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..++..+|+|++....... .+.+.+|+.++++++||||+++++++... ...|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDN-TDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeEEEEE
Confidence 47999999999999999999999999999999997654332 35688999999999999999999987654 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe---cCCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL---~~~g~vKL~DFGlak~~~~~~ 158 (610)
||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred eccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999999998765 68999999999999999999999999999999999999 778899999999998876666
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc---ccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT---VYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~---~~s~~l~~LI 235 (610)
.....+||+.|+|||++.+. ++.++|||||||++|+|++|..||...+..+....+.......... .++..+.+||
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLI 242 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence 66778999999999998765 8999999999999999999999999998888888876655433222 5789999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.+||+.||.+||++.++|+||||+..+
T Consensus 243 ~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 243 RRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHccCChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=399.20 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=227.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH----HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~----~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||+|++..+++.||+|.+....... ...+.+.+|+.+++++.||||+++++++... ..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 90 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-TDV 90 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CEE
Confidence 47999999999999999999999999999999997644321 1245688999999999999999999987654 578
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC----Ceeeeecccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKM 153 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g----~vKL~DFGlak~ 153 (610)
|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999999999998644 689999999999999999999999999999999999999888 799999999988
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchH
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGA 230 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~ 230 (610)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+........ +..++..
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 7655555677899999999999999999999999999999999999999999988888877765543322 2457889
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+.+||.+||..||.+|||++|+|+||||+...
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 99999999999999999999999999998643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=405.29 Aligned_cols=256 Identities=21% Similarity=0.399 Sum_probs=216.4
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++... ...|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEE
Confidence 58999999999999999999999999999999999654332 2345688999999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--- 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--- 157 (610)
||||+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999987543 6899999999999999999999999999999999999999999999999999865322
Q ss_pred cccccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHH--HHHHHHhhccCCCCCcccchHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQ--ALINKINKSIVAPLPTVYSGAFRGL 234 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~--~l~~~I~~~~~~~~p~~~s~~l~~L 234 (610)
......+||+.|+|||++.+..+ +.++|||||||+||+|++|..||...... ............+....++..+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 23456789999999999987775 77899999999999999999999865542 2222222233333346789999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|.+||+.||.+|||++|+|+||||+.
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHccCChhhCcCHHHHhhChhhcc
Confidence 99999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=390.32 Aligned_cols=256 Identities=28% Similarity=0.505 Sum_probs=224.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||++.+..++..||+|++....... .....+.+|+.++++++||||+++++++... ...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-CEEEE
Confidence 578999999999999999999999999999999986543222 2245688999999999999999999987655 57899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus 87 v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence 999999999999998765 6899999999999999999999999999999999999999999999999998654332 3
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ...+..++..+++||.+||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLL 242 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHC
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHh
Confidence 455789999999999999999999999999999999999999999999888887776543 3467778999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCch
Q 007266 240 RKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+.||.+||++.|+|+||||+..
T Consensus 243 ~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp CSSGGGSCCHHHHHHCHHHHHH
T ss_pred ccChhhCCCHHHHhhCccccCC
Confidence 9999999999999999999763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=408.31 Aligned_cols=254 Identities=29% Similarity=0.484 Sum_probs=207.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++++..+++.||||++....... +.+.+|+.+++.++||||+++++++... ..+|+||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~ 95 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTP-THLAIIM 95 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeC-CEEEEEE
Confidence 68999999999999999999999999999999997544332 3477999999999999999999988765 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC--eeeeecccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKMLISDDL 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~--vKL~DFGlak~~~~~~~ 159 (610)
||+.|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.......
T Consensus 96 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 96 EYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 9999999999998765 6899999999999999999999999999999999999987766 99999999986554555
Q ss_pred cccccCCCcccCCccccCCCCCCC-ccccccchhHHhhhhcCccccccC----HHHHHHHHhhcc-CCCCCcccchHHHH
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSK-SDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSI-VAPLPTVYSGAFRG 233 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~k-sDIWSLG~iLyeLltG~~PF~~~~----~~~l~~~I~~~~-~~~~p~~~s~~l~~ 233 (610)
....+||+.|+|||++.+..+..+ +|||||||++|+|++|..||.+.. ....+..+.... ..+....++..+++
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 253 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence 567789999999999988887655 899999999999999999998754 334444443322 22334468999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
||.+||+.||.+|||+.|+|+||||...
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 254 LISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 9999999999999999999999999653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=400.74 Aligned_cols=251 Identities=29% Similarity=0.526 Sum_probs=217.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-----CCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-----NPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-----HpnIV~l~~~~~~~~~~ 76 (610)
++|++++.||+|+||.||+|++..+++.||||++... ......+..|+.+++.+. |||||++++.+...+ .
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~-~ 110 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD-H 110 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT-E
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC-e
Confidence 6899999999999999999999999999999998632 334456778999999986 999999999887654 7
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-----------------
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR----------------- 139 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~----------------- 139 (610)
.|+||||+ |++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 89999999 999999999876567999999999999999999999999999999999999975
Q ss_pred --------CCCeeeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHH
Q 007266 140 --------DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 211 (610)
Q Consensus 140 --------~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l 211 (610)
++.+||+|||+++... ......+||+.|+|||++.+..|+.++|||||||+||+|++|..||...+..+.
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 267 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH
Confidence 7889999999998643 234567899999999999999999999999999999999999999998887777
Q ss_pred HHHHhhccCCCCC---------------------------------------------cccchHHHHHHHHhhcCCCCCC
Q 007266 212 INKINKSIVAPLP---------------------------------------------TVYSGAFRGLVKSMLRKNPEFR 246 (610)
Q Consensus 212 ~~~I~~~~~~~~p---------------------------------------------~~~s~~l~~LI~kmL~~dP~~R 246 (610)
+..+......... ...++.+.+||.+||+.||.+|
T Consensus 268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 347 (360)
T 3llt_A 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR 347 (360)
T ss_dssp HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence 6665443221110 0123678899999999999999
Q ss_pred CCHHHHhcCCCCC
Q 007266 247 PSAAELLCHPHLQ 259 (610)
Q Consensus 247 pSa~eiL~Hp~f~ 259 (610)
||++|+|+||||+
T Consensus 348 pta~elL~hp~f~ 360 (360)
T 3llt_A 348 PSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHTTSGGGC
T ss_pred CCHHHHhcCcccC
Confidence 9999999999995
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=402.48 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=213.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+|+.++||||+++++++... ..+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-SCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-CEEEEE
Confidence 78999999999999999999999999999999999754322 2222355799999999999999999987655 478899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
|||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 79 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 99997 59999888753 36899999999999999999999999999999999999999999999999999765432 23
Q ss_pred cccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC--------------
Q 007266 160 ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-------------- 224 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p-------------- 224 (610)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+......+.+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 445689999999999876 56899999999999999999999999999888877776554332211
Q ss_pred ---------------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 225 ---------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 225 ---------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
..++.++.+||.+||+.||.+|||++|+|+||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 23577899999999999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=424.03 Aligned_cols=256 Identities=28% Similarity=0.532 Sum_probs=224.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|++++|||||++++++... ..+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-CEEEEEE
Confidence 579999999999999999999999999999999975443333346688999999999999999999987654 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec---CCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT---RDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~---~~g~vKL~DFGlak~~~~~~ 158 (610)
|||.|++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++......
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999999999998765 689999999999999999999999999999999999995 45679999999998776665
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC---CCCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~---~~p~~~s~~l~~LI 235 (610)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+...... +.+..+++++++||
T Consensus 179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 257 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHH
T ss_pred ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHH
Confidence 5667899999999999876 5899999999999999999999999999988888888765433 22346899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||+.||.+|||+.|+|+||||+.+
T Consensus 258 ~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 258 RKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHcCCChhhCcCHHHHhcCHhhccC
Confidence 99999999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=411.30 Aligned_cols=255 Identities=22% Similarity=0.442 Sum_probs=226.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+|+.++||||++++++|... ..+|+||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-CEEEEEE
Confidence 589999999999999999999999999999999975432 3345688999999999999999999987654 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC--CCCeeeeecccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~--~g~vKL~DFGlak~~~~~~~ 159 (610)
|||.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......
T Consensus 128 E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 128 EFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp ECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999999999998754 336899999999999999999999999999999999999974 46799999999988766655
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC---CCCcccchHHHHHHH
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVK 236 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~---~~p~~~s~~l~~LI~ 236 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...... .....++.++++||.
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 286 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 66678999999999999999999999999999999999999999999888887777654322 233468999999999
Q ss_pred HhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 237 SMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+||+.||.+|||+.|+|+||||+.
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 287 NLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHcCCChhHCcCHHHHhhCccccC
Confidence 999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=440.04 Aligned_cols=261 Identities=25% Similarity=0.475 Sum_probs=232.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|++++.||+|+||.||+|++..+++.||||++..... .....+.+..|..+|..+ +||||+.++++|... ..+|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-~~~~ 418 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLY 418 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-SEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-CEEE
Confidence 4789999999999999999999999999999999975432 112335677899999987 689999999877654 5889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc-cc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SD 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~-~~ 157 (610)
|||||++||+|.+++.... .|++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 9999999999999998865 69999999999999999999999999999999999999999999999999998643 33
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
......+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+++..|..... .+|..++.++++||++
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 575 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKG 575 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-CCCTTSCHHHHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999999999999877553 4677899999999999
Q ss_pred hhcCCCCCCCCH-----HHHhcCCCCCchhhhh
Q 007266 238 MLRKNPEFRPSA-----AELLCHPHLQPYVLGI 265 (610)
Q Consensus 238 mL~~dP~~RpSa-----~eiL~Hp~f~~~~~~~ 265 (610)
||+.||.+|+++ +||++||||+...|..
T Consensus 576 lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 576 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp HSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred HccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 999999999997 9999999999876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=386.48 Aligned_cols=261 Identities=37% Similarity=0.654 Sum_probs=232.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee-cCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~-~~~~~~L 79 (610)
+++|++++.||+|+||.||++.+..+++.||+|.+..........+.+.+|+.++++++||||+++++.+.. .+..+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999999999999999998776666777889999999999999999999998764 3568899
Q ss_pred EEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCCCceEecCCCCeeeeeccccc
Q 007266 80 IIGYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHANH-----ILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~g-----IiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
||||++|++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997632 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc-ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHH
Q 007266 153 MLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231 (610)
Q Consensus 153 ~~~~~~-~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l 231 (610)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...+...+........+..++.++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 244 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHH
Confidence 754332 2335689999999999999999999999999999999999999999999888888888777777888899999
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||.+||+.||.+||++.|+|+|+|+..-
T Consensus 245 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 999999999999999999999999999763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=421.49 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=223.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|++..++..||+|++............+.+|+.+|+.++|||||+++++|... ..+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-RNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEE
Confidence 369999999999999999999999999999999986554433456688999999999999999999988654 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC---CCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~---g~vKL~DFGlak~~~~~~ 158 (610)
|||.||+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||++.......
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999999999998765 68999999999999999999999999999999999999764 459999999998876666
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~l~~LI 235 (610)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+++..+........ ...++..+++||
T Consensus 194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 272 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272 (494)
T ss_dssp CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHH
T ss_pred cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHH
Confidence 667789999999999886 4689999999999999999999999999999988888876654322 245799999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
.+||+.||.+|||+.|+|+||||+.....
T Consensus 273 ~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 273 KQMLQFDSQRRISAQQALEHPWIKEMCSK 301 (494)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHHHHHHHHH
T ss_pred HHHCCCChhhCccHHHHhcCcccccCccc
Confidence 99999999999999999999999876443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=388.37 Aligned_cols=256 Identities=28% Similarity=0.484 Sum_probs=215.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||+|.+..++..+|+|++...... ...+.+.+|+++|++++||||+++++++... ...|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-HNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecC-CeEEEEE
Confidence 5799999999999999999999999999999999765432 2345688999999999999999999987654 5789999
Q ss_pred eecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe---cCCCCeeeeeccccccccc
Q 007266 82 GYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL---~~~g~vKL~DFGlak~~~~ 156 (610)
||++|++|.+.+... .+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999998643 23479999999999999999999999999999999999999 4457899999999987766
Q ss_pred ccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--CCcccchHHHHH
Q 007266 157 DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGL 234 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--~p~~~s~~l~~L 234 (610)
.......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+....... ....+++.+.+|
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHH
T ss_pred cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHH
Confidence 66666788999999999886 468899999999999999999999999998887777665443222 223478999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|.+||+.||.+|||+.|+|+||||+.
T Consensus 259 i~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 259 LKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=401.66 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=219.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-------
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK------- 73 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~------- 73 (610)
+++|++++.||+|+||.||+|++..+++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4689999999999999999999999999999999976655444445678999999999999999999988764
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
+..+|+||||++| +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 3468999999975 8888776543 3699999999999999999999999999999999999999999999999999987
Q ss_pred cccc-----cccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcc-
Q 007266 154 LISD-----DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV- 226 (610)
Q Consensus 154 ~~~~-----~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~- 226 (610)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.........+........+..
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5421 23345689999999998876 5689999999999999999999999999988877777655333222111
Q ss_pred ------------------------------cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 227 ------------------------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 227 ------------------------------~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 2667999999999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=384.43 Aligned_cols=259 Identities=29% Similarity=0.487 Sum_probs=227.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-------cHHHHHHHHHHHHHHHhcC-CCceeeeeeeEee
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-------TDRARRSAHQEMELISRVR-NPFIVEYKDSWVE 72 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-------~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~ 72 (610)
+++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999975431 1234567889999999995 9999999998765
Q ss_pred cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccc
Q 007266 73 KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 73 ~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
+...|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 96 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 -NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred -CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 458899999999999999998764 68999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccccCCCcccCCcccc------CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC---CC
Q 007266 153 MLISDDLASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PL 223 (610)
Q Consensus 153 ~~~~~~~~~~~vGTp~Y~APEvl~------~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~---~~ 223 (610)
...........+||+.|+|||++. ...++.++|||||||++|+|++|..||...+.......+...... +.
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence 776655566778999999999884 456789999999999999999999999998887777776554332 22
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
...++..+.+||.+||+.||.+||++.|+|+||||+.+.
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 346889999999999999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=411.50 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=205.4
Q ss_pred CCeEEE-eEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHH-hcCCCceeeeeeeEee---cCcE
Q 007266 2 EQYEVL-EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELIS-RVRNPFIVEYKDSWVE---KGCY 76 (610)
Q Consensus 2 d~Y~il-k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~-~L~HpnIV~l~~~~~~---~~~~ 76 (610)
++|.++ +.||+|+||.||++.+..+++.||||++... ..+.+|+.++. .++||||++++++|.. .+..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 578887 7899999999999999999999999998632 23667888874 4589999999998764 2457
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC---CCCeeeeecccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKM 153 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~---~g~vKL~DFGlak~ 153 (610)
+|+|||||.||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 899999999999999998765556999999999999999999999999999999999999998 78899999999987
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHH----HHHHHhhccC---CCCCcc
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA----LINKINKSIV---APLPTV 226 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~----l~~~I~~~~~---~~~p~~ 226 (610)
..........+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+..... +...+..... .+....
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 665555667899999999999999999999999999999999999999997654221 2333332221 222356
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
++.++++||.+||+.||++|||+.|+|+||||..
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 8999999999999999999999999999999964
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=403.16 Aligned_cols=252 Identities=25% Similarity=0.467 Sum_probs=203.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+|++++||||+++++++... ..+|+||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ 127 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-TEISLVL 127 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC-CeEEEEE
Confidence 46999999999999999999999999999999997543 234578899999999999999999988654 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC---CCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~---~g~vKL~DFGlak~~~~~~ 158 (610)
||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++......
T Consensus 128 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999999997644 6899999999999999999999999999999999999976 7899999999998776555
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH-HHHHHHhhccCC---CCCcccchHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVA---PLPTVYSGAFRGL 234 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~-~l~~~I~~~~~~---~~p~~~s~~l~~L 234 (610)
.....+||+.|+|||++.+..++.++|||||||+||+|++|..||...... .++..+...... +....++..+++|
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 285 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL 285 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHH
Confidence 566788999999999999999999999999999999999999999765543 355555443322 2335689999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|.+||+.||++|||+.|+|+||||+.
T Consensus 286 i~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 286 VRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHccCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=405.83 Aligned_cols=255 Identities=25% Similarity=0.464 Sum_probs=219.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec--------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-------- 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-------- 73 (610)
++|++++.||+|+||.||+|.+..+++.||||++...... ..+|+.+|+.++|||||+++++|...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 6899999999999999999999999999999998654322 34799999999999999999988543
Q ss_pred -----------------------------CcEEEEEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007266 74 -----------------------------GCYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHA 122 (610)
Q Consensus 74 -----------------------------~~~~~LVmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs 122 (610)
+.++++||||+. ++|.+.+.. ..+..+++..++.++.||+.||.|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 235889999997 588877764 234579999999999999999999999
Q ss_pred CCeecccCCCCceEec-CCCCeeeeecccccccccccccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcC
Q 007266 123 NHILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQK 200 (610)
Q Consensus 123 ~gIiHRDLKPeNILL~-~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~ 200 (610)
+||+||||||+|||++ .++.+||+|||+++...........+||+.|+|||++.+. .|+.++|||||||++|+|++|.
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 9999999999999998 6789999999999987666667778999999999998765 4899999999999999999999
Q ss_pred ccccccCHHHHHHHHhhccCCC----------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHH
Q 007266 201 AAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 252 (610)
Q Consensus 201 ~PF~~~~~~~l~~~I~~~~~~~----------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~ei 252 (610)
+||.+.+..+.+..+......+ .+..++.++.+||.+||+.||.+|||+.|+
T Consensus 240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9999988887777765432222 244578889999999999999999999999
Q ss_pred hcCCCCCchhh
Q 007266 253 LCHPHLQPYVL 263 (610)
Q Consensus 253 L~Hp~f~~~~~ 263 (610)
|+||||+.+..
T Consensus 320 l~hp~f~~~~~ 330 (383)
T 3eb0_A 320 MAHPFFDHLRN 330 (383)
T ss_dssp HTSGGGHHHHH
T ss_pred hcCHHHHHHHh
Confidence 99999987643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=393.41 Aligned_cols=252 Identities=27% Similarity=0.481 Sum_probs=209.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||+||+|++..+++.||||++...............|+..+.++ .||||++++++|... ..+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-CEEEEE
Confidence 469999999999999999999999999999999876665555555566666666655 899999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 9999 779999888754 36999999999999999999999999999999999999999999999999999887665556
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhcc-CCCCCcccchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~-~~~~p~~~s~~l~~LI~kmL 239 (610)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..+|.+... ...+.... ....+..++.++.+||.+||
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L 289 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMML 289 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHc
Confidence 67789999999999876 789999999999999999999766654332 22222221 11234467899999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCc
Q 007266 240 RKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+.||++|||++|+|+||||+.
T Consensus 290 ~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 290 EPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CSSTTTSCCHHHHHTSGGGSC
T ss_pred CCChhhCcCHHHHHhCccccC
Confidence 999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=424.00 Aligned_cols=257 Identities=23% Similarity=0.459 Sum_probs=230.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+|+.++||||+++++++... ..+|+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-SDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEE
Confidence 368999999999999999999999999999999997543211 2345688999999999999999999987655 47899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|||||.|++|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 94 v~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 999999999999997644 689999999999999999999999999999999999999999999999999988766666
Q ss_pred cccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...++.++..... ..+..++..+.+||.+|
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 250 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLKHM 250 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHHHHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHHHHHHHH
Confidence 677899999999999988776 6899999999999999999999999888888888876543 45677899999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCch
Q 007266 239 LRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
|+.||.+|||++|+++||||+..
T Consensus 251 L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 251 LQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TCSSTTTSCCHHHHHTCHHHHTT
T ss_pred cCCCchhCcCHHHHHhCHHhhhc
Confidence 99999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=381.01 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=216.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|.+..+++.||+|.+............+.+|+.++..+ +||||+++++++...+ .+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~-~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD-HMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-EEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-eEEEE
Confidence 479999999999999999999999999999999987655555667788999999999 8999999999886654 88999
Q ss_pred EeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-----------------
Q 007266 81 IGYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----------------- 141 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g----------------- 141 (610)
|||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999999997642 13689999999999999999999999999999999999998544
Q ss_pred --CeeeeecccccccccccccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhc
Q 007266 142 --DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS 218 (610)
Q Consensus 142 --~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~ 218 (610)
.++|+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++.... ....+...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~ 243 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQG 243 (289)
T ss_dssp CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTT
T ss_pred ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcC
Confidence 7999999999876433 345699999999998765 56689999999999999999998876543 24445555
Q ss_pred cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 219 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 219 ~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.....+..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 566678889999999999999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=431.73 Aligned_cols=261 Identities=27% Similarity=0.458 Sum_probs=228.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+|+.++|||||+++++|... ..+|+|
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lV 262 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLV 262 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-CEEEEE
Confidence 5799999999999999999999999999999999754321 12234578999999999999999999988665 489999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||++||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++........
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence 99999999999998765556999999999999999999999999999999999999999999999999999887655555
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC----HHHHHHHHhhccCCCCCcccchHHHHHHH
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~----~~~l~~~I~~~~~~~~p~~~s~~l~~LI~ 236 (610)
...+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.. ...+...+... ....+..++.++++||.
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~p~~~s~~~~dLI~ 421 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYSERFSPQARSLCS 421 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHH
T ss_pred cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccCCccCCHHHHHHHH
Confidence 66799999999999999999999999999999999999999998753 34455554433 34467789999999999
Q ss_pred HhhcCCCCCCC-----CHHHHhcCCCCCchhhh
Q 007266 237 SMLRKNPEFRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 237 kmL~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
+||+.||.+|| +++|+++||||+...+.
T Consensus 422 ~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 422 QLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp HHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred HhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 99999999999 89999999999986554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=419.53 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=224.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-----------HHHHHHHHHHHHHHhcCCCceeeeeeeE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-----------RARRSAHQEMELISRVRNPFIVEYKDSW 70 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-----------~~~~~l~~Ei~iL~~L~HpnIV~l~~~~ 70 (610)
++|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+|++++|||||+++++|
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 58999999999999999999999999999999997644221 2346788999999999999999999987
Q ss_pred eecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeee
Q 007266 71 VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGD 147 (610)
Q Consensus 71 ~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~D 147 (610)
... ..+|+|||||.||+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus 116 ~~~-~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDK-KYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECS-SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcC-CEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 654 58899999999999999998765 689999999999999999999999999999999999999876 699999
Q ss_pred cccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---C
Q 007266 148 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---P 224 (610)
Q Consensus 148 FGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p 224 (610)
||+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+........ +
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 999988766666677899999999999874 689999999999999999999999999999999888877654322 2
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
..++.++++||++||+.||.+|||++|+|+||||+.+.
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 45799999999999999999999999999999998643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=403.21 Aligned_cols=250 Identities=30% Similarity=0.503 Sum_probs=216.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|.++.+++.||||++...... ..+|+++|.++ +||||++++++|.+. ..+|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDG-KYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcC-CEEEEE
Confidence 4799999999999999999999999999999999755432 34688888887 799999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-C---Ceeeeeccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-Q---DIRLGDFGLAKMLIS 156 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-g---~vKL~DFGlak~~~~ 156 (610)
||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+..+ + .+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp ECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999998754 69999999999999999999999999999999999998543 3 499999999987643
Q ss_pred c-cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccc---cCHHHHHHHHhhccCCC---CCcccch
Q 007266 157 D-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA---FDMQALINKINKSIVAP---LPTVYSG 229 (610)
Q Consensus 157 ~-~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~---~~~~~l~~~I~~~~~~~---~p~~~s~ 229 (610)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+ ....+++..+....... .+..++.
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence 3 345567999999999999988899999999999999999999999985 45667777776544332 2356899
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 230 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 230 ~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
++++||.+||..||++||++.++|+||||..
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 9999999999999999999999999999965
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=399.46 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=218.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||+|+||.||+|++..+++.||+|++..........+.+.+|+.++++++||||+++++++... ..+|+|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-KRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-CEEEEE
Confidence 5799999999999999999999999999999999987766666777889999999999999999999988655 578999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 103 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 99999999988776544 6899999999999999999999999999999999999999999999999999765432 33
Q ss_pred cccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---------------
Q 007266 160 ASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--------------- 223 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--------------- 223 (610)
....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+........
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 4567899999999998775 689999999999999999999999998887666555432211110
Q ss_pred ---------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 224 ---------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 224 ---------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
...++..+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 12468899999999999999999999999999999763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=422.25 Aligned_cols=257 Identities=27% Similarity=0.495 Sum_probs=227.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|++..+++.||||++...... ....+.+.+|+.+|++++|||||+++++|... ..+|+|
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv 104 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-GYFYLV 104 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEE
Confidence 4799999999999999999999999999999999654322 23346688999999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe---cCCCCeeeeecccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL---~~~g~vKL~DFGlak~~~~~ 157 (610)
||||.|++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.....
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999999998754 68999999999999999999999999999999999999 46788999999999887665
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC---CCcccchHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGL 234 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---~p~~~s~~l~~L 234 (610)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+....... .+..++..+++|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 261 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence 55566789999999999876 68999999999999999999999999999988888887664332 234689999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
|.+||+.||.+|||+.|+|+||||+.+.
T Consensus 262 i~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 262 IRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=386.64 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=205.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|++..+++.||+|.+..........+.+.++...++.++||||+++++++...+ ..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-~~~lv~ 85 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-DVWICM 85 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-SEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-CEEEEE
Confidence 6899999999999999999999999999999999866555555556666777788899999999999887654 788999
Q ss_pred eecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
||++| +|.+++.. ..+..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 99974 88887764 2344799999999999999999999998 99999999999999999999999999998776655
Q ss_pred ccccccCCCcccCCccc----cCCCCCCCccccccchhHHhhhhcCcccccc-CHHH-HHHHHhhccCCCCCcccchHHH
Q 007266 159 LASSVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQA-LINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl----~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~-~~~~-l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
......||+.|+|||++ .+..++.++|||||||++|+|++|..||... .... +...+........+..++..+.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (290)
T 3fme_A 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV 244 (290)
T ss_dssp -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHH
T ss_pred cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHH
Confidence 55667899999999996 5667899999999999999999999999853 3333 3333333333334456899999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+||.+||+.||.+|||+.|+|+||||+..
T Consensus 245 ~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 245 DFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 99999999999999999999999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=381.78 Aligned_cols=255 Identities=25% Similarity=0.502 Sum_probs=221.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec---CcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK---GCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~~~ 78 (610)
+.|++.+.||+|+||.||+|.+..++..||+|.+..........+.+.+|+.++++++||||++++++|... +..+|
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 358999999999999999999999999999999987776777778899999999999999999999987653 46789
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEec-CCCCeeeeecccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~-~~g~vKL~DFGlak~~~ 155 (610)
+||||++|++|.+++.... .+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999998764 6899999999999999999999999 99999999999998 78899999999997543
Q ss_pred cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC-HHHHHHHHhhccC-CCCCcccchHHHH
Q 007266 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIV-APLPTVYSGAFRG 233 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~~~~~-~~~p~~~s~~l~~ 233 (610)
. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .......+..... ...+..+++++.+
T Consensus 184 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 261 (290)
T 1t4h_A 184 A-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred c-cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHH
Confidence 3 33456789999999998874 58999999999999999999999998744 4444544444322 2234557789999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
||.+||+.||.+|||++++|+||||+.
T Consensus 262 li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=398.92 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=221.7
Q ss_pred CeEEE-eEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEE
Q 007266 3 QYEVL-EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 3 ~Y~il-k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LV 80 (610)
+|.+. +.||+|+||.||+|.+..+++.||+|++............+.+|+.++..+. ||||++++++|... ..+|+|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-SEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-CeEEEE
Confidence 58887 8999999999999999999999999999866554444567889999999995 69999999987654 578999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC---CCCeeeeecccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~---~g~vKL~DFGlak~~~~~ 157 (610)
|||+.|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999999999987654457999999999999999999999999999999999999998 789999999999887655
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC---CCCCcccchHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGL 234 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~---~~~p~~~s~~l~~L 234 (610)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... ......++..+++|
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 267 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF 267 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHH
Confidence 555677899999999999999999999999999999999999999999988887776655433 23345689999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
|.+||+.||.+|||++++|+||||+..
T Consensus 268 i~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 268 IQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 999999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=406.67 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=206.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-----CcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~ 76 (610)
++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++... ...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 689999999999999999999999999999999987666666677889999999999999999999988643 246
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+ |++|.++++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred EEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 78999999 78999988763 699999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------ 223 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~------------ 223 (610)
.....+||++|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 262 (367)
T 2fst_X 185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 2456789999999999877 6789999999999999999999999999988777776654332211
Q ss_pred ------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 224 ------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 224 ------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
...+++.+.+||.+||..||.+|||++|+|+||||+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 1235778999999999999999999999999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=384.72 Aligned_cols=256 Identities=22% Similarity=0.443 Sum_probs=226.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++.+.||+|+||.||++.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++... ...|+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-KRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-CEEEE
Confidence 478999999999999999999999999999999996543211 1235688999999999999999999987654 58899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus 92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred EEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence 999999999999998765 6899999999999999999999999999999999999999999999999998765432 3
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ...+..++..+++||.+||
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 247 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKLL 247 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHS
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHHh
Confidence 456789999999999999999999999999999999999999999988877777765543 3466778999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCch
Q 007266 240 RKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+.||.+||+++++++||||+..
T Consensus 248 ~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 248 RYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHH
T ss_pred hcCHhhCCCHHHHhhCHHHHhh
Confidence 9999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=382.56 Aligned_cols=257 Identities=23% Similarity=0.446 Sum_probs=218.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++.+.||+|+||.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++.+... ...|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CeEEE
Confidence 36899999999999999999999999999999999654321 12345688999999999999999999987654 57899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999999999998765 689999999999999999999999999999999999999999999999999988765555
Q ss_pred cccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......+...+..... ..+..++..+.+||.+|
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~ 245 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YIPEYLNRSVATLLMHM 245 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHH
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-cCchhcCHHHHHHHHHH
Confidence 566789999999999988776 6899999999999999999999999888888877765543 45677899999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCch
Q 007266 239 LRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
|+.||.+|||+.++++||||+..
T Consensus 246 l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 246 LQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp TCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccCChhhCCCHHHHHhChhhccC
Confidence 99999999999999999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=398.44 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=220.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~ 77 (610)
++|++++.||+|+||.||+|.+..++..||||++... ......+.+.+|+++|++++||||+++++++.... ..+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4899999999999999999999999999999999743 34445567889999999999999999999886543 468
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|+||||+. ++|.++++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99999996 5999999764 5899999999999999999999999999999999999999999999999999876433
Q ss_pred c----ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---------
Q 007266 158 D----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--------- 223 (610)
Q Consensus 158 ~----~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--------- 223 (610)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2 2345689999999998654 5589999999999999999999999998876666666543322211
Q ss_pred ---------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 224 ---------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 224 ---------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
...++.++.+||.+||+.||.+|||++|+|+||||+.+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 13467899999999999999999999999999999986543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=399.03 Aligned_cols=261 Identities=24% Similarity=0.447 Sum_probs=218.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc---cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ---TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~---~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++++.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.++++++||||+++++++... ...|
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-QYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-CeEE
Confidence 479999999999999999999999999999999975431 233456789999999999999999999988654 5889
Q ss_pred EEEeecCCCCHHHHHHHh--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 007266 79 IIIGYCEGGDMAEAIKKA--------------------------------------NGVHFPEEKLCKWLVQLLMALNYL 120 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~--------------------------------------~~~~lse~~i~~i~~QLl~aL~yL 120 (610)
+|||||+|++|.+++... ....+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999988421 011246888999999999999999
Q ss_pred HHCCeecccCCCCceEecCCC--Ceeeeeccccccccccc-----ccccccCCCcccCCccccC--CCCCCCccccccch
Q 007266 121 HANHILHRDVKCSNIFLTRDQ--DIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGC 191 (610)
Q Consensus 121 Hs~gIiHRDLKPeNILL~~~g--~vKL~DFGlak~~~~~~-----~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~ 191 (610)
|++||+||||||+||||+.++ .+||+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 89999999998653321 2346789999999999875 67899999999999
Q ss_pred hHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 192 CVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 192 iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
+||+|++|..||.+....+....+........ ...++..+++||.+||+.||.+||++.++|+||||+.+..
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 99999999999999888887777765443322 2247899999999999999999999999999999987543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=384.77 Aligned_cols=257 Identities=28% Similarity=0.536 Sum_probs=198.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++.+.||+|+||.||++.+..+++.||+|.+....... ...+.+.+|+.++++++||||+++++++... ...|+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-NYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-SEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-CeEEE
Confidence 478999999999999999999999999999999996433211 1235688999999999999999999987654 58899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-c
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-D 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~ 158 (610)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999998642 36899999999999999999999999999999999999999999999999999875432 2
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+... ....+..++.++.+||.+|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHHHHHH
Confidence 234568999999999999989999999999999999999999999877655555444322 2335667899999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|+.||.+||+++++|+||||+.
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC-
T ss_pred cccCHhhCCCHHHHhcCccccC
Confidence 9999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=390.57 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=223.1
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
.|+..+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.++++++||||+++++.|...+ ..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-ELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECC-EEEEEEe
Confidence 388899999999999999999999999999999755433 2356889999999999999999999887654 7899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-ccc
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LAS 161 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~~ 161 (610)
|++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 123 ~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred cCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 99999999988653 68999999999999999999999999999999999999999999999999998764432 345
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC--CCcccchHHHHHHHHhh
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSML 239 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--~p~~~s~~l~~LI~kmL 239 (610)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....... .+..++..+.+||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 6789999999999999999999999999999999999999999988887777776554332 23467899999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCc
Q 007266 240 RKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+.||.+|||+.|+|+||||..
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGG
T ss_pred cCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=383.45 Aligned_cols=258 Identities=26% Similarity=0.462 Sum_probs=222.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH----HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~----~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||++++..+++.||+|.+....... ...+.+.+|+.++++++||||+++++.+... ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-TDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-CeE
Confidence 47999999999999999999999999999999997544321 1345688999999999999999999987654 478
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC----Ceeeeecccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKM 153 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g----~vKL~DFGlak~ 153 (610)
++||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999998754 689999999999999999999999999999999999999877 799999999987
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchH
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGA 230 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~ 230 (610)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+........ +..++..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 6555555667899999999999999999999999999999999999999999988887777755433221 2457889
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+.+||.+||..||.+||++.++|+||||+...
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99999999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=422.03 Aligned_cols=261 Identities=27% Similarity=0.483 Sum_probs=227.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH-HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|+++.+|+.||||++....... .....+.+|+.+|++++||||++++++|... ..+|+|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-TDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-CEEEEE
Confidence 68999999999999999999999999999999997543221 2235678999999999999999999987655 578999
Q ss_pred EeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
|||++||+|.+++.... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99999999999997643 3469999999999999999999999999999999999999999999999999998765443
Q ss_pred -ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc----CHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 -LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF----DMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 -~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~----~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
.....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+. ....+...+.... ...|..++..+++
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 422 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYPDKFSPASKD 422 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-CCCCTTSCHHHHH
T ss_pred cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-cCCCcccCHHHHH
Confidence 344569999999999999999999999999999999999999999875 3456666665443 3467789999999
Q ss_pred HHHHhhcCCCCCCCC-----HHHHhcCCCCCchhhh
Q 007266 234 LVKSMLRKNPEFRPS-----AAELLCHPHLQPYVLG 264 (610)
Q Consensus 234 LI~kmL~~dP~~RpS-----a~eiL~Hp~f~~~~~~ 264 (610)
||.+||+.||.+||+ ++++++||||+...+.
T Consensus 423 li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp HHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred HHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 999999999999995 5999999999986554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=389.85 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=210.0
Q ss_pred CCeEEE-eEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVL-EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~il-k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~L 79 (610)
++|+++ +.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+|.++ +||||+++++++... ..+|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEE
Confidence 579996 7899999999999999999999999999755332 245688999999985 799999999988765 48899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC---eeeeeccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLIS 156 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~---vKL~DFGlak~~~~ 156 (610)
||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999998765 6899999999999999999999999999999999999998776 99999999876532
Q ss_pred cc--------ccccccCCCcccCCccccC-----CCCCCCccccccchhHHhhhhcCccccccC---------------H
Q 007266 157 DD--------LASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---------------M 208 (610)
Q Consensus 157 ~~--------~~~~~vGTp~Y~APEvl~~-----~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---------------~ 208 (610)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 21 2234579999999999875 558899999999999999999999997653 2
Q ss_pred HHHHHHHhhccCCCCC----cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 209 QALINKINKSIVAPLP----TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 209 ~~l~~~I~~~~~~~~p----~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
..+...+...... .+ ..++..+++||.+||+.||.+|||++|+|+||||+..
T Consensus 247 ~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 247 NMLFESIQEGKYE-FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHCCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHhccCcc-cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 3445555444332 22 3578899999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=396.43 Aligned_cols=255 Identities=24% Similarity=0.462 Sum_probs=224.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc------cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecC
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ------TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKG 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~------~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~ 74 (610)
++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++++ +||||++++++|...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS- 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-
Confidence 469999999999999999999998999999999976542 123356788999999999 799999999987654
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
...|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++...
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 58899999999999999998754 6899999999999999999999999999999999999999999999999999887
Q ss_pred ccccccccccCCCcccCCccccC------CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---Cc
Q 007266 155 ISDDLASSVVGTPSYMCPELLAD------IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PT 225 (610)
Q Consensus 155 ~~~~~~~~~vGTp~Y~APEvl~~------~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~ 225 (610)
.........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||...+.......+........ +.
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 66666667899999999998853 3588999999999999999999999999888887777765543322 23
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
.++..+.+||.+||+.||++||+++++|+||||+
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 5788999999999999999999999999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=408.01 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=214.4
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-----CcEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~~ 77 (610)
+|++++.||+|+||.||+|++..+++.||||++..... ...+|+++|+.++|||||+++++|... ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 69999999999999999999999999999999864332 234799999999999999999988643 2357
Q ss_pred EEEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-CCeeeeeccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKML 154 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-g~vKL~DFGlak~~ 154 (610)
++||||+.+ +|.+.+.. .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++..
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 899999975 67766653 234579999999999999999999999999999999999999965 56899999999887
Q ss_pred ccccccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-----------
Q 007266 155 ISDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------- 222 (610)
Q Consensus 155 ~~~~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----------- 222 (610)
.........+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+.+..+.+..+......+
T Consensus 208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 666666678999999999998764 78999999999999999999999999988777666654422111
Q ss_pred -----------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 -----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 -----------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
++..++.++++||.+||..||.+||++.|+|+||||+.+.
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1234678999999999999999999999999999998653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=385.54 Aligned_cols=253 Identities=27% Similarity=0.493 Sum_probs=221.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|++..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++... ..+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYEST-THYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccC-CEEEEEE
Confidence 479999999999999999999999999999999975432 2235688999999999999999999987654 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe---cCCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL---~~~g~vKL~DFGlak~~~~~~ 158 (610)
||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..... .
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-G 162 (304)
T ss_dssp CCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-B
T ss_pred EcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-C
Confidence 9999999999998765 68999999999999999999999999999999999999 6788999999999876433 2
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC---CCCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~---~~p~~~s~~l~~LI 235 (610)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......+...+...... +.+..++..+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 344567999999999999999999999999999999999999999999888888887665432 33456899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+||..||.+||+++|+|+||||+.
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHcCCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=404.77 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=219.1
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeec
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~ 84 (610)
...+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+|++++|||||++++++... ..+|+||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESK-NDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCC
Confidence 336789999999999999999999999999975432 3456789999999999999999999987665 4789999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe--cCCCCeeeeeccccccccccccccc
Q 007266 85 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL--TRDQDIRLGDFGLAKMLISDDLASS 162 (610)
Q Consensus 85 ~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL--~~~g~vKL~DFGlak~~~~~~~~~~ 162 (610)
+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..........
T Consensus 169 ~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 169 DGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp TTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999999887643 358999999999999999999999999999999999999 5667899999999988766666667
Q ss_pred ccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchHHHHHHHHhh
Q 007266 163 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSML 239 (610)
Q Consensus 163 ~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~l~~LI~kmL 239 (610)
.+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.+..+.+..+........ ...++.++++||.+||
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L 327 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLL 327 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTS
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHc
Confidence 7899999999999999999999999999999999999999999998888887766543222 2457899999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCchhh
Q 007266 240 RKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
+.||.+||++.|+|+||||+....
T Consensus 328 ~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 328 IKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp CSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred CCChhhCCCHHHHhcCcCcCCCch
Confidence 999999999999999999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=392.45 Aligned_cols=255 Identities=24% Similarity=0.493 Sum_probs=228.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 119 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFVV 119 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEE
Confidence 57999999999999999999999999999999997554 2345567789999999999999999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
|||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 99999999999998764 6899999999999999999999999999999999999999999999999999876432 33
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.+..+.... ...+..++..+.+||.+||
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKML 276 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHc
Confidence 456789999999999999999999999999999999999999999988877777665543 3466788999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCc
Q 007266 240 RKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+.||++||+++|+|+||||..
T Consensus 277 ~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 277 QTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp CSSGGGSCCGGGGGGSHHHHT
T ss_pred cCChhHCcCHHHHhcCccccC
Confidence 999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=383.11 Aligned_cols=255 Identities=24% Similarity=0.493 Sum_probs=227.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++... ...|+|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 93 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFVV 93 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-CEEEEE
Confidence 579999999999999999999999999999999976542 345567789999999999999999999987654 578999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 99999999999998765 6899999999999999999999999999999999999999999999999999875432 23
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.... ...+..++..+.+||.+||
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKML 250 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHHHHc
Confidence 455789999999999999889999999999999999999999999988877777765543 3467788999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCc
Q 007266 240 RKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+.||++||+++|+|+||||..
T Consensus 251 ~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 251 QTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp CSSGGGSCCGGGGGGSHHHHT
T ss_pred ccChhhCcCHHHHhhChheec
Confidence 999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=388.04 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=221.5
Q ss_pred CCeEEEeEecccCceEEEEEEEe-CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc---CCCceeeeeeeEee----c
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-HERKKYVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVE----K 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIV~l~~~~~~----~ 73 (610)
++|++++.||+|+||.||+|++. .+++.||+|++............+.+|+.+++.+ .||||+++++++.. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 58999999999999999999995 6789999999975543322223455677777666 89999999998762 4
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
...+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 457899999997 5999999886655699999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC------------
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA------------ 221 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~------------ 221 (610)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (326)
T 1blx_A 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249 (326)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred ccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence 66555556778999999999999999999999999999999999999999998887777666542211
Q ss_pred --------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 222 --------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 222 --------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.....++..+++||.+||..||.+||++.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred chhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 1224578899999999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=405.33 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=217.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc------CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV------RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L------~HpnIV~l~~~~~~~~~ 75 (610)
.+|++++.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.+ +|+||+.+++.+... .
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-N 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-T
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-C
Confidence 5799999999999999999999999999999999743 33445677888888877 577999999987765 4
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC--eeeeecccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKM 153 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~--vKL~DFGlak~ 153 (610)
.+|+||||+. ++|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||+++.
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 8899999995 69999998876566999999999999999999999999999999999999999987 99999999976
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC----------
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---------- 223 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---------- 223 (610)
... .....+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..+.+..+......+.
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~ 329 (429)
T 3kvw_A 252 EHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329 (429)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred cCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence 432 34567999999999999999999999999999999999999999999988777766654322111
Q ss_pred ------------------------------------------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 224 ------------------------------------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 224 ------------------------------------------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+...++.+.+||.+||+.||.+|||++|+|+|
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 11236789999999999999999999999999
Q ss_pred CCCCchh
Q 007266 256 PHLQPYV 262 (610)
Q Consensus 256 p~f~~~~ 262 (610)
|||+...
T Consensus 410 pw~~~~~ 416 (429)
T 3kvw_A 410 PWLRRRL 416 (429)
T ss_dssp TTTC---
T ss_pred hhhccCC
Confidence 9998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=385.97 Aligned_cols=259 Identities=24% Similarity=0.440 Sum_probs=223.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc--HHHHHHHHHHHHHHHhcCCCceeeeeeeEee-cCcEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT--DRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYV 77 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~--~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~-~~~~~ 77 (610)
+++|++++.||+|+||.||++.+..++..||+|++...... ......+.+|+.++++++||||+++++++.. .+...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999999999999999999754321 2345678999999999999999999998753 34578
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|+||||+.++ |.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 888887765667999999999999999999999999999999999999999999999999999875422
Q ss_pred ---cccccccCCCcccCCccccCCCC--CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHH
Q 007266 158 ---DLASSVVGTPSYMCPELLADIPY--GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 158 ---~~~~~~vGTp~Y~APEvl~~~~y--t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
.......||+.|+|||++.+... +.++|||||||++|+|++|..||.+.+...+...+..... ..+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~l~ 241 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-AIPGDCGPPLS 241 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CCCSSSCHHHH
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-CCCCccCHHHH
Confidence 23345679999999999886543 7799999999999999999999999998888887766543 46777899999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+||.+||..||.+||+++|+++||||+..
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=388.78 Aligned_cols=251 Identities=23% Similarity=0.412 Sum_probs=213.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeec-CcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEK-GCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~-~~~~~L 79 (610)
++|++++.||+|+||.||+|++..+++.||||++.... .+.+.+|+.+|+++. ||||+++++.+... ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 58999999999999999999999999999999987432 245889999999997 99999999988763 457889
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeeccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDD 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~~~~~~ 158 (610)
||||+.+++|.++++ .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++......
T Consensus 111 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999999999999884 378999999999999999999999999999999999999777 79999999998776666
Q ss_pred ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccc-cCHHHHHHHHhh-------------cc----
Q 007266 159 LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKA-FDMQALINKINK-------------SI---- 219 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~-~~~~~l~~~I~~-------------~~---- 219 (610)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+.+..+.. ..
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 6677899999999999877 6789999999999999999999999843 232222222211 10
Q ss_pred -------------------CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 220 -------------------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 220 -------------------~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
....+..++.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1112233789999999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=395.15 Aligned_cols=251 Identities=25% Similarity=0.449 Sum_probs=197.4
Q ss_pred CCeEEE---eEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEE
Q 007266 2 EQYEVL---EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~il---k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~ 77 (610)
++|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++... ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-LHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-CEE
Confidence 468876 7899999999999999999999999999643 2345678999999997 99999999987655 578
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeeeccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKML 154 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~DFGlak~~ 154 (610)
|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999998754 699999999999999999999999999999999999998766 7999999999865
Q ss_pred ccc-cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC-------HHHHHHHHhhccCCCCC--
Q 007266 155 ISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------MQALINKINKSIVAPLP-- 224 (610)
Q Consensus 155 ~~~-~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-------~~~l~~~I~~~~~~~~p-- 224 (610)
... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+ ..+++..+.........
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 433 23456789999999999999999999999999999999999999998644 34566666554433222
Q ss_pred -cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 225 -TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 225 -~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
..+++++++||.+||..||.+|||++|+|+||||+.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 347999999999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=395.04 Aligned_cols=253 Identities=26% Similarity=0.467 Sum_probs=211.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC--CceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN--PFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H--pnIV~l~~~~~~~~~~~~L 79 (610)
++|++++.||+|+||.||++.+. +++.||||++..........+.+.+|+.+|+++.| +||+++++++... ..+|+
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~l 86 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYM 86 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-CEEEE
Confidence 57999999999999999999884 68899999998777777777889999999999986 9999999987654 58899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
|||| .+++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++......
T Consensus 87 v~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 9995 5889999998754 689999999999999999999999999999999999997 6789999999998764332
Q ss_pred --ccccccCCCcccCCccccC-----------CCCCCCccccccchhHHhhhhcCccccccC-HHHHHHH-HhhccCCCC
Q 007266 159 --LASSVVGTPSYMCPELLAD-----------IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINK-INKSIVAPL 223 (610)
Q Consensus 159 --~~~~~vGTp~Y~APEvl~~-----------~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~-I~~~~~~~~ 223 (610)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.... ....+.. +........
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence 2346789999999999864 678899999999999999999999998643 2223333 333344456
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+...+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 243 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 7778889999999999999999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=399.04 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=217.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH------HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD------RARRSAHQEMELISRVRNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~------~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|++..+++.||||.+....... .....+.+|+.+|++++||||++++++|... .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-~ 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-G 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-S
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-C
Confidence 47999999999999999999999999999999997654221 1233467899999999999999999987654 5
Q ss_pred EEEEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 76 YVCIIIGYCEGG-DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 76 ~~~LVmEy~~Gg-sL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
.+++||||+.+| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 889999999766 9999998754 6899999999999999999999999999999999999999999999999999887
Q ss_pred ccccccccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 155 ISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 155 ~~~~~~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .. ......+..++.++.+
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~-~~~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV-EAAIHPPYLVSKELMS 253 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT-TTCCCCSSCCCHHHHH
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH-hhccCCCcccCHHHHH
Confidence 66666667889999999999988876 7899999999999999999999976431 11 1223346668999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
||.+||+.||.+|||++++|+||||+..
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=394.18 Aligned_cols=256 Identities=31% Similarity=0.501 Sum_probs=219.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..++..||+|++.... .....+.+.+|+.++++++||||+++++++... ..+|+||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 110 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM 110 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEE
Confidence 58999999999999999999999999999999997553 445567789999999999999999999988765 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
||++|++|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+||||+.++.++|+|||++...... ..
T Consensus 111 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 187 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 187 (360)
T ss_dssp CCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C-
T ss_pred ECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 9999999999998765 689999999999999999999996 9999999999999999999999999999765332 34
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHH---------------------------
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALIN--------------------------- 213 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~--------------------------- 213 (610)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+...+..
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 56789999999999999999999999999999999999999998766544322
Q ss_pred ---------------HHhhccCCCC-CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 214 ---------------KINKSIVAPL-PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 214 ---------------~I~~~~~~~~-p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.+........ ...++.++++||.+||+.||.+|||++|+|+||||+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 2222222222 234788999999999999999999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=395.42 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=211.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC--------CCceeeeeeeEee-
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR--------NPFIVEYKDSWVE- 72 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~--------HpnIV~l~~~~~~- 72 (610)
++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+|+.+. |+||+++++.|..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 6899999999999999999999999999999999743 344567889999999885 7889999998873
Q ss_pred --cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCC--------
Q 007266 73 --KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQ-------- 141 (610)
Q Consensus 73 --~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g-------- 141 (610)
.+..+|+||||+ +++|.+.+.......+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 345889999999 67777777765545799999999999999999999999 999999999999999776
Q ss_pred -----------------------------------------CeeeeecccccccccccccccccCCCcccCCccccCCCC
Q 007266 142 -----------------------------------------DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180 (610)
Q Consensus 142 -----------------------------------------~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~y 180 (610)
.+||+|||+++..... ....+||+.|+|||++.+..|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCC
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCC
Confidence 7999999999876432 456789999999999999999
Q ss_pred CCCccccccchhHHhhhhcCccccccC------HHHHHHHHhhccCC---------------------------------
Q 007266 181 GSKSDIWSLGCCVYEMSAQKAAFKAFD------MQALINKINKSIVA--------------------------------- 221 (610)
Q Consensus 181 t~ksDIWSLG~iLyeLltG~~PF~~~~------~~~l~~~I~~~~~~--------------------------------- 221 (610)
+.++|||||||+||+|++|..||...+ ....+..+......
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 999999999999999999999997544 22222222211110
Q ss_pred --------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 222 --------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 222 --------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
..+...+..+.+||.+||+.||.+|||++|+|+||||+
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 12334567899999999999999999999999999996
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=377.73 Aligned_cols=256 Identities=21% Similarity=0.392 Sum_probs=218.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++... ...|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-CEEEEEE
Confidence 5899999999999999999999999999999999754433 3446788999999999999999999987654 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---D 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~---~ 158 (610)
||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp ECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999886543 6899999999999999999999999999999999999999999999999999765332 2
Q ss_pred ccccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHH-HHHHHHhh-ccCCCCCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINK-SIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~-~l~~~I~~-~~~~~~p~~~s~~l~~LI 235 (610)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..+..+.. ....+....++..+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 3456789999999999987765 77899999999999999999999875532 22222222 222233456899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||..||.+|||++|+++||||+..
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccCh
Confidence 99999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=387.97 Aligned_cols=254 Identities=21% Similarity=0.363 Sum_probs=214.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~~~LV 80 (610)
++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+++|++++||||+++++++...+ ...|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4799999999999999999999999999999999754322 22455789999999999999999999887654 378999
Q ss_pred EeecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe----cCCCCeeeeecccccccc
Q 007266 81 IGYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~-~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL----~~~g~vKL~DFGlak~~~ 155 (610)
|||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999999999986432 238999999999999999999999999999999999999 777789999999998876
Q ss_pred cccccccccCCCcccCCcccc--------CCCCCCCccccccchhHHhhhhcCccccccC----HHHHHHHHhhccCC--
Q 007266 156 SDDLASSVVGTPSYMCPELLA--------DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVA-- 221 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~--------~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~----~~~l~~~I~~~~~~-- 221 (610)
........+||+.|+|||++. +..++.++|||||||++|+|++|..||.... ..+++..+......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 666666788999999999886 5778999999999999999999999997432 33444444332211
Q ss_pred ----------------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 007266 222 ----------------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256 (610)
Q Consensus 222 ----------------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp 256 (610)
.++..++..+.+||.+||+.||++|||++|+|+||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 12334667899999999999999999999999995
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=394.83 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=213.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH---HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD---RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~---~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++++.||+|+||.||+|.+..+|+.||||.+....... ...+.+.+|+.+++.++||||++++++|... ...+
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 88 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SNIS 88 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TCCE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-CceE
Confidence 68999999999999999999999999999999997543322 1234678999999999999999999988654 4788
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD- 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~- 157 (610)
+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 99999976 898888764 346899999999999999999999999999999999999999999999999999876433
Q ss_pred cccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC-------------
Q 007266 158 DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------- 223 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~------------- 223 (610)
......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence 234567899999999998754 588999999999999999999999999988877777654322211
Q ss_pred --------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 224 --------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 224 --------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
...++..+++||.+||..||.+|||++|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 1345789999999999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=381.89 Aligned_cols=253 Identities=24% Similarity=0.423 Sum_probs=215.9
Q ss_pred CCeEEEeEecccCceEEEEEEE-eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC------ceeeeeeeEeecC
Q 007266 2 EQYEVLEQIGKGSFGSALLVRH-KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP------FIVEYKDSWVEKG 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d-~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp------nIV~l~~~~~~~~ 74 (610)
++|++++.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.++|+ +++++++.+...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~- 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH- 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-
Confidence 6899999999999999999999 568899999998643 34456788999999988765 489999987655
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC---------------
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR--------------- 139 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~--------------- 139 (610)
..+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 4889999999 899999998876667999999999999999999999999999999999999987
Q ss_pred ----CCCeeeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHH
Q 007266 140 ----DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 215 (610)
Q Consensus 140 ----~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I 215 (610)
++.+||+|||+++... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp EEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred ccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 6679999999997643 2345678999999999999999999999999999999999999999988876655544
Q ss_pred hhccCCC-------------------------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHH
Q 007266 216 NKSIVAP-------------------------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 252 (610)
Q Consensus 216 ~~~~~~~-------------------------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~ei 252 (610)
....... .+...+..+.+||.+||+.||.+|||++|+
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 3322110 122346789999999999999999999999
Q ss_pred hcCCCCCch
Q 007266 253 LCHPHLQPY 261 (610)
Q Consensus 253 L~Hp~f~~~ 261 (610)
|+||||+..
T Consensus 327 l~hp~f~~~ 335 (339)
T 1z57_A 327 LKHPFFDLL 335 (339)
T ss_dssp TTSGGGGGG
T ss_pred hcCHHHHHH
Confidence 999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=391.43 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=217.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC---cEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~---~~~ 77 (610)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.++++++||||+++++++...+ ...
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 689999999999999999999999999999999976543 3445667899999999999999999999877543 246
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 89999999999999998765 6899999999999999999999999999999999999999999999999999875433
Q ss_pred c----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchH
Q 007266 158 D----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGA 230 (610)
Q Consensus 158 ~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~ 230 (610)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+. ...++..
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence 2 23346799999999999999999999999999999999999999999887776665554433221 2348899
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+.+||.+||+.||.+||++.++|.|+|++.
T Consensus 250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 250 LDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 999999999999999999999999998864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=395.74 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=218.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc-----E
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-----Y 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~-----~ 76 (610)
++|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++...+. .
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 58999999999999999999999999999999998776677777889999999999999999999998876543 2
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 122 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 489999996 688877733 589999999999999999999999999999999999999999999999999986533
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------- 222 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------- 222 (610)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 4exu_A 197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence 3456789999999999887 778999999999999999999999999988777766664422211
Q ss_pred -----------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 -----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 -----------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.+..++..+.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 1224688999999999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=389.25 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=213.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc---------cHHHHHHHHHHHHHHHhcCCCceeeeeeeEee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ---------TDRARRSAHQEMELISRVRNPFIVEYKDSWVE 72 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~---------~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~ 72 (610)
++|++++.||+|+||.||++.+.. +..||||++..... .....+.+.+|+.++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 689999999999999999999865 89999999865332 23345778999999999999999999998864
Q ss_pred c----CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeec
Q 007266 73 K----GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 73 ~----~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
. ...+|+||||+. ++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3 347899999997 6888888754 346899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-----
Q 007266 149 GLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----- 222 (610)
Q Consensus 149 Glak~~~~~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----- 222 (610)
|+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258 (362)
T ss_dssp TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence 99987665555667789999999999877 678999999999999999999999999988777776664422211
Q ss_pred --------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhhhcc
Q 007266 223 --------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHL 267 (610)
Q Consensus 223 --------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~~~~ 267 (610)
.+..+++.+.+||.+||+.||.+|||+.|+|+||||+........
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 329 (362)
T 3pg1_A 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL 329 (362)
T ss_dssp HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGG
T ss_pred hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccc
Confidence 122457889999999999999999999999999999987655444
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=408.58 Aligned_cols=257 Identities=27% Similarity=0.472 Sum_probs=207.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc------HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT------DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~------~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|++++||||+++++++. . .
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~-~ 212 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A-E 212 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S-S
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-C
Confidence 6899999999999999999999999999999999754321 122235789999999999999999999764 3 3
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeeeccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAK 152 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~DFGlak 152 (610)
.+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 5789999999999999887543 689999999999999999999999999999999999997655 49999999999
Q ss_pred ccccccccccccCCCcccCCccccC---CCCCCCccccccchhHHhhhhcCccccccCHH-HHHHHHhhccCCCCC---c
Q 007266 153 MLISDDLASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPLP---T 225 (610)
Q Consensus 153 ~~~~~~~~~~~vGTp~Y~APEvl~~---~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~-~l~~~I~~~~~~~~p---~ 225 (610)
...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||...... .+...+........+ .
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 370 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence 8766666677899999999999864 56788999999999999999999999765422 233344433333222 3
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.++..+.+||.+||+.||.+||+++|+|+||||+...
T Consensus 371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 5789999999999999999999999999999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=399.38 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=212.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 76 (610)
.+|++++.||+|+||.||+|++..++. +|+|++...... ..+|+.+|+.++||||++++++|...+ .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 379999999999999999999987766 788877543321 236999999999999999999886543 35
Q ss_pred EEEEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec-CCCCeeeeecccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKM 153 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~-~~g~vKL~DFGlak~ 153 (610)
+|+||||+.++ +...+.. .....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 113 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 113 LNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 88999999764 4443332 2234799999999999999999999999999999999999999 789999999999988
Q ss_pred cccccccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----------
Q 007266 154 LISDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------- 222 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---------- 222 (610)
..........+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||.+.+..+.+..+......+
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 7666667778999999999998764 58999999999999999999999999988777766665432221
Q ss_pred ------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 223 ------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 223 ------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
.+..+++++.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 12247789999999999999999999999999999987643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=384.45 Aligned_cols=256 Identities=26% Similarity=0.501 Sum_probs=215.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec-----Cc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK-----GC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~-----~~ 75 (610)
++|++++.||+|+||.||+|++..+++.||||++...... .+.+.+|+.+++++ +||||+++++.+... +.
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 6899999999999999999999999999999999754433 24578999999999 799999999998764 45
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+|+||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 78999999999999999987654579999999999999999999999999999999999999999999999999987754
Q ss_pred cc-cccccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC-CCCcccc
Q 007266 156 SD-DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYS 228 (610)
Q Consensus 156 ~~-~~~~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-~~p~~~s 228 (610)
.. ......+||+.|+|||++. +..++.++|||||||++|+|++|..||...........+...... ..+..++
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSC
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccC
Confidence 32 2344568999999999987 567899999999999999999999999988877666665544332 2345689
Q ss_pred hHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 229 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 229 ~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
..+.+||.+||..||.+||+++++|+||||+.
T Consensus 261 ~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 99999999999999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=381.14 Aligned_cols=254 Identities=31% Similarity=0.565 Sum_probs=228.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||||.+...... ...+.+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEE
Confidence 4799999999999999999999999999999999755433 2346688999999999999999999988765 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ..
T Consensus 100 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp ECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 999999999998652 68999999999999999999999999999999999999999999999999997764433 34
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+........+..++..+.+||.+||.
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 256 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 256 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcC
Confidence 56789999999999999999999999999999999999999999988888777777666666777899999999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCc
Q 007266 241 KNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 241 ~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.||.+|||+.++|+||||..
T Consensus 257 ~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 257 KEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp SSGGGSCCHHHHTTCHHHHH
T ss_pred CChhhCcCHHHHhhChhhhc
Confidence 99999999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=400.68 Aligned_cols=252 Identities=27% Similarity=0.478 Sum_probs=212.7
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC--CCceeeeeeeEeecCcEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR--NPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~--HpnIV~l~~~~~~~~~~~~LV 80 (610)
+|++++.||+|+||.||++.+.. ++.||||++..........+.+.+|+.+|+++. |||||++++++...+ .+|+|
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-~~~lv 134 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMV 134 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-EEEEE
Confidence 59999999999999999999865 889999999877666677788999999999996 599999999877654 79999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++......
T Consensus 135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 99 55889999998754 689999999999999999999999999999999999995 6899999999998764332
Q ss_pred -ccccccCCCcccCCccccC-----------CCCCCCccccccchhHHhhhhcCccccccC-HHHHHHHHhh-ccCCCCC
Q 007266 159 -LASSVVGTPSYMCPELLAD-----------IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINK-SIVAPLP 224 (610)
Q Consensus 159 -~~~~~vGTp~Y~APEvl~~-----------~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~~-~~~~~~p 224 (610)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.... ....+..+.. ......+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 2356789999999999865 368889999999999999999999998653 3333333332 3334456
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
...+..+.+||.+||+.||.+||++.|+|+||||+.
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 677889999999999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=380.28 Aligned_cols=257 Identities=32% Similarity=0.565 Sum_probs=218.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++... ...|+||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGAYYHD-GKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C--CHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH--HHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-CeEEEEE
Confidence 5799999999999999999999999999999998754322 345688999999999999999999988765 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 96 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp ECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred EeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 9999999999987643 36899999999999999999999999999999999999999999999999987653222 223
Q ss_pred ccccCCCcccCCccc-----cCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--CCCcccchHHHH
Q 007266 161 SSVVGTPSYMCPELL-----ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl-----~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~--~~p~~~s~~l~~ 233 (610)
...+||+.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+...... ..+..++..+.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 254 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence 456899999999988 4677899999999999999999999999998887777666554433 235678999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
||.+||..||.+|||+.++++||||+...
T Consensus 255 li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 255 FLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 99999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=380.11 Aligned_cols=256 Identities=27% Similarity=0.514 Sum_probs=225.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++.+... ..+|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-CeEEEEE
Confidence 479999999999999999999999999999999976655444556788999999999999999999987654 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC---CCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~---g~vKL~DFGlak~~~~~~ 158 (610)
||+.|++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 101 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999999999988765 68999999999999999999999999999999999999764 469999999998766555
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-C--CcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-L--PTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~-~--p~~~s~~l~~LI 235 (610)
......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+...+...+....... . ...++.++.+||
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 257 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHH
T ss_pred ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHH
Confidence 55566799999999998764 8899999999999999999999999998888877776554322 2 245789999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||..||.+|||+.|+|+||||+.+
T Consensus 258 ~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 258 RKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=394.78 Aligned_cols=260 Identities=27% Similarity=0.506 Sum_probs=217.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEe---CCCeEEEEEEEccccc--cHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecC
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQ--TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKG 74 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~--~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~ 74 (610)
+++|++++.||+|+||.||++++. .+++.||||++..... .....+.+.+|+.+|+++ +||||+++++.+...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 368999999999999999999995 4889999999875432 112234467899999999 699999999987665
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
..+|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 47899999999999999998765 6899999999999999999999999999999999999999999999999999865
Q ss_pred ccc--cccccccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCcccccc----CHHHHHHHHhhccCCCCCcc
Q 007266 155 ISD--DLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAF----DMQALINKINKSIVAPLPTV 226 (610)
Q Consensus 155 ~~~--~~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF~~~----~~~~l~~~I~~~~~~~~p~~ 226 (610)
... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||... ....+...+... ..+.+..
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 288 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQE 288 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCCCCTT
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCCCCcc
Confidence 332 23445789999999999985 34789999999999999999999999743 234444444333 3456778
Q ss_pred cchHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCchhhh
Q 007266 227 YSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
++..+.+||.+||..||.+|| +++|+++||||+...+.
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 899999999999999999999 99999999999976543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=391.75 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=207.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC------
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG------ 74 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~------ 74 (610)
+++|++++.||+|+||.||+|++..+++.||||++...... .....+|+..+..++||||++++++|...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 47899999999999999999999999999999988644322 224567888889999999999999987543
Q ss_pred cEEEEEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCCCceEecC-CCCeeeeecc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLH--ANHILHRDVKCSNIFLTR-DQDIRLGDFG 149 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~--~~~~~lse~~i~~i~~QLl~aL~yLH--s~gIiHRDLKPeNILL~~-~g~vKL~DFG 149 (610)
.++++||||+.| +|.+.+.. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 258899999976 55554442 23347899999999999999999999 999999999999999997 8999999999
Q ss_pred cccccccccccccccCCCcccCCccccCCC-CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC------
Q 007266 150 LAKMLISDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------ 222 (610)
Q Consensus 150 lak~~~~~~~~~~~vGTp~Y~APEvl~~~~-yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------ 222 (610)
+++...........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+......+
T Consensus 178 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 178 SAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp TCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence 998876666666788999999999986654 8999999999999999999999999988877777665432221
Q ss_pred -------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 223 -------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 223 -------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
.+..++.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 12225678999999999999999999999999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=388.38 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=213.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc------cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ------TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~------~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+|++++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 479999999999999999999999999999999975432 1122345789999999999999999999875443
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC---eeeeeccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAK 152 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~---vKL~DFGlak 152 (610)
+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 789999999999999987643 6899999999999999999999999999999999999987765 9999999998
Q ss_pred ccccccccccccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHH-HHHHHHhhccCCCC---Cc
Q 007266 153 MLISDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPL---PT 225 (610)
Q Consensus 153 ~~~~~~~~~~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~-~l~~~I~~~~~~~~---p~ 225 (610)
...........+||+.|+|||++. ...++.++|||||||++|+|++|..||...... .+...+........ +.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 765554445678999999999873 567889999999999999999999999765422 23333333332222 23
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
.++..+.+||.+||..||.+||+++++|+||||+...
T Consensus 246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 5789999999999999999999999999999998644
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=378.44 Aligned_cols=253 Identities=31% Similarity=0.574 Sum_probs=217.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+|+.||+|.+...... +.+.+|+.+++.++||||+++++.+...+ .+|+||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 103 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL----QEIIKEISIMQQCDSPHVVKYYGSYFKNT-DLWIVM 103 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH----HHHHHHHHHHHhCCCCCCccEEEEEEeCC-EEEEEe
Confidence 5799999999999999999999999999999999754432 35788999999999999999999887654 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ..
T Consensus 104 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp ECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence 9999999999997543 368999999999999999999999999999999999999999999999999997754332 34
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--CCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~--~~p~~~s~~l~~LI~km 238 (610)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...... ..+..++..+.+||.+|
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 262 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHH
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHH
Confidence 4568999999999999999999999999999999999999999988776665555443322 23566899999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|..||.+||++.++|+||||+.
T Consensus 263 l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 263 LVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp TCSCTTTSCCHHHHTTSHHHHT
T ss_pred ccCChhhCcCHHHHHhCHHHhc
Confidence 9999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=390.73 Aligned_cols=252 Identities=27% Similarity=0.531 Sum_probs=219.6
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+|++++.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+|++++||||+++++++... ...|+||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~ 133 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVM 133 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEEEE
Confidence 59999999999999999999999999999999976543 344556789999999999999999999988765 4889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ..
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~ 208 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---AN 208 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BC
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CC
Confidence 9997 58888886543 3689999999999999999999999999999999999999999999999999976543 34
Q ss_pred cccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC-CCCcccchHHHHHHHH
Q 007266 162 SVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAFRGLVKS 237 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~-~~p~~~s~~l~~LI~k 237 (610)
..+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+....+..+...... ..+..++..+++||.+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 578999999999884 567899999999999999999999999988877666665544332 3355689999999999
Q ss_pred hhcCCCCCCCCHHHHhcCCCCCc
Q 007266 238 MLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
||+.||.+|||++++|+||||..
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HcccChhhCcCHHHHhhChhhhc
Confidence 99999999999999999999854
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=382.36 Aligned_cols=251 Identities=22% Similarity=0.414 Sum_probs=212.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++++ ++..||+|++..........+.+.+|+.+|++++||||+++++++...+ .+++||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~ 113 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-NLSIVT 113 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-CCEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-ceEEEE
Confidence 5899999999999999999976 6889999999877766777778999999999999999999999876554 688999
Q ss_pred eecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~-~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
||++|++|.+++..... ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99999999999986431 13899999999999999999999999 9999999999999999999999999997654332
Q ss_pred -ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHh-hccCCCCCcccchHHHHHHH
Q 007266 159 -LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN-KSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 159 -~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~-~~~~~~~p~~~s~~l~~LI~ 236 (610)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+. .......+..++..+.+||.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 2445789999999999999999999999999999999999999999998887777664 33445567889999999999
Q ss_pred HhhcCCCCCCCCHHHHhcC
Q 007266 237 SMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~H 255 (610)
+||+.||.+|||++++++.
T Consensus 274 ~~l~~dP~~Rps~~~ll~~ 292 (309)
T 3p86_A 274 GCWTNEPWKRPSFATIMDL 292 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999999873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=385.23 Aligned_cols=259 Identities=20% Similarity=0.371 Sum_probs=206.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe---EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE--
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK---KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-- 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~---~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~-- 76 (610)
++|++++.||+|+||.||+|.+..++. .||+|.+..........+.+.+|+.++++++||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 579999999999999999999887765 899999986655555677899999999999999999999988765432
Q ss_pred ---EEEEEeecCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecc
Q 007266 77 ---VCIIIGYCEGGDMAEAIKKAN----GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 149 (610)
Q Consensus 77 ---~~LVmEy~~GgsL~~~Ik~~~----~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFG 149 (610)
.++||||+.|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 389999999999999997542 1258999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCc
Q 007266 150 LAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPT 225 (610)
Q Consensus 150 lak~~~~~~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~ 225 (610)
+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+...+........+.
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 262 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP 262 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCC
Confidence 9987644332 234467788999999999999999999999999999999 999999988888888887777777788
Q ss_pred ccchHHHHHHHHhhcCCCCCCCC-------HHHHhcCCCCCc
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPS-------AAELLCHPHLQP 260 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpS-------a~eiL~Hp~f~~ 260 (610)
.++..+.+||.+||+.||.+||| +++++.|||+..
T Consensus 263 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 263 ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 89999999999999999999999 778889998865
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=391.93 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=214.4
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CC-----ceeeeeeeEeecC
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NP-----FIVEYKDSWVEKG 74 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-Hp-----nIV~l~~~~~~~~ 74 (610)
+++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+. |+ +|+.+++.+...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR- 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence 47899999999999999999999999999999999743 234456778888888875 44 489999887765
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCCCceEec--CCCCeeeeeccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH--ANHILHRDVKCSNIFLT--RDQDIRLGDFGL 150 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLH--s~gIiHRDLKPeNILL~--~~g~vKL~DFGl 150 (610)
..+|+||||+. ++|.+++.......+++..++.++.||+.||.||| ..||+||||||+||||+ .++.+||+|||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 48899999995 59999998865557999999999999999999999 46999999999999995 467899999999
Q ss_pred ccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc-----
Q 007266 151 AKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT----- 225 (610)
Q Consensus 151 ak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~----- 225 (610)
++.... .....+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..+.+..+......+...
T Consensus 208 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 208 SCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp CEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987643 3456789999999999999999999999999999999999999999988887777765432211100
Q ss_pred ----------------------------------------------------------ccchHHHHHHHHhhcCCCCCCC
Q 007266 226 ----------------------------------------------------------VYSGAFRGLVKSMLRKNPEFRP 247 (610)
Q Consensus 226 ----------------------------------------------------------~~s~~l~~LI~kmL~~dP~~Rp 247 (610)
..+.++++||.+||+.||++||
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp 365 (382)
T 2vx3_A 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365 (382)
T ss_dssp TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence 0013789999999999999999
Q ss_pred CHHHHhcCCCCCch
Q 007266 248 SAAELLCHPHLQPY 261 (610)
Q Consensus 248 Sa~eiL~Hp~f~~~ 261 (610)
|++|+|+||||+..
T Consensus 366 ta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 366 QPYYALQHSFFKKT 379 (382)
T ss_dssp CHHHHTTSGGGCC-
T ss_pred CHHHHhcCcccccC
Confidence 99999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=378.97 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=211.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||++++..++..||+|.+.... ......+.+.+|+.++++++||||+++++++... ..+|+|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv 89 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-DCYYLV 89 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-SEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-CeEEEE
Confidence 58999999999999999999999999999999986543 3445567899999999999999999999987654 578999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-- 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-- 158 (610)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999999998765 68999999999999999999999999999999999999999999999999998764332
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----CCcccchHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----LPTVYSGAFRGL 234 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----~p~~~s~~l~~L 234 (610)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+................. .+..++..+.++
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 2345689999999999999999999999999999999999999999988766655544433322 245578999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCC
Q 007266 235 VKSMLRKNPEFRPSAAELLCHP 256 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp 256 (610)
|.+||+.||.+||+..+.+.+.
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~ 269 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDD 269 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHH
T ss_pred HHHHhcCCHhHccccHHHHHHH
Confidence 9999999999999544444443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=384.88 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=216.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec----CcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK----GCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~----~~~~ 77 (610)
++|++.+.||+|+||.||++.+..+++.||||.+... ........+.+|+.++++++||||+++++++... ....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 6899999999999999999999999999999999643 3444556788999999999999999999976543 2578
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 99999996 5999998863 6899999999999999999999999999999999999999999999999999875432
Q ss_pred c-----------ccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC---
Q 007266 158 D-----------LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--- 222 (610)
Q Consensus 158 ~-----------~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~--- 222 (610)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 1 1234589999999998764 678999999999999999999999999988766655543321111
Q ss_pred ----------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 ----------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 ----------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
....++..+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 1135788999999999999999999999999999998653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=389.09 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=217.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc-----E
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-----Y 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~-----~ 76 (610)
++|.+.+.||+|+||.||+|.+..+|+.||||.+..........+.+.+|+.+++.++||||+++++++...+. .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 58999999999999999999999999999999998766666667789999999999999999999998876542 3
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 589999997 588776642 589999999999999999999999999999999999999999999999999986533
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC---------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--------------- 220 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--------------- 220 (610)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 179 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 179 E--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred C--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 2 445689999999999877 6789999999999999999999999999887766665543211
Q ss_pred ---------------CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 221 ---------------APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 221 ---------------~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
......++..+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 112345789999999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=393.06 Aligned_cols=252 Identities=20% Similarity=0.391 Sum_probs=222.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-------ERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~ 73 (610)
++|++.+.||+|+||.||+|++.. ++..||||++... ......+.+.+|+.+|+++ +||||+++++++...
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 589999999999999999999863 4568999999754 3445567799999999999 899999999987655
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKANG--------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~~--------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
+ .+|+||||+.||+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 160 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 160 G-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred C-CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 4 68899999999999999987531 35899999999999999999999999999999999999999
Q ss_pred CCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHH
Q 007266 140 DQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKI 215 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I 215 (610)
++.+||+|||+++...... ......+|+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++...+
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~ 318 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999998654332 2334567889999999999999999999999999999998 99999999888888888
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
........+..++..+.+||.+||+.||.+||++.|++++
T Consensus 319 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 319 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7777777788899999999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=389.64 Aligned_cols=253 Identities=19% Similarity=0.397 Sum_probs=218.8
Q ss_pred CCeEEEeEecccCceEEEEEEE-----eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRH-----KHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d-----~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|++ ..+++.||||.+.... .....+.+.+|++++.++ +|||||++++++...+.
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 6899999999999999999994 4566899999997543 334456789999999999 78999999999988777
Q ss_pred EEEEEEeecCCCCHHHHHHHhCC---------------------------------------------------------
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANG--------------------------------------------------------- 98 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~--------------------------------------------------------- 98 (610)
.+++|||||.||+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 78999999999999999986432
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---ccccccCCCc
Q 007266 99 -------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPS 168 (610)
Q Consensus 99 -------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~ 168 (610)
..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......||+.
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 128999999999999999999999999999999999999999999999999998653322 2345678999
Q ss_pred ccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCH-HHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCC
Q 007266 169 YMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDM-QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 246 (610)
Q Consensus 169 Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~-~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~R 246 (610)
|+|||++.+..++.++|||||||++|+|++ |..||.+... ..+...+........+..+++++.+||.+||+.||.+|
T Consensus 261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 340 (359)
T 3vhe_A 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340 (359)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999998 9999987663 34455555555666788899999999999999999999
Q ss_pred CCHHHHhcC
Q 007266 247 PSAAELLCH 255 (610)
Q Consensus 247 pSa~eiL~H 255 (610)
||+.|+++|
T Consensus 341 ps~~ell~~ 349 (359)
T 3vhe_A 341 PTFSELVEH 349 (359)
T ss_dssp CCHHHHHHH
T ss_pred CCHHHHHHH
Confidence 999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=370.32 Aligned_cols=248 Identities=22% Similarity=0.434 Sum_probs=222.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+. +++.||+|++....... +.+.+|+.++++++||||+++++++...+ ..|+||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 84 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVF 84 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC-ceEEEE
Confidence 58999999999999999999987 47789999998655443 35889999999999999999999876654 688999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp ECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999999997643 368999999999999999999999999999999999999999999999999998654332 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+||.+|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 243 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 243 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHH
Confidence 344567888999999998899999999999999999999 9999999999999998888777777888999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||.+||++.++++|
T Consensus 244 l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 244 WRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCcccCcCHHHHHHH
Confidence 99999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=398.12 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=195.0
Q ss_pred CeEE-EeEecccCceEEEEEEEe--CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee-cCcEEE
Q 007266 3 QYEV-LEQIGKGSFGSALLVRHK--HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVC 78 (610)
Q Consensus 3 ~Y~i-lk~LG~G~fG~Vyla~d~--~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~-~~~~~~ 78 (610)
.|++ .++||+|+||.||+|++. .+++.||||++....... .+.+|+.+|++++|||||+++++|.. .+..+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 5777 447999999999999976 468899999997554433 46789999999999999999999875 456899
Q ss_pred EEEeecCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe----cCCCCeeeee
Q 007266 79 IIIGYCEGGDMAEAIKKAN-------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGD 147 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~-------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL----~~~g~vKL~D 147 (610)
+||||+. ++|.+++.... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999996 58888876321 1248999999999999999999999999999999999999 6778999999
Q ss_pred cccccccccc----cccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCH---------HHHHH
Q 007266 148 FGLAKMLISD----DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------QALIN 213 (610)
Q Consensus 148 FGlak~~~~~----~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~---------~~l~~ 213 (610)
||+++..... ......+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||.+... .+.+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999876432 234567899999999998874 589999999999999999999999976543 23344
Q ss_pred HHhhccCCCCCc-------------------------------------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 007266 214 KINKSIVAPLPT-------------------------------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256 (610)
Q Consensus 214 ~I~~~~~~~~p~-------------------------------------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp 256 (610)
.+......+... ..+..+.+||.+||+.||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 443322222111 1267889999999999999999999999999
Q ss_pred CCCch
Q 007266 257 HLQPY 261 (610)
Q Consensus 257 ~f~~~ 261 (610)
||+..
T Consensus 336 ~f~~~ 340 (405)
T 3rgf_A 336 YFLED 340 (405)
T ss_dssp GGTSS
T ss_pred hhccC
Confidence 99763
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=404.84 Aligned_cols=252 Identities=14% Similarity=0.092 Sum_probs=204.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHH---HHHHhcCCCceeeee-------eeE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEM---ELISRVRNPFIVEYK-------DSW 70 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei---~iL~~L~HpnIV~l~-------~~~ 70 (610)
++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+ ++|++++|||||+++ +.+
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 57999999999999999999999999999999997542 2333456788999 455566899999988 443
Q ss_pred eecCc----------------EEEEEEeecCCCCHHHHHHHhCCCCCCH-------HHHHHHHHHHHHHHHHHHHCCeec
Q 007266 71 VEKGC----------------YVCIIIGYCEGGDMAEAIKKANGVHFPE-------EKLCKWLVQLLMALNYLHANHILH 127 (610)
Q Consensus 71 ~~~~~----------------~~~LVmEy~~GgsL~~~Ik~~~~~~lse-------~~i~~i~~QLl~aL~yLHs~gIiH 127 (610)
...+. ..|+||||+ +|+|.+++.... .+++ ..+..|+.||+.||.|||++||+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 33321 378999999 679999998754 3444 888889999999999999999999
Q ss_pred ccCCCCceEecCCCCeeeeecccccccccccccccccCCCcccCCccccCC-----------CCCCCccccccchhHHhh
Q 007266 128 RDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-----------PYGSKSDIWSLGCCVYEM 196 (610)
Q Consensus 128 RDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~-----------~yt~ksDIWSLG~iLyeL 196 (610)
|||||+||||+.++.+||+|||+++... ......+| +.|+|||++.+. .|+.++|||||||+||+|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999999999999999998643 23456678 999999999887 899999999999999999
Q ss_pred hhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 197 SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 197 ltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
++|..||.+.........+.. .+..++..+.+||.+||+.||.+||++.|+|+||||+.....
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHSSCCC------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHCCCCCcccccccchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 999999987664443333322 235688999999999999999999999999999999876443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=380.17 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=213.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCC-eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCc------eeeeeeeEeecC
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHER-KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF------IVEYKDSWVEKG 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~-~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hpn------IV~l~~~~~~~~ 74 (610)
++|++++.||+|+||.||+|.+..++ ..||+|++... ....+.+.+|+.+++.+.|++ ++.+++.+...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~- 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH- 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-
Confidence 68999999999999999999998766 79999999643 344566888999999987655 78888776554
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe-----------------
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL----------------- 137 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL----------------- 137 (610)
..+|+||||+ +++|.+.+.......+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 4889999999 6788888877655679999999999999999999999999999999999999
Q ss_pred --cCCCCeeeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHH
Q 007266 138 --TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 215 (610)
Q Consensus 138 --~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I 215 (610)
+.++.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||+||+|++|..||...+....+..+
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5678899999999976432 345678999999999999999999999999999999999999999988876655554
Q ss_pred hhccCCC-------------------------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHH
Q 007266 216 NKSIVAP-------------------------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 252 (610)
Q Consensus 216 ~~~~~~~-------------------------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~ei 252 (610)
....... .....+..+.+||.+||+.||.+|||++|+
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 3322111 011234578999999999999999999999
Q ss_pred hcCCCCCchh
Q 007266 253 LCHPHLQPYV 262 (610)
Q Consensus 253 L~Hp~f~~~~ 262 (610)
|+||||+...
T Consensus 332 l~hp~f~~~~ 341 (355)
T 2eu9_A 332 LLHPFFAGLT 341 (355)
T ss_dssp TTSGGGGGCC
T ss_pred hcChhhcCCC
Confidence 9999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=378.32 Aligned_cols=254 Identities=29% Similarity=0.422 Sum_probs=210.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee---------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE--------- 72 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~--------- 72 (610)
++|++++.||+|+||.||++.+..+++.||+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 6899999999999999999999999999999998644 34456778899999999999999999987642
Q ss_pred ----cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec-CCCCeeeee
Q 007266 73 ----KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGD 147 (610)
Q Consensus 73 ----~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~-~~g~vKL~D 147 (610)
.....|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3357899999997 5999998652 689999999999999999999999999999999999997 567899999
Q ss_pred cccccccccc----cccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC
Q 007266 148 FGLAKMLISD----DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP 222 (610)
Q Consensus 148 FGlak~~~~~----~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~ 222 (610)
||+++..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999875432 22345678999999998865 678999999999999999999999999988777666654432111
Q ss_pred -----------------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 223 -----------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 223 -----------------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+..++.++++||.+||+.||.+|||++|+|+||||+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 123478999999999999999999999999999999854
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=382.98 Aligned_cols=251 Identities=20% Similarity=0.354 Sum_probs=220.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe---EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK---KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~---~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||.||++.+..++. .||||.+.... .....+.+.+|+.+|++++||||+++++++... ...|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 126 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-RLAM 126 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-GCCE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CccE
Confidence 579999999999999999999986544 59999997443 445567789999999999999999999987654 5788
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 127 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999997643 369999999999999999999999999999999999999999999999999998764332
Q ss_pred ----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 ----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
......+|+.|+|||++.+..++.++|||||||+||+|++ |..||.+....++...+......+.+..++..+.+
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 285 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ 285 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHH
Confidence 2233456788999999998899999999999999999998 99999999999999998888777788889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||..||.+||++.++++.
T Consensus 286 li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 286 LMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=370.58 Aligned_cols=253 Identities=27% Similarity=0.542 Sum_probs=207.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec--------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-------- 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-------- 73 (610)
++|++++.||+|+||.||+|++..+++.||||.+.. .....+.+.+|+.++++++||||+++++.|...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 479999999999999999999999999999999864 234456788999999999999999999988653
Q ss_pred ----CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecc
Q 007266 74 ----GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 149 (610)
Q Consensus 74 ----~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFG 149 (610)
....|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 45789999999999999999864 3467899999999999999999999999999999999999999999999999
Q ss_pred cccccccc---------------cccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCcccc-ccCHHHHH
Q 007266 150 LAKMLISD---------------DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFK-AFDMQALI 212 (610)
Q Consensus 150 lak~~~~~---------------~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~-~~~~~~l~ 212 (610)
++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++ ||. +.+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 99765321 223456799999999999865 68999999999999999998 443 33334444
Q ss_pred HHHhhcc---CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 213 NKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 213 ~~I~~~~---~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
..+.... ....+...+..+++||.+||+.||.+|||+.++|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 4443322 222344567789999999999999999999999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=393.65 Aligned_cols=255 Identities=19% Similarity=0.310 Sum_probs=222.2
Q ss_pred CCeEEEeEecccCceEEEEEE-----EeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVR-----HKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~-----d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++++.||+|+||.||+|. +..++..||||.+... ........+.+|+.++++++|||||++++++...+ .
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-P 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-C
Confidence 579999999999999999999 4557889999998643 33444556889999999999999999999886554 6
Q ss_pred EEEEEeecCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC---eeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKANG-----VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~-----~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~---vKL~DF 148 (610)
.|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|. +||+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 7899999999999999987542 35899999999999999999999999999999999999996654 999999
Q ss_pred ccccccccc---cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCC
Q 007266 149 GLAKMLISD---DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLP 224 (610)
Q Consensus 149 Glak~~~~~---~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p 224 (610)
|+++..... ......+||+.|+|||++.+..|+.++|||||||+||+|++ |..||.+.+..++...+........+
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~ 308 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999865332 23345678999999999999999999999999999999998 99999999999999988887777778
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
..++..+.+||.+||+.||.+||++.++++|.++
T Consensus 309 ~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 8899999999999999999999999999998554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=383.73 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=211.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-----------CCceeeeeeeE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-----------NPFIVEYKDSW 70 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpnIV~l~~~~ 70 (610)
++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++++. |+||+++++.+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 5899999999999999999999999999999999743 234456788999998886 78999999988
Q ss_pred eecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecC------C
Q 007266 71 VEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTR------D 140 (610)
Q Consensus 71 ~~~~---~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~------~ 140 (610)
...+ ..+++||||+ |++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||||+. .
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 7543 3789999999 89999999886555799999999999999999999998 9999999999999954 3
Q ss_pred CCeeeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC------HHHHHHH
Q 007266 141 QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD------MQALINK 214 (610)
Q Consensus 141 g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~------~~~l~~~ 214 (610)
+.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||+||+|++|..||...+ ....+..
T Consensus 175 ~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 175 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 4799999999987643 2445689999999999999999999999999999999999999998654 1222222
Q ss_pred Hhhcc-----------------------------------------CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHh
Q 007266 215 INKSI-----------------------------------------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253 (610)
Q Consensus 215 I~~~~-----------------------------------------~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL 253 (610)
+.... ....+..++.++.+||.+||+.||.+|||++|+|
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 21111 1123445678899999999999999999999999
Q ss_pred cCCCCCchh
Q 007266 254 CHPHLQPYV 262 (610)
Q Consensus 254 ~Hp~f~~~~ 262 (610)
+||||+...
T Consensus 333 ~hp~f~~~~ 341 (373)
T 1q8y_A 333 NHPWLKDTL 341 (373)
T ss_dssp TCGGGTTCT
T ss_pred hChhhhccc
Confidence 999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=381.64 Aligned_cols=252 Identities=19% Similarity=0.324 Sum_probs=222.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++++.||+|+||.||++++.. +++.||+|.+.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 124 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG-KP 124 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SS
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-Cc
Confidence 589999999999999999999984 45899999997543 445567799999999999999999999987654 47
Q ss_pred EEEEEeecCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCc
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN----------------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSN 134 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~----------------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeN 134 (610)
+|+||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 204 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 889999999999999998742 1468999999999999999999999999999999999
Q ss_pred eEecCCCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHH
Q 007266 135 IFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQA 210 (610)
Q Consensus 135 ILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~ 210 (610)
|||+.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 284 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence 999999999999999998754332 2335678999999999998899999999999999999998 999999999888
Q ss_pred HHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 211 LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 211 l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+...+........+..++..+.+||.+||+.||.+||++.+++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 285 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 888888777777788899999999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=378.77 Aligned_cols=258 Identities=29% Similarity=0.517 Sum_probs=196.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||||.+..... ....+.+.+|+.++++++||||+++++.+...+ ..|+||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 92 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWLVM 92 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS-CEEEEE
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEEEe
Confidence 689999999999999999999999999999998865432 234456889999999999999999999887655 688999
Q ss_pred eecCCCCHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 82 GYCEGGDMAEAIKKA------NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~------~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
||+.|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 999999999999752 23358999999999999999999999999999999999999999999999999987654
Q ss_pred cc------cccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC-------
Q 007266 156 SD------DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA------- 221 (610)
Q Consensus 156 ~~------~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~------- 221 (610)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence 32 12345689999999999875 56899999999999999999999999887655544433332221
Q ss_pred --CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 222 --PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 222 --~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.....++..+.+||.+||+.||.+||++.++++||||+..
T Consensus 253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1234578899999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=395.95 Aligned_cols=259 Identities=14% Similarity=0.167 Sum_probs=198.8
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhc--CCCceeeeee-------eEee
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRV--RNPFIVEYKD-------SWVE 72 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L--~HpnIV~l~~-------~~~~ 72 (610)
+|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.+ +||||++++. .+..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 59999999999999999999999999999999987654 334556677885544444 6999888653 3322
Q ss_pred cC----------------cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH------HHHHHHHHHHHHHHHHCCeecccC
Q 007266 73 KG----------------CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL------CKWLVQLLMALNYLHANHILHRDV 130 (610)
Q Consensus 73 ~~----------------~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i------~~i~~QLl~aL~yLHs~gIiHRDL 130 (610)
.+ ..+|+|||||+ ++|.+++...+. .+++..+ ..++.||+.||.|||++||+||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 22 35899999998 899999987532 3455555 677799999999999999999999
Q ss_pred CCCceEecCCCCeeeeecccccccccccccccccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCccccccCH
Q 007266 131 KCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 208 (610)
Q Consensus 131 KPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~ 208 (610)
||+||||+.+|.+||+|||+++..... .....||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+...
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999865432 225667799999999987 7799999999999999999999999987632
Q ss_pred HHH--HHHH------hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhhh
Q 007266 209 QAL--INKI------NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 209 ~~l--~~~I------~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~~ 265 (610)
... +..+ ......+.+..++..+.+||.+||+.||++|||+.++|+||||+...+..
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence 110 0000 01112223347899999999999999999999999999999998876544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=387.91 Aligned_cols=256 Identities=26% Similarity=0.456 Sum_probs=220.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH---------------HHHHHHHHHHHHHhcCCCceee
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR---------------ARRSAHQEMELISRVRNPFIVE 65 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~---------------~~~~l~~Ei~iL~~L~HpnIV~ 65 (610)
+++|++++.||+|+||.||+|.+ +++.||+|.+........ ..+.+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 36899999999999999999999 899999999975432211 1156889999999999999999
Q ss_pred eeeeEeecCcEEEEEEeecCCCCHHHH------HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEec
Q 007266 66 YKDSWVEKGCYVCIIIGYCEGGDMAEA------IKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLT 138 (610)
Q Consensus 66 l~~~~~~~~~~~~LVmEy~~GgsL~~~------Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~ 138 (610)
+++++... ..+|+||||++|++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 108 ~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 108 CEGIITNY-DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CSEEEESS-SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEEeeC-CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 99987765 488999999999999998 655435579999999999999999999999 9999999999999999
Q ss_pred CCCCeeeeecccccccccccccccccCCCcccCCccccCC-CCCC-CccccccchhHHhhhhcCccccccCH-HHHHHHH
Q 007266 139 RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-PYGS-KSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKI 215 (610)
Q Consensus 139 ~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~-~yt~-ksDIWSLG~iLyeLltG~~PF~~~~~-~~l~~~I 215 (610)
.++.++|+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..... ..+...+
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i 265 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 9999999999999876443 44567899999999999887 6666 99999999999999999999988766 6666666
Q ss_pred hhccCCCCC-------------------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 216 NKSIVAPLP-------------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 216 ~~~~~~~~p-------------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
..... ..+ ..++..+.+||.+||+.||.+||++.|+|+||||+..
T Consensus 266 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 266 RTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp TSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 54432 223 5689999999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=366.43 Aligned_cols=248 Identities=20% Similarity=0.400 Sum_probs=220.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+. ++..||+|++....... +.+.+|+.++++++||||+++++++... ...|+||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 82 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKE-YPIYIVT 82 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEE
T ss_pred hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccC-CceEEEE
Confidence 68999999999999999999775 57789999997655443 3588999999999999999999987654 4788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus 83 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred EccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999998753 358999999999999999999999999999999999999999999999999998764433 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+++.+.+||.+|
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 241 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSC 241 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHT
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHH
Confidence 234556778999999998889999999999999999998 9999999998888888887777777888999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||.+|||+.++++|
T Consensus 242 l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 242 WHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=377.19 Aligned_cols=252 Identities=19% Similarity=0.361 Sum_probs=222.3
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++.+.||+|+||.||++.+. .++..||+|++... ......+.+.+|+.++++++||||+++++++...+ .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 100 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG-P 100 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC-c
Confidence 58999999999999999999984 35589999999744 34455677899999999999999999999876554 6
Q ss_pred EEEEEeecCCCCHHHHHHHhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANG----------------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSN 134 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~----------------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeN 134 (610)
.|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 8899999999999999987532 238999999999999999999999999999999999
Q ss_pred eEecCCCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHH
Q 007266 135 IFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQA 210 (610)
Q Consensus 135 ILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~ 210 (610)
|||+.++.+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998654332 2334567889999999998889999999999999999999 999999988888
Q ss_pred HHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 211 LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 211 l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+...+........+..++..+.+||.+||+.||.+||++.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 888887777777788899999999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=376.17 Aligned_cols=258 Identities=27% Similarity=0.463 Sum_probs=202.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||+|+||.||+|.+..+++.||||++..........+.+.++..+++.++||||+++++++... ..+|+|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEE
Confidence 4689999999999999999999999999999999986655555555566666788889999999999988765 478999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|||+ ++.+..++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 103 ~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp ECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred Eecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 9999 66676666543 34689999999999999999999995 999999999999999999999999999987665555
Q ss_pred cccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCcccccc-CHHHHHHHHhhccCCCCC--cccchHH
Q 007266 160 ASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVAPLP--TVYSGAF 231 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~-~~~~l~~~I~~~~~~~~p--~~~s~~l 231 (610)
.....||+.|+|||++. ...++.++|||||||++|+|++|..||... .....+..+........+ ..++..+
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHH
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHH
Confidence 56678999999999984 556889999999999999999999999873 455555555554433333 4589999
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||.+||+.||.+||+++++|+||||+.+
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=377.46 Aligned_cols=249 Identities=22% Similarity=0.421 Sum_probs=209.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..+++.||+|.+.. ......+.+.+|+.++++++||||+++++++... ...++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEE
Confidence 689999999999999999999999999999998853 3445567799999999999999999999988765 4788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc-
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA- 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~- 160 (610)
||++|++|.++++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 87 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp ECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999998743 36899999999999999999999999999999999999999999999999999875433211
Q ss_pred --------------ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHH--HHHHhhccCCCCC
Q 007266 161 --------------SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPLP 224 (610)
Q Consensus 161 --------------~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l--~~~I~~~~~~~~p 224 (610)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+........+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence 256899999999999999999999999999999999999999865321100 0000000111245
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
..++..+.+||.+||+.||++|||+.++++
T Consensus 246 ~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 678899999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=368.89 Aligned_cols=248 Identities=20% Similarity=0.368 Sum_probs=218.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+. ++..||+|++....... +.+.+|++++++++||||+++++++... ..+|+||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 98 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIIT 98 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEE
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecC-CCeEEEE
Confidence 58999999999999999999776 67789999998655443 3578999999999999999999987654 4788999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 99 EYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999999998633 268999999999999999999999999999999999999999999999999998764332 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+........+..+++.+.+||.+|
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 257 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 257 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHH
Confidence 334567788999999998899999999999999999998 9999999999999988888877777888999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||.+|||+.++++|
T Consensus 258 l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 258 WHEKADERPTFKILLSN 274 (283)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhHCcCHHHHHHH
Confidence 99999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=370.50 Aligned_cols=255 Identities=26% Similarity=0.488 Sum_probs=212.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
+|.....||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-FIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-cEEEEEE
Confidence 3444559999999999999999999999999987543 234566889999999999999999999886654 7899999
Q ss_pred ecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-CCCeeeeeccccccccccc-c
Q 007266 83 YCEGGDMAEAIKKAN-GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~-~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-~g~vKL~DFGlak~~~~~~-~ 159 (610)
|+.|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999999998753 345779999999999999999999999999999999999987 8999999999998754322 3
Q ss_pred cccccCCCcccCCccccCCC--CCCCccccccchhHHhhhhcCccccccCHHH--HHHHHhhccCCCCCcccchHHHHHH
Q 007266 160 ASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA--LINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~--yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~--l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... .............+..++.++.+||
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 44568999999999987644 7899999999999999999999997654222 2222233344556778999999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+||+.||++||+++++|+||||+.
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHccCChhhCCCHHHHhcChhhhh
Confidence 9999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=384.79 Aligned_cols=252 Identities=20% Similarity=0.394 Sum_probs=224.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC-------CeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE-------RKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~-------~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~ 73 (610)
++|++.+.||+|+||.||+|.+... +..||+|++... ........+.+|+++++++ +|||||++++++...
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 5899999999999999999998643 357999999754 3445567789999999999 899999999988665
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKANG--------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~~--------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
+ .+|+||||+.|++|.+++..... ..+++..++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 148 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 148 G-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred C-ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 4 68899999999999999987542 35899999999999999999999999999999999999999
Q ss_pred CCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHH
Q 007266 140 DQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKI 215 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I 215 (610)
++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~ 306 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999998764432 2344567889999999999999999999999999999999 99999999999999888
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
........+..++.++.+||.+||+.||++||++.|++++
T Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 307 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8887777888899999999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=378.39 Aligned_cols=253 Identities=21% Similarity=0.389 Sum_probs=219.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEE--EEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKY--VLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~v--AIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~ 77 (610)
+++|++.+.||+|+||.||+|++..++..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++... ..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-Cce
Confidence 368999999999999999999999988865 899886432 333456688999999999 899999999988655 478
Q ss_pred EEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCe
Q 007266 78 CIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 143 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~v 143 (610)
|+||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 99999999999999997642 2468999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCC
Q 007266 144 RLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAP 222 (610)
Q Consensus 144 KL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~ 222 (610)
||+|||+++............+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+...+.......
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 261 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCC
Confidence 9999999976543334445677899999999998889999999999999999998 999999999988888888776677
Q ss_pred CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 223 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 223 ~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+..++..+.+||.+||..||.+||++++++++
T Consensus 262 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 262 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 788899999999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=363.82 Aligned_cols=249 Identities=14% Similarity=0.281 Sum_probs=219.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~~L 79 (610)
+++|++++.||+|+||.||++++. +..||+|++..........+.+.+|+.++++++||||+++++++... +...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 468999999999999999999984 88999999988776777778899999999999999999999988765 257889
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
||||++|++|.+++.......+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 999999999999998766556999999999999999999999999 9999999999999999999999988875432
Q ss_pred cccccccCCCcccCCccccCCCCCC---CccccccchhHHhhhhcCccccccCHHHHHHHHh-hccCCCCCcccchHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGS---KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN-KSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~---ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~-~~~~~~~p~~~s~~l~~ 233 (610)
....+||+.|+|||++.+..++. ++|||||||++|+|++|..||.+.+.......+. .......+..++..+.+
T Consensus 165 --~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (271)
T 3kmu_A 165 --SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242 (271)
T ss_dssp --CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHH
T ss_pred --ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 33467899999999998766544 7999999999999999999999888777665554 34455667789999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||+.||.+|||++++++.
T Consensus 243 li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 243 LMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=370.94 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=209.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||.||++.+..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++.+ ...|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 91 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW 91 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--CccE
Confidence 5899999999999999999999753 457999988643 344556778999999999999999999998743 3578
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999999999998643 368999999999999999999999999999999999999999999999999998764433
Q ss_pred c--cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 159 L--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~--~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
. .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+......+.+..++..+.+||
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 250 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 250 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 2 234567789999999998899999999999999999996 9999998888888888877776778888999999999
Q ss_pred HHhhcCCCCCCCCHHHHhcC
Q 007266 236 KSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~H 255 (610)
.+||..||++||++.+++++
T Consensus 251 ~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 251 TKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=370.01 Aligned_cols=250 Identities=19% Similarity=0.336 Sum_probs=224.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..++..||+|.+..... ..+.+.+|+.++++++||||+++++++... ..+|+||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~ 88 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIIT 88 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEE
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCEEEEE
Confidence 579999999999999999999999999999999975432 345688999999999999999999987654 4688999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||+.|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 99999999999988666679999999999999999999999999999999999999999999999999998765433 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+........+..++..+.+||.+|
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 248 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 334567889999999998899999999999999999999 9999999888888888877777777888999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|..||.+||+++++++.
T Consensus 249 l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 249 WQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred hCCChhhCcCHHHHHHH
Confidence 99999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=371.70 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=211.2
Q ss_pred CCeEEEeEecccCceEEEEEE----EeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVR----HKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~----d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~ 76 (610)
++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|++++||||+++++++...+ ..
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 589999999999999999999 5668999999998743 3445567899999999999999999999876543 45
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+++||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred eEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 789999999999999998753 2589999999999999999999999999999999999999999999999999987643
Q ss_pred cc----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH----------------HHHHHHh
Q 007266 157 DD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ----------------ALINKIN 216 (610)
Q Consensus 157 ~~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~----------------~l~~~I~ 216 (610)
.. ......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .+...+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 32 233456778899999999999999999999999999999999988643221 3344444
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.....+.+..++.++.+||.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 555566788899999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=376.22 Aligned_cols=245 Identities=18% Similarity=0.242 Sum_probs=208.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|++..+++.||||++...... +.+.+|+.+++++ +||||+.+++++... ...|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCG-KYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEET-TEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecC-CccEEE
Confidence 5899999999999999999999999999999998754432 2477899999999 999999999987664 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC-----eeeeecccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-----IRLGDFGLAKMLI 155 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~-----vKL~DFGlak~~~ 155 (610)
|||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9999 99999999874 337999999999999999999999999999999999999999887 9999999998764
Q ss_pred cccc--------cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc---CHHHHHHHHhhccCCCC-
Q 007266 156 SDDL--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVAPL- 223 (610)
Q Consensus 156 ~~~~--------~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~---~~~~l~~~I~~~~~~~~- 223 (610)
.... ....+||+.|+|||++.+..++.++|||||||+||+|++|..||.+. ...+.+..+........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 3321 24678999999999999999999999999999999999999999874 44444555433221111
Q ss_pred ---CcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 224 ---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 224 ---p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
...++ ++.+||..||..||.+||+++++++
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 12345 9999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=360.25 Aligned_cols=248 Identities=22% Similarity=0.432 Sum_probs=221.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+. ++..||+|.+....... +.+.+|+.++++++||||+++++++...+ ..|+||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 82 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVT 82 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCC-CeEEEE
Confidence 58999999999999999999986 67789999998655443 45889999999999999999999876654 688999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus 83 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred eCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999999998753 368999999999999999999999999999999999999999999999999998754332 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+........+..++..+.+||.+|
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 241 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 241 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHH
Confidence 334567889999999998889999999999999999999 9999999998888888887766667788899999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||.+||++.+++++
T Consensus 242 l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 242 WRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=367.88 Aligned_cols=250 Identities=20% Similarity=0.345 Sum_probs=216.9
Q ss_pred CCeEEEe-EecccCceEEEEEEE--eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLE-QIGKGSFGSALLVRH--KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk-~LG~G~fG~Vyla~d--~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+ .||+|+||.||++.+ ..+++.||+|++..........+.+.+|+.+++.++||||+++++++ . ....|
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~-~~~~~ 93 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E-AESWM 93 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E-SSSEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C-CCCcE
Confidence 4799998 999999999999965 45678999999986655555667899999999999999999999987 3 34678
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 9999999999999998754 68999999999999999999999999999999999999999999999999998764332
Q ss_pred c----cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 L----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ~----~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
. .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+...+........+..++..+.+
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 251 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 223456789999999988889999999999999999999 99999999988888888777767778889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||+.||.+||++.++++.
T Consensus 252 li~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=381.64 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=186.4
Q ss_pred CCeEEEe-EecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee---cCcEE
Q 007266 2 EQYEVLE-QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---KGCYV 77 (610)
Q Consensus 2 d~Y~ilk-~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~---~~~~~ 77 (610)
++|++++ .||+|+||.||+|.+..+++.||||++.... .. ..+....++.+.||||++++++|.. .+..+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 6899966 6999999999999999999999999986431 21 2223344667799999999998865 24468
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC---CCeeeeeccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKML 154 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~---g~vKL~DFGlak~~ 154 (610)
|+|||||+|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999999999999988665679999999999999999999999999999999999999864 45999999999865
Q ss_pred ccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHH----HHhh---ccCCCCCccc
Q 007266 155 ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALIN----KINK---SIVAPLPTVY 227 (610)
Q Consensus 155 ~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~----~I~~---~~~~~~p~~~ 227 (610)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+.. ....+....+
T Consensus 182 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T 3fhr_A 182 TQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred cc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence 43 23456789999999999988889999999999999999999999998765443321 1111 1122233568
Q ss_pred chHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 228 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
+..+++||.+||+.||.+|||++|+|+||||+..
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 9999999999999999999999999999999764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=378.11 Aligned_cols=250 Identities=22% Similarity=0.386 Sum_probs=212.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeE----EEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKK----YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~----vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||+|++..+++. ||+|.+.... .....+.+.+|+.++++++||||+++++++...+ .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 91 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V 91 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--E
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--e
Confidence 5899999999999999999999877765 4777765332 2334467889999999999999999999887653 6
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++|+||+.+|+|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 78999999999999998743 36899999999999999999999999999999999999999999999999999876443
Q ss_pred cc---cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 DL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~~---~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
.. .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....+...+......+.+..++..+.+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 32 234567889999999999999999999999999999999 99999998888888777777777778889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||+.||.+||++.+++++
T Consensus 251 li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 251 IMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=364.24 Aligned_cols=245 Identities=26% Similarity=0.522 Sum_probs=213.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee---------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE--------- 72 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~--------- 72 (610)
++|++++.||+|+||.||++.+..+++.||+|.+.... +.+.+|+.++++++||||+++++.+..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 47999999999999999999999999999999997543 236689999999999999999998753
Q ss_pred ------cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeee
Q 007266 73 ------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 146 (610)
Q Consensus 73 ------~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~ 146 (610)
....+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 23468999999999999999987655579999999999999999999999999999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcc
Q 007266 147 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV 226 (610)
Q Consensus 147 DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~ 226 (610)
|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+.. ...+..
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~---~~~~~~ 239 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD---GIISDI 239 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT---TCCCTT
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc---cccccc
Confidence 999998876655556678999999999999999999999999999999999999988643 223333332 234567
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 257 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~ 257 (610)
++..+++||.+||..||.+||++.|+++|++
T Consensus 240 ~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 8999999999999999999999999999854
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=370.37 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=214.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeC---CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc---
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH---ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC--- 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~---~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~--- 75 (610)
++|++.+.||+|+||.||+|.+.. ++..||+|.+..........+.+.+|+.++++++||||+++++++...+.
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 579999999999999999998876 45689999998776666777889999999999999999999998876543
Q ss_pred -EEEEEEeecCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccc
Q 007266 76 -YVCIIIGYCEGGDMAEAIKKA----NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 150 (610)
Q Consensus 76 -~~~LVmEy~~GgsL~~~Ik~~----~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGl 150 (610)
..++||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 458999999999999999642 334699999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcc
Q 007266 151 AKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTV 226 (610)
Q Consensus 151 ak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~ 226 (610)
++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.....+...+........+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED 273 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTT
T ss_pred ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCcc
Confidence 98764332 2234567889999999999999999999999999999999 9999998888888888877777777888
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
++..+.+||.+||..||.+||++.+++++
T Consensus 274 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 274 CLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=376.52 Aligned_cols=259 Identities=28% Similarity=0.465 Sum_probs=191.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHH-HHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEME-LISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~-iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
.++|++++.||+|+||.||++.+..+++.||||.+........ ...+.+|+. +++.++||||+++++++...+ ..|+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREG-DCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-EEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-ceEE
Confidence 3789999999999999999999999999999999976544333 334455555 778889999999999887654 7899
Q ss_pred EEeecCCCCHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 80 IIGYCEGGDMAEAIKK---ANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~---~~~~~lse~~i~~i~~QLl~aL~yLHs~-gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
||||+.| +|.+++.. .....+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++...
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9999975 88887763 2234789999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccccccCCCcccCCccc----cCCCCCCCccccccchhHHhhhhcCccccccCH-HHHHHHHhhccCCCC----Ccc
Q 007266 156 SDDLASSVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAPL----PTV 226 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl----~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~-~~l~~~I~~~~~~~~----p~~ 226 (610)
.........||+.|+|||++ .+..++.++|||||||++|+|++|..||..... .+.+..+.......+ ...
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence 55445556899999999998 466789999999999999999999999987542 122222222221112 235
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
++..+.+||.+||..||.+||++.++++||||....
T Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 789999999999999999999999999999997653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=372.38 Aligned_cols=252 Identities=20% Similarity=0.352 Sum_probs=221.8
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++.+.||+|+||.||+|.+. .+++.||+|.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 102 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QP 102 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-SS
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC-Cc
Confidence 57999999999999999999987 35788999998744 3344556788999999999999999999987654 47
Q ss_pred EEEEEeecCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN--------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~--------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
.|+||||+.|++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcC
Confidence 789999999999999997632 135799999999999999999999999999999999999999999999999
Q ss_pred cccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCC
Q 007266 149 GLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLP 224 (610)
Q Consensus 149 Glak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p 224 (610)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+...+........+
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 262 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCC
Confidence 9998654332 2334567899999999998899999999999999999999 89999999988888888777766778
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..++..+.+||.+||+.||.+|||+.|+++|
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 263 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8899999999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=386.93 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=221.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..+++.||||.+... ......+.+.+|+.+|++++|||||++++++... ..+|+||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~ 191 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVM 191 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-CCcEEEE
Confidence 5799999999999999999999989999999998743 3344556788999999999999999999988655 4688999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc-
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA- 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~- 160 (610)
||++||+|.++++..+ ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 192 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999999998753 35899999999999999999999999999999999999999999999999999865433211
Q ss_pred --ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 161 --SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 161 --~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
....+++.|+|||++.+..++.++|||||||+||||++ |..||.+.........+......+.+..++..+.+||.+
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 350 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQ 350 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 12345678999999998889999999999999999998 999999999888888888777777888899999999999
Q ss_pred hhcCCCCCCCCHHHHhcC
Q 007266 238 MLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~H 255 (610)
||+.||++|||++++++.
T Consensus 351 cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 351 CWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCCchhCcCHHHHHHH
Confidence 999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=366.91 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=207.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||++.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++... ..+|+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-GQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-CeEEE
Confidence 4789999999999999999999999999999999976543 344557789999999999999999999987665 48899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999999999998765 68999999999999999999999999999999999999999999999999987764432
Q ss_pred -ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--CCCcccchHHHHHH
Q 007266 159 -LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLV 235 (610)
Q Consensus 159 -~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~--~~p~~~s~~l~~LI 235 (610)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+...... ..+..++..+.+||
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 269 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence 234568999999999999999999999999999999999999999988766555555443322 23556899999999
Q ss_pred HHhhcCCCCCCC-CHHHHhc
Q 007266 236 KSMLRKNPEFRP-SAAELLC 254 (610)
Q Consensus 236 ~kmL~~dP~~Rp-Sa~eiL~ 254 (610)
.+||..||++|| +++++++
T Consensus 270 ~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 270 ARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHTCSSGGGSCSSHHHHHH
T ss_pred HHhccCCHHHHHHhHHHHHH
Confidence 999999999999 8888875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=372.38 Aligned_cols=253 Identities=19% Similarity=0.392 Sum_probs=218.5
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||+|.+. .+++.||||.+.... .....+.+.+|+.++.++ +||||+++++++...+.
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 58999999999999999999964 467899999997543 344456789999999999 68999999999887777
Q ss_pred EEEEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANG--------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~--------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
.+|+||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 78999999999999999986432 1289999999999999999999999999999999999999999
Q ss_pred Ceeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCH-HHHHHHHh
Q 007266 142 DIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDM-QALINKIN 216 (610)
Q Consensus 142 ~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~-~~l~~~I~ 216 (610)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+... ......+.
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 265 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence 99999999998654332 2335678899999999999999999999999999999998 9999987653 34445555
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.......+..++..+.++|.+||+.||.+|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555566677889999999999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=370.14 Aligned_cols=253 Identities=27% Similarity=0.483 Sum_probs=209.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC--CCceeeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR--NPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~--HpnIV~l~~~~~~~~~~~~L 79 (610)
++|++++.||+|+||.||++.+. +++.||+|++..........+.+.+|+.++.++. |+||+++++++... ..+|+
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~l 105 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYM 105 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-SEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-CEEEE
Confidence 47999999999999999999985 4889999999877666677788999999999997 59999999987665 47899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 106 v~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred EEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 999 55889999998754 689999999999999999999999999999999999996 5889999999998764332
Q ss_pred --ccccccCCCcccCCccccC-----------CCCCCCccccccchhHHhhhhcCccccccC-HHHHHHH-HhhccCCCC
Q 007266 159 --LASSVVGTPSYMCPELLAD-----------IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINK-INKSIVAPL 223 (610)
Q Consensus 159 --~~~~~vGTp~Y~APEvl~~-----------~~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~-I~~~~~~~~ 223 (610)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+.. +........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence 2345689999999999875 467889999999999999999999997653 2222333 333334455
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+...+..+.+||.+||..||.+||++.|+|+||||+.
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 6677899999999999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=365.58 Aligned_cols=251 Identities=18% Similarity=0.289 Sum_probs=217.3
Q ss_pred CeEEEeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+|++.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++...+...|+
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 699999999999999999997643 346899988753 3444567789999999999999999999988777778899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||||+.|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999999999764 3468999999999999999999999999999999999999999999999999998654332
Q ss_pred ----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 ----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+........+..++..+.+
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 263 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 263 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 2334567889999999999999999999999999999999 78888888777777777777777778889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||..||.+||++.++++.
T Consensus 264 li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 264 VMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=379.89 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=215.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeE----EEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKK----YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~----vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||+|.+..+++. ||+|.+...... .....+.+|+.++++++||||+++++++.. ...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-SCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Ccc
Confidence 6899999999999999999999887765 777776533211 122346789999999999999999997643 357
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++||||+.|++|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 89999999999999998642 36899999999999999999999999999999999999999999999999999876443
Q ss_pred c---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 D---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
. ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....+...+........+..++..+.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM 248 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTH
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHH
Confidence 2 2345678889999999998899999999999999999999 99999998888888888777777778889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||..||.+||++.++++|
T Consensus 249 li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 249 VMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=375.00 Aligned_cols=252 Identities=21% Similarity=0.355 Sum_probs=213.1
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+|.++ +||||+++++++...+
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 122 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 122 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC-
Confidence 58999999999999999999984 356789999997443 233456789999999999 8999999999887654
Q ss_pred EEEEEEeecCCCCHHHHHHHhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANG---------------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSN 134 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~---------------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeN 134 (610)
.+|+||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 68899999999999999986432 237999999999999999999999999999999999
Q ss_pred eEecCCCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHH
Q 007266 135 IFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQA 210 (610)
Q Consensus 135 ILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~ 210 (610)
|||+.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||+||+|++ |..||.+.....
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 999999999999999998764332 2345677889999999998899999999999999999998 999998776433
Q ss_pred -HHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 211 -LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 211 -l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+......+.+..++..+.+||.+||..||.+||++.++++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 344444555556677889999999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.63 Aligned_cols=247 Identities=22% Similarity=0.407 Sum_probs=211.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||+|+||.||++.+ .++.||+|.+.... ..+.+.+|+.++++++||||+++++.+...+..+|+|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 36899999999999999999987 48899999987543 3456889999999999999999999887766678999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 171 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--Q 171 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--c
Confidence 99999999999998754334899999999999999999999999999999999999999999999999998765432 3
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+........+..++..+.+||.+||
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 251 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 251 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHh
Confidence 34578899999999998899999999999999999998 99999988887888887777666778889999999999999
Q ss_pred cCCCCCCCCHHHHhcC
Q 007266 240 RKNPEFRPSAAELLCH 255 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~H 255 (610)
..||.+||++.++++.
T Consensus 252 ~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 252 HLDAAMRPSFLQLREQ 267 (278)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCCCHHHHHHH
Confidence 9999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=361.70 Aligned_cols=248 Identities=20% Similarity=0.404 Sum_probs=210.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHH-----HHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRAR-----RSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~-----~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++.+.||+|+||.||+|++..+++.||+|.+.......... +.+.+|+.++++++||||+++++++....
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 68999999999999999999999999999999986544322111 56889999999999999999999875543
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEecCCCC-----eeeeecc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQD-----IRLGDFG 149 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~~~g~-----vKL~DFG 149 (610)
++||||+.|++|.+.+.... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 68999999999999887643 46899999999999999999999999 999999999999988876 9999999
Q ss_pred cccccccccccccccCCCcccCCcccc--CCCCCCCccccccchhHHhhhhcCccccccCHHH--HHHHH-hhccCCCCC
Q 007266 150 LAKMLISDDLASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA--LINKI-NKSIVAPLP 224 (610)
Q Consensus 150 lak~~~~~~~~~~~vGTp~Y~APEvl~--~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~--l~~~I-~~~~~~~~p 224 (610)
+++.... .....+||+.|+|||++. ...++.++|||||||++|+|++|..||....... ....+ ........+
T Consensus 175 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 4f0f_A 175 LSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252 (287)
T ss_dssp TCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC
T ss_pred ccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC
Confidence 9975432 344578999999999984 4557889999999999999999999998654322 23333 234445567
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 7899999999999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=389.09 Aligned_cols=246 Identities=22% Similarity=0.401 Sum_probs=218.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+. ++.||||.+.... ..+.+.+|+.+|++++|||||++++++...+..+|+||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 68999999999999999999874 7799999997543 23458899999999999999999999887766789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
||+.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ..
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 344 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 344 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--cc
Confidence 9999999999999876556899999999999999999999999999999999999999999999999999864322 23
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
...+++.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+......+.+..++..+.+||.+||.
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 424 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWH 424 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcC
Confidence 3477899999999999999999999999999999998 999999988888888887777777888899999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q 007266 241 KNPEFRPSAAELLCH 255 (610)
Q Consensus 241 ~dP~~RpSa~eiL~H 255 (610)
.||.+|||+.++++.
T Consensus 425 ~dp~~Rpt~~~l~~~ 439 (450)
T 1k9a_A 425 LDAATRPTFLQLREQ 439 (450)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhHCcCHHHHHHH
Confidence 999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=361.96 Aligned_cols=251 Identities=18% Similarity=0.309 Sum_probs=219.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCe---EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERK---KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~---~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
.|++.+.||+|+||.||+|.+..++. .||+|.+... ......+.+.+|+.++++++||||+++++++...+...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 47778999999999999999876544 7999998743 3444567789999999999999999999998877766689
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~- 158 (610)
||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999863 3468999999999999999999999999999999999999999999999999997653322
Q ss_pred ----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 ----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+...+...+......+.+..++..+.+
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 259 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence 2345678899999999999999999999999999999999 66777777777788888777777788889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||+.||.+|||+.++++.
T Consensus 260 li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=360.90 Aligned_cols=248 Identities=25% Similarity=0.514 Sum_probs=203.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH--HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD--RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~--~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
+++|++.+.||+|+||.||++.+ .+..||+|++....... ...+.+.+|+.+++.++||||+++++++... ...|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-PNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-CceE
Confidence 47899999999999999999997 48899999987543322 2346788999999999999999999987655 4788
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCCCceEecC--------CCCeeeee
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH---ILHRDVKCSNIFLTR--------DQDIRLGD 147 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g---IiHRDLKPeNILL~~--------~g~vKL~D 147 (610)
+||||++|++|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 83 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999998542 6899999999999999999999999 999999999999986 67799999
Q ss_pred cccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhh-ccCCCCCcc
Q 007266 148 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK-SIVAPLPTV 226 (610)
Q Consensus 148 FGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~-~~~~~~p~~ 226 (610)
||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.. ....+.+..
T Consensus 160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred CCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 99998654332 3356899999999999998999999999999999999999999998887766655543 334556778
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
++..+.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=372.39 Aligned_cols=252 Identities=19% Similarity=0.383 Sum_probs=220.8
Q ss_pred CCeEEEeEecccCceEEEEEEEe-------CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-------HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-------~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~ 73 (610)
++|++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 68999999999999999999986 356789999997543 445567789999999999 899999999987655
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKANG--------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~~--------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
..+|+||||+.|++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 114 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 114 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp -SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred -CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 478899999999999999986431 24899999999999999999999999999999999999999
Q ss_pred CCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHH
Q 007266 140 DQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKI 215 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I 215 (610)
++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 272 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence 9999999999998764432 2334567889999999998889999999999999999999 99999999988888888
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
........+..++..+.+||.+||..||.+||++.+++++
T Consensus 273 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777777788899999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=366.23 Aligned_cols=252 Identities=21% Similarity=0.383 Sum_probs=213.1
Q ss_pred CCeEEEeEecccCceEEEEEE----EeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVR----HKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~----d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~ 76 (610)
++|++++.||+|+||.||+|+ +..+++.||+|.+..... ....+.+.+|+.++++++||||+++++++...+ ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 469999999999999999999 567899999999975432 223456889999999999999999999887653 46
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+++||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 889999999999999997654 3689999999999999999999999999999999999999999999999999987654
Q ss_pred cc----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc---------------CHHHHHHHHhh
Q 007266 157 DD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---------------DMQALINKINK 217 (610)
Q Consensus 157 ~~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~---------------~~~~l~~~I~~ 217 (610)
.. ......||..|+|||++.+..++.++|||||||++|+|++|..||... ....+...+..
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 32 344567888999999999988999999999999999999999876422 23344455555
Q ss_pred ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 218 ~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+.+..++..+.+||.+||+.||.+|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 56666788899999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=367.37 Aligned_cols=252 Identities=19% Similarity=0.360 Sum_probs=216.2
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||++.+. .+++.||+|.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 100 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence 58999999999999999999963 467899999997543 334457789999999999 9999999999886654
Q ss_pred EEEEEEeecCCCCHHHHHHHhCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANG----------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~----------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
..++||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 67899999999999999987542 24899999999999999999999999999999999999999
Q ss_pred CCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHH-HHHH
Q 007266 140 DQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQA-LINK 214 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~-l~~~ 214 (610)
++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||+||+|++ |..||.+..... ....
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 260 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence 9999999999998764432 2334567889999999999899999999999999999998 999998766433 3344
Q ss_pred HhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 215 INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 215 I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+........+..++..+.+||.+||..||.+|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 44444555567789999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=363.75 Aligned_cols=250 Identities=20% Similarity=0.342 Sum_probs=219.5
Q ss_pred CCeEEEe-EecccCceEEEEEEEe--CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLE-QIGKGSFGSALLVRHK--HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk-~LG~G~fG~Vyla~d~--~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|.+++ .||+|+||.||++.+. .++..||+|.+.... .....+.+.+|+.++++++||||+++++++. ....+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcE
Confidence 5788887 9999999999999864 467889999997543 3455677899999999999999999999873 33588
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 86 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999999753 3368999999999999999999999999999999999999999999999999998764332
Q ss_pred ----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 ----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
......||+.|+|||++.+..++.++|||||||++|+|++ |..||......++...+........+..++..+.+
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 244 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 244 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHH
Confidence 1234467899999999988889999999999999999998 99999998888888888777667778889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||..||.+||++.++++|
T Consensus 245 li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=371.22 Aligned_cols=251 Identities=22% Similarity=0.412 Sum_probs=217.5
Q ss_pred CCeEEEeEecccCceEEEEEE----EeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee-cCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVR----HKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~----d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~-~~~~ 76 (610)
++|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 589999999999999999999 4668999999998754 34445678999999999999999999998764 4567
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||++|++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 8999999999999999987432 589999999999999999999999999999999999999999999999999987643
Q ss_pred cc----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH---------------HHHHHHHhh
Q 007266 157 DD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------------QALINKINK 217 (610)
Q Consensus 157 ~~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~---------------~~l~~~I~~ 217 (610)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 32 23456788899999999988899999999999999999999999865432 234445555
Q ss_pred ccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 218 ~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+.+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55666778899999999999999999999999999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=361.98 Aligned_cols=253 Identities=17% Similarity=0.262 Sum_probs=209.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||||++...... ..+.+|+.+++.+.|++++..+..+...+...++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 5899999999999999999999999999999987654333 247789999999999999988888878888999999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe---cCCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL---~~~g~vKL~DFGlak~~~~~~ 158 (610)
||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 999 999999998643 369999999999999999999999999999999999999 788999999999998764432
Q ss_pred --------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH---HHHHHHhhc-cCC---CC
Q 007266 159 --------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---ALINKINKS-IVA---PL 223 (610)
Q Consensus 159 --------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~---~l~~~I~~~-~~~---~~ 223 (610)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+... ... ..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 223568999999999999999999999999999999999999999764311 122222111 111 12
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
...++..+.+||.+||+.||++||+++++++. |+.++
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~~~ 279 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL--FRNLF 279 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH--HHHHH
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH--HHHHH
Confidence 35578999999999999999999999999873 44443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.58 Aligned_cols=248 Identities=18% Similarity=0.265 Sum_probs=210.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++++..+++.||+|++....... .+.+|+.+++.+.|++++..+..+...+...++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh----HHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 68999999999999999999999999999999987654433 47889999999999998888888777778999999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe---cCCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL---~~~g~vKL~DFGlak~~~~~~ 158 (610)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.......
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred Eec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999 999999998543 369999999999999999999999999999999999999 478899999999998765432
Q ss_pred c--------cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC---HHHHHHHHhhc----cCCCC
Q 007266 159 L--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKS----IVAPL 223 (610)
Q Consensus 159 ~--------~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---~~~l~~~I~~~----~~~~~ 223 (610)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+... .....
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 2 346789999999999999999999999999999999999999998643 11222222211 11112
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+..++..+.+||.+||+.||.+||++.++++.
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 35678999999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=360.94 Aligned_cols=248 Identities=19% Similarity=0.379 Sum_probs=218.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+. ++..||+|.+...... .+.+.+|++++++++||||+++++.+.. ...++||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~ 86 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIIT 86 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEE
Confidence 58999999999999999999975 5678999999755433 3468899999999999999999997653 3578999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||+.|++|.+++....+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 99999999999975443468999999999999999999999999999999999999999999999999998765433 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+........+..++..+.+||.+|
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 246 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHH
Confidence 234567889999999998889999999999999999999 9999999998888888877766677788999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|..||++|||+.++++.
T Consensus 247 l~~~p~~Rps~~~l~~~ 263 (279)
T 1qpc_A 247 WKERPEDRPTFDYLRSV 263 (279)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred hccChhhCCCHHHHHHH
Confidence 99999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=373.61 Aligned_cols=255 Identities=19% Similarity=0.308 Sum_probs=217.5
Q ss_pred CCeEEEeEecccCceEEEEEE-----EeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVR-----HKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~-----d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++++.||+|+||.||+++ +..++..||||.+... ........+.+|+.++++++||||+++++++...+ .
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 107 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-P 107 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-C
Confidence 589999999999999999999 5567889999999643 34445567889999999999999999999877654 6
Q ss_pred EEEEEeecCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC---Ceeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKANG-----VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~-----~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g---~vKL~DF 148 (610)
.|+||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 7899999999999999987532 3489999999999999999999999999999999999999544 5999999
Q ss_pred cccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCC
Q 007266 149 GLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLP 224 (610)
Q Consensus 149 Glak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p 224 (610)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 267 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCC
Confidence 9997653332 2334678999999999998899999999999999999998 99999999988888888777666777
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
..++..+.+||.+||+.||.+||++.++++|.|+
T Consensus 268 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 268 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 8899999999999999999999999999998664
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=360.20 Aligned_cols=247 Identities=17% Similarity=0.190 Sum_probs=209.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.+ +|+|++.+++.+.. +...|+|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEE
Confidence 5799999999999999999999999999999998654332 2477899999999 79999999987654 4588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC-----eeeeecccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-----IRLGDFGLAKMLI 155 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~-----vKL~DFGlak~~~ 155 (610)
|||+ |++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 85 ~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 9999 999999998753 36999999999999999999999999999999999999988776 9999999998765
Q ss_pred ccc--------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc---CHHHHHHHHhhccC----
Q 007266 156 SDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIV---- 220 (610)
Q Consensus 156 ~~~--------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~---~~~~l~~~I~~~~~---- 220 (610)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. .....+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 432 234668999999999999999999999999999999999999999874 34444444432211
Q ss_pred CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 221 APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 221 ~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
......++..+.+||.+||+.||.+||+++++++.
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11233678999999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=366.94 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=208.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee---cCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---KGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~---~~~~~~ 78 (610)
++|++++.||+|+||.||++.+..+++.||||.+... .....+.+.+|+.+++.++||||+++++++.. .....|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 4799999999999999999999999999999998643 34456678999999999999999999998873 234789
Q ss_pred EEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+||||+.+++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 999999999999999763 234799999999999999999999999999999999999999999999999998876432
Q ss_pred cc----------ccccccCCCcccCCccccCCC---CCCCccccccchhHHhhhhcCccccccCH--HHHHHHHhhccCC
Q 007266 157 DD----------LASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQKAAFKAFDM--QALINKINKSIVA 221 (610)
Q Consensus 157 ~~----------~~~~~vGTp~Y~APEvl~~~~---yt~ksDIWSLG~iLyeLltG~~PF~~~~~--~~l~~~I~~~~~~ 221 (610)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+......
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC
Confidence 11 112356899999999987654 68899999999999999999999965211 1122233333444
Q ss_pred CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 222 PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 222 ~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+.+..++..+.+||.+||+.||.+||++.+++++
T Consensus 267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 4556789999999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=374.64 Aligned_cols=250 Identities=22% Similarity=0.392 Sum_probs=212.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEE----EEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKY----VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~v----AIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.++++++||||+++++++...+ .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 91 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V 91 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--E
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--c
Confidence 68999999999999999999998877654 666665332 2233456889999999999999999999887654 7
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++|++|+.+++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred eEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 78999999999999998754 36899999999999999999999999999999999999999999999999999876433
Q ss_pred c---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 D---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
. ......||+.|+|||++.+..|+.++|||||||++|+|++ |..||.+.....+...+......+.+..++..+.+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 250 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 2 2234567889999999999999999999999999999999 99999998888888888777777788889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||..||.+||++.|+++.
T Consensus 251 li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 251 IMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=362.42 Aligned_cols=254 Identities=32% Similarity=0.587 Sum_probs=205.8
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccc-ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+++|++++.||+|+||.||++.+..+++.||+|++.... ........+.+|+.++++++||||+++++.+...+ ..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-cEEE
Confidence 368999999999999999999999999999999997533 34456677899999999999999999999887654 7899
Q ss_pred EEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999999999752 3346899999999999999999999999999999999999999999999999998765433
Q ss_pred c-ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc--CHHHHHHHHhhccCCCC-CcccchHHHH
Q 007266 158 D-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF--DMQALINKINKSIVAPL-PTVYSGAFRG 233 (610)
Q Consensus 158 ~-~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~--~~~~l~~~I~~~~~~~~-p~~~s~~l~~ 233 (610)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+. ....+...+......+. ...++.++.+
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 269 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence 2 334568999999999999999999999999999999999999999754 34455555554443333 3568999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||..||.+||++.+++++
T Consensus 270 li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 270 LVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=371.48 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=207.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH----HHHHHHHHHHHHHHhc----CCCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD----RARRSAHQEMELISRV----RNPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~----~~~~~l~~Ei~iL~~L----~HpnIV~l~~~~~~~ 73 (610)
++|++++.||+|+||.||++++..+++.||||++....... .....+.+|+.++.++ +|+||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 57999999999999999999999999999999997554322 1223456799999998 899999999987655
Q ss_pred CcEEEEEEee-cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec-CCCCeeeeecccc
Q 007266 74 GCYVCIIIGY-CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLA 151 (610)
Q Consensus 74 ~~~~~LVmEy-~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~-~~g~vKL~DFGla 151 (610)
+ ..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 111 ~-~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 111 E-GFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred C-eEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 4 67899999 78999999998765 689999999999999999999999999999999999999 7899999999999
Q ss_pred cccccccccccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchH
Q 007266 152 KMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGA 230 (610)
Q Consensus 152 k~~~~~~~~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~ 230 (610)
...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... . +.. .....+..++..
T Consensus 188 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~-~~~~~~~~~~~~ 259 (312)
T 2iwi_A 188 ALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILE-AELHFPAHVSPD 259 (312)
T ss_dssp EECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH-TCCCCCTTSCHH
T ss_pred hhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhh-hccCCcccCCHH
Confidence 876543 3456789999999999877665 458999999999999999999997642 1 111 123356778999
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhhh
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~~ 265 (610)
+.+||.+||+.||++||+++|+|+||||+......
T Consensus 260 ~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~ 294 (312)
T 2iwi_A 260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294 (312)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred HHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence 99999999999999999999999999998755443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=375.40 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=213.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH----HHHHHHHHHHHHHHhcC--CCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD----RARRSAHQEMELISRVR--NPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~----~~~~~l~~Ei~iL~~L~--HpnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|.+..+++.||||.+....... .....+.+|+.+++++. |+||+++++++... .
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-~ 121 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-D 121 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-S
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-C
Confidence 58999999999999999999999999999999997654321 12234667999999996 59999999987655 4
Q ss_pred EEEEEEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec-CCCCeeeeecccccc
Q 007266 76 YVCIIIGYCEG-GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKM 153 (610)
Q Consensus 76 ~~~LVmEy~~G-gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~-~~g~vKL~DFGlak~ 153 (610)
.+++||||+.+ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred cEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 78899999986 89999998765 689999999999999999999999999999999999999 678999999999987
Q ss_pred cccccccccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHH
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... +... ....+..++.++.
T Consensus 200 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~-~~~~~~~~~~~~~ 271 (320)
T 3a99_A 200 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQRVSSECQ 271 (320)
T ss_dssp CCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCCSSCCCHHHH
T ss_pred cccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc-cccccccCCHHHH
Confidence 6533 3455789999999999887665 6789999999999999999999976431 1111 2235667899999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+||.+||+.||.+||+++|+++||||+...
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=360.64 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=215.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||.||++.+... +..||+|.+.... .....+.+.+|+.+++.++||||+++++++... ..|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 88 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--PTW 88 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS--SCE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCE
Confidence 5899999999999999999997653 4469999987543 344567789999999999999999999987543 457
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+.|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999999998753 358999999999999999999999999999999999999999999999999998764432
Q ss_pred --ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 159 --LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 159 --~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+......+.+..+++.+.+||
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLM 247 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 2334567889999999998899999999999999999998 9999988777777777777666677888999999999
Q ss_pred HHhhcCCCCCCCCHHHHhcC
Q 007266 236 KSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~H 255 (610)
.+||..||.+||++.|++++
T Consensus 248 ~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 248 TRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCchhCcCHHHHHHH
Confidence 99999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=361.53 Aligned_cols=245 Identities=20% Similarity=0.317 Sum_probs=209.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCC-------eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHER-------KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG 74 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~-------~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~ 74 (610)
++|++.+.||+|+||.||++.+..++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++...+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 68999999999999999999998876 5799999865433 23456889999999999999999999887654
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC--------eeee
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--------IRLG 146 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~--------vKL~ 146 (610)
..|+||||+.|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+
T Consensus 86 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 86 -ENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp -CCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred -CCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 6789999999999999998753 24899999999999999999999999999999999999998887 9999
Q ss_pred ecccccccccccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCC
Q 007266 147 DFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLP 224 (610)
Q Consensus 147 DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p 224 (610)
|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+.......... ....+
T Consensus 164 Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~~~~ 238 (289)
T 4fvq_A 164 DPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RHQLP 238 (289)
T ss_dssp CCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TCCCC
T ss_pred cCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cCCCC
Confidence 99998765332 34568999999999987 678999999999999999999 5667777666555544433 33456
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..++..+.+||.+||+.||.+|||+.++++|
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6678899999999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=367.84 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=214.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCC----eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHER----KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~----~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++++++||||+++++++... ...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-CCc
Confidence 57999999999999999999987653 469999997543 444556789999999999999999999987654 478
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 89999999999999998743 36899999999999999999999999999999999999999999999999999876433
Q ss_pred c----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHH
Q 007266 158 D----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 158 ~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
. ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+......+.+..++..+.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 280 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 280 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHH
Confidence 2 1223456788999999999999999999999999999998 9999999998888888887766777788999999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcC
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+||.+||+.||.+||++.+++++
T Consensus 281 ~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 281 QLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.37 Aligned_cols=247 Identities=18% Similarity=0.368 Sum_probs=219.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+. ++..||||.+...... .+.+.+|+.+|++++|||||++++++. +..+|+||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~ 261 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIIT 261 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEE
T ss_pred HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEE
Confidence 57999999999999999999885 4678999999765433 456889999999999999999999875 34678999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 99999999999986544468999999999999999999999999999999999999999999999999998764332 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+++.|+|||++....++.++|||||||+||||++ |..||.+.+..++...+......+.+..++..+.+||.+|
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 421 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 421 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 234456788999999998899999999999999999999 9999999999888888888777778888999999999999
Q ss_pred hcCCCCCCCCHHHHhc
Q 007266 239 LRKNPEFRPSAAELLC 254 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~ 254 (610)
|..||++|||+++++.
T Consensus 422 l~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 422 WKNRPEERPTFEYIQS 437 (454)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHHH
Confidence 9999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=380.99 Aligned_cols=251 Identities=22% Similarity=0.377 Sum_probs=209.6
Q ss_pred CCeEEEeEecccCceEEEEEEEe---CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK---HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~---~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||.||++++. .++..||||.+.... .....+.+.+|+.+|++++||||+++++++... ..+|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 122 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-KPVM 122 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CceE
Confidence 47999999999999999999987 456789999997543 445567799999999999999999999987654 4788
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 123 lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999998643 468999999999999999999999999999999999999999999999999998764332
Q ss_pred c----cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 L----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ~----~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
. .....+++.|+|||++.+..++.++|||||||+||||++ |..||......++...+......+.+..++..+.+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 281 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHH
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHH
Confidence 1 122345778999999999999999999999999999987 99999999988888888877767777889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||+.||.+||++.++++.
T Consensus 282 li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 282 LMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCcChhhCcCHHHHHHH
Confidence 9999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=368.81 Aligned_cols=246 Identities=20% Similarity=0.303 Sum_probs=202.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC---cEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~---~~~~ 78 (610)
++|++++.||+|+||.||++++. ++.||||++.... .......+|+.+|++++|||||++++++.... ..+|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 58999999999999999999874 7899999996443 22344567999999999999999999988653 3589
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CeecccCCCCceEecCCCCeeeeec
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN----------HILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~----------gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
+|||||++|+|.++++.. .+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+||
T Consensus 99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999999874 589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccc---ccccccCCCcccCCccccCC-----CCCCCccccccchhHHhhhhcCcccccc--------------
Q 007266 149 GLAKMLISDD---LASSVVGTPSYMCPELLADI-----PYGSKSDIWSLGCCVYEMSAQKAAFKAF-------------- 206 (610)
Q Consensus 149 Glak~~~~~~---~~~~~vGTp~Y~APEvl~~~-----~yt~ksDIWSLG~iLyeLltG~~PF~~~-------------- 206 (610)
|+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 9998764432 23346899999999998863 4566889999999999999999999653
Q ss_pred --CHHHHHHHHhhccCCC-CCc-----ccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 207 --DMQALINKINKSIVAP-LPT-----VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 207 --~~~~l~~~I~~~~~~~-~p~-----~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+...+......+ .+. ..+.++.+||.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2233333333222222 222 234569999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=393.86 Aligned_cols=250 Identities=18% Similarity=0.335 Sum_probs=223.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+..++..||||.+...... .+.+.+|+.+|++++|||||++++++...+ .+|+||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~ 295 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIIT 295 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC-cEEEEE
Confidence 4799999999999999999999999999999999755433 356889999999999999999999876554 688999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||+.||+|.+++.......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 99999999999988665679999999999999999999999999999999999999999999999999998764332 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+++.|+|||++.+..|+.++|||||||+||||++ |..||.+.+...+...+......+.+..++..+.+||.+|
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 455 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 234456788999999998899999999999999999998 9999999888888888877777777888999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||.+|||+.++++.
T Consensus 456 l~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 456 WQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCcChhHCcCHHHHHHH
Confidence 99999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=367.66 Aligned_cols=252 Identities=20% Similarity=0.386 Sum_probs=214.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe-----EEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK-----KYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~-----~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||++.+..++. .||+|.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 123 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG- 123 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC-
Confidence 689999999999999999999976654 79999997543 334556789999999999 8999999999876554
Q ss_pred EEEEEEeecCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCe
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 143 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~v 143 (610)
.+|+||||++|++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence 6889999999999999997642 2358999999999999999999999999999999999999999999
Q ss_pred eeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHH-HHHHhhc
Q 007266 144 RLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQAL-INKINKS 218 (610)
Q Consensus 144 KL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l-~~~I~~~ 218 (610)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+...... ...+...
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 283 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence 999999998654332 2334567889999999998899999999999999999998 9999987654433 3333444
Q ss_pred cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 219 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 219 ~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 4455677789999999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=382.80 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=211.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~~~LV 80 (610)
++|++.+.||+|+||.||+|++..+++.||||++...... ...+.+.+|+++|++++||||+++++++...+ ...|+|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4799999999999999999999999999999999754322 22456779999999999999999999887654 368999
Q ss_pred EeecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe----cCCCCeeeeecccccccc
Q 007266 81 IGYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~-~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL----~~~g~vKL~DFGlak~~~ 155 (610)
||||+|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999999999999976432 238999999999999999999999999999999999999 677779999999998876
Q ss_pred cccccccccCCCcccCCccccC--------CCCCCCccccccchhHHhhhhcCcccccc----CHHHHHHHHhhccCC--
Q 007266 156 SDDLASSVVGTPSYMCPELLAD--------IPYGSKSDIWSLGCCVYEMSAQKAAFKAF----DMQALINKINKSIVA-- 221 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~--------~~yt~ksDIWSLG~iLyeLltG~~PF~~~----~~~~l~~~I~~~~~~-- 221 (610)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||... ...+.+..+......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 6666667889999999999865 56788999999999999999999999743 233444444333211
Q ss_pred ----------------------CCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 222 ----------------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 222 ----------------------~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+...++..+.+||.+||+.||++||+++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1223466789999999999999999999999765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=360.02 Aligned_cols=248 Identities=25% Similarity=0.466 Sum_probs=200.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+.. .||+|++..........+.+.+|+.+|++++||||+.++++. .....++||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~lv~ 98 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--TAPQLAIVT 98 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSCEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec--cCCccEEEE
Confidence 589999999999999999998643 599999988777777778899999999999999999999854 334578999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---D 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~---~ 158 (610)
||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred EecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999999999996543 46899999999999999999999999999999999999999999999999999765422 2
Q ss_pred ccccccCCCcccCCcccc---CCCCCCCccccccchhHHhhhhcCccccccCH-HHHHHHHhhccCCC----CCcccchH
Q 007266 159 LASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAP----LPTVYSGA 230 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~-~~l~~~I~~~~~~~----~p~~~s~~ 230 (610)
......||+.|+|||++. +..++.++|||||||++|+|++|..||.+... ..+...+......+ ....++..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 334568999999999986 56688899999999999999999999987543 34444444333222 33467899
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+.+||.+||+.||.+||++.++++.
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHH
Confidence 9999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=358.62 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=197.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHh--cCCCceeeeeeeEeec---CcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVEK---GCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIV~l~~~~~~~---~~~ 76 (610)
++|++++.||+|+||.||++.+ +++.||||++.... ...+.+|.+++.. ++||||+++++.+... +..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 5899999999999999999987 68999999986432 2335566777666 7999999999987653 356
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCeecccCCCCceEecCCCCeeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH--------ANHILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLH--------s~gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
+|+||||+++|+|.++++.. .+++..+..++.||+.||.||| ++||+||||||+||||+.++.+||+||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 89999999999999999643 6899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccc-----cccccCCCcccCCccccCC------CCCCCccccccchhHHhhhhc----------Ccccccc-
Q 007266 149 GLAKMLISDDL-----ASSVVGTPSYMCPELLADI------PYGSKSDIWSLGCCVYEMSAQ----------KAAFKAF- 206 (610)
Q Consensus 149 Glak~~~~~~~-----~~~~vGTp~Y~APEvl~~~------~yt~ksDIWSLG~iLyeLltG----------~~PF~~~- 206 (610)
|+++....... ....+||+.|+|||++.+. .++.++|||||||++|+|++| ..||...
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99976543321 2345899999999999876 455789999999999999999 8888543
Q ss_pred ----CHHHHHHHHhhcc-CCCCC-----cccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 207 ----DMQALINKINKSI-VAPLP-----TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 207 ----~~~~l~~~I~~~~-~~~~p-----~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+...+.... ....+ ..++..+.+||.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2223332222221 22222 2356789999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=361.86 Aligned_cols=247 Identities=26% Similarity=0.445 Sum_probs=191.0
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEe-------ecC
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWV-------EKG 74 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~-------~~~ 74 (610)
+|++.+.||+|+||.||++++..+++.||+|.+... .....+.+.+|+.++.++. ||||+++++++. ...
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 799999999999999999999999999999998543 3445567889999999996 999999999885 344
Q ss_pred cEEEEEEeecCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEecCCCCeeeeecccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKA-NGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLA 151 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~-~~~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~~~g~vKL~DFGla 151 (610)
..+++||||+. |+|.+++... ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 56899999995 6999988752 3346999999999999999999999999 999999999999999999999999999
Q ss_pred cccccccc-------------cccccCCCcccCCccc---cCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHH
Q 007266 152 KMLISDDL-------------ASSVVGTPSYMCPELL---ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 215 (610)
Q Consensus 152 k~~~~~~~-------------~~~~vGTp~Y~APEvl---~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I 215 (610)
+....... ....+||+.|+|||++ .+..++.++|||||||++|+|++|..||..........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-- 263 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-- 263 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc--
Confidence 87643321 1245799999999998 56678899999999999999999999998765443332
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.....+.+..++..+.+||.+||+.||.+||++.|+++|
T Consensus 264 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 264 -GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ---CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 223344456678889999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=371.68 Aligned_cols=252 Identities=16% Similarity=0.229 Sum_probs=201.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC-----CeEEEEEEEccccccHHH---------HHHHHHHHHHHHhcCCCceeeee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE-----RKKYVLKKIRLARQTDRA---------RRSAHQEMELISRVRNPFIVEYK 67 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~-----~~~vAIK~i~~~~~~~~~---------~~~l~~Ei~iL~~L~HpnIV~l~ 67 (610)
++|++++.||+|+||.||+|.+..+ ++.||||.+......... ...+.+|+..+..++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999999765 578999998754321110 12234566677788999999999
Q ss_pred eeEeec---CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec--CCCC
Q 007266 68 DSWVEK---GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT--RDQD 142 (610)
Q Consensus 68 ~~~~~~---~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~--~~g~ 142 (610)
+++... ..+.|+||||+ |++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||+ .++.
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 988764 25689999999 99999999874 34699999999999999999999999999999999999999 8899
Q ss_pred eeeeecccccccccccc--------cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH-HHHH
Q 007266 143 IRLGDFGLAKMLISDDL--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALIN 213 (610)
Q Consensus 143 vKL~DFGlak~~~~~~~--------~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~-~l~~ 213 (610)
+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.... ....
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 99999999987643321 23456999999999999999999999999999999999999999864211 1111
Q ss_pred HHhhccCCC---------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 214 KINKSIVAP---------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 214 ~I~~~~~~~---------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
......... ....++.++.+||..||..||.+||++.++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 111100000 124578999999999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.80 Aligned_cols=250 Identities=18% Similarity=0.247 Sum_probs=201.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeC---CCeEEEEEEEccccccHH---------HHHHHHHHHHHHHhcCCCceeeeeee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH---ERKKYVLKKIRLARQTDR---------ARRSAHQEMELISRVRNPFIVEYKDS 69 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~---~~~~vAIK~i~~~~~~~~---------~~~~l~~Ei~iL~~L~HpnIV~l~~~ 69 (610)
++|++++.||+|+||.||+|.+.. ++..+|+|.+........ ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 788999999875432111 11336678899999999999999998
Q ss_pred Eeec---CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC--Cee
Q 007266 70 WVEK---GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ--DIR 144 (610)
Q Consensus 70 ~~~~---~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g--~vK 144 (610)
+... +...|+||||+ |++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+|
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 8763 56899999999 999999998755 789999999999999999999999999999999999999887 999
Q ss_pred eeeccccccccccc--------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc--CHHHHHHH
Q 007266 145 LGDFGLAKMLISDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF--DMQALINK 214 (610)
Q Consensus 145 L~DFGlak~~~~~~--------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~--~~~~l~~~ 214 (610)
|+|||+++...... .....+||+.|+|||++.+..++.++|||||||+||+|++|..||.+. +.......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999998764322 124568999999999999999999999999999999999999999652 22222221
Q ss_pred HhhccCCCCCc---------ccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 215 INKSIVAPLPT---------VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 215 I~~~~~~~~p~---------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
. .......+. .++.++.+||.+||..||++||+++++++.
T Consensus 274 ~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 K-TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp H-HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred H-HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1 111111222 678899999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=364.32 Aligned_cols=247 Identities=21% Similarity=0.409 Sum_probs=211.0
Q ss_pred eEEEeEecccCceEEEEEEE----eCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRH----KHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVC 78 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d----~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~~ 78 (610)
|++++.||+|+||.||++.. ..+++.||||++... ......+.+.+|+.+|++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 49999999999999988754 447899999999754 3445567789999999999999999999998875 36889
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 999999999999999764 48999999999999999999999999999999999999999999999999998765432
Q ss_pred ----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH---------------HHHHHHhhcc
Q 007266 159 ----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---------------ALINKINKSI 219 (610)
Q Consensus 159 ----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~---------------~l~~~I~~~~ 219 (610)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+...+....
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 234567888999999999888999999999999999999999999754321 2333444555
Q ss_pred CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 220 VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 220 ~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
..+.+..++..+.+||.+||+.||.+|||+.|+++
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 56677889999999999999999999999999996
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=369.85 Aligned_cols=246 Identities=19% Similarity=0.257 Sum_probs=205.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeC--------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceee--------
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH--------ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE-------- 65 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~--------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~-------- 65 (610)
++|++.+.||+|+||.||+|++.. .++.||+|.+... +.+.+|+.+++++.||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 689999999999999999999987 4889999998744 24778999999999999987
Q ss_pred -------eeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec
Q 007266 66 -------YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 138 (610)
Q Consensus 66 -------l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~ 138 (610)
+++.+...+...|+||||+ |++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 5666666567899999999 99999999875344799999999999999999999999999999999999999
Q ss_pred CCC--Ceeeeeccccccccccc--------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC-
Q 007266 139 RDQ--DIRLGDFGLAKMLISDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD- 207 (610)
Q Consensus 139 ~~g--~vKL~DFGlak~~~~~~--------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~- 207 (610)
.++ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+||+|++|..||....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 89999999998764332 1244589999999999999999999999999999999999999998763
Q ss_pred -HHHHHHHHhh--ccCCCC------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 208 -MQALINKINK--SIVAPL------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 208 -~~~l~~~I~~--~~~~~~------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
...+...+.. .....+ ...++..+.+||.+||..||.+||+++++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3333332221 111111 12468999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=377.77 Aligned_cols=251 Identities=17% Similarity=0.290 Sum_probs=208.5
Q ss_pred CeEEEeEecccCceEEEEEEEeCCC---eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHER---KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~---~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+|++.+.||+|+||.||++.+..++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++...+...|+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4889999999999999999987533 468999886433 334566789999999999999999999988776667889
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 169 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999997643 3689999999999999999999999999999999999999999999999999986543321
Q ss_pred -----cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 160 -----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 160 -----~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
.....+|+.|+|||++.+..++.++|||||||+||+|++ |.+||.+.+..+....+........+..++..+.+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~ 327 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 234567889999999999999999999999999999999 78899887766666667666666677889999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||+.||++||++.+++++
T Consensus 328 li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 328 VMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=383.29 Aligned_cols=248 Identities=19% Similarity=0.372 Sum_probs=214.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+.. +..||||++...... .+.+.+|+.+|++++||||+++++++.. ..+|+||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~ 257 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVT 257 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEe
Confidence 579999999999999999999864 467999999765443 3468899999999999999999998754 4578999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
||+.||+|.+++....+..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999999765444689999999999999999999999999999999999999999999999999987643322
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+++.|+|||++.+..++.++|||||||+||||++ |..||.+....++...+......+.+..++..+.+||.+|
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 417 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 417 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 234457789999999998899999999999999999999 9999999998888888887777777888999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||++|||++++++.
T Consensus 418 l~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 418 WRKEPEERPTFEYLQAF 434 (452)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=356.56 Aligned_cols=251 Identities=20% Similarity=0.359 Sum_probs=206.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-CCe--EEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-ERK--KYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-~~~--~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||++.+.. ++. .||+|.+..... .....+.+.+|+.++++++||||+++++++...+ .
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 95 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--M 95 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--C
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--c
Confidence 589999999999999999998754 333 689998875432 2345677899999999999999999999887654 7
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 89999999999999998753 25899999999999999999999999999999999999999999999999999876433
Q ss_pred c----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhc-cCCCCCcccchHH
Q 007266 158 D----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKS-IVAPLPTVYSGAF 231 (610)
Q Consensus 158 ~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~-~~~~~p~~~s~~l 231 (610)
. ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+...+... ...+.+..++..+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 254 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence 2 2334567889999999998889999999999999999999 99999999888888777554 3344567789999
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.++|.+||..||.+||++.+++++
T Consensus 255 ~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 255 YNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=359.65 Aligned_cols=243 Identities=25% Similarity=0.479 Sum_probs=202.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++++ .++.||+|.+... ...+.+.+|+.+|++++||||+++++.+.+ ..|+||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~ 78 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVM 78 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEE
Confidence 5899999999999999999987 4788999998633 234568899999999999999999997653 368999
Q ss_pred eecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCCCceEecCCCC-eeeeeccccccccc
Q 007266 82 GYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMALNYLHA---NHILHRDVKCSNIFLTRDQD-IRLGDFGLAKMLIS 156 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~-~~lse~~i~~i~~QLl~aL~yLHs---~gIiHRDLKPeNILL~~~g~-vKL~DFGlak~~~~ 156 (610)
||++|++|.+++..... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999999986432 247899999999999999999999 89999999999999998887 79999999976533
Q ss_pred ccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc--CHHHHHHHHhhccCCCCCcccchHHHHH
Q 007266 157 DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF--DMQALINKINKSIVAPLPTVYSGAFRGL 234 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~--~~~~l~~~I~~~~~~~~p~~~s~~l~~L 234 (610)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+......+.+..++..+.+|
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 159 H--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred c--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHH
Confidence 2 33457999999999999999999999999999999999999999754 3334444555555566777899999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcC
Q 007266 235 VKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~H 255 (610)
|.+||+.||.+|||+++++++
T Consensus 237 i~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=370.01 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=206.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++... ...|+||
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 114 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDER-NEMILIY 114 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-TCCEEEE
T ss_pred hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEEE
Confidence 68999999999999999999964 688999998875433 2345688999999999999999999987654 4788999
Q ss_pred eecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc--
Q 007266 82 GYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-- 157 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-- 157 (610)
||++|++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999886532 235899999999999999999999999999999999999999999999999999764322
Q ss_pred -cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHH-------HHHhhc---------cC
Q 007266 158 -DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALI-------NKINKS---------IV 220 (610)
Q Consensus 158 -~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~-------~~I~~~---------~~ 220 (610)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.. ...... ..
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 2234567999999999999889999999999999999999999999754321111 111111 11
Q ss_pred CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 221 APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 221 ~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
...+..++..+.++|.+||+.||++|||+.|+++|
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12334567789999999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=355.25 Aligned_cols=233 Identities=26% Similarity=0.445 Sum_probs=192.5
Q ss_pred CCCeEEE-eEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHH-HhcCCCceeeeeeeEee---cCc
Q 007266 1 MEQYEVL-EQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELI-SRVRNPFIVEYKDSWVE---KGC 75 (610)
Q Consensus 1 md~Y~il-k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL-~~L~HpnIV~l~~~~~~---~~~ 75 (610)
+++|.++ +.||+|+||.||++.+..+++.||+|.+... ..+.+|+.++ +.++||||+++++.|.. .+.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3689998 7899999999999999999999999998632 2366788887 56689999999998765 245
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC---CCCeeeeeccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAK 152 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~---~g~vKL~DFGlak 152 (610)
.+|+||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 7899999999999999999876667999999999999999999999999999999999999998 7889999999986
Q ss_pred ccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC---CCCC----c
Q 007266 153 MLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLP----T 225 (610)
Q Consensus 153 ~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~---~~~p----~ 225 (610)
... +..|+.++|||||||++|+|++|..||.+.........+..... ...+ .
T Consensus 169 ~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (299)
T 3m2w_A 169 ETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227 (299)
T ss_dssp ECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHT
T ss_pred ccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcc
Confidence 532 24567899999999999999999999987654443222211111 1112 4
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 228 ~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 578999999999999999999999999999999753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=388.04 Aligned_cols=248 Identities=19% Similarity=0.371 Sum_probs=219.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++.+.. +..||||++...... .+.+.+|+.+|++++|||||++++++.. ..+||||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~ 340 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVT 340 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEee
Confidence 579999999999999999999864 467999999765443 3458899999999999999999998754 4578999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
||+.+|+|.++++...+..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 99999999999976544468999999999999999999999999999999999999999999999999998764332 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....++..|+|||++.+..++.++|||||||+||||++ |..||.+....+++..+......+.+..++..+.+||.+|
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 500 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 500 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 234567789999999998899999999999999999999 9999999998888888887777777888999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||++|||+++|++.
T Consensus 501 l~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 501 WRKEPEERPTFEYLQAF 517 (535)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhHCcCHHHHHHH
Confidence 99999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=376.47 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=197.9
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+|++.+.||+|+||+||. ....+++.||||++...... .+.+|+.+|+.+ +|||||++++++... ...|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDR-QFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecC-CEEEEEE
Confidence 599999999999999874 55668899999999654332 256799999999 799999999987654 5789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC---CC--Ceeeeeccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQ--DIRLGDFGLAKMLIS 156 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~---~g--~vKL~DFGlak~~~~ 156 (610)
|||. ++|.+++.... ..+.+..+..++.||+.||.|||++||+||||||+||||+. ++ .+||+|||+++....
T Consensus 98 E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp ECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred ECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 9996 59999998754 34666778899999999999999999999999999999953 33 477999999987643
Q ss_pred c----cccccccCCCcccCCcccc---CCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCC--CCCcc
Q 007266 157 D----DLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA--PLPTV 226 (610)
Q Consensus 157 ~----~~~~~~vGTp~Y~APEvl~---~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~--~~p~~ 226 (610)
. ......+||+.|+|||++. ...++.++|||||||++|+|++ |..||...........+...... ..+..
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 3 2344578999999999997 4567889999999999999999 99999765544333222211111 12234
Q ss_pred cchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhh
Q 007266 227 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 263 (610)
Q Consensus 227 ~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~ 263 (610)
.+..+++||.+||+.||.+|||++++|+||||....+
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 5677899999999999999999999999999987554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=358.44 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=211.3
Q ss_pred CCeEEEeEecccCceEEEEEE----EeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVR----HKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~----d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~ 76 (610)
++|++++.||+|+||.||+++ +..+++.||+|++... .....+.+.+|+.++++++||||+++++.+...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 469999999999999999998 4568999999999753 3345567899999999999999999999876543 46
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+++||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred eEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 789999999999999998753 3589999999999999999999999999999999999999999999999999987644
Q ss_pred cc----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCH----------------HHHHHHHh
Q 007266 157 DD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM----------------QALINKIN 216 (610)
Q Consensus 157 ~~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~----------------~~l~~~I~ 216 (610)
.. ......++..|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 32 12345677889999999988899999999999999999999998864311 12233333
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.....+.+..++..+.+||.+||+.||.+||++.++++.
T Consensus 278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444455677899999999999999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=354.81 Aligned_cols=244 Identities=23% Similarity=0.381 Sum_probs=196.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHh--cCCCceeeeeeeEeecC---cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVEKG---CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIV~l~~~~~~~~---~~ 76 (610)
++|++++.||+|+||.||++++. ++.||||++..... ....+|.+++.. ++||||+++++.+.... ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 47999999999999999999874 88999999864322 223445555554 48999999999887653 57
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecccCCCCceEecCCCCeeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN--------HILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~--------gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
+|+||||++|++|.++++.. .+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 89999999999999999764 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccc-----cccccCCCcccCCccccCCCCCCC------ccccccchhHHhhhhc----------Ccccccc-
Q 007266 149 GLAKMLISDDL-----ASSVVGTPSYMCPELLADIPYGSK------SDIWSLGCCVYEMSAQ----------KAAFKAF- 206 (610)
Q Consensus 149 Glak~~~~~~~-----~~~~vGTp~Y~APEvl~~~~yt~k------sDIWSLG~iLyeLltG----------~~PF~~~- 206 (610)
|+++....... ....+||+.|+|||++.+..+... +|||||||++|||++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99976543321 235689999999999988777665 9999999999999999 6676543
Q ss_pred ----CHHHHHHHHhh-ccCCCCCc-----ccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 207 ----DMQALINKINK-SIVAPLPT-----VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 207 ----~~~~l~~~I~~-~~~~~~p~-----~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
........+.. ......+. .++..+.+||.+||+.||.+|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 12223322222 12222332 466789999999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=393.04 Aligned_cols=244 Identities=19% Similarity=0.346 Sum_probs=213.8
Q ss_pred eEecccCceEEEEEEEe--CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHK--HERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~--~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||++.+. .+++.||||++..........+.+.+|+.+|++++|||||++++++.. ..+++|||||.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence 48999999999999654 567899999998766555556779999999999999999999998753 34789999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc----ccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LAS 161 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~----~~~ 161 (610)
||+|.+++.... .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ...
T Consensus 453 ~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 453 LGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp TEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 999999998654 68999999999999999999999999999999999999999999999999998764332 123
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
...+|+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++...+........+..++.++.+||.+||+
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 3457789999999999999999999999999999998 999999999999999988887777888999999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q 007266 241 KNPEFRPSAAELLCH 255 (610)
Q Consensus 241 ~dP~~RpSa~eiL~H 255 (610)
.||++||+++++++.
T Consensus 611 ~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 611 YDVENRPGFAAVELR 625 (635)
T ss_dssp SSTTTSCCHHHHHHH
T ss_pred CCHhHCcCHHHHHHH
Confidence 999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=364.94 Aligned_cols=242 Identities=16% Similarity=0.239 Sum_probs=195.6
Q ss_pred CCeEEEeEecccCceEEEEE-----EEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC---CCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLV-----RHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR---NPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla-----~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIV~l~~~~~~~ 73 (610)
++|++.+.||+|+||.||+| .+..+++.||+|++.... ...+.+|+.++..+. |+||+.+++.+...
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 57999999999999999999 467789999999997542 234667888888776 89999999988765
Q ss_pred CcEEEEEEeecCCCCHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-----------
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKA---NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR----------- 139 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~---~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~----------- 139 (610)
+ ..|+|||||+||+|.+++... ....+++..++.|+.||+.||+|||++||+||||||+||||+.
T Consensus 140 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 140 N-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp S-CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred C-CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 5 678999999999999999753 2346999999999999999999999999999999999999998
Q ss_pred CCCeeeeecccccccc---cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHh
Q 007266 140 DQDIRLGDFGLAKMLI---SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN 216 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~---~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~ 216 (610)
++.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||+||+|++|..||......... +
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~- 295 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--P- 295 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--E-
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--e-
Confidence 8999999999997543 233456678999999999999999999999999999999999999999754321000 0
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
..... ....++.+.+++..||+.+|.+|++..+.|.
T Consensus 296 ~~~~~--~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 296 EGLFR--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp CSCCT--TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred chhcc--ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 00111 1134778999999999999999955444443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.18 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=204.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||++++. +++.||||.+...... .....+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 106 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVY 106 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS-CCEEEE
T ss_pred hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCC-ceEEEE
Confidence 68999999999999999999854 6889999998754322 12235789999999999999999999887654 678999
Q ss_pred eecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 82 GYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHAN---HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~--~~~lse~~i~~i~~QLl~aL~yLHs~---gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
||+.|++|.+++.... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 186 (326)
T 3uim_A 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186 (326)
T ss_dssp ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence 9999999999998643 23489999999999999999999999 999999999999999999999999999987643
Q ss_pred c--cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC--------HHHHHHHHhhc--------
Q 007266 157 D--DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--------MQALINKINKS-------- 218 (610)
Q Consensus 157 ~--~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~--------~~~l~~~I~~~-------- 218 (610)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+........
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 3uim_A 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266 (326)
T ss_dssp SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC
T ss_pred ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC
Confidence 3 23445679999999999988889999999999999999999999996321 11111111000
Q ss_pred --cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 007266 219 --IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256 (610)
Q Consensus 219 --~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp 256 (610)
.....+...+..+.+||.+||+.||.+|||+.|+++|.
T Consensus 267 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 01112334567899999999999999999999999883
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=380.19 Aligned_cols=247 Identities=17% Similarity=0.262 Sum_probs=209.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||++.+..+++.||||++....... .+.+|+++++.|.|++++..+..|...+...||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999887554433 36789999999998777776666767777899999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEe---cCCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL---~~~g~vKL~DFGlak~~~~~~ 158 (610)
||+ |++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 83 e~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred ECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 999 999999998643 369999999999999999999999999999999999999 578999999999998765432
Q ss_pred c--------cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC---HHHHHHHHhhcc----CCCC
Q 007266 159 L--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSI----VAPL 223 (610)
Q Consensus 159 ~--------~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---~~~l~~~I~~~~----~~~~ 223 (610)
. ....+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.. ....+..+.... ...+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 1 236789999999999999999999999999999999999999998743 333333332221 1122
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+..++.++.+||..||+.+|++||++.+|++
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3567899999999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=373.82 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=192.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+.|.+.+.||+|+||+||.+ ...+|+.||||.+.... .+.+.+|+.+|+++ +|||||++++.+... ..+|+|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTD-RFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecC-CeEEEE
Confidence 34667899999999999875 55679999999986432 23467899999886 899999999987654 588999
Q ss_pred EeecCCCCHHHHHHHhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-------------CC
Q 007266 81 IGYCEGGDMAEAIKKANGVH-----FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-------------QD 142 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~-----lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-------------g~ 142 (610)
||||. |+|.+++....... .++..+..++.||+.||.|||++||+||||||+||||+.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 59999998643211 1333467899999999999999999999999999999764 37
Q ss_pred eeeeeccccccccccc-----ccccccCCCcccCCccccC-------CCCCCCccccccchhHHhhhh-cCccccccCHH
Q 007266 143 IRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLAD-------IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQ 209 (610)
Q Consensus 143 vKL~DFGlak~~~~~~-----~~~~~vGTp~Y~APEvl~~-------~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~ 209 (610)
+||+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998765432 1235689999999999875 668999999999999999998 99999765433
Q ss_pred HHHHHHhhccCCC-----CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 210 ALINKINKSIVAP-----LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 210 ~l~~~I~~~~~~~-----~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
. ...+......+ .+..++.++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus 247 ~-~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 247 E-SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp H-HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred H-HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 2 11122111111 123467899999999999999999999999999999764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=357.31 Aligned_cols=247 Identities=18% Similarity=0.297 Sum_probs=191.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee----cCcE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE----KGCY 76 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~----~~~~ 76 (610)
+++|++++.||+|+||.||++++ +++.||||++....... .....|+..+..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh---HHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 57999999999999999999976 68999999997443211 112234444556899999999875432 3346
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CeecccCCCCceEecCCCCeeeee
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN---------HILHRDVKCSNIFLTRDQDIRLGD 147 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~---------gIiHRDLKPeNILL~~~g~vKL~D 147 (610)
+|+|||||+||+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 78999999999999999875 458999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccc---------ccccccCCCcccCCccccC-------CCCCCCccccccchhHHhhhhcCccccccC----
Q 007266 148 FGLAKMLISDD---------LASSVVGTPSYMCPELLAD-------IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---- 207 (610)
Q Consensus 148 FGlak~~~~~~---------~~~~~vGTp~Y~APEvl~~-------~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---- 207 (610)
||+++...... .....+||+.|+|||++.+ ..++.++|||||||+||||++|..||....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99998754321 2335689999999999987 456678999999999999999977653211
Q ss_pred --------------HHHHHHHHhh-ccCCCCCcc------cchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 208 --------------MQALINKINK-SIVAPLPTV------YSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 208 --------------~~~l~~~I~~-~~~~~~p~~------~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.......+.. .....++.. ++..+.+||.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 1111111111 111222222 45589999999999999999999999763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=387.12 Aligned_cols=249 Identities=19% Similarity=0.334 Sum_probs=213.2
Q ss_pred CeEEEe-EecccCceEEEEEEEeC--CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 3 QYEVLE-QIGKGSFGSALLVRHKH--ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 3 ~Y~ilk-~LG~G~fG~Vyla~d~~--~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
+|.+.+ .||+|+||.||++.+.. ++..||||++..... ....+.+.+|+++|++++|||||++++++.. ..+|+
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~l 412 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML 412 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEE
Confidence 456666 89999999999998864 566799999975432 2334668899999999999999999998765 35889
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|||||.||+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 413 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999999754 34699999999999999999999999999999999999999999999999999987643321
Q ss_pred ----cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHH
Q 007266 160 ----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234 (610)
Q Consensus 160 ----~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~L 234 (610)
.....+++.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++...+......+.+..++.++.+|
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 571 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 571 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 123345689999999998999999999999999999998 999999998888888888877777888899999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcC
Q 007266 235 VKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~H 255 (610)
|.+||..||++||++.++++.
T Consensus 572 i~~cl~~dP~~RPs~~~l~~~ 592 (613)
T 2ozo_A 572 MSDCWIYKWEDRPDFLTVEQR 592 (613)
T ss_dssp HHHTTCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=358.82 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=208.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
.++|++.+.||+|+||.||++.+.. .+|+|++..........+.+.+|+.++++++||||+++++++...+ .+++|
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~iv 107 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-HLAII 107 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-CEEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-ceEEE
Confidence 3789999999999999999998854 4999998765544444455778999999999999999999887654 68899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc----
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---- 156 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~---- 156 (610)
|||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.++|+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred eecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 9999999999999764 34689999999999999999999999999999999999998 78999999999876421
Q ss_pred --ccccccccCCCcccCCccccC---------CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC-C
Q 007266 157 --DDLASSVVGTPSYMCPELLAD---------IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-P 224 (610)
Q Consensus 157 --~~~~~~~vGTp~Y~APEvl~~---------~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~-p 224 (610)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........ +
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ 265 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc
Confidence 122344579999999999864 4578899999999999999999999999988888777766544433 3
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..++..+.+||.+||..||.+|||+.++++.
T Consensus 266 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 266 IGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 3688999999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.10 Aligned_cols=244 Identities=21% Similarity=0.314 Sum_probs=202.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHh--cCCCceeeeeeeEeecC---cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVEKG---CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIV~l~~~~~~~~---~~ 76 (610)
++|++.+.||+|+||.||++.+ +++.||||.+.... ...+.+|++++.. ++||||+++++.+...+ ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 4799999999999999999987 58999999986432 2346788888887 78999999999887654 27
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCeecccCCCCceEecCCCCeeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH--------ANHILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLH--------s~gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
+|+||||+.+++|.+++.+. .+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999864 5899999999999999999999 899999999999999999999999999
Q ss_pred cccccccccc-----ccccccCCCcccCCccccCCC------CCCCccccccchhHHhhhhc----------Ccccccc-
Q 007266 149 GLAKMLISDD-----LASSVVGTPSYMCPELLADIP------YGSKSDIWSLGCCVYEMSAQ----------KAAFKAF- 206 (610)
Q Consensus 149 Glak~~~~~~-----~~~~~vGTp~Y~APEvl~~~~------yt~ksDIWSLG~iLyeLltG----------~~PF~~~- 206 (610)
|++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++| ..||...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998765433 235568999999999987753 33689999999999999999 7788654
Q ss_pred ----CHHHHHHHHhhcc-CCCCCc-----ccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 207 ----DMQALINKINKSI-VAPLPT-----VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 207 ----~~~~l~~~I~~~~-~~~~p~-----~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
....+...+.... ....+. .++..+.+||.+||+.||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2344444443322 222332 345689999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=351.24 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=202.5
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEcccc--ccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEee
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR--QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~--~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy 83 (610)
..+.||+|+||.||++.+ ++..||+|++.... ......+.+.+|+.++++++||||+++++++...+ ..|+||||
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 111 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD-DLCLVYVY 111 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEEEC
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC-ceEEEEEe
Confidence 448999999999999986 67899999987543 23345667899999999999999999999876554 68899999
Q ss_pred cCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---c
Q 007266 84 CEGGDMAEAIKKAN-GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---L 159 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~-~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---~ 159 (610)
++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 191 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence 99999999997532 3468999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHH----HHHHHhh----------ccCCCCCc
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA----LINKINK----------SIVAPLPT 225 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~----l~~~I~~----------~~~~~~p~ 225 (610)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... +...+.. ......+.
T Consensus 192 ~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (307)
T 2nru_A 192 TSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270 (307)
T ss_dssp CSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCH
T ss_pred ccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccch
Confidence 345689999999998875 47899999999999999999999997654221 1111111 11222345
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.++..+.+||.+||..||.+||++.+++++
T Consensus 271 ~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 567889999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=359.43 Aligned_cols=243 Identities=18% Similarity=0.214 Sum_probs=194.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc------cHHHHHHHHHHHHHHHhcC---------CCceeee
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ------TDRARRSAHQEMELISRVR---------NPFIVEY 66 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~------~~~~~~~l~~Ei~iL~~L~---------HpnIV~l 66 (610)
++|++++.||+|+||.||+|++ +++.||||++..... .....+.+.+|+.+|+.++ |||||.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5789999999999999999998 689999999986542 1223356888999998886 6777666
Q ss_pred eeeEe-----------------e------------cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Q 007266 67 KDSWV-----------------E------------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117 (610)
Q Consensus 67 ~~~~~-----------------~------------~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL 117 (610)
.+.+. . .+..+|+|||||.+|++.+.+.+ ..+++..++.|+.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 66543 2 15689999999999977666644 2689999999999999999
Q ss_pred HHHH-HCCeecccCCCCceEecCCC--------------------CeeeeecccccccccccccccccCCCcccCCcccc
Q 007266 118 NYLH-ANHILHRDVKCSNIFLTRDQ--------------------DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 176 (610)
Q Consensus 118 ~yLH-s~gIiHRDLKPeNILL~~~g--------------------~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~ 176 (610)
.||| ++||+||||||+||||+.++ .+||+|||+++.... ...+||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhc
Confidence 9999 99999999999999999887 899999999987653 2458999999999998
Q ss_pred CCCCCCCccccccchh-HHhhhhcCccccccCH-HHHHHHHhhccCC------CCCcccchHHHHHHHHhhcCCCCCCCC
Q 007266 177 DIPYGSKSDIWSLGCC-VYEMSAQKAAFKAFDM-QALINKINKSIVA------PLPTVYSGAFRGLVKSMLRKNPEFRPS 248 (610)
Q Consensus 177 ~~~yt~ksDIWSLG~i-LyeLltG~~PF~~~~~-~~l~~~I~~~~~~------~~p~~~s~~l~~LI~kmL~~dP~~RpS 248 (610)
+.. +.++||||||++ .++++.|..||.+... ..+...+...... +.+..+++++++||++||+.| |
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 776 889999998776 8889999999975321 2223333321111 112357899999999999987 9
Q ss_pred HHHHh-cCCCCC
Q 007266 249 AAELL-CHPHLQ 259 (610)
Q Consensus 249 a~eiL-~Hp~f~ 259 (610)
++|+| +||||+
T Consensus 325 a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 ATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHCGGGC
T ss_pred HHHHHhcCCCcC
Confidence 99999 999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=383.94 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=217.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||.||++.+..+ +..||+|.+... ......+.+.+|+.+|++++||||+++++++.+ ...|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 466 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW 466 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CceE
Confidence 5799999999999999999998653 467999988643 344556778999999999999999999998743 3578
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999999999998643 468999999999999999999999999999999999999999999999999998764432
Q ss_pred c--cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 159 L--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~--~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
. .....+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+......+.+..++..+.+||
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 625 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 625 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHH
Confidence 2 234567789999999998899999999999999999996 9999999999898888888777778888999999999
Q ss_pred HHhhcCCCCCCCCHHHHhcC
Q 007266 236 KSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~H 255 (610)
.+||..||.+||++.+++++
T Consensus 626 ~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 626 TKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=392.79 Aligned_cols=264 Identities=24% Similarity=0.365 Sum_probs=216.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEee-----cCc
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-----KGC 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~-----~~~ 75 (610)
+++|++++.||+|+||.||++.+..+|+.||||++... ......+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 46899999999999999999999999999999998754 345556778999999999999999999987643 245
Q ss_pred EEEEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC---eeeeecccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN-GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLA 151 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~-~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~---vKL~DFGla 151 (610)
..|+|||||+|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7789999999999999998643 235899999999999999999999999999999999999998776 899999999
Q ss_pred cccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHH---------Hh------
Q 007266 152 KMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK---------IN------ 216 (610)
Q Consensus 152 k~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~---------I~------ 216 (610)
............+||+.|+|||++.+..++.++|||||||++|+|++|..||........+.. +.
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~ 251 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence 887666666778999999999999999999999999999999999999999976532221100 00
Q ss_pred hc----c----CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhhh
Q 007266 217 KS----I----VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 217 ~~----~----~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~~ 265 (610)
.. . .......++..+.+||.+||..||.+|||+.++|+||||+....-+
T Consensus 252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00 0 0112334678999999999999999999999999999998754433
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=370.09 Aligned_cols=254 Identities=13% Similarity=0.086 Sum_probs=199.0
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCC-Cceee---------------
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRN-PFIVE--------------- 65 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~H-pnIV~--------------- 65 (610)
+|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.+.| .|...
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 48889999999999999999999999999999874332 22335678899999999977 21110
Q ss_pred ------eeeeEeec----CcEEEEEEeecCCCCHHHHHHH-----hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccC
Q 007266 66 ------YKDSWVEK----GCYVCIIIGYCEGGDMAEAIKK-----ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDV 130 (610)
Q Consensus 66 ------l~~~~~~~----~~~~~LVmEy~~GgsL~~~Ik~-----~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDL 130 (610)
+...+... ...++++|+++ +++|.++++. .....+++..+..++.||+.||.|||++||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 00111110 12356777766 6899999852 12335788899999999999999999999999999
Q ss_pred CCCceEecCCCCeeeeecccccccccccccccccCCCcccCCccc----------cCCCCCCCccccccchhHHhhhhcC
Q 007266 131 KCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL----------ADIPYGSKSDIWSLGCCVYEMSAQK 200 (610)
Q Consensus 131 KPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl----------~~~~yt~ksDIWSLG~iLyeLltG~ 200 (610)
||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..|+.++|||||||+||+|++|.
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999999999999998875433 556788 999999998 5666888999999999999999999
Q ss_pred ccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhhh
Q 007266 201 AAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 265 (610)
Q Consensus 201 ~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~~ 265 (610)
.||...+.......+.. ....++..+.+||.+||+.||++||++.++|+||||+.....+
T Consensus 315 ~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 315 LPNTDDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp CCCCTTGGGSCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred CCCCCcchhhhHHHHHh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 99987654433333221 2235789999999999999999999999999999998765443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.31 Aligned_cols=222 Identities=13% Similarity=0.094 Sum_probs=185.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||.||+|.+..+++.||||++...... ....+.+.+|+.++.+++||||+++++++... ...|+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEEE
Confidence 5799999999999999999999999999999999865543 45567789999999999999999999988765 478999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||++|++|.++++. ...+..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999954 23566789999999999999999999999999999999999999998543
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHH---HHhhccCC---CCCcccchHHHHH
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALIN---KINKSIVA---PLPTVYSGAFRGL 234 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~---~I~~~~~~---~~p~~~s~~l~~L 234 (610)
|++ +++.++|||||||+||+|++|..||.+.+....+. +....... .....++..+.+|
T Consensus 175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (286)
T 3uqc_A 175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239 (286)
T ss_dssp --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence 333 36889999999999999999999998765322110 00011111 1224578999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcC
Q 007266 235 VKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~H 255 (610)
|.+||+.||.+| |+.|+++.
T Consensus 240 i~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 240 AARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHcccCCccC-CHHHHHHH
Confidence 999999999999 99999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=378.14 Aligned_cols=241 Identities=22% Similarity=0.330 Sum_probs=201.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc----E
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC----Y 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~----~ 76 (610)
++|++++.||+|+||.||++.+.. +++.||||.+... ........+.+|+.+|.+++|||||++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 689999999999999999999986 7899999988643 334556678899999999999999999998876653 2
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
.||||||++|++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+||||+.+ .+||+|||+++....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 7999999999999987754 68999999999999999999999999999999999999875 899999999987643
Q ss_pred ccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-CCcccchHHHHHH
Q 007266 157 DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLV 235 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~-~p~~~s~~l~~LI 235 (610)
. ...+||+.|+|||++.+.. +.++|||||||+||+|++|.+||.+.... ..... .....+..+.+||
T Consensus 234 ~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYDSYGRLL 301 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCHHHHHHH
T ss_pred C---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCHHHHHHH
Confidence 3 5678999999999987654 88999999999999999999998753211 00000 1112467899999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+||+.||.+||+..+++.|+|+.-
T Consensus 302 ~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 302 RRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred hhhccCChhhCCCHHHHHHHHHHHH
Confidence 9999999999999999999887643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-33 Score=316.65 Aligned_cols=230 Identities=16% Similarity=0.108 Sum_probs=158.4
Q ss_pred eEecccCceEEEEEEEeCCCeEEEEEEEcccc--------ccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEEE
Q 007266 8 EQIGKGSFGSALLVRHKHERKKYVLKKIRLAR--------QTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~--------~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~~ 78 (610)
..++.|++|.+..++....|+.|++|.+.... ..+...+.+.+|+++|+++ .|+||+++++++.+ +..+|
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~y 318 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGW 318 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEE
Confidence 34678888888888888899999999997542 2234567799999999999 69999999997654 55899
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD- 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~- 157 (610)
||||||+|++|.++|++.+ .+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 319 LVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999998754 56665 47899999999999999999999999999999999999999999876443
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
....+.+||+.|||||++.+. +..++|+|++|+++|+|.++..+|.. .+... +. ....+..++..
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~~--------~l~~~-----~~-~~~~~~~l~~~ 458 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWLY--------AVWQE-----PV-ERWNFVLLLAL 458 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHHHH--------HHHTS-----CG-GGCSHHHHHHH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchhHH--------HhhcC-----CC-CCCcHHHHHHH
Confidence 345568999999999999764 56789999999999999887665421 11111 11 11134567777
Q ss_pred hhcCCCCCCCCHHHHhcCCCC
Q 007266 238 MLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f 258 (610)
++..+|..|+.......|+|.
T Consensus 459 l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 459 FEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHTGGGSCCGGGSSCCHHHHH
T ss_pred HhCCCCCCCCChhhhccchhH
Confidence 778888877766555555443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-28 Score=268.56 Aligned_cols=184 Identities=19% Similarity=0.198 Sum_probs=141.9
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc------HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT------DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~------~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
...+.||+|+||.||++ ...+..+++|........ ....+.+.+|+++|++++||||+.+..++...+ ..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD-NKR 415 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-TTE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-ccE
Confidence 34678999999999999 446778899987543321 122456899999999999999995555444443 458
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+|||||+|++|.+++.. +..|+.||+.||.|||++||+||||||+|||++. .+||+|||+++......
T Consensus 416 lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999998865 5689999999999999999999999999999998 99999999998875432
Q ss_pred --------ccccccCCCcccCCccccC--CCCCCCccccccchhHHhhhhcCccc
Q 007266 159 --------LASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAF 203 (610)
Q Consensus 159 --------~~~~~vGTp~Y~APEvl~~--~~yt~ksDIWSLG~iLyeLltG~~PF 203 (610)
.....+||+.|||||++.. ..|+..+|+|+.++-..+.+.+..+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1246799999999999987 66888899999888777766655544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-25 Score=225.43 Aligned_cols=145 Identities=14% Similarity=0.170 Sum_probs=116.7
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH----------------HHHHHHHHHHHHHHhcCCCceeeee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD----------------RARRSAHQEMELISRVRNPFIVEYK 67 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~----------------~~~~~l~~Ei~iL~~L~HpnIV~l~ 67 (610)
|.+.+.||+|+||.||+|.+ .+|+.||+|.++...... .....+.+|+.+|++++ | +.+.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44559999999999999999 889999999997543211 23566889999999998 4 6666
Q ss_pred eeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeee
Q 007266 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 147 (610)
Q Consensus 68 ~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~D 147 (610)
+.+.. ...|+||||++|++|.+ +. . .....++.||+.||.|||++||+||||||+||||+ +|.+||+|
T Consensus 168 ~~~~~--~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW--EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE--ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec--cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 64433 34589999999999987 41 1 23457999999999999999999999999999999 99999999
Q ss_pred cccccccccccccccccCCCcccCCcccc
Q 007266 148 FGLAKMLISDDLASSVVGTPSYMCPELLA 176 (610)
Q Consensus 148 FGlak~~~~~~~~~~~vGTp~Y~APEvl~ 176 (610)
||+++. +..|+|||++.
T Consensus 236 FG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHH
T ss_pred CCCCeE------------CCCCCHHHHHH
Confidence 999863 44678899774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=191.09 Aligned_cols=139 Identities=13% Similarity=0.158 Sum_probs=109.0
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeE--EEEEEEcccccc----------------------HHHHHHHHHHHHHHHhcC
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKK--YVLKKIRLARQT----------------------DRARRSAHQEMELISRVR 59 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~--vAIK~i~~~~~~----------------------~~~~~~l~~Ei~iL~~L~ 59 (610)
|++.+.||+|+||.||+|.+..+|+. ||||+++..... ......+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999778888 999997643211 112235789999999998
Q ss_pred CCce--eeeeeeEeecCcEEEEEEeecCC-C----CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCC
Q 007266 60 NPFI--VEYKDSWVEKGCYVCIIIGYCEG-G----DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH-ANHILHRDVK 131 (610)
Q Consensus 60 HpnI--V~l~~~~~~~~~~~~LVmEy~~G-g----sL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLH-s~gIiHRDLK 131 (610)
|+++ ...+. . . ..++||||+.+ | .|.++... +++..+..++.||+.+|.||| ++||+|||||
T Consensus 129 ~~~i~~p~~~~--~-~--~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYT--Y-M--KNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEE--E-E--TTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred hCCCCCCeEEE--c-C--CCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 7754 22332 1 1 35799999942 3 67765432 246678899999999999999 9999999999
Q ss_pred CCceEecCCCCeeeeeccccccc
Q 007266 132 CSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 132 PeNILL~~~g~vKL~DFGlak~~ 154 (610)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999988 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=177.98 Aligned_cols=138 Identities=19% Similarity=0.244 Sum_probs=100.9
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc---------------HH-----HHHHHHHHHHHHHhcCCCce
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT---------------DR-----ARRSAHQEMELISRVRNPFI 63 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~---------------~~-----~~~~l~~Ei~iL~~L~HpnI 63 (610)
|++.++||.|+||.||+|.+. +|+.||||+++..... .. ..-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999985 6889999998643211 00 11123467788888754443
Q ss_pred eeeeeeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCC-
Q 007266 64 VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD- 142 (610)
Q Consensus 64 V~l~~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~- 142 (610)
. ....+.... .+|||||++|++|.++. ..+....++.||+.+|.|||++|||||||||.||||+.+|.
T Consensus 176 ~-vp~p~~~~~--~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 P-VPEPIAQSR--HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp S-CCCEEEEET--TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred C-CCeeeeccC--ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 2 222121222 26999999998885432 22345678899999999999999999999999999998874
Q ss_pred ---------eeeeecccccc
Q 007266 143 ---------IRLGDFGLAKM 153 (610)
Q Consensus 143 ---------vKL~DFGlak~ 153 (610)
+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 78999996643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=6.5e-12 Score=125.52 Aligned_cols=140 Identities=14% Similarity=0.124 Sum_probs=107.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LV 80 (610)
+.|++...+|.|+++.||++.. .+..+++|......... ...+.+|+.+|+.+. +.++.++++.+.. +...|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEE
Confidence 5799999999999999999974 36789999986432111 124788999999885 5566677776554 4578899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-------------------------------------- 122 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-------------------------------------- 122 (610)
|||++|.+|.+.+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999987531 222345788999999999998
Q ss_pred ---------------------CCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 123 ---------------------NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 123 ---------------------~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4599999999999998655567999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=2e-11 Score=120.41 Aligned_cols=135 Identities=16% Similarity=0.125 Sum_probs=94.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCce--eeeeeeEeecCcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI--VEYKDSWVEKGCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnI--V~l~~~~~~~~~~~~L 79 (610)
..|.+....+.|..+.||++.. .+|..+++|...... ...+.+|+.+++.+.+.++ .+++..+.. +...++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEE
Confidence 4566544444566699999964 456789999876431 1346789999988865444 446665443 346789
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH----------------------------------- 124 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g----------------------------------- 124 (610)
||||++|.+|. . . ... ...++.++...|..||+..
T Consensus 93 v~e~i~G~~l~--~---~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--S---S--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--T---S--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--c---C--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998883 1 1 112 1256677777777777643
Q ss_pred -----------------------eecccCCCCceEecCCCCeeeeecccccc
Q 007266 125 -----------------------ILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 125 -----------------------IiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998765567999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.7e-10 Score=121.00 Aligned_cols=143 Identities=10% Similarity=0.165 Sum_probs=103.8
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEc--cccccHHHHHHHHHHHHHHHhcCC--CceeeeeeeEeecC--cEEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRVRN--PFIVEYKDSWVEKG--CYVC 78 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~--~~~~~~~~~~~l~~Ei~iL~~L~H--pnIV~l~~~~~~~~--~~~~ 78 (610)
..++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+|+.+.. .++.+++..+.+.. ...|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 34788999999999999764 4578888765 32211 123457889999999874 44666666554331 2467
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA------------------------------------ 122 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs------------------------------------ 122 (610)
+||||++|..+.+.. ...++++....++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999998775321 1246788889999999999999997
Q ss_pred ----------------------CCeecccCCCCceEecCCCC--eeeeeccccccc
Q 007266 123 ----------------------NHILHRDVKCSNIFLTRDQD--IRLGDFGLAKML 154 (610)
Q Consensus 123 ----------------------~gIiHRDLKPeNILL~~~g~--vKL~DFGlak~~ 154 (610)
..++|+|++|.|||++.++. +.|+||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999998764 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=1.3e-10 Score=119.30 Aligned_cols=187 Identities=17% Similarity=0.206 Sum_probs=122.6
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCc--eeeeeeeEeecC--cEEEEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPF--IVEYKDSWVEKG--CYVCIII 81 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-Hpn--IV~l~~~~~~~~--~~~~LVm 81 (610)
++.++.|.+..||++. ..+++|+.... .....+.+|+.+|+.+. +.. +...+......+ ...|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4678999999999874 35888876422 34567889999998884 322 222332211122 1347899
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA--------------------------------------- 122 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs--------------------------------------- 122 (610)
++++|.+|.+.... .++.+....++.|+...|..||+
T Consensus 96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99999988764433 47888888899999999999986
Q ss_pred -------------------CCeecccCCCCceEecC--CCCeeeeeccccccccccc-ccccccCCCcccCCccccC--C
Q 007266 123 -------------------NHILHRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLAD--I 178 (610)
Q Consensus 123 -------------------~gIiHRDLKPeNILL~~--~g~vKL~DFGlak~~~~~~-~~~~~vGTp~Y~APEvl~~--~ 178 (610)
..++|+|++|.||+++. ++.+.|+||+.+....... +....... .-..|+.... .
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHH
Confidence 13799999999999998 4557899999886542211 11100000 0022221110 0
Q ss_pred CCC------------CCccccccchhHHhhhhcCccccccC
Q 007266 179 PYG------------SKSDIWSLGCCVYEMSAQKAAFKAFD 207 (610)
Q Consensus 179 ~yt------------~ksDIWSLG~iLyeLltG~~PF~~~~ 207 (610)
.|. ...+.|++|.++|.+.+|..+|....
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~g 291 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEG 291 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHH
Confidence 011 12588999999999999998875443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.3e-07 Score=95.68 Aligned_cols=134 Identities=19% Similarity=0.238 Sum_probs=93.3
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC---ceeeeeeeEeecCcEEEEEEee
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP---FIVEYKDSWVEKGCYVCIIIGY 83 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp---nIV~l~~~~~~~~~~~~LVmEy 83 (610)
++.++.|....||++ +..+++|+-. .......+.+|..+|+.|.+. .+...+..........|+||+|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 567889999999998 4567888743 223456788999999999753 2334444333334457799999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 007266 84 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN---------------------------------------- 123 (610)
Q Consensus 84 ~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~---------------------------------------- 123 (610)
++|..|....-. .++.+....++.++...|..||+.
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 999888764221 245555555666666666666542
Q ss_pred --------------------CeecccCCCCceEecC---CCCe-eeeecccccc
Q 007266 124 --------------------HILHRDVKCSNIFLTR---DQDI-RLGDFGLAKM 153 (610)
Q Consensus 124 --------------------gIiHRDLKPeNILL~~---~g~v-KL~DFGlak~ 153 (610)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4564 8999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.6e-06 Score=84.91 Aligned_cols=133 Identities=14% Similarity=0.096 Sum_probs=94.6
Q ss_pred EecccCce-EEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC-CceeeeeeeEeecCcEEEEEEeecCC
Q 007266 9 QIGKGSFG-SALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEG 86 (610)
Q Consensus 9 ~LG~G~fG-~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIV~l~~~~~~~~~~~~LVmEy~~G 86 (610)
.+..|..| .||++....++..+++|.-... ....+.+|..+|+.+.. -.+.+++..+.. +...|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEEEEeeCC
Confidence 44445555 6999988878888999976532 23457889999988752 234455554444 4578899999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------------
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN------------------------------------------- 123 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~------------------------------------------- 123 (610)
.++.+..... ......+..++...|..||..
T Consensus 105 ~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 105 KTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 9988776542 223345666777777777741
Q ss_pred ---------------CeecccCCCCceEecCCCCeeeeecccccc
Q 007266 124 ---------------HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 124 ---------------gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 279999999999998777677999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.4e-05 Score=81.88 Aligned_cols=139 Identities=15% Similarity=0.214 Sum_probs=77.4
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-----CCceeeee-e-eEeecCcEEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-----NPFIVEYK-D-SWVEKGCYVCI 79 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-----HpnIV~l~-~-~~~~~~~~~~L 79 (610)
++.|+.|..+.||++... +..+++|..... . ..+..|+.+++.|. .|.++... + .+...++..++
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 456777788999999753 345889988752 1 12334455554442 34444311 1 11123446789
Q ss_pred EEeecCCCCHH---------------HHHHHhCCC--C--C-------CHH--------H--------------------
Q 007266 80 IIGYCEGGDMA---------------EAIKKANGV--H--F-------PEE--------K-------------------- 105 (610)
Q Consensus 80 VmEy~~GgsL~---------------~~Ik~~~~~--~--l-------se~--------~-------------------- 105 (610)
||+|++|..+. .+....... . . .+. .
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986431 111111110 0 0 110 0
Q ss_pred ---HHHHHHHHHHHHHHHHH-------------CCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 106 ---LCKWLVQLLMALNYLHA-------------NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 106 ---i~~i~~QLl~aL~yLHs-------------~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
+..++.++..++.+|+. ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11122234445666653 5899999999999998888899999997753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=3.7e-06 Score=89.16 Aligned_cols=79 Identities=11% Similarity=0.148 Sum_probs=48.7
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccc--cH---HHHHHHHHHHHHHHhcCC--Ccee-eeeeeEeecCcEE
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ--TD---RARRSAHQEMELISRVRN--PFIV-EYKDSWVEKGCYV 77 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~--~~---~~~~~l~~Ei~iL~~L~H--pnIV-~l~~~~~~~~~~~ 77 (610)
.++.||.|.++.||++.+..++..+++|....... .. ...+.+..|.++|+.+.. +..+ .++. + +.+ ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~-d~~-~~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-S-DTE-MA 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E-ETT-TT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-E-cCC-cc
Confidence 36789999999999997766678899998653221 00 112346778888887742 4444 3433 2 232 34
Q ss_pred EEEEeecCCC
Q 007266 78 CIIIGYCEGG 87 (610)
Q Consensus 78 ~LVmEy~~Gg 87 (610)
++||||+.|.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=6.7e-06 Score=85.62 Aligned_cols=85 Identities=13% Similarity=0.099 Sum_probs=51.6
Q ss_pred EEEeEe-cccCceEEEEEEEe---C---CCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCC---CceeeeeeeEeec
Q 007266 5 EVLEQI-GKGSFGSALLVRHK---H---ERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRN---PFIVEYKDSWVEK 73 (610)
Q Consensus 5 ~ilk~L-G~G~fG~Vyla~d~---~---~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~H---pnIV~l~~~~~~~ 73 (610)
..++.| +.|....+|++... . ++..+++|....... .......+.+|+.+|+.|.. -.+.+++......
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 346778 88999999998764 1 156788887654320 00001235678888877642 2344555543332
Q ss_pred C--cEEEEEEeecCCCCH
Q 007266 74 G--CYVCIIIGYCEGGDM 89 (610)
Q Consensus 74 ~--~~~~LVmEy~~GgsL 89 (610)
+ ...|+||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 1 245789999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00025 Score=75.96 Aligned_cols=33 Identities=18% Similarity=0.308 Sum_probs=28.6
Q ss_pred HHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 121 Hs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
+...++|+|++|.|||++.++ +.|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456899999999999998776 999999988653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0005 Score=67.98 Aligned_cols=123 Identities=19% Similarity=0.133 Sum_probs=83.0
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCeecccCCCCceEecCCCCeeeeecccccccccccccccccC
Q 007266 87 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL-HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 165 (610)
Q Consensus 87 gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yL-Hs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~~~vG 165 (610)
.+|.++++..+ .+|+|+++|.++.|.+.+|.-+ +...-..+=+-|..|+|..+|.|.+.+ +.+. ..
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 37999998764 4899999999999999998876 222222444557999999999998864 2111 12
Q ss_pred CCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhcC
Q 007266 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241 (610)
Q Consensus 166 Tp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~ 241 (610)
...+.|||... ...+.+.=|||||++||.-+--. .....+..+|+.+..||..|..-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg------------------L~e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG------------------LKENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTT------------------CCTTEEECCCHHHHHHHHHHTTC
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC------------------CCcccchhhCHHHHHHHHHHHhc
Confidence 23466888753 33456778999999999876322 22334566899999999999866
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00047 Score=70.13 Aligned_cols=134 Identities=14% Similarity=0.133 Sum_probs=72.8
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCce-eeeeeeEeecCcEEEEEEeec-
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI-VEYKDSWVEKGCYVCIIIGYC- 84 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~~~LVmEy~- 84 (610)
++.|+.|....+|++ ..+++|+........ ....+|+.+++.+....+ .+++.. ..+ .-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~--~~~-~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHV--DPA-TGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEE--CTT-TCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEE--ECC-CCEEEEeecC
Confidence 678999999999999 457888775421110 112457777766642222 333332 221 235899999
Q ss_pred CCCCHHH---------------HHHHhC--CCCCC-----HHHHHHHHHH--------------HHHHHHHHH----H--
Q 007266 85 EGGDMAE---------------AIKKAN--GVHFP-----EEKLCKWLVQ--------------LLMALNYLH----A-- 122 (610)
Q Consensus 85 ~GgsL~~---------------~Ik~~~--~~~ls-----e~~i~~i~~Q--------------Ll~aL~yLH----s-- 122 (610)
+|.+|.. .+.+-. ...+. ...+..+..+ +...+..|. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6654421 111110 11111 1222222211 111111111 1
Q ss_pred --CCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 123 --NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 123 --~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 24899999999999 5677899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00071 Score=69.01 Aligned_cols=143 Identities=20% Similarity=0.232 Sum_probs=77.1
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-----CCceeeee-e-eEeecCcEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-----NPFIVEYK-D-SWVEKGCYV 77 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-----HpnIV~l~-~-~~~~~~~~~ 77 (610)
.-++.|+.|....+|++... ++ .+++|....... ...+..|+.++..|. .|.++... + .+...++..
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34677888999999999753 33 688898865211 123456777776653 23333211 1 011122456
Q ss_pred EEEEeecCCCCHH-----------HH---HHHh-CCCCC------C---HHHHH-H-----------HHHHHHHHHHHHH
Q 007266 78 CIIIGYCEGGDMA-----------EA---IKKA-NGVHF------P---EEKLC-K-----------WLVQLLMALNYLH 121 (610)
Q Consensus 78 ~LVmEy~~GgsL~-----------~~---Ik~~-~~~~l------s---e~~i~-~-----------i~~QLl~aL~yLH 121 (610)
+++|+|++|..+. +. +... ..... . +.... . +...+...+++|+
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999986431 11 1111 11000 0 11100 0 0011334455555
Q ss_pred H-------CCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 122 A-------NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 122 s-------~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
. .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3 3799999999999998765568999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00086 Score=69.56 Aligned_cols=76 Identities=9% Similarity=0.007 Sum_probs=54.6
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC---CCceeeeeeeEeecCcEEEEEEe
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR---NPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
-++.|+.|.+..+|++.. ++..+++|..... ....+..|...|+.|. ...+.+.+..... ....++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEE
Confidence 467899999999999975 4667888987533 1345788988888774 2445556654433 347889999
Q ss_pred ecCCCCH
Q 007266 83 YCEGGDM 89 (610)
Q Consensus 83 y~~GgsL 89 (610)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0018 Score=65.38 Aligned_cols=78 Identities=5% Similarity=-0.033 Sum_probs=51.8
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC---ceeeeeeeEeecCcEEEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP---FIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp---nIV~l~~~~~~~~~~~~LV 80 (610)
..-++.+|.|..+.||++.. .+|+.|++|+....... ....+..|+..|+.|..- .+.+.+.. +. -++|
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~--~~lv 88 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW---DD--RTLA 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ET--TEEE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec---cC--ceEE
Confidence 45678899999999999975 46788999976433211 123477899999887422 23333332 22 2689
Q ss_pred EeecCCCCH
Q 007266 81 IGYCEGGDM 89 (610)
Q Consensus 81 mEy~~GgsL 89 (610)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00059 Score=70.23 Aligned_cols=32 Identities=25% Similarity=0.349 Sum_probs=27.5
Q ss_pred CCeecccCCCCceEecCC----CCeeeeeccccccc
Q 007266 123 NHILHRDVKCSNIFLTRD----QDIRLGDFGLAKML 154 (610)
Q Consensus 123 ~gIiHRDLKPeNILL~~~----g~vKL~DFGlak~~ 154 (610)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999875 67899999988653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0025 Score=69.56 Aligned_cols=76 Identities=13% Similarity=0.134 Sum_probs=47.5
Q ss_pred EEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCcee-eeeeeEeecCcEEEEEEeec
Q 007266 6 VLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV-EYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV-~l~~~~~~~~~~~~LVmEy~ 84 (610)
-++.|+.|-...+|++.....+..+++|+........ .+ -.+|..++..|...++. ++++.+ .+ .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~--id-R~~E~~vl~~L~~~gl~P~ll~~~--~~---G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI--IN-REREKKISCILYNKNIAKKIYVFF--TN---GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC--SC-HHHHHHHHHHHTTSSSBCCEEEEE--TT---EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh--cC-HHHHHHHHHHHHhcCCCCCEEEEe--CC---eEEEEee
Confidence 3678888999999999875445788899874322110 00 14788888888655454 455543 22 2599999
Q ss_pred CCCCH
Q 007266 85 EGGDM 89 (610)
Q Consensus 85 ~GgsL 89 (610)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0028 Score=68.32 Aligned_cols=74 Identities=15% Similarity=0.154 Sum_probs=48.1
Q ss_pred EEeEecccCceEEEEEEEeC-------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCce-eeeeeeEeecCcEE
Q 007266 6 VLEQIGKGSFGSALLVRHKH-------ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI-VEYKDSWVEKGCYV 77 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~-------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~~ 77 (610)
-++.|+.|....||++.... .+..+++|+.... .. .+.+.+|..+++.+...++ .++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG--- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC---
Confidence 36788889999999998653 2568889987432 11 1234578888888753333 3455433 22
Q ss_pred EEEEeecCCCC
Q 007266 78 CIIIGYCEGGD 88 (610)
Q Consensus 78 ~LVmEy~~Ggs 88 (610)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 27999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0011 Score=70.68 Aligned_cols=139 Identities=14% Similarity=0.144 Sum_probs=82.1
Q ss_pred EeEecccCceEEEEEEEeC-------CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCce-eeeeeeEeecCcEEE
Q 007266 7 LEQIGKGSFGSALLVRHKH-------ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI-VEYKDSWVEKGCYVC 78 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~-------~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~~~ 78 (610)
++.|..|-...+|++.... ++..|++++...... ....+.+|..+++.|....+ .++++.+ .+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~---g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVF--PE---G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT---E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC---c
Confidence 4567778888999998642 356888887532111 12345689998887753233 3444432 22 2
Q ss_pred EEEeecCCCCHH--------------HHHHHhCC------CCC--CHHHHHHHHHHHHH-------------------HH
Q 007266 79 IIIGYCEGGDMA--------------EAIKKANG------VHF--PEEKLCKWLVQLLM-------------------AL 117 (610)
Q Consensus 79 LVmEy~~GgsL~--------------~~Ik~~~~------~~l--se~~i~~i~~QLl~-------------------aL 117 (610)
+||||++|..|. +.+.+-.. ... -+.++..|+.++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999985542 12222111 111 24667777765532 23
Q ss_pred HHHH----H----CCeecccCCCCceEecCC----CCeeeeecccccc
Q 007266 118 NYLH----A----NHILHRDVKCSNIFLTRD----QDIRLGDFGLAKM 153 (610)
Q Consensus 118 ~yLH----s----~gIiHRDLKPeNILL~~~----g~vKL~DFGlak~ 153 (610)
..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3333 2 269999999999999876 6899999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0028 Score=64.68 Aligned_cols=140 Identities=15% Similarity=0.155 Sum_probs=77.0
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCC--ceeeeeee----EeecCcEEEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP--FIVEYKDS----WVEKGCYVCII 80 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIV~l~~~----~~~~~~~~~LV 80 (610)
+..|+ |....||++.. .+|+.+++|......... ..+..|..++..+... .++.++.. +...++..++|
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 34567 88889998864 345678899986443322 2355677777766321 12333321 11123466889
Q ss_pred EeecCCCCHH-----------HHH---HHh-CC------CCCCHHHH----------------------HHHHHHHHHHH
Q 007266 81 IGYCEGGDMA-----------EAI---KKA-NG------VHFPEEKL----------------------CKWLVQLLMAL 117 (610)
Q Consensus 81 mEy~~GgsL~-----------~~I---k~~-~~------~~lse~~i----------------------~~i~~QLl~aL 117 (610)
|+|++|..+. ..+ ... .. ..++.... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885321 111 110 00 01111111 11112222222
Q ss_pred HHH----HHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 118 NYL----HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 118 ~yL----Hs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 224689999999999998 4 899999997754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0022 Score=67.09 Aligned_cols=75 Identities=17% Similarity=0.157 Sum_probs=42.8
Q ss_pred EEeEecccCceEEEEEEEeCC--------CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCce-eeeeeeEeecCcE
Q 007266 6 VLEQIGKGSFGSALLVRHKHE--------RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI-VEYKDSWVEKGCY 76 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~--------~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~ 76 (610)
-++.|+.|....+|++..... +..+++|+.......- .....|..+++.+....+ .++++.+ .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~---~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL---YNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT---SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce---ecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 366788898999999986531 2678888765322110 013467777777743333 3444432 22
Q ss_pred EEEEEeecCCCC
Q 007266 77 VCIIIGYCEGGD 88 (610)
Q Consensus 77 ~~LVmEy~~Ggs 88 (610)
++||+|++|..
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 57999998854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.031 Score=57.97 Aligned_cols=31 Identities=16% Similarity=0.384 Sum_probs=27.6
Q ss_pred CCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 123 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 123 ~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.21 E-value=0.044 Score=58.21 Aligned_cols=30 Identities=30% Similarity=0.407 Sum_probs=25.1
Q ss_pred CeecccCCCCceEec------CCCCeeeeecccccc
Q 007266 124 HILHRDVKCSNIFLT------RDQDIRLGDFGLAKM 153 (610)
Q Consensus 124 gIiHRDLKPeNILL~------~~g~vKL~DFGlak~ 153 (610)
.++|+|+.+.|||+. .++.+.|+||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 368999999999993 456799999998865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.39 E-value=0.17 Score=54.50 Aligned_cols=139 Identities=13% Similarity=0.200 Sum_probs=82.3
Q ss_pred EEeEecccCceEEEEEEEeCC-------CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCce-eeeeeeEeecCcEE
Q 007266 6 VLEQIGKGSFGSALLVRHKHE-------RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI-VEYKDSWVEKGCYV 77 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~-------~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~~ 77 (610)
-++.|..|-...+|++..... +..|++++....... .. ...+|..+++.+....+ .++++. ..+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~i-dR~~E~~~l~~L~~~gi~P~l~~~--~~~--- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FY-DSKVELDVFRYLSNINIAPNIIAD--FPE--- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CC-CHHHHHHHHHHHHHTTSSCCEEEE--ETT---
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hc-CHHHHHHHHHHHHhcCCCCCEEEE--cCC---
Confidence 367788888999999987531 577888886432211 11 12467787777743223 334432 222
Q ss_pred EEEEeecCCCCHH--------------HHHHH-----h---------CCCCCCHHHHHHHHHHHHH--------------
Q 007266 78 CIIIGYCEGGDMA--------------EAIKK-----A---------NGVHFPEEKLCKWLVQLLM-------------- 115 (610)
Q Consensus 78 ~LVmEy~~GgsL~--------------~~Ik~-----~---------~~~~lse~~i~~i~~QLl~-------------- 115 (610)
++||||++|..|. +.+.+ . ...+.-+.++..|+.++-.
T Consensus 146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~ 225 (424)
T 3mes_A 146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY 225 (424)
T ss_dssp EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence 5799999986531 11111 1 0011124555555543321
Q ss_pred -----HHHHHH--------------------H----CCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 116 -----ALNYLH--------------------A----NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 116 -----aL~yLH--------------------s----~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
.+..|. . ..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 222222 1 25899999999998 7788899999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 610 | ||||
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-77 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-72 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-71 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-70 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-70 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-65 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-65 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-64 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-61 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-58 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-58 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-57 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-57 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-57 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-55 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-55 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-54 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-54 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-53 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-52 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-52 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-52 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-51 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-50 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-49 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-46 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-43 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-35 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-21 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (620), Expect = 9e-77
Identities = 97/264 (36%), Positives = 144/264 (54%), Gaps = 9/264 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E YEVL IG GS+G +R K + K V K++ T+ ++ E+ L+ +++P
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 62 FIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALN 118
IV Y D +++ + I++ YCEGGD+A I K + EE + + + QL +AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 119 YLH-----ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCP 172
H + +LHRD+K +N+FL Q+++LGDFGLA++L D A + VGTP YM P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232
E + + Y KSDIWSLGC +YE+ A F AF + L KI + +P YS
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243
Query: 233 GLVKSMLRKNPEFRPSAAELLCHP 256
++ ML RPS E+L +P
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENP 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 1e-72
Identities = 70/260 (26%), Positives = 128/260 (49%), Gaps = 6/260 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVR 59
+E +E+ +GKG FG+ L R K + LK + A+ + +E+E+ S +R
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+P I+ + + V +I+ Y G + ++K + F E++ ++ +L AL+Y
Sbjct: 65 HPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSY 121
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
H+ ++HRD+K N+ L ++++ DFG + +++ GT Y+ PE++
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
+ K D+WSLG YE K F+A Q +I++ + P + R L+ +L
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLL 239
Query: 240 RKNPEFRPSAAELLCHPHLQ 259
+ NP RP E+L HP +
Sbjct: 240 KHNPSQRPMLREVLEHPWIT 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 230 bits (588), Expect = 5e-71
Identities = 63/313 (20%), Positives = 132/313 (42%), Gaps = 9/313 (2%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
++ Y++ E++G G+FG V + + K + ++D+ +E++ +S +R+
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET--VRKEIQTMSVLRH 82
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P +V D++ + + +I + GG++ E + + E++ +++ Q+ L ++
Sbjct: 83 PTLVNLHDAFEDDN-EMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHM 140
Query: 121 HANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
H N+ +H D+K NI T + ++L DFGL L GT + PE+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG---AFRGLV 235
P G +D+WS+G Y + + + F + + + + +SG + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 236 KSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPE 295
+ +L +P R + + L HP L P R T + + + P
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPP 320
Query: 296 AISIHSNREKRQS 308
I + R+
Sbjct: 321 LGRISNYSSLRKH 333
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 2e-70
Identities = 78/266 (29%), Positives = 133/266 (50%), Gaps = 12/266 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +E++ ++G G+FG ++K K I + + E+++++ +P
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED--YMVEIDILASCDHP 69
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV+ D++ + + I+I +C GG + + + E ++ Q L ALNYLH
Sbjct: 70 NIVKLLDAFYYEN-NLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH 127
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA---- 176
N I+HRD+K NI T D DI+L DFG++ S +GTP +M PE++
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 177 -DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRG 233
D PY K+D+WSLG + EM+ + + ++ KI KS L P+ +S F+
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 234 LVKSMLRKNPEFRPSAAELLCHPHLQ 259
+K L KN + R + ++LL HP +
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 228 bits (581), Expect = 6e-70
Identities = 65/326 (19%), Positives = 141/326 (43%), Gaps = 18/326 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ Y++LE++G G+FG K + +V K I D+ E+ +++++ +P
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--VKNEISIMNQLHHP 86
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
++ D++ +K + +I+ + GG++ + I E ++ ++ Q L ++H
Sbjct: 87 KLINLHDAFEDKY-EMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH 144
Query: 122 ANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
+ I+H D+K NI + +++ DFGLA L D++ T + PE++ P
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG---AFRGLVK 236
G +D+W++G Y + + + F D + + + +S + +K
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264
Query: 237 SMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFP-------LEWSDSNFKKT 289
++L+K P R + + L HP L+ + ++ R N +W
Sbjct: 265 NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIG 324
Query: 290 RFMEPEAISIHSNREKR--QSFSNDR 313
R ++ H +E + S+ + +
Sbjct: 325 RIANFSSLRKHRPQEYQIYDSYFDRK 350
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 219 bits (560), Expect = 7e-68
Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 20/278 (7%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRL-------ARQTDRARRSAHQEMEL 54
E YE E +G+G HK K+Y +K I + A + R + +E+++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 55 ISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+ +V P I++ KD E + ++ + G++ + + + V E++ K + L
Sbjct: 63 LRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRAL 119
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
L + LH +I+HRD+K NI L D +I+L DFG + L + V GTPSY+ PE
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 174 LLA------DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI---NKSIVAPLP 224
++ YG + D+WS G +Y + A F ++ I N +P
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262
YS + LV L P+ R +A E L HP Q YV
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 1e-67
Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 9/261 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
++Y E+IG+G+ G+ ++ ++++ L +Q + E+ ++ +NP
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV Y DS++ + +++ Y GG + + + + E ++ + L AL +LH
Sbjct: 78 NIVNYLDSYLVGD-ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH 133
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIPY 180
+N ++HRD+K NI L D ++L DFG + S++VGTP +M PE++ Y
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSM 238
G K DIWSLG EM + + + + I + L P S FR +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 239 LRKNPEFRPSAAELLCHPHLQ 259
L + E R SA ELL H L+
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (558), Expect = 5e-67
Identities = 71/260 (27%), Positives = 129/260 (49%), Gaps = 11/260 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLA-RQTDRARRSAHQEMELISRVRN 60
+ + L +IG GSFG+ R + +KK+ + +Q++ + +E+ + ++R+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P ++Y+ ++ + +++ YC G E ++ L L YL
Sbjct: 75 PNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA---D 177
H+++++HRDVK NI L+ ++LGDFG A ++ A+S VGTP +M PE++ +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDE 188
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-PTVYSGAFRGLVK 236
Y K D+WSLG E++ +K + + + I ++ L +S FR V
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 237 SMLRKNPEFRPSAAELLCHP 256
S L+K P+ RP++ LL H
Sbjct: 249 SCLQKIPQDRPTSEVLLKHR 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-66
Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 49/302 (16%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +E + ++G G+ G V HK K I L + R +E++++ +P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 64
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+IV + ++ G + I + + +GG + + +KKA PE+ L K + ++ L YL
Sbjct: 65 YIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR 121
Query: 122 -ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
+ I+HRDVK SNI + +I+L DFG++ L D +A+S VGT SYM PE L Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHY 180
Query: 181 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQ------------------------------- 209
+SDIWS+G + EM+ + D +
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 210 -----------ALINKINKSIVAPLPT-VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 257
L++ I LP+ V+S F+ V L KNP R +L+ H
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 258 LQ 259
++
Sbjct: 301 IK 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 6e-66
Identities = 57/264 (21%), Positives = 116/264 (43%), Gaps = 10/264 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E +++++ +G+G++G L ++ + +K + + R D +E+ + + +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHE 63
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V++ +G + + YC GG++ + I+ + PE ++ QL+ + YLH
Sbjct: 64 NVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADI 178
I HRD+K N+ L ++++ DFGLA + ++ L + + GT Y+ PELL
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 179 PY-GSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPLPTVYSGAFRGLV 235
+ D+WS G + M A + + Q + K A L+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 236 KSMLRKNPEFRPSAAELLCHPHLQ 259
+L +NP R + ++
Sbjct: 241 HKILVENPSARITIPDIKKDRWYN 264
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-65
Identities = 73/312 (23%), Positives = 134/312 (42%), Gaps = 13/312 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+Y + E +G+G FG +K Y+ K +++ + TD+ +E+ +++ R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVL--VKKEISILNIARHR 61
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I+ +S+ + +I + G D+ E I + E ++ ++ Q+ AL +LH
Sbjct: 62 NILHLHESFESME-ELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH 119
Query: 122 ANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
+++I H D++ NI + I++ +FG A+ L D + P Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY---SGAFRGLVK 236
+ +D+WSLG VY + + F A Q +I I + + S V
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 237 SMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEA 296
+L K + R +A+E L HP L+ + + K+ R + + KK M A
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKV---IRTLKHRRYYHTLIKKDLNMVVSA 296
Query: 297 ISIHSNREKRQS 308
I R
Sbjct: 297 ARISCGGAIRSQ 308
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-65
Identities = 61/265 (23%), Positives = 119/265 (44%), Gaps = 17/265 (6%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
Q V ++IG GSFG+ + +K + + T + ++ E+ ++ + R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I+ + + I+ +CEG + + F KL Q ++YLH
Sbjct: 65 NILLFMG--YSTAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 121
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELL--- 175
A I+HRD+K +NIFL D +++GDFGLA + + G+ +M PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAP----LPTVYSGA 230
PY +SD+++ G +YE+ + + + +I + + ++P + + A
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCH 255
+ L+ L+K + RP ++L
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 8e-65
Identities = 68/264 (25%), Positives = 123/264 (46%), Gaps = 12/264 (4%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
+ +IG+GSF + + +++ + T R+ +E E++ +++P I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 64 VEYKDSW---VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
V + DSW V+ + ++ G + +K+ + L W Q+L L +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFL 128
Query: 121 HANH--ILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
H I+HRD+KC NIF+T +++GD GLA + A +V+GTP +M PE+ +
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE 187
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLV 235
Y D+++ G C+ EM+ + + A I + S V P V + ++
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 236 KSMLRKNPEFRPSAAELLCHPHLQ 259
+ +R+N + R S +LL H Q
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (541), Expect = 1e-64
Identities = 74/300 (24%), Positives = 134/300 (44%), Gaps = 13/300 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ Y+ + +G G+F +L K +K +K I + S E+ ++ ++++P
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHP 67
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
IV D + G ++ +I+ GG++ + I + + E + + Q+L A+ YLH
Sbjct: 68 NIVALDDIYESGG-HLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH 124
Query: 122 ANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 178
I+HRD+K N+ + I + DFGL+KM + S+ GTP Y+ PE+LA
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGLV 235
PY D WS+G Y + F + L +I K+ +P S + + +
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244
Query: 236 KSMLRKNPEFRPSAAELLCHPHLQPYVL---GIHLKLNGPRRNTFPLEWSDSNFKKTRFM 292
+ ++ K+PE R + + L HP + IH ++ + F F T +
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVV 304
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 3e-64
Identities = 74/270 (27%), Positives = 133/270 (49%), Gaps = 10/270 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR-QTDRARRSAHQEMELISRVRN 60
E ++ + +G+GSF + +L R ++Y +K + + +E +++SR+ +
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
PF V+ ++ + + + Y + G++ + I+K F E + +++ AL YL
Sbjct: 68 PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYL 124
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLAD 177
H I+HRD+K NI L D I++ DFG AK+L + A+S VGT Y+ PELL +
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237
SD+W+LGC +Y++ A F+A + + KI K P + R LV+
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEK 243
Query: 238 MLRKNPEFRPSAAELLCHPHLQ--PYVLGI 265
+L + R E+ + L+ P+ +
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 6e-63
Identities = 57/256 (22%), Positives = 119/256 (46%), Gaps = 9/256 (3%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M++ ++L+ IGKG FG +L ++ K +K I+ D ++ E +++++R+
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIK----NDATAQAFLAEASVMTQLRH 59
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
+V+ VE+ + I+ Y G + + ++ + L K+ + + A+ YL
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 180
N+ +HRD+ N+ ++ D ++ DFGL K S + + PE L + +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKF 177
Query: 181 GSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
+KSD+WS G ++E+ S + + ++ ++ ++ K P A ++K+
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 240 RKNPEFRPSAAELLCH 255
+ RPS +L
Sbjct: 238 HLDAAMRPSFLQLREQ 253
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-61
Identities = 77/333 (23%), Positives = 145/333 (43%), Gaps = 27/333 (8%)
Query: 1 MEQYEVLEQ-IGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRV- 58
++ Y+V Q +G G G L + +K ++K+ LK ++ + R E+EL R
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------EVELHWRAS 62
Query: 59 RNPFIVEYKDSW---VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+ P IV D + + I++ +GG++ I+ F E + + + +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCP 172
A+ YLH+ +I HRDVK N+ T + ++L DFG AK S + ++ TP Y+ P
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
Query: 173 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-------PLPT 225
E+L Y D+WSLG +Y + F + A+ + I P +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSN 285
S + L++++L+ P R + E + H P+++ P + L+
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNH----PWIMQSTKVPQTPLHTSRVLKEDKER 298
Query: 286 FKKTRFMEPEAI-SIHSNREKRQSFSNDRALNP 317
++ + A+ ++ + E+ + + A NP
Sbjct: 299 WEDVKEEMTSALATMRVDYEQIKIKKIEDASNP 331
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-59
Identities = 64/263 (24%), Positives = 120/263 (45%), Gaps = 8/263 (3%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIR--LARQTDRARRSAHQEMELISRV 58
+E + + + +GKGSFG L K + + +K ++ + D + ++ L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+PF+ ++ K + ++ Y GGD+ I+ + F + + ++++ L
Sbjct: 61 EHPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQ 117
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLAD 177
+LH+ I++RD+K NI L +D I++ DFG+ K + D ++ GTP Y+ PE+L
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 178 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237
Y D WS G +YEM ++ F D + L + I P + L+
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDLLVK 236
Query: 238 MLRKNPEFRPSAA-ELLCHPHLQ 259
+ + PE R ++ HP +
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-58
Identities = 52/257 (20%), Positives = 112/257 (43%), Gaps = 9/257 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ L+++G G FG + + + +K I+ ++ +E +++ + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSED---EFIEEAKVMMNLSHE 59
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+ ++ + II Y G + +++ F ++L + + A+ YL
Sbjct: 60 KLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE 117
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS--VVGTPSYMCPELLADIP 179
+ LHRD+ N + +++ DFGL++ ++ D+ SS + PE+L
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 180 YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+ SKSDIW+ G ++E+ S K ++ F I + + P + S ++ S
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237
Query: 239 LRKNPEFRPSAAELLCH 255
+ + RP+ LL +
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 63/271 (23%), Positives = 127/271 (46%), Gaps = 14/271 (5%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR----QTDRARRSAHQEMELISR 57
+ Y+ E++G G F R K +Y K I+ R + +R +E+ ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+++P ++ + + K V +I+ GG++ + + + EE+ ++L Q+L +
Sbjct: 70 IQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGV 126
Query: 118 NYLHANHILHRDVKCSNIFLTRDQD----IRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
YLH+ I H D+K NI L I++ DFGLA + + ++ GTP ++ PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK---SIVAPLPTVYSGA 230
++ P G ++D+WS+G Y + + + F Q + ++ + S
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
+ ++ +L K+P+ R + + L HP ++P
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 4e-58
Identities = 62/305 (20%), Positives = 129/305 (42%), Gaps = 14/305 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERK----KYVLKKIRLARQTDRARRSAHQEMELISR 57
+++ ++ +G G+FG+ E + +K++R A + +A + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMAS 67
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
V NP + + +I G + + +++ + + + L W VQ+ +
Sbjct: 68 VDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGM 124
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPEL 174
NYL ++HRD+ N+ + Q +++ DFGLAK+L +++ A +M E
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 175 LADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233
+ Y +SD+WS G V+E+ + + + + + K P P + +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244
Query: 234 LVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFME 293
++ + + RP EL+ +L + G R P +DSNF + M+
Sbjct: 245 IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSP-TDSNFYR-ALMD 302
Query: 294 PEAIS 298
E +
Sbjct: 303 EEDMD 307
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-58
Identities = 50/255 (19%), Positives = 110/255 (43%), Gaps = 9/255 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E +++E++G G FG + + K +K ++ Q + + E L+ ++++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V ++ Y II Y E G + + +K +G+ KL Q+ + ++
Sbjct: 69 RLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIP 179
+ +HRD++ +NI ++ ++ DFGLA+++ ++ + PE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 180 YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+ KSD+WS G + E+ + + + +I + + P L++
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 239 LRKNPEFRPSAAELL 253
++ PE RP+ L
Sbjct: 247 WKERPEDRPTFDYLR 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 7e-58
Identities = 52/263 (19%), Positives = 113/263 (42%), Gaps = 11/263 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E + ++G+G FG + + +K ++ + A QE +++ ++R+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+ E+ Y I+ Y G + + +K G + +L Q+ + Y+
Sbjct: 73 KLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIP 179
+ +HRD++ +NI + + ++ DFGLA+++ ++ + PE
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 180 YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+ KSD+WS G + E+ + + + + +++++ + P P + L+
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250
Query: 239 LRKNPEFRPSAAELLCHPHLQPY 261
RK PE RP+ L L+ Y
Sbjct: 251 WRKEPEERPTFEYL--QAFLEDY 271
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (491), Expect = 9e-58
Identities = 61/266 (22%), Positives = 113/266 (42%), Gaps = 13/266 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVRN 60
++YE+ E +G G L R + +K +R D +E + + + +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 61 PFIVEYKDSWVEK---GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
P IV D+ + G I++ Y +G + + + ++ + + AL
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQAL 124
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPE 173
N+ H N I+HRDVK +NI ++ +++ DFG+A+ + ++V+GT Y+ PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV---YSGA 230
++SD++SLGC +YE+ + F ++ + + P S
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 231 FRGLVKSMLRKNPEFRPSAAELLCHP 256
+V L KNPE R A +
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (493), Expect = 1e-57
Identities = 67/265 (25%), Positives = 129/265 (48%), Gaps = 12/265 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVR 59
++ +++L +G GSFG L+R +H + Y +K ++ + + E ++S V
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+PFI+ ++ + +I+ Y EGG++ ++ FP + ++ +AL Y
Sbjct: 63 HPFIIRMWGTFQDAQQI-FMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEY 119
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
LH+ I++RD+K NI L ++ I++ DFG AK + D+ ++ GTP Y+ PE+++ P
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKP 177
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
Y D WS G +YEM A F + KI + + P ++ + L+ ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLI 236
Query: 240 RKNPEFR-----PSAAELLCHPHLQ 259
++ R ++ HP +
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 6e-57
Identities = 81/300 (27%), Positives = 133/300 (44%), Gaps = 33/300 (11%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME ++ +E+IG+G++G R+K + LKKIRL +T+ +A +E+ L+ + +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
P IV+ D + ++ D+ + + + P + +L QLL L +
Sbjct: 61 PNIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIP 179
H++ +LHRD+K N+ + + I+L DFGLA+ + V T Y PE+L
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 180 Y-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG--------- 229
Y + DIWSLGC EM ++A F + +I +++ P V+ G
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 230 -------------------AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI-HLKL 269
R L+ ML +P R SA L HP Q + HL+L
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 9e-57
Identities = 77/263 (29%), Positives = 129/263 (49%), Gaps = 11/263 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVR 59
M ++ L+ +GKG+FG +LVR K + Y +K +R + E ++ R
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+PF+ K ++ +C ++ Y GG++ + + F EE+ + +++ AL Y
Sbjct: 64 HPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEY 120
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI 178
LH+ +++RD+K N+ L +D I++ DFGL K ISD + GTP Y+ PE+L D
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
YG D W LG +YEM + F D + L I + P S + L+ +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGL 239
Query: 239 LRKNPEFRPS-----AAELLCHP 256
L+K+P+ R A E++ H
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHR 262
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 35/292 (11%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYV-LKKIRLARQTDRARRSAHQE---MELISR 57
+QYE + +IG+G++G R ++V LK++R+ + S +E + +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 58 VRNPFIVEYKDSWV----EKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+P +V D ++ + ++ + + + + K P E + + QL
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE 173
L L++LH++ ++HRD+K NI +T I+L DFGLA++ +SVV T Y PE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 174 LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------- 222
+L Y + D+WS+GC EM +K F+ + KI I P
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 223 ---------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
T + L+ L NP R SA L HP+ Q
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-56
Identities = 57/257 (22%), Positives = 117/257 (45%), Gaps = 9/257 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ +++IG G FG L + + K +K IR ++ +E E++ ++ +P
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHP 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+ +E+ +C++ + E G +++ + F E L + + + YL
Sbjct: 61 KLVQLYGVCLEQA-PICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS--VVGTPSYMCPELLADIP 179
++HRD+ N + +Q I++ DFG+ + ++ D SS + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 180 YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
Y SKSD+WS G ++E+ S K ++ ++ I+ P + S ++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 239 LRKNPEFRPSAAELLCH 255
++ PE RP+ + LL
Sbjct: 239 WKERPEDRPAFSRLLRQ 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 191 bits (487), Expect = 4e-56
Identities = 73/348 (20%), Positives = 143/348 (41%), Gaps = 23/348 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLAR----QTDRARRSAHQEMELIS 56
M + V IG+G FG R K Y +K + R Q + + + L+S
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 57 RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
PFIV ++ + I+ GGD+ + + F E + + ++++
Sbjct: 63 TGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILG 119
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 176
L ++H +++RD+K +NI L +R+ D GLA S + VGT YM PE+L
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQ 178
Query: 177 D-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM--QALINKINKSIVAPLPTVYSGAFRG 233
+ Y S +D +SLGC ++++ + F+ + I+++ ++ LP +S R
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 234 LVKSMLRKNPEFRPS-----AAELLCHPHLQPYVL-GIHLKLNGP------RRNTFPLEW 281
L++ +L+++ R A E+ P + + L+ P +
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAF 298
Query: 282 SDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLSS 329
+F + + + + + V+ET D++++
Sbjct: 299 DIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINA 346
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-55
Identities = 48/252 (19%), Positives = 106/252 (42%), Gaps = 11/252 (4%)
Query: 9 QIGKGSFGSALLVRHKHER--KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEY 66
++G G+FG+ ++ ++ K +K ++ + E ++ ++ NP+IV
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 67 KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 126
+ +++ E G + + +++ H ++ + + + Q+ M + YL ++ +
Sbjct: 74 IGICEAESWM--LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 127 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGS 182
HRD+ N+ L ++ DFGL+K L +D+ + + PE + + S
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 183 KSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 241
KSD+WS G ++E S + ++ + + K P L+
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 242 NPEFRPSAAELL 253
+ E RP A +
Sbjct: 250 DVENRPGFAAVE 261
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-55
Identities = 71/312 (22%), Positives = 128/312 (41%), Gaps = 46/312 (14%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+ +YE L +IG+G+FG RH+ +K LKK+ + + + +A +E++++ +++
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 61 PFIVEYKDSWVEKG-------CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+V + K + ++ +CE V F ++ + + L
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQML 126
Query: 114 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-----SSVVGTPS 168
L L Y+H N ILHRD+K +N+ +TRD ++L DFGLA+ + ++ V T
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 169 YMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY 227
Y PELL + YG D+W GC + EM + + Q + I++ + P V+
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 228 -------------------------------SGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
L+ +L +P R + + L H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 257 HLQPYVLGIHLK 268
+ LK
Sbjct: 307 FFWSDPMPSDLK 318
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 6e-55
Identities = 51/260 (19%), Positives = 107/260 (41%), Gaps = 12/260 (4%)
Query: 2 EQYEVLE-QIGKGSFGSALLVRHKHERKK--YVLKKIRLARQTDRARRSAHQEMELISRV 58
+ + + ++G G+FGS ++ +K+ +K ++ + +E +++ ++
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQL 66
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
NP+IV + + +++ GG + + + P + + L Q+ M +
Sbjct: 67 DNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMK 123
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPEL 174
YL + +HRD+ N+ L ++ DFGL+K L +DD S+ + PE
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 175 LADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233
+ + S+SD+WS G ++E S + +K ++ I + P
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243
Query: 234 LVKSMLRKNPEFRPSAAELL 253
L+ E RP +
Sbjct: 244 LMSDCWIYKWEDRPDFLTVE 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 184 bits (468), Expect = 2e-54
Identities = 64/289 (22%), Positives = 122/289 (42%), Gaps = 34/289 (11%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
ME+Y LE+IG+G++G ++ + + LKKIRL ++ + + +E+ ++ +++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
IV+ D K + ++ + + G +L+QLL + Y
Sbjct: 60 SNIVKLYDVIHTK-KRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYC 116
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLA-DI 178
H +LHRD+K N+ + R+ ++++ DFGLA+ I + + T Y P++L
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 179 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY----------- 227
Y + DIWS+GC EM F + +I + + P +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 228 -----------------SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
+ L+ ML+ +P R +A + L H + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (469), Expect = 2e-54
Identities = 47/255 (18%), Positives = 104/255 (40%), Gaps = 7/255 (2%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ ++G G +G K +K ++ +E ++ +++P
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHP 73
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+V+ + + II + G++ + +++ N L Q+ A+ YL
Sbjct: 74 NLVQLLGVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS--VVGTPSYMCPELLADIP 179
+ +HRD+ N + + +++ DFGL++++ D + + PE LA
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 180 YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+ KSD+W+ G ++E+ + + + D+ + + K P L+++
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252
Query: 239 LRKNPEFRPSAAELL 253
+ NP RPS AE+
Sbjct: 253 WQWNPSDRPSFAEIH 267
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 3e-54
Identities = 60/262 (22%), Positives = 119/262 (45%), Gaps = 12/262 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD-RARRSAHQEMELISRVR 59
++Q++ ++ +G GSFG +LV+HK Y +K + + + E ++ V
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
PF+V+ + S+ + ++ G + + F E + Q+++ Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEY 156
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 179
LH+ +++RD+K N+ + + I++ DFG AK + ++ GTP + PE++
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKG 214
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239
Y D W+LG +YEM+A F A + KI V P+ +S + L++++L
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLL 273
Query: 240 RKNPEFR-----PSAAELLCHP 256
+ + R ++ H
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHK 295
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-54
Identities = 56/285 (19%), Positives = 108/285 (37%), Gaps = 32/285 (11%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKY----VLKKIRLARQTDRARRSAHQEMELISR 57
E E + +G G+FG + K V K+ + R + E++++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 58 VRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH---------------- 100
+ + IV + G + +I YC GD+ ++
Sbjct: 97 LGSHENIVNLLGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 101 -----FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155
E L + Q+ + +L +HRD+ N+ +T + +++ DFGLA+ ++
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 156 SDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL 211
SD + + +M PE L + Y KSD+WS G ++E+ S + + A
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 212 INKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255
K+ P + +++S + RPS L
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 7e-54
Identities = 61/259 (23%), Positives = 104/259 (40%), Gaps = 8/259 (3%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ--TDRARRSAHQEMELISRVR 59
E+ E+ IG+G FG + + I+ + +D R QE + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 60 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 119
+P IV+ E V II+ C G++ ++ L + QL AL Y
Sbjct: 67 HPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAY 123
Query: 120 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLAD 177
L + +HRD+ N+ ++ + ++LGDFGL++ + AS +M PE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 178 IPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236
+ S SD+W G C++E+ F+ +I +I P+P L+
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 237 SMLRKNPEFRPSAAELLCH 255
+P RP EL
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 7e-54
Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 18/269 (6%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRA----RRSAHQEMELISRV 58
QY+V +G G FGS + +K + R +D E+ L+ +V
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 59 RN--PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
+ ++ D + + +I+ E G EE + Q+L A
Sbjct: 65 SSGFSGVIRLLDWFERPDSF-VLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEA 122
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
+ + H +LHRD+K NI + ++ +++L DFG L+ D + + GT Y PE +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 181
Query: 176 ADIPYGSKS-DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGL 234
Y +S +WSLG +Y+M F+ +I + V S + L
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQV-FFRQRVSSECQHL 234
Query: 235 VKSMLRKNPEFRPSAAELLCHPHLQPYVL 263
++ L P RP+ E+ HP +Q +L
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLL 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-53
Identities = 54/272 (19%), Positives = 108/272 (39%), Gaps = 18/272 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR-ARRSAHQEMELISRVR 59
+ + IG+G+FG L R K + + R+ + R E+E++ ++
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 60 N-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK--------------ANGVHFPEE 104
+ P I+ + +G Y+ + I Y G++ + ++K + +
Sbjct: 69 HHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 105 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVV 164
+L + + ++YL +HRD+ NI + + ++ DFGL++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 165 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPL 223
+M E L Y + SD+WS G ++E+ S + L K+ +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255
P L++ R+ P RPS A++L
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-53
Identities = 52/262 (19%), Positives = 104/262 (39%), Gaps = 13/262 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKK---YVLKKIRLARQTDR-ARRSAHQEMELISR 57
+ +LE++G GSFG K +K ++ + A +E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+ + ++ + ++ G + + ++K G HF L ++ VQ+ +
Sbjct: 68 LDHRNLIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGM 124
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPE 173
YL + +HRD+ N+ L +++GDFGL + L +D + ++ PE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 174 LLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAF 231
L + SD W G ++EM + + + + +++KI+K P P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 232 RGLVKSMLRKNPEFRPSAAELL 253
++ PE RP+ L
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALR 266
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-53
Identities = 68/287 (23%), Positives = 123/287 (42%), Gaps = 35/287 (12%)
Query: 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT---DRARRSAHQEMELISRVRNP 61
E L+ +G+G F + R K+ + +KKI+L ++ D R+A +E++L+ + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
I+ D++ K + ++ + E E I K N + + +++ L L YLH
Sbjct: 61 NIIGLLDAFGHKS-NISLVFDFMET--DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI-P 179
+ ILHRD+K +N+ L + ++L DFGLAK S + V T Y PELL
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 180 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY------------ 227
YG D+W++GC + E+ + + +I +++ P +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 228 ---------------SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 259
L++ + NP R +A + L +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (461), Expect = 4e-53
Identities = 56/262 (21%), Positives = 110/262 (41%), Gaps = 11/262 (4%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ--TDRARRSAHQEMELISRV 58
+ ++ + IG G FG K K+ + I+ + T++ RR E ++ +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 59 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
+P ++ + + V II + E G + +++ +G F +L L + +
Sbjct: 85 DHPNVIHLEGVVTKST-PVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMK 142
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV------VGTPSYMCP 172
YL + +HRD+ NI + + ++ DFGL++ L D + + P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 173 ELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231
E + + S SD+WS G ++E+ S + + Q +IN I + P P A
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL 262
Query: 232 RGLVKSMLRKNPEFRPSAAELL 253
L+ +K+ RP +++
Sbjct: 263 HQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 2e-52
Identities = 51/283 (18%), Positives = 99/283 (34%), Gaps = 33/283 (11%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELIS 56
E + IG+G+FG R +K ++ D + +E L++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-QADFQREAALMA 71
Query: 57 RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK--------------------- 95
NP IV+ +C++ Y GD+ E ++
Sbjct: 72 EFDNPNIVKLLGVCAVGK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 96 -ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154
+ Q+ + YL +HRD+ N + + +++ DFGL++ +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 155 ISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQA 210
S D + +M PE + Y ++SD+W+ G ++E+ S + +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 211 LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
+I + + P L++ K P RPS +
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-52
Identities = 70/293 (23%), Positives = 129/293 (44%), Gaps = 34/293 (11%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
M++YE LE+IG+G++G+ +++ + LK++RL + SA +E+ L+ +++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 120
IV D + + E + +L QLL L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFC 117
Query: 121 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIP 179
H+ ++LHRD+K N+ + R+ +++L +FGLA+ I S+ V T Y P++L
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 180 -YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVY---------- 227
Y + D+WS GC E+ +A + F D+ + +I + + P +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 228 ------------------SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262
+ R L++++L+ NP R SA E L HP+ +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 6e-52
Identities = 71/298 (23%), Positives = 121/298 (40%), Gaps = 42/298 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+Y L IG+G++G + + +KKI +R +E++++ R R+
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR-TLREIKILLRFRHE 66
Query: 62 FIVEYKDSWVEKGCY---VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
I+ D ++ + G D+ + +K H + +C +L Q+L L
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLK 123
Query: 119 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD----DLASSVVGTPSYMCPEL 174
Y+H+ ++LHRD+K SN+ L D+++ DFGLA++ D + V T Y PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 175 LA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------- 222
+ Y DIWS+GC + EM + + F +N I + +P
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 223 -------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
L L+ ML NP R + L HP+L+ Y
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 4e-51
Identities = 68/326 (20%), Positives = 126/326 (38%), Gaps = 51/326 (15%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN 60
+++Y+ L+ IG G+ G + +KK+ Q + A++E+ L+ V +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 61 PFIVEYKDSWVEKGC-----YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
I+ + + + V +++ + E++ L Q+L
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLC 130
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 175
+ +LH+ I+HRD+K SNI + D +++ DFGLA+ + + + V T Y PE++
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY-------- 227
+ Y DIWS+GC + EM K F D NK+ + + P P
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 228 ---------------------------------SGAFRGLVKSMLRKNPEFRPSAAELLC 254
+ R L+ ML +P R S + L
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
Query: 255 HPHLQPYVLGIHLKLNGPRRNTFPLE 280
HP++ + ++ P+ L+
Sbjct: 311 HPYINVWYDPAEVEAPPPQIYDKQLD 336
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-51
Identities = 59/294 (20%), Positives = 106/294 (36%), Gaps = 42/294 (14%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI 63
Y + IG GSFG + + +KK+ + +R ++E++++ ++ + I
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCNI 75
Query: 64 VEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKAN-GVHFPEEKLCKWLVQLLMAL 117
V + + G Y+ +++ Y A + P + ++ QL +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 118 NYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDLASSVVGTPSYMCP-ELL 175
Y+H+ I HRD+K N+ L D ++L DFG AK L+ + S + + Y P +
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY-------- 227
Y S D+WS GC + E+ + F + +I K + P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 228 --------------------SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261
L +L P R + E H
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-50
Identities = 70/276 (25%), Positives = 133/276 (48%), Gaps = 19/276 (6%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHER---KKYVLKKIRLARQTDRARRSAH--QEMELI 55
+E +E+L+ +G G++G LVR K Y +K ++ A +A+ + H E +++
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 56 SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM 115
+R + + + +I+ Y GG++ + + F E ++ ++ ++++
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVL 140
Query: 116 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPE 173
AL +LH I++RD+K NI L + + L DFGL+K ++D+ A GT YM P+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 174 LL--ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYS 228
++ D + D WSLG +YE+ + F + +I++ I+ P P S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 229 GAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQ 259
+ L++ +L K+P+ R A E+ H Q
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 1e-50
Identities = 42/269 (15%), Positives = 88/269 (32%), Gaps = 24/269 (8%)
Query: 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF 62
+Y + +IG GSFG L ++ +K + + + E ++ ++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI----ESKIYKMMQGGV 63
Query: 63 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 122
+ +G Y +++ + F + + Q++ + Y+H+
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS 121
Query: 123 NHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDDL--------ASSVVGTPSYMC 171
+ +HRDVK N + + + + DFGLAK ++ GT Y
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 172 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV----- 226
I + D+ SLG + + ++ K + + T
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 227 --YSGAFRGLVKSMLRKNPEFRPSAAELL 253
Y F + + +P + L
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLR 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 74/328 (22%), Positives = 136/328 (41%), Gaps = 46/328 (14%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
Y L+ +G G++G+ K +KK+ Q++ + A++E+ L+ +R+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 62 FIVEYKDSWVEKGC-----YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMA 116
++ D + +++ + G D+ + +K E+++ + Q+L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKG 133
Query: 117 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE-LL 175
L Y+HA I+HRD+K N+ + D ++++ DFGLA+ D + V T Y PE +L
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVIL 191
Query: 176 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------- 222
+ Y DIWS+GC + EM K FK D + +I K P
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 223 -----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 265
+ T S L++ ML + E R +A E L HP+ + +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES----L 307
Query: 266 HLKLNGPRRNTFPLEWSDSNFKKTRFME 293
H + P+ + + D + +
Sbjct: 308 HDTEDEPQVQKYDDSFDDVDRTLDEWKR 335
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-49
Identities = 44/257 (17%), Positives = 97/257 (37%), Gaps = 11/257 (4%)
Query: 8 EQIGKGSFGS---ALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV 64
E IG+G FG L+ + ++ +K + + E ++ +P ++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 91
Query: 65 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 124
+ +++ Y + GD+ + + + L + +Q+ + +L +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 125 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-----SVVGTPSYMCPELLADIP 179
+HRD+ N L +++ DFGLA+ + + S +M E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 180 YGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238
+ +KSD+WS G ++E+ + + + + + + P ++
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270
Query: 239 LRKNPEFRPSAAELLCH 255
E RPS +EL+
Sbjct: 271 WHPKAEMRPSFSELVSR 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 170 bits (432), Expect = 9e-49
Identities = 57/297 (19%), Positives = 119/297 (40%), Gaps = 51/297 (17%)
Query: 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR- 59
+ Y+++ ++G+G + + +K V+K ++ + ++ +E++++ +R
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRG 88
Query: 60 NPFIVEYKDSWVEKGC-YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
P I+ D + ++ + D + + + + ++ ++L AL+
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALD 143
Query: 119 YLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
Y H+ I+HRDVK N+ + + +RL D+GLA+ + V + + PELL D
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 178 IP-YGSKSDIWSLGCCVYEMSAQKAAFKA----FDMQALINKI----------------- 215
Y D+WSLGC + M +K F +D I K+
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 216 ----------------NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 256
+ + + + S + +LR + + R +A E + HP
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-48
Identities = 50/277 (18%), Positives = 109/277 (39%), Gaps = 26/277 (9%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERK-------KYVLKKIRLARQTDRARRSAHQEMEL 54
++ + + +G+G+FG +L K K +K ++ T++ EME+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEM 71
Query: 55 ISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--------------KANGVH 100
+ + + + + +I+ Y G++ E ++
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 101 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160
+ L Q+ + YL + +HRD+ N+ +T D +++ DFGLA+ + D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 161 SS---VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKIN 216
+M PE L D Y +SD+WS G ++E+ + + + ++ L +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
+ P+ + +++ P RP+ +L+
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 7e-48
Identities = 48/278 (17%), Positives = 107/278 (38%), Gaps = 24/278 (8%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHER-----KKYVLKKIRLARQTDRARRSAHQEMELIS 56
++ ++ + +G+G+FG + + +K ++ R + LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 57 RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGV--------------HFP 102
+ +V + + G + +I+ +C+ G+++ ++
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 103 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---L 159
E L + Q+ + +L + +HRD+ NI L+ +++ DFGLA+ + D
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFD-MQALINKINK 217
+M PE + D Y +SD+WS G ++E+ S + + + ++ +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252
Query: 218 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255
P + + P RP+ +EL+ H
Sbjct: 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 5e-47
Identities = 54/261 (20%), Positives = 107/261 (40%), Gaps = 12/261 (4%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKH----ERKKYVLKKIRLARQTDRARRSAHQEMELISR 57
+ IG G FG K + +K ++ A T++ R E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQ 65
Query: 58 VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
+ I+ + + + II Y E G + + +++ +G F +L L + +
Sbjct: 66 FSHHNIIRLEGVISKYK-PMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGM 123
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA----SSVVGTPSYMCPE 173
YL + +HRD+ NI + + ++ DFGL+++L D A S + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 174 LLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232
++ + S SD+WS G ++E+ + + + ++ IN P P A
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243
Query: 233 GLVKSMLRKNPEFRPSAAELL 253
L+ ++ RP A+++
Sbjct: 244 QLMMQCWQQERARRPKFADIV 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 164 bits (417), Expect = 5e-47
Identities = 42/271 (15%), Positives = 82/271 (30%), Gaps = 26/271 (9%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
Y+V +IG+GSFG + ++ +K + R E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD----EYRTYKLLAGC 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
+ + ++G + ++I G E + G F + + Q+L + +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 122 ANHILHRDVKCSNIFLTR-----DQDIRLGDFGLAKMLISDD--------LASSVVGTPS 168
+++RD+K N + R I + DFG+ K ++ GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV-- 226
YM + D+ +LG ++ K + T
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 227 -----YSGAFRGLVKSMLRKNPEFRPSAAEL 252
+ F + + P L
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-46
Identities = 51/279 (18%), Positives = 110/279 (39%), Gaps = 29/279 (10%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKK-----YVLKKIRLARQTDRARRSAHQEMELIS 56
+ + +G G+FG + K +K ++ + R + E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLS 81
Query: 57 RVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK----------------ANGV 99
+ N IV + G +I YC GD+ +++ + +
Sbjct: 82 YLGNHMNIVNLLGACTIGG-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 100 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 158
E L + Q+ + +L + + +HRD+ NI LT + ++ DFGLA+ + +D
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 159 --LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINK 214
+ + +M PE + + Y +SD+WS G ++E+ + ++
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 215 INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
I + P ++K+ +P RP+ +++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 64/327 (19%), Positives = 132/327 (40%), Gaps = 44/327 (13%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
E+Y+ L +G G++GS + +KK+ Q+ + ++E+ L+ +++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 62 FIVEYKDSWVEKGCYV----CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 117
++ D + ++ + G D+ +K ++ + + Q+L L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGL 134
Query: 118 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 177
Y+H+ I+HRD+K SN+ + D ++++ DFGLA+ DD + V T Y PE++ +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLN 192
Query: 178 -IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY--------- 227
+ Y DIWS+GC + E+ + F D + I + + P +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 228 ---------------------SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIH 266
+ L++ ML + + R +AA+ L H + Y H
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY----H 308
Query: 267 LKLNGPRRNTFPLEWSDSNFKKTRFME 293
+ P + + + + +
Sbjct: 309 DPDDEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 53/269 (19%), Positives = 110/269 (40%), Gaps = 19/269 (7%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERK-----KYVLKKIRLARQTDRARRSAHQEMELIS 56
E+ + ++G+GSFG K K + +K + A + R R E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMK 78
Query: 57 RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH--------FPEEKLCK 108
+V V +G +I+ GD+ ++ K+ +
Sbjct: 79 EFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 109 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVG 165
++ + YL+AN +HRD+ N + D +++GDFG+ + + D +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 166 TPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLP 224
+M PE L D + + SD+WS G ++E+ + + ++ + ++ + + + P
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELL 253
L++ + NP+ RPS E++
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 3e-43
Identities = 51/295 (17%), Positives = 105/295 (35%), Gaps = 51/295 (17%)
Query: 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNP 61
+ E IGKG FG + + E + +K + R E+ +R+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE---AEIYQTVMLRHE 57
Query: 62 FIVEYKDSWVEKGC---YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 118
I+ + + + + ++ Y E G + + + + E + K + L
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 114
Query: 119 YLHA--------NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVG 165
+LH I HRD+K NI + ++ + D GLA S + VG
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 166 TPSYMCPELLAD------IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD------------ 207
T YM PE+L D ++DI+++G +E++ + + +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 208 ---MQALINKINKSIVAP-LPTVYSG-----AFRGLVKSMLRKNPEFRPSAAELL 253
++ + + + + P +P + +++ N R +A +
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 135 bits (339), Expect = 1e-35
Identities = 60/318 (18%), Positives = 112/318 (35%), Gaps = 62/318 (19%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRA--------RRSAHQEMELI 55
Y ++ ++G G F + L + +K +R + A +R +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 56 SRVRNPFIVEYKDSWVE--KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 113
+ I++ D + +++ G ++ IKK P + + QL
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 114 LMALNYLHANH-ILHRDVKCSNIFLTRD----QDIRLGDFGLAKMLISDDLASSVVGTPS 168
L+ L+Y+H I+H D+K N+ + I++ L D+ ++ + T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 169 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA----------------------- 205
Y PE+L P+G +DIWS C ++E+ F+
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 206 --------------FDMQALINKINKSIVAPLPTV----------YSGAFRGLVKSMLRK 241
F+ + L+ I+K PL V + + ML+
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 242 NPEFRPSAAELLCHPHLQ 259
+P R A L+ HP L+
Sbjct: 315 DPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 5e-21
Identities = 27/204 (13%), Positives = 68/204 (33%), Gaps = 26/204 (12%)
Query: 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSA--HQEMELISRVRNP 61
+ + +G+G + + + V+K ++ + + + + ++
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 62 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 121
E++ +G V + + + E I E + L +L + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 122 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA-DI-- 178
I+H D+ N+ ++ ++ I + DF + V E+L D+
Sbjct: 121 HRGIVHGDLSQYNVLVS-EEGIWIIDFPQS------------VEVGEEGWREILERDVRN 167
Query: 179 -------PYGSKSDIWSLGCCVYE 195
Y ++ DI S + +
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 610 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.16 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.84 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.51 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-59 Score=474.03 Aligned_cols=255 Identities=28% Similarity=0.512 Sum_probs=230.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
|++|++++.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|+.+|++++|||||++++++.+. ..+|+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-CEEEE
Confidence 58999999999999999999999999999999999754322 22345688999999999999999999988765 47899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|||||+||+|.+++.+.. .+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++..... .
T Consensus 84 vmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R 160 (263)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-C
T ss_pred EEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-c
Confidence 999999999999998765 6899999999999999999999999999999999999999999999999999875433 3
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+..+++..+..... ..|..+++++++||.+||
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCccCCHHHHHHHHHHc
Confidence 4567899999999999999999999999999999999999999999999999888876543 467789999999999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCc
Q 007266 240 RKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
+.||++|||++|+|+||||+.
T Consensus 240 ~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 240 KHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CSSGGGSCCHHHHHTCHHHHH
T ss_pred cCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-59 Score=474.17 Aligned_cols=257 Identities=38% Similarity=0.675 Sum_probs=224.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-CcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~~~LV 80 (610)
|+|++++.||+|+||.||+|+++.+|+.||+|.+......+...+.+.+|+++|++++|||||+++++|.+. +..+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 789999999999999999999999999999999988777777778899999999999999999999998753 4568999
Q ss_pred EeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCCCceEecCCCCeeeeecccccc
Q 007266 81 IGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHANH-----ILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~--~~~~lse~~i~~i~~QLl~aL~yLHs~g-----IiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
||||+||+|.+++.+. ....+++..++.|+.||+.||+|||+.| |+||||||+||||+.+|.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998652 2347999999999999999999999976 99999999999999999999999999988
Q ss_pred cccc-cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHH
Q 007266 154 LISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 154 ~~~~-~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++..++......+++..+|++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 243 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 6543 345678999999999999999999999999999999999999999999999999999988877778889999999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCC
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHL 258 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f 258 (610)
+||.+||+.||.+|||++|+|+|||+
T Consensus 244 ~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 244 EIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-57 Score=477.81 Aligned_cols=260 Identities=29% Similarity=0.541 Sum_probs=235.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
|++|++++.||+|+||.||+|+++.+|+.||||++.+.... ....+.+.+|+.+|++++|||||+++++|.+. ..+|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-ccccc
Confidence 68999999999999999999999999999999999754321 22346688999999999999999999988765 48999
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc-cc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DD 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~-~~ 158 (610)
|||||+||+|.+++.+.. .++|+.++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.... ..
T Consensus 83 v~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred ceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999999998866 689999999999999999999999999999999999999999999999999987643 34
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+...++..+.... ..+|..+|+++++||++|
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHhh
Confidence 5667899999999999999999999999999999999999999999999999998887765 356888999999999999
Q ss_pred hcCCCCCCCC-----HHHHhcCCCCCchhhh
Q 007266 239 LRKNPEFRPS-----AAELLCHPHLQPYVLG 264 (610)
Q Consensus 239 L~~dP~~RpS-----a~eiL~Hp~f~~~~~~ 264 (610)
|++||.+|++ ++|+++||||+...+.
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 9999999994 9999999999876443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=470.58 Aligned_cols=256 Identities=21% Similarity=0.404 Sum_probs=218.4
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+|++++|||||++++++.+.+ .+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-eeEEE
Confidence 58999999999999999999999999999999999765432 33456889999999999999999999887654 88999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--- 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--- 157 (610)
||||+||+|.+++.... .+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 82 mEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999997543 6999999999999999999999999999999999999999999999999999876433
Q ss_pred cccccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHH-HHHHH-hhccCCCCCcccchHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQA-LINKI-NKSIVAPLPTVYSGAFRGL 234 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~-l~~~I-~~~~~~~~p~~~s~~l~~L 234 (610)
......+||+.|||||++.+..| +.++|||||||+||+|++|.+||....... .+..+ ........+..+++++++|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 24566799999999999988876 678999999999999999999997654322 22222 2223333446789999999
Q ss_pred HHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 235 VKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 235 I~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|.+||+.||++|||++|+|+||||+.
T Consensus 240 i~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 99999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=471.37 Aligned_cols=253 Identities=28% Similarity=0.504 Sum_probs=226.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|++++|||||+++++|...+ .+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECC-EEEEEE
Confidence 47999999999999999999999999999999997654433 356899999999999999999999887655 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
|||+||+|.+++.+. .+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++..... ...
T Consensus 97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 999999999988764 5899999999999999999999999999999999999999999999999999876543 345
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC--CCCCcccchHHHHHHHHh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~--~~~p~~~s~~l~~LI~km 238 (610)
...+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+..+.+..+..... .+.+..+++++++||.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 677899999999999999999999999999999999999999999887777666654432 334677899999999999
Q ss_pred hcCCCCCCCCHHHHhcCCCCCc
Q 007266 239 LRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
|+.||++|||++|+|+||||+.
T Consensus 254 L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp TCSSTTTSCCHHHHTTCGGGGG
T ss_pred ccCChhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999963
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-58 Score=472.46 Aligned_cols=259 Identities=29% Similarity=0.504 Sum_probs=228.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||+||+|+++.+++.||||++..... .....+.+.+|+++|++++|||||+++++|.+. ..+|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-SEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-CEEEEE
Confidence 579999999999999999999999999999999975432 222346689999999999999999999987655 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc---
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--- 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~--- 157 (610)
||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 87 mEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999998765 7999999999999999999999999999999999999999999999999999876433
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
......+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+..+++.+|..... .+|..+++++++||.+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEK 243 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCTTCCHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-CCCccCCHHHHHHHHH
Confidence 234567899999999999999999999999999999999999999999999999988876543 4677899999999999
Q ss_pred hhcCCCCCCCCHHH------HhcCCCCCchhhh
Q 007266 238 MLRKNPEFRPSAAE------LLCHPHLQPYVLG 264 (610)
Q Consensus 238 mL~~dP~~RpSa~e------iL~Hp~f~~~~~~ 264 (610)
||+.||.+|||++| +++||||+...+.
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 99999999999987 6889999876443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-57 Score=469.85 Aligned_cols=255 Identities=27% Similarity=0.488 Sum_probs=210.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||+||+|+++.+++.||||.+....... ....+.+|+.+|++++|||||+++++|.++ ..+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESG-GHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEE
Confidence 46999999999999999999999999999999997654332 235678999999999999999999987655 5889999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec---CCCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT---RDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~---~~g~vKL~DFGlak~~~~~~ 158 (610)
|||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||+. .++.+||+|||+++......
T Consensus 87 E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred eccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999999998754 699999999999999999999999999999999999995 47889999999999877666
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC---CCCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~---~~p~~~s~~l~~LI 235 (610)
...+.+||+.|||||++.+..|+.++|||||||+||+|++|.+||.+....++...+...... +.+..+|+++++||
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence 677889999999999999999999999999999999999999999999988888888765432 34457899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+||++||++|||++|+|+||||+.
T Consensus 245 ~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=464.87 Aligned_cols=255 Identities=30% Similarity=0.526 Sum_probs=225.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
|.|++++.||+|+||.||+|+++.+++.||||++...... ..+.+.+|+++|++++|||||+++++|...+ .+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-eEEEEE
Confidence 4699999999999999999999999999999999754332 3456889999999999999999999887655 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-ccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~~ 160 (610)
|||+||+|.+++.+.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..... ...
T Consensus 89 Ey~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp ECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred ecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999999999987643 36999999999999999999999999999999999999999999999999999765433 234
Q ss_pred ccccCCCcccCCcccc-----CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC--CCCcccchHHHH
Q 007266 161 SSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRG 233 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~-----~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~--~~p~~~s~~l~~ 233 (610)
...+||+.|+|||++. +..|+.++|||||||+||+|++|.+||.+.+..+++..+...... ..+..+++++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5689999999999884 566899999999999999999999999998888887777665433 345678999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 234 LVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
||.+||+.||++|||++|+|+||||+.
T Consensus 248 li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-57 Score=470.56 Aligned_cols=255 Identities=32% Similarity=0.543 Sum_probs=217.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
|+|++++.||+|+||+||+|+++.+|+.||+|++..... ....+.+.+|+.+|++++|||||+++++|.+.+ .+|+||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~iVm 83 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM 83 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 689999999999999999999999999999999976543 334567899999999999999999999887654 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||+||+|.+++.+.+ .+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.... ...
T Consensus 84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~~~ 160 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMA 160 (322)
T ss_dssp ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-HTC
T ss_pred EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-Ccc
Confidence 9999999999998765 68999999999999999999997 5999999999999999999999999999987643 345
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHH------------------------------
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA------------------------------ 210 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~------------------------------ 210 (610)
.+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+...
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 57899999999999999999999999999999999999999997654221
Q ss_pred ------------HHHHHhhccCCCCC-cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 211 ------------LINKINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 211 ------------l~~~I~~~~~~~~p-~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
....+........+ ..+|.++++||.+||+.||.+|||++|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 11111111122222 2368899999999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-56 Score=453.55 Aligned_cols=252 Identities=25% Similarity=0.508 Sum_probs=221.5
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec---CcEEEEE
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK---GCYVCII 80 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~~~LV 80 (610)
|++.+.||+|+||+||+|.+..++..||+|.+..........+.+.+|+++|++++|||||+++++|... +..+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3677899999999999999999999999999987766666777899999999999999999999998652 4578999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCCCceEec-CCCCeeeeecccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~g--IiHRDLKPeNILL~-~~g~vKL~DFGlak~~~~~ 157 (610)
||||+||+|.+++.+.. .+++..++.|+.||+.||+|||++| |+||||||+||||+ .++.+||+|||+++... .
T Consensus 91 mE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-A 167 (270)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-T
T ss_pred EeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-C
Confidence 99999999999998765 6899999999999999999999998 99999999999997 47899999999998643 3
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccccc-CHHHHHHHHhhccCC-CCCcccchHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVA-PLPTVYSGAFRGLV 235 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~-~~~~l~~~I~~~~~~-~~p~~~s~~l~~LI 235 (610)
......+||+.|||||++.+ .|+.++|||||||++|||++|..||.+. +...+...+...... ..+..+++++++||
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 34567899999999999876 5999999999999999999999999765 455566666554332 24456789999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCC
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQ 259 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~ 259 (610)
.+||+.||++|||++|+|+||||+
T Consensus 247 ~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-56 Score=473.05 Aligned_cols=257 Identities=22% Similarity=0.427 Sum_probs=230.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|++++|||||+++++|.+. ..+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-TEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEE
Confidence 5789999999999999999999999999999999975433 3456789999999999999999999988765 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC--CCCeeeeeccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~--~g~vKL~DFGlak~~~~~~ 158 (610)
||||+||+|.+++.+.. ..+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+++......
T Consensus 102 mE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp ECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999999996543 26999999999999999999999999999999999999964 5789999999999887766
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC---CCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---~p~~~s~~l~~LI 235 (610)
.....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+++..|....... ....+|+++++||
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 6777899999999999999999999999999999999999999999999988888887654332 2345899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||+.||++|||++|+|+||||+..
T Consensus 261 ~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 261 RKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=459.11 Aligned_cols=258 Identities=24% Similarity=0.445 Sum_probs=230.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH----HHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~----~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
|+|++++.||+|+||+||+|+++.+|+.||||++....... ...+.+.+|+.+|++++|||||+++++|.+. ..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEE
Confidence 47999999999999999999999999999999997543221 2346789999999999999999999988665 588
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC----Ceeeeecccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKM 153 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g----~vKL~DFGlak~ 153 (610)
|||||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999998765 699999999999999999999999999999999999998876 499999999988
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchH
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGA 230 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~ 230 (610)
..........+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+..+++..+........ +..+|..
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 7766667778999999999999999999999999999999999999999999999998888876544322 3457899
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+++||++||+.||.+|||++|+|+||||++..
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999998644
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-56 Score=465.64 Aligned_cols=258 Identities=26% Similarity=0.549 Sum_probs=232.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
|++|++++.||+|+||+||+|+++.+|+.||||++...... ....+.+.+|+.+|+.++|||||++++++... ..+|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-Ceeee
Confidence 57999999999999999999999999999999999754321 22346688999999999999999999988765 58899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
|||||.||+|..++.... .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.... .
T Consensus 82 vmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~ 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--V 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--C
T ss_pred EeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--c
Confidence 999999999999998765 689999999999999999999999999999999999999999999999999987643 3
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
..+.+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+..+++.++..... ..|..++++++++|.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHh
Confidence 4568999999999999999999999999999999999999999999999999988876643 467789999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCCCCCchhhh
Q 007266 240 RKNPEFRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 240 ~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
..||.+|+ |++++|+||||+...+.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred hhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 99999996 99999999999986554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-56 Score=472.03 Aligned_cols=257 Identities=22% Similarity=0.441 Sum_probs=231.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+|+.+|++|+|||||+++++|.++ ..+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEE
Confidence 3679999999999999999999999999999999875443 3345788999999999999999999988755 588999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEec--CCCCeeeeeccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT--RDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~--~~g~vKL~DFGlak~~~~~~ 158 (610)
||||+||+|.+.+.... ..|++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+......
T Consensus 105 mE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999999999886543 3699999999999999999999999999999999999998 56889999999999887777
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCC---CCCcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~---~~p~~~s~~l~~LI 235 (610)
.....+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..+++..+...... ..+..+++++++||
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 777889999999999999999999999999999999999999999999999888888765433 23456899999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||+.||.+|||++|+|+||||+..
T Consensus 264 ~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999853
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-56 Score=468.97 Aligned_cols=258 Identities=24% Similarity=0.483 Sum_probs=232.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCI 79 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~L 79 (610)
||+|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++|||||+++++|... ..+++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-ccccc
Confidence 5899999999999999999999999999999999865432 122345688999999999999999999988765 47889
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 159 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~ 159 (610)
||||+.||+|.+++.+.+ .+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.... .
T Consensus 119 v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~ 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--R 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--C
T ss_pred ccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--c
Confidence 999999999999998765 699999999999999999999999999999999999999999999999999987643 3
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+...++..|..... ..+..+++++.+||++||
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHS
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHh
Confidence 4567999999999999999999999999999999999999999999999999888876654 457789999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCCCCCchhhh
Q 007266 240 RKNPEFRP-----SAAELLCHPHLQPYVLG 264 (610)
Q Consensus 240 ~~dP~~Rp-----Sa~eiL~Hp~f~~~~~~ 264 (610)
+.||.+|+ +++++|+||||+...+.
T Consensus 274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred hhCHHhccccccccHHHHHcCccccCCCHH
Confidence 99999994 99999999999876443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-55 Score=448.73 Aligned_cols=259 Identities=29% Similarity=0.488 Sum_probs=230.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc-------HHHHHHHHHHHHHHHhcC-CCceeeeeeeEee
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT-------DRARRSAHQEMELISRVR-NPFIVEYKDSWVE 72 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~-------~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~ 72 (610)
.++|++++.||+|+||+||+|++..+++.||||++...... ....+.+.+|+.+|+++. |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47999999999999999999999999999999999765432 234466889999999997 9999999998865
Q ss_pred cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccc
Q 007266 73 KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 152 (610)
Q Consensus 73 ~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak 152 (610)
+ ..+|||||||+||+|.++|+..+ .++++.++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus 82 ~-~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 N-TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp S-SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred C-cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 4 58999999999999999998765 68999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccCCCcccCCcccc------CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccC---CCC
Q 007266 153 MLISDDLASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APL 223 (610)
Q Consensus 153 ~~~~~~~~~~~vGTp~Y~APEvl~------~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~---~~~ 223 (610)
...........+||+.|+|||++. ...|+.++||||+||++|+|++|..||.+.+.......+..... .+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 877666667789999999999885 34468899999999999999999999999998888887765543 223
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
...+|+++++||.+||+.||.+|||++|+|+||||+.|+
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~~ 277 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHhC
Confidence 447899999999999999999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-56 Score=459.79 Aligned_cols=252 Identities=27% Similarity=0.514 Sum_probs=223.5
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
.|++++.||+|+||+||+|++..+++.||||++..... .....+.+.+|+++|++++|||||+++++|.+. ..+|+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEEE
Confidence 49999999999999999999999999999999976554 344557789999999999999999999988765 4789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS 161 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~~ 161 (610)
|||.||+|..++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ..
T Consensus 95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---AN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BC
T ss_pred EecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CC
Confidence 9999999987776644 799999999999999999999999999999999999999999999999999986543 34
Q ss_pred cccCCCcccCCccccC---CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-CCcccchHHHHHHHH
Q 007266 162 SVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLVKS 237 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~---~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~-~p~~~s~~l~~LI~k 237 (610)
..+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..+....... .+..+|+++++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 6789999999999864 458999999999999999999999999988888777776554433 455689999999999
Q ss_pred hhcCCCCCCCCHHHHhcCCCCCc
Q 007266 238 MLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 238 mL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
||+.||.+|||++|+|+||||..
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HCcCChhHCcCHHHHHhCHHhcC
Confidence 99999999999999999999963
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=460.11 Aligned_cols=259 Identities=25% Similarity=0.480 Sum_probs=228.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHH-hcCCCceeeeeeeEeecCcEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELIS-RVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~-~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
||+|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|..++. .++|||||+++++|.+++ .+|
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~-~~y 79 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLF 79 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-cee
Confidence 7999999999999999999999999999999999975432 1122344556666654 689999999999887654 799
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD- 157 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~- 157 (610)
+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 80 ivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999998765 6899999999999999999999999999999999999999999999999999875433
Q ss_pred cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHH
Q 007266 158 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKS 237 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~k 237 (610)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...++.++.... ...|..+|+++++||.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHH
Confidence 34556799999999999999999999999999999999999999999999999998887654 35677899999999999
Q ss_pred hhcCCCCCCCCHH-HHhcCCCCCchhh
Q 007266 238 MLRKNPEFRPSAA-ELLCHPHLQPYVL 263 (610)
Q Consensus 238 mL~~dP~~RpSa~-eiL~Hp~f~~~~~ 263 (610)
||+.||.+||++. ++++||||+.+.+
T Consensus 237 ~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred hcccCCCCCcCHHHHHHhCchhccCCH
Confidence 9999999999995 8999999997543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=457.11 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=229.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+|+|++++.||+|+||+||+|.++.+++.||||++..... ....+.+|+++|+.++|||||+++++|.+. ..+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESM-EELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEE
Confidence 5899999999999999999999999999999999975432 234578999999999999999999988765 489999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC--CCeeeeeccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD--QDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~--g~vKL~DFGlak~~~~~~ 158 (610)
||||+||+|.++|...+ ..++++.++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++......
T Consensus 80 mE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999999997643 368999999999999999999999999999999999999855 479999999998876666
Q ss_pred ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---CcccchHHHHHH
Q 007266 159 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLV 235 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---p~~~s~~l~~LI 235 (610)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+++..|........ +..+|.++++||
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 66778999999999999999999999999999999999999999999999999988876554322 235799999999
Q ss_pred HHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 236 KSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+||..||.+|||++|+|+||||+..
T Consensus 239 ~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-54 Score=460.58 Aligned_cols=260 Identities=24% Similarity=0.454 Sum_probs=221.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc----HHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT----DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~----~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
|++|++++.||+|+||.||+|+++.+|+.||||++...... ........+|+.+++.++|||||+++++|... ..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~ 81 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DK 81 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CE
Confidence 78999999999999999999999999999999999654322 12222334457788888999999999988765 47
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+|||||+||+|.++|.+.. .+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 899999999999999998765 689999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccCCCcccCCcccc-CCCCCCCccccccchhHHhhhhcCccccccCHHHHHH--HHhhccCCCCCcccchHHHH
Q 007266 157 DDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALIN--KINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~--~I~~~~~~~~p~~~s~~l~~ 233 (610)
. .....+||+.|+|||++. +..|+.++|||||||+||+|++|..||.+.+..+... ..........+..+++++++
T Consensus 160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 3 355678999999999986 4568999999999999999999999998754332222 22223344567789999999
Q ss_pred HHHHhhcCCCCCCCC-----HHHHhcCCCCCchhhh
Q 007266 234 LVKSMLRKNPEFRPS-----AAELLCHPHLQPYVLG 264 (610)
Q Consensus 234 LI~kmL~~dP~~RpS-----a~eiL~Hp~f~~~~~~ 264 (610)
||.+||++||.+||| |+|+|+||||+...+.
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 999999999999999 8999999999986544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=445.74 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=219.2
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
||+|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+++|++++|||||+++++|.+. ..+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-cceeEE
Confidence 7999999999999999999999999999999999976655444556788999999999999999999998765 488999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc-cc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~-~~ 159 (610)
||||.| .+.+.+.......+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999965 5555665555567999999999999999999999999999999999999999999999999999876543 34
Q ss_pred cccccCCCcccCCccccCCC-CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC---------------
Q 007266 160 ASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--------------- 223 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~-yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~--------------- 223 (610)
....+||+.|+|||++.... ++.++|||||||++|+|++|..||.+.+..+.+..+......+.
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 55679999999999877766 47899999999999999999999999887777766543221110
Q ss_pred -------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 224 -------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 224 -------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
...++.++++||++||..||.+|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 11357889999999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=445.64 Aligned_cols=259 Identities=28% Similarity=0.426 Sum_probs=220.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC-CeEEEEEEEccccccHHHHHHHHHHHHHHHhc---CCCceeeeeeeEee----c
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE-RKKYVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVE----K 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~-~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIV~l~~~~~~----~ 73 (610)
++|++++.||+|+||+||+|++..+ ++.||||++............+.+|+.+|+.| +|||||+++++|.. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999754 67899999976544433333455677776665 79999999998863 3
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
+..+|++||||.|+.+..... .....++++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 457899999998876654443 3445799999999999999999999999999999999999999999999999999988
Q ss_pred cccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-----------
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------- 222 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----------- 222 (610)
..........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..+......+
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 766667778899999999999999999999999999999999999999999999888877765432211
Q ss_pred ---------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 223 ---------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 223 ---------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
.+..+++.+++||.+||+.||++|||++|+|+||||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 233468899999999999999999999999999999863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=456.28 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=215.3
Q ss_pred CCCeEEEe-EecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHh-cCCCceeeeeeeEee---cCc
Q 007266 1 MEQYEVLE-QIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISR-VRNPFIVEYKDSWVE---KGC 75 (610)
Q Consensus 1 md~Y~ilk-~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIV~l~~~~~~---~~~ 75 (610)
+++|++++ .||+|+||+||+|++..+++.||||++... ..+.+|+.++.+ ++|||||+++++|.. .+.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 47899986 599999999999999999999999998632 246789998765 489999999998864 246
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC---CCCeeeeeccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAK 152 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~---~g~vKL~DFGlak 152 (610)
.+|+|||||+||+|.++|++.+...|+|..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 7899999999999999998766667999999999999999999999999999999999999986 4569999999999
Q ss_pred ccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhh----ccCC---CCCc
Q 007266 153 MLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK----SIVA---PLPT 225 (610)
Q Consensus 153 ~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~----~~~~---~~p~ 225 (610)
...........+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+.......+.. .... +...
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHH
T ss_pred eccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccc
Confidence 87777777788999999999999999999999999999999999999999988764443333322 1111 1123
Q ss_pred ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 226 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 226 ~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
.+|+++++||.+||+.||++|||+.|+|+||||+.
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 57899999999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=447.36 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=213.5
Q ss_pred EEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHH---HHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 5 EVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDR---ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 5 ~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~---~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
+.++.||+|+||+||+|+++.+|+.||||++........ ..+.+.+|+.+|++++|||||+++++|...+ .+|+||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-NISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-CCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-ceeehh
Confidence 468999999999999999999999999999976543322 2356889999999999999999999887655 789999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-cc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LA 160 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~~ 160 (610)
|||.|+++..++.. ...+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 E~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 80 DFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp ECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 99988877666543 3369999999999999999999999999999999999999999999999999998765443 34
Q ss_pred ccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC----------------
Q 007266 161 SSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---------------- 223 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~---------------- 223 (610)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++.+|......+.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 56789999999998865 4689999999999999999999999999998888887765432211
Q ss_pred -----------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 224 -----------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 224 -----------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
...+++++++||++||+.||++|||++|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 1245789999999999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-53 Score=436.30 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=216.0
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
||+|++++.||+|+||+||+|+++ +|+.||||++......+...+.+.+|+.+|++++|||||+++++|...+ ..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEE
Confidence 799999999999999999999985 7799999999776555444567889999999999999999999887665 68899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
|||+.++.+..+.+.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 9999877666665543 379999999999999999999999999999999999999999999999999998765433 3
Q ss_pred cccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC----------------
Q 007266 160 ASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------- 222 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---------------- 222 (610)
....+|++.|+|||++.+. .++.++|||||||+||||++|.+||.+.+..+.+.++......+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 4566899999999998754 56999999999999999999999999988877777664322211
Q ss_pred ------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 223 ------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 223 ------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
....+++.+++||++||+.||++|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 12346789999999999999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=433.43 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=213.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccH----HHHHHHHHHHHHHHhcC--CCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTD----RARRSAHQEMELISRVR--NPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~----~~~~~l~~Ei~iL~~L~--HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+|++++ |||||+++++|... .
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-~ 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-D 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-S
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-C
Confidence 58999999999999999999999999999999997543221 11233568999999997 89999999987665 4
Q ss_pred EEEEEEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCC-CCeeeeecccccc
Q 007266 76 YVCIIIGYCEG-GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKM 153 (610)
Q Consensus 76 ~~~LVmEy~~G-gsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~-g~vKL~DFGlak~ 153 (610)
.+|+||||+.+ +++.+++.+.. .++++.++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 78999999976 68888888765 68999999999999999999999999999999999999855 7899999999986
Q ss_pred cccccccccccCCCcccCCccccCCCC-CCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCcccchHHH
Q 007266 154 LISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 154 ~~~~~~~~~~vGTp~Y~APEvl~~~~y-t~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
.. .......+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.+ .+... ....+..+|++++
T Consensus 161 ~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 161 LK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFRQRVSSECQ 232 (273)
T ss_dssp CC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCCCSSCCCHHHH
T ss_pred cc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-ccCCCCCCCHHHH
Confidence 54 334567899999999999987665 678999999999999999999998643 22222 2345678999999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 233 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
+||.+||+.||++|||++|+|+||||+...
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=424.54 Aligned_cols=259 Identities=27% Similarity=0.469 Sum_probs=224.3
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
|++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++|||||+++++|...+ ..++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-ceeEE
Confidence 79999999999999999999999999999999999877666666788999999999999999999999887655 78899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc-c
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-L 159 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~-~ 159 (610)
++|+.|++|..++.... .+++..++.++.|++.||+|||++||+||||||+||||+.++.+||+|||.++...... .
T Consensus 80 ~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99999999888877544 78999999999999999999999999999999999999999999999999998865433 4
Q ss_pred cccccCCCcccCCccccCCC-CCCCccccccchhHHhhhhcCcc-ccccCHHHHHHHHhhccCCC---------------
Q 007266 160 ASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVAP--------------- 222 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~-yt~ksDIWSLG~iLyeLltG~~P-F~~~~~~~l~~~I~~~~~~~--------------- 222 (610)
.....+++.|+|||++.+.. ++.++|||||||++|||++|..| |.+.+..+.+.++......+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 44567888999999987665 68999999999999999999887 56666666666654322211
Q ss_pred -------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 -------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 -------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
....+++.+++||++||+.||.+||||+|+|+||||+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 2334678999999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-52 Score=426.35 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=214.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC---cEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~---~~~ 77 (610)
|+|++++.||+|+||.||+|++..+|+.||||++..... +......+.+|+++|+.++|||||++++++...+ ..+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 689999999999999999999999999999999976543 3455677999999999999999999999987654 368
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
|+|||||+|++|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+||||+.++.++|+|||+++.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999999999998765 6899999999999999999999999999999999999999999999999998765332
Q ss_pred ----cccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC---CCcccchH
Q 007266 158 ----DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGA 230 (610)
Q Consensus 158 ----~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~---~p~~~s~~ 230 (610)
......+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..++..++......+ ....+|++
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 23456789999999999999999999999999999999999999999998888777665543322 34568999
Q ss_pred HHHHHHHhhcCCCCCCC-CHHHHhcCCCC
Q 007266 231 FRGLVKSMLRKNPEFRP-SAAELLCHPHL 258 (610)
Q Consensus 231 l~~LI~kmL~~dP~~Rp-Sa~eiL~Hp~f 258 (610)
+.+||.+||++||.+|| |+++++ |+|+
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~-~~l~ 272 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMR-ADLV 272 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHH-HHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHH-HHHH
Confidence 99999999999999999 555554 4443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=437.25 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=216.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC-----cE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 76 (610)
++|++++.||+|+||+||+|.++.+|+.||||++..........+.+.+|+++|++++|||||+++++|...+ ..
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 6899999999999999999999999999999999877677777788999999999999999999999987654 25
Q ss_pred EEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccc
Q 007266 77 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 156 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~ 156 (610)
+|+||||| |.+|..+++.. .|++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 78999999 77888887653 699999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-------------
Q 007266 157 DDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------- 222 (610)
Q Consensus 157 ~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------- 222 (610)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+......+
T Consensus 174 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 174 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred --ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 3466889999999999876 456899999999999999999999999888766655543322111
Q ss_pred -----------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 223 -----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 223 -----------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
....+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 223468899999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-52 Score=431.54 Aligned_cols=249 Identities=19% Similarity=0.340 Sum_probs=223.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||+||+|.+..+++.||||++...... .+.+.+|+.+|++++|||||+++++|.+.+ .+|+||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~iv~ 92 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIIT 92 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCC-eeEEEe
Confidence 5799999999999999999999999999999998755443 345889999999999999999999887654 678999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
|||++|+|.+++.+.....+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 99999999999988766789999999999999999999999999999999999999999999999999998765443 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhhc-CccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG-~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+...+.+.+......+.+..+++++.+||.+|
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 252 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHH
Confidence 3345689999999999999999999999999999999985 556777788888888888777788889999999999999
Q ss_pred hcCCCCCCCCHHHHhc
Q 007266 239 LRKNPEFRPSAAELLC 254 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~ 254 (610)
|+.||++|||++|+++
T Consensus 253 l~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 253 WQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCCHhHCcCHHHHHH
Confidence 9999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=438.33 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=212.6
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-----Cc
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GC 75 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~ 75 (610)
+++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||+++++|... ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3789999999999999999999999999999999987777777777899999999999999999999998643 36
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 155 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~ 155 (610)
.+|+|||||.|+ +.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++...
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eeEEEEeccchH-HHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 899999999765 4444432 68999999999999999999999999999999999999999999999999998877
Q ss_pred cccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCC-----------
Q 007266 156 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP----------- 224 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p----------- 224 (610)
........+||+.|+|||++.+..|+.++||||+||++|+|++|.+||.+.+......++......+.+
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 666677889999999999999999999999999999999999999999988877776665433222111
Q ss_pred ------------------------------cccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchhhh
Q 007266 225 ------------------------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 264 (610)
Q Consensus 225 ------------------------------~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~~~ 264 (610)
...+.++++||++||..||++||||+|+|+||||+...+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~ 320 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence 1246789999999999999999999999999999976543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=432.57 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=214.5
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-------
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK------- 73 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~------- 73 (610)
+++|++++.||+|+||+||+|++..+|+.||||++......+.....+.+|+++|++++||||+.+++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4799999999999999999999999999999999976655555556788999999999999999999987643
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccc
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
+..+|+|||||.++.+...... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 3468999999977666544333 34789999999999999999999999999999999999999999999999999976
Q ss_pred cccc-----cccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCCCc--
Q 007266 154 LISD-----DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT-- 225 (610)
Q Consensus 154 ~~~~-----~~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~p~-- 225 (610)
.... ......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.......+......+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 5422 234457899999999998754 68999999999999999999999999988877776665433222111
Q ss_pred -----------------------------ccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCc
Q 007266 226 -----------------------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 260 (610)
Q Consensus 226 -----------------------------~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~ 260 (610)
..++.+++||.+||+.||++|||++|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 13567889999999999999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=426.57 Aligned_cols=251 Identities=19% Similarity=0.385 Sum_probs=222.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|.+. ++..||||++....... +.+.+|+.+|++++|||||++++++.++ .+|+||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE--PIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeeccC--CeEEEE
Confidence 58999999999999999999975 67889999997654433 4689999999999999999999976543 468999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
|||++|+|.+++....+..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... .
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 99999999998865544469999999999999999999999999999999999999999999999999998865443 3
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....||+.|+|||++.+..|+.++|||||||+||||++ |.+||...+..+++..+......+.|..+++++.+||.+|
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 246 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHH
Confidence 445689999999999998899999999999999999998 5777888888888999888877778889999999999999
Q ss_pred hcCCCCCCCCHHHHhc--CCCC
Q 007266 239 LRKNPEFRPSAAELLC--HPHL 258 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~--Hp~f 258 (610)
|+.||++|||++++++ |+||
T Consensus 247 l~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 247 WKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHHhhhhh
Confidence 9999999999999987 5554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-52 Score=435.78 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=216.1
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeec-----CcEE
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GCYV 77 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~~ 77 (610)
+|+.+++||+|+||+||+|++..+|+.||||++...... +.+|+.+|++++|||||+++++|... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 599999999999999999999999999999999754322 34799999999999999999988643 3468
Q ss_pred EEEEeecCCCCHHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeecccccccc
Q 007266 78 CIIIGYCEGGDMAEAIK-KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLI 155 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik-~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~~~ 155 (610)
|+|||||.++.+..+.. ......+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999997654443332 12344799999999999999999999999999999999999999876 79999999999887
Q ss_pred cccccccccCCCcccCCccccC-CCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC------------
Q 007266 156 SDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------ 222 (610)
Q Consensus 156 ~~~~~~~~vGTp~Y~APEvl~~-~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~------------ 222 (610)
......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...+..+.+..+......+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 7777778899999999998765 578999999999999999999999999988877776664322111
Q ss_pred ----------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 ----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 ----------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
....+++++.+||.+||+.||++|||+.|+|+||||+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1234688999999999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-52 Score=428.73 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=211.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe---EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK---KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~---~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||+||+|+++.+++ .||||.+... ......+.+.+|+++|++++|||||++++++...+ .+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-PVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EEE
Confidence 579999999999999999999987654 5888887643 34455667999999999999999999999886554 688
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+|||||+||+|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 104 iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999888643 368999999999999999999999999999999999999999999999999998765432
Q ss_pred c------cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHH
Q 007266 159 L------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 231 (610)
Q Consensus 159 ~------~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l 231 (610)
. .....||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+....++...+......+.+..++..+
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 262 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL 262 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHH
Confidence 1 122468899999999999999999999999999999997 899999999999999998887778888899999
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+||.+||+.||++|||+.|++++
T Consensus 263 ~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 263 HQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=425.78 Aligned_cols=247 Identities=19% Similarity=0.337 Sum_probs=214.2
Q ss_pred eEecccCceEEEEEEEeC--CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEeecC
Q 007266 8 EQIGKGSFGSALLVRHKH--ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 85 (610)
Q Consensus 8 k~LG~G~fG~Vyla~d~~--~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmEy~~ 85 (610)
+.||+|+||.||+|.+.. +++.||||++.....+....+.+.+|+.+|++++|||||++++++..+ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~--~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS--SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC--CEEEEEEcCC
Confidence 469999999999998764 457899999976655556667899999999999999999999987543 4679999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc----ccc
Q 007266 86 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LAS 161 (610)
Q Consensus 86 GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~----~~~ 161 (610)
||+|.+++.+.. .+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ...
T Consensus 91 ~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 91 LGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp TEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999998754 69999999999999999999999999999999999999999999999999998764332 233
Q ss_pred cccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhhc
Q 007266 162 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 240 (610)
Q Consensus 162 ~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~ 240 (610)
...||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++...+......+.|..++.++.+||.+||+
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~ 248 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcC
Confidence 4679999999999999999999999999999999997 899999999999998888877778888999999999999999
Q ss_pred CCCCCCCCHHHHh---cCCCC
Q 007266 241 KNPEFRPSAAELL---CHPHL 258 (610)
Q Consensus 241 ~dP~~RpSa~eiL---~Hp~f 258 (610)
.||++|||+++++ +|+|+
T Consensus 249 ~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 249 YDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp SSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999984 55544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-52 Score=419.46 Aligned_cols=248 Identities=22% Similarity=0.434 Sum_probs=212.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|++. ++..||||++....... +.+.+|++++++++|||||++++++...+ .+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCC-ceEEEE
Confidence 58999999999999999999976 56789999997655443 45889999999999999999999887655 678999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
|||++|+|.+++.... ..++++.+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.......
T Consensus 80 E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999999987643 4689999999999999999999999999999999999999999999999999987654432
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....||+.|+|||++.+..|+.++|||||||+||||++ |.+||...+..+++..+........|..+++++.+||.+|
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence 334689999999999999999999999999999999998 6888888888889999888877778888999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||++|||++|+++|
T Consensus 239 l~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=428.36 Aligned_cols=257 Identities=27% Similarity=0.459 Sum_probs=213.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCc---EEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC---YVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~---~~~ 78 (610)
++|++++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+|++++|||||++++.+..... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999999999999999997544 34455678899999999999999999998865431 223
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
++++|+.||+|.++++.. .+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++......
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 445566699999999764 58999999999999999999999999999999999999999999999999998754332
Q ss_pred ----ccccccCCCcccCCcccc-CCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCC-----------
Q 007266 159 ----LASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------- 222 (610)
Q Consensus 159 ----~~~~~vGTp~Y~APEvl~-~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~----------- 222 (610)
.....+||+.|+|||++. +..|+.++||||+||++|+|++|..||.+.+..+....+......+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 345678999999999984 5567899999999999999999999999887666555543221111
Q ss_pred -------------------CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 223 -------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 223 -------------------~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
....++.++++||.+||+.||.+|||++|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 1224677899999999999999999999999999998653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=431.65 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=218.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC----cEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~~ 77 (610)
++|++++.||+|+||+||+|++..+|+.||||++.....+....+.+.+|+.+|++++|||||+++++|.... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 6899999999999999999999999999999999877777677778999999999999999999999886322 234
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
+++|+|+.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....
T Consensus 98 ~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred EEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 5667778899999998653 69999999999999999999999999999999999999999999999999997653
Q ss_pred cccccccCCCcccCCccccCCC-CCCCccccccchhHHhhhhcCccccccCHHHHHHHHhhccCCCC-------------
Q 007266 158 DLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------- 223 (610)
Q Consensus 158 ~~~~~~vGTp~Y~APEvl~~~~-yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~~~~~~~~------------- 223 (610)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+......+.
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 3345678999999999876654 68999999999999999999999999988777777654433221
Q ss_pred -----------------CcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCch
Q 007266 224 -----------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 261 (610)
Q Consensus 224 -----------------p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~ 261 (610)
...+++++++||.+||+.||.+|||++|+|+||||+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 12468899999999999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=430.22 Aligned_cols=252 Identities=21% Similarity=0.355 Sum_probs=214.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe-----EEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK-----KYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~-----~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||+||+|++...++ .||+|.+..... ......+.+|+.+|.++ +|||||+++++|...+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 589999999999999999999986543 699998864432 33445688999999998 8999999999887655
Q ss_pred EEEEEEeecCCCCHHHHHHHhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCc
Q 007266 76 YVCIIIGYCEGGDMAEAIKKANG---------------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSN 134 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~~---------------------~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeN 134 (610)
.+|+|||||+||+|.++|+.... ..+++..++.|+.||+.||+|||++|||||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 68899999999999999976431 248999999999999999999999999999999999
Q ss_pred eEecCCCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHH
Q 007266 135 IFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQA 210 (610)
Q Consensus 135 ILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~ 210 (610)
||++.++.+||+|||+|+...... .....+||+.|||||++.+..|+.++|||||||+||||++ |.+||.+.+...
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998765443 2345678999999999999999999999999999999997 899998876544
Q ss_pred H-HHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 211 L-INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 211 l-~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
. ...+......+.|..+++++++||.+||+.||++|||++||++|
T Consensus 275 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4 44445555666788899999999999999999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=423.78 Aligned_cols=248 Identities=25% Similarity=0.450 Sum_probs=208.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.+ ..+|+||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~ 82 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVT 82 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEE
Confidence 57999999999999999999753 359999998776666677889999999999999999999987543 3578999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc---
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--- 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--- 158 (610)
|||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......
T Consensus 83 Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp ECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred ecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999997643 369999999999999999999999999999999999999999999999999998764322
Q ss_pred ccccccCCCcccCCccccC---CCCCCCccccccchhHHhhhhcCccccccCHH-HHHHHHhhccCCC----CCcccchH
Q 007266 159 LASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAP----LPTVYSGA 230 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~---~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~-~l~~~I~~~~~~~----~p~~~s~~ 230 (610)
.....+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+.+.. .+...+......+ .+..++++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 3456789999999999864 35889999999999999999999999886644 3444444443332 35568899
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 231 FRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 231 l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
+.+||.+||+.||++|||++|+++|
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=423.24 Aligned_cols=253 Identities=19% Similarity=0.329 Sum_probs=220.8
Q ss_pred CCeEEEeE-ecccCceEEEEEEEeC--CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQ-IGKGSFGSALLVRHKH--ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~-LG~G~fG~Vyla~d~~--~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|.+.+. ||+|+||.||+|.++. ++..||||.+.... .....+.+.+|+++|++++|||||++++++..+ .+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--eEE
Confidence 46888885 9999999999998764 45689999997543 344567799999999999999999999987543 478
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+|||||+||+|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 85 lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999999886532 369999999999999999999999999999999999999999999999999998765432
Q ss_pred ----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 159 ----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 159 ----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
.....+||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++...+..+...+.|..+++++.+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 2345679999999999999999999999999999999997 99999998888888888888777888899999999
Q ss_pred HHHHhhcCCCCCCCCHHHHh---cCCCC
Q 007266 234 LVKSMLRKNPEFRPSAAELL---CHPHL 258 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL---~Hp~f 258 (610)
||.+||+.||++|||+.+|+ +|+|+
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999884 45544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=413.65 Aligned_cols=248 Identities=20% Similarity=0.371 Sum_probs=224.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+++++ +++.||||++....... +.+.+|+.++++++|||||++++++.++ ..+++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEE
Confidence 68999999999999999999984 78899999998765543 4588999999999999999999988765 4689999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccccc--
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~-- 159 (610)
||+++|+|.+++..... .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999999999876433 689999999999999999999999999999999999999999999999999987654432
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..++..++......+.|..++.++.+||.+|
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence 334679999999999999999999999999999999997 8999999999999999988888888899999999999999
Q ss_pred hcCCCCCCCCHHHHhcC
Q 007266 239 LRKNPEFRPSAAELLCH 255 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~H 255 (610)
|+.||++|||++++|+|
T Consensus 238 l~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSN 254 (258)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.8e-51 Score=424.72 Aligned_cols=251 Identities=23% Similarity=0.406 Sum_probs=211.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeec-CcEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEK-GCYVCI 79 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~-~~~~~L 79 (610)
|+|++++.||+|+||+||+|+++.+|+.||||++.... .+.+.+|+.+|+++. ||||++++++|... ...+|+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 68999999999999999999999999999999987432 245788999999995 99999999988743 457899
Q ss_pred EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC-Ceeeeeccccccccccc
Q 007266 80 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDD 158 (610)
Q Consensus 80 VmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g-~vKL~DFGlak~~~~~~ 158 (610)
|||||.+++|..+. ..|++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+......
T Consensus 110 v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 99999999997653 2589999999999999999999999999999999999998765 59999999999877766
Q ss_pred ccccccCCCcccCCccccCC-CCCCCccccccchhHHhhhhcCccccccC-HHHHHHHHhhc------------------
Q 007266 159 LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKS------------------ 218 (610)
Q Consensus 159 ~~~~~vGTp~Y~APEvl~~~-~yt~ksDIWSLG~iLyeLltG~~PF~~~~-~~~l~~~I~~~------------------ 218 (610)
.....+||+.|+|||++.+. .|+.++|||||||++|+|++|..||.... ..+....+...
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 77788999999999998765 47999999999999999999999996543 22222222110
Q ss_pred ------------------cCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCchh
Q 007266 219 ------------------IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 262 (610)
Q Consensus 219 ------------------~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~Hp~f~~~~ 262 (610)
........+++++++||++||..||.+|||++|+|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 01112234688999999999999999999999999999998743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=416.42 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=211.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeCC---CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHE---RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~---~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~ 78 (610)
++|++.+.||+|+||.||+|++..+ +..||||.+... ..+...+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEE
Confidence 6899999999999999999998754 356888888643 344556779999999999999999999998753 3678
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~ 158 (610)
+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999999887643 368999999999999999999999999999999999999999999999999998764332
Q ss_pred --ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHH
Q 007266 159 --LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLV 235 (610)
Q Consensus 159 --~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI 235 (610)
......||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.+..+++..+......+.+..+++.+.+||
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 242 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 3345678999999999999999999999999999999987 8999999998889988888877788899999999999
Q ss_pred HHhhcCCCCCCCCHHHHhcC
Q 007266 236 KSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 236 ~kmL~~dP~~RpSa~eiL~H 255 (610)
.+||+.||++|||+.||++|
T Consensus 243 ~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 243 TKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=420.95 Aligned_cols=250 Identities=21% Similarity=0.380 Sum_probs=215.5
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCe----EEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERK----KYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~----~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+|++++|||||++++++.+. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Ce
Confidence 579999999999999999999988776 58888876432 233456789999999999999999999998764 45
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
+++|||+.+++|.+.+.... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 78899999999999888753 46999999999999999999999999999999999999999999999999999876543
Q ss_pred c---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHH
Q 007266 158 D---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 233 (610)
Q Consensus 158 ~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~ 233 (610)
. ......||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.+..++...+......+.|..++..+.+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 3 2334578999999999999999999999999999999998 89999998888888888887777788899999999
Q ss_pred HHHHhhcCCCCCCCCHHHHhcC
Q 007266 234 LVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 234 LI~kmL~~dP~~RpSa~eiL~H 255 (610)
||.+||+.||.+|||+.|++.|
T Consensus 245 li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999988
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=408.69 Aligned_cols=250 Identities=20% Similarity=0.339 Sum_probs=213.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCC----eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHER----KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~----~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++.+.||+|+||.||+|.+..++ ..||||++.... .+.....+.+|+.+|++++|||||++++++...+ .+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~-~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-PM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC-ce
Confidence 57999999999999999999987654 479999996543 3444567889999999999999999999887654 67
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++|||||.++++.+.+.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 89999999999999887643 36999999999999999999999999999999999999999999999999999876433
Q ss_pred c----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHH
Q 007266 158 D----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 232 (610)
Q Consensus 158 ~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~ 232 (610)
. ......||+.|+|||++.+..|+.++|||||||+||||++ |.+||...+..+++..+......+.+..++..+.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHH
Confidence 2 2234578999999999999999999999999999999998 5666777788888888888888888888999999
Q ss_pred HHHHHhhcCCCCCCCCHHHHhc
Q 007266 233 GLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 233 ~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+||.+||+.||++|||+.||++
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=416.17 Aligned_cols=253 Identities=19% Similarity=0.369 Sum_probs=217.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++.+.||+|+||.||+|++..+ ..||||++....... +.+.+|+.+|++++|||||++++++.++ .+|+||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~~--~~~lv~ 90 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVT 90 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEecC--CeEEEE
Confidence 7899999999999999999998655 579999997655443 4588999999999999999999987543 468999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc--c
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--L 159 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~--~ 159 (610)
|||.+|+|..++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999999998876544469999999999999999999999999999999999999999999999999998764433 2
Q ss_pred cccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHh
Q 007266 160 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 238 (610)
Q Consensus 160 ~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~km 238 (610)
.....||+.|+|||++.+..++.++|||||||+||||++ |.+||.+....+++..+......+.+..+++++++||.+|
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 250 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHH
Confidence 344679999999999999999999999999999999998 5677788888888888888877788899999999999999
Q ss_pred hcCCCCCCCCHHHHhc--CCCCCc
Q 007266 239 LRKNPEFRPSAAELLC--HPHLQP 260 (610)
Q Consensus 239 L~~dP~~RpSa~eiL~--Hp~f~~ 260 (610)
|+.||++||++++++. |+||..
T Consensus 251 l~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 251 WRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999987 677753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=414.29 Aligned_cols=253 Identities=18% Similarity=0.384 Sum_probs=208.9
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++++.||+|+||.||+|.+.. +++.||||++...... ...+.+.+|..++.++ +|+|||.+++.+...+.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 679999999999999999999865 3468999998754433 3445677788887776 68899999998888777
Q ss_pred EEEEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCC
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 141 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g 141 (610)
.+++|||||+||+|.+++.... ...+++..+..|+.||+.||.|||++|||||||||+||||+.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 8899999999999999997642 23589999999999999999999999999999999999999999
Q ss_pred Ceeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhc-CccccccCH-HHHHHHHh
Q 007266 142 DIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDM-QALINKIN 216 (610)
Q Consensus 142 ~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG-~~PF~~~~~-~~l~~~I~ 216 (610)
.+||+|||+|+...... .....+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+... ..+...+.
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999998754332 34457899999999999999999999999999999999986 568877653 44455566
Q ss_pred hccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 217 KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 217 ~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.....+.+..+++++.+||.+||+.||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666677788899999999999999999999999999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=423.30 Aligned_cols=259 Identities=27% Similarity=0.487 Sum_probs=217.9
Q ss_pred CCCeEEEeEecccCceEEEEEEEeC---CCeEEEEEEEccccc--cHHHHHHHHHHHHHHHhcCC-CceeeeeeeEeecC
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKH---ERKKYVLKKIRLARQ--TDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKG 74 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~---~~~~vAIK~i~~~~~--~~~~~~~l~~Ei~iL~~L~H-pnIV~l~~~~~~~~ 74 (610)
|++|++++.||+|+||+||+|++.. +|+.||||++..... .....+.+.+|+++|++++| |||+++++.+...
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 5789999999999999999999854 689999999875432 22233457889999999976 7999999877655
Q ss_pred cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccc
Q 007266 75 CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 154 (610)
Q Consensus 75 ~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~ 154 (610)
..++++|||+.||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 48899999999999999998876 6789999999999999999999999999999999999999999999999999875
Q ss_pred ccc--cccccccCCCcccCCccccCC--CCCCCccccccchhHHhhhhcCccccccCHHHHHHHH---hhccCCCCCccc
Q 007266 155 ISD--DLASSVVGTPSYMCPELLADI--PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI---NKSIVAPLPTVY 227 (610)
Q Consensus 155 ~~~--~~~~~~vGTp~Y~APEvl~~~--~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I---~~~~~~~~p~~~ 227 (610)
... .......|++.|++||.+.+. .++.++|||||||+||+|++|..||.+.........+ ......+.+..+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 433 344567899999999998754 4678999999999999999999999876533332222 223345567789
Q ss_pred chHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCchh
Q 007266 228 SGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPYV 262 (610)
Q Consensus 228 s~~l~~LI~kmL~~dP~~Rp-----Sa~eiL~Hp~f~~~~ 262 (610)
++++++||++||++||.+|| +++|+|+||||+++.
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 99999999999999999998 589999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=411.55 Aligned_cols=247 Identities=22% Similarity=0.407 Sum_probs=214.7
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LV 80 (610)
+++|++++.||+|+||.||+|++ .|..||||++.... ..+.+.+|+++|++++|||||++++++.+....+|+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 57899999999999999999997 47789999996443 2346889999999999999999999987766678999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 160 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~~~ 160 (610)
|||+++|+|.+++.+.....+++..+..|+.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++..... .
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~ 157 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--Q 157 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--C
Confidence 99999999999997654446899999999999999999999999999999999999999999999999999875432 4
Q ss_pred ccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhccCCCCCcccchHHHHHHHHhh
Q 007266 161 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSML 239 (610)
Q Consensus 161 ~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~kmL 239 (610)
....+|+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..++...+......+.+..+++++++||.+||
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl 237 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 45678999999999999999999999999999999997 89999999988999999888888889999999999999999
Q ss_pred cCCCCCCCCHHHHhcC
Q 007266 240 RKNPEFRPSAAELLCH 255 (610)
Q Consensus 240 ~~dP~~RpSa~eiL~H 255 (610)
..||.+|||+.+++++
T Consensus 238 ~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 238 HLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred ccCHhHCcCHHHHHHH
Confidence 9999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-50 Score=413.11 Aligned_cols=253 Identities=21% Similarity=0.396 Sum_probs=220.1
Q ss_pred CCCeEEEeEecccCceEEEEEEEeCCCeE--EEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCcEE
Q 007266 1 MEQYEVLEQIGKGSFGSALLVRHKHERKK--YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 1 md~Y~ilk~LG~G~fG~Vyla~d~~~~~~--vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~~ 77 (610)
+++|++.+.||+|+||.||+|.++.++.. ||||.+..... ....+.+.+|+++|.++ +|||||++++++...+ .+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-EE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-ee
Confidence 46899999999999999999999988875 66777653322 23456689999999999 7999999999987654 78
Q ss_pred EEEEeecCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCe
Q 007266 78 CIIIGYCEGGDMAEAIKKA--------------NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 143 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~--------------~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~v 143 (610)
|+|||||+||+|.++|... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 9999999999999999753 23578999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhc-CccccccCHHHHHHHHhhccCCC
Q 007266 144 RLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAP 222 (610)
Q Consensus 144 KL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG-~~PF~~~~~~~l~~~I~~~~~~~ 222 (610)
||+|||+++............||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+++..+......+
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~ 246 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99999999876655555667899999999999999999999999999999999986 56899999999999998877777
Q ss_pred CCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 223 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 223 ~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
.+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 888899999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-49 Score=407.04 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=221.2
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++++.||+|+||+||+|+++. +++.||||++... ......+.+.+|+.+|++++||||+++++++...+ .
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~ 90 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-P 90 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-S
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC-c
Confidence 579999999999999999999863 5678999998754 34455677999999999999999999999887654 6
Q ss_pred EEEEEeecCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCc
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN----------------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSN 134 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~----------------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeN 134 (610)
.+++|||+.+|+|.+++.... ...+++..+..|+.||+.||+|||++|||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 789999999999999997532 2348899999999999999999999999999999999
Q ss_pred eEecCCCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcC-ccccccCHHH
Q 007266 135 IFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQK-AAFKAFDMQA 210 (610)
Q Consensus 135 ILL~~~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~-~PF~~~~~~~ 210 (610)
|||+.++.+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||+||||++|. +||.+.+..+
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 999999999999999998764432 334578999999999999999999999999999999999884 7899999999
Q ss_pred HHHHHhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 211 LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 211 l~~~I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+...+......+.|..++.++.+||.+||+.||.+|||+.||++
T Consensus 251 ~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999888888888899999999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=406.05 Aligned_cols=251 Identities=20% Similarity=0.386 Sum_probs=218.3
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCC-------eEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeec
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHER-------KKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK 73 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~-------~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~ 73 (610)
++|++++.||+|+||.||+|++..++ ..||||++.... .......+.+|...+.++ +|||||+++++|.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 68999999999999999999987654 479999997544 334456788899998888 799999999998765
Q ss_pred CcEEEEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 74 GCYVCIIIGYCEGGDMAEAIKKAN--------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 74 ~~~~~LVmEy~~GgsL~~~Ik~~~--------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
..+++|||||++|+|.++|.... ...+++..+..|+.||+.||+|||++|||||||||+|||++.
T Consensus 92 -~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 92 -GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp -SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred -CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 47889999999999999997543 235899999999999999999999999999999999999999
Q ss_pred CCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHH
Q 007266 140 DQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKI 215 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I 215 (610)
++.+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+...++..+
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i 250 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 9999999999998765443 2345789999999999999999999999999999999997 79999999999999998
Q ss_pred hhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 216 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 216 ~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
......+.|..+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 251 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 888778888899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=401.52 Aligned_cols=250 Identities=20% Similarity=0.363 Sum_probs=206.8
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-CC--eEEEEEEEccccc-cHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-ER--KKYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV 77 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-~~--~~vAIK~i~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~ 77 (610)
++|++++.||+|+||.||+|++.. ++ ..||||++..... .....+.+.+|+.+|++++|||||++++++.+. .+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--ch
Confidence 579999999999999999998764 33 3689998875443 334456789999999999999999999988643 56
Q ss_pred EEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeecccccccccc
Q 007266 78 CIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 157 (610)
Q Consensus 78 ~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~ 157 (610)
++|||||++|+|.+.+....+ .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred heeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 799999999999998876543 5999999999999999999999999999999999999999999999999999876433
Q ss_pred c----ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHHHHHhhcc-CCCCCcccchHH
Q 007266 158 D----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSI-VAPLPTVYSGAF 231 (610)
Q Consensus 158 ~----~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~~~I~~~~-~~~~p~~~s~~l 231 (610)
. ......|+..|+|||++.+..|+.++|||||||++|||++ |..||.+.+..+....+.... ..+.+..++..+
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 2 2334578889999999999999999999999999999997 899999999999888886553 445677899999
Q ss_pred HHHHHHhhcCCCCCCCCHHHHhc
Q 007266 232 RGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 232 ~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
++||.+||..||++|||++||++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=398.45 Aligned_cols=252 Identities=20% Similarity=0.349 Sum_probs=222.6
Q ss_pred CCeEEEeEecccCceEEEEEEEeC-----CCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKH-----ERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY 76 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~-----~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 76 (610)
++|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.++++++|||||++++.+...+ .
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~ 97 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-P 97 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-S
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC-c
Confidence 689999999999999999998863 35789999997543 4455567899999999999999999999886554 6
Q ss_pred EEEEEeecCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeec
Q 007266 77 VCIIIGYCEGGDMAEAIKKAN--------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 148 (610)
Q Consensus 77 ~~LVmEy~~GgsL~~~Ik~~~--------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DF 148 (610)
.++|||||.+|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence 789999999999999886431 134789999999999999999999999999999999999999999999999
Q ss_pred cccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhc-CccccccCHHHHHHHHhhccCCCCC
Q 007266 149 GLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLP 224 (610)
Q Consensus 149 Glak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG-~~PF~~~~~~~l~~~I~~~~~~~~p 224 (610)
|+++...... .....+||+.|+|||.+.+..|+.++|||||||+||||++| .+||.+.+..+.+..+......+.+
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p 257 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 9998764433 23455799999999999999999999999999999999988 5899999999999998887777788
Q ss_pred cccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 225 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 225 ~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
..++..+.+||.+||+.||++|||+.+++++
T Consensus 258 ~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8999999999999999999999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=394.43 Aligned_cols=251 Identities=20% Similarity=0.362 Sum_probs=216.2
Q ss_pred CCeEEEeEecccCceEEEEEEEe-----CCCeEEEEEEEccccccHHHHHHHHHHHHHHHhc-CCCceeeeeeeEeecCc
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHK-----HERKKYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGC 75 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~-----~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 75 (610)
++|++.+.||+|+||.||+|++. .+++.||||++..... ......+.+|+.+++++ +|||||++++++...+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 68999999999999999999874 3567999999976543 34456788999999999 6999999999887654
Q ss_pred EEEEEEeecCCCCHHHHHHHhC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC
Q 007266 76 YVCIIIGYCEGGDMAEAIKKAN----------------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 139 (610)
Q Consensus 76 ~~~LVmEy~~GgsL~~~Ik~~~----------------~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~ 139 (610)
.+|+|||||+||+|.+++.+.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 6889999999999999997642 235899999999999999999999999999999999999999
Q ss_pred CCCeeeeeccccccccccc---ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhh-cCccccccCHHHHH-HH
Q 007266 140 DQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALI-NK 214 (610)
Q Consensus 140 ~g~vKL~DFGlak~~~~~~---~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLlt-G~~PF~~~~~~~l~-~~ 214 (610)
++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||+||||++ |.+||.+.+....+ ..
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999998764332 2345789999999999999999999999999999999998 77778776654444 44
Q ss_pred HhhccCCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 215 INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 215 I~~~~~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
+........+..++..+.+||.+||+.||++|||++||++
T Consensus 261 i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4555666677789999999999999999999999999996
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=393.61 Aligned_cols=248 Identities=18% Similarity=0.282 Sum_probs=210.3
Q ss_pred EEeEecccCceEEEEEEEeCCC---eEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEEe
Q 007266 6 VLEQIGKGSFGSALLVRHKHER---KKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG 82 (610)
Q Consensus 6 ilk~LG~G~fG~Vyla~d~~~~---~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVmE 82 (610)
.-++||+|+||+||+|++..++ ..||||.+... ......+.+.+|+++|++++|||||++++++...+...++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3578999999999999987643 36899998643 3455567899999999999999999999998877778999999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeeeccccccccccc----
Q 007266 83 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---- 158 (610)
Q Consensus 83 y~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~DFGlak~~~~~~---- 158 (610)
||++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999987643 357889999999999999999999999999999999999999999999999998764432
Q ss_pred -ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCcccc-ccCHHHHHHHHhhccCCCCCcccchHHHHHHH
Q 007266 159 -LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK-AFDMQALINKINKSIVAPLPTVYSGAFRGLVK 236 (610)
Q Consensus 159 -~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~-~~~~~~l~~~I~~~~~~~~p~~~s~~l~~LI~ 236 (610)
......||+.|+|||.+....++.++|||||||+||||++|..||. ..+..++...+..+.....|..+++.+.+||.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~ 268 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence 2234578999999999999999999999999999999999666654 44555666777777667778889999999999
Q ss_pred HhhcCCCCCCCCHHHHhcC
Q 007266 237 SMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 237 kmL~~dP~~RpSa~eiL~H 255 (610)
+||+.||++||++.|+++|
T Consensus 269 ~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 269 KCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-47 Score=388.80 Aligned_cols=246 Identities=18% Similarity=0.254 Sum_probs=201.7
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecCcEEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIII 81 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~~~~~LVm 81 (610)
++|++++.||+|+||.||+|++..+|+.||||++....... .+.+|+++++.+.|+|+|..+..+...+...++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC----CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH----HHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999987654332 37789999999999888877777777777899999
Q ss_pred eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC---CCCeeeeeccccccccccc
Q 007266 82 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDD 158 (610)
Q Consensus 82 Ey~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~---~g~vKL~DFGlak~~~~~~ 158 (610)
||+ +++|.+.+.... ..+++..+..++.||+.||+|||++|||||||||+|||++. +..++|+|||+|+......
T Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999 567777666533 46999999999999999999999999999999999999864 4469999999998764332
Q ss_pred --------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHHHHHHHHh---hc----cCCCC
Q 007266 159 --------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN---KS----IVAPL 223 (610)
Q Consensus 159 --------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~~l~~~I~---~~----~~~~~ 223 (610)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+. .. .....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 2345689999999999999999999999999999999999999998765443332221 11 11112
Q ss_pred CcccchHHHHHHHHhhcCCCCCCCCHHHHh
Q 007266 224 PTVYSGAFRGLVKSMLRKNPEFRPSAAELL 253 (610)
Q Consensus 224 p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL 253 (610)
...+++++.+||.+||+.||++||+++++.
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 346889999999999999999999998653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-45 Score=376.43 Aligned_cols=246 Identities=17% Similarity=0.198 Sum_probs=203.4
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC-CceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIV~l~~~~~~~~~~~~LV 80 (610)
++|++++.||+|+||+||+|++..+|+.||||++....... .+.+|+++++.+.| +|++.+++.+.. +...|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC----CHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH----HHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEE
Confidence 58999999999999999999999999999999886544332 36788999999976 788888876654 5578999
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecC-----CCCeeeeecccccccc
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-----DQDIRLGDFGLAKMLI 155 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~-----~g~vKL~DFGlak~~~ 155 (610)
|||+ |++|.+++...+ ..+++..+..++.|++.||+|||++||+||||||+||||+. ++.+||+|||+|+...
T Consensus 80 me~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999 789999987643 46999999999999999999999999999999999999974 5679999999998764
Q ss_pred ccc--------ccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccC---HHHHHHHHhhcc----C
Q 007266 156 SDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSI----V 220 (610)
Q Consensus 156 ~~~--------~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~---~~~l~~~I~~~~----~ 220 (610)
... .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.. ......++.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 321 2345789999999999999999999999999999999999999997543 323333332211 1
Q ss_pred CCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhc
Q 007266 221 APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 254 (610)
Q Consensus 221 ~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~ 254 (610)
..++..+++++.+++..|+..+|++||+++.+.+
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1123457889999999999999999999988754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=376.79 Aligned_cols=246 Identities=20% Similarity=0.270 Sum_probs=195.1
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCceeeeeeeEeecC---cEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYVC 78 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV~l~~~~~~~~---~~~~ 78 (610)
++|.+.+.||+|+||.||+|++ +|+.||||++..... .......|+..+.+++|||||++++++...+ ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 4799999999999999999986 688999999864322 1222334555666789999999999988654 3689
Q ss_pred EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCeecccCCCCceEecCCCCeeeeeccc
Q 007266 79 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA--------NHILHRDVKCSNIFLTRDQDIRLGDFGL 150 (610)
Q Consensus 79 LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs--------~gIiHRDLKPeNILL~~~g~vKL~DFGl 150 (610)
+|||||++|+|.+++++. .++++.+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999999874 58999999999999999999996 5999999999999999999999999999
Q ss_pred cccccccc-----ccccccCCCcccCCccccCCC------CCCCccccccchhHHhhhhcCcccccc-------------
Q 007266 151 AKMLISDD-----LASSVVGTPSYMCPELLADIP------YGSKSDIWSLGCCVYEMSAQKAAFKAF------------- 206 (610)
Q Consensus 151 ak~~~~~~-----~~~~~vGTp~Y~APEvl~~~~------yt~ksDIWSLG~iLyeLltG~~PF~~~------------- 206 (610)
++...... .....+||+.|+|||++.+.. ++.++|||||||+||||++|.+||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98764332 234578999999999987643 567899999999999999998877431
Q ss_pred --CHHHHHHHHhhccC-CCCCcc-----cchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 207 --DMQALINKINKSIV-APLPTV-----YSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 207 --~~~~l~~~I~~~~~-~~~p~~-----~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
........+..... ..++.. ....+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22333333322222 223332 23468899999999999999999999875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-44 Score=374.85 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=201.2
Q ss_pred CeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-----------CCceeeeeeeEe
Q 007266 3 QYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-----------NPFIVEYKDSWV 71 (610)
Q Consensus 3 ~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpnIV~l~~~~~ 71 (610)
+|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|+.++ |+|||++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 6999999999999999999999999999999997543 33456788999988875 578999998876
Q ss_pred ec-CcEEEEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCCCceEecCCCC------
Q 007266 72 EK-GCYVCIIIGYCEGG-DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQD------ 142 (610)
Q Consensus 72 ~~-~~~~~LVmEy~~Gg-sL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-~gIiHRDLKPeNILL~~~g~------ 142 (610)
.. ....+++|+++..+ .............+++..++.++.||+.||.|||+ .||+||||||+||||+.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 43 34666677666544 34444444455678999999999999999999998 89999999999999987664
Q ss_pred eeeeecccccccccccccccccCCCcccCCccccCCCCCCCccccccchhHHhhhhcCccccccCHH------HHHHHHh
Q 007266 143 IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ------ALINKIN 216 (610)
Q Consensus 143 vKL~DFGlak~~~~~~~~~~~vGTp~Y~APEvl~~~~yt~ksDIWSLG~iLyeLltG~~PF~~~~~~------~l~~~I~ 216 (610)
++|+|||.+.... ......+||+.|+|||++.+..|+.++||||+||++++|++|..||...+.. +.+..+.
T Consensus 171 ~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 171 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 9999999997653 3356778999999999999999999999999999999999999999754321 1111110
Q ss_pred hcc-----------------------------------------CCCCCcccchHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 007266 217 KSI-----------------------------------------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 255 (610)
Q Consensus 217 ~~~-----------------------------------------~~~~p~~~s~~l~~LI~kmL~~dP~~RpSa~eiL~H 255 (610)
... ....+...+.++++||.+||..||.+|||++|+|+|
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 011223457789999999999999999999999999
Q ss_pred CCCCchh
Q 007266 256 PHLQPYV 262 (610)
Q Consensus 256 p~f~~~~ 262 (610)
|||++..
T Consensus 329 p~f~~~~ 335 (362)
T d1q8ya_ 329 PWLKDTL 335 (362)
T ss_dssp GGGTTCT
T ss_pred cccCCCC
Confidence 9998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=4.5e-25 Score=211.06 Aligned_cols=165 Identities=15% Similarity=0.154 Sum_probs=121.9
Q ss_pred eEEEeEecccCceEEEEEEEeCCCeEEEEEEEcccccc----------------HHHHHHHHHHHHHHHhcCCCceeeee
Q 007266 4 YEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQT----------------DRARRSAHQEMELISRVRNPFIVEYK 67 (610)
Q Consensus 4 Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~----------------~~~~~~l~~Ei~iL~~L~HpnIV~l~ 67 (610)
|.+.+.||+|+||.||+|.+. +|+.||||+++..... ........+|+..+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999985 6889999987643211 11234456789999999999998877
Q ss_pred eeEeecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCCCceEecCCCCeeeee
Q 007266 68 DSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 147 (610)
Q Consensus 68 ~~~~~~~~~~~LVmEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs~gIiHRDLKPeNILL~~~g~vKL~D 147 (610)
+. ... +++|||+++..+. .+++..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|
T Consensus 81 ~~--~~~---~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 81 AW--EGN---AVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EE--ETT---EEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred Ee--cCC---EEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEE
Confidence 54 222 6899999876542 35667778999999999999999999999999999999865 499999
Q ss_pred cccccccccccccccccCCCcccCC--c---cccCCCCCCCccccccch
Q 007266 148 FGLAKMLISDDLASSVVGTPSYMCP--E---LLADIPYGSKSDIWSLGC 191 (610)
Q Consensus 148 FGlak~~~~~~~~~~~vGTp~Y~AP--E---vl~~~~yt~ksDIWSLG~ 191 (610)
||+|........ . .|... + .+....|+.++|+||+.-
T Consensus 146 FG~a~~~~~~~~-~------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 146 FPQSVEVGEEGW-R------EILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CTTCEETTSTTH-H------HHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred CCCcccCCCCCc-H------HHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 999876532211 0 11110 0 012356889999999644
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=4.8e-07 Score=87.44 Aligned_cols=140 Identities=14% Similarity=0.142 Sum_probs=89.0
Q ss_pred CCeEEEeEecccCceEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcC-CCceeeeeeeEeecCcEEEEE
Q 007266 2 EQYEVLEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCII 80 (610)
Q Consensus 2 d~Y~ilk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~~~LV 80 (610)
+.|++++..+-++.+.||++. .+++.+++|......... ...+.+|..++..+. +-.+.+++... ..++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~-~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFE-RHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEE-EETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEE-ecCCceEEE
Confidence 567877766555567899885 355667788775432221 223567888887764 22234444433 345578899
Q ss_pred EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 007266 81 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-------------------------------------- 122 (610)
Q Consensus 81 mEy~~GgsL~~~Ik~~~~~~lse~~i~~i~~QLl~aL~yLHs-------------------------------------- 122 (610)
|++++|.++.+.... ......++.++...|..||+
T Consensus 89 ~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 999999888654321 11122234444444444553
Q ss_pred ---------------C------CeecccCCCCceEecCCCCeeeeecccccc
Q 007266 123 ---------------N------HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 123 ---------------~------gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
. .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 289999999999998766567999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=1e-05 Score=83.87 Aligned_cols=79 Identities=10% Similarity=0.107 Sum_probs=47.3
Q ss_pred EeEecccCceEEEEEEEeCCCeEEEEEEEccccc-c----HHHHHHHHHHHHHHHhcC--CCc-eeeeeeeEeecCcEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHERKKYVLKKIRLARQ-T----DRARRSAHQEMELISRVR--NPF-IVEYKDSWVEKGCYVC 78 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~~~~vAIK~i~~~~~-~----~~~~~~l~~Ei~iL~~L~--Hpn-IV~l~~~~~~~~~~~~ 78 (610)
.+.||.|....||++.+..+++.+++|.-..... . ....++...|.+.|+.+. .|. +.+++. + +.+ ..+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~-~-d~~-~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-S-DTE-MAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E-ETT-TTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE-E-cCC-CCE
Confidence 5689999999999999888888899997643111 0 111233556888887663 233 334443 2 333 346
Q ss_pred EEEeecCCCC
Q 007266 79 IIIGYCEGGD 88 (610)
Q Consensus 79 LVmEy~~Ggs 88 (610)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=1.5e-05 Score=76.07 Aligned_cols=75 Identities=13% Similarity=0.091 Sum_probs=47.0
Q ss_pred eEecccCc-eEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCc--eeeeeeeEeecCcEEEEEEeec
Q 007266 8 EQIGKGSF-GSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPF--IVEYKDSWVEKGCYVCIIIGYC 84 (610)
Q Consensus 8 k~LG~G~f-G~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--IV~l~~~~~~~~~~~~LVmEy~ 84 (610)
+.+..|.. +.||++.. .++..+++|........ .+..|+..|+.+.... +.+++... ..+...++||+++
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~-~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVV-TEAGRDWLLLGEV 88 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEE-ECSSCEEEEEECC
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeec-ccccceEEEEEee
Confidence 34555554 67898875 45666888876544322 3567788777664322 34445443 3445778999999
Q ss_pred CCCCH
Q 007266 85 EGGDM 89 (610)
Q Consensus 85 ~GgsL 89 (610)
+|.++
T Consensus 89 ~G~~~ 93 (255)
T d1nd4a_ 89 PGQDL 93 (255)
T ss_dssp SSEET
T ss_pred ecccc
Confidence 98665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.16 E-value=0.00079 Score=67.16 Aligned_cols=69 Identities=16% Similarity=0.290 Sum_probs=42.8
Q ss_pred eEEEEEEEeCCCeEEEEEEEccccccHHHHHHHHHHHHHHHhcCC---C--ceeeee-eeEeecCcEEEEEEeecCCCC
Q 007266 16 GSALLVRHKHERKKYVLKKIRLARQTDRARRSAHQEMELISRVRN---P--FIVEYK-DSWVEKGCYVCIIIGYCEGGD 88 (610)
Q Consensus 16 G~Vyla~d~~~~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~H---p--nIV~l~-~~~~~~~~~~~LVmEy~~Ggs 88 (610)
-.||++.. .+|..|++|+.+....+.. .+..|+..+..|.. | ..+..- +.....+...+.+++++.|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~---~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTAD---QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHH---HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHH---HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47999976 4678899999887655543 35567777766531 2 111111 122234557889999998743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.84 E-value=0.0013 Score=67.26 Aligned_cols=74 Identities=14% Similarity=0.162 Sum_probs=47.8
Q ss_pred EeEecccCceEEEEEEEeCC-------CeEEEEEEEccccccHHHHHHHHHHHHHHHhcCCCcee-eeeeeEeecCcEEE
Q 007266 7 LEQIGKGSFGSALLVRHKHE-------RKKYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIV-EYKDSWVEKGCYVC 78 (610)
Q Consensus 7 lk~LG~G~fG~Vyla~d~~~-------~~~vAIK~i~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV-~l~~~~~~~~~~~~ 78 (610)
++.|+.|-.=.+|++..... .+.|++++.- ...... ...+|..+++.+.-.++. ++++.+ . + .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~i---dr~~E~~i~~~ls~~gl~Pkll~~~-~-~---g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETES---HLVAESVIFTLLSERHLGPKLYGIF-S-G---G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHH---HHHHHHHHHHHHHHTTSSSCEEEEE-T-T---E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccchhh---HHHHHHHHHHHHHhCCCCCeEEEEc-C-C---c
Confidence 57888899999999987642 3567777664 222222 245788888887544444 444433 2 3 4
Q ss_pred EEEeecCCCCH
Q 007266 79 IIIGYCEGGDM 89 (610)
Q Consensus 79 LVmEy~~GgsL 89 (610)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.51 E-value=0.0073 Score=59.03 Aligned_cols=30 Identities=30% Similarity=0.346 Sum_probs=26.8
Q ss_pred CeecccCCCCceEecCCCCeeeeecccccc
Q 007266 124 HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 153 (610)
Q Consensus 124 gIiHRDLKPeNILL~~~g~vKL~DFGlak~ 153 (610)
|+||+|+.+.||+++.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 799999999999999887678999998753
|